16139	O
||||	O
98	O
||||	O
15836	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
03	O
-	O
24	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
17	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
24	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1974	O
-	O
10	O
-	O
03	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
neurosurgery	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
40	O
-	O
year	O
-	O
old	O
female	O
with	O
complaints	O
of	O
headache	B
and	O
dizziness	B
.	O

in	O
[	O
*	O
*	O
2015	O
-	O
01	O
-	O
14	O
*	O
*	O
]	O
,	O
the	O
patient	O
had	O
headache	B
with	O
neck	B
stiffness	I
and	O
was	O
unable	B
to	I
walk	I
for	O
45	O
minutes	O
.	O

the	O
patient	O
also	O
had	O
a	O
similar	O
episode	O
a	O
year	O
and	O
a	O
half	O
ago	O
where	O
she	O
had	O
inability	B
to	I
walk	I
without	O
pain	B
.	O

she	O
had	O
a	O
headache	B
at	O
that	O
time	O
which	O
was	O
relieved	O
with	O
tylenol	O
.	O

past	O
medical	O
history	O
:	O
hypothyroidism	B
.	O

allergies	O
:	O
penicillin	O
and	O
bactrim	O
which	O
causes	O
a	O
rash	B
.	O

medications	O
:	O
levoxyl	O
1	O
.	O
75	O
mg	O
.	O

physical	O
examination	O
:	O
on	O
physical	O
examination	O
,	O
her	O
blood	O
pressure	O
was	O
104	O
/	O
73	O
,	O
pulse	O
79	O
.	O

in	O
general	O
,	O
she	O
was	O
a	O
woman	O
in	O
no	O
acute	B
distress	I
.	O

heent	O
:	O
nonicteric	O
.	O

pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

extraocular	O
movements	O
are	O
full	O
.	O

pharynx	O
is	O
benign	O
.	O

tongue	O
midline	O
.	O

neck	O
is	O
supple	O
.	O

chest	O
was	O
clear	O
to	O
auscultation	O
.	O

cardiac	O
:	O
s1	O
,	O
s2	O
,	O
regular	O
,	O
rate	O
,	O
and	O
rhythm	O
.	O

abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	B
,	O
negative	O
bruits	O
.	O

extremities	O
:	O
no	O
clubbing	B
,	O
cyanosis	B
,	O
or	O
edema	B
.	O

palpable	O
pulses	O
.	O

gait	O
was	O
steady	O
.	O

the	O
patient	O
is	O
being	O
admitted	O
status	O
post	O
cerebral	B
aneurysm	I
with	O
clipping	O
.	O

the	O
patient	O
underwent	O
right	O
mca	O
and	O
a	O
right	O

a	O
-	O
comm	O
aneurysm	O
clipping	O
via	O
a	O
right	O
pterional	O
craniotomy	O
without	O
intraoperative	O
complication	O
.	O

postoperative	O
vital	O
signs	O
are	O
stable	O
.	O

patient	O
was	O
afebrile	B
.	O

she	O
was	O
awake	O
,	O
alert	O
.	O

pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

eoms	O
are	O
full	O
.	O

no	O
facial	B
droop	I
,	O
no	O
drift	B
.	O

strength	O
down	O
the	O
legs	O
was	O
[	O
*	O
*	O
05	O
-	O
18	O
*	O
*	O
]	O
.	O

on	O
postoperative	O
day	O
#1	O
,	O
the	O
patient	O
was	O
taken	O
to	O
arteriogram	O
,	O
where	O
she	O
underwent	O
a	O
cerebral	O
angiogram	O
to	O
evaluate	O
clipping	O
of	O
the	O
aneurysm	B
.	O

it	O
was	O
found	O
at	O
that	O
time	O
that	O
the	O
patient	O
had	O
a	O
third	O
aneurysm	B
and	O
that	O
the	O
mca	B
aneurysm	I
which	O
was	O
clipped	O
was	O
at	O
the	O
origin	O
of	O
the	O
anterior	O
temporal	O
artery	O
and	O
not	O
the	O
one	O
at	O
the	O
mca	O
bifurcation	O
.	O

the	O
patient	O
was	O
therefore	O
taken	O
back	O
to	O
the	O
operating	O
room	O
for	O
a	O
clipping	O
of	O
the	O
second	O
mca	B
aneurysm	I
without	O
intraoperative	O
complication	O
.	O

the	O
patient	O
was	O
monitored	O
in	O
the	O
surgical	O
intensive	O
care	O

unit	O
.	O

she	O
was	O
alert	O
,	O
awake	O
,	O
oriented	O
,	O
complaining	O
of	O
severe	O
headache	B
,	O
moving	B
all	I
extremities	I
.	O

eoms	O
full	O
,	O
negative	O
drift	B
,	O
a	O
smile	O
was	O
symmetric	O
,	O
ip	O
is	O
[	O
*	O
*	O
05	O
-	O
18	O
*	O
*	O
]	O
.	O

the	O
patient	O
was	O
then	O
discharged	O
to	O
the	O
floor	O
on	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
20	O
*	O
*	O
]	O
.	O

she	O
has	O
been	O
out	O
of	O
bed	O
and	O
ambulating	O
with	O
physical	O
therapy	O
,	O
tolerating	O
a	O
regular	O
diet	O
,	O
and	O
voiding	O
spontaneously	O
.	O

she	O
has	O
been	O
seen	O
by	O
physical	O
therapy	O
,	O
and	O
was	O
found	O
to	O
be	O
safe	O
to	O
discharge	O
to	O
home	O
with	O
home	O
physical	O
therapy	O
on	O

[	O
*	O
*	O
2015	O
-	O
03	O
-	O
24	O
*	O
*	O
]	O
.	O

her	O
incision	O
is	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
and	O
she	O
is	O
neurologically	O
stable	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
hydromorphone	O
2	O
-	O
6	O
mg	O
po	O
q4h	O
prn	O
.	O

2	O
.	O
synthroid	O
175	O
mcg	O
po	O
q	O
day	O
.	O

3	O
.	O
colace	O
100	O
mg	O
po	O
bid	O
.	O

condition	O
on	O
discharge	O
:	O
stable	O
.	O

follow	O
-	O
up	O
instructions	O
:	O
she	O
will	O
follow	O
up	O
in	O
10	O
days	O
for	O
staple	O
removal	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
570	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
location	O
(	O
un	O
)	O
571	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
572	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
489	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
23	O
*	O
*	O
]	O
08	O
:	O
14	O

t	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
23	O
*	O
*	O
]	O
08	O
:	O
20	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
1537	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
571	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
20	O
*	O
*	O
]	O
7	O
:	O
51	O
am	O

(	O
end	O
of	O
report	O
)	O

27889	O
||||	O
211	O
||||	O
5653	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
04	O
-	O
08	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
28	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
08	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1930	O
-	O
09	O
-	O
21	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
565	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

chest	B
pain	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

coronary	O
artery	O
bypass	O
graft	O
4	O
.	O

history	O
of	O
present	O
illness	O
:	O

83	O
year	O
-	O
old	O
woman	O
,	O
patient	O
of	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
5005	O
*	O
*	O
]	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
5804	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
2275	O
*	O
*	O
]	O
,	O
with	O
increased	O
sob	B
with	O
activity	O
,	O
left	O
shoulder	O
blade	O
/	O
back	B
pain	I
at	O
rest	O
,	O
+	O
mibi	O
,	O
referred	O
for	O
cardiac	O
cath	O
.	O

this	O
pleasant	O
83	O
year	O
-	O
old	O
patient	O
notes	O
becoming	O
sob	B
when	O
walking	O
up	O
hills	O
or	O
inclines	O
about	O
one	O
year	O
ago	O
.	O

this	O
sob	B
has	O
progressively	O
worsened	O
and	O
she	O
is	O
now	O
sob	B
when	O
walking	O
[	O
*	O
*	O
01	O
-	O
19	O
*	O
*	O
]	O
city	O
block	O
(	O
flat	O
surface	O
)	O
.	O

she	O
also	O
notes	O
new	O
sharp	O
pain	O
in	O
left	O
shoulder	O
blade	O
/	O
back	O
area	O
.	O

this	O
pain	B
occurs	O
at	O
rest	O
and	O
is	O
not	O
associated	O
with	O
activity	O
or	O
sob	B
.	O

adenosine	O
mibi	O
at	O
osh	O
showed	O
+	O
moderately	O
reversible	B
inferior	I
defect	I
,	O
mild	O
reversible	B
anterior	I
defect	I
,	O
nl	O
lvef	O
70%	O
.	O

referred	O
for	O
cath	O
here	O
today	O
which	O
showed	O
80%	O
lmca	O
,	O
60%	O
lad	O
at	O
origin	O
of	O
d1	O
,	O
rca	O
diffusely	O
diseased	B
with	O
90%	O
stenosis	B
.	O

past	O
medical	O
history	O
:	O

arthritis	B

carpal	I
tunnel	I

shingles	I
right	O
arm	O
2000	O

needs	O
right	O
knee	O
replacement	O

left	O
knee	O
replacement	O
in	O
[	O
*	O
*	O
2010	O
*	O
*	O
]	O

thyroidectomy	O
1978	O

cholecystectomy	O
[	O
*	O
*	O
1981	O
*	O
*	O
]	O

hysterectomy	O
2001	O

h	O
/	O
o	O
lgib	B
2000	O
-	O
2001	O
after	O
taking	O
baby	O
asa	O
81	O
qod	O

social	O
history	O
:	O

her	O
husband	O
died	O
recently	O
.	O

she	O
has	O
two	O
children	O
.	O

family	O
history	O
:	O

father	O
died	O
of	O
mi	B
at	O
age	O
69	O
.	O

physical	O
exam	O
:	O

pe	O
:	O
t	O
97	O
.	O
6	O
bp	O
142	O
/	O
70	O
r	O
arm	O
,	O
150	O
/	O
70	O
p	O
42	O
-	O
64	O
r	O
16	O
sat	O
92%	O
ra	O
g	O
:	O
elderly	O
female	O
,	O
nad	B

heent	O
:	O
mmm	O
,	O
anicteric	O

neck	O
:	O
jvd	B
diff	O
to	O
assess	O

lungs	O
:	O
+	O
end	O
exp	O
rhonchi	B
bilaterally	O
upper	O
lung	O
zones	O

cv	O
:	O
rrr	O
,	O
s1s2	O
,	O
distant	O
heart	O
sounds	O
,	O
+	O
2	O
/	O
6	O
systolic	B
murmur	I
at	I
apex	I

abd	O
:	O
soft	O
,	O
nt	O
,	O
nd	O
,	O
bs	O
+	O

ext	O
:	O
trace	O
bilateral	O
lower	B
ext	I
edema	I
;	O
r	O
groin	O
small	O
hematoma	B
,	O
no	O
bruits	B

nails	O
:	O
no	O
bed	B
abnormalities	I
,	O
lunulas	O
present	O
,	O
no	O
splinters	B
,	O
pulses	O

rectal	O
:	O
guiac	O
neg	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
03	O
-	O
28	O
*	O
*	O
]	O
cath	O
:	O
lmca	O
had	O
80%	O
eccentric	O
distal	O
stenosis	B
;	O
lad	O
diffusely	O
diseased	B
with	O
mid	O
60%	O
stenosis	B
at	O
the	O
origin	O
of	O
a	O
large	O
diagonal	O
branch	O
;	O
lcx	O
diffusely	O
diseased	B
;	O
rca	O
mid	O
90%	O
stenosis	B
;	O
r	O
-	O
pda	O
occluded	B
;	O
ef	O
60%	O
.	O

[	O
*	O
*	O
2014	O
-	O
04	O
-	O
07	O
*	O
*	O
]	O
06	O
:	O
10am	O
blood	O
wbc	O
-	O
7	O
.	O
4	O
rbc	O
-	O
3	O
.	O
53	O
*	O
hgb	O
-	O
10	O
.	O
7	O
*	O
hct	O
-	O
32	O
.	O
3	O
*	O

mcv	O
-	O
92	O
mch	O
-	O
30	O
.	O
3	O
mchc	O
-	O
33	O
.	O
1	O
rdw	O
-	O
14	O
.	O
4	O
plt	O
ct	O
-	O
339	O

[	O
*	O
*	O
2014	O
-	O
04	O
-	O
07	O
*	O
*	O
]	O
06	O
:	O
10am	O
blood	O
plt	O
ct	O
-	O
339	O

[	O
*	O
*	O
2014	O
-	O
04	O
-	O
06	O
*	O
*	O
]	O
09	O
:	O
59am	O
blood	O
pt	O
-	O
13	O
.	O
3	O
ptt	O
-	O
25	O
.	O
1	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2014	O
-	O
04	O
-	O
07	O
*	O
*	O
]	O
06	O
:	O
10am	O
blood	O
glucose	O
-	O
124	O
*	O
urean	O
-	O
21	O
*	O
creat	O
-	O
1	O
.	O
0	O
na	O
-	O
141	O
k	O
-	O
4	O
.	O
5	O
cl	O
-	O
100	O
hco3	O
-	O
31	O
*	O
angap	O
-	O
15	O

brief	O
hospital	O
course	O
:	O

mrs	O
.	O
[	O
*	O
*	O
lastname	O
2977	O
*	O
*	O
]	O
was	O
admitted	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
27	O
*	O
*	O
]	O
for	O
cardiac	O
cath	O
showing	O
3vd	B
.	O

a	O
cardiac	O
surgery	O
consult	O
was	O
obtained	O
and	O
after	O
pre	O
-	O
operative	O
testing	O
,	O
she	O
proceeded	O
top	O
the	O
operating	O
room	O
on	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
31	O
*	O
*	O
]	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
.	O

she	O
had	O
a	O
cabg	O
x	O
4	O
with	O
lima	O
to	O
the	O
lad	O
,	O
svg	O
to	O
the	O
pda	O
,	O
svg	O
to	O
the	O
plb	O
,	O
and	O
svg	O
to	O
the	O
om	O
.	O

please	O
see	O
op	O
note	O
for	O
full	O
details	O
.	O

she	O
was	O
transferred	O
to	O
teh	O
csru	O
post	O
-	O
op	O
for	O
hemodynamic	O
monitoring	O
.	O

she	O
was	O
unsuccessfully	O
weened	O
on	O
her	O
operative	O
evening	O
and	O
was	O
kept	O
on	O
simv	O
overnight	O
ans	O
successfully	O
weened	O
and	O
extubated	O
on	O
pod	O
one	O
.	O

pod	O
three	O
was	O
significant	O
for	O
dropping	B
oxygen	I
saturation	I
with	O
increased	O
pulmonary	B
toilet	I
.	O

she	O
also	O
had	O
a	O
drop	O
in	O
her	O
blood	O
pressure	O
for	O
which	O
she	O
was	O
a	O
-	O
paced	O
with	O
effect	O
and	O
her	O
lopressor	O
was	O
discontinued	O
.	O

on	O
pod	O
five	O
,	O
she	O
was	O
in	O
a	O
rapid	O
atrial	B
flutter	I
with	O
pauses	O
.	O

she	O
was	O
started	O
on	O
amiodarone	O
and	O
woumadin	O
for	O
anticoaguation	O
.	O

pod	O
six	O
continued	O
with	O
bursts	O
of	O
atrial	B
fibrillation	I
.	O

she	O
was	O
also	O
transferred	O
to	O
the	O
inpatient	O
floor	O
for	O
ongoing	O
recovery	O
and	O
rehabilitation	O
.	O

on	O
pod	O
seven	O
it	O
was	O
decided	O
that	O
she	O
would	O
benefit	O
from	O
rehabilitation	O
prior	O
to	O
discharge	O
home	O
and	O
on	O
pod	O
eight	O
she	O
was	O
discharged	O
to	O
rehab	O
.	O

medications	O
on	O
admission	O
:	O

levothyroxine	O
200	O
mcg	O
daily	O
.	O

avalide	O
300	O
/	O
12	O
.	O
5	O
daily	O
.	O

norvasc	O
5	O
daily	O
.	O

ferrous	O
sulfate	O
bid	O
.	O

tylenol	O
prn	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

2	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

3	O
.	O
levothyroxine	O
sodium	O
200	O
mcg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

4	O
.	O
furosemide	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
for	O
10	O
days	O
.	O

disp	O
:	O
*	O
20	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

5	O
.	O
potassium	O
chloride	O
10	O
meq	O
capsule	O
,	O
sustained	O
release	O
sig	O
:	O
two	O
(	O
2	O
)	O
capsule	O
,	O
sustained	O
release	O
po	O
twice	O
a	O
day	O
for	O
10	O
days	O
.	O

disp	O
:	O
*	O
40	O
capsule	O
,	O
sustained	O
release	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

6	O
.	O
amiodarone	O
hcl	O
200	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
for	O
2	O
weeks	O
then	O
decrease	O
to	O
200mg	O
po	O
qd	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

7	O
.	O
coumadin	O
as	O
directed	O
for	O
goal	O
inr	O
2	O
.	O
0	O
-	O
2	O
.	O
5	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
hospital	O
5805	O
*	O
*	O
]	O
manor	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
348	O
*	O
*	O
]	O

discharge	O
diagnosis	O
:	O

coronary	B
artery	I
disease	I
.	O

s	O
/	O
p	O
cabg	O

post	O
op	O
atrial	B
fibrillation	I

discharge	O
condition	O
:	O

stable	O
.	O

discharge	O
instructions	O
:	O

shower	O
daily	O
and	O
wash	O
incisions	O
with	O
soap	O
and	O
water	O
.	O

rinse	O
well	O
.	O

do	O
not	O
apply	O
any	O
creams	O
,	O
lotions	O
,	O
powders	O
,	O
or	O
ointments	O
.	O

no	O
tub	O
bathing	O
or	O
swimming	O
.	O

no	O
heavy	O
lifting	O
greater	O
than	O
10	O
pounds	O
.	O

no	O
driving	O
for	O
6	O
weeks	O
.	O

check	O
pt	O
/	O
inr	O
qd	O
and	O
prn	O
and	O
dose	O
coumadin	O
for	O
goal	O
inr	O
2	O
.	O
0	O
-	O
2	O
.	O
5	O

followup	O
instructions	O
:	O

follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
4	O
weeks	O
.	O

follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
5005	O
*	O
*	O
]	O
in	O
1	O
-	O
2	O
weeks	O
.	O

follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2275	O
*	O
*	O
]	O
in	O
1	O
-	O
2	O
weeks	O
.	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
574	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
575	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
352	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
353	O
*	O
*	O
]	O
pa	O
80	O
-	O
axp	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
08	O
*	O
*	O
]	O
@	O
1039	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
16	O
*	O
*	O
]	O
11	O
:	O
09	O
am	O

(	O
end	O
of	O
report	O
)	O

104513	O
||||	O
414	O
||||	O
8517	O
||||	O
echo	O
_	O
report	O
||||	O
2014	O
-	O
04	O
-	O
22	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
congestive	B
heart	I
failure	I
.	O

left	B
ventricular	I
function	I
.	O

shortness	B
of	I
breath	I
.	O

height	O
:	O
(	O
in	O
)	O
71	O

weight	O
(	O
lb	O
)	O
:	O
208	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
15	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
104	O
/	O
66	O

hr	O
(	O
bpm	O
)	O
:	O
90	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
22	O
*	O
*	O
]	O
at	O
09	O
:	O
34	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
moderate	O
la	B
enlargement	I
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
.	O

suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
lv	B
wall	I
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
.	O

moderate	O
global	O
rv	O
free	O
wall	O
hypokinesis	B
.	O

aorta	O
:	O
moderately	O
dilated	B
aortic	I
root	I
.	O

moderately	O
dilated	B
ascending	I
aorta	I
.	O

aortic	O
valve	O
:	O
moderately	O
thickened	B
aortic	O
valve	O
leaflets	O
.	O

mitral	O
valve	O
:	O
mitral	O
valve	O
not	O
well	O
seen	O
.	O

mild	O
mitral	B
annular	I
calcification	I
.	O

tricuspid	O
valve	O
:	O
tricuspid	O
valve	O
not	O
well	O
visualized	O
.	O

indeterminate	O
pa	O
systolic	O
pressure	O
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
-	O
poor	O
echo	O
windows	O
.	O

the	O
rhythm	O
appears	O
to	O
be	O
atrial	B
fibrillation	I
.	O

echocardiographic	O
results	O
were	O
reviewed	O
by	O
telephone	O
with	O
the	O
houseofficer	O
caring	O
for	O
the	O
patient	O
.	O

conclusions	O
:	O

technically	O
suboptimal	O
study	O
due	O
to	O
pooor	O
acoustic	O
windows	O
.	O

the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

due	O
to	O
suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
wall	B
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

global	O
systolic	O
function	O
is	O
depressed	O
?global	O
(	O
lvef?40%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
with	O
moderate	O
global	O
free	O
wall	O
hypokinesis	B
.	O

the	O
aortic	O
root	O
and	O
ascending	O
aorta	O
are	O
moderately	O
dilated	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened	B
.	O

significant	O
aortic	B
stenosis	I
is	O
probably	O
not	O
present	O
.	O

the	O
mitral	O
valve	O
is	O
not	O
well	O
seen	O
.	O

mitral	B
stenosis	I
is	O
not	O
present	O
and	O
definate	O
mitral	B
regurgitation	I
is	O
not	O
seen	O
.	O

the	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
determined	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

if	O
clinically	O
indicated	O
,	O
a	O
radionuclide	O
ventriculogram	O
is	O
suggested	O
to	O
better	O
characterize	O
regional	O
and	O
global	O
biventricular	O
systolic	O
function	O
.	O

97836	O
||||	O
500	O
||||	O
19685	O
||||	O
echo	O
_	O
report	O
||||	O
2018	O
-	O
05	O
-	O
04	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
intraop	O
monitoring	O
for	O
aaa	B
repair	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2018	O
-	O
05	O
-	O
04	O
*	O
*	O
]	O
at	O
18	O
:	O
35	O

test	O
:	O
portable	O
tee	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
moderate	O
la	B
enlargement	I
.	O

no	O
spontaneous	O
echo	O
contrast	O
is	O
seen	O
in	O
the	O
laa	O
.	O

all	O
four	O
pulmonary	O
veins	O
not	O
identified	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
mildly	O
dilated	B
ra	I
.	O

a	O
catheter	O
or	O
pacing	O
wire	O
is	O
seen	O
in	O
the	O
ra	O
.	O

normal	O
interatrial	O
septum	O
.	O

left	O
ventricle	O
:	O
mild	O
symmetric	O
lvh	B
.	O

normal	O
lv	O
cavity	O
size	O
.	O

normal	O
regional	O
lv	O
systolic	O
function	O
.	O

low	O
normal	O
lvef	O
.	O

lv	O
wall	O
motion	O
:	O
basal	O
anterior	O
-	O
normal	O
;	O
mid	O
anterior	O
-	O
normal	O
;	O
basal	O
anteroseptal	O
-	O
normal	O
;	O
mid	O
anteroseptal	O
-	O
normal	O
;	O
basal	O
inferoseptal	O
-	O
normal	O
;	O
mid	O
inferoseptal	O
-	O
normal	O
;	O
basal	O
inferior	O
-	O
normal	O
;	O
mid	O
inferior	O
-	O
normal	O
;	O
basal	O
inferolateral	O
-	O
normal	O
;	O
mid	O
inferolateral	O
-	O
normal	O
;	O
basal	O
anterolateral	O
-	O
normal	O
;	O
mid	O
anterolateral	O
-	O
normal	O
;	O
anterior	O
apex	O
-	O
normal	O
;	O
septal	O
apex	O
-	O
normal	O
;	O
inferior	O
apex	O
-	O
normal	O
;	O
lateral	O
apex	O
-	O
normal	O
;	O
apex	O
-	O
normal	O
;	O

right	O
ventricle	O
:	O
mildly	O
dilated	B
rv	I
cavity	O
.	O

mild	O
global	O
rv	O
free	O
wall	O
hypokinesis	B
.	O

aorta	O
:	O
complex	O
(	O
>4mm	O
)	O
atheroma	B
in	O
the	O
ascending	O
aorta	O
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
normal	O
mitral	O
valve	O
leaflets	O
.	O

mild	O
(	O
1	O
+	O
)	O
mr	B
.	O

tricuspid	O
valve	O
:	O
mild	O
[	O
1	O
+	O
]	O
tr	B
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
physiologic	O
(	O
normal	O
)	O
pr	B
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

left	O
ventricular	O
ejection	O
fraction	O
is	O
normal	O
with	O
no	O
regional	O
wall	B
motion	I
abnormality	I
.	O
.	O
there	O
is	O
mild	O
symmetrical	O
hypertrophy	O
of	O
the	O
left	O
ventricular	O
wall	O
.	O

right	O
ventricular	O
is	O
mildly	O
dilated	O
with	O
mild	O
hypokinesis	B
of	O
the	O
free	O
wall	O
.	O

there	O
is	O
mild	O
mitral	B
regurgitation	I
.	O
there	O
is	O
mild	O
tricuspid	B
regurgitation	I
.	O

the	O
ascending	O
and	O
descending	O
thoracic	O
aorta	O
is	O
normal	O
in	O
size	O
with	O
complex	O
atheromatous	B
disease	I
.	O

400001	O
||||	O
587	O
||||	O
22383	O
||||	O
radiology	O
_	O
report	O
||||	O
2012	O
-	O
03	O
-	O
13	O
13	O
:	O
03	O
:	O
00	O
.	O
0	O
||||	O
q116	O
ct	O
sinus	O
/	O
mandible	O
/	O
maxillofacial	O
w	O
/	O
o	O
contrast	O
||||	O
||||	O
clip	O
#	O
361	O
-	O
6033	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
13	O
*	O
*	O
]	O
1	O
:	O
03	O
pm	O

ct	O
sinus	O
/	O
mandible	O
/	O
maxillofacial	O
w	O
/	O
o	O
contrast	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
5189	O
*	O
*	O
]	O
reason	O
:	O
please	O
evaluate	O
for	O
sinusitis	B
admitting	O
diagnosis	O
:	O
splenomegalia	B

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

56	O
year	O
old	O
man	O
with	O
new	O
bilateral	O
ear	B
fullness	I
reason	O
for	O
this	O
examination	O
:	O
please	O
evaluate	O
for	O
sinusitis	B
no	O
contraindications	O
for	O
iv	O
contrast	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

clinical	O
information	O
:	O
bilateral	O
ear	B
fullness	I
,	O
question	O
sinusitis	B
.	O

noncontrast	O
ct	O
of	O
the	O
sinuses	O
and	O
axial	O
and	O
coronal	O
projection	O

findings	O
:	O
the	O
visualized	O
paranasal	O
sinuses	O
are	O
clear	O
with	O
the	O
exception	O
of	O
some	O
slight	O
thickening	B
of	O
central	O
ethmoid	O
cells	O
on	O
the	O
right	O
.	O

the	O
osteomeatal	O
units	O
demonstrate	O
soft	B
tissue	I
compromise	I
.	O

there	O
appears	O
to	O
be	O
a	O
medial	O
maxillotomy	O
on	O
the	O
right	O
.	O

the	O
nasal	B
septum	I
deviates	I
to	O
the	O
left	O
with	O
a	O
rather	O
large	O
spur	O
.	O

the	O
cribriform	O
plates	O
are	O
symmetric	O
in	O
height	O
.	O

the	O
anterior	O
clinoids	O
are	O
not	O
pneumatized	B
.	O

the	O
sphenoid	O
septum	O
inserts	O
on	O
the	O
right	O
carotid	O
groove	O
.	O

the	O
mastoid	O
sinuses	O
are	O
clear	O
.	O

the	O
nasal	O
pharynx	O
is	O
symmetric	O
in	O
appearance	O
.	O

impression	O
:	O
minimal	O
ethmoid	B
sinus	I
thickening	I
.	O

evidence	O
of	O
prior	O
right	O
maxillary	O
surgery	O
.	O

otherwise	O
,	O
negative	O
study	O
.	O

83601	O
||||	O
1114	O
||||	O
23168	O
||||	O
ecg	O
_	O
report	O
||||	O
2016	O
-	O
01	O
-	O
05	O
03	O
:	O
57	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
tachycardia	I
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
04	O
*	O
*	O
]	O
multiple	O
abnormalities	O
persist	O
without	O
major	O
change	O
.	O

tracing	O
#2	O

29456	O
||||	O
1234	O
||||	O
14329	O
||||	O
discharge	O
_	O
summary	O
||||	O
2017	O
-	O
11	O
-	O
30	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
11	O
-	O
29	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
11	O
-	O
30	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1934	O
-	O
07	O
-	O
12	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

no	O
drug	O
allergy	O
information	O
on	O
file	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1071	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

hypoxia	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

n	O
/	O
a	O

history	O
of	O
present	O
illness	O
:	O

resident	O
admit	O
note	O
reviewed	O
and	O
appreciated	O
.	O

information	O
presented	O
here	O
largely	O
gleaned	O
from	O
that	O
source	O
given	O
non	B
-	I
verbal	I
status	I
of	O
patient	O
.	O

83	O
yo	O
m	O
w	O
/	O
vascular	B
dementia	I
,	O
recently	O
admitted	O
to	O
nebh	O
for	O
r	O
cerebellar	B
stroke	I
w	O
/	O
subsequent	O
g	O
-	O
tube	O
placement	O
.	O

on	O
1day	O
of	O
admission	O
,	O
pt	O
noted	O
to	O
be	O
tachypnic	B
w	O
/	O
o2	O
sat	O
to	O
84%	O
and	O
moderately	O
thick	B
whitish	I
secreations	I
.	O

pt	O
suctioned	O
w	O
/	O
improvement	O
to	O
94%	O
.	O

febrile	B
to	O
102	O
.	O

in	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
given	O
vanc	O
,	O
ceftriaxone	O
and	O
azithro	O
,	O
started	O
on	O
sepsis	B
protocol	O
w	O
/	O
lac	O
5	O
.	O
0	O

past	O
medical	O
history	O
:	O

pud	B

s	O
/	O
p	O
r	O
aka	O
[	O
*	O
*	O
06	O
-	O
16	O
*	O
*	O
]	O

dementia	B

cva	I

gib	I
(	O
on	O
coumadin	O
)	O

h	O
/	O
o	O
dvt	B

echo	O
at	O
nebh	O
[	O
*	O
*	O
06	O
-	O
16	O
*	O
*	O
]	O
:	O
lvef	O
55%	O
,	O
trace	O
mr	B
.	O

social	O
history	O
:	O

nh	O
resident	O
since	O
[	O
*	O
*	O
2009	O
*	O
*	O
]	O
.	O

family	O
history	O
:	O

nc	O

physical	O
exam	O
:	O

t	O
99	O
.	O
8	O
,	O
bp	O
111	O
/	O
44	O
,	O
p	O
115	O
,	O
r	O
18	O
,	O
98%	O
10l	O
nrb	O

minimally	O
arousable	O
,	O
localized	B
pain	I
.	O

pupils	B
pinpoint	I
.	O

op	O
-	O
midline	B
lesion	I
of	O
upper	O
hard	O
palate	O
,	O
generally	O
yellow	O
and	O
discolored	O
.	O

dry	O
mmm	O
.	O

regular	O
s1	O
,	O
s2	O
.	O
no	O
m	B
/	O
r	B
/	O
g	B

b	O
/	O
l	O
coarse	B
rhonchi	I
w	O
/	O
assoc	O
upper	O
airway	O
sounds	O
.	O
+	O
bs	O
.	O

peg	O
site	O
clean	O
/	O
dry	O
,	O
minimal	O
erythema	B
surrounding	O
.	O
mildly	O
distended	B
.	O
soft	O
.	O

r	O
bka	O
,	O
amputions	O
site	O
c	O
/	O
d	O
/	O
i	O
.	O

l	O
w	O
/	O
o	O
le	B
edema	I
,	O
poor	B
foot	I
hygiene	I
.	O

trace	O
dp	B
pulse	I

skin	O
:	O
by	O
report	O
,	O
sacral	O
decubitus	B
.	O

pertinent	O
results	O
:	O

cbc	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
10	O
:	O
33pm	O
blood	O
wbc	O
-	O
3	O
.	O
4	O
*	O
rbc	O
-	O
4	O
.	O
23	O
*	O
hgb	O
-	O
12	O
.	O
6	O
*	O
hct	O
-	O
34	O
.	O
5	O
*	O
mcv	O
-	O
82	O
mch	O
-	O
29	O
.	O
8	O
mchc	O
-	O
36	O
.	O
5	O
*	O
rdw	O
-	O
15	O
.	O
1	O
plt	O
ct	O
-	O
340	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
10	O
:	O
33pm	O
blood	O
neuts	O
-	O
55	O
bands	O
-	O
22	O
*	O
lymphs	O
-	O
4	O
*	O
monos	O
-	O
14	O
*	O
eos	O
-	O
0	O
baso	O
-	O
0	O
atyps	O
-	O
2	O
*	O
metas	O
-	O
2	O
*	O
myelos	O
-	O
1	O
*	O

coags	O
:	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
11	O
:	O
40pm	O
blood	O
pt	O
-	O
14	O
.	O
1	O
*	O
ptt	O
-	O
32	O
.	O
7	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
3	O

chemistries	O
:	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
11	O
:	O
40pm	O
blood	O
glucose	O
-	O
108	O
*	O
urean	O
-	O
21	O
*	O
creat	O
-	O
0	O
.	O
8	O
na	O
-	O
142	O
k	O
-	O
3	O
.	O
7	O
cl	O
-	O
106	O
hco3	O
-	O
26	O
angap	O
-	O
14	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
11	O
:	O
40pm	O
blood	O
alt	O
-	O
6	O
ast	O
-	O
20	O
ld	O
(	O
ldh	O
)	O
-	O
180	O
ck	O
(	O
cpk	O
)	O
-	O
743	O
*	O
alkphos	O
-	O
68	O
amylase	O
-	O
63	O
totbili	O
-	O
0	O
.	O
6	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
11	O
:	O
40pm	O
blood	O
ctropnt	O
-	O
<0	O
.	O
01	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
11	O
:	O
40pm	O
blood	O
albumin	O
-	O
2	O
.	O
4	O
*	O
calcium	O
-	O
8	O
.	O
0	O
*	O
iron	O
-	O
pnd	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
11	O
:	O
40pm	O
blood	O
cortsol	O
-	O
pnd	O

blood	O
gas	O
:	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
29	O
*	O
*	O
]	O
03	O
:	O
25am	O
blood	O
type	O
-	O
art	O
temp	O
-	O
38	O
.	O
8	O
po2	O
-	O
133	O
*	O
pco2	O
-	O
47	O
*	O
ph	O
-	O
7	O
.	O
34	O
*	O
calhco3	O
-	O
26	O
base	O
xs	O
-	O
0	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
29	O
*	O
*	O
]	O
01	O
:	O
06am	O
blood	O
lactate	O
-	O
3	O
.	O
0	O
*	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
29	O
*	O
*	O
]	O
02	O
:	O
01am	O
blood	O
lactate	O
-	O
3	O
.	O
3	O
*	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
29	O
*	O
*	O
]	O
03	O
:	O
02am	O
blood	O
lactate	O
-	O
4	O
.	O
6	O
*	O

urine	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
11	O
:	O
40pm	O
urine	O
color	O
-	O
yellow	O
appear	O
-	O
clear	O
sp	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
-	O
1	O
.	O
023	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
11	O
:	O
40pm	O
urine	O
blood	O
-	O
neg	O
nitrite	O
-	O
neg	O
protein	O
-	O
tr	O
glucose	O
-	O
neg	O
ketone	O
-	O
neg	O
bilirub	O
-	O
neg	O
urobiln	O
-	O
neg	O
ph	O
-	O
6	O
.	O
5	O
leuks	O
-	O
neg	O
[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
11	O
:	O
40pm	O
urine	O
rbc	O
-	O
0	O
wbc	O
-	O
0	O
-	O
2	O
bacteri	O
-	O
occ	O
yeast	O
-	O
none	O
epi	O
-	O
0	O
-	O
2	O

micro	O
:	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
29	O
*	O
*	O
]	O
blood	O
culture	O
emergency	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
pending	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
blood	O
culture	O
emergency	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
pending	O

[	O
*	O
*	O
2017	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
urine	O
emergency	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
pending	O

ecg	O
:	O
100bpm	O
,	O
nl	O
axis	O
,	O
nl	O
intervals	O
,	O
no	O
st	B
-	I
tw	I
changes	I
.	O

cxr	O
:	O
1	O
.	O
suboptimal	O
positioning	O
of	O
central	O
venous	O
catheter	O
within	O
the	O
mid	O
-	O
right	O

atrium	O
.	O

this	O
should	O
be	O
withdrawn	O
by	O
5	O
cm	O
.	O

2	O
.	O
increasing	O
parenchymal	O
opacities	B
at	O
the	O
left	O
lung	O
base	O
.	O

this	O
likely	O
represents	O
asymmetric	O
edema	B
.	O

alternatively	O
,	O
this	O
could	O
be	O
a	O
manifestation	O
of	O
aspiration	B
.	O

kub	O
:	O
diffusely	O
dilated	O
loops	O
of	O
small	O
bowel	O
with	O
air	B
-	I
filled	I
colonic	I

loops	I
.	O

these	O
findings	O
could	O
represent	O
ileus	B
or	O
early	O
small	B
bowel	I
obstruction	I
.	O

abg	O
:	O
7	O
.	O
34	O
/	O
47	O
/	O
133	O
on	O
nrb	O

brief	O
hospital	O
course	O
:	O

83	O
yo	O
m	O
w	O
/	O
h	O
/	O
o	O
recent	O
cva	B
and	O
g	O
-	O
tube	O
placement	O
who	O
p	O
/	O
w	O
new	O
onset	O
hypoxia	B
,	O
w	O
/	O
rhonchi	B
on	O
exam	O
,	O
lll	O
opacity	B
on	O
cxr	O
,	O
elevated	B
lactate	I
on	O
must	O
protocol	O
.	O

1	O
)	O
must	O
-	O
lactate	O
remains	O
elevated	O
despite	O
high	O
svo2	O
.	O

bps	O
stable	O
so	O
no	O
indication	O
for	O
pressors	O
/	O
inotropes	O
.	O

pt	O
rec'd	O
4l	O
ns	O
in	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
so	O
adequately	O
volume	O
resuscitated	O
by	O
criteria	O
.	O

cortisol	O
stim	O
test	O
pending	O
.	O

does	O
not	O
meet	O
criteria	O
for	O
apc	O
given	O
recent	O
cva	B
and	O
low	O
[	O
*	O
*	O
doctor	O
first	O
name	O
2672	O
*	O
*	O
]	O
score	O
(	O
11	O
)	O
.	O

likely	O
etiology	O
is	O
infectious	B
given	O
significant	O
bandemia	B
,	O
most	O
probable	O
is	O
pulmonary	O
given	O
lll	O
findings	O
and	O
lung	O
exam	O
.	O

pna	B
vs	O
aspiration	B
.	O

other	O
possibilities	O
included	O
enteric	B
given	O
findings	O
on	O
kub	O
and	O
recent	O
surgical	O
placement	O
of	O
peg	O
tube	O
.	O

covered	O
w	O
/	O
vanc	O
/	O
ceftriaxone	O
/	O
azithro	O
,	O
no	O
indication	O
for	O
additional	O
pseudomonal	O
coverage	O
w	O
/	O
cefepime	O
.	O

used	O
ns	O
boluses	O
to	O
maintain	O
cvp>8	O
and	O
patient	O
was	O
continued	O
on	O
must	O
protocol	O
.	O

hospital	O
course	O
as	O
below	O
.	O

2	O
)	O
pna	B
-	O
presumptively	O
treating	O
for	O
,	O
pt	O
rec'd	O

vanc	O
/	O
azithro	O
/	O
ceftrixone	O
/	O
cefepime	O
/	O
clindamycin	O
in	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
.	O

simplified	O
regimen	O
to	O
include	O
vanc	O
/	O
ceftriaxone	O
/	O
azithro	O
.	O

sputum	O
culture	O
grew	O
out	O
e	O
.	O
coli	O
and	O
klebsiella	O
.	O

over	O
the	O
hospital	O
course	O
the	O
patient's	O
respiratory	B
status	I
deteriorated	O
.	O

in	O
d	O
/	O
w	O
family	O
,	O
patient's	O
goals	O
of	O
care	O
were	O
changed	O
to	O
cmo	O
given	O
his	O
ongoing	O
decompensation	B
.	O

patient	O
passed	O
away	O
on	O
hd2	O
of	O
respiratory	B
failure	I
.	O

3	O
)	O
illeus	B
-	O
also	O
possible	O
that	O
pt	O
may	O
have	O
transmigrated	B
bacteria	I
secondary	O
to	O
illeus	B
.	O
covered	O
for	O
gram	O
neg	O
on	O
admission	O
.	O

4	O
)	O
glucose	O
-	O
riss	O
,	O
qid	O
fs	O

5	O
)	O
prophylaxis	O
-	O
maintained	O
on	O
gi	O
,	O
hep	O
sc	O
,	O
pneumoboots	O
(	O
aggressive	O
given	O
h	O
/	O
o	O
dvt	B
)	O

6	O
)	O
contact	O
:	O
[	O
*	O
*	O
last	O
name	O
(	O
lf	O
)	O
194	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
*	O
*	O
]	O
h	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
2673	O
*	O
*	O
]	O
,	O
w	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
2674	O
*	O
*	O
]	O

medications	O
on	O
admission	O
:	O

prevacid	O
30mg	O
pgt	O
daily	O

metoprolol	O
25	O
mg	O
po	O

duonebs	O

bowel	O
regimen	O

discharge	O
medications	O
:	O

n	O
/	O
a	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
healthcare	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
78	O
*	O
*	O
]	O

discharge	O
diagnosis	O
:	O

sepsis	B

pna	I

discharge	O
condition	O
:	O

expired	O

discharge	O
instructions	O
:	O

followup	O
instructions	O
:	O

[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
weiss	O
md	O
[	O
*	O
*	O
md	O
number	O
1073	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
737	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
738	O
*	O
*	O
]	O
[	O
*	O
*	O
2018	O
-	O
07	O
-	O
18	O
*	O
*	O
]	O
@	O
1101	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
weiss	O
on	O
:	O
wed	O
[	O
*	O
*	O
2018	O
-	O
08	O
-	O
01	O
*	O
*	O
]	O
11	O
:	O
53	O
am	O

(	O
end	O
of	O
report	O
)	O

28800	O
||||	O
1314	O
||||	O
22413	O
||||	O
discharge	O
_	O
summary	O
||||	O
2018	O
-	O
01	O
-	O
25	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
14	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
25	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1947	O
-	O
07	O
-	O
23	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
surgery	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
905	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

s	O
/	O
p	O
mva	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

exploratory	O
laparotomy	O
with	O
1	O
foot	O
small	O
bowel	O
resection	O

orif	O
of	O
r	O
tibia	O
,	O
r	O
olecranon	O

history	O
of	O
present	O
illness	O
:	O

pt	O
is	O
a	O
70	O
year	O
old	O
male	O
unrestrained	O
driver	O
,	O
lost	O
control	O
of	O
vehicle	O
and	O
hit	O
pole	O
travelling	O
at	O
approx	O
45	O
mph	O
.	O

possible	O
loc	B
,	O
chest	O
struck	O
steering	O
wheel	O
.	O

c	O
/	O
o	O
facial	B
laceration	I
,	O
right	O
elbow	B
pain	I
,	O
l	O
hand	B
laceration	I
,	O
diffuse	O
chest	B
pain	I
,	O
r	O
knee	B
swelling	I
.	O

past	O
medical	O
history	O
:	O

unknown	O
congenitcal	B
spine	I
abnormality	I

social	O
history	O
:	O

noncontributory	O

family	O
history	O
:	O

noncontributory	O

physical	O
exam	O
:	O

pt	O
aaox3	O

perrla	O

heent	O
:	O
midface	O
stable	O
,	O
large	O
through&	O
through	O
lip	B
laceration	I
chest	O
:	O
crepitus	B
on	O
palpation	O
of	O
l	O
chest	O
with	O
palpable	O
bony	O
instability	B
.	O

cta	O

card	O
:	O
rrr	O

abd	O
:	O
soft	O
,	O
diffusely	O
tender	O
,	O
stable	O
pelvis	O
,	O
rectal	O
neg	O

ext	O
:	O
lue	O
diffusely	O
tender	B
,	O
decreased	B
rom	I

l	O
hand	B
lacerated	I
,	O
no	O
visible	O
tendons	O
or	O
deep	O
structures	O
bilateral	O
knee	B
abrasions	I

pertinent	O
results	O
:	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
14	O
*	O
*	O
]	O
03	O
:	O
00pm	O
wbc	O
-	O
12	O
.	O
8	O
*	O
rbc	O
-	O
5	O
.	O
13	O
hgb	O
-	O
15	O
.	O
5	O
hct	O
-	O
45	O
.	O
1	O
mcv	O
-	O
88	O
mch	O
-	O
30	O
.	O
2	O
mchc	O
-	O
34	O
.	O
4	O
rdw	O
-	O
13	O
.	O
9	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
14	O
*	O
*	O
]	O
03	O
:	O
00pm	O
asa	O
-	O
neg	O
ethanol	O
-	O
neg	O
acetmnphn	O
-	O
neg	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
tricyclic	O
-	O
neg	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
14	O
*	O
*	O
]	O
03	O
:	O
00pm	O
amylase	O
-	O
65	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
14	O
*	O
*	O
]	O
03	O
:	O
15pm	O
urine	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
opiates	O
-	O
neg	O
cocaine	O
-	O
neg	O
amphetmn	O
-	O
neg	O
mthdone	O
-	O
neg	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
14	O
*	O
*	O
]	O
05	O
:	O
52pm	O
hgb	O
-	O
11	O
.	O
1	O
*	O
calchct	O
-	O
33	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
14	O
*	O
*	O
]	O
05	O
:	O
52pm	O
type	O
-	O
art	O
po2	O
-	O
125	O
*	O
pco2	O
-	O
32	O
*	O
ph	O
-	O
7	O
.	O
43	O
total	O
co2	O
-	O
22	O
base	O
xs	O
-	O
-	O
1	O

studies	O
on	O
presentation	O
:	O

head	O
ct	O
:	O
impression	O
:	O
no	O
mass	B
effect	I
,	O
hemorrhage	B
,	O
or	O
skull	B
fractures	I
.	O

c	O
-	O
spine	O
ct	O
:	O
impression	O
:	O
no	O
fractures	B
or	O
dislocations	B
.	O

ct	O
tls	O
spine	O
:	O

impression	O
:	O
bilateral	O
spondylolysis	B
l5	O
/	O
s1	O
without	O
spondylolisthesis	B
.	O

no	O
evidence	O
of	O
fracture	B
.	O

ct	O
chest	O
/	O
abd	O
/	O
pelvis	O
:	O

impression	O

1	O
.	O
left	B
pneumo	I
-	O
and	O
hemothorax	B
.	O

2	O
.	O
left	O
-	O
sided	O
pulmonary	B
contusions	I
.	O

3	O
.	O
multiple	O
left	O
-	O
sided	O
rib	O
fractures	O
and	O
sternal	B
fracture	I
.	O

4	O
.	O
left	O
-	O
sided	O
subcutaneous	B
emphysema	I
and	O
air	O
around	O
the	O
pectoralis	O
muscles	O
.	O

5	O
.	O
small	O
amount	O
of	O
mesenteric	B
stranding	I
likely	O
representing	O
mesenteric	B
injury	I
and	O
hemorrhage	B
.	O

ct	O
facial	B
cuts	I
:	O

impression	O
:	O
nasal	B
fracture	I
.	O

no	O
definite	O
acute	O
fracture	B
.	O

sinus	B
disease	I
.	O

xr	O
bilateral	O
ue	O
:	O
findings	O
:	O
two	O
views	O
of	O
the	O
right	O
forearm	O
and	O
a	O
single	O
view	O
of	O
the	O
left	O
hand	O
show	O
an	O
avulsion	B
fracture	I
of	O
the	O
olecranon	O
process	O
.	O

there	O
is	O
distraction	B
of	O
approximately	O
2	O
cm	O
between	O
fracture	O
fragments	O
.	O

there	O
is	O
no	O
evidence	O
of	O
dislocation	B
.	O

no	O
radio	O
-	O
opague	O
foreign	B
bodies	I
are	O
seen	O
.	O

extensive	O
soft	B
tissue	I
swelling	I
is	O
seen	O
in	O
the	O
right	O
elbow	O
.	O

a	O
minimally	O
displaced	B
fracture	I
of	O
the	O
sahft	O
of	O
the	O
proximal	O
phalanx	O
of	O
the	O
left	O
thumb	O
is	O
also	O
seen	O
.	O

r	O
tib	O
/	O
fib	O
xr	O
:	O

findings	O
:	O
an	O
oblique	O
minimally	O
displaced	O
right	O
tibial	B
plateau	I
fracture	I
traverses	O
the	O
knee	O
joint	O
from	O
the	O
lateral	O
tibial	O
plateau	O
to	O
the	O
metaphysis	O
medially	O
.	O

there	O
is	O
minimal	O
step	B
-	I
off	I
at	O
the	O
articular	O
surface	O
.	O

no	O
other	O
fractures	B
are	O
seen	O
.	O

associated	O
lipohemarthrosis	B
is	O
seen	O
.	O

brief	O
hospital	O
course	O
:	O

the	O
pt	O
presented	O
to	O
the	O
trauma	O
bay	O
on	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
14	O
*	O
*	O
]	O
by	O
ems	O
.	O

vitals	O
on	O
presentation	O
were	O
normal	O
and	O
stable	O
.	O

physical	O
exam	O
and	O
results	O
of	O
studies	O
obtained	O
on	O
admission	O
are	O
as	O
above	O
.	O

when	O
the	O
l	O
hemopneumothorax	B
was	O
noted	O
on	O
cxr	O
,	O
a	O
l	O
chest	O
tube	O
was	O
placed	O
.	O

orhtopedics	O
was	O
consulted	O
for	O
the	O
tibial	O
plateau	O
and	O
elbow	B
fx	I
.	O

plastics	O
was	O
consulted	O
for	O
the	O
hand	B
fx	I
.	O

omfs	O
was	O
consulted	O
for	O
the	O
nasal	B
fx	I
.	O

the	O
pt	O
was	O
admitted	O
to	O
the	O
trauma	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
47	O
*	O
*	O
]	O
.	O

plastics	O
placed	O
the	O
l	O
hand	O
in	O
thumb	O
spica	O
splint	O
and	O
planned	O
on	O
following	O
up	O
with	O
the	O
pt	O
in	O
clinic	O
.	O

orthopedics	O
placed	O
the	O
r	O
arm	O
in	O
a	O
posterior	O
splint	O
and	O
the	O
r	O
knee	O
in	O
an	O
immobilizer	O
with	O
a	O
plan	O
for	O
operative	O
fixation	O
of	O
injuries	B
the	O
following	O
day	O
.	O

omfs	O
repaired	O
the	O
pt's	O
lip	B
laceration	I
and	O
upon	O
review	O
of	O
the	O
facial	O
ct	O
stated	O
there	O
was	O
no	O
nasal	B
fracture	I
.	O

while	O
waiting	O
in	O
the	O
emergency	O
department	O
for	O
a	O
trauma	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
47	O
*	O
*	O
]	O
bed	O
to	O
become	O
available	O
,	O
the	O
pt	O
was	O
noted	O
to	O
become	O
tachycardic	B
and	O
hypotensive	B
to	O
the	O
80s	O
with	O
a	O
hct	B
drop	I
of	O
14	O
points	O
4	O
hours	O
after	O
arrival	O
.	O

a	O
repeat	O
abdominal	O
ct	O
was	O
obtained	O
showing	O
evolution	O
of	O
the	O
mesenteric	B
hematoma	I
noted	O
on	O
the	O
initial	O
scan	O
.	O

the	O
pt	O
was	O
then	O
brought	O
to	O
the	O
or	O
for	O
an	O
emergent	O
exploratory	O
laparotomy	O
during	O
which	O
a	O
branch	O
of	O
the	O
sma	O
was	O
noted	O
to	O
be	O
lacerated	B
and	O
was	O
clamped	O
.	O

a	O
one	O
-	O
foot	O
section	O
of	O
non	B
-	I
viable	I
small	I
bowel	I
was	O
resected	O
.	O

post	O
operatively	O
,	O
the	O
pt	O
was	O
transferred	O
to	O
the	O
trauma	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
47	O
*	O
*	O
]	O
still	O
intubated	O
.	O

the	O
pt	O
did	O
well	O
on	O
the	O
night	O
of	O
1	O
/	O
9	O
and	O
on	O
[	O
*	O
*	O
01	O
-	O
15	O
*	O
*	O
]	O
was	O
taken	O
to	O
the	O

or	O
by	O
othopedics	O
for	O
orif	O
of	O
the	O
right	O
elbow	O
and	O
right	O
tibial	B
plateau	I
fx	I
.	O

the	O
pt	O
remained	O
stable	O
until	O
[	O
*	O
*	O
01	O
-	O
19	O
*	O
*	O
]	O
when	O
he	O
was	O
extubated	O
.	O

from	O
[	O
*	O
*	O
01	O
-	O
19	O
*	O
*	O
]	O
to	O
[	O
*	O
*	O
01	O
-	O
21	O
*	O
*	O
]	O
the	O
pt	O
was	O
noted	O
to	O
have	O
severl	O
bloody	B
stools	I
,	O
likely	O
from	O
oozing	B
from	O
his	O
small	O
bowel	O
anastomosis	O
.	O

his	O
hct	O
trended	O
downward	O
over	O
this	O
period	O
to	O
25	O
.	O

he	O
was	O
given	O
2	O
units	O
prbcs	O
on	O
[	O
*	O
*	O
01	O
-	O
20	O
*	O
*	O
]	O
which	O
increased	O
his	O
hct	O
to	O

31	O
.	O
5	O
on	O
[	O
*	O
*	O
01	O
-	O
21	O
*	O
*	O
]	O
.	O

he	O
was	O
transferred	O
to	O
the	O
floor	O
in	O
the	O
evening	O
of	O

[	O
*	O
*	O
01	O
-	O
21	O
*	O
*	O
]	O
.	O

hct	O
remained	O
stable	O
throughout	O
his	O
stay	O
on	O
the	O
floor	O
and	O
the	O
pt	O
had	O
no	O
adverse	B
events	I
until	O
discharge	O
.	O

medications	O
on	O
admission	O
:	O

none	O

discharge	O
medications	O
:	O

1	O
.	O
insulin	O
regular	O
human	O
100	O
unit	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
injection	O
asdir	O
(	O
as	O
directed	O
)	O
:	O
see	O
sliding	O
scale	O
.	O

2	O
.	O
acetaminophen	O
650	O
mg	O
suppository	O
sig	O
:	O
one	O
(	O
1	O
)	O
suppository	O
rectal	O
q6h	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

3	O
.	O
albuterol	O
sulfate	O
0	O
.	O
083	O
%	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
inhalation	O
q6h	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

4	O
.	O
ipratropium	O
bromide	O
0	O
.	O
02	O
%	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
inhalation	O
q6h	O
(	O
every	O
6	O
hours	O
)	O
.	O

5	O
.	O
oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
/	O
5	O
ml	O
solution	O
sig	O
:	O
5	O
-	O
10	O
mls	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

6	O
.	O
hydralazine	O
hcl	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q6h	O
(	O
every	O
6	O
hours	O
)	O
.	O

7	O
.	O
oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

8	O
.	O
metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
1	O
.	O
5	O
tablets	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

9	O
.	O
enoxaparin	O
sodium	O
40	O
mg	O
/	O
0	O
.	O
4ml	O
syringe	O
sig	O
:	O
one	O
(	O
1	O
)	O
syringe	O
subcutaneous	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
hospital	O
1021	O
*	O
*	O
]	O
for	O
the	O
aged	O
-	O
acute	O
rehab	O

discharge	O
diagnosis	O
:	O

r	O
olecranon	B
fx	I

l	O
hemopneumothorax	B

l	O
[	O
*	O
*	O
02	O
-	O
12	O
*	O
*	O
]	O
rib	B
fx	I
with	O
flail	B
chest	I

mesenteric	O
vessel	O
injury	O

l	O
1st	B
metacarpal	I
fx	I

discharge	O
condition	O
:	O

improved	O

discharge	O
instructions	O
:	O

please	O
take	O
all	O
medications	O
as	O
directed	O
.	O

return	O
to	O
the	O
er	O
if	O
you	O
develop	O
:	O

chest	B
pain	I
,	O
shortness	B
of	I
breath	I
,	O
severe	O
nausea	B
or	O
vomiting	B
,	O
high	O
fever	B
,	O
weakness	B

followup	O
instructions	O
:	O

please	O
arrange	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
from	O
orthopedics	O
in	O
2	O
weeks	O
.	O

his	O
number	O
is	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
2561	O
*	O
*	O
]	O
.	O

you	O
will	O
need	O
to	O
arrange	O
to	O
have	O
a	O
pin	O
placed	O
in	O
your	O
elbow	O
.	O

please	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
7687	O
*	O
*	O
]	O
from	O
gerontology	O
,	O
your	O
new	O
pcp	O
.	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
*	O
*	O
]	O
expects	O
to	O
see	O
you	O
on	O
thursday	O
,	O
[	O
*	O
*	O
03	O
-	O
01	O
*	O
*	O
]	O
at	O
3	O
:	O
30	O
pm	O
.	O

her	O
address	O
is	O
[	O
*	O
*	O
street	O
address	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
55	O
*	O
*	O
]	O
,	O
1st	O
floor	O
.	O

please	O
call	O
ahead	O
to	O
confirm	O
your	O
appointment	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
407	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
906	O
*	O
*	O
]	O
md	O
,	O
phd	O
02	O
-	O
239	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
4348	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
4349	O
*	O
*	O
]	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
25	O
*	O
*	O
]	O
@	O
1511	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
407	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
28	O
*	O
*	O
]	O
10	O
:	O
01	O
am	O
(	O
end	O
of	O
report	O
)	O

342648	O
||||	O
1427	O
||||	O
12755	O
||||	O
radiology	O
_	O
report	O
||||	O
2016	O
-	O
01	O
-	O
10	O
19	O
:	O
57	O
:	O
00	O
.	O
0	O
||||	O
w841	O
-	O
76	O
by	O
same	O
physician	O
||||	O
||||	O
clip	O
#	O
421	O
-	O
2406	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
10	O
*	O
*	O
]	O
7	O
:	O
57	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
;	O
-	O
76	O
by	O
same	O
physician	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
4443	O
*	O
*	O
]	O
reason	O
:	O
s	O
/	O
p	O
right	O
central	O
line	O
placement	O
admitting	O
diagnosis	O
:	O
claudication	B
/	O
sda	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

77	O
year	O
old	O
woman	O
s	O
/	O
p	O
cvl	O
placement	O
reason	O
for	O
this	O
examination	O
:	O
s	O
/	O
p	O
right	O
central	O
line	O
placement	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

chest	O
,	O
single	O
view	O
,	O
on	O
[	O
*	O
*	O
01	O
-	O
10	O
*	O
*	O
]	O

history	O
:	O
status	O
post	O
central	O
line	O
placement	O
.	O

findings	O
:	O
there	O
are	O
bilateral	O
ij	O
lines	O
.	O

the	O
left	O
ij	O
line	O
is	O
at	O
the	O
junction	O
of	O
the	O
ij	O
and	O
left	O
subclavian	O
vein	O
.	O

the	O
right	O
ij	O
line	O
tip	O
is	O
in	O
the	O
superior	O
vena	O
cava	O
.	O

the	O
right	O
subclavian	O
line	O
tip	O
is	O
in	O
the	O
superior	O
vena	O
cava	O
.	O

there	O
continues	O
to	O
be	O
bilateral	B
pleural	I
effusions	I
that	O
are	O
probably	O
smaller	O
than	O
on	O
the	O
film	O
from	O
earlier	O
the	O
same	O
day	O
and	O
dense	O
retrocardiac	B
opacification	I
likely	O
due	O
to	O
volume	B
loss	I
/	O
infiltrate	B
.	O

there	O
continues	O
to	O
be	O
pulmonary	B
vascular	I
redistribution	I
and	O
some	O
perihilar	B
haze	I
suggesting	O
fluid	B
overload	I
.	O

the	O
endotracheal	O
tube	O
tip	O
is	O
3	O
cm	O
above	O
the	O
carina	O
.	O

there	O
is	O
no	O
pneumothorax	B
.	O

67052	O
||||	O
1455	O
||||	O
18439	O
||||	O
ecg	O
_	O
report	O
||||	O
2014	O
-	O
03	O
-	O
26	O
16	O
:	O
08	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

atrial	B
fibrillation	I
with	O
a	O
rapid	B
ventricular	I
response	I
.	O

prior	O
anterior	B
myocardial	I
infarction	I
.	O

low	O
limb	O
lead	O
voltage	O
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
26	O
*	O
*	O
]	O
no	O
diagnostic	O
interim	O
change	O
.	O

tracing	O
#1	O

290421	O
||||	O
1487	O
||||	O
25856	O
||||	O
radiology	O
_	O
report	O
||||	O
2010	O
-	O
02	O
-	O
24	O
13	O
:	O
04	O
:	O
00	O
.	O
0	O
||||	O
j32	O
carotid	O
series	O
complete	O
||||	O
||||	O
clip	O
#	O
284	O
-	O
6317	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2010	O
-	O
02	O
-	O
24	O
*	O
*	O
]	O
1	O
:	O
04	O
pm	O

carotid	O
series	O
complete	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
4864	O
*	O
*	O
]	O
reason	O
:	O
preop	O
for	O
cabg	O
in	O
am	O
.	O
?	O
carotid	B
disease	I
.	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

79	O
year	O
old	O
woman	O
with	O
severe	O
cad	B
.	O

preop	O
for	O
cabg	O
in	O
am	O
.	O
?	O
carotid	B
disease	I
.	O

reason	O
for	O
this	O
examination	O
:	O

preop	O
for	O
cabg	O
in	O
am	O
.	O
?	O
carotid	B
disease	I
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
preop	O
for	O
aaa	B
repair	O
,	O
questionable	O
bruit	B
.	O

findings	O
:	O
minimal	O
plaque	B
involving	O
the	O
origin	O
of	O
the	O
left	O
ica	O
,	O
moderate	O
hypoechoic	O
right	O
ica	O
plaque	B
.	O

peak	O
systolic	O
velocities	O
on	O
the	O
right	O
are	O
171	O
,	O
62	O
,	O
and	O
138	O
cm	O
/	O
s	O
for	O
the	O
ica	O
,	O
cca	O
,	O
and	O
eca	O
respectively	O
.	O

the	O
ica	O
/	O
cca	O
ratio	O
is	O
2	O
.	O
8	O
.	O

the	O
findings	O
indicate	O
a	O
60	O
to	O
69%	O
right	O
ica	B
stenosis	I
.	O

on	O
the	O
left	O
,	O
the	O
peak	O
systolic	O
velocities	O
are	O
89	O
,	O
81	O
,	O
and	O
88	O
cm	O
/	O
s	O
for	O
the	O
ica	O
,	O
cca	O
,	O
and	O
eca	O
respectively	O
.	O

the	O
ica	O
/	O
cca	O
ratio	O
is	O
normal	O
.	O

the	O
findings	O
indicate	O
no	O
significant	O
left	O
ica	B
stenosis	I
.	O

there	O
is	O
antegrade	O
flow	O
in	O
both	O
vertebral	O
arteries	O
.	O

impression	O
:	O

1	O
.	O
moderate	O
predominantly	O
hypoechoic	O
right	O
ica	O
plaque	B
with	O
an	O
associated	O
60	O
to	O
69%	O
stenosis	O
.	O

2	O
.	O
minimal	O
left	O
ica	O
plaque	B
,	O
no	O
appreciable	O
associated	O
stenosis	O
.	O

60190	O
||||	O
1982	O
||||	O
19870	O
||||	O
ecg	O
_	O
report	O
||||	O
2016	O
-	O
09	O
-	O
01	O
07	O
:	O
43	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
bradycardia	I

probable	O
prior	O
inferior	B
myocardial	I
infarction	I

prolonged	I
q	I
-	I
tc	I
interval	I
-	O
clinical	O
correlation	O
is	O
suggested	O
for	O
possible	O
in	O
part	O
metabolc	O
/	O
drug	O
effect	O
since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2016	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
,	O
sinus	B
bradycardia	I
and	O
prolonged	B
q	I
-	I
tc	I
interval	I
present	O

37300	O
||||	O
2034	O
||||	O
14990	O
||||	O
ecg	O
_	O
report	O
||||	O
2017	O
-	O
05	O
-	O
26	O
17	O
:	O
02	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

baseline	O
artifact	O
.	O

sinus	B
rhythm	I
.	O

right	B
bundle	I
-	I
branch	I
block	I
.	O

since	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2017	O
-	O
05	O
-	O
17	O
*	O
*	O
]	O
atrial	B
ectopy	I
is	O
not	O
seen	O
.	O

10823	O
||||	O
2115	O
||||	O
18284	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
05	O
-	O
31	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
16	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
31	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1927	O
-	O
09	O
-	O
19	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1362	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

code	O
stroke	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

mri	O
/	O
mra	O
head	O

mra	O
neck	O

endotracheal	O
intubation	O

history	O
of	O
present	O
illness	O
:	O

the	O
pt	O
is	O
an	O
87	O
year	O
-	O
old	O
right	O
-	O
handed	O
woman	O
with	O
a	O
prior	O
history	O
of	O
stroke	B
who	O
presented	O
with	O
alteration	B
in	I
mental	I
status	I
.	O

the	O
pt	O
was	O
unable	O
to	O
offer	O
a	O
history	O
at	O
the	O
time	O
of	O
my	O
encounter	O
.	O

therefore	O
,	O
the	O
following	O
history	O
is	O
per	O
the	O
primary	O
team	O
,	O
the	O
medical	O
record	O
,	O
and	O
the	O
pt's	O
daughter	O
.	O

she	O
had	O
been	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
approximately	O
1440	O
today	O
.	O

at	O
that	O
time	O
,	O
she	O
was	O
sitting	O
in	O
her	O
wheelchair	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
478	O
*	O
*	O
]	O
the	O
newspaper	O
when	O
her	O
daughter	O
suddenly	O
saw	O
the	O
pt's	O
right	O
arm	O
moving	B
abnormally	I
(	O
not	O
clear	O
if	O
rhythmically	O
)	O
.	O

the	O
pt's	O

face	O
appeared	O
"contorted"	O
and	O
her	O
eyes	B
were	I
clamped	I
closed	I
.	O

her	O
extremities	O
appeared	O
turned	O
in	O
and	O
clinched	O
together	O
except	O
for	O
her	O
right	O
arm	O
that	O
was	O
moving	B
abnormally	I
for	O
an	O
uncertain	O
amount	O
of	O
time	O
.	O

her	O
daughter	O
had	O
never	O
witnessed	O
such	O
an	O
event	O
in	O
the	O
past	O
.	O

she	O
became	O
concerned	O
and	O
called	O
ems	O
who	O
brought	O
the	O
pt	O
to	O
the	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
.	O

code	O
stroke	B
was	O
called	O
at	O
1530	O
and	O
neurology	O
was	O
immediately	O
at	O
the	O
bedside	O
.	O

nihss	O
was	O
documented	O
as	O
follows	O
:	O

past	O
medical	O
history	O
:	O

-	O
multiple	O
strokes	B
,	O
most	O
significant	O
event	O
around	O
10	O
years	O
ago	O
with	O
resultant	O
left	B
hemiparesis	I
.	O

has	O
been	O
wheelchair	B
bound	I
since	O
that	O
time	O
.	O
-	O
atrial	B
fibrillation	I
,	O
warfarin	O
was	O
discontinued	O
10	O
days	O
pta	O
for	O
supratherapeutic	O
level	O
-	O
history	O
of	O
congenital	B
heart	I
defect	I
(	O
unclear	O
of	O
exact	O
etiology	O
)	O
-	O
nephrolithiasis	B

-	O
history	O
of	O
blood	B
clot	I
in	O
small	O
bowel	O

-	O
congestive	B
heart	I
failure	I
,	O
ef	O
unknown	O

social	O
history	O
:	O

lives	O
with	O
daughter	O
wheelchair	O
bound	O
at	O
baseline	O
.	O

dependent	O
on	O
others	O
for	O
adls	O
.	O

no	O
history	O
of	O
tobacco	O
,	O
alcohol	O
,	O
illicit	O
drug	O
use	O
.	O

family	O
history	O
:	O

-	O

physical	O
exam	O
:	O

vitals	O
:	O
t	O
:	O
98	O
.	O
6f	O
p	O
:	O
64	O
r	O
:	O
16	O
bp	O
:	O
125	O
/	O
46	O
sao2	O
:	O
99%	O
nrb	O

general	O
:	O
lying	O
in	O
bed	O
with	O
eyes	O
closed	O
and	O
nrb	O
in	O
place	O
.	O

heent	O
:	O
nc	O
/	O
at	O
,	O
no	O
scleral	B
icterus	I
noted	O
,	O
mmm	O
,	O
no	O
lesions	B
noted	O
in	O
oropharynx	O

neck	O
:	O
no	O
jvd	B
or	O
carotid	B
bruits	I
appreciated	O
.	O

no	O
nuchal	B
rigidity	I
pulmonary	O
:	O
lungs	O
cta	O
bilaterally	O
without	O
r	B
/	O
r	B
/	O
w	B

cardiac	O
:	O
irregularly	B
irregular	I
rhythm	I
,	O
nl	O
.	O

s1s2	O
,	O
no	O
murmur	B
noted	O
abdomen	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
,	O
normoactive	O
bowel	O
sounds	O
,	O
no	O
masses	B
or	O
organomegaly	B
noted	O
.	O

extremities	O
:	O
no	O
c	B
/	O
c	B
/	O
e	B
bilaterally	O
,	O
1	O
+	O
radial	O
,	O
dp	O
pulses	O
bilaterally	O
.	O

neurologic	O
:	O

-	O
mental	O
status	O
:	O
opens	O
eyes	O
transiently	O
to	O
verbal	O
or	O
noxious	O
stimuli	O
,	O
but	O
very	O
inattentive	B
.	O

oriented	B
to	I
self	I
only	I
.	O

language	B
nonfluent	I
with	O
intact	O
repetition	O
for	O
one	O
word	O
phrases	O
,	O
inconsistently	B
follows	I
commands	I
.	O

-	O
cranial	O
nerves	O
:	O
perrl	O
3	O
to	O
2mm	O
.	O

funduscopic	O
exam	O
revealed	O
no	O
papilledema	B
,	O
exudates	B
,	O
or	O
hemorrhages	B
.	O

vff	O
to	O
threat	O
.	O

eomi	O
.	O

left	O
facial	B
droop	I
.	O

tongue	B
protrudes	I
in	O
midline	O
.	O

-	O
motor	O
:	O
atrophic	B
musculature	I
throughout	O
.	O

tone	B
is	I
spastic	I
on	O
the	O
left	O
.	O

dense	O
left	B
hemiplegia	I
.	O

withdraws	O
to	O
noxious	O
stimuli	O
on	O
the	O
right	O
and	O
is	O
at	O
least	O
antigravity	O
strength	O
throughout	O
on	O
the	O
right	O
(	O
formal	O
strength	O
testing	O
limited	O
by	O
impersistence	O
)	O
.	O

no	O
adventitious	B
movements	I
noted	O
.	O

-	O
sensory	O
:	O
grimaces	O
to	O
noxious	O
stimuli	O
in	O
all	O
four	O
extremities	O
.	O

-	O
dtrs	O
:	O

[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
*	O
*	O
]	O
tri	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
3127	O
*	O
*	O
]	O
pat	O
ach	O

l	O
3	O
3	O
3	O
3	O
0	O

r	O
3	O
3	O
3	O
3	O
0	O

plantar	O
response	O
was	O
extensor	O
bilaterally	O
.	O

pertinent	O
results	O
:	O

laboratory	O
data	O
:	O

6	O
.	O
5>	O
13	O
.	O
4	O
<177	O
mcv	O
99	O

40	O
.	O
7	O

pt	O
:	O
12	O
.	O
2	O
ptt	O
:	O
29	O
.	O
4	O
inr	O
:	O
1	O

na	O
:	O
143	O

k	O
:	O
5	O
.	O
2	O

cl	O
:	O
110	O
tco2	O
:	O
21	O

glu	O
:	O
80	O

lactate	O
:	O
3	O
.	O
3	O

bun	O
29	O
creatinine	O
1	O
.	O
8	O

ua	O
positive	O

radiologic	O
data	O
:	O

nchct	O
:	O
large	O
area	O
of	O
encephalomalacia	B
in	O
mca	O
territory	O
on	O
the	O
right	O
.	O

no	O
evidence	O
of	O
hemorrhage	B
or	O
evolving	O
infarction	B
.	O

brief	O
hospital	O
course	O
:	O

in	O
brief	O
,	O
the	O
patient	O
is	O
an	O
87	O
year	O
old	O
woman	O
with	O
history	O
of	O
right	O
mca	O
stroke	B
who	O
was	O
admitted	O
with	O
signs	O
and	O
symptoms	O
consistent	O
with	O
seizure	B
activity	I
potentially	O
related	O
to	O
a	O
new	O
cerebral	B
infarct	I
whose	O
course	O
was	O
complicated	O
by	O
asystolic	B
arrrest	I
,	O
and	O
anoxic	B
brain	I
injury	I
.	O

1	O
.	O
)	O

neurologically	O
,	O
as	O
mentioned	O
above	O
patient	O
has	O
history	O
of	O
right	O
mca	O
stroke	B
with	O
residual	O
left	B
hemiplegia	I
.	O

differential	O
for	O
her	O
acute	O
mental	B
status	I
change	I
included	O
seizure	B
,	O
infectious	B
,	O
metabolic	B
,	O
cardioembolic	B
with	O
clot	B
dissolution	O
.	O

an	O
mri	O
an	O
acute	O
ischemic	B
event	I
to	O
left	O
insula	O
and	O
the	O
left	O
parietotemporal	O
lobe	O
.	O

an	O
eeg	O
showed	O
encephalopathy	B
and	O
frequent	O
posterior	O
temporal	O
-	O
occipital	O
sharp	O
and	O
slow	B
wave	I
discharges	I
but	O
no	O
clear	O
seizure	B
activity	O
.	O

there	O
were	O
no	O
witnessed	O
convulsive	B
seizures	I
during	O
the	O
admission	O
.	O

as	O
the	O
patient	O
had	O
a	O
good	O
clinical	O
description	O
and	O
reason	O
for	O
seizure	B
focus	O
,	O
she	O
was	O
started	O
on	O
keppra	O
500iv	O
bid	O
and	O
increased	O
up	O
to	O
750mg	O
bid	O
after	O
72	O
hours	O
.	O

fasting	O
lipid	O
profile	O
was	O
acceptable	O
and	O
was	O
not	O
started	O
on	O
statin	O
.	O

she	O
was	O
normotensive	O
.	O

her	O
mental	B
status	I
did	O
not	O
improve	O
significantly	O
during	O
the	O
admission	O
.	O

she	O
continued	O
to	O
be	O
largely	O
unresponsive	B
only	O
very	O
rarely	O
speaking	O
,	O
and	O
never	O
responding	B
appropriately	I
.	O

it	O
was	O
thought	O
that	O
she	O
was	O
debilitated	O
by	O
the	O
old	O
right	O
hemisphere	O
infarct	B
combined	O
with	O
the	O
new	O
left	B
sided	I
infarct	I
.	O

as	O
her	O
quality	O
of	O
life	O
prior	O
to	O
admission	O
was	O
questionable	O
,	O
her	O
daughter	O
requested	O
palliative	O
care	O
involvement	O
.	O

patient's	O
uti	B
undergoing	O
treatment	O
and	O
recent	O
acute	O
stroke	B
were	O
discussed	O
with	O
palliative	O
care	O
.	O

after	O
discussing	O
with	O
palliative	O
care	O
,	O
the	O
daughter	O
requested	O
continuing	O
all	O
non	O
invasive	O
medical	O
care	O
to	O
see	O
if	O
there	O
would	O
be	O
any	O
improvement	O
.	O

on	O
[	O
*	O
*	O
05	O
-	O
21	O
*	O
*	O
]	O
,	O
the	O
daughter	O
requested	O
a	O
trial	O
of	O
tube	O
feeds	O
for	O
12	O
-	O
24	O
hours	O
to	O
see	O
if	O
this	O
would	O
improve	O
the	O
patient's	O
strength	O
and	O
ability	O
to	O
interact	O
.	O

on	O
[	O
*	O
*	O
05	O
-	O
22	O
*	O
*	O
]	O
she	O
requested	O
that	O
the	O
tube	O
feeds	O
be	O
continued	O
throughout	O
the	O
weekend	O
.	O

repeat	O
ct	O
[	O
*	O
*	O
05	O
-	O
22	O
*	O
*	O
]	O
showed	O
evolving	O
infarct	B
in	O
the	O
distribution	O
seen	O
on	O
mri	O
,	O
and	O
no	O
new	O
processess	B
.	O

a	O
second	O
eeg	O
study	O
[	O
*	O
*	O
05	O
-	O
23	O
*	O
*	O
]	O
showed	O
continued	O
intermittent	O
spike	O
/	O
waves	O
from	O
the	O
area	O
of	O
the	O
old	B
infarct	I
,	O
but	O
no	O
epileptiform	B
activity	I
.	O

her	O
course	O
was	O
further	O
complicated	O
as	O
she	O
suffered	O
an	O
asystolic	B
arrest	I
on	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
which	O
was	O
of	O
unclear	O
etiology	O
but	O
could	O
relate	O
to	O
depressed	O
mental	B
status	I
with	O
resulting	O
aspiration	B
pneumonia	I
/	O
pneumonitis	B
.	O

following	O
this	O
event	O
she	O
was	O
transferred	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
team	O
,	O
however	O
she	O
recovered	O
no	O
meaningful	B
neurologic	I
function	I
.	O

in	O
discussions	O
with	O
her	O
daughter	O
following	O
the	O
arrest	B
,	O
her	O
code	O
status	O
was	O
confirmed	O
to	O
be	O
dnr	B
.	O

her	O
gcs	O
and	O
brainstem	O
function	O
over	O
3	O
days	O
were	O
consistent	O
with	O
very	O
poor	O
prognosis	O
for	O
recovery	O
.	O

she	O
could	O
not	O
complete	O
an	O
apnea	B
test	O
secondary	O
to	O
abrupt	O
development	O
of	O
hypotension	B
that	O
recovered	O
following	O
early	O
termination	O
of	O
the	O
test	O
.	O

eeg	O
showed	O
no	O
cortical	B
activity	I
at	O
30	O
minutes	O
.	O

cerebral	O
blood	O
flow	O
studies	O
revealed	O
a	O
trace	B
amount	I
of	I
blood	I
flow	I
.	O

ultimately	O
,	O
the	O
patient's	O
condition	B
worsened	I
and	O
she	O
expired	O
.	O

the	O
family	O
was	O
notified	O
.	O

autopsy	O
was	O
declined	O
.	O

arrangements	O
were	O
made	O
for	O
the	O
patient	O
to	O
be	O
flown	O
to	O
[	O
*	O
*	O
country	O
*	O
*	O
]	O
for	O
burial	O
arrangements	O
.	O

patient	O
has	O
history	O
of	O
afib	B
and	O
was	O
subtherapeutic	O
on	O
admission	O
.	O

telemetry	O
showed	O
intermittent	O
afib	B
/	O
flutter	B
.	O

she	O
was	O
ruled	O
out	O
for	O
mi	B
with	O
3	O
consecutive	O
cardiac	O
enzymes	O
.	O

heparin	O
drip	O
was	O
started	O
and	O
titrated	O
for	O
goal	O
ptt	O
of	O
40	O
-	O
60	O
,	O
and	O
patient	O
was	O
unable	O
to	O
take	O
coumadin	O
due	O
to	O
failed	B
swallow	I
studies	O
.	O

infectious	O
disease	O
:	O
patient	O
had	O
positive	O
urinalysis	O
for	O
infection	B
and	O
cultures	O
grew	O
ecoli	O
sensitive	O
to	O
ceftriaxone	O
.	O

infection	B
was	O
treated	O
with	O
rocephin	O
1gm	O
iv	O
daily	O
.	O

gi	O
:	O
she	O
failed	B
swallow	I
study	O
on	O
[	O
*	O
*	O
05	O
-	O
18	O
*	O
*	O
]	O
and	O
she	O
was	O
maintained	O
npo	O
.	O

ng	O
tube	O
feeds	O
were	O
initially	O
not	O
started	O
per	O
daughter's	O
request	O
as	O
patient	O
had	O
previous	O
poor	O
baseline	O
.	O

however	O
,	O
as	O
explained	O
above	O
daughter	O
requested	O
tube	O
feeds	O
[	O
*	O
*	O
05	O
-	O
21	O
*	O
*	O
]	O
.	O

renal	O
:	O
there	O
were	O
no	O
acute	B
issues	I
on	O
presentation	O
,	O
however	O
following	O
her	O
arrest	B
she	O
developed	O
acute	O
non	B
-	I
oliguric	I
renal	I
failure	I
likely	O
secondary	O
to	O
atn	B
.	O

endocrine	O
:	O
tsh	O
was	O
normal	O
.	O

hba1c	O
:	O
5	O
.	O
6	O

disp	O
:	O
as	O
above	O
.	O

the	O
patient	O
was	O
pronounced	O
dead	O
on	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
31	O
*	O
*	O
]	O
.	O

medications	O
on	O
admission	O
:	O

-	O
sertraline	O
50mg	O
po	O
daily	O

-	O
mirtazapine	O
15mg	O
po	O
qhs	O

-	O
warfarin	O
3mg	O
po	O
qhs	O
(	O
on	O
hold	O
for	O
the	O
past	O
10	O
days	O
)	O
-	O
pantoprazole	O
40mg	O
po	O
daily	O

-	O
folate	O
1mg	O
po	O
daily	O

-	O
atenolol	O
12	O
.	O
5mg	O
po	O
daily	O

discharge	O
medications	O
:	O

na	O

discharge	O
disposition	O
:	O

expired	O

discharge	O
diagnosis	O
:	O

primary	O
:	O

seizure	B

stroke	I

cardiac	I
arrest	I

anoxic	I
brain	I
injury	I

aspiration	I
pneumonitis	I

secondary	O
:	O

urinary	B
tract	I
infection	I

atrial	I
fibrillation	I

discharge	O
condition	O
:	O

expired	O

discharge	O
instructions	O
:	O

na	O

followup	O
instructions	O
:	O

na	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1365	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1366	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
black	O
md	O
[	O
*	O
*	O
md	O
number	O
2962	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
31	O
*	O
*	O
]	O
@	O
2203	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
5	O
:	O
38	O
pm	O

(	O
end	O
of	O
report	O
)	O

17465	O
||||	O
2136	O
||||	O
1793	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
02	O
-	O
22	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
02	O
-	O
15	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
02	O
-	O
22	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1946	O
-	O
12	O
-	O
16	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
c	O
-	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
64	O
-	O
year	O
-	O
old	O
male	O
with	O
a	O
past	O
medical	O
history	O
significant	O
for	O
end	B
-	I
stage	I
renal	I
disease	I
(	O
on	O
hemodialysis	O
)	O
who	O
was	O
admitted	O
on	O
[	O
*	O
*	O
02	O
-	O
15	O
*	O
*	O
]	O
to	O
the	O
surgical	O
transplant	O
service	O
for	O
arteriovenous	B
fistula	I
revision	O
and	O
thrombectomy	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
end	B
-	I
stage	I
renal	I
disease	I
(	O
on	O
hemodialysis	O
on	O
monday	O
,	O

wednesday	O
,	O
and	O
friday	O
)	O
.	O

2	O
.	O
history	O
of	O
pancreatitis	B
.	O

3	O
.	O
status	O
post	O
cerebrovascular	B
accident	I
in	O
[	O
*	O
*	O
1996	O
*	O
*	O
]	O
with	O
residual	O
left	O
hemiparesis	B
.	O

4	O
.	O
history	O
of	O
gout	B
.	O

5	O
.	O
multiple	O
escherichia	B
coli	I
bacteremia	I
infections	I
.	O

6	O
.	O
diverticulosis	B
.	O

7	O
.	O
chronic	B
obstructive	I
pulmonary	I
disease	I
.	O

8	O
.	O
hypertension	B
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
on	O
admission	O
:	O

1	O
.	O
enalapril	O
20	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
labetalol	O
200	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
isosorbide	O
dinitrate	O
20	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

4	O
.	O
clonidine	O
tts	O
#3	O
patch	O
every	O
thursday	O
.	O

5	O
.	O
sevelamer	O
800	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

6	O
.	O
nephrocaps	O
one	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

7	O
.	O
lipitor	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

social	O
history	O
:	O
the	O
patient	O
is	O
an	O
emigrant	O
from	O
[	O
*	O
*	O
country	O
1052	O
*	O
*	O
]	O
.	O

the	O
patient	O
is	O
married	O
and	O
lives	O
with	O
his	O
wife	O
.	O

the	O
patient	O
speaks	O
[	O
*	O
*	O
ethnicity	O
1991	O
*	O
*	O
]	O
creole	O
as	O
well	O
as	O
some	O
english	O
.	O

the	O
patient	O
denies	O
a	O
history	O
of	O
tobacco	O
,	O
alcohol	O
,	O
as	O
well	O
as	O
illicit	O
drug	O
use	O
.	O

family	O
history	O
:	O
family	O
history	O
unknown	O
.	O

physical	O
examination	O
on	O
presentation	O
:	O
physical	O
examination	O
on	O
transfer	O
from	O
the	O
surgery	O
service	O
to	O
cardiology	O
service	O
revealed	O
temperature	O
was	O
98	O
.	O
6	O
,	O
blood	O
pressure	O
was	O
140	O
/	O
70	O
,	O
heart	O
rate	O
was	O
91	O
,	O
respiratory	O
rate	O
was	O
16	O
,	O
and	O
oxygen	O
saturation	O
was	O
98%	O
on	O
room	O
air	O
.	O

in	O
general	O
,	O
the	O
patient	O
was	O
a	O
well	O
-	O
developed	O
and	O
well	O
-	O
nourished	O
male	O
complaining	O
of	O
chest	B
pain	I
.	O

in	O
moderate	O
distress	B
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
examination	O
revealed	O
normocephalic	O
and	O
atraumatic	O
.	O

sclerae	O
were	O
anicteric	O
.	O

pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

the	O
oropharynx	O
was	O
clear	O
.	O

mucous	O
membranes	O
were	O
moist	O
.	O

the	O
neck	O
was	O
supple	O
.	O

no	O
jugular	B
venous	I
distention	I
or	O
lymphadenopathy	B
appreciated	O
.	O

cardiovascular	O
examination	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

normal	O
first	O
heart	O
sound	O
and	O
second	O
heart	O
sound	O
.	O

a	O
systolic	B
murmur	I
at	O
the	O
right	O
upper	O
sternal	O
border	O
with	O
no	O
third	B
heart	I
sound	I
or	O
fourth	B
heart	I
sound	I
appreciated	O
.	O

pulmonary	O
examination	O
was	O
clear	O
to	O
auscultation	O
bilaterally	O
without	O
wheezes	B
,	O
rhonchi	B
,	O
or	O
rales	B
.	O

abdominal	O
examination	O
revealed	O
soft	O
and	O
nondistended	O
.	O

diffusely	O
tender	O
without	O
guarding	B
or	O
rebound	B
.	O

normal	O
active	O
bowel	O
sounds	O
.	O

extremity	O
examination	O
revealed	O
no	O
edema	B
.	O

dorsalis	O
pedis	O
and	O
posterior	O
tibialis	O
pulses	O
were	O
2	O
+	O
.	O

right	O
arm	O
arteriovenous	B
fistula	I
dressing	O
was	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
with	O
a	O
palpable	O
thrill	B
.	O

pertinent	O
laboratory	O
values	O
on	O
presentation	O
:	O
admission	O
laboratories	O
revealed	O
complete	O
blood	O
count	O
with	O
a	O
white	O
blood	O
cell	O
count	O
of	O
5	O
.	O
2	O
,	O
hematocrit	O
was	O
31	O
.	O
3	O
,	O
and	O
platelets	O
were	O

121	O
.	O

inr	O
was	O
1	O
.	O
1	O
.	O

chemistry	O
-	O
7	O
revealed	O
sodium	O
was	O
138	O
,	O
potassium	O
was	O
4	O
.	O
2	O
,	O
chloride	O
was	O
99	O
,	O
bicarbonate	O
was	O
19	O
,	O
blood	O
urea	O
nitrogen	O
was	O
76	O
,	O
creatinine	O
was	O
3	O
.	O
3	O
,	O
and	O
blood	O
glucose	O
was	O
126	O
.	O

calcium	O
was	O
9	O
.	O
4	O
,	O
magnesium	O
was	O
2	O
.	O
1	O
,	O
and	O
phosphate	O
was	O
9	O
.	O
5	O
.	O

the	O
patient	O
had	O
multiple	O
sets	O
of	O
cardiac	O
enzymes	O
with	O
negative	O
creatine	O
kinase	O
(	O
peak	O
of	O
90	O
)	O
and	O
an	O
evaluated	O
troponin	O
i	O
with	O
a	O
peak	O
of	O
29	O
.	O

she	O
also	O
had	O
a	O
cholesterol	O
panel	O
during	O
her	O
hospitalization	O
with	O
a	O
total	O
cholesterol	O
of	O
118	O
,	O
triglycerides	O
were	O
87	O
,	O
high	O
-	O
density	O
lipoprotein	O
was	O
34	O
,	O
and	O
low	O
-	O
density	O
lipoprotein	O
was	O
67	O
.	O

hemoglobin	O
a1c	O
was	O
5	O
.	O
8	O
.	O

radiology	O
/	O
imaging	O
:	O
the	O
patient's	O
electrocardiogram	O
on	O
hospital	O
day	O
two	O
demonstrated	O
a	O
normal	O
sinus	O
rhythm	O
at	O
68	O
with	O
atrioventricular	O
conduction	B
delay	I
.	O

new	O
t	B
wave	I
inversions	I
in	O
leads	O
i	O
,	O
avl	O
,	O
v4	O
through	O
v6	O
.	O

q	O
waves	O
in	O
leads	O
in	O
iii	O
and	O
avf	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
underwent	O
arteriovenous	B
fistula	I
repair	O
and	O
thrombectomy	O
on	O
hospital	O
day	O
one	O
without	O
complications	B
.	O

however	O
,	O
on	O
postoperative	O
day	O
one	O
,	O
the	O
patient	O
developed	O
the	O
acute	O
onset	O
of	O
substernal	B
chest	I
pain	I
with	O
diaphoresis	B
,	O
nausea	B
,	O
and	O
vomiting	B
.	O

an	O
electrocardiogram	O
demonstrated	O
new	O
t	B
wave	I
inversions	I
in	O
the	O
anterolateral	O
leads	O
,	O
and	O
the	O
patient	O
was	O
sent	O
for	O
emergent	O
cardiac	O
catheterization	O
.	O

cardiac	O
catheterization	O
revealed	O
3	B
-	I
vessel	I
disease	I
with	O
70%	O
proximal	O
and	O
95%	O
mid	O
left	O
anterior	O
descending	O
artery	O
stenosis	B
,	O
70%	O
proximal	O
left	O
circumflex	O
stenosis	B
,	O
80%	O
second	O
obtuse	O
marginal	O
stenosis	B
,	O
and	O
75%	O
proximal	O
and	O
80%	O
mid	O
right	O
coronary	B
artery	I
stenosis	I
.	O

the	O
patient	O
underwent	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
and	O
stenting	O
(	O
times	O
two	O
)	O
of	O
the	O
left	O
anterior	O
descending	O
artery	O
with	O
good	O
results	O
.	O

the	O
patient	O
had	O
a	O
stable	O
post	O
catheterization	O
course	O
until	O

[	O
*	O
*	O
02	O
-	O
17	O
*	O
*	O
]	O
;	O
when	O
,	O
during	O
hemodialysis	O
,	O
the	O
patient	O
complained	O
of	O
abdominal	B
pain	I
with	O
nausea	B
and	O
vomiting	B
.	O

hemodialysis	O
was	O
discontinued	O
early	O
,	O
and	O
the	O
patient	O
was	O
returned	O
to	O
the	O
floor	O
where	O
the	O
nausea	B
and	O
vomiting	B
continued	O
,	O
and	O
the	O
patient	O
complained	O
of	O
recurrent	O
chest	B
pain	I
.	O

a	O
repeat	O
electrocardiogram	O
demonstrated	O
anteroinferior	B
st	I
elevations	I
,	O
and	O
the	O
patient	O
went	O
for	O
emergent	O
re	O
-	O
look	O
catheterization	O
.	O

catheterization	O
was	O
without	O
evidence	O
of	O
acute	O
thrombosis	B
or	O
change	O
in	O
anatomy	O
,	O
and	O
no	O
intervention	O
was	O
required	O
.	O

however	O
,	O
immediately	O
status	O
post	O
catheterization	O
,	O
the	O
patient	O
developed	O
large	O
hematemesis	B
;	O
initially	O
coffee	B
-	I
grounds	I
emesis	I
followed	O
by	O
bright	B
red	I
blood	I
per	I
rectum	I
.	O

the	O
patient	O
was	O
hemodynamically	O
stable	O
and	O
without	O
chest	B
pain	I
at	O
the	O
time	O
and	O
was	O
transferred	O
to	O
the	O
cardiothoracic	O
intensive	O
care	O
unit	O
for	O
further	O
management	O
.	O

the	O
patient's	O
blood	O
pressure	O
medications	O
were	O
held	O
,	O
and	O
the	O
patient	O
was	O
transfused	O
one	O
unit	O
of	O
packed	O
red	O
blood	O
cells	O
for	O
a	O
hematocrit	O
of	O
25	O
.	O
6	O
(	O
down	O
from	O
31	O
twelve	O
hours	O
prior	O
)	O
.	O

the	O
patient	O
refused	O
a	O
nasogastric	O
lavage	O
and	O
was	O
started	O
on	O
high	O
-	O
dose	O
proton	O
pump	O
inhibitor	O
without	O
further	O
episodes	O
of	O
hematemesis	B
.	O

the	O
patient	O
continued	O
to	O
remain	O
hemodynamically	O
stable	O
without	O
further	O
episodes	O
of	O
chest	B
pain	I
.	O

an	O
echocardiogram	O
was	O
performed	O
which	O
demonstrated	O
mild	O
left	O
and	O
right	B
atrial	I
dilatation	I
,	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
,	O
normal	O
right	O
and	O
left	O
ventricular	O
size	O
and	O
function	O
,	O
with	O
an	O
ejection	O
fraction	O
of	O
55%	O
,	O
moderate	O
aortic	B
root	I
dilatation	I
,	O
and	O
1	O
+	O
aortic	B
regurgitation	I
,	O
and	O
trivial	O
tricuspid	B
regurgitation	I
.	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
cardiac	O
medicine	O
floor	O
where	O
he	O
remained	O
for	O
48	O
hours	O
.	O

the	O
patient's	O
hematocrit	O
remained	O
stable	O
with	O
a	O
discharge	O
hematocrit	O
of	O
33	O
.	O
4	O
.	O

there	O
was	O
no	O
further	O
need	O
for	O
a	O
transfusion	O
.	O

the	O
patient	O
remained	O
hemodynamically	O
stable	O
,	O
and	O
blood	O
pressure	O
medications	O
were	O
restarted	O
without	O
complications	B
.	O

the	O
patient	O
has	O
a	O
history	O
of	O
end	B
-	I
stage	I
renal	I
disease	I
(	O
on	O
hemodialysis	O
three	O
times	O
per	O
week	O
)	O
.	O

the	O
patient	O
was	O
continued	O
on	O
hemodialysis	O
throughout	O
the	O
hospitalization	O
via	O
a	O
temporary	O
port	O
while	O
the	O
arteriovenous	B
fistula	I
matured	O
.	O

the	O
arteriovenous	B
fistula	I
remained	O
dressed	O
and	O
without	O
signs	O
of	O
infection	B
.	O

condition	O
at	O
discharge	O
:	O
condition	O
on	O
discharge	O
was	O
good	O
;	O
ambulating	O
without	O
difficulty	O
,	O
chest	B
pain	I
free	O
,	O
and	O
without	O
further	O
evidence	O
of	O
bleeding	B
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
non	B
-	I
st	I
-	I
elevation	I
myocardial	I
infarction	I
.	O

2	O
.	O
status	O
post	O
cardiac	O
catheterization	O
with	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
and	O
stenting	O
of	O
the	O
left	O
anterior	O
descending	O
artery	O
.	O

3	O
.	O
upper	B
gastrointestinal	I
bleed	I
(	O
no	O
intervention	O
)	O
.	O

4	O
.	O
status	O
post	O
arteriovenous	B
fistula	I
repair	O
and	O
thrombectomy	O
.	O

5	O
.	O
end	B
-	I
stage	I
renal	I
disease	I
(	O
on	O
hemodialysis	O
)	O
.	O

6	O
.	O
cerebrovascular	B
accident	I
with	O
residual	O
left	O
hemiparesis	B
.	O

7	O
.	O
chronic	B
obstructive	I
pulmonary	I
disease	I
.	O

8	O
.	O
gout	B
.	O

9	O
.	O
diverticulosis	B
.	O

10	O
.	O

multiple	O
escherichia	B
coli	I
bacteremia	I
infections	I
.	O

medications	O
on	O
discharge	O
:	O

1	O
.	O
plavix	O
75	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O
(	O
times	O
three	O
months	O
)	O
.	O

2	O
.	O
enalapril	O
20	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
labetalol	O
200	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
protonix	O
40	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

5	O
.	O
isosorbide	O
dinitrate	O
20	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

6	O
.	O
sevelamer	O
hydrochloride	O
800	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

7	O
.	O
nephrocaps	O
one	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

8	O
.	O
sublingual	O
nitroglycerin	O
0	O
.	O
3	O
mg	O
tablet	O
as	O
needed	O
(	O
for	O
chest	B
pain	I
)	O
.	O

9	O
.	O
clonidine	O
patch	O
tts	O
#3	O
every	O
week	O
.	O

discharge	O
status	O
:	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
with	O

visiting	O
nurse	O
association	O
services	O
for	O
medication	O
teaching	O
and	O
compliance	O
reinforcement	O
.	O

discharge	O
instructions	O
/	O
followup	O
:	O

1	O
.	O
the	O
patient	O
was	O
instructed	O
to	O
continue	O
hemodialysis	O
as	O
per	O
usual	O
on	O
the	O
day	O
status	O
post	O
discharge	O
.	O

2	O
.	O
an	O
appointment	O
with	O
vascular	O
/	O
transplant	O
surgery	O
;	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
201	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
03	O
-	O
03	O
*	O
*	O
]	O
at	O
2	O
p	O
.	O
m	O
.	O
at	O
[	O
*	O
*	O
street	O
address	O
4745	O
*	O
*	O
]	O
.	O

3	O
.	O
the	O
patient	O
was	O
scheduled	O
with	O
primary	O
care	O
physician	O
(	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
)	O
for	O
an	O
initial	O
appointment	O
on	O
[	O
*	O
*	O
03	O
-	O
14	O
*	O
*	O
]	O
at	O
3	O
:	O
30	O
p	O
.	O
m	O
.	O
in	O
the	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
636	O
*	O
*	O
]	O
building	O
,	O
sixth	O
floor	O
,	O
[	O
*	O
*	O
hospital	O
146	O
*	O
*	O
]	O
clinic	O
.	O

4	O
.	O
the	O
patient	O
was	O
scheduled	O
for	O
an	O
initial	O
gastroenterology	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
915	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
03	O
-	O
15	O
*	O
*	O
]	O
at	O
1	O
:	O
20	O
in	O
the	O
west	O
campus	O
clinic	O
.	O

5	O
.	O
the	O
patient	O
was	O
scheduled	O
for	O
an	O
initial	O
cardiology	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3755	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
03	O
-	O
16	O
*	O
*	O
]	O
at	O
9	O
a	O
.	O
m	O
.	O
at	O
[	O
*	O
*	O
street	O
address	O
4745	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
130	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
4445	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1089	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2011	O
-	O
02	O
-	O
25	O
*	O
*	O
]	O
12	O
:	O
48	O

t	O
:	O
[	O
*	O
*	O
2011	O
-	O
03	O
-	O
01	O
*	O
*	O
]	O
07	O
:	O
53	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
4746	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
130	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2011	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
2	O
:	O
58	O
pm	O

(	O
end	O
of	O
report	O
)	O

69810	O
||||	O
2405	O
||||	O
26570	O
||||	O
ecg	O
_	O
report	O
||||	O
2016	O
-	O
10	O
-	O
16	O
10	O
:	O
49	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I

atrial	I
premature	I
complex	I

left	I
atrial	I
abnormality	I

left	I
anterior	I
fascicular	I
block	I

nonspecific	O
inferoapical	O
t	B
wave	I
abnormalities	I
-	O
clinical	O
correlation	O
is	O
suggested	O
since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2016	O
-	O
10	O
-	O
12	O
*	O
*	O
]	O
,	O
further	O
t	B
wave	I
changes	I
present	O

26171	O
||||	O
2410	O
||||	O
20111	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
07	O
-	O
24	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
24	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1943	O
-	O
07	O
-	O
08	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
4235	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

aortic	B
stenosis	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

redo	O
sternotomy	O
,	O
avr	O
(	O
23mm	O
st	O
.	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
)	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O

history	O
of	O
present	O
illness	O
:	O

the	O
patient	O
is	O
a	O
71	O
year	O
old	O
man	O
.	O

he	O
was	O
approximately	O
19	O
years	O
status	O
post	O
coronary	O
bypass	O
grafting	O
.	O

all	O
the	O
grafts	O
are	O
patent	O
,	O
including	O
the	O
left	O
internal	O
mammary	O
artery	O
to	O
the	O
left	O
anterior	O
descending	O
artery	O
.	O

he	O
had	O
a	O
70%	O
lesion	B
of	O
the	O
proximal	O
circumflex	O
graft	O
.	O

he	O
has	O
,	O
however	O
,	O
severe	O
aortic	B
stenosis	I
,	O
aortic	B
insufficiency	I
,	O
and	O
recent	O
onset	O
atrial	B
fibrillation	I
.	O

it	O
was	O
proposed	O
to	O
perform	O
re	O
-	O
do	O
sternotomy	O
,	O
aortic	O
valve	O
replacement	O
and	O
possible	O
bypass	O
grafting	O
to	O
the	O
circumflex	O
artery	O
.	O

past	O
medical	O
history	O
:	O

myocardial	B
infarction	I
1980	O

cabgx4	O
1986	O

atrial	B
fibrillation	I
[	O
*	O
*	O
11	O
-	O
18	O
*	O
*	O
]	O

failed	O
cardioversion	O
[	O
*	O
*	O
03	O
-	O
21	O
*	O
*	O
]	O

s	O
/	O
p	O
turp	O

past	O
pneumonia	B
/	O
sepsis	B

hyperlipidemia	I

hypercholesterolemia	I

social	O
history	O
:	O

40	O
pack	O
year	O
smoking	O
history	O
quit	O
in	O
[	O
*	O
*	O
1972	O
*	O
*	O
]	O
.	O

drinks	O
2	O
-	O
3	O
drinks	O
nightly	O
.	O

married	O
and	O
lives	O
in	O
[	O
*	O
*	O
location	O
684	O
*	O
*	O
]	O

family	O
history	O
:	O

notable	O
for	O
coronary	B
artery	I
disease	I
.	O

physical	O
exam	O
:	O

gen	O
:	O
elderly	O
gentleman	O
in	O
no	O
acute	O
distress	O

heent	O
:	O
normocephalic	O
/	O
atraumatic	O
,	O
pupils	O
equal	O
,	O
round	O
and	O
reactive	O
.	O

oropharynx	O
benign	O
.	O

lungs	O
:	O
clear	O

heart	O
:	O
iii	O
/	O
vi	O
systolic	B
murmur	I
,	O
irregular	O
rate	O
and	O
rhythm	O

abd	O
:	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
normal	O
active	O
bowel	O
sounds	O
/	O
ext	O
:	O
no	O
clubbing	B
,	O
cyanosis	B
or	O
edema	B
.	O

right	O
leg	O
saphenectomy	O
partial	O
left	O
leg	O
saphenectomy	O
.	O

pulses	O
2	O
+	O
femoral	O
,	O
1	O
+	O
dp	O
/	O
pt	O
.	O

neuro	O
:	O
nonfocal	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2014	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
11	O
:	O
51pm	O
pt	O
-	O
13	O
.	O
4	O
*	O
ptt	O
-	O
47	O
.	O
3	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O

[	O
*	O
*	O
2014	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
05	O
:	O
16pm	O
urine	O
color	O
-	O
yellow	O
appear	O
-	O
clear	O
sp	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
7	O
*	O
*	O
]	O
-	O
1	O
.	O
018	O

[	O
*	O
*	O
2014	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
05	O
:	O
16pm	O
urine	O
blood	O
-	O
neg	O
nitrite	O
-	O
neg	O
protein	O
-	O
neg	O
glucose	O
-	O
neg	O
ketone	O
-	O
neg	O
bilirubin	O
-	O
neg	O
urobilngn	O
-	O
neg	O
ph	O
-	O
5	O
.	O
0	O
leuk	O
-	O
neg	O

[	O
*	O
*	O
2014	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
03	O
:	O
54pm	O
glucose	O
-	O
107	O
*	O
urea	O
n	O
-	O
22	O
*	O
creat	O
-	O
1	O
.	O
0	O
sodium	O
-	O
139	O
potassium	O
-	O
4	O
.	O
4	O
chloride	O
-	O
103	O
total	O
co2	O
-	O
25	O
anion	O
gap	O
-	O
15	O

[	O
*	O
*	O
2014	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
03	O
:	O
54pm	O
alt	O
(	O
sgpt	O
)	O
-	O
33	O
ast	O
(	O
sgot	O
)	O
-	O
22	O
alk	O
phos	O
-	O
92	O
amylase	O
-	O
39	O
tot	O
bili	O
-	O
1	O
.	O
0	O

[	O
*	O
*	O
2014	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
03	O
:	O
54pm	O
wbc	O
-	O
5	O
.	O
3	O
rbc	O
-	O
4	O
.	O
33	O
*	O
hgb	O
-	O
13	O
.	O
4	O
*	O
hct	O
-	O
39	O
.	O
0	O
*	O
mcv	O
-	O
90	O
mch	O
-	O
30	O
.	O
9	O
mchc	O
-	O
34	O
.	O
4	O
rdw	O
-	O
13	O
.	O
7	O

[	O
*	O
*	O
2014	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
05	O
:	O
15am	O
blood	O
wbc	O
-	O
4	O
.	O
8	O
rbc	O
-	O
2	O
.	O
51	O
*	O
hgb	O
-	O
7	O
.	O
5	O
*	O
hct	O
-	O
23	O
.	O
3	O
*	O
mcv	O
-	O
93	O
mch	O
-	O
30	O
.	O
0	O
mchc	O
-	O
32	O
.	O
3	O
rdw	O
-	O
13	O
.	O
9	O
plt	O
ct	O
-	O
132	O
*	O

[	O
*	O
*	O
2014	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
01	O
:	O
00pm	O
blood	O
hct	O
-	O
24	O
.	O
7	O
*	O

[	O
*	O
*	O
2014	O
-	O
07	O
-	O
23	O
*	O
*	O
]	O
06	O
:	O
10am	O
blood	O
glucose	O
-	O
114	O
*	O
urean	O
-	O
12	O
creat	O
-	O
1	O
.	O
1	O
na	O
-	O
139	O
k	O
-	O
5	O
.	O
0	O
cl	O
-	O
103	O
hco3	O
-	O
26	O
angap	O
-	O
15	O

[	O
*	O
*	O
2014	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
03	O
:	O
54pm	O
blood	O
alt	O
-	O
33	O
ast	O
-	O
22	O
alkphos	O
-	O
92	O
amylase	O
-	O
39	O
totbili	O
-	O
1	O
.	O
0	O

ekg	O

-	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O

atrial	B
fibrillation	I

consider	O
prior	O
inferior	B
myocardial	I
infarction	I
although	O
is	O
nondiagnostic	O

modest	O
right	B
ventricular	I
conduction	I
delay	I

left	I
ventricular	I
hypertrophy	I
by	O
voltage	O

since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
07	O
*	O
*	O
]	O
,	O
limb	O
lead	O
qrs	O
voltage	O
more	O
prominent	O

-	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O

sinus	B
tachycardia	I

consider	O
prior	O
inferior	B
myocardial	I
infarction	I
although	O
is	O
nondiagnostic	O

nonspecific	O
st	O
-	O
t	O
abnormalities	O

since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
,	O
atrial	B
fibrillation	I
absent	O
and	O
sinus	B

tachycardia	I
with	O
st	B
-	I
t	I
wave	I
changes	I
now	O
seen	O

cxr	O

-	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O

1	O
)	O
tiny	O
right	O
apical	O
pneumothorax	B
;	O
no	O
other	O
acute	B
cardiopulmonary	I
process	I
.	O

2	O
)	O
multiple	O
lines	O
and	O
tubes	O
as	O
described	O
above	O
;	O
ng	O
tube	O
could	O
be	O
advanced	O
several	O
cm	O

-	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
23	O
*	O
*	O
]	O

no	O
pleural	B
effusions	I
are	O
identified	O
.	O

brief	O
hospital	O
course	O
:	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
was	O
admitted	O
to	O
the	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1505	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
medical	O
center	O
on	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
13	O
*	O
*	O
]	O
for	O
preoperative	O
anticoagulation	O
and	O
surgical	O
management	O
of	O
his	O
aortic	B
valve	I
disease	I
.	O

heparin	O
was	O
started	O
and	O
he	O
was	O
worked	O
-	O
up	O
in	O
the	O
usual	O
preoperative	O
manner	O
.	O

on	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O
,	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
was	O
taken	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
a	O
redo	O
sternotomy	O
with	O
an	O
aortic	O
valve	O
replacement	O
utilizing	O
a	O
23mm	O
st	O
.	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
mechanical	O
valve	O
.	O

postoperatively	O
he	O
was	O
taken	O
to	O
the	O
cardiac	O
surgical	O
intensive	O
care	O
unit	O
for	O
monitoring	O
.	O

on	O
postoperative	O
day	O
one	O
,	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
7875	O
*	O
*	O
]	O
neurologically	O
intact	O
and	O
was	O
extubated	O
.	O

he	O
was	O
then	O
transferred	O
to	O
the	O
cardiac	O
surgical	O
step	O
down	O
unit	O
for	O
further	O
recovery	O
.	O

he	O
was	O
gently	O
diuresed	O
towards	O
his	O
preoperative	O
weight	O
.	O

coumadin	O
was	O
started	O
for	O
anticoagulation	O
for	O
his	O
mechanical	O
valve	O
and	O
atrial	B
fibrillation	I
.	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
had	O
pain	B
with	I
swallowing	I
and	O
his	O
medications	O
were	O
changed	O
to	O
elixirs	O
.	O

the	O
physical	O
therapy	O
service	O
was	O
consulted	O
for	O
assistance	O
with	O
his	O
postoperative	O
strength	O
and	O
mobility	O
.	O

the	O
otolaryngology	O
service	O
was	O
consulted	O
who	O
noted	O
a	O
mucosal	B
irregularity	I
on	O
the	O
posterior	O
pharyngeal	O
wall	O
.	O

saline	O
gargles	O
were	O
recommended	O
and	O
bactroban	O
nasal	O
ointment	O
for	O
epistaxis	B
prophylaxis	O
.	O

follow	O
-	O
up	O
was	O
recommended	O
in	O
3	O
weeks	O
to	O
assess	O
resolution	O
of	O
the	O
lesion	B
.	O

mr	O
.	O
[	O
*	O
*	O
name13	O
(	O
stitle	O
)	O
*	O
*	O
]	O
sore	B
throat	I
slowly	O
improved	O
so	O
that	O
he	O
was	O
able	O
to	O
adequately	O
take	O
in	O
sufficient	O
nutrition	O
.	O

as	O
his	O
inr	O
was	O
subtherapeutic	O
,	O
heparin	O
was	O
started	O
until	O
his	O
inr	O
was	O
within	O
range	O
.	O

ultimately	O
,	O
his	O
inr	O
rose	O
above	O
2	O
.	O
0	O
and	O
his	O
heparin	O
was	O
discontinued	O
.	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
continued	O
to	O
make	O
steady	O
progress	O
and	O
was	O
discharged	O
home	O
on	O
postoperative	O
day	O
ten	O
.	O

he	O
will	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
457	O
*	O
*	O
]	O
,	O
his	O
cardiologist	O
and	O
his	O
primary	O
care	O
physician	O
as	O
an	O
outpatient	O
.	O

medications	O
on	O
admission	O
:	O

zocor	O
20mg	O
daily	O

digoxin	O
0	O
.	O
25mg	O
daily	O

atenolol	O
12	O
.	O
5mg	O
daily	O

coumadin	O

discharge	O
medications	O
:	O

1	O
.	O
potassium	O
chloride	O
20	O
meq	O
tab	O
sust	O
.	O
rel	O
.	O

particle	O
/	O
crystal	O
sig	O
:	O
one	O
(	O
1	O
)	O
tab	O
sust	O
.	O
rel	O
.	O

particle	O
/	O
crystal	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
for	O
10	O
doses	O
.	O

disp	O
:	O
*	O
10	O
tab	O
sust	O
.	O
rel	O
.	O

particle	O
/	O
crystal	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

2	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

3	O
.	O
ranitidine	O
hcl	O
150	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4h	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B
.	O

disp	O
:	O
*	O
50	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

6	O
.	O
simvastatin	O
10	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

7	O
.	O
lorazepam	O
0	O
.	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q8h	O
(	O
every	O
8	O
hours	O
)	O
as	O
needed	O
.	O

disp	O
:	O
*	O
20	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

8	O
.	O
ascorbic	O
acid	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

9	O
.	O
ferrous	O
gluconate	O
300	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

10	O
.	O

metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
90	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

11	O
.	O

furosemide	O
40	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

12	O
.	O

coumadin	O
5	O
mg	O
tablet	O
sig	O
:	O
1	O
.	O
5	O
tablets	O
po	O
once	O
a	O
day	O
:	O
take	O
as	O
directed	O
by	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
1525	O
*	O
*	O
]	O
for	O
inr	O
goal	O
of	O
2	O
.	O
5	O
-	O
3	O
.	O

disp	O
:	O
*	O
45	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

aortic	B
stenosis	I

discharge	O
condition	O
:	O

good	O
.	O

discharge	O
instructions	O
:	O

follow	O
medications	O
on	O
discharge	O
instructions	O
.	O

you	O
may	O
not	O
drive	O
for	O
4	O
weeks	O
.	O

you	O
may	O
not	O
lift	O
more	O
than	O
10	O
lbs	O
.	O
for	O
3	O
months	O
.	O

you	O
should	O
shower	O
,	O
let	O
water	O
flow	O
over	O
wounds	O
,	O
pat	O
dry	O
with	O
a	O
towel	O
.	O

do	O
not	O
use	O
creams	O
,	O
lotions	O
,	O
or	O
powders	O
on	O
wounds	O
.	O

call	O
our	O
office	O
if	O
you	O
have	O
sternal	B
drainage	I
,	O
temp>101	O
.	O
5	O
.	O

followup	O
instructions	O
:	O

with	O
[	O
*	O
*	O
hospital	O
75	O
*	O
*	O
]	O
clinic	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
8766	O
*	O
*	O
]	O
in	O
2	O
-	O
3	O
weeks	O
make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
for	O
1	O
-	O
2	O
weeks	O
.	O

make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
457	O
*	O
*	O
]	O
for	O
4	O
weeks	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
4238	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
7876	O
*	O
*	O
]	O
pa	O
80	O
-	O
bye	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
25	O
*	O
*	O
]	O
@	O
1030	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
25	O
*	O
*	O
]	O
3	O
:	O
43	O
pm	O

(	O
end	O
of	O
report	O
)	O

6395	O
||||	O
2652	O
||||	O
26172	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
05	O
-	O
13	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
07	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
13	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1935	O
-	O
08	O
-	O
14	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
surgery	O

allergies	O
:	O

lipitor	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
3249	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

right	B
flank	I
pain	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

abscess	O
excision	O
,	O
right	O
flank	O

history	O
of	O
present	O
illness	O
:	O

79	O
year	O
-	O
old	O
gentleman	O
who	O
presents	O
with	O
a	O
30	O
-	O
pound	O
weight	B
loss	I
over	O
4	O
years	O
duration	O
and	O
some	O
feeling	O
of	O
fatigue	B
and	O
lack	B
of	I
function	I
in	O
addition	O
to	O
a	O
mass	B
,	O
which	O
has	O
now	O
become	O
quite	O
prominent	O
.	O

this	O
first	O
came	O
to	O
attention	O
when	O
he	O
presented	O
with	O
an	O
enlarging	O
mass	B
of	O
the	O
right	O
flank	O
approximately	O
twelve	O
months	O
ago	O
.	O

he	O
had	O
a	O
ct	O
scan	O
on	O
[	O
*	O
*	O
2014	O
-	O
02	O
-	O
25	O
*	O
*	O
]	O
which	O
reported	O
a	O
subcutaneous	B
mass	I
and	O
/	O
or	O
collection	O
of	O
2	O
.	O
7	O
x	O
3	O
.	O
9	O
cm	O
overlying	O
the	O
posterior	O
lateral	O
subcutaneous	O
fat	O
.	O

he	O
noted	O
the	O
mass	B
enlarging	O
in	O
size	O
for	O
the	O
past	O
6	O
months	O
.	O

he	O
has	O
slight	O
discomfort	B
when	O
he	O
sits	O
.	O

he	O
denies	O
fever	B
,	O
chills	B
,	O
and	O
redness	B
.	O

past	O
medical	O
history	O
:	O

*	O
cad	B

*	O
cabg	O
x	O
2	O

*	O
anterior	B
mi	I
at	O
age	O
37	O

*	O
chf	B
,	O
ef	O
25%	O
s	O
/	O
p	O
cardiac	O
resynchronization	O
and	O
biv	O
pacer	O
placement	O

*	O
hypertension	B

*	O
dyslipidemia	B

*	O
ccy	O
2002	O

*	O
remote	O
motor	O
vehicle	O
accident	O

social	O
history	O
:	O

retired	O
sales	O
officer	O
,	O
lives	O
along	O
in	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
5357	O
*	O
*	O
]	O
,	O
remote	O
tobacco	O
,	O
occasional	O
etoh	O

family	O
history	O
:	O

diabetes	B
,	O
hypertension	B
on	O
both	O
sides	O
of	O
the	O
family	O

physical	O
exam	O
:	O

well	O
appearing	O
male	O
in	O
no	O
acute	B
distress	I

chest	O
is	O
clear	O

regular	O
sinus	O
rhythm	O
,	O
grade	O
3	O
-	O
4	O
/	O
6	O
mitral	O
valve	O
murmur	B

abdomen	O
soft	O
,	O
non	O
-	O
tender	O
,	O
non	O
-	O
distended	O
,	O
well	O
healed	O
small	O
laparoscopic	O
scar	B
at	O
umbilicus	O
.	O

on	O
the	O
right	O
flank	O
,	O
there	O
is	O
a	O
12	O
x	O
13	O
cm	O
mass	B
,	O
which	O
is	O
bulging	O
upward	O
and	O
feels	O
somewhat	O
cystic	B
.	O

no	O
hernias	B

pertinent	O
results	O
:	O

admission	O
/	O
post	O
-	O
op	O
labs	O

[	O
*	O
*	O
2015	O
-	O
05	O
-	O
07	O
*	O
*	O
]	O
02	O
:	O
10pm	O
blood	O
wbc	O
-	O
12	O
.	O
1	O
*	O
rbc	O
-	O
3	O
.	O
87	O
*	O
hgb	O
-	O
10	O
.	O
7	O
*	O
hct	O
-	O
32	O
.	O
5	O
*	O

mcv	O
-	O
84	O
mch	O
-	O
27	O
.	O
8	O
mchc	O
-	O
33	O
.	O
1	O
rdw	O
-	O
15	O
.	O
7	O
*	O
plt	O
ct	O
-	O
233	O

[	O
*	O
*	O
2015	O
-	O
05	O
-	O
07	O
*	O
*	O
]	O
02	O
:	O
10pm	O
blood	O
glucose	O
-	O
133	O
*	O
urean	O
-	O
24	O
*	O
creat	O
-	O
1	O
.	O
1	O
na	O
-	O
137	O
k	O
-	O
4	O
.	O
7	O
cl	O
-	O
102	O
hco3	O
-	O
28	O
angap	O
-	O
12	O

[	O
*	O
*	O
2015	O
-	O
05	O
-	O
07	O
*	O
*	O
]	O
02	O
:	O
10pm	O
blood	O
calcium	O
-	O
7	O
.	O
9	O
*	O
phos	O
-	O
3	O
.	O
7	O
mg	O
-	O
2	O
.	O
0	O

microbiology~~~~~~~~~~~~~~~~~	O

#1	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
07	O
*	O
*	O
]	O
12	O
:	O
40	O
pm	O
tissue	O
contents	O
of	O
abscess	B
.	O

gram	O
stain	O
(	O
final	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
07	O
*	O
*	O
]	O
)	O
:	O

1	O
+	O
(	O
<1	O
per	O
1000x	O
field	O
)	O
:	O
polymorphonuclear	O

leukocytes	O
.	O

no	O
microorganisms	O
seen	O
.	O

tissue	O
(	O
final	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
10	O
*	O
*	O
]	O
)	O
:	O
no	O
growth	O
.	O

anaerobic	O
culture	O
(	O
final	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
13	O
*	O
*	O
]	O
)	O
:	O
no	O
growth	O
.	O

#2	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
07	O
*	O
*	O
]	O
11	O
:	O
50	O
am	O
abscess	O
rt	O
flank	O
.	O

gram	O
stain	O
(	O
final	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
07	O
*	O
*	O
]	O
)	O
:	O

3	O
+	O
(	O
5	O
-	O
10	O
per	O
1000x	O
field	O
)	O
:	O
polymorphonuclear	O

leukocytes	O
.	O

no	O
microorganisms	O
seen	O
.	O

wound	O
culture	O
(	O
final	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
09	O
*	O
*	O
]	O
)	O
:	O
no	O
growth	O
.	O

anaerobic	O
culture	O
(	O
final	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
13	O
*	O
*	O
]	O
)	O
:	O
no	O
growth	O
.	O

pathology~~~~~~~~~~~~~~~~~~~~~	O

specimen	O
submitted	O
:	O
abscess	B
right	I
flank	I
,	O
cavity	B
stones	I
,	O
and	O
gallstones	B
(	O
1	O
)	O
.	O

diagnosis	O
:	O

i	O
.	O

skin	O
,	O
right	O
flank	O
(	O
a	O
-	O
c	O
)	O
:	O

skin	O
with	O
subcutaneous	B
abscess	I
formation	O
.	O

ii	O
.	O

abscess	B
cautery	I
stones	I
:	O

gross	O
examination	O
only	O
.	O

iii	O
.	O

gallstones	B
:	O

gross	O
examination	O
only	O
.	O

radiology~~~~~~~~~~~~~~~~~~~~	O

carotid	O
series	O
complete	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
12	O
*	O
*	O
]	O
1	O
:	O
24	O
pm	O

findings	O
:	O
duplex	O
evaluation	O
was	O
performed	O
of	O
both	O
carotid	O
arteries	O
.	O

moderate	O
plaque	B
was	O
identified	O
on	O
the	O
right	O
.	O

on	O
the	O
right	O
,	O
peak	B
systolic	I
velocities	I
are	O
136	O
,	O
62	O
,	O
75	O
in	O
the	O
ica	O
,	O
cca	O
,	O
and	O
eca	O
respectively	O
.	O

the	O
ica	O
to	O
cca	O
ratio	O
is	O
2	O
.	O
1	O
.	O

this	O
is	O
consistent	O
with	O
a	O
40	O
-	O
59%	O
stenosis	B
.	O

on	O
the	O
left	O
,	O
peak	B
systolic	I
velocities	I
are	O
95	O
,	O
57	O
,	O
66	O
in	O
the	O
ica	O
,	O
cca	O
,	O
and	O
eca	O
respectively	O
.	O

the	O
ica	O
to	O
cca	O
ratio	O
is	O
1	O
.	O
6	O
.	O

this	O
is	O
consistent	O
with	O
less	O
than	O
40%	O
stenosis	B
.	O

there	O
is	O
antegrade	B
flow	I
in	O
both	O
vertebral	O
arteries	O
.	O

impression	O
:	O
on	O
the	O
right	O
,	O
there	O
is	O
moderate	O
plaque	B
with	O
a	O
40	O
-	O
59%	O
carotid	B
stenosis	I
.	O

on	O
the	O
left	O
,	O
there	O
is	O
a	O
less	O
than	O
40%	O
stenosis	B
.	O

brief	O
hospital	O
course	O
:	O

the	O
patient	O
was	O
admitted	O
on	O
the	O
day	O
of	O
surgery	O
.	O

due	O
to	O
his	O
significant	O
cardiac	O
history	O
a	O
pulmonary	O
artery	O
catheter	O
was	O
placed	O
in	O
the	O
or	O
for	O
hemodynamic	O
monitoring	O
post	O
-	O
operatively	O
.	O

he	O
was	O
extubated	O
easily	O
and	O
transferred	O
to	O
the	O
recovery	O
room	O
.	O

he	O
was	O
monitored	O
in	O
the	O
intensive	O
care	O
unit	O
post	O
-	O
operatively	O
for	O
fluid	O
management	O
and	O
cardiology	O
was	O
involved	O
for	O
recommendations	O
.	O

he	O
was	O
maintained	O
on	O
antibiotics	O
throughout	O
his	O
hospital	O
stay	O
,	O
however	O
the	O
culture	O
from	O
the	O
operating	O
room	O
failed	O
to	O
reveal	O
a	O
pathogen	O
.	O

he	O
tolerated	O
a	O
regular	O
diet	O
pod1	O
.	O

the	O
pa	O
catheter	O
was	O
removed	O
on	O
pod3	O
.	O

he	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
pod4	O
.	O

a	O
carotid	O
duplex	O
ultrasound	O
was	O
obtained	O
to	O
evaluate	O
a	O
soft	O
left	O
carotid	B
bruit	I
heard	O
during	O
his	O
hospital	O
stay	O
.	O
(	O
see	O
results	O
section	O
)	O
.	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
265	O
*	O
*	O
]	O
of	O
vascular	O
surgery	O
was	O
consulted	O
and	O
will	O
follow	O
-	O
up	O
with	O
the	O
patient	O
as	O
an	O
outpatient	O
for	O
further	O
monitoring	O
.	O

the	O
patient	O
had	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
1320	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
1321	O
*	O
*	O
]	O
drains	O
placed	O
during	O
the	O
surgery	O
and	O
these	O
remained	O
in	O
for	O
his	O
hospitalization	O
.	O

the	O
output	O
of	O
each	O
was	O
less	O
than	O
30cc	O
of	O
serosanguinous	O
fluid	O
at	O
discharge	O
.	O

he	O
was	O
instructed	O
as	O
to	O
care	O
and	O
emptying	O
of	O
the	O
drains	O
and	O
will	O
record	O
outputs	O
regularly	O
.	O

he	O
will	O
also	O
have	O
visiting	O
nursing	O
care	O
to	O
aid	O
in	O
his	O
wound	B
and	O
drain	O
care	O
.	O

he	O
was	O
discharged	O
to	O
home	O
on	O
augmentin	O
for	O
another	O
week	O
and	O
will	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
clinic	O
.	O

medications	O
on	O
admission	O
:	O

lasix	O
10mg	O
po	O
bid	O

lopressor	O
50mg	O
po	O
bid	O

lanoxin	O
0	O
.	O
25mg	O
po	O
bid	O

fosinopril	O
10mg	O
po	O
qday	O

aspirin	O
325	O
po	O
qday	O
(	O
held	O
)	O

zetia	O
10mg	O
po	O
qday	O

discharge	O
medications	O
:	O

1	O
.	O
metoprolol	O
tartrate	O
50	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

2	O
.	O
digoxin	O
250	O
mcg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

3	O
.	O
ezetimibe	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

4	O
.	O
hydrocodone	O
-	O
acetaminophen	O
5	O
-	O
500	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

5	O
.	O
aspirin	O
325	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

6	O
.	O
fosinopril	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
)	O
.	O

7	O
.	O
furosemide	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

8	O
.	O
augmentin	O
875	O
-	O
125	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
for	O
7	O
days	O
.	O

disp	O
:	O
*	O
14	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

dropped	B
gallstone	I
abscess	I
,	O
right	O
flank	O

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

please	O
call	O
if	O
you	O
are	O
experiencing	O
fevers	B
(	O
>101	O
.	O
5	O
)	O
,	O
are	O
having	O
a	O
significant	O
increase	O
in	O
pain	B
or	O
discomfort	B
,	O
notice	O
increasing	O
redness	O
,	O
swelling	O
,	O
or	O
drainage	O
from	O
your	O
wound	O
.	O

followup	O
instructions	O
:	O

please	O
call	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
4340	O
*	O
*	O
]	O
office	O
for	O
your	O
follow	O
-	O
up	O
appointment	O
in	O
2	O
weeks	O
.	O

follow	O
-	O
up	O
with	O
your	O
outpatient	O
cardiologist	O
.	O

you	O
may	O
make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
5358	O
*	O
*	O
]	O
at	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
373	O
*	O
*	O
]	O
if	O
you	O
wish	O
to	O
remain	O
under	O
his	O
care	O
for	O
cardiology	O
.	O

follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
265	O
*	O
*	O
]	O
will	O
be	O
arranged	O
through	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
after	O
your	O
follow	O
-	O
up	O
visit	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
126	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
3255	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
3256	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
1113	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1114	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1115	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
14	O
*	O
*	O
]	O
@	O
0922	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
126	O
*	O
*	O
]	O
[	O
*	O
*	O
initial	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
44	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
11	O
*	O
*	O
]	O
2	O
:	O
41	O
pm	O
(	O
end	O
of	O
report	O
)	O

100844	O
||||	O
2916	O
||||	O
22316	O
||||	O
echo	O
_	O
report	O
||||	O
2019	O
-	O
07	O
-	O
08	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
avr	B

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
07	O
-	O
08	O
*	O
*	O
]	O
at	O
15	O
:	O
20	O

test	O
:	O
tee	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
no	O
spontaneous	O
echo	O
contrast	O
is	O
seen	O
in	O
the	O
laa	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
interatrial	O
septum	O
.	O

left	O
ventricle	O
:	O
wall	O
thickness	O
and	O
cavity	O
dimensions	O
were	O
obtained	O
from	O
2d	O
images	O
.	O

normal	O
lv	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
.	O

lv	O
wall	O
motion	O
:	O
basal	O
anterior	O
-	O
normal	O
;	O
mid	O
anterior	O
-	O
normal	O
;	O
basal	O
anteroseptal	O
-	O
normal	O
;	O
mid	O
anteroseptal	O
-	O
normal	O
;	O
basal	O
inferoseptal	O
-	O
normal	O
;	O
mid	O
inferoseptal	O
-	O
normal	O
;	O
basal	O
inferior	O
-	O
normal	O
;	O
mid	O
inferior	O
-	O
normal	O
;	O
basal	O
inferolateral	O
-	O
normal	O
;	O
mid	O
inferolateral	O
-	O
normal	O
;	O
basal	O
anterolateral	O
-	O
normal	O
;	O
mid	O
anterolateral	O
-	O
normal	O
;	O
anterior	O
apex	O
-	O
normal	O
;	O
septal	O
apex	O
-	O
normal	O
;	O
inferior	O
apex	O
-	O
normal	O
;	O
lateral	O
apex	O
-	O
normal	O
;	O
apex	O
-	O
normal	O
;	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
ascending	O
aorta	O
diameter	O
.	O

normal	O
descending	O
aorta	O
diameter	O
.	O

simple	O
atheroma	B
in	O
descending	O
aorta	O
.	O

aortic	O
valve	O
:	O
three	O
aortic	O
valve	O
leaflets	O
.	O

severely	O
thickened	B
/	O
deformed	B
aortic	O
valve	O
leaflets	O
.	O

severe	O
as	B
(	O
aova	O
<0	O
.	O
8cm2	O
)	O
.	O

moderate	O
to	O
severe	O
(	O
3	O
+	O
)	O
ar	B
.	O

mitral	O
valve	O
:	O
trivial	O
mr	B
.	O

tricuspid	O
valve	O
:	O
physiologic	O
tr	B
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
physiologic	O
(	O
normal	O
)	O
pr	B
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
a	O
tee	O
was	O
performed	O
in	O
the	O
location	O
listed	O
above	O
.	O

i	O
certify	O
i	O
was	O
present	O
in	O
compliance	O
with	O
hcfa	O
regulations	O
.	O

no	O
tee	O
related	O
complications	O
.	O

the	O
tee	O
probe	O
was	O
passed	O
with	O
assistance	O
from	O
the	O
anesthesioology	O
staff	O
using	O
a	O
laryngoscope	O
.	O

the	O
patient	O
was	O
under	O
general	O
anesthesia	O
throughout	O
the	O
procedure	O
.	O

conclusions	O
:	O

pre	O
-	O
cpb	O
:	O
no	O
spontaneous	O
echo	O
contrast	O
is	O
seen	O
in	O
the	O
left	O
atrial	O
appendage	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

there	O
are	O
simple	O
atheroma	B
in	O
the	O
descending	O
thoracic	O
aorta	O
.	O

there	O
are	O
three	O
aortic	O
valve	O
leaflets	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
severely	O
thickened	B
/	O
deformed	B
.	O

there	O
is	O
severe	O
aortic	B
valve	I
stenosis	I
(	O
area	O
<0	O
.	O
8cm2	O
)	O
.	O

moderate	O
to	O
severe	O
(	O
3	O
+	O
)	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

post	O
-	O
cpb	O
:	O
there	O
is	O
an	O
aortic	O
valve	O
prosthesis	O
with	O
no	O
peri	B
-	I
valve	I
leaks	I
and	O
no	O
ai	B
.	O

trivial	O
mr	B
.	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
75	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
76	O
*	O
*	O
]	O
systolic	O
fxn	O
.	O

aorta	O
intact	O
.	O

other	O
parameters	O
as	O
pre	O
-	O
bypass	O
.	O

84521	O
||||	O
3066	O
||||	O
13096	O
||||	O
ecg	O
_	O
report	O
||||	O
2013	O
-	O
07	O
-	O
09	O
13	O
:	O
43	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
,	O
rate	O
95	O
.	O

since	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
09	O
*	O
*	O
]	O
minimal	O
slowing	O
of	O
the	O
heart	O
rate	O
has	O
occurred	O
.	O

no	O
other	O
significant	O
changes	O
are	O
seen	O
.	O

97913	O
||||	O
3089	O
||||	O
27868	O
||||	O
echo	O
_	O
report	O
||||	O
2012	O
-	O
06	O
-	O
22	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O
/	O
post	O
pm	O
implant	O
/	O
hypotension	B
post	O
new	O
rv	O
lead	O
.	O

height	O
:	O
(	O
in	O
)	O
60	O

weight	O
(	O
lb	O
)	O
:	O
170	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
74	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
92	O
/	O
59	O

hr	O
(	O
bpm	O
)	O
:	O
98	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
22	O
*	O
*	O
]	O
at	O
12	O
:	O
09	O

test	O
:	O
portable	O
tte	O
(	O
focused	O
views	O
)	O

doppler	O
:	O
limited	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
dilated	B
la	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

a	O
catheter	O
or	O
pacing	O
wire	O
is	O
seen	O
in	O
the	O
ra	O
.	O

left	O
ventricle	O
:	O
mild	O
symmetric	O
lvh	B
.	O

normal	O
lv	O
cavity	O
size	O
.	O

severely	O
depressed	B
lvef	I
.	O

no	O
resting	B
lvot	I
gradient	I
.	O

no	O
lv	B
mass	I
/	O
thrombus	O
.	O

no	O
vsd	B
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
wall	O
thickness	O
.	O

normal	O
rv	O
chamber	O
size	O
.	O

rv	B
function	I
depressed	O
.	O

paradoxic	B
septal	I
motion	I
consistent	O
with	O
conduction	B
abnormality	I
/	O
ventricular	O
pacing	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

focal	O
calcifications	B
in	O
aortic	O
root	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

focal	O
calcifications	B
in	O
ascending	O
aorta	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	I
valve	I
leaflets	I
(	O
3	O
)	O
.	O

no	O
as	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

mild	O
mitral	B
annular	I
calcification	I
.	O

mild	O
thickening	O
of	O
mitral	O
valve	O
chordae	O
.	O

calcified	B
tips	I
of	O
papillary	O
muscles	O
.	O

mild	O
(	O
1	O
+	O
)	O
mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
with	O
trivial	O
tr	B
.	O

normal	O
tricuspid	O
valve	O
supporting	O
structures	O
.	O

normal	O
pa	O
systolic	O
pressure	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

normal	O
main	O
pa	O
.	O

no	O
doppler	O
evidence	O
for	O
pda	B

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
the	O
patient	O
is	O
in	O
a	O
ventricularly	O
paced	O
rhythm	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
dilated	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
(	O
ejection	O
fraction	O
20	O
percent	O
)	O
secondary	O
to	O
severe	O
hypokinesis	B
of	O
all	O
walls	O
except	O
the	O
posterior	O
and	O
lateral	O
walls	O
.	O

no	O
masses	O
or	O
thrombi	O
are	O
seen	O
in	O
the	O
left	O
ventricle	O
.	O

there	O
is	O
no	O
ventricular	B
septal	I
defect	I
.	O

right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

right	B
ventricular	I
systolic	I
function	I
appears	O
depressed	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	O
but	O
aortic	B
stenosis	I
is	O
not	O
present	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

compared	O
with	O
the	O
findings	O
of	O
the	O
prior	O
study	O
(	O
tape	O
reviewed	O
)	O
of	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
,	O
no	O
major	O
change	O
is	O
evident	O
.	O

9330	O
||||	O
3273	O
||||	O
19315	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
12	O
-	O
25	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
13	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1965	O
-	O
12	O
-	O
18	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
207	O
*	O
*	O
]	O
/	O
kurla	O

history	O
of	O
present	O
illness	O
:	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
6938	O
*	O
*	O
]	O
is	O
a	O
47	O
-	O
year	O
-	O
old	O
gentleman	O
with	O
a	O
history	O
of	O
alcohol	B
abuse	I
and	O
prior	O
delirium	B
tremens	I
who	O
had	O
four	O
witnessed	O
seizures	B
at	O
home	O
on	O
the	O
day	O
of	O
admission	O
.	O

emts	O
were	O
called	O
and	O
found	O
the	O
patient	O
confused	B
and	O
lethargic	B
,	O
with	O
dried	B
blood	I
in	O
his	O
mouth	O
.	O

he	O
was	O
also	O
tachycardic	B
and	O
had	O
a	O
fingerstick	O
of	O
142	O
.	O

in	O
transport	O
to	O
an	O
outside	O
hospital	O
emergency	O
department	O
,	O
the	O
patient	O
had	O
two	O
more	O
thirty	O
second	O
seizures	B
and	O
in	O
the	O
outside	O
hospital	O

emergency	O
department	O
,	O
he	O
was	O
witnessed	O
to	O
have	O
another	O
seizure	B
.	O

he	O
was	O
intubated	O
secondary	O
to	O
agitation	B
,	O
combativeness	B
,	O
and	O
airway	O
protection	O
and	O
was	O
given	O
ativan	O
,	O
fosphenytoin	O
,	O
phenergan	O
,	O
and	O
phenobarbital	O
,	O
as	O
well	O
as	O
versed	O
,	O
succinylcholine	O
,	O
and	O
pancuronium	O
.	O

he	O
was	O
transferred	O
to	O
the	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
surgical	O
intensive	O
care	O
unit	O
where	O
a	O
head	O
ct	O
scan	O
was	O
negative	O
for	O
acute	B
intracranial	I
process	I
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
alcohol	B
abuse	I
,	O
status	O
post	O
alcohol	B
withdrawal	I
with	O
delirium	B
tremens	I
.	O

2	O
.	O
status	O
post	O
appendectomy	O
in	O
[	O
*	O
*	O
2011	O
*	O
*	O
]	O
.	O

3	O
.	O
polysubstance	B
abuse	I
.	O

4	O
.	O
hypertension	B
.	O

5	O
.	O
thrombophlebitis	B
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

admitting	O
medications	O
:	O
unknown	O
.	O

family	O
history	O
:	O
the	O
patient's	O
father	O
has	O
emphysema	B
,	O
his	O
sister	O
had	O
breast	B
cancer	I
,	O
his	O
brother	O
had	O
esophageal	B
varices	I
,	O
and	O
his	O
mother	O
has	O
emphysema	B
.	O

social	O
history	O
:	O
the	O
patient	O
is	O
unemployed	O
and	O
is	O
living	O
with	O
four	O
roommates	O
who	O
apparently	O
also	O
engaged	O
in	O
alcohol	B
abuse	I
.	O

the	O
patient	O
has	O
an	O
extensive	O
history	O
of	O
alcohol	B
use	I
and	O
they	O
said	O
he	O
has	O
had	O
withdrawal	B
seizures	I
in	O
the	O
past	O
.	O

physical	O
examination	O
:	O
on	O
admission	O
,	O
temperature	O
100	O
.	O
4	O
f	O
,	O
heart	O
rate	O
100	O
,	O
blood	O
pressure	O
170	O
/	O
70	O
.	O

in	O
general	O
,	O
this	O
patient	O
was	O
intubated	O
and	O
sedated	O
,	O
not	O
responding	B
to	I
voice	I
or	O
painful	O
stimuli	O
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
:	O
the	O
patient	O
had	O
blood	B
in	I
his	I
mouth	I
and	O
on	O
his	O
tongue	O
,	O
pupils	O
were	O
pinpoint	O
and	O
reactive	O
.	O

the	O
neck	O
was	O
supple	O
.	O

chest	O
was	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

the	O
abdomen	O
was	O
soft	O
.	O

on	O
extremity	O
examination	O
,	O
the	O
patient	O
had	O
equal	O
tone	O
in	O
all	O
four	O
extremities	O
and	O
no	O
response	B
to	I
painful	I
stimulus	I
in	O
his	O
extremities	O
.	O

he	O
did	O
have	O
rhythmic	O
movements	O
bilaterally	O
in	O
the	O
arms	O
,	O
but	O
these	O
were	O
also	O
very	O
stimulus	B
sensitive	I
.	O

admission	O
laboratory	O
data	O
:	O
initial	O
laboratory	O
studies	O
indicated	O
valproic	O
acid	O
level	O
of	O
less	O
than	O
0	O
.	O
7	O
,	O
dilantin	O
level	O
of	O
less	O
than	O
0	O
.	O
5	O
,	O
tsh	O
of	O
2	O
.	O
27	O
,	O
glucose	O
134	O
,	O
bun	O
4	O
.	O
0	O
,	O
creatinine	O
1	O
.	O
1	O
.	O

sodium	O
140	O
,	O
potassium	O
4	O
.	O
2	O
,	O
chloride	O
104	O
,	O
bicarbonate	O
18	O
.	O

total	O
bilirubin	O
0	O
.	O
9	O
,	O
ast	O
68	O
,	O
alt	O
33	O
,	O
alkaline	O
phosphatase	O
135	O
,	O
ammonia	O
39	O
.	O

white	O
blood	O
cell	O
count	O
10	O
.	O
8	O
,	O
hematocrit	O
39	O
,	O
platelets	O
93	O
,	O
000	O
.	O

cardiac	O
enzymes	O
were	O
negative	O
.	O

arterial	O
blood	O
gas	O
indicated	O
a	O
ph	O
of	O
7	O
.	O
3	O
,	O
co2	O
of	O
37	O
,	O
o2	O
of	O
330	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
initially	O
to	O
the	O

surgical	O
intensive	O
care	O
unit	O
,	O
intubated	O
for	O
airway	O
protection	O
.	O

a	O
head	O
ct	O
scan	O
was	O
negative	O
for	O
acute	B
intracranial	I
process	I
;	O
however	O
,	O
there	O
was	O
a	O
small	O
old	O
right	O
subdural	B
hematoma	I
.	O

initial	O
electroencephalogram	O
was	O
negative	O
for	O
epileptiform	B
activity	I
.	O

the	O
patient	O
did	O
have	O
mildly	O
elevated	B
transaminases	I
and	O
elevated	B
lipase	I
and	O
amylase	O
.	O

serum	O
toxicology	O
screen	O
was	O
negative	O
and	O
rapid	O
plasma	O
reagent	O
was	O
negative	O
.	O

in	O
the	O
surgical	O
intensive	O
care	O
unit	O
the	O
patient	O
was	O
noted	O
to	O
be	O
febrile	B
.	O

a	O
chest	O
x	O
-	O
ray	O
showed	O
possible	O
left	O
lower	O
lobe	O
and	O
a	O
right	B
lower	I
lobe	I
pneumonia	I
which	O
was	O
presumed	O
to	O
be	O
aspiration	B
.	O

he	O
was	O
started	O
on	O
levaquin	O
and	O
metronidazole	O
.	O

he	O
was	O
weaned	O
off	O
of	O
the	O
ativan	O
drip	O
and	O
extubated	O
on	O
hospital	O
day	O
three	O
with	O
some	O
improvement	O
in	O
his	O
mental	B
status	I
,	O
although	O
he	O
was	O
still	O
obtunded	B
,	O
but	O
rousable	O
on	O
the	O
day	O
of	O
transfer	O
.	O

an	O
abdominal	O
ultrasound	O
was	O
completed	O
which	O
indicated	O
an	O
echogenic	O
appearing	O
liver	O
with	O
no	O
biliary	B
tree	I
abnormalities	I
and	O
no	O
ascites	B
.	O

the	O
patient	O
continued	O
to	O
be	O
febrile	B
on	O
the	O
floor	O
.	O

blood	O
cultures	O
from	O
hospital	O
day	O
four	O
grew	O
out	O
coag	O
negative	O
staphylococcus	O
in	O
one	O
out	O
of	O
four	O
bottles	O
.	O

he	O
received	O
one	O
dose	O
of	O
vancomycin	O
while	O
awaiting	O
speciation	O
.	O

a	O
second	O
electroencephalogram	O
was	O
conducted	O
on	O
hospital	O
day	O
two	O
with	O
results	O
pending	O
at	O
the	O
time	O
of	O
this	O
dictation	O
.	O

to	O
this	O
point	O
,	O
the	O
patient	O
has	O
been	O
continued	O
on	O
dilantin	O
during	O
his	O
hospital	O
stay	O
.	O

on	O
hospital	O
day	O
seven	O
,	O
the	O
patient	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

a	O
physical	O
therapy	O
evaluation	O
indicated	O
the	O
patient	O
was	O
unsafe	O
for	O
discharge	O
to	O
home	O
due	O
to	O
poor	B
balance	I
and	O
lack	B
of	I
safety	I
awareness	I
and	O
therefore	O
the	O
patient	O
was	O
being	O
screened	O
for	O
discharge	O
to	O
a	O
rehabilitation	O
facility	O
at	O
the	O
time	O
of	O
this	O
dictation	O
.	O

the	O
patient	O
was	O
refusing	O
alcohol	O
rehabilitation	O
;	O
however	O
,	O
was	O
amenable	O
to	O
a	O
substance	B
abuse	I
consult	O
which	O
has	O
been	O
ordered	O
at	O
the	O
time	O
of	O
this	O
dictation	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
alcohol	B
abuse	I
.	O

2	O
.	O
alcohol	B
withdrawal	I
seizures	I
.	O

3	O
.	O
hypertension	B
.	O

4	O
.	O
polysubstance	B
abuse	I
.	O

discharge	O
medications	O
:	O

1	O
.	O
lopressor	O
25	O
mg	O
po	O
bid	O
.	O

2	O
.	O
folate	O
1	O
.	O
0	O
mg	O
po	O
q	O
day	O
.	O

3	O
.	O
thiamine	O
100	O
mg	O
po	O
q	O
day	O
.	O

4	O
.	O
multivitamin	O
one	O
tablet	O
po	O
q	O
day	O
.	O

5	O
.	O
enteric	O
coated	O
a	O
.	O
s	O
.	O
a	O
.	O
81	O
mg	O
po	O
q	O
day	O
.	O

6	O
.	O
metronidazole	O
500	O
mg	O
po	O
tid	O
through	O
[	O
*	O
*	O
12	O
-	O
23	O
*	O
*	O
]	O
.	O

7	O
.	O
levofloxacin	O
250	O
mg	O
po	O
q	O
day	O
through	O
[	O
*	O
*	O
12	O
-	O
23	O
*	O
*	O
]	O
.	O

disposition	O
:	O
at	O
the	O
time	O
of	O
this	O
dictation	O
,	O
the	O
patient	O
was	O
being	O
screened	O
for	O
discharge	O
to	O
an	O
acute	O
rehabilitation	O
facility	O
.	O

[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
5495	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
5356	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
19	O
*	O
*	O
]	O
14	O
:	O
44	O

t	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
19	O
*	O
*	O
]	O
14	O
:	O
48	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
6939	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2014	O
-	O
01	O
-	O
29	O
*	O
*	O
]	O
8	O
:	O
23	O
pm	O

(	O
end	O
of	O
report	O
)	O

360395	O
||||	O
3392	O
||||	O
4043	O
||||	O
radiology	O
_	O
report	O
||||	O
2017	O
-	O
07	O
-	O
31	O
12	O
:	O
14	O
:	O
00	O
.	O
0	O
||||	O
d51	O
naso	O
-	O
intestinal	O
tube	O
placement	O
(	O
w	O
/	O
fluoro	O
)	O
||||	O
||||	O
clip	O
#	O
345	O
-	O
1565	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2017	O
-	O
07	O
-	O
31	O
*	O
*	O
]	O
12	O
:	O
14	O
pm	O

[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
210	O
*	O
*	O
]	O
-	O
intestinal	O
tube	O
placement	O
(	O
w	O
/	O
fluoro	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
4093	O
*	O
*	O
]	O
reason	O
:	O
pt	O
w	O
/	O
esld	B
,	O
needs	O
placement	O
of	O
post	O
-	O
pyloric	O
feeding	O
tube	O
.	O

admitting	O
diagnosis	O
:	O
anemia	B
-	O
thrombocytopenia	B
-	O
coagulopathy	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

37	O
year	O
old	O
woman	O
with	O
reason	O
for	O
this	O
examination	O
:	O
pt	O
w	O
/	O
esld	B
,	O
needs	O
placement	O
of	O
post	O
-	O
pyloric	O
feeding	O
tube	O
.	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
end	B
stage	I
liver	I
disease	I
,	O
please	O
place	O
post	O
pyloric	O
feeding	O
tube	O
.	O

procedure	O
:	O
a	O
feeding	O
tube	O
was	O
advanced	O
via	O
the	O
right	O
nostril	O
under	O
direct	O
fluoroscopic	O
guidance	O
to	O
the	O
level	O
of	O
the	O
ligament	O
of	O
treitz	O
.	O

10	O
cc	O
of	O
water	O
soluble	O
contrast	O
was	O
injected	O
to	O
confirm	O
proper	O
positioning	O
.	O

there	O
were	O
no	O
immediate	O
complications	B
.	O

surgical	O
staples	O
overlie	O
the	O
mid	O
abdomen	O
.	O

an	O
ivc	O
filter	O
is	O
in	O
place	O
.	O

98383	O
||||	O
3702	O
||||	O
20229	O
||||	O
echo	O
_	O
report	O
||||	O
2010	O
-	O
10	O
-	O
19	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
cerebrovascular	B
event	I
/	O
tia	B
.	O

height	O
:	O
(	O
in	O
)	O
72	O

weight	O
(	O
lb	O
)	O
:	O
212	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
19	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
117	O
/	O
46	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2010	O
-	O
10	O
-	O
19	O
*	O
*	O
]	O
at	O
12	O
:	O
04	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
saline	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
moderately	O
dilated	O
.	O

no	O
atrial	B
septal	I
defect	I
is	O
seen	O
by	O
2d	O
or	O
color	O
doppler	O
.	O

left	O
ventricle	O
:	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
moderately	O
dilated	O
.	O

lv	O
systolic	O
function	O
appears	O
depressed	O
.	O

overall	O
left	B
ventricular	I
systolic	I
function	I
cannot	O
be	O
reliably	O
assessed	O
.	O

right	O
ventricle	O
:	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
moderately	O
dilated	O
.	O

there	O
are	O
focal	O
calcifications	B
in	O
the	O
aortic	O
root	O
.	O

the	O
ascending	O
aorta	O
is	O
moderately	O
dilated	O
.	O

there	O
are	O
focal	O
calcifications	B
in	O
the	O
ascending	O
aorta	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
but	O
not	O
stenotic	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

there	O
is	O
mild	O
mitral	B
annular	I
calcification	I
.	O

there	O
is	O
mild	O
thickening	O
of	O
the	O
mitral	O
valve	O
chordae	O
.	O

there	O
is	O
no	O
significant	O
mitral	B
stenosis	I
.	O

tricuspid	O
valve	O
:	O
the	O
tricuspid	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
tricuspid	B
regurgitation	I
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
the	O
pulmonic	O
valve	O
leaflets	O
appear	O
structurally	O
normal	O
with	O
physiologic	O
pulmonic	B
regurgitation	I
.	O

pericardium	O
:	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
due	O
to	O
poor	O
echo	O
windows	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

the	O
right	O
atrium	O
is	O
moderately	O
dilated	O
.	O

no	O
atrial	B
septal	I
defect	I
is	O
seen	O
by	O
2d	O
or	O
color	O
doppler	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
moderately	O
dilated	O
.	O

lv	O
systolic	O
function	O
appears	O
depressed	O
.	O

overall	O
left	B
ventricular	I
systolic	I
function	I
cannot	O
be	O
reliably	O
quantitated	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
root	O
is	O
moderately	O
dilated	O
.	O

the	O
ascending	O
aorta	O
is	O
moderately	O
dilated	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
but	O
not	O
stenotic	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

40506	O
||||	O
3990	O
||||	O
26269	O
||||	O
ecg	O
_	O
report	O
||||	O
2016	O
-	O
11	O
-	O
10	O
22	O
:	O
39	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
with	O
1st	B
degree	I
a	I
-	I
v	I
block	I
.	O

left	B
bundle	I
branch	I
block	I

nonspecific	O
inferior	O
/	O
lateral	O
st	O
-	O
t	O
changes	O

since	O
previous	O
tracing	O
,	O
atrial	B
fibrillation	I
resolved	O

520	O
||||	O
4266	O
||||	O
21497	O
||||	O
discharge	O
_	O
summary	O
||||	O
2009	O
-	O
10	O
-	O
10	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2009	O
-	O
09	O
-	O
27	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1932	O
-	O
12	O
-	O
15	O
*	O
*	O
]	O
sex	O
:	O
m	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
76	O
-	O
year	O
-	O
old	O
man	O
with	O
a	O
history	O
of	O
compression	B
fractures	I
,	O
chronic	B
back	I
pain	I
and	O
atrial	B
fibrillation	I
who	O
presents	O
this	O
admission	O
to	O
the	O

neurology	O
service	O
on	O
[	O
*	O
*	O
2009	O
-	O
09	O
-	O
27	O
*	O
*	O
]	O
with	O
new	O

patient	O
had	O
reported	O
a	O
fall	B
two	O
days	O
ago	O
where	O
legs	O
gave	O
way	O
without	O
warning	O
and	O
he	O
did	O
not	O
injure	B
himself	O
.	O

his	O
wife	O
was	O
there	O
to	O
support	O
him	O
and	O
he	O
had	O
no	O
alternation	B
in	I
consciousness	I
,	O
no	O
vertigo	B
,	O
no	O
lightheadedness	B
,	O
shortness	B
of	I
breath	I
,	O
acute	O
weakness	B
.	O

then	O
,	O
he	O
had	O
shortly	O
thereafter	O
,	O
had	O
worsening	O
of	O
his	O
back	B
pain	I
,	O
as	O
per	O
his	O
primary	O
care	O
physician	O
,	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
*	O
*	O
]	O
his	O
wife	O
.	O

the	O
patient	O
himself	O
denied	O
yesterday	O
,	O
he	O
was	O
able	O
to	O
use	O
his	O
walker	O
as	O
usual	O
and	O
apart	O
from	O
the	O
back	B
pain	I
felt	O
in	O
his	O
usual	O
state	O
of	O
health	O
.	O

when	O
he	O
awoke	O
the	O
day	O
later	O
(	O
morning	O
of	O
admission	O
)	O
it	O
was	O
found	O
that	O
he	O
was	O
unable	B
to	I
move	I
his	I
legs	I
.	O

no	O
urinary	B
frequency	I
or	O
urgency	O
,	O
incontinence	O
,	O
no	O
bowel	B
movements	I
on	O
the	O
day	O
of	O
admission	O
which	O
patient	O
reported	O
was	O
unusual	O
.	O

denies	O
weakness	O
in	O
his	O
arms	O
,	O
neck	B
pain	I
,	O
numbness	B
and	O
tingling	B
,	O
no	O
fever	B
,	O
night	B
sweats	I
,	O
headache	B
.	O

patient	O
and	O
his	O
wife	O
denies	O
any	O
progression	O
of	O
his	O
weakness	B
beyond	O
the	O

a	O
.	O
m	O
.	O

past	O
medical	O
history	O
:	O
atrial	B
fibrillation	I
,	O
hypothyroidism	B
,	O
chronic	B
back	I
pain	I
,	O
recent	O
ct	O
of	O
the	O
chest	O
with	O
multiple	O
nodules	O
,	O
inflammatory	B
versus	O
infection	B
,	O
most	O
likely	O
neoplasm	B
,	O
bipolar	B
disorder	I
,	O
chronic	B
obstructive	I
pulmonary	I
disease	I
,	O
left	O
hip	O
replacement	O
,	O
left	O
knee	O
replacement	O
,	O
left	O
femoral	O
plate	O
,	O
shoulder	O
surgery	O
,	O
hernia	B
repair	O
,	O
peripheral	B
vascular	I
disease	I
,	O
organic	B
mania	I
,	O
sleep	B
disorder	I
,	O
basal	B
cell	I
cancer	I
of	O
the	O
back	O
.	O

social	O
history	O
:	O
drank	O
heavily	O
eight	O
years	O
ago	O
,	O
approximately	O
one	O
pint	O
of	O
vodka	O
per	O
day	O
,	O
on	O
and	O
off	O
,	O
now	O
drinks	O
one	O
to	O
two	O
vodka	O
and	O
tonics	O
a	O
day	O
.	O

smokes	O
approximately	O
a	O
pack	O
per	O
day	O
for	O
many	O
years	O
,	O
retired	O
business	O
man	O
.	O

family	O
history	O
:	O
father	O
with	O
acute	B
leukemia	I
.	O

mother	O
with	O
rheumatoid	B
arthritis	I
.	O

allergies	O
:	O
penicillin	O
.	O

medications	O
on	O
admission	O
:	O
depakote	O
,	O
coumadin	O
,	O
digoxin	O
,	O

restoril	O
,	O
synthroid	O
,	O
hydrocodone	O
,	O
zantac	O
and	O
oxycontin	O
.	O

physical	O
exam	O
on	O
admission	O
:	O
blood	O
pressure	O
130	O
/	O
77	O
.	O

heart	O
rate	O
96	O
.	O

temperature	O
98	O
.	O

respiratory	O
rate	O
16	O
,	O
02	O
saturation	O
98%	O
.	O

appearance	O
,	O
emaciated	B
elderly	O
lying	O
uncomfortably	O
on	O
his	O
right	O
side	O
,	O
unwilling	B
to	I
cooperate	I
full	O
,	O
disinterested	O
,	O
was	O
fed	O
and	O
irritated	O
.	O

the	O
patient	O
has	O
severe	O
cervical	B
rigidity	I
and	O
kyphosis	B
.	O

range	O
of	O
motion	O
of	O
the	O
neck	O
is	O
severely	O
decreased	O
.	O

the	O
neck	O
is	O
nontender	O
to	O
palpation	O
.	O

lungs	O
are	O
clear	O
to	O
auscultation	O
.	O

cardiac	O
:	O
normal	O
s1	O
,	O
s2	O
.	O

abdomen	O
:	O
soft	O
,	O
tender	O
,	O
no	O
organomegaly	B
,	O
+	O
2	O
brachial	O
pulses	O
bilaterally	O
.	O

neurologic	O
exam	O
:	O
he	O
is	O
awake	O
,	O
alert	O
,	O
oriented	O
to	O
all	O
modalities	O
except	O
he	O
believes	O
that	O
it	O
is	O
[	O
*	O
*	O
10	O
-	O
04	O
*	O
*	O
]	O
.	O

aware	O
of	O
all	O
the	O
recent	O
current	O
events	O
.	O

speech	O
fluent	O
,	O
spontaneous	O
,	O
no	O
paraphasic	B
errors	I
.	O

there	O
is	O
no	O
right	B
-	I
left	I
confusion	I
,	O
neglect	O
.	O

release	O
testing	O
reveals	O
left	O
greater	O
that	O
right	B
palmomental	I
reflex	I
,	O
normal	O
jaw	O
jerk	O
,	O
no	O
rooting	B
,	O
slight	O
grasp	B
bilaterally	I
.	O

on	O
cranial	O
nerve	O
exam	O
:	O
ocular	O
discs	O
are	O
sharp	O
.	O

visual	O
fields	O
full	O
,	O
[	O
*	O
*	O
02	O
-	O
08	O
*	O
*	O
]	O
round	O
and	O
reactive	O
.	O

there	O
is	O
no	O
relative	B
afferent	I
defect	I
.	O

extraocular	O
movements	O
are	O
full	O
,	O
no	O
nystagmus	B
.	O

facial	O
sensation	O
intact	O
to	O
light	O
touch	O
.	O

face	O
is	O
symmetric	O
and	O
movements	O
are	O
intact	O
.	O

sternocleidomastoid	O
strength	O
of	O
5	O
/	O
5	O
.	O
tongue	O
movements	O
are	O
intact	O
and	O
palatal	O
elevation	O
is	O
symmetric	O
.	O

on	O
motor	O
exam	O
,	O
there	O
is	O
generally	O
decreased	B
bulk	I
and	O
tone	O
,	O
decreased	O
symmetrically	O
,	O
there	O
is	O
generalized	O
wasting	O
,	O
especially	O
of	O
the	O
intrinsic	O
muscles	O
of	O
the	O
hands	O
,	O
quads	O
,	O
gastrocnemius	O
bilaterally	O
.	O

no	O
drift	B
.	O

motor	O
strength	O
testing	O
reveals	O
generally	O
4	O
+	O
/	O
5	O
in	O
the	O
upper	O
extremities	O
and	O
anywhere	O
from	O
0	O
-	O
3	O
in	O
the	O
lower	O
extremities	O
.	O

he	O
was	O
able	O
to	O
exert	O
some	O
proximal	O
movements	O
,	O
but	O
no	O
distal	O
.	O

reflexes	O
are	O
brachial	O
3	O
+	O
bilaterally	O
and	O
1	O
+	O
bilaterally	O
otherwise	O
with	O
downgoing	B
toes	I
bilaterally	O
and	O
no	O
clonus	B
.	O

on	O
sensory	O
exam	O
,	O
light	B
touch	I
is	O
decreased	O
in	O
the	O
feet	O
bilaterally	O
.	O

it	O
is	O
difficult	O
to	O
determine	O
whether	O
or	O
not	O
there	O
is	O
a	O
sensory	O
level	O
.	O

repeated	O
testing	O
does	O
not	O
show	O
any	O
clear	O
finding	O
.	O

pinprick	B
and	O
temperature	O
is	O
decreased	O
in	O
the	O
feet	O
symmetrically	O
.	O

position	O
sense	O
was	O
impaired	O
in	O
the	O
toes	O
,	O
but	O
not	O
impaired	O
in	O
the	O
ankles	O
.	O

mildly	O
impaired	B
position	I
sense	I
in	O
the	O
fingers	O
bilaterally	O
.	O

coordination	O
testing	O
,	O
finger	O
to	O
nose	O
is	O
without	O
ataxia	O
.	O

stance	O
and	O
gait	O
could	O
not	O
be	O
tested	O
.	O

laboratory	O
data	O
:	O
electrocardiogram	O
1996	O
:	O
atrial	B
fibrillation	I
,	O
nonspecific	B
st	I
changes	I
.	O

laboratories	O
from	O

[	O
*	O
*	O
09	O
-	O
16	O
*	O
*	O
]	O
:	O
cbc	O
:	O
white	O
blood	O
cell	O
count	O
13	O
.	O
9	O
,	O
hematocrit	O
34	O
and	O
cb	O
115	O
,	O
platelets	O
110	O
.	O

inr	O
2	O
.	O
4	O
,	O
ck	O
171	O
.	O

hospital	O
course	O
:	O
as	O
noted	O
above	O
,	O
76	O
-	O
year	O
-	O
old	O
man	O
admitted	O
initially	O
to	O
the	O
neurology	O
service	O
on	O
[	O
*	O
*	O
2009	O
-	O
09	O
-	O
27	O
*	O
*	O
]	O
,	O
ultimately	O
transferred	O
to	O
the	O
medical	O
service	O
on	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
07	O
*	O
*	O
]	O
.	O

he	O
was	O
admitted	O
with	O
severe	O
paraparesis	B
,	O
status	O
post	O
fall	B
without	O
loss	B
of	I
consciousness	I
or	O
head	B
trauma	I
and	O
worsening	O
back	B
pain	I
.	O

ct	O
of	O
the	O
thoracolumbar	O
spine	O
done	O
on	O
[	O
*	O
*	O
09	O
-	O
28	O
*	O
*	O
]	O
showed	O
t12	O
,	O
l1	O
,	O
l4	O
-	O
l5	O
compression	O
fractures	O
with	O
retrolisthesis	B
of	O
l3	O
and	O
l4	O
and	O
l4	O
on	O
l5	O
and	O
a	O
calcified	B
mass	I
on	O
the	O
tail	O
of	O
the	O
pancreas	O
.	O

ct	O
of	O
abdomen	O
[	O
*	O
*	O
09	O
-	O
29	O
*	O
*	O
]	O
with	O
contrast	O
showed	O
a	O
4	O
x	O
8	O
x	O
5	O
.	O
cm	O
mass	O
in	O
the	O
tail	O
of	O
the	O
pancreas	O
and	O
several	O
tiny	O
nodules	O
in	O
lung	O
bases	O
,	O
left	O
greater	O
with	O
right	O
with	O
patchy	B
linear	I
opacities	I
in	O
right	O
base	O
.	O

bone	O
scan	O
on	O
[	O
*	O
*	O
09	O
-	O
30	O
*	O
*	O
]	O
showed	O
increased	O
foci	O
in	O
the	O
lower	O
lumbar	O
spine	O
and	O
right	O
iliac	O
ring	O
suspicious	O
for	O
metastatic	B
disease	I
.	O

mri	O
of	O
lumbar	O
spine	O
showed	O
mass	B
in	O
the	O
lumbo	O
-	O
sacral	O
region	O
.	O

a	O
myelogram	O
was	O
ordered	O
initially	O
,	O
but	O
could	O
not	O
be	O
done	O
because	O
the	O
patient	O
refused	O
the	O
myelogram	O
on	O
the	O
first	O
day	O
and	O
subsequently	O
had	O
abnormally	B
high	I
inr	I
.	O

on	O
the	O
day	O
that	O
the	O
myelogram	O
was	O
scheduled	O
for	O
,	O
he	O
was	O
transferred	O
to	O
the	O
medical	O
intensive	O
care	O
unit	O
after	O
a	O
respiratory	B
arrest	I
on	O
[	O
*	O
*	O
10	O
-	O
02	O
*	O
*	O
]	O
and	O
intubated	O
.	O

bronchoscopy	O
at	O
that	O
time	O
showed	O
significant	O
aspirated	O
material	O
.	O

differential	O
diagnoses	O
include	O
:	O

secondary	O
to	O
his	O
narcotic	B
pain	I
medications	I
versus	O
aspiration	B
pneumonia	I
.	O

his	O
pco2	O
at	O
that	O
time	O
was	O
noted	O
to	O
be	O
89	O
.	O

he	O
was	O
started	O
on	O
levofloxacin	O
and	O
clindamycin	O
and	O
counseling	O
service	O
while	O
he	O
was	O
in	O
the	O
medical	O
intensive	O
care	O
unit	O
.	O

he	O
was	O
initially	O
started	O
on	O
dexamethasone	O
for	O
presumed	O
cord	B
compression	I
on	O
[	O
*	O
*	O
10	O
-	O
02	O
*	O
*	O
]	O
and	O
family	O
ultimately	O
declined	O
transfer	O
to	O
[	O
*	O
*	O
hospital	O
446	O
*	O
*	O
]	O
for	O
ct	O
myelogram	O
.	O

it	O
should	O
be	O
noted	O
that	O
the	O
patient	O
was	O
unable	O
to	O
tolerate	O
an	O
mri	O
secondary	O
to	O
his	O
scoliosis	B
.	O

transiently	O
on	O
dopamine	O
for	O
hypotension	B
and	O
transfused	O
one	O
unit	O
of	O
packed	O
red	O
blood	O
cells	O
.	O

ultimately	O
,	O
patient	O
did	O
receive	O
a	O
ct	O
myelogram	O
which	O
showed	O
obstruction	B
to	I
flow	I
of	I
contrast	I
from	O
below	O
at	O
t8	O
and	O
t9	O
level	O
.	O

it	O
was	O
an	O
overall	O
limited	O
study	O
.	O

also	O
a	O
sacral	B
mass	I
at	O
the	O
epidural	O
extension	O
.	O

question	O
of	O
a	O
t	O
spine	O
epidural	B
mass	I
and	O
ultimately	O
his	O
decadron	O
was	O
discontinued	O
on	O
[	O
*	O
*	O
10	O
-	O
06	O
*	O
*	O
]	O
,	O
because	O
of	O
no	O
improvement	O
.	O

he	O
received	O
neurosurgery	O
and	O
radiation	O
oncology	O
consults	O
.	O

the	O
patient	O
was	O
extubated	O
on	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
06	O
*	O
*	O
]	O
with	O
a	O
plan	O
for	O
a	O
sacral	B
mass	I
biopsy	O
.	O

ct	O
guided	O
biopsy	O
which	O
was	O
done	O
on	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
06	O
*	O
*	O
]	O
.	O

patient	O
was	O
transiently	O
transferred	O
to	O
the	O
medical	O
service	O
from	O
[	O
*	O
*	O
10	O
-	O
06	O
*	O
*	O
]	O
through	O
[	O
*	O
*	O
10	O
-	O
08	O
*	O
*	O
]	O
but	O
had	O
another	O
respiratory	B
arrest	I
while	O
on	O
the	O
floor	O
with	O
gradually	O
worsening	O
hypercapnia	B
and	O
acidosis	B
.	O

he	O
was	O
found	O
unresponsive	B
,	O
without	O
respirations	B
and	O
reintubated	O
and	O
transferred	O
to	O
the	O
medical	O

intensive	O
care	O
unit	O
.	O

overall	O
impression	O
at	O
this	O
time	O
on	O

[	O
*	O
*	O
10	O
-	O
08	O
*	O
*	O
]	O
was	O
that	O
patient	O
likely	O
had	O
metastatic	O
pancreatic	O
disease	O
,	O
left	O
pancreatic	B
cancer	I
.	O

he	O
had	O
a	O
mildly	O
elevated	B
psa	I
but	O
this	O
was	O
not	O
thought	O
to	O
be	O
related	O
to	O
his	O
current	O
process	O
.	O

ultimately	O
,	O
his	O
biopsy	O
of	O
his	O
sacral	B
lesions	I
was	O
consistent	O
with	O
malignancy	B
,	O
likely	O
adenocarcinoma	B
.	O

respiratory	O
support	O
was	O
continued	O
with	O
suspected	O
patient	O
more	O
than	O
likely	O
had	O
a	O
mucus	B
plugging	I
event	I
.	O

in	O
discussion	O
between	O
the	O
family	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1835	O
*	O
*	O
]	O
,	O
patient's	O
primary	O
care	O
physician	O
,	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
*	O
*	O
]	O
the	O
team	O
,	O
it	O
was	O
felt	O
that	O
the	O
patient	O
clearly	O
had	O
another	O
source	O
of	O
adenocarcinoma	B
.	O

his	O
overall	O
prognosis	O
is	O
extremely	O
grave	O
and	O
the	O
patient's	O
dopamine	O
was	O
weaned	O
.	O

the	O
patient	O
was	O
extubated	O
and	O
accepted	O
by	O
deacon	O
hospice	O
and	O
was	O
transferred	O
there	O
on	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
.	O

patient	O
had	O
requested	O
that	O
his	O
body	O
be	O
donated	O
as	O
an	O
anatomic	O
gift	O
to	O
[	O
*	O
*	O
hospital	O
1005	O
*	O
*	O
]	O
medical	O
school	O
.	O

family	O
was	O
given	O
the	O
number	O
to	O
contact	O
.	O

condition	O
of	O
discharge	O
:	O
grave	O
.	O

past	O
medical	O
history	O
:	O
same	O
as	O
presenting	O
medical	O
history	O
with	O
addition	O
of	O
metastatic	B
adenocarcinoma	I
.	O

medications	O
on	O
discharge	O
:	O
not	O
known	O
to	O
this	O
dictator	O
at	O
this	O
time	O
though	O
medical	O
care	O
was	O
guided	O
as	O
to	O
focused	O
on	O
comfort	O
care	O
and	O
hospice	O
care	O
.	O

[	O
*	O
*	O
doctor	O
first	O
name	O
1713	O
*	O
*	O
]	O
[	O
*	O
*	O
doctor	O
last	O
name	O
1712	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1768	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1675	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
11	O
*	O
*	O
]	O
13	O
:	O
13	O

t	O
:	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
11	O
*	O
*	O
]	O
13	O
:	O
13	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
1836	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
1713	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
1712	O
*	O
*	O
]	O
on	O
:	O
sat	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
21	O
*	O
*	O
]	O
8	O
:	O
11	O
pm	O

(	O
end	O
of	O
report	O
)	O

27967	O
||||	O
4269	O
||||	O
23223	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
03	O
-	O
28	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
21	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
28	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1976	O
-	O
04	O
-	O
05	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
2111	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

pleuritic	B
chest	I
pain	I
and	O
shortness	B
of	I
breath	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

mechanical	O
ventilation	O
and	O
intubation	O
.	O

history	O
of	O
present	O
illness	O
:	O

39	O
yo	O
previously	O
healthy	O
[	O
*	O
*	O
ethnicity	O
796	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
ethnicity	O
797	O
*	O
*	O
]	O
male	O
patient	O
is	O
transferred	O
from	O
an	O
outside	O
hospital	O
with	O
respiratory	B
distress	I
.	O

the	O
patient	O
was	O
in	O
his	O
usual	O
state	O
of	O
good	O
health	O
until	O
approximately	O
one	O
week	O
prior	O
to	O
transfer	O
when	O
he	O
had	O
an	O
episode	O
of	O
vomiting	B
and	O
believes	O
he	O
may	O
have	O
aspirated	B
.	O

he	O
developed	O
a	O
right	B
sided	I
chest	I
pain	I
,	O
sharp	O
and	O
pleuritic	O
in	O
nature	O
.	O

he	O
subsequently	O
developed	O
shortness	B
of	I
breath	I
and	O
presented	O
to	O
the	O
hospital	O
where	O
he	O
works	O
.	O

he	O
was	O
noted	O
to	O
have	O
concerning	O
lesion	B
on	O
chest	O
x	O
-	O
ray	O
and	O
he	O
was	O
admitted	O
and	O
placed	O
on	O
100%	O
oxygen	O
.	O

he	O
was	O
given	O
broad	O
spectrum	O
antibiotics	O
with	O
gatifloxacin	O
and	O
clindamycin	O
.	O

linezolid	O
was	O
eventually	O
added	O
.	O

he	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
79	O
*	O
*	O
]	O
per	O
the	O
family's	O
request	O
.	O

on	O
arrival	O
,	O
the	O
patient	O
continues	O
to	O
report	O
shortness	B
of	I
breath	I
and	O
pleuritic	O
right	B
-	I
sided	I
chest	I
pain	I
.	O

he	O
states	O
that	O
when	O
he	O
takes	O
the	O
oxygen	O
off	O
,	O
he	O
can	O
only	O
speak	O
two	O
sentences	O
before	O
becomming	O
short	B
of	I
breath	I
.	O

he	O
denies	O
fevers	B
,	O
chills	B
and	O
night	B
sweats	I
.	O

past	O
medical	O
history	O
:	O

none	O

social	O
history	O
:	O

the	O
patient	O
lives	O
in	O
[	O
*	O
*	O
location	O
6016	O
*	O
*	O
]	O
with	O
his	O
girlfriend	O
and	O
her	O
parents	O
.	O

he	O
and	O
his	O
girlfriend	O
have	O
been	O
together	O
and	O
monogomous	O
for	O
over	O
six	O
years	O
.	O

he	O
has	O
had	O
less	O
than	O
five	O
sexual	O
partners	O
in	O
his	O
lifetime	O
,	O
all	O
women	O
.	O

he	O
denies	O
travel	O
outside	O
of	O
the	O
state	O
in	O
over	O
ten	O
years	O
.	O

his	O
girlfriend's	O
parents	O
just	O
got	O
a	O
new	O
dog	O
.	O

he	O
works	O
as	O
a	O
health	O
aid	O
at	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
and	O
does	O
direct	O
patient	O
care	O
.	O

he	O
has	O
a	O
ten	O
-	O
pack	O
year	O
smoking	O
history	O
.	O

one	O
beer	O
per	O
night	O
.	O

no	O
illicit	O
drug	O
use	O
.	O

family	O
history	O
:	O

mother	O
and	O
father	O
alive	O
and	O
healthy	O
.	O

physical	O
exam	O
:	O

t	O
102	O
bp	O
110	O
/	O
57	O
hr	O
113	O
rr	O
27	O
100%	O
on	O
100%	O
nrb	O

general	O
:	O
young	O
man	O
in	O
moderate	O
respiratory	B
distress	I
.	O

able	O
to	O
speak	O
,	O
but	O
cannot	O
complete	O
full	O
sentences	O
.	O

heent	O
:	O
moist	O
mucous	O
membranes	O
,	O
posterior	O
op	O
erythema	B
,	O
white	B
tongue	I
but	O
no	O
evidence	O
of	O
plaques	B

neck	O
:	O
supple	O
,	O
from	O
,	O
no	O
evidence	O
of	O
jvd	B
,	O
lad	B
,	O
or	O
thyromegaly	B

chest	O
:	O
no	O
dullness	B
to	I
percussion	I
,	O
scattered	O
wheezes	B
,	O
no	O
egophony	B
card	O
:	O
tachycardic	B
,	O
regular	O
rhythm	O
,	O
nml	O
s1s2	O
,	O
no	O
m	B
/	O
r	B
/	O
g	B

abd	O
:	O
nabs	O
,	O
soft	O
ntnd	O

ext	O
:	O
no	O
edema	B
,	O
2	O
+	O
dp	O
pulses	O
bilaterally	O
,	O
no	O
calf	O
tenderness	B
,	O
ppd	O
site	O
on	O
right	O
forearm	O
with	O
no	O
evidence	O
of	O
induration	B
at	O
this	O
time	O
(	O
placed	O
earlier	O
today	O
)	O

pertinent	O
results	O
:	O

labs	O
at	O
osh	O
(	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
20	O
*	O
*	O
]	O
)	O
:	O

wbc	O
12	O
.	O
0	O
(	O
88%	O
n	O
,	O
8%	O
l	O
,	O
3	O
.	O
5%	O
m	O
)	O
,	O
hct	O
35	O
.	O
7	O
,	O
plt	O
454	O

na	O
136	O
,	O
k	O
3	O
.	O
8	O
,	O
cl	O
95	O
,	O
co2	O
29	O
,	O
bun	O
4	O
,	O
cr	O
0	O
.	O
9	O

alt	O
13	O
,	O
ast	O
42	O
,	O
alk	O
phos	O
84	O
,	O
tb	O
0	O
.	O
4	O
,	O
alb	O
2	O
.	O
2	O
,	O
tp	O
6	O
.	O
1	O

fe	O
15	O
,	O
tibc	O
162	O

abg	O
:	O
7	O
.	O
44	O
/	O
50	O
/	O
74	O

cxr	O
(	O
osh	O
)	O
:	O
right	O
upper	O
lobe	O
cavitary	B
infiltrate	I

chest	O
ct	O
(	O
osh	O
)	O
:	O
diffuse	O
prominent	O
right	O
upper	O
lobe	O
infiltrate	B
with	O
5cm	O
cavitary	B
mass	I
,	O
2cm	O
right	O
upper	O
lobe	O
cavitary	B
mass	I
,	O
small	O
right	O
pleural	B
effusion	I
,	O
some	O
right	O
hilar	B
lymphadenopathy	I

[	O
*	O
*	O
hospital1	O
79	O
*	O
*	O
]	O
labs	O
/	O
studies	O
:	O

ct	O
chest	O
(	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
23	O
*	O
*	O
]	O
)	O
-	O
impression	O
:	O
1	O
)	O
3	O
.	O
5	O
-	O
cm	O
cavitary	B
lesion	I
with	O
air	B
-	I
fluid	I
level	I
and	O
thickened	B
wall	I
in	O
the	O
right	O
middle	O
lobe	O
as	O
described	O
above	O
,	O
probably	O
representing	O
lung	B
abscess	I
,	O
mentioned	O
in	O
the	O
requisition	O
.	O

however	O
,	O
please	O
also	O
consider	O
the	O
possibility	O
of	O
septic	B
emboli	I
.	O

2	O
)	O
multiple	O
patchy	B
opacities	I
in	O
bilateral	O
lungs	O
,	O
more	O
on	O
the	O
right	O
,	O
which	O
may	O
represent	O
multifocal	O
pneumonia	B
versus	O
atypical	O
edema	B
.	O

3	O
)	O
bilateral	O
diffuse	O
opacity	B
,	O
representing	O
pulmonary	B
edema	I
due	O
to	O
ards	B
.	O

4	O
)	O
bilateral	B
pleural	I
effusion	I
,	O
greater	O
on	O
the	O
right	O
,	O
associated	O
with	O
bibasilar	O
atelectasis	B
.	O

5	O
)	O
perivascular	O
lymphadenopathy	B
.	O

echo	O
/	O
tte	O
(	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
22	O
*	O
*	O
]	O
)	O
:	O
the	O
la	O
is	O
mildly	O
dilated	O
.	O

lv	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
lv	O
cavity	O
is	O
moderately	O
dilated	O
.	O

overall	O
lv	O
systolic	O
function	O
is	O
normal	O
(	O
lvef	O
60%	O
)	O
.	O

no	O
masses	B
or	O
thrombi	B
are	O
seen	O
in	O
the	O
lv	O
.	O

there	O
is	O
no	O
vsd	B
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
root	O
is	O
mildly	O
dilated	O
.	O

the	O
av	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

no	O
masses	B
or	O
vegetations	B
are	O
seen	O
on	O
the	O
av	O
.	O

the	O
mv	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

there	O
is	O
no	O
mvp	B
.	O

no	O
mass	B
or	O
vegetation	B
is	O
seen	O
on	O
the	O
mv	O
.	O

the	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal	O
.	O

no	O
vegetation	B
/	O
mass	B
is	O
seen	O
on	O
the	O
pulmonic	O
valve	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

the	O
absence	O
of	O
a	O
vegetation	B
by	O
2d	O
echocardiography	O
does	O
not	O
exclude	O
endocarditis	B
if	O
clinically	O
suggested	O
.	O

brief	O
hospital	O
course	O
:	O

1	O
)	O
respirtory	B
distress	I
/	O
pna	B
:	O
the	O
patient	O
presented	O
to	O
an	O
osh	O
with	O
fever	B
,	O
bandemia	B
,	O
and	O
respiratory	B
discomcomfort	I
.	O

he	O
was	O
then	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
79	O
*	O
*	O
]	O
with	O
ards	B
-	O
like	O
findings	O
(	O
ards	B
,	O
pna	B
or	O
lung	B
injury	I
via	I
mechanical	I
ventilation	I
)	O
and	O
a	O
rul	O
cavitary	B
lesion	I
(	O
infarction	B
vs	O
abscess	B
/	O
infection	B
)	O
.	O

he	O
was	O
then	O
intubated	O
and	O
mechanically	O
ventilated	O
for	O
respiratory	B
failure	I
with	O
an	O
intialy	O
abg	O
of	O
7	O
.	O
46	O
/	O
44	O
/	O
103	O
/	O
32	O
.	O

he	O
was	O
afebrile	B
over	O
his	O
course	O
.	O

since	O
his	O
admission	O
to	O
the	O
outside	O
hospital	O
,	O
he	O
had	O
been	O
on	O
gatifloxacin	O
,	O
linezolid	O
,	O
clindamycin	O
,	O
zosyn	O
,	O
and	O
vancomycin	O
.	O

his	O
final	O
antibiotic	O
regimen	O
was	O
levofloxacin	O
and	O
clindamycin	O
for	O
cap	B
/	O
aspiration	B
pna	I
coverage	O
.	O

bronchoscopy	O
/	O
bal	O
was	O
not	O
revealing	O
.	O

hiv	B
,	O
ppd	O
,	O
legionalla	O
urine	O
ag	O
,	O
bcxr	O
,	O
ucxr	O
,	O
bal	O
/	O
afb	O
,	O
and	O
a	O
viral	O
panel	O
were	O
negative	O
.	O

he	O
was	O
continued	O
on	O
albuterol	O
/	O
atrovent	O
nebulizers	O
as	O
needed	O
.	O

of	O
note	O
,	O
a	O
tte	O
/	O
echo	O
showed	O
a	O
normal	O
ef	O
without	O
clear	O
signs	O
of	O
endocarditis	B
.	O

the	O
patient	O
had	O
improved	O
dramatically	O
over	O
his	O
course	O
and	O
was	O
comfortable	O
on	O
room	O
air	O
upon	O
discharge	O
.	O

he	O
was	O
discharged	O
with	O
pulmonary	O
follow	O
-	O
up	O
.	O

he	O
was	O
counseled	O
in	O
regards	O
to	O
smoking	O
cessation	O
.	O

2	O
)	O
normocytic	B
anemia	I
:	O
he	O
had	O
a	O
hct	O
in	O
the	O
high	O
20's	O
to	O
low	O
30's	O
early	O
in	O
his	O
course	O
.	O

the	O
baseline	O
was	O
unknown	O
.	O

his	O
iron	O
studies	O
,	O
ldh	O
/	O
bili	O
/	O
hapto	O
,	O
b12	O
/	O
folate	O
were	O
normal	O
.	O

his	O
clinical	O
picture	O
was	O
consistent	O
with	O
anemia	B
of	I
chronic	I
disease	I
and	O
as	O
his	O
pulmonary	O
inflammation	B
/	O
infection	O
resolved	O
,	O
his	O
hct	O
improved	O
.	O

medications	O
on	O
admission	O
:	O

none	O

discharge	O
medications	O
:	O

1	O
.	O
guaifenesin	O
100	O
mg	O
/	O
5	O
ml	O
syrup	O
sig	O
:	O
5	O
-	O
10	O
mls	O
po	O
q6h	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

disp	O
:	O
*	O
qs	O
1	O
week	O
ml	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

2	O
.	O
albuterol	O
90	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
one	O
(	O
1	O
)	O
inhalation	O
every	O
4	O
-	O
6	O
hours	O
as	O
needed	O
for	O
shortness	B
of	I
breath	I
or	O
wheezing	B
for	O
1	O
weeks	O
.	O

disp	O
:	O
*	O
1	O
inh	O
*	O
refills	O
:	O
*	O
0	O
*	O

3	O
.	O
nicotine	O
21	O
mg	O
/	O
24	O
hr	O
patch	O
24hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
patch	O
24hr	O

transdermal	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
patch	O
24hr	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

4	O
.	O
levofloxacin	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
for	O
2	O
weeks	O
.	O

disp	O
:	O
*	O
14	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

5	O
.	O
clindamycin	O
hcl	O
300	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
four	O
times	O
a	O
day	O
for	O
3	O
months	O
.	O

disp	O
:	O
*	O
360	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

primary	O
diagnosis	O
:	O

1	O
)	O
right	B
upper	I
lobe	I
pneumonia	I
with	O
cavitary	B
lesion	I
.	O

2	O
)	O
right	O
upper	O
lobe	O
mass	B
.	O

3	O
)	O
bilateral	O
pulmonary	O
infiltrates	B
.	O

secondary	O
diagnosis	O
:	O

4	O
)	O
idiopathic	B
anemia	I
.	O

discharge	O
condition	O
:	O

good	O
/	O
stable	O
.	O

discharge	O
instructions	O
:	O

1	O
)	O
please	O
call	O
your	O
doctor	O
or	O
return	O
to	O
the	O
er	O
if	O
you	O
have	O
any	O
trouble	B
breathing	I
,	O
increased	O
cough	B
,	O
fevers	B
,	O
chills	B
,	O
fatigue	B
,	O
or	O
any	O
other	O
concenring	O
symptoms	B
.	O

2	O
)	O
please	O
take	O
your	O
oral	O
temperature	O
twice	O
daily	O
.	O

if	O
you	O
have	O
a	O
fever	B
,	O
call	O
your	O
pulmonary	O
doctor	O
(	O
see	O
below	O
for	O
the	O
number	O
)	O
.	O

3	O
)	O
if	O
you	O
resume	O
smoking	O
,	O
stop	O
taking	O
the	O
nicoderm	O
patch	O
.	O

followup	O
instructions	O
:	O

1	O
)	O
please	O
see	O
your	O
new	O
primary	O
doctor	O
for	O
the	O
following	O
appointment	O
.	O

your	O
primary	O
doctor	O
will	O
follow	O
up	O
on	O
your	O
anemia	B
and	O
albumin	O
levels	O
:	O

provider	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
939	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
940	O
*	O
*	O
]	O
,	O
md	O
where	O
:	O
[	O
*	O
*	O
hospital	O
56	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital	O
496	O
*	O
*	O
]	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
58	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2016	O
-	O
04	O
-	O
08	O
*	O
*	O
]	O
1	O
:	O
30	O

2	O
)	O
please	O
have	O
a	O
ct	O
of	O
your	O
chest	O
for	O
the	O
following	O
appointment	O
:	O

cat	O
scan	O
where	O
:	O
[	O
*	O
*	O
hospital	O
56	O
*	O
*	O
]	O
radiology	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1141	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2016	O
-	O
04	O
-	O
18	O
*	O
*	O
]	O
11	O
:	O
30	O
.	O

2	O
)	O
please	O
see	O
your	O
new	O
lung	O
doctor	O
and	O
obtain	O
pulmonary	O
function	O
tests	O
at	O
the	O
[	O
*	O
*	O
hospital1	O
79	O
*	O
*	O
]	O
pulmonary	O
clinic	O
for	O
the	O
following	O
appointment	O
:	O

provider	O
pulmonary	O
breathing	O
tests	O
where	O
:	O
[	O
*	O
*	O
hospital	O
56	O
*	O
*	O
]	O
pulmonary	O
function	O
lab	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1185	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2016	O
-	O
04	O
-	O
25	O
*	O
*	O
]	O
12	O
:	O
45	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2122	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2123	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
3886	O
*	O
*	O
]	O
[	O
*	O
*	O
2016	O
-	O
04	O
-	O
10	O
*	O
*	O
]	O
@	O
1535	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
sat	O
[	O
*	O
*	O
2016	O
-	O
04	O
-	O
30	O
*	O
*	O
]	O
3	O
:	O
14	O
pm	O

(	O
end	O
of	O
report	O
)	O

5081	O
||||	O
4303	O
||||	O
14858	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
10	O
-	O
22	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
18	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
22	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1956	O
-	O
05	O
-	O
01	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
neurosurgery	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1196	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

i	O
fell	B
in	O
my	O
bathroom	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

hpi	O
:	O
this	O
is	O
a	O
57	O
year	O
old	O
male	O
who	O
was	O
transfered	O
to	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
from	O
[	O
*	O
*	O
hospital	O
2601	O
*	O
*	O
]	O
hospital	O
.	O

at	O
11am	O
on	O
[	O
*	O
*	O
10	O
-	O
07	O
*	O
*	O
]	O
,	O
the	O
patient	O
was	O
urinating	O
in	O
his	O
bathroom	O
at	O
home	O
when	O
he	O
suddenly	O
fell	B
and	O
hit	O
his	O
head	O
against	O
the	O
toilet	O
.	O

there	O
may	O
have	O
been	O
a	O
period	O
of	O
lightheadedness	B
prior	O
to	O
falling	B
down	I
but	O
the	O
patient	O
is	O
unsure	O
.	O

he	O
denies	O
any	O
loss	B
of	I
consciousness	I
and	O
was	O
able	O
to	O
get	O
up	O
,	O
go	O
downstairs	O
and	O
watch	O
tv	O
.	O

throughout	O
the	O
day	O
,	O
he	O
states	O
he	O
began	O
to	O
progressively	O
feel	O
lethargic	B
and	O
weak	B
(	O
entire	O
body	O
weakness	B
)	O
.	O

he	O
called	O
ems	O
and	O
was	O
taken	O
to	O
[	O
*	O
*	O
hospital	O
2601	O
*	O
*	O
]	O
hospital	O
,	O
which	O
showed	O
cerebral	B
contusions	I
and	O
a	O
possible	O
sah	B
.	O
at	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
,	O
he	O
was	O
re	O
-	O
imaged	O
and	O
evaluated	O
.	O

the	O
patient	O
denies	O

nausea	B
/	O
vomiting	B
/	O
chest	O

pain	O
/	O
shortness	B
of	I
breath	I
.	O

currently	O
,	O
at	O
time	O
of	O
evaluation	O
,	O
the	O
pt	O
is	O
complaining	O
of	O
a	O
headache	B
.	O

past	O
medical	O
history	O
:	O

pmhx	O
:	O

-	O
seizure	B
(	O
[	O
*	O
*	O
02	O
-	O
25	O
*	O
*	O
]	O
)	O

-	O
pneumonia	B
(	O
[	O
*	O
*	O
02	O
-	O
25	O
*	O
*	O
]	O
)	O

-	O
bronchitis	B
(	O
[	O
*	O
*	O
02	O
-	O
25	O
*	O
*	O
]	O
)	O

-	O
numerous	O
visits	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
s	O
/	O
p	O
alcoholic	B
episodes	I
with	O
various	O
falls	B
or	O
episodes	B
of	I
unconsciousness	I

social	O
history	O
:	O

social	O
hx	O
:	O
this	O
patient	O
lives	O
alone	O
.	O

he	O
drinks	O
1	O
pint	O
/	O
day	O
and	O
smokes	O
approximately	O
2	O
packs	O
a	O
day	O
of	O
cigarettes	O
for	O
the	O
last	O
40	O
years	O
(	O
=80	O
pack	O
year	O
history	O
)	O
.	O

the	O
patient	O
is	O
not	O
married	O
.	O

he	O
works	O
for	O
a	O
company	O
which	O
restores	O
cars	O
.	O

he	O
lives	O
in	O
[	O
*	O
*	O
location	O
1424	O
*	O
*	O
]	O
.	O

he	O

has	O
3	O
children	O
.	O

family	O
history	O
:	O

family	O
hx	O
:	O
noncontributory	O
.	O

physical	O
exam	O
:	O

on	O
admission	O

-	O
-	O
-	O
-	O
-	O
physical	O
exam	O
:	O
-	O
-	O
-	O
-	O
-	O
-	O
-	O
-	O
-	O
-	O
-	O
-	O
-	O

gen	O
:	O
wd	O
/	O
wn	O
,	O
comfortable	O
,	O
nad	O
.	O

heent	O
:	O
pupils	O
:	O
2	O
.	O
5	O
to	O
2mm	O
bilaterally	O
.	O

eoms	O
intact	O
.	O

no	O
nystagmus	B
.	O

c	O
-	O
collar	O
in	O
place	O
.	O

neck	O
:	O
supple	O
.	O

lungs	O
:	O
cta	O
bilaterally	O
.	O

cardiac	O
:	O
rrr	O
.	O

s1	O
/	O
s2	O
.	O

abd	O
:	O
soft	O
,	O
nt	O
,	O
bs	O
+	O

extrem	O
:	O
warm	O
and	O
well	O
-	O
perfused	O
.	O

no	O
c	B
/	O
c	B
/	O
e	B
.	O

neuro	O
:	O

mental	O
status	O
:	O
awake	O
and	O
alert	O
,	O
cooperative	O
with	O
exam	O
,	O
normal	O
affect	O
.	O

orientation	O
:	O
alert	O
and	O
orientated	O
x	O
2	O
.	O
oriented	O
to	O
person	O
,	O
place	O
,	O

but	O
not	O
date	O
.	O

recall	O
:	O
[	O
*	O
*	O
03	O
-	O
22	O
*	O
*	O
]	O
objects	O
at	O
5	O
minutes	O
.	O

language	O
:	O
speech	O
fluent	O
with	O
good	O
comprehension	O
and	O
repetition	O
.	O

naming	O
intact	O
.	O

no	O
dysarthria	B
or	O
paraphasic	B
errors	I
.	O

cranial	O
nerves	O
:	O

i	O
:	O
not	O
tested	O

ii	O
:	O
pupils	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
,	O
2	O
.	O
5	O
to	O
2	O
mm	O
bilaterally	O
.	O

visual	O
fields	O
are	O
full	O
to	O
confrontation	O
.	O

iii	O
,	O
iv	O
,	O
vi	O
:	O
extraocular	O
movements	O
intact	O
bilaterally	O
without	O
nystagmus	B
.	O

v	O
,	O
vii	O
:	O
facial	O
strength	O
and	O
sensation	O
intact	O
and	O
symmetric	O
.	O

viii	O
:	O
hearing	O
intact	O
to	O
finger	O
rub	O
bilaterally	O
.	O

ix	O
,	O
x	O
:	O
palatal	O
elevation	O
symmetrical	O
.	O

xi	O
:	O
sternocleidomastoid	O
and	O
trapezius	O
normal	O
bilaterally	O
.	O

xii	O
:	O
tongue	O
midline	O
without	O
fasciculations	O
.	O

motor	O
:	O
normal	O
bulk	O
and	O
tone	O
bilaterally	O
.	O

no	O
abnormal	B
movements	I
,	O
tremors	B
.	O

strength	O
full	O
power	O
[	O
*	O
*	O
05	O
-	O
24	O
*	O
*	O
]	O
throughout	O
.	O

no	O
pronator	B
drift	I

sensation	O
:	O
intact	O
to	O
light	O
touch	O
bilaterally	O
.	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
11	O
:	O
00pm	O
pt	O
-	O
11	O
.	O
5	O
ptt	O
-	O
24	O
.	O
9	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
0	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
11	O
:	O
00pm	O
plt	O
count	O
-	O
325	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
11	O
:	O
00pm	O
macrocyt	O
-	O
1	O
+	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
11	O
:	O
00pm	O
neuts	O
-	O
80	O
.	O
6	O
*	O
lymphs	O
-	O
13	O
.	O
6	O
*	O
monos	O
-	O
4	O
.	O
4	O
eos	O
-	O
0	O
.	O
5	O
basos	O
-	O
0	O
.	O
9	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
11	O
:	O
00pm	O
wbc	O
-	O
6	O
.	O
7	O
rbc	O
-	O
3	O
.	O
96	O
*	O
hgb	O
-	O
13	O
.	O
9	O
*	O
hct	O
-	O
39	O
.	O
8	O
*	O
mcv	O
-	O
100	O
*	O
mch	O
-	O
35	O
.	O
0	O
*	O
mchc	O
-	O
34	O
.	O
9	O
rdw	O
-	O
13	O
.	O
2	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
11	O
:	O
00pm	O
glucose	O
-	O
86	O
urea	O
n	O
-	O
17	O
creat	O
-	O
0	O
.	O
6	O
sodium	O
-	O
140	O
potassium	O
-	O
3	O
.	O
9	O
chloride	O
-	O
100	O
total	O
co2	O
-	O
24	O
anion	O
gap	O
-	O
20	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
18	O
*	O
*	O
]	O
02	O
:	O
45am	O
urine	O
rbc	O
-	O
<1	O
wbc	O
-	O
<1	O
bacteria	O
-	O
occ	O
yeast	O
-	O
none	O
epi	O
-	O
<1	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
18	O
*	O
*	O
]	O
02	O
:	O
45am	O
urine	O
blood	O
-	O
neg	O
nitrite	O
-	O
neg	O
protein	O
-	O
tr	O
glucose	O
-	O
neg	O
ketone	O
-	O
tr	O
bilirubin	O
-	O
sm	O
urobilngn	O
-	O
1	O
ph	O
-	O
6	O
.	O
0	O
leuk	O
-	O
neg	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
18	O
*	O
*	O
]	O
02	O
:	O
45am	O
urine	O
color	O
-	O
yellow	O
appear	O
-	O
clear	O
sp	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
83	O
*	O
*	O
]	O
-	O
>=1	O
.	O
035	O

[	O
*	O
*	O
2013	O
-	O
10	O
-	O
18	O
*	O
*	O
]	O
02	O
:	O
45am	O
urine	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
opiates	O
-	O
neg	O
cocaine	O
-	O
neg	O
amphetmn	O
-	O
neg	O
mthdone	O
-	O
neg	O

ct	O
head	O
w	O
/	O
o	O
contrast	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
18	O
*	O
*	O
]	O
1	O
:	O
24	O
am	O

impression	O
:	O

1	O
.	O
hemorrhagic	B
contusion	I
in	O
the	O
left	O
frontal	O
lobe	O
.	O

2	O
.	O
small	O
subdural	B
hematoma	I
along	O
the	O
falx	O
cerebri	O
and	O
tentorium	O
.	O

3	O
.	O
probable	O
chronic	B
subdural	I
hematoma	I
along	O
the	O
left	O
frontal	O
convexity	O
,	O
and	O
possibly	O
along	O
the	O
right	O
as	O
well	O
.	O

the	O
latter	O
appearance	O
of	O
extraaxial	B
widening	I
is	O
felt	O
more	O
likely	O
due	O
to	O
atrophy	B
,	O
however	O
.	O

4	O
.	O
sinus	B
mucosal	I
thickening	I
with	O
a	O
small	B
air	I
-	I
fluid	I
level	I
in	O
the	O
sphenoid	O
.	O

5	O
.	O
nasal	B
bone	I
fractures	I
.	O

note	O
added	O
at	O
attending	O
review	O
:	O
i	O
agree	O
that	O
the	O
right	O
frontal	O
extra	B
axial	I
fluid	I
is	O
most	O
likely	O
an	O
enlarged	B
subarachnoid	I
space	I
.	O

ct	O
c	O
-	O
spine	O
w	O
/	O
o	O
contrast	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
18	O
*	O
*	O
]	O
1	O
:	O
24	O
am	O

impression	O
:	O

1	O
.	O
no	O
evidence	O
of	O
fracture	B
or	O
dislocation	B
.	O

2	O
.	O
moderately	O
severe	O
emphysema	B
.	O

3	O
.	O
findings	O
suggesting	O
chronic	B
sinusitis	I
in	O
the	O
left	O
maxillary	O
sinus	O
.	O

4	O
.	O
cervical	B
spondylosis	I
.	O

brief	O
hospital	O
course	O
:	O

this	O
patient	O
was	O
admitted	O
to	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
18	O
*	O
*	O
]	O
after	O
a	O
fall	B
in	O
his	O
bathroom	O
.	O

he	O
was	O
evaluated	O
and	O
admitted	O
to	O
the	O
trauma	O
service	O
initially	O
for	O
neuro	O
checks	O
,	O
a	O
repeat	O
ct	O
head	O
the	O
following	O
morning	O
and	O
observation	O
(	O
especially	O
given	O
his	O
history	O
of	O
alcohol	O
)	O
.	O

overnight	O
,	O
the	O
patient	O
was	O
stable	O
and	O
he	O
neurlogically	O
was	O
intact	O
.	O

a	O
repeat	O
ct	O
in	O
the	O
morning	O
showed	O
a	O
contusion	B
which	O
potentially	O
was	O
read	O
as	O
an	O
underlying	B
mass	I
.	O

the	O
patient	O
was	O
hence	O
kept	O
for	O
furthur	O
observation	O
.	O

as	O
an	O
mri	O
was	O
unable	O
to	O
be	O
done	O
,	O
a	O
repeat	O
ct	O
head	O
with	O
and	O
without	O
contrast	O
was	O
done	O
,	O
which	O
showed	O
no	O
underlying	O
lesions	B
.	O

the	O
patient	O
had	O
no	O
other	O
medical	O
or	O
surgical	O
issues	O
and	O
was	O
stable	O
.	O

over	O
the	O
weekend	O
from	O
[	O
*	O
*	O
10	O
-	O
18	O
*	O
*	O
]	O
to	O
[	O
*	O
*	O
10	O
-	O
20	O
*	O
*	O
]	O
,	O
the	O
patient	O
remained	O
in	O
the	O
trauma	O
icu	O
awaiting	O
a	O
bed	O
on	O
the	O
floor	O
.	O

he	O
remained	O
stable	O
and	O
without	O
issues	O
.	O

he	O
was	O
put	O
on	O
a	O
ciwa	O
scale	O
per	O
his	O
alcoholic	O
history	O
.	O

he	O
was	O
intermittently	B
confused	I
at	O
some	O
points	O
overnight	O
,	O
likely	O
due	O
to	O
his	O
pain	B
medications	O
and	O
alcoholic	B
history	I
.	O

he	O
was	O
seen	O
by	O
physical	O
therapy	O
on	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
21	O
*	O
*	O
]	O
,	O
who	O
reccomended	O
one	O
more	O
session	O
prior	O
to	O
discharge	O
on	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
22	O
*	O
*	O
]	O
.	O

on	O
[	O
*	O
*	O
10	O
-	O
22	O
*	O
*	O
]	O
he	O
was	O
seen	O
and	O
evaluated	O
by	O
physical	O
therapy	O
and	O
cleared	O
for	O
discharge	O
.	O

he	O
was	O
seen	O
by	O
physical	O
therapy	O
on	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
22	O
*	O
*	O
]	O
,	O
and	O
then	O
discharged	O
in	O
a	O
stable	O
condition	O
.	O

he	O
is	O
due	O
to	O
follow	O
-	O
up	O
with	O
dr	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
the	O
clinic	O
in	O
4	O
weeks	O
with	O
another	O
repeat	O
head	O
scan	O
.	O

medications	O
on	O
admission	O
:	O

-	O
oxycontin	O
(	O
prescribed	O
for	O
the	O
last	O
2	O
weeks	O
as	O
he	O
has	O
rib	B
fractures	I
from	O
a	O
previous	O
fall	B
)	O

-	O
regular	O
vitamins	O

discharge	O
medications	O
:	O

1	O
.	O
phenytoin	O
sodium	O
extended	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
for	O
30	O
days	O
.	O

disp	O
:	O
*	O
45	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
1	O
*	O

2	O
.	O
oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
pain	B
.	O

disp	O
:	O
*	O
40	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

3	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

traumatic	B
brain	I
injury	I
s	O
/	O
p	O
fall	B

discharge	O
condition	O
:	O

neurologically	O
stable	O

discharge	O
instructions	O
:	O

please	O
call	O
your	O
doctor	O
or	O
return	O
to	O
the	O
er	O
for	O
any	O
of	O
the	O
following	O
:	O
call	O
if	O
you	O
have	O
any	O
lethargy	B
,	O
numbness	B
tingling	I
weakness	I
,	O
seizure	B
or	O
slurred	B
speech	I
.	O
*	O
you	O
experience	O
new	O
chest	O
pain	O
,	O
pressure	O
,	O
squeezing	O
or	O
tightness	O
.	O

*	O
new	O
or	O
worsening	O
cough	O
or	O
wheezing	O
.	O

*	O
if	O
you	O
are	O
vomitting	B
and	O
cannot	B
keep	I
in	I
fluids	I
or	O
your	O
medications	O
.	O
*	O
you	O
are	O
getting	O
dehydrated	B
due	O
to	O
continued	O
vomitting	B
,	O
diarrhea	B
or	O
other	O
reasons	O
.	O

signs	O
of	O
dehydration	B
include	O
dry	B
mouth	I
,	O
rapid	B
heartbeat	I
or	O
feeling	B
dizzy	I
or	O
faint	B
when	O
standing	O
.	O
*	O
you	O
see	O
blood	O
or	O
dark	O
/	O
black	O
material	O
when	O
you	O
vomit	O
or	O
have	O
a	O
bowel	O
movement	O
.	O
*	O
your	O
skin	O
,	O
or	O
the	O
whites	O
of	O
your	O
eyes	O
become	O
yellow	O
.	O
*	O
your	O
pain	B
is	O
not	O
improving	O
within	O
8	O
-	O
12	O
hours	O
or	O
not	O
gone	O
within	O
24	O
hours	O
.	O

call	O
or	O
return	O
immediately	O
if	O
your	O
pain	B
is	O
getting	O
worse	O
or	O
is	O
changing	O
location	O
or	O
moving	O
to	O
your	O
chest	O
or	O
back	O
.	O
*	O
you	O
have	O
shaking	B
chills	I
,	O
or	O
a	O
fever	B
greater	O
than	O
101	O
.	O
5	O
(	O
f	O
)	O
degrees	O
or	O
38	O
(	O
c	O
)	O
degrees	O
.	O
*	O
any	O
serious	O
change	O
in	O
your	O
symptoms	B
,	O
or	O
any	O
new	B
symptoms	I
that	O
concern	O
you	O
.	O

followup	O
instructions	O
:	O

please	O
call	O
the	O
office	O
to	O
be	O
seen	O
in	O
4	O
weeks	O
with	O
a	O
cat	O
scan	O
of	O
the	O
brain	O
.	O

the	O
cat	O
scan	O
should	O
be	O
with	O
and	O
without	O
contrast	O
.	O

please	O
call	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2602	O
*	O
*	O
]	O
office	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
*	O
*	O
]	O
for	O
and	O
appointment	O
.	O

you	O
should	O
see	O
your	O
primary	O
care	O
doctor	O
within	O
2	O
weeks	O
for	O
evaluation	O
and	O
follow	O
up	O
.	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1197	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1198	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
409	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1308	O
*	O
*	O
]	O
np	O
80	O
-	O
bze	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
22	O
*	O
*	O
]	O
@	O
0940	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
1	O
:	O
25	O
pm	O

(	O
end	O
of	O
report	O
)	O

230044	O
||||	O
5062	O
||||	O
9810	O
||||	O
radiology	O
_	O
report	O
||||	O
2013	O
-	O
12	O
-	O
26	O
19	O
:	O
45	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
421	O
-	O
7138	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
26	O
*	O
*	O
]	O
7	O
:	O
45	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
2894	O
*	O
*	O
]	O
reason	O
:	O
eval	O
for	O
pneumothorax	B
admitting	O
diagnosis	O
:	O
spinal	O
mass	B

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

71	O
year	O
old	O
man	O
s	O
/	O
p	O
verterbral	O
fusion	O
after	O
spinal	B
abscess	I
,	O
hx	O
loculated	B
l	I
effusion	I
,	O
s	O
/	O
p	O
thoracentesis	O
.	O

now	O
with	O
chest	B
pain	I
.	O

reason	O
for	O
this	O
examination	O
:	O

eval	O
for	O
pneumothorax	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
71	O
-	O
year	O
-	O
old	O
man	O
status	O
post	O
vertebral	O
fusion	O
after	O
spinal	B
abscess	I
.	O

history	O
of	O
loculated	B
left	I
effusion	I
post	O
-	O
thoracentesis	O
,	O
now	O
with	O
chest	B
pain	I
.	O

evaluate	O
for	O
pneumothorax	B
.	O

spinal	O
rods	O
are	O
in	O
place	O
with	O
associated	O
screws	O
and	O
vertebral	O
body	O
spacer	O
.	O

the	O
heart	O
size	O
is	O
normal	O
.	O

there	O
is	O
a	O
somewhat	O
tortuous	B
aorta	I
.	O

the	O
mediastinal	O
contours	O
are	O
otherwise	O
unremarkable	O
.	O

there	O
are	O
some	O
interstitial	B
opacities	I
predominantly	O
within	O
the	O
lung	O
bases	O
along	O
with	O
small	O
bilateral	B
pleural	I
effusions	I
.	O

a	O
right	O
-	O
sided	O
pacemaker	O
with	O
single	O
lead	O
is	O
present	O
extending	O
into	O
the	O
right	O
ventricle	O
.	O

the	O
previously	O
placed	O
left	O
-	O
sided	O
picc	O
line	O
has	O
been	O
pulled	O
back	O
and	O
now	O
is	O
seen	O
with	O
tip	O
overlying	O
the	O
axillary	O
region	O
.	O

impression	O
:	O

1	O
.	O
no	O
evidence	O
of	O
pneumothorax	B
.	O

2	O
.	O
interval	O
retraction	O
of	O
picc	O
line	O
now	O
overlying	O
the	O
axillary	O
region	O
.	O

note	O
shoud	O
be	O
made	O
that	O
this	O
location	O
is	O
intentional	O
per	O
recommendation	O
for	O
picc	O
line	O
retraction	O
secondary	O
to	O
cardiac	O
pacer	O
procedure	O
to	O
be	O
performed	O
.	O

3	O
.	O
otherwise	O
stable	O
chest	O
radiograph	O
.	O

90812	O
||||	O
5308	O
||||	O
27655	O
||||	O
ecg	O
_	O
report	O
||||	O
2019	O
-	O
02	O
-	O
11	O
13	O
:	O
29	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	O
rhythm	O

short	O
run	O
of	O
supraventricular	B
tachycardia	I

probable	O
acute	B
inferior	I
myocardial	I
infarction	I

since	O
last	O
ecg	O
,	O
inferior	B
myocardial	I
infarction	I
and	O
supraventricular	B
tachycardia	I
are	O
new	O

106998	O
||||	O
5367	O
||||	O
15218	O
||||	O
echo	O
_	O
report	O
||||	O
2015	O
-	O
03	O
-	O
11	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O

myocardial	B
infarction	I
.	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
99	O
/	O
55	O

hr	O
(	O
bpm	O
)	O
:	O
62	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
11	O
*	O
*	O
]	O
at	O
12	O
:	O
32	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

left	O
ventricle	O
:	O
the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

there	O
is	O
mild	O
regional	O
left	B
ventricular	I
systolic	I
dysfunction	I
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

there	O
is	O
no	O
aortic	B
valve	I
stenosis	I
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

pericardium	O
:	O
there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

there	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade	B
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
due	O
to	O
poor	O
echo	O
windows	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

there	O
is	O
mild	O
regional	O
left	B
ventricular	I
systolic	I
dysfunction	I
with	O
inferior	O
and	O
inferolateral	O
akinesis	B
/	O
hypokinesis	B
.	O

right	O
ventricular	O
free	O
wall	O
appears	O
hypokinetic	B
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

there	O
is	O
no	O
aortic	B
valve	I
stenosis	I
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

95003	O
||||	O
5797	O
||||	O
7131	O
||||	O
ecg	O
_	O
report	O
||||	O
2011	O
-	O
07	O
-	O
20	O
09	O
:	O
30	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
tachycardia	I

right	I
bundle	I
branch	I
block	I

since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O
,	O
atrial	B
fibrillation	I
has	O
reverted	O
to	O
sinus	O
rhythm	O

87704	O
||||	O
5955	O
||||	O
22377	O
||||	O
ecg	O
_	O
report	O
||||	O
2013	O
-	O
01	O
-	O
29	O
10	O
:	O
13	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
followed	O
by	O
pause	O
and	O
junctional	B
rhythm	I
rate	O
,	O
40	O
intraventricular	B
conduction	I
delay	I
-	O
probably	O
left	B
bundle	I
branch	I
block	I
clinical	O
correlation	O
is	O
suggested	O
since	O
previous	O
tracing	O
of	O
the	O
same	O
date	O
,	O
probably	O
no	O
significant	O
change	O

95720	O
||||	O
5967	O
||||	O
14456	O
||||	O
echo	O
_	O
report	O
||||	O
2009	O
-	O
11	O
-	O
10	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O

aortic	B
valve	I
disease	I
.	O

hypertension	B
.	O

height	O
:	O
(	O
in	O
)	O
65	O

weight	O
(	O
lb	O
)	O
:	O
280	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
28	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
120	O
/	O
62	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
10	O
*	O
*	O
]	O
at	O
13	O
:	O
20	O

test	O
:	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
elongated	B
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
mildly	O
dilated	O
.	O

left	O
ventricle	O
:	O
there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
with	O
normal	O
cavity	O
size	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

due	O
to	O
suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
wall	B
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

right	O
ventricle	O
:	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

the	O
ascending	O
aorta	O
is	O
normal	O
in	O
diameter	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

there	O
is	O
no	O
aortic	B
valve	I
stenosis	I
.	O

trace	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

there	O
is	O
mild	O
mitral	B
annular	I
calcification	I
.	O

tricuspid	O
valve	O
:	O
the	O
tricuspid	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
tricuspid	B
regurgitation	I
.	O

the	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
determined	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
the	O
pulmonic	O
valve	O
is	O
not	O
well	O
seen	O
.	O

pericardium	O
:	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
due	O
to	O
poor	O
echo	O
windows	O
.	O

based	O
on	O
1997	O
aha	O
endocarditis	B
prophylaxis	O
recommendations	O
,	O
the	O
echo	O
findings	O
indicate	O
a	O
low	O
risk	O
(	O
prophylaxis	O
not	O
recommended	O
)	O
.	O

clinical	O
decisions	O
regarding	O
the	O
need	O
for	O
prophylaxis	O
should	O
be	O
based	O
on	O
clinical	O
and	O
echocardiographic	O
data	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
elongated	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
with	O
normal	O
cavity	O
size	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

due	O
to	O
suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
wall	B
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

there	O
is	O
no	O
aortic	B
valve	I
stenosis	I
.	O

trace	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

the	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
determined	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

impression	O
:	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
with	O
normal	O
global	O
biventricular	O
systolic	O
function	O
.	O

based	O
on	O
1997	O
aha	O
endocarditis	B
prophylaxis	O
recommendations	O
,	O
the	O
echo	O
findings	O
indicate	O
a	O
low	O
risk	O
(	O
prophylaxis	O
not	O
recommended	O
)	O
.	O

clinical	O
decisions	O
regarding	O
the	O
need	O
for	O
prophylaxis	O
should	O
be	O
based	O
on	O
clinical	O
and	O
echocardiographic	O
data	O
.	O

383430	O
||||	O
6091	O
||||	O
9227	O
||||	O
radiology	O
_	O
report	O
||||	O
2014	O
-	O
07	O
-	O
04	O
10	O
:	O
15	O
:	O
00	O
.	O
0	O
||||	O
u51	O
pelvis	O
,	O
non	O
-	O
obstetric	O
||||	O
||||	O
clip	O
#	O
405	O
-	O
0991	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
04	O
*	O
*	O
]	O
10	O
:	O
15	O
am	O

pelvis	O
u	O
.	O
s	O
.	O
,	O
transvaginal	O
;	O
pelvis	O
,	O
non	O
-	O
obstetric	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
3378	O
*	O
*	O
]	O
reason	O
:	O
21	O
year	O
old	O
with	O
delayed	B
pp	I
hemorrhage	I
,	O
s	O
/	O
p	O
d&c	O
with	O
?	O
accre	B
admitting	O
diagnosis	O
:	O
retained	B
products	I
of	I
conception	I
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

21	O
year	O
old	O
woman	O
with	O
delayed	B
pp	I
hemorrhage	I
,	O
s	O
/	O
p	O
d&c	O
with	O
?	O
accreta	B
,	O
please	O
evaluate	O
uterus	O
for	O
any	O
further	O
retained	B
products	I
.	O

reason	O
for	O
this	O
examination	O
:	O

21	O
year	O
old	O
with	O
delayed	B
pp	I
hemorrhage	I
,	O
s	O
/	O
p	O
d&c	O
with	O
?	O
accreta	B
,	O
please	O
evaluate	O
uterus	O
for	O
any	O
further	O
retained	B
products	I
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

pelvic	O
ultrasound	O

indication	O
for	O
study	O
:	O
postpartum	B
bleeding	I
.	O

the	O
study	O
is	O
performed	O
as	O
a	O
followup	O
from	O
the	O
recent	O
study	O
of	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
01	O
*	O
*	O
]	O
.	O

the	O
patient	O
has	O
subsequently	O
had	O
curettage	O
and	O
pelvic	O
embolization	O
.	O

transabdominal	O
and	O
endovaginal	O
ultrasound	O
were	O
performed	O
and	O
showed	O
the	O
uterus	O
to	O
be	O
anteverted	O
and	O
within	O
normal	O
limits	O
for	O
a	O
recently	O
postpartum	O
uterus	O
.	O

the	O
endometrial	O
cavity	O
echoes	O
show	O
a	O
maximum	O
thickness	O
of	O
approximately	O
7	O
mm	O
.	O

the	O
area	O
of	O
increased	O
vascularity	B
in	O
the	O
left	O
anterior	O
fundus	O
is	O
again	O
visualized	O
with	O
a	O
feeding	O
vessel	O
to	O
a	O
small	O
focus	O
of	O
material	O
within	O
the	O
endometrial	O
cavity	O
which	O
measures	O
less	O
than	O
5	O
mm	O
maximum	O
dimension	O
.	O

the	O
ovaries	O
are	O
within	O
normal	O
limits	O
for	O
size	O
with	O
no	O
evidence	O
of	O
adnexal	B
mass	I
nor	O
any	O
evidence	O
of	O
free	B
pelvic	I
fluid	I
.	O

impression	O
:	O

significant	O
improvement	O
in	O
the	O
appearance	O
of	O
the	O
uterus	O
since	O
the	O
prior	O
examination	O
.	O

the	O
area	O
of	O
vascularity	B
is	O
again	O
seen	O
in	O
the	O
left	O
anterior	O
fundus	O
myometrium	O
.	O

there	O
is	O
likely	O
a	O
small	O
retained	B
product	I
of	I
conception	I
less	O
than	O
5	O
mm	O
in	O
size	O
.	O

findings	O
were	O
discussed	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3374	O
*	O
*	O
]	O
.	O

dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3379	O
*	O
*	O
]	O

371824	O
||||	O
6292	O
||||	O
19492	O
||||	O
radiology	O
_	O
report	O
||||	O
2013	O
-	O
01	O
-	O
16	O
18	O
:	O
01	O
:	O
00	O
.	O
0	O
||||	O
c91	O
chest	O
port	O
.	O

line	O
placement	O
||||	O
||||	O
clip	O
#	O
391	O
-	O
0781	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
16	O
*	O
*	O
]	O
6	O
:	O
01	O
pm	O

chest	O
port	O
.	O

line	O
placement	O
;	O
-	O
77	O
by	O
different	O
physician	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
5121	O
*	O
*	O
]	O
reason	O
:	O
assess	O
effusion	B
.	O
r	O
/	O
o	O
ptx	B
admitting	O
diagnosis	O
:	O
non	B
-	I
st	I
segment	I
elevation	I
myocardial	I
infarction	I
;	O
peumonia\cath	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

75	O
yom	O
s	O
/	O
p	O
cabg	O
and	O
dart	O
placement	O
reason	O
for	O
this	O
examination	O
:	O
assess	O
effusion	B
.	O
r	O
/	O
o	O
ptx	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

history	O
:	O
75	O
-	O
year	O
-	O
old	O
man	O
status	O
post	O
cabg	O
and	O
dart	O
placement	O
.	O

assess	O
effusion	B
and	O
rule	O
out	O
pneumothorax	B
.	O

comparison	O
:	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
16	O
*	O
*	O
]	O
,	O
at	O
8	O
:	O
25	O
a	O
.	O
m	O
.	O

portable	O
chest	O
:	O
cardiac	O
,	O
mediastinal	O
and	O
hilar	O
contours	O
are	O
stable	O
.	O

there	O
is	O
improved	O
aeration	O
of	O
the	O
left	O
lung	O
and	O
decrease	O
in	O
the	O
pleural	B
effusion	I
.	O

there	O
is	O
no	O
evidence	O
of	O
pneumothorax	B
.	O

a	O
small	O
catheter	O
is	O
noted	O
over	O
the	O
mid	O
left	O
chest	O
.	O

the	O
right	O
hemidiaphragm	O
remains	O
elevated	O
.	O

linear	B
atelectasis	I
and	O
mild	O
pulmonary	B
edema	I
is	O
observed	O
on	O
the	O
right	O
.	O

osseous	O
and	O
soft	O
tissue	O
structures	O
are	O
stable	O
.	O

impression	O
:	O
interval	O
decrease	O
in	O
left	O
pleural	B
effusion	I
and	O
no	O
evidence	O
of	O
pneumothorax	B
status	O
post	O
left	O
chest	O
catheter	O
placement	O
.	O

89652	O
||||	O
6296	O
||||	O
26694	O
||||	O
ecg	O
_	O
report	O
||||	O
2019	O
-	O
06	O
-	O
15	O
19	O
:	O
15	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
.	O

left	B
atrial	I
enlargement	I
.	O

frequent	O
atrial	B
ectopy	I
.	O

left	B
ventricular	I
hypertrophy	I
.	O

delayed	B
precordial	I
r	I
wave	I
progression	O
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2019	O
-	O
06	O
-	O
15	O
*	O
*	O
]	O
frequent	O
atrial	B
ectopy	I
has	O
appeared	O
.	O

tracing	O
#2	O

96221	O
||||	O
6445	O
||||	O
10055	O
||||	O
echo	O
_	O
report	O
||||	O
2019	O
-	O
06	O
-	O
05	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
murmur	B
.	O

source	O
of	O
embolism	B
.	O

height	O
:	O
(	O
in	O
)	O
73	O

weight	O
(	O
lb	O
)	O
:	O
185	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
08	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
112	O
/	O
57	O

hr	O
(	O
bpm	O
)	O
:	O
95	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
06	O
-	O
05	O
*	O
*	O
]	O
at	O
11	O
:	O
35	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

large	O
left	O
pleural	B
effusion	I
.	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

normal	O
interatrial	O
septum	O
.	O

no	O
asd	B
by	O
2d	O
or	O
color	O
doppler	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

normal	O
regional	O
lv	O
systolic	O
function	O
.	O

no	O
resting	B
lvot	I
gradient	I
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

no	O
2d	O
or	O
doppler	O
evidence	O
of	O
distal	O
arch	B
coarctation	I
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

no	O
masses	B
or	O
vegetations	O
on	O
aortic	O
valve	O
.	O

no	O
as	B
.	O

mitral	O
valve	O
:	O
normal	O
mitral	O
valve	O
leaflets	O
with	O
trivial	O
mr	B
.	O

no	O
mvp	B
.	O

no	O
mass	B
or	O
vegetation	O
on	O
mitral	O
valve	O
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
.	O

no	O
mass	B
or	O
vegetation	O
on	O
tricuspid	O
valve	O
.	O

mild	O
[	O
1	O
+	O
]	O
tr	B
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
no	O
ps	B
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

no	O
atrial	B
septal	I
defect	I
is	O
seen	O
by	O
2d	O
or	O
color	O
doppler	O
.	O

left	O
ventricular	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
are	O
normal	O
(	O
lvef>55%	O
)	O
.	O

regional	O
left	O
ventricular	O
wall	O
motion	O
is	O
normal	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

no	O
masses	B
or	O
vegetations	O
are	O
seen	O
on	O
the	O
aortic	O
valve	O
.	O

there	O
is	O
no	O
aortic	B
valve	I
stenosis	I
.	O

the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

no	O
mass	O
or	O
vegetation	O
is	O
seen	O
on	O
the	O
mitral	O
valve	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

impression	O
:	O
no	O
valvular	B
vegetations	I
seen	O
.	O

71352	O
||||	O
6567	O
||||	O
23567	O
||||	O
ecg	O
_	O
report	O
||||	O
2017	O
-	O
08	O
-	O
25	O
08	O
:	O
29	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
bradycardia	I
.	O

a	B
-	I
v	I
conduction	I
delay	I
.	O

p	O
-	O
r	O
interval	O
0	O
.	O
23	O
.	O

left	B
ventricular	I
hypertrophy	I
with	O
st	B
-	I
t	I
wave	I
changes	I
.	O

probable	O
prior	B
inferior	I
wall	I
myocardial	I
infarction	I
.	O

q	B
-	I
t	I
interval	I
prolongation	I
.	O

no	O
diagnostic	O
change	O
compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2017	O
-	O
08	O
-	O
23	O
*	O
*	O
]	O
.	O

81911	O
||||	O
6653	O
||||	O
3153	O
||||	O
ecg	O
_	O
report	O
||||	O
2010	O
-	O
12	O
-	O
01	O
21	O
:	O
46	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
bradycardia	I

consider	O
left	B
atrial	I
abnormality	I

right	I
bundle	I
branch	I
block	I

clinical	O
correlation	O
is	O
suggested	O

no	O
previous	O
tracing	O
for	O
comparison	O

294691	O
||||	O
7048	O
||||	O
6824	O
||||	O
radiology	O
_	O
report	O
||||	O
2015	O
-	O
05	O
-	O
16	O
21	O
:	O
19	O
:	O
00	O
.	O
0	O
||||	O
v154	O
36248	O
add'l	O
2nd	O
/	O
3rd	O
order	O
abd	O
/	O
pel	O
/	O
lower	O
ext	O
a	O
-	O
gram	O
||||	O
||||	O
clip	O
#	O
287	O
-	O
6582	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
16	O
*	O
*	O
]	O
9	O
:	O
19	O
pm	O

mesenteric	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
3649	O
*	O
*	O
]	O
reason	O
:	O
pt	O
with	O
lgi	B
bleed	I
,	O
s	O
/	O
p	O
rbc	O
scan	O
.	O

for	O
possible	O
intervention	O
.	O

contrast	O
:	O
optiray	O
amt	O
:	O
150	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
cpt	O
codes	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
36247	O
inital	O
3rd	O
order	O
abd	O
/	O
pel	O
/	O
lower	O
36245	O
ea	O
1st	O
order	O
abd	O
/	O
pel	O
/	O
lower	O
ext	O
*	O
*	O
-	O
59	O
distinct	O
procedural	O
service	O
36248	O
add'l	O
2nd	O
/	O
3rd	O
order	O
abd	O
/	O
pel	O
/	O
lo	O
*	O
*	O
75726	O
viseral	O
sel	O
/	O
supersel	O
a	O
-	O
gram	O
75726	O
viseral	O
sel	O
/	O
supersel	O
a	O
-	O
gram	O
*	O
*	O
-	O
59	O
distinct	O
procedural	O
service	O
75774	O
ea	O
add'l	O
vessel	O
after	O
basic	O
a	O
-	O
*	O
*	O
75774	O
ea	O
add'l	O
vessel	O
after	O
basic	O
a	O
-	O
99141	O
iv	O
conscioutious	O
sedation	O
pro	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

81	O
year	O
old	O
woman	O
with	O

reason	O
for	O
this	O
examination	O
:	O

pt	O
with	O
lgi	B
bleed	I
,	O
s	O
/	O
p	O
rbc	O
scan	O
.	O

for	O
possible	O
intervention	O
.	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
81	O
year	O
old	O
female	O
with	O
lower	B
gastrointestinal	I
bleed	I
proven	O
by	O
nuclear	O
medicine	O
scan	O
,	O
please	O
embolized	O
.	O

significant	B
hematocrit	I
drop	I
.	O

radiologist	O
:	O

attending	O
radiologist	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
161	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
162	O
*	O
*	O
]	O
.	O

interventional	O
radiology	O
fellow	O
:	O
dr	O
.	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3278	O
*	O
*	O
]	O
rao	O
.	O

technique	O
:	O
informed	O
consent	O
was	O
obtained	O
prior	O
to	O
the	O
procedure	O
.	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
162	O
*	O
*	O
]	O
was	O
present	O
for	O
the	O
entirety	O
of	O
the	O
procedure	O
.	O

the	O
right	O
groin	O
was	O
sterilely	O
prepped	O
and	O
draped	O
and	O
a	O
19	O
gauge	O
needle	O
was	O
used	O
to	O
access	O
the	O
right	O
common	O
femoral	O
artery	O
.	O

a	O
.	O
018	O
guidewire	O
was	O
advanced	O
under	O
fluoroscopic	O
observation	O
into	O
the	O
abdominal	O
aorta	O
,	O
over	O
which	O
a	O
5	O
fr	O
sheath	O
was	O
placed	O
.	O

through	O
the	O
5	O
fr	O
sheath	O
,	O
a	O
5	O
fr	O
cobra	O
catheter	O
was	O
used	O
to	O
select	O
the	O
superior	O
mesenteric	O
artery	O
.	O

the	O
superior	O
mesenteric	O
artery	O
angiogram	O
was	O
obtained	O
.	O

a	O
5	O
fr	O
sos	O
catheter	O
was	O
used	O
to	O
select	O
the	O
inferior	O
mesenteric	O
artery	O
and	O
inferior	O
mesenteric	O
angiogram	O
in	O
multiple	O
projections	O
was	O
obtained	O
.	O

a	O
3	O
fr	O
microcatheter	O
was	O
placed	O
through	O
the	O
5	O
fr	O
sos	O
catheter	O
into	O
the	O
left	O
colic	O
artery	O
,	O
and	O
multiple	O
angiograms	O
obtained	O
.	O

the	O
catheter	O
was	O
then	O
advanced	O
into	O
the	O
ascending	O
branch	O
of	O
the	O
left	O
colic	O
artery	O
and	O
angiogram	O
was	O
obtained	O
.	O

the	O
catheter	O
was	O
repositioned	O
so	O
that	O
its	O
tip	O
was	O
in	O
the	O
descending	O
branch	O
of	O
the	O
left	O
colic	O
artery	O
,	O
and	O
images	O
obtained	O
.	O

the	O
catheter	O
and	O
sheath	O
were	O
removed	O
,	O
and	O
manual	O
pressure	O
applied	O
until	O
hemostasis	O
was	O
achieved	O
.	O

a	O
small	O
hematoma	B
(	O
less	O
than	O
3	O
cm	O
)	O
was	O
noted	O
.	O

medications	O
:	O
under	O
continuous	O
monitoring	O
small	O
divided	O
doses	O
of	O
versed	O
totaling	O
1	O
mg	O
,	O
and	O
fentanyl	O
totaling	O
50	O
mcg	O
was	O
administered	O
.	O

1%	O
lidocaine	O
was	O
used	O
for	O
local	O
anesthesia	O
the	O
right	O
common	O
femoral	O
artery	O
puncture	O
site	O
.	O

complications	O
:	O
there	O
was	O
a	O
small	O
(	O
less	O
than	O
3	O
cm	O
)	O
hematoma	B
at	O
the	O
groin	O
site	O
,	O
likely	O
secondary	O
to	O
this	O
patient's	O
inability	O
to	O
remain	O
motionless	O
during	O
compression	O
and	O
immediately	O
after	O
compression	O
.	O

ultrasound	O
at	O
time	O
showed	O
no	O
evidence	O
of	O
pseudoaneurysm	B
.	O

examination	O
of	O
the	O
groin	O
the	O
next	O
morning	O
showed	O
great	O
improvement	O
of	O
the	O
hematoma	B
,	O
measuring	O
less	O
than	O
1	O
cm	O
the	O
following	O
(	O
over	O
)	O

date	O
:	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
16	O
*	O
*	O
]	O
9	O
:	O
19	O
pm	O

mesenteric	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
3649	O
*	O
*	O
]	O
reason	O
:	O
pt	O
with	O
lgi	B
bleed	I
,	O
s	O
/	O
p	O
rbc	O
scan	O
.	O

for	O
possible	O
intervention	O
.	O

contrast	O
:	O
optiray	O
amt	O
:	O
150	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

(	O
cont	O
)	O

morning	O
.	O

findings	O
:	O
superior	O
mesenteric	O
angiogram	O
demonstrated	O
atherosclerotic	B
disease	I
with	O
mild	O
(	O
less	O
than	O
25%	O
)	O
narrowing	B
of	O
the	O
mid	O
portion	O
of	O
the	O
main	O
sma	O
.	O

angiogram	O
of	O
the	O
left	O
colic	O
artery	O
demonstrated	O
the	O
anatomy	O
to	O
be	O
very	O
well	O
visualized	O
with	O
mucosal	O
stain	O
seen	O
,	O
but	O
no	O
evidence	O
of	O
bleeding	B
.	O

similarly	O
,	O
the	O
angiograms	O
of	O
the	O
ascending	O
and	O
descending	O
branches	O
of	O
the	O
left	O
colic	O
artery	O
did	O
not	O
demonstrate	O
any	O
evidence	O
of	O
contrast	B
extravasation	I
.	O

the	O
venous	O
system	O
appeared	O
normal	O
,	O
and	O
the	O
superior	O
mesenteric	O
vein	O
and	O
portal	O
vein	O
were	O
patent	O
.	O

impression	O
:	O

1	O
.	O
angiograms	O
of	O
the	O
superior	O
mesenteric	O
artery	O
,	O
in	O
multiple	O
branches	O
of	O
the	O
left	O
colic	O
artery	O
via	O
the	O
inferior	O
mesenteric	O
artery	O
demonstrated	O
no	O
active	O
extravasation	B
.	O

2	O
.	O
the	O
decision	O
not	O
to	O
infuse	O
vasopressin	O
was	O
made	O
after	O
consultation	O
with	O
the	O
surgical	O
team	O
given	O
this	O
patient's	O
recent	O
st	B
segment	I
depression	I
on	O
ekg	O
.	O

96163	O
||||	O
7156	O
||||	O
5114	O
||||	O
echo	O
_	O
report	O
||||	O
2012	O
-	O
04	O
-	O
30	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
43	O
m	O
s	O
/	O
p	O
cardiomyopathy	B
and	O
cabg	O
.	O

lvef	B
follow	O
-	O
up	O
weight	O
(	O
lb	O
)	O
:	O
213	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
120	O
/	O
70	O

hr	O
(	O
bpm	O
)	O
:	O
113	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
30	O
*	O
*	O
]	O
at	O
11	O
:	O
02	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
moderately	O
dilated	O
.	O

left	O
ventricle	O
:	O
there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

there	O
is	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	B
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
.	O

right	O
ventricle	O
:	O
the	O
right	O
ventricular	O
wall	O
thickness	O
is	O
normal	O
.	O

right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

right	O
ventricular	O
systolic	O
function	O
appears	O
depressed	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

the	O
ascending	O
aorta	O
is	O
mildly	O
dilated	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
mild	O
mitral	B
annular	I
calcification	I
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

tricuspid	O
valve	O
:	O
mild	O
tricuspid	O
[	O
1	O
+	O
]	O
regurgitation	O
is	O
seen	O
.	O

there	O
is	O
mild	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

pericardium	O
:	O
there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

the	O
right	O
atrium	O
is	O
moderately	O
dilated	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

there	O
is	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	B
with	O
relative	O
sparing	O
of	O
the	O
base	O
of	O
the	O
heart	O
.	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
.	O

right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

right	O
ventricular	O
systolic	O
function	O
appears	O
depressed	O
.	O

the	O
ascending	O
aorta	O
is	O
mildly	O
dilated	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
mild	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

compared	O
with	O
the	O
prior	O
study	O
of	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
21	O
*	O
*	O
]	O
,	O
no	O
change	O
.	O

13977	O
||||	O
7352	O
||||	O
22880	O
||||	O
discharge	O
_	O
summary	O
||||	O
2010	O
-	O
05	O
-	O
28	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
05	O
-	O
22	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
05	O
-	O
28	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1942	O
-	O
06	O
-	O
10	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
gold	O
surge	O

history	O
of	O
the	O
present	O
illness	O
:	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
538	O
*	O
*	O
]	O
is	O
a	O
67	O
-	O
year	O
-	O
old	O
man	O
with	O
the	O
past	O
medical	O
history	O
significant	O
for	O
advanced	O
multiple	B
sclerosis	I
,	O
who	O
underwent	O
an	O
endoscopic	O
resection	O
of	O
the	O
esophageal	B
polyp	I
on	O
[	O
*	O
*	O
2010	O
-	O
05	O
-	O
21	O
*	O
*	O
]	O
by	O

dr	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O

the	O
indication	O
was	O
for	O
high	O
grade	O
dysplasia	B
/	O
barrett's	B
esophagus	I
.	O

the	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
was	O
actually	O
discharged	O
the	O
same	O
day	O
.	O

the	O
patient	O
returned	O
home	O
to	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
.	O

the	O
following	O
morning	O
,	O
he	O
woke	O
up	O
and	O
had	O
substernal	O
chest	O
pain	O
,	O
sharp	O
in	O
nature	O
without	O
radiation	O
,	O
no	O
nausea	B
or	O
vomiting	B
,	O
no	O
fevers	B
or	O
chills	B
.	O

he	O
went	O
to	O
his	O
local	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
hospital	O
for	O
evaluation	O
.	O

there	O
,	O
he	O
was	O
started	O
on	O
a	O
cardiac	O
workup	O
,	O
but	O
the	O
chest	O
x	O
-	O
ray	O
revealed	O
pneumomediastinum	B
/	O
widened	B
mediastinum	I
.	O

the	O
patient	O
received	O
iv	O
ampicillin	O
,	O
gentamicin	O
,	O
and	O
flagyl	O
.	O

he	O
also	O
received	O
an	O
iv	O
steroid	O
bolus	O
and	O
he	O
had	O
a	O
ng	O
tube	O
placed	O
by	O
direct	O
vision	O
.	O

he	O
was	O
then	O
transferred	O
to	O
[	O
*	O
*	O
hospital	O
1026	O
*	O
*	O
]	O
for	O
further	O

evaluation	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
history	O
is	O
significant	O
for	O
hypertension	B
.	O

2	O
.	O
multiple	B
sclerosis	I
since	O
[	O
*	O
*	O
1988	O
*	O
*	O
]	O
.	O

3	O
.	O
osteoporosis	B
.	O

4	O
.	O
depression	B
.	O

5	O
.	O
gastroesophageal	B
reflux	I
disease	I
/	O
barrett's	B
esophagus	I
status	O
post	O
endoscopic	O
resection	O
of	O
polyp	B
.	O

6	O
.	O
obesity	B
.	O

7	O
.	O
status	O
post	O
excision	O
of	O
a	O
pilonidal	B
cyst	I
.	O

outpatient	O
medications	O
:	O

1	O
.	O
prednisone	O
15	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O

2	O
.	O
detrol	O
4	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
prozac	O
20	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
cylert	O
75	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

5	O
.	O
fosamax	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

6	O
.	O
lopressor	O
50	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O

7	O
.	O
baclofen	O
100	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

8	O
.	O
methotrexate	O
2	O
.	O
5	O
three	O
times	O
weekly	O
.	O

9	O
.	O
avonex	O
1	O
mg	O
one	O
time	O
a	O
week	O
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

social	O
history	O
:	O
the	O
patient	O
does	O
not	O
drink	O
any	O
alcohol	O
.	O

he	O
does	O
not	O
smoke	O
.	O

physical	O
examination	O
:	O
upon	O
admission	O
,	O
the	O
patient's	O
physical	O
examination	O
was	O
significant	O
for	O
a	O
temperature	O
of	O
100	O
.	O
1	O
,	O
pulse	O
93	O
,	O
blood	O
pressure	O
127	O
/	O
109	O
.	O

he	O
was	O
alert	O
,	O
oriented	O
.	O

he	O
was	O
in	O
no	O
acute	B
distress	I
.	O

he	O
had	O
decreased	B
breath	I
sounds	I
at	O
the	O
bases	O
.	O

he	O
was	O
also	O
slightly	O
tachypneic	B
with	O
no	O
crepitus	B
.	O

cardiovascular	O
:	O
tachycardia	B
,	O
but	O
with	O
a	O
regular	O
rate	O
,	O
normal	O
s1	O
and	O
s2	O
normal	O
.	O

abdomen	O
:	O
soft	O
,	O
nontender	O
,	O
no	O
rebound	B
or	O
guarding	O
.	O

he	O
had	O
a	O
fascia	B
defect	I
approximately	O
2	O
cm	O
at	O
the	O
umbilicus	O
,	O
with	O
no	O
incarceration	B
.	O

groin	O
was	O
notable	O
for	O
no	O
hernia	B
.	O

rectal	O
:	O
examination	O
was	O
guaiac	O
negative	O
,	O
no	O
masses	O
.	O

extremities	O
:	O
examination	O
was	O
notable	O
for	O
peripheral	B
edema	I
.	O

laboratory	O
data	O
:	O
laboratory	O
data	O
revealed	O
the	O
following	O
:	O

white	O
count	O
at	O
the	O
outside	O
hospital	O
was	O
15	O
,	O
hematocrit	O
45	O
,	O
platelet	O
count	O
150	O
,	O
000	O
.	O

electrolytes	O
:	O
within	O
normal	O
limits	O
.	O

lfts	O
were	O
also	O
within	O
normal	O
limits	O
.	O

chest	O
x	O
-	O
ray	O
:	O
significant	O
for	O
widening	O
of	O
the	O
mediastinum	O
.	O

ekg	O
:	O
st	O
changes	O
,	O
but	O
not	O
significant	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
surgical	O

intensive	O
care	O
unit	O
and	O
transferred	O
to	O
the	O
icu	O
for	O
close	O
monitoring	O
given	O
his	O
pneumomediastinum	B
,	O
most	O
likely	O
secondary	O
to	O
perforation	B
during	O
his	O
endoscopic	O
procedure	O
.	O

at	O
that	O
point	O
,	O
it	O
was	O
unclear	O
if	O
he	O
perforation	B
was	O
contained	O
.	O

he	O
underwent	O
a	O
cat	O
scan	O
with	O
oral	O
and	O
iv	O
contract	O
,	O
which	O
revealed	O
that	O
there	O
was	O
no	O
extravasation	B
of	I
contrast	I
from	O
the	O
esophagus	O
into	O
the	O
mediastinum	O
.	O

the	O
patient	O
was	O
made	O
npo	O
with	O
ng	O
tube	O
suction	O
,	O
given	O
iv	O
fluids	O
and	O
iv	O
ampicillin	O
,	O
gentamicin	O
,	O
and	O
flagyl	O
.	O

the	O
patient	O
was	O
closely	O
monitored	O
in	O
the	O
icu	O
setting	O
.	O

on	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
189	O
*	O
*	O
]	O
day	O
#3	O
,	O
the	O
patient's	O
condition	O
was	O
felt	O
to	O
be	O
stable	O
and	O
he	O
was	O
transferred	O
to	O
the	O
floor	O
.	O

at	O
this	O
point	O
,	O
he	O
was	O
kept	O
npo	O
with	O
the	O
ng	O
tube	O
to	O
suction	O
.	O

a	O
thoracic	O
consultation	O
by	O
dr	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
was	O
obtained	O
.	O

it	O
was	O
his	O
opinion	O
that	O
the	O
patient	O
undergo	O
a	O
barium	O
swallow	O
to	O
again	O
re	O
-	O
evaluate	O
his	O
esophageal	B
perforation	I
.	O

therefore	O
,	O
on	O
hospital	O
day	O
#5	O
,	O
the	O
patient	O
underwent	O
a	O
barium	O
swallow	O
,	O
which	O
revealed	O
no	O
extravasation	B
of	I
barium	I
from	O
the	O
esophagus	O
.	O

at	O
this	O
point	O
,	O
the	O
patient's	O
ng	O
tube	O
was	O
discontinued	O
,	O
although	O
he	O
was	O
kept	O
npo	O
overnight	O
.	O

tpn	O
was	O
continued	O
and	O
,	O
therefore	O
,	O
on	O
the	O
next	O
morning	O
,	O
hospital	O
day	O
#6	O
,	O
he	O
was	O
advanced	O
to	O
clears	O
.	O

the	O
patient	O
tolerated	O
the	O
clears	O
and	O
on	O
hospital	O
day	O
#7	O
,	O
the	O
patient	O
was	O
advanced	O
to	O
regular	O
diet	O
.	O

he	O
was	O
tolerating	O
a	O
regular	O
diet	O
,	O
therefore	O
,	O
the	O
tpn	O
and	O
central	O
line	O
were	O
discontinued	O
.	O

the	O
antibiotics	O
were	O
changed	O
from	O
iv	O
ampicillin	O
,	O
gentamycin	O
,	O
and	O
flagyl	O
to	O
p	O
.	O
o	O
.	O

augmentin	O
.	O

of	O
note	O
:	O
the	O
patient's	O
hypertensive	O
medication	O
was	O
increased	O
from	O
lopressor	O
50	O
q	O
.	O
d	O
.	O
to	O
50	O
b	O
.	O
i	O
.	O
d	O
.	O

of	O
note	O
:	O
given	O
the	O
patient's	O
advanced	O
multiple	B
sclerosis	I
,	O
he	O
has	O
a	O
chronic	O
suprapubic	O
catheter	O
in	O
place	O
.	O

the	O
urology	O
service	O
was	O
consulted	O
and	O
on	O
[	O
*	O
*	O
2010	O
-	O
05	O
-	O
28	O
*	O
*	O
]	O
the	O
patient's	O
catheter	O
was	O
changed	O
given	O
that	O
he	O
was	O
admitted	O
when	O
he	O
was	O
due	O
to	O
see	O
his	O
urologist	O
in	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
to	O
have	O
it	O
changed	O
.	O

the	O
patient	O
was	O
discharged	O
home	O
on	O
[	O
*	O
*	O
2010	O
-	O
05	O
-	O
28	O
*	O
*	O
]	O
.	O

his	O
personal	O
care	O
attendant	O
was	O
notified	O
and	O
will	O
be	O
seeing	O
him	O
at	O
home	O
to	O
help	O
him	O
with	O
activities	O
of	O
daily	O
living	O
.	O

condition	O
on	O
discharge	O
:	O
stable	O
.	O

discharge	O
status	O
:	O
the	O
patient	O
is	O
discharged	O
home	O
with	O
services	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
detrol	O
4	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
prozac	O
20	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

3	O
.	O
prednisone	O
50	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
cylert	O
75	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

5	O
.	O
fosamax	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

6	O
.	O
lopressor	O
50	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

7	O
.	O
baclofen	O
100	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

8	O
.	O
methotrexate	O
2	O
.	O
5	O
,	O
three	O
times	O
a	O
week	O
.	O

9	O
.	O
avonex	O
1	O
mg	O
per	O
week	O
.	O

10	O
.	O

the	O
patient	O
will	O
also	O
take	O
a	O
ten	O
-	O
day	O
course	O
of	O
augmentin	O
of	O
875	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

11	O
.	O

protonix	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

discharge	O
diagnosis	O
:	O
esophageal	B
perforation	I
.	O

[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
2860	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
5942	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2010	O
-	O
05	O
-	O
28	O
*	O
*	O
]	O
13	O
:	O
29	O

t	O
:	O
[	O
*	O
*	O
2010	O
-	O
05	O
-	O
28	O
*	O
*	O
]	O
14	O
:	O
40	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
5943	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2010	O
-	O
07	O
-	O
14	O
*	O
*	O
]	O
3	O
:	O
55	O
pm	O

(	O
end	O
of	O
report	O
)	O

1857	O
||||	O
7429	O
||||	O
29057	O
||||	O
discharge	O
_	O
summary	O
||||	O
2018	O
-	O
12	O
-	O
20	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
11	O
-	O
23	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1940	O
-	O
09	O
-	O
07	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
surgery	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
3042	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

history	O
of	O
present	O
illness	O
:	O
seventy	O
-	O
eight	O
-	O
year	O
-	O
old	O
female	O
involved	O
in	O
a	O
motor	O
vehicle	O
accident	O
.	O

she	O
was	O
an	O
unrestrained	O
driver	O
with	O
no	O
loss	B
of	I
consciousness	I
,	O
but	O
was	O
hit	O
by	O
a	O
dump	O
truck	O
with	O
significant	O
intrusion	O
into	O
the	O
car	O
.	O

she	O
has	O
complaint	O
of	O
chest	B
pain	I
and	O
systolic	O
blood	O
pressure	O
of	O
88	O
and	O
heart	O
rate	O
of	O
100	O
in	O
the	O
field	O
.	O

78f	O
re	O
-	O
admit	O
(	O
s	O
/	O
p	O
mvc	O
with	O
c	B
spine	I
fx	I
/	O
pulm	B
contusions	I
/	O
rib	B
fx	I
s	O
/	O
p	O
trach	O
/	O
spenic	B
lac	I
s	O
/	O
p	O
splenectomy	O
/	O
pelvic	B
fx	I
)	O
-	O
from	O
rehab	O
,	O
septic	B
picture	O
likely	O
aspiration	B
pneumonia	I
secondary	O
to	O
dobhoff	O
being	O
placed	O
into	O
lung	O
.	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

placement	O
of	O
g	O
tube	O

history	O
of	O
present	O
illness	O
:	O

history	O
of	O
present	O
illness	O
:	O
78f	O
re	O
-	O
admit	O
(	O
s	O
/	O
p	O
mvc	O
with	O
c	B
spine	I
fx	I
/	O
pulm	B
contusions	I
/	O
rib	B
fx	I
s	O
/	O
p	O
trach	O
/	O
spenic	B
lac	I
s	O
/	O
p	O
splenectomy	O
/	O
pelvic	B
fx	I
)	O
-	O
from	O
rehab	O
,	O
septic	B
picture	O
likely	O
aspiration	B
pneumonia	I
secondary	O
to	O
dobhoff	O
being	O
placed	O
into	O
lung	O
.	O

seventy	O
-	O
eight	O
-	O
year	O
-	O
old	O
female	O
involved	O
in	O
a	O
motor	O
vehicle	O
accident	O
.	O

she	O
was	O
an	O
unrestrained	O
driver	O
with	O
no	O
loss	B
of	I
consciousness	I
,	O
but	O
was	O
hit	O
by	O
a	O
dump	O
truck	O
with	O
significant	O
intrusion	O
into	O
the	O
car	O
.	O

she	O
has	O
complaint	O
of	O
chest	B
pain	I
and	O
systolic	O
blood	O
pressure	O
of	O
88	O
and	O
heart	O
rate	O
of	O
100	O
in	O
the	O
field	O
.	O
admitted	O
to	O
[	O
*	O
*	O
hospital1	O
461	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
10	O
-	O
29	O
*	O
*	O
]	O
with	O
c2	B
fracture	I
,	O
bilateral	O
pleural	O
hematomas	B
,	O
l	O
breast	B
implant	I
rupture	I
,	O
rib	B
fractures	I
,	O
splenic	B
laceration	I
s	O
/	O
p	O
splenectomy	O
and	O
s	O
/	O
p	O
nephrostomy	O
tube	O
placement	O
,	O
who	O
returned	O
to	O
[	O
*	O
*	O
hospital1	O
461	O
*	O
*	O
]	O
from	O
rehab	O
on	O
[	O
*	O
*	O
11	O
-	O
23	O
*	O
*	O
]	O
with	O
hypoxia	B
and	O
respiratory	B
distress	I
.	O

past	O
medical	O
history	O
:	O

pmh	O
:	O

amyloidosis	B
,	O
depression	B
,	O
kidney	B
stones	I
,	O
hx	O
of	O
tubal	O
ligation	O
,	O
l	O
hip	O
replacement	O

social	O
history	O
:	O

sh	O
:	O
2	O
cigs	O
per	O
day	O
,	O
1	O
-	O
2	O
drinks	O
per	O
day	O

family	O
history	O
:	O

fh	O
:	O
daughter	O
[	O
*	O
*	O
name	O
(	O
ni	O
)	O
*	O
*	O
]	O
is	O
currently	O
undergoing	O
temporary	O
guardianship	O

physical	O
exam	O
:	O

tc	O
afebrile	B
hr	O
96	O
,	O
bp	O
161	O
/	O
67	O
,	O
rr	O
34	O
,	O
99%	O
on	O
ps	O

[	O
*	O
*	O
10	O
-	O
05	O
*	O
*	O
]	O
,	O
40%	O
fi02	O

gen	O
:	O
lying	O
in	O
bed	O
,	O
eyes	O
open	O
,	O
minimal	O
mvmt	O
.	O

heent	O
:	O
trach	O
in	O
place	O
,	O
copious	O
sputum	O
out	O
of	O
trach	O
opening	O
,	O
coughing	B
,	O
mmm	O
,	O
op	O
benign	O

neck	O
:	O
in	O
c	O
collar	O

cv	O
:	O
rrr	O
,	O
difficult	O
to	O
auscultate	O
given	O
breath	O
sounds	O

resp	O
:	O
coarse	B
upper	I
airway	I
sounds	I
bilaterally	O

abd	O
:	O
multiple	O
dressings	O
covering	O
postop	O
incisions	B
,	O
ileostomy	O
bag	O

c	O
/	O
d	O
/	O
i	O

ext	O
:	O
warm	O
,	O
well	O
perfused	O

skin	O
:	O
ecchymoses	B
on	O
legs	O
and	O
arms	O
.	O

ms	O
:	O
awake	O
,	O
opens	O
eyes	O
to	O
voice	O
but	O
not	O
command	O
and	O
looks	O
to	O
right	O
at	O
calling	O
of	O
name	O
,	O
not	O
consistently	O
to	O
left	O
.	O

wiggles	O
toes	O
to	O
commands	O
,	O
will	O
not	O
squeeze	O
hands	O
to	O
command	O
,	O
will	O
not	O
lift	O
arms	O
to	O
command	O
.	O

cn	O
:	O
perrla	O
,	O
blinks	O
to	O
threat	O
bilaterally	O
.	O

full	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
90	O
*	O
*	O
]	O
movements	O
horizontally	O
but	O
seems	O
to	O
have	O
r	O
gaze	O
preference	O
.	O

no	O
evidence	O
of	O

nystagmus	B
,	O
no	O
ptosis	B
.	O

grimaces	O
to	O
stim	O
on	O
both	O
sides	O
of	O
face	O
.	O

corneal	B
reflex	I
present	I
.	O

face	O
symmetric	O
but	O
difficult	O
to	O
assess	O
wtih	O
collar	O
.	O

hears	O
voice	O
.	O

no	B
speech	I
.	O
+	O
cough	B
.	O

motor	O
:	O
nl	O
bulk	O
,	O
perhaps	O
increased	B
tone	I
to	O
passive	O
motion	O
in	O
bilateral	O
upper	O
extremities	O
.	O

spontaneously	O
wiggles	O
toes	O
r	O
more	O
briskly	O
than	O
l	O
,	O
and	O
spontaneously	O
flexes	O
r	O
arm	O
at	O
elbow	O
.	O

otherwise	O
,	O
no	O
spontaneous	O
movements	O
.	O

on	O
passive	O
flexion	O
she	O
does	O

resist	O
my	O
motion	O
in	O
both	O
upper	O
extremities	O
.	O

on	O
painful	O
stimulation	O
she	O
grimaces	O
but	O
only	O
withdraws	O
in	O
rue	O
and	O
rle	O
.	O

reflexes	O
:	O

[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
tri	O
br	O
pat	O
ach	O
plantar	O

l	O
2	O
2	O
1	O
1	O
1	O
down	O

r	O
2	O
2	O
1	O
2	O
1	O
down	O

[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
4816	O
*	O
*	O
]	O
:	O
feels	O
pain	B
in	O
all	O
four	O
extremities	O
.	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2018	O
-	O
11	O
-	O
23	O
*	O
*	O
]	O
04	O
:	O
10am	O
urine	O
blood	O
-	O
lg	O
nitrite	O
-	O
neg	O
protein	O
-	O
tr	O
glucose	O
-	O
neg	O
ketone	O
-	O
neg	O
bilirubin	O
-	O
neg	O
urobilngn	O
-	O
4	O
*	O
ph	O
-	O
6	O
.	O
5	O
leuk	O
-	O
neg	O

[	O
*	O
*	O
2018	O
-	O
11	O
-	O
23	O
*	O
*	O
]	O
04	O
:	O
10am	O
urine	O
rbc	O
-	O
>50	O
wbc	O
-	O
0	O
-	O
2	O
bacteria	O
-	O
occ	O
yeast	O
-	O
none	O
epi	O
-	O
0	O

[	O
*	O
*	O
2018	O
-	O
12	O
-	O
19	O
*	O
*	O
]	O
02	O
:	O
30am	O
blood	O
wbc	O
-	O
12	O
.	O
0	O
*	O
rbc	O
-	O
3	O
.	O
14	O
*	O
hgb	O
-	O
9	O
.	O
6	O
*	O
hct	O
-	O
28	O
.	O
1	O
*	O
mcv	O
-	O
90	O
mch	O
-	O
30	O
.	O
5	O
mchc	O
-	O
34	O
.	O
0	O
rdw	O
-	O
15	O
.	O
3	O
plt	O
ct	O
-	O
465	O
*	O

[	O
*	O
*	O
2018	O
-	O
12	O
-	O
18	O
*	O
*	O
]	O
02	O
:	O
13am	O
blood	O
wbc	O
-	O
10	O
.	O
7	O
rbc	O
-	O
2	O
.	O
87	O
*	O
hgb	O
-	O
9	O
.	O
0	O
*	O
hct	O
-	O
26	O
.	O
0	O
*	O
mcv	O
-	O
91	O
mch	O
-	O
31	O
.	O
3	O
mchc	O
-	O
34	O
.	O
5	O
rdw	O
-	O
15	O
.	O
3	O
plt	O
ct	O
-	O
457	O
*	O

brief	O
hospital	O
course	O
:	O

id	O
:	O
patient	O
has	O
been	O
consistently	O
febrile	B
,	O
initially	O
started	O
on	O
vancomycin	O
and	O
zosyn	O
for	O
presumed	O
pneumonia	B
,	O
sputum	O
cultures	O
and	O

blood	O
cultures	O
positive	O
for	O
yeast	O
.	O

she	O
was	O
treated	O
with	O
meropenam	O
,	O
vancomycin	O
,	O
flagyl	O
,	O
and	O
then	O
on	O
[	O
*	O
*	O
12	O
-	O
01	O
*	O
*	O
]	O
caspofungin	O
added	O
.	O

she	O
continues	O
to	O
be	O
febrile	B
.	O

since	O
[	O
*	O
*	O
11	O
-	O
30	O
*	O
*	O
]	O
blood	O
cultures	O
have	O
been	O
negative	O
,	O
sputum	O
continues	O
to	O
grow	O
yeast	O
.	O

gi	O
:	O
on	O
[	O
*	O
*	O
11	O
-	O
29	O
*	O
*	O
]	O
she	O
was	O
noted	O
to	O
have	O
rise	O
in	O
her	O
lft's	O
and	O
abdominal	B

tenderness	I
,	O
she	O
was	O
taken	O
to	O
the	O
or	O
for	O
an	O
exploratory	O
laparotomy	O
and	O
found	O
to	O
have	O
an	O
ischemic	B
colonic	I
perforation	I
.	O

r	O
colectomy	O
and	O
ileostomy	O
placement	O
was	O
performed	O
at	O
that	O
time	O
.	O

she	O
is	O
still	O

not	O
receiving	O
feeds	O
through	O
the	O
g	O
tube	O
.	O

heme	O
:	O
initially	O
anemic	B
,	O
now	O
hct	O
has	O
been	O
stable	O
in	O
mid	O
-	O
20's	O
.	O

neuro	O
:	O
pt	O
when	O
admitted	O
on	O
[	O
*	O
*	O
11	O
-	O
23	O
*	O
*	O
]	O
was	O
noted	O
to	O
follow	O
commands	O
and	O

express	O
pain	B
.	O

she	O
was	O
on	O
her	O
home	O
regimen	O
of	O
paxil	O
for	O
anxiety	B
.	O

on	O
day	O
of	O
admission	O
she	O
was	O
started	O
on	O
propofol	O
for	O
agitation	B
,	O
it	O

caused	O
hypotension	B
and	O
it	O
was	O
weaned	O
.	O

she	O
was	O
at	O
that	O
time	O
noted	O

to	O
be	O
sedated	O
but	O
still	O
following	O
commands	O
.	O

on	O
[	O
*	O
*	O
11	O
-	O
24	O
*	O
*	O
]	O
she	O
was	O
switched	O
to	O
a	O
versed	O
drip	O
.	O

on	O
[	O
*	O
*	O
11	O
-	O
26	O
*	O
*	O
]	O
she	O
was	O
unarousable	B
,	O
versed	O
stopped	O
and	O
only	O
given	O
morphine	O
prn	O
.	O

she	O
was	O
noted	O
on	O
[	O
*	O
*	O
11	O
-	O
27	O
*	O
*	O
]	O
to	O
follow	O
commands	O
and	O
"awake	O
and	O
alert	O
.	O
"	O
[	O
*	O
*	O
11	O
-	O
29	O
*	O
*	O
]	O
went	O
to	O
the	O
or	O
,	O
and	O
afterwards	O
was	O
treated	O
with	O
propofol	O
and	O
fentanyl	O
.	O

on	O
[	O
*	O
*	O
11	O
-	O
30	O
*	O
*	O
]	O
she	O
was	O
noted	O
to	O
have	O
minial	O
movement	B
of	O
her	O
lue	O
and	O
none	O
of	O
her	O
rue	O
,	O

but	O
moved	B
both	O
lower	O
extremities	O
in	O
response	B
to	I
pain	I
.	O

on	O
[	O
*	O
*	O
12	O
-	O
02	O
*	O
*	O
]	O
she	O
was	O
reported	O
to	O
be	O
"following	O
commands"	O
and	O
responding	B
to	I
painful	I
stimuli	I
.	O

she	O
has	O
been	O
on	O
a	O
fentanyl	O
drip	O
until	O
[	O
*	O
*	O
12	O
-	O
06	O
*	O
*	O
]	O
,	O
when	O
she	O
was	O
switched	O
to	O
a	O
fentanyl	O
patch	O
.	O

on	O
[	O
*	O
*	O
12	O
-	O
08	O
*	O
*	O
]	O
fentanyl	O
patch	O
was	O
d	O
/	O
c'ed	O
and	O
she	O
has	O
only	O
been	O
receiving	O
fentanyl	O
prn	O
dressing	O
changes	O
.	O

today	O
,	O
it	O
was	O
noted	O
that	O
despite	O
being	O
off	O
sedation	O
for	O
several	O
days	O
,	O
she	O
has	O
not	O
been	O
awake	O
or	O
following	O
commands	O
initially	O
however	O
this	O
status	O
has	O
continues	O
to	O
improve	O
and	O
patient	O
had	O
remained	O
afebrile	B
on	O
trach	O
trial	O
up	O
to	O
5	O
hours	O
,	O
she	O
will	O
need	O
continued	O
wound	B
care	O
to	O
incision	B
with	O
wet	O
to	O
dry	O
dressing	O

medications	O
on	O
admission	O
:	O

m	O

a	O

h	O

:	O

p	O

r	O

o	O

z	O

a	O

c	O

,	O

t	O

y	O

l	O

,	O

[	O
*	O
*	O
initials	O
(	O
namepattern5	O
)	O
6031	O
*	O
*	O
]	O

[	O
*	O
*	O
last	O
name	O
(	O
namepattern5	O
)	O
6032	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
*	O
*	O
]	O
,	O
dulcolax	O
,	O
diazepam	O
,	O
colace	O
,	O
lovenox	O
,	O
prevacid	O
,	O
lopressor	O
,	O
oxycodone	O

discharge	O
medications	O
:	O

1	O
.	O
insulin	O
regular	O
human	O
100	O
unit	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
injection	O
asdir	O
(	O
as	O
directed	O
)	O
.	O

2	O
.	O
albuterol	O
sulfate	O
0	O
.	O
083	O
%	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
inhalation	O
q6h	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

3	O
.	O
fluoxetine	O
20	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
daily	O
(	O
daily	O
)	O
.	O

4	O
.	O
heparin	O
(	O
porcine	O
)	O
5	O
,	O
000	O
unit	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O

injection	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

5	O
.	O
acetaminophen	O
325	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

6	O
.	O
albuterol	O
90	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
1	O
-	O
2	O
puffs	O
inhalation	O
q4h	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
.	O

7	O
.	O
erythromycin	O
5	O
mg	O
/	O
g	O
ointment	O
sig	O
:	O
one	O
(	O
1	O
)	O
ophthalmic	O
qid	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

8	O
.	O
polyvinyl	O
alcohol	O
-	O
povidone	O
1	O
.	O
4	O
-	O
0	O
.	O
6	O
%	O
dropperette	O
sig	O
:	O
[	O
*	O
*	O
03	O
-	O
04	O
*	O
*	O
]	O
drops	O
ophthalmic	O
q2h	O
(	O
every	O
2	O
hours	O
)	O
.	O

9	O
.	O
levofloxacin	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
for	O
10	O
days	O
.	O

10	O
.	O

lansoprazole	O
30	O
mg	O
susp	O
,	O
delayed	O
release	O
for	O
recon	O
sig	O
:	O
one	O
(	O
1	O
)	O
po	O
daily	O
(	O
daily	O
)	O
.	O

11	O
.	O

metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
1	O
.	O
5	O
tablets	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

12	O
.	O

magnesium	O
sulfate	O
50	O
%	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
injection	O
prn	O
(	O
as	O
needed	O
)	O
as	O
needed	O
for	O
<2	O
.	O
0	O
.	O

13	O
.	O

caspofungin	O
50	O
mg	O
recon	O
soln	O
sig	O
:	O
one	O
(	O
1	O
)	O
recon	O
soln	O

intravenous	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
for	O
7	O
days	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

discharge	O
diagnosis	O
:	O

78f	O
re	O
-	O
admit	O
(	O
s	O
/	O
p	O
mvc	O
with	O
c	B
spine	I
fx	I
/	O
pulm	B
contusions	I
/	O
rib	B
fx	I
s	O
/	O
p	O
trach	O
/	O
spenic	B
lac	I
s	O
/	O
p	O
splenectomy	O
/	O
pelvic	B
fx	I
)	O
-	O
from	O
rehab	O
,	O
septic	B
picture	O
likely	O
aspiration	B
pneumonia	I
secondary	O
to	O
dobhoff	O
being	O
placed	O
into	O
lung	O
.	O
ventilator	O
dependent	O
respiratoy	B
failure	I
,	O
chronic	B
anemia	I
,	O
sepsis	B
,	O
poor	B
nutritional	I
status	I
,	O
tube	B
feed	I
dependence	I

discharge	O
condition	O
:	O

stable	O

discharge	O
instructions	O
:	O

please	O
continue	O
to	O
ween	O
ventilatory	O
status	O
(	O
pt	O
has	O
been	O
on	O
trach	O
trial	O
for	O
4	O
-	O
5	O
hr	O
windows	O
,	O
continue	O
local	O
wound	B
care	I
,	O
to	O
midline	O
incicion	O
,	O
continue	O
to	O
monitor	O
urine	O
output	O
via	O
nephrostomy	O
tube	O
and	O
ostomy	O
ourtput	O
,	O
please	O
continue	O
to	O
ensure	O
that	O
she	O
does	O
not	O
become	O
dehydrated	B
.	O

followup	O
instructions	O
:	O

f	O
/	O
u	O
recommended	O
with	O
interval	O
ct	O
scan	O
[	O
*	O
*	O
04	O
-	O
05	O
*	O
*	O
]	O
weeks	O
to	O
evaluate	O
fluid	B
collection	I
in	O
right	O
pelvis	O
for	O
catheter	O
to	O
be	O
removed	O
if	O
fluid	O
is	O
no	O
longer	O
draining	O
as	O
weel	O
as	O
be	O
evaluated	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
6033	O
*	O
*	O
]	O
please	O
call	O
regarding	O
f	O
/	O
u	O
and	O
progress	O
trauma	O
clinic	O
trauma	O
w	O
/	O
lmob	O
3a	O
[	O
*	O
*	O
hospital1	O
461	O
*	O
*	O
]	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
4904	O
*	O
*	O
]	O
.	O

trauma	B
outreach	O
nurse	O
trauma	O
outreach	O
w	O
/	O
lmob	O
2g	O
[	O
*	O
*	O
hospital1	O
461	O
*	O
*	O
]	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
6034	O
*	O
*	O
]	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
3043	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
494	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
340	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
6035	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
6036	O
*	O
*	O
]	O
[	O
*	O
*	O
2018	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O
@	O
1227	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2018	O
-	O
12	O
-	O
25	O
*	O
*	O
]	O
8	O
:	O
01	O
pm	O

(	O
end	O
of	O
report	O
)	O

53844	O
||||	O
7452	O
||||	O
1525	O
||||	O
ecg	O
_	O
report	O
||||	O
2013	O
-	O
11	O
-	O
24	O
17	O
:	O
20	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

baseline	O
artifact	O
.	O

sinus	B
tachycardia	I
.	O

right	B
bundle	I
-	I
branch	I
block	I
.	O

left	O
axis	O
deviation	O
consistent	O
with	O
left	B
anterior	I
fascicular	I
block	I
.	O

since	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2013	O
-	O
11	O
-	O
22	O
*	O
*	O
]	O
probably	O
no	O
significant	O
change	O
.	O

25655	O
||||	O
7514	O
||||	O
11643	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
03	O
-	O
12	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
08	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
12	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1966	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
icu	O

chief	O
complaint	O
:	O
change	B
in	I
mental	I
status	I
.	O

history	O
of	O
present	O
illness	O
:	O
a	O
46	O
-	O
year	O
-	O
old	O
male	O
with	O
a	O
history	O
of	O
hepatitis	B
-	I
c	I
cirrhosis	I
on	O
the	O
transplant	O
list	O
,	O
now	O
admitted	O
with	O
change	B
in	I
mental	I
status	I
.	O

per	O
the	O
family	O
,	O
the	O
patient	O
has	O
been	O
in	O
his	O
usual	O
state	O
of	O
health	O
,	O
until	O
two	O
days	O
prior	O
to	O
admission	O
,	O
when	O
he	O
became	O
profoundly	O
confused	B
and	O
somnolent	B
after	O
his	O
lactulose	O
was	O
held	O
prior	O
to	O
an	O
elective	O
cardiac	O
catheterization	O
on	O
[	O
*	O
*	O
03	O
-	O
05	O
*	O
*	O
]	O
for	O
his	O
liver	O
transplant	O
evaluation	O
.	O

per	O
his	O
wife	O
,	O
the	O
patient	O
did	O
not	O
get	O
lactulose	O
on	O
three	O
consecutive	O
days	O
and	O
started	O
developing	O
confusion	B
two	O
days	O
prior	O
to	O
admission	O
.	O

he	O
,	O
also	O
,	O
had	O
decreased	O
po	B
intake	I
at	O
the	O
time	O
,	O
but	O
apparently	O
no	O
fever	B
,	O
chills	B
,	O
nausea	B
or	O
vomiting	B
.	O

he	O
has	O
been	O
having	O
no	O
bright	B
red	I
blood	I
per	I
rectum	I
,	O
no	O
black	B
stools	I
,	O
and	O
no	O
hematemesis	B
.	O

he	O
also	O
has	O
no	O
chest	B
pain	I
,	O
shortness	B
of	I
breath	I
.	O

there	O
were	O
no	O
sick	O
contacts	O
at	O
home	O
.	O

in	O
the	O
emergency	O
department	O
,	O
despite	O
multiple	O
doses	O
of	O
ativan	O
and	O
haldol	O
and	O
po	O
lactulose	O
,	O
the	O
patient's	O
mental	B
status	I
did	O
not	O
improve	O
.	O

a	O
nasogastric	O
tube	O
was	O
not	O
placed	O
secondary	O
to	O
the	O
patient's	O
mental	B
status	I
and	O
non	B
-	I
cooperation	I
.	O

the	O
patient	O
was	O
admitted	O
to	O
the	O
medical	O
icu	O
for	O
management	O
of	O
encephalopathy	B
,	O
given	O
the	O
risk	O
of	O
self	B
-	I
harm	I
and	O
question	O
of	O
airway	O
protection	O
,	O
as	O
well	O
as	O
continued	O
administration	O
of	O
lactulose	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
hepatitis	B
-	I
c	I
cirrhosis	I
.	O

the	O
patient	O
is	O
on	O
the	O
transplant	O
list	O
status	O
post	O
interferon	O
and	O
ribavirin	O
.	O

his	O
previous	O
egd's	O
have	O
shown	O
no	O
varices	B
.	O

2	O
.	O
hypertension	B
.	O

3	O
.	O
history	O
of	O
nephrolithiasis	B
.	O

4	O
.	O
cryoglobulinemia	B
.	O

medications	O
:	O

1	O
.	O
diovan	O
,	O
80	O
po	O
q	O
d	O
.	O

2	O
.	O
magnesium	O
oxide	O
,	O
100	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O

3	O
.	O
lactulose	O
,	O
two	O
tablespoons	O
po	O
q	O
a	O
.	O
m	O
.	O

4	O
.	O
nexium	O
,	O
40	O
mg	O
po	O
q	O
d	O
.	O

5	O
.	O
oxycodone	O
,	O
5	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
p	O
.	O
r	O
.	O
n	O
.	O

6	O
.	O
ambien	O
,	O
10	O
mg	O
q	O
h	O
.	O
s	O
.	O

7	O
.	O
lasix	O
,	O
20	O
mg	O
po	O
q	O
d	O
.	O

8	O
.	O
aldactone	O
,	O
50	O
mg	O
po	O
q	O
d	O
.	O

9	O
.	O
multivitamins	O
.	O

allergies	O
:	O
codeine	O
which	O
gives	O
him	O
nausea	B
and	O
vomiting	B
.	O

social	O
history	O
:	O
he	O
works	O
as	O
a	O
substance	O
abuse	O
counselor	O
.	O

he	O
is	O
married	O
.	O

he	O
has	O
a	O
history	O
of	O
heavy	O
alcohol	O
use	O
in	O
the	O
past	O
.	O

physical	O
examination	O
:	O
temperature	O
98	O
.	O
8	O
,	O
heart	O
rate	O
100	O
,	O
blood	O
pressure	O
118	O
/	O
66	O
,	O
respiratory	O
rate	O
20	O
,	O
saturation	O
100	O
on	O
room	O
air	O
.	O

general	O
:	O
an	O
agitated	B
male	O
,	O
struggling	O
in	O
bed	O
.	O

heent	O
:	O
anicteric	B
sclerae	O
.	O

dry	B
mucous	I
membranes	O
.	O

nose	O
mildly	O
bloody	O
.	O

cardiovascular	O
:	O
s1	O
,	O
s2	O
.	O

tachycardiac	B
.	O

no	O
murmurs	B
.	O

lungs	O
:	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

abdomen	O
:	O
soft	O
,	O
nontender	O
.	O

there	O
is	O
no	O
evidence	O
of	O
caput	B
medusae	I
.	O

liver	O
is	O
palpated	O
about	O
2	O
cm	O
below	O
the	O
costal	O
margin	O
.	O

extremities	O
:	O

palm	O
erythema	B
and	O
asterixis	B
.	O

there	O
is	O
no	O
edema	B
.	O

skin	O
:	O

telangiectasias	B
.	O

neuro	O
:	O
alert	O
and	O
agitated	B
and	O
not	O
oriented	B
to	I
place	I
and	I
time	I
.	O

uncooperative	B
with	O
neuro	O
exam	O
.	O

laboratory	O
/	O
diagnostics	O
:	O
laboratories	O
on	O
admission	O
reveal	O
a	O
white	O
count	O
of	O
6	O
.	O
5	O
,	O
hematocrit	O
35	O
,	O
platelets	O
114	O
.	O

initial	O
electrolytes	O
:	O
sodium	O
of	O
130	O
,	O
potassium	O
of	O
6	O
,	O
chloride	O
104	O
,	O
bicarbonate	O
20	O
,	O
bun	O
31	O
,	O
creatinine	O
1	O
.	O
4	O
.	O

initial	O
ammonia	O
level	O
was	O
240	O
.	O

brief	O
hospital	O
course	O
:	O

1	O
.	O
hepatic	B
encephalopathy	I
:	O
upon	O
arrival	O
in	O
the	O
icu	O
,	O
ng	O
tube	O
was	O
placed	O
and	O
the	O
patient	O
was	O
started	O
on	O
aggressive	O
lactulose	O
regimen	O
.	O

after	O
about	O
two	O
days	O
,	O
his	O
mental	B
status	I
significantly	O
improved	O
.	O

the	O
patient	O
was	O
oriented	O
to	O
time	O
and	O
place	O
,	O
recognized	O
family	O
members	O
,	O
and	O
was	O
cooperative	O
and	O
conversant	O
with	O
the	O
icu	O
staff	O
.	O

2	O
.	O
acute	B
renal	I
failure	I
:	O
creatinine	O
was	O
1	O
.	O
4	O
up	O
from	O
0	O
.	O
8	O
,	O
most	O
likely	O
secondary	O
to	O
prerenal	B
azotemia	I
.	O

urine	O
electrolytes	O
confirmed	O
that	O
.	O

his	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
were	O
being	O
withheld	O
and	O
he	O
received	O
some	O
iv	O
fluids	O
which	O
led	O
to	O
eventual	O
improvement	O
in	O
his	O
renal	B
function	I
.	O

3	O
.	O
nephrolithiasis	B
:	O
during	O
his	O
icu	O
stay	O
,	O
the	O
patient	O
developed	O
acute	O
onset	O
of	O
groin	B
pain	I
which	O
he	O
said	O
resembles	O
his	O
previous	O
episodes	O
of	O
nephrolithiasis	B
.	O

a	O
kub	O
was	O
obtained	O
,	O
but	O
that	O
was	O
nondiagnostic	O
.	O

an	O
abdominal	O
ultrasound	O
revealed	O
two	O
stones	B
,	O
one	O
a	O
5	O
mm	O
stone	O
in	O
the	O
right	O
inferior	O
kidney	O
which	O
showed	O
no	O
evidence	O
of	O
hydronephrosis	B
and	O
was	O
consistent	O
with	O
old	O
stone	O
in	O
that	O
same	O
area	O
.	O

he	O
,	O
also	O
,	O
had	O
a	O
second	O
new	O
stone	O
in	O
his	O
bladder	O
with	O
no	O
evidence	O
of	O
hydroureter	B
.	O

the	O
second	O
stone	B
was	O
3	O
mm	O
.	O

given	O
the	O
patient	O
had	O
a	O
mild	O
amount	O
of	O
pain	B
,	O
it	O
was	O
felt	O
he	O
could	O
manage	O
his	O
condition	O
at	O
home	O
.	O

he	O
was	O
advised	O
to	O
drink	O
plenty	O
of	O
fluids	O
and	O
strain	O
his	O
urine	O
with	O
the	O
hope	O
of	O
obtaining	O
the	O
stone	B
and	O
submitting	O
it	O
to	O
chemical	O
analysis	O
as	O
an	O
outpatient	O
.	O

4	O
.	O
hypertension	B
:	O
his	O
antihypertensives	O
were	O
being	O
held	O
,	O
given	O
he	O
was	O
dehydrated	B
upon	O
arrival	O
.	O

he	O
is	O
discharged	O
on	O
his	O
outpatient	O
regimen	O
.	O

5	O
.	O
hepatitis	B
-	I
c	I
cirrhosis	I
:	O
the	O
patient	O
is	O
on	O
the	O
transplant	O
list	O
.	O

lft's	O
remained	O
stable	O
during	O
this	O
admission	O
.	O

coags	O
remained	O
stable	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
diovan	O
,	O
80	O
po	O
q	O
d	O
.	O

2	O
.	O
mag	O
-	O
ox	O
,	O
400	O
po	O
q	O
d	O
.	O

3	O
.	O
lactulose	O
,	O
two	O
tablespoons	O
b	O
.	O
i	O
.	O
d	O
.	O
and	O
titrate	O
to	O
two	O
to	O
three	O
bowel	O
movements	O
a	O
day	O
.	O

4	O
.	O
nexium	O
,	O
40	O
po	O
q	O
d	O
.	O

5	O
.	O
oxycodone	O
,	O
p	O
.	O
r	O
.	O
n	O
.	O

6	O
.	O
ambien	O
,	O
10	O
mg	O
q	O
h	O
.	O
s	O
.	O

7	O
.	O
lasix	O
,	O
20	O
mg	O
po	O
q	O
o	O
.	O
d	O
.	O

8	O
.	O
aldactone	O
,	O
50	O
mg	O
po	O
q	O
o	O
.	O
d	O
.	O

9	O
.	O
flagyl	O
,	O
250	O
mg	O
po	O
q	O
d	O
.	O

disposition	O
:	O
discharged	O
to	O
home	O
.	O

discharge	O
condition	O
:	O
dramatically	O
improved	O
since	O
arrival	O
with	O
clearing	O
in	O
mental	B
status	I
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
hepatic	B
encephalopathy	I
.	O

2	O
.	O
cirrhosis	B
secondary	O
to	O
hepatitis	B
-	I
c	I
.	O

3	O
.	O
hypertension	B
.	O

4	O
.	O
acute	B
renal	I
failure	I
.	O

5	O
.	O
nephrolithiasis	B
.	O

[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
7620	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
12	O
*	O
*	O
]	O
19	O
:	O
39	O

t	O
:	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
12	O
*	O
*	O
]	O
20	O
:	O
18	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
7621	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2013	O
-	O
04	O
-	O
26	O
*	O
*	O
]	O
2	O
:	O
07	O
pm	O

(	O
end	O
of	O
report	O
)	O

413490	O
||||	O
7700	O
||||	O
20127	O
||||	O
radiology	O
_	O
report	O
||||	O
2014	O
-	O
02	O
-	O
21	O
19	O
:	O
56	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
393	O
-	O
5522	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2014	O
-	O
02	O
-	O
21	O
*	O
*	O
]	O
7	O
:	O
56	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
;	O
-	O
76	O
by	O
same	O
physician	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
2419	O
*	O
*	O
]	O
reason	O
:	O
please	O
evaluate	O
placement	O
of	O
ogt	O
admitting	O
diagnosis	O
:	O
pneumonia	B

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

38	O
year	O
old	O
man	O
s	O
/	O
p	O
;	O
r	O
vats	O
with	O
ogt	O
placed	O
.	O

reason	O
for	O
this	O
examination	O
:	O

please	O
evaluate	O
placement	O
of	O
ogt	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

history	O
:	O
orogastric	O
tube	O
placement	O
.	O

single	O
portable	O
chest	O
radiograph	O
demonstrates	O
a	O
nasogastric	O
tube	O
coiled	O
in	O
the	O
stomach	O
.	O

contrast	O
material	O
was	O
again	O
seen	O
within	O
the	O
stomach	O
and	O
is	O
unchanged	O
from	O
radiograph	O
obtained	O
earlier	O
the	O
same	O
day	O
.	O

two	O
right	O
-	O
sided	O
chest	O
tubes	O
are	O
again	O
noted	O
and	O
are	O
unchanged	O
in	O
position	O
.	O

bibasilar	B
atelectasis	I
,	O
worse	O
on	O
the	O
left	O
remains	O
similar	O
in	O
appearance	O
.	O

cardiomediastinal	O
contours	O
are	O
unchanged	O
.	O

there	O
is	O
probably	O
mild	O
pulmonary	B
edema	I
which	O
is	O
unchanged	O
.	O

a	O
right	O
internal	O
jugular	O
central	O
venous	O
catheter	O
is	O
again	O
noted	O
in	O
the	O
svc	O
.	O

surgical	O
drain	O
projects	O
over	O
the	O
epigastrium	O
.	O

impression	O
:	O

nasogastric	O
tube	O
coiled	O
within	O
the	O
stomach	O
.	O

otherwise	O
,	O
no	O
significant	O
interval	O
change	O
.	O

23607	O
||||	O
7726	O
||||	O
4044	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
07	O
-	O
28	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
25	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
28	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1965	O
-	O
02	O
-	O
21	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
46	O
-	O
year	O
-	O
old	O
woman	O
with	O
past	O
medical	O
history	O
significant	O
for	O
end	B
-	I
stage	I
renal	I
disease	I
and	O
poorly	O
controlled	O
hypertension	B
who	O
was	O
brought	O
in	O
to	O
the	O
[	O
*	O
*	O
hospital	O
137	O
*	O
*	O
]	O

emergency	O
department	O
by	O
ems	O
after	O
her	O
husband	O
activated	O
911	O
due	O
to	O
her	O
lethargy	B
and	O
decreased	B
responsiveness	I
.	O

of	O
note	O
,	O
the	O
patient	O
has	O
had	O
multiple	O
admissions	O
to	O
the	O
same	O
facility	O
over	O
the	O
prior	O
year	O
for	O
uncontrolled	O
hypertension	B
and	O
associated	O
chest	B
pain	I
without	O
evidence	O
of	O
myocardial	B
ischemia	I
,	O
all	O
in	O
the	O
setting	O
of	O
poor	B
medicine	I
compliance	I
and	O
missed	O
dialysis	O
sessions	O
.	O

on	O
history	O
,	O
the	O
patient	O
reports	O
missing	O
approximately	O
two	O
weeks	O
worth	O
of	O
hemodialysis	O
appointments	O
after	O
her	O
most	O
recent	O
infected	B
tunneled	I
catheter	I
was	O
removed	O
.	O

the	O
patient	O
reported	O
feeling	O
both	O
tired	O
and	O
depressed	B
,	O
expressing	O
suicidal	B
ideations	I
,	O
and	O
admitted	O
refusal	O
of	O
dialysis	O
.	O

review	O
of	O
systems	O
:	O
otherwise	O
significant	O
for	O
the	O
absence	O
of	O
chest	B
pain	I
or	O
cough	B
,	O
but	O
presence	O
of	O
paroxysmal	B
nocturnal	I
dyspnea	I
over	O
the	O
week	O
leading	O
to	O
admission	O
.	O

the	O
patient	O
denied	O
headache	B
,	O
fever	B
,	O
nausea	B
,	O
vomiting	B
,	O
or	O
abdominal	B
pain	I
.	O

past	O
medical	O
history	O
:	O
end	B
-	I
stage	I
renal	I
disease	I
,	O
significant	O
for	O
multiple	O
tunneled	O
catheter	O
dialysis	O
infections	O
.	O

hypertension	B
.	O

hepatitis	B
c	I
.	O

polysubstance	B
abuse	I
.	O

asthma	B
.	O

history	O
of	O
left	B
-	I
sided	I
cva	I
with	O
residual	B
right	I
-	I
sided	I
weakness	I
.	O

bilateral	O
internal	O
jugular	O
clots	B
in	O
05	O
/	O
04	O
.	O

allergies	O
:	O
penicillin	O
,	O
kefzol	O
,	O
codeine	O
,	O
and	O
vancomycin	O
.	O

medications	O
:	O

1	O
.	O
bumex	O
2	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

2	O
.	O
enalapril	O
40	O
mg	O
q	O
.	O
d	O
.	O

3	O
.	O
labetalol	O
600	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

4	O
.	O
clonidine	O
0	O
.	O
3	O
mg	O
ttp	O
patch	O
.	O

5	O
.	O
norvasc	O
10	O
mg	O
q	O
.	O
d	O
.	O

6	O
.	O
iron	O
sulfate	O
supplements	O
.	O

physical	O
examination	O
:	O
temperature	O
97	O
.	O
2	O
degrees	O
,	O
blood	O
pressure	O
164	O
/	O
104	O
,	O
heart	O
rate	O
100	O
to	O
110	O
,	O
respiratory	O
rate	O
16	O
,	O
saturating	O
97	O
percent	O
on	O
room	O
air	O
.	O

in	O
general	O
,	O
tearful	B
and	O
angry	O
appearing	O
woman	O
,	O
responding	O
to	O
questions	O
,	O
and	O
in	O
no	O
acute	B
distress	I
.	O

heent	O
exam	O
:	O
pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

extraocular	O
movements	O
are	O
intact	O
.	O

sclarea	O
anicteric	O
.	O

chest	O
is	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

cardiovascular	O
:	O
tachycardiac	B
without	O
murmur	B
.	O

abdomen	O
:	O
soft	O
and	O
nontender	O
with	O
normoactive	O
bowel	O
sounds	O
.	O

extremities	O
:	O
no	O
pedal	B
edema	I
,	O
fistula	B
,	O
left	O
antecubital	O
fossa	O
with	O
palpable	O
thrill	B
.	O

neuro	O
:	O
alert	O
and	O
oriented	O
to	O
person	O
,	O
place	O
,	O
month	O
,	O
and	O
year	O
.	O

following	O
commands	O
.	O

moving	O
all	O
extremities	O
.	O

laboratory	O
data	O
:	O
labs	O
on	O
admission	O
,	O
sodium	O
141	O
,	O
potassium	O

5	O
.	O
8	O
,	O
chloride	O
114	O
,	O
bicarbonate	O
11	O
,	O
bun	O
107	O
,	O
creatinine	O
10	O
.	O
6	O
,	O
glucose	O
115	O
,	O
calcium	O
7	O
.	O
7	O
,	O
magnesium	O
2	O
.	O
2	O
,	O
and	O
phosphorous	O
7	O
.	O
8	O
.	O

cbc	O
,	O
white	O
blood	O
cell	O
count	O
8	O
.	O
7	O
,	O
hematocrit	O
36	O
.	O
5	O
,	O
and	O
platelets	O
277	O
.	O

coags	O
within	O
normal	O
limits	O
.	O

chest	O
x	O
-	O
ray	O
,	O
cardiomegaly	B
with	O
mild	O
vascular	B
congestion	I
.	O

ekg	O
,	O
normal	O
sinus	O
rhythm	O
of	O
90	O
,	O
lvh	B
,	O
and	O
left	B
atrial	I
enlargement	I
.	O

ct	O
of	O
the	O
head	O
is	O
significant	O
for	O
right	O
thalamic	O
hypodense	B
lesion	I
,	O
new	O
compared	O
with	O
prior	O
study	O
of	O
03	O
/	O
04	O
.	O

summary	O
of	O
hospital	O
course	O
:	O
hypertensive	B
urgency	I
.	O

the	O
patient	O
was	O
placed	O
on	O
nipride	O
drip	O
in	O
the	O
emergency	O
department	O
to	O
which	O
she	O
responded	O
well	O
.	O

her	O
outpatient	O
medications	O
including	O
labetalol	O
,	O
enalapril	O
,	O
and	O
norvasc	O
were	O
reinitiated	O
given	O
her	O
recent	O
noncompliance	O
with	O
these	O
medications	O
.	O

additionally	O
,	O
a	O
catapres	O
patch	O
was	O
placed	O
on	O
the	O
patient	O
.	O

given	O
her	O
fluid	B
overload	I
secondary	O
to	O
dialysis	B
noncompliance	I
,	O
plans	O
were	O
made	O
to	O
initiate	O
hemodialysis	O
after	O
appropriate	O
access	O
was	O
placed	O
.	O

the	O
patient	O
was	O
maintained	O
on	O
nipride	O
drip	O
upon	O
transfer	O
to	O
the	O
medical	O
intensive	O
care	O
unit	O
and	O
throughout	O
her	O
three	O
to	O
four	O
day	O
hospital	O
course	O
was	O
placed	O
back	O
on	O
her	O
outpatient	O
regimen	O
with	O
the	O
nipride	O
drip	O
being	O
weaned	O
off	O
during	O
her	O
second	O
day	O
of	O
medical	O
intensive	O

care	O
unit	O
stay	O
.	O

end	B
stage	I
renal	I
disease	I
.	O

interventional	O
radiology	O
was	O
consulted	O
from	O
the	O
emergency	O
department	O
to	O
establish	O
access	O
for	O
hemodialysis	O
.	O

the	O
patient	O
initially	O
refused	O
such	O
intervention	O
,	O
but	O
ultimately	O
consented	O
to	O
such	O
on	O
the	O
evening	O
of	O
admission	O
.	O

the	O
renal	O
consult	O
team	O
was	O
asked	O
to	O
see	O
the	O
patient	O
in	O
the	O
emergency	O
department	O
and	O
managed	O
her	O
end	B
-	I
stage	I
renal	I
disease	I
throughout	O
her	O
hospital	O
course	O
,	O
receiving	O
several	O
rounds	O
of	O
hemodialysis	O
prior	O
to	O
discharge	O
.	O

the	O
patient's	O
outpatient	O
nephrologist	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1945	O
*	O
*	O
]	O
,	O
evaluated	O
the	O
patient	O
on	O
a	O
daily	O
basis	O
in	O
the	O
medical	O
intensive	O
care	O
unit	O
and	O
contributed	O
to	O
her	O
care	O
.	O

psychiatry	O
.	O

the	O
patient	O
expressed	O
suicidal	B
ideations	I
and	O
all	O
her	O
statements	O
that	O
indicated	O
her	O
noncompliance	B
with	I
medications	I
and	O
hemodialysis	O
were	O
secondary	O
to	O
her	O
depression	B
.	O

the	O
psychiatry	O
consult	O
team	O
evaluated	O
the	O
patient	O
in	O
the	O
emergency	O
department	O
and	O
consulted	O
during	O
her	O
medical	O
intensive	O
care	O
unit	O
stay	O
and	O
deemed	O
her	O
competent	O
to	O
make	O
decisions	O
regarding	O
her	O
own	O
care	O
and	O
not	O
an	O
acute	B
risk	I
to	I
herself	I
or	O
others	O
.	O

neurology	O
.	O

given	O
the	O
above	O
-	O
mentioned	O
ct	O
findings	O
,	O
the	O

neurology	O
stroke	B
consult	O
service	O
was	O
consulted	O
and	O
felt	O
that	O
the	O
findings	O
seen	O
on	O
ct	O
were	O
consistent	O
with	O
small	B
-	I
vessel	I
disease	I
resulting	O
in	O
a	O
lacunar	B
infarct	I
.	O

given	O
the	O
patient's	O
nonfocal	O
neurology	O
exam	O
,	O
recommendations	O
were	O
made	O
to	O
control	O
the	O
patient's	O
blood	O
pressure	O
adequately	O
and	O
start	O
the	O
patient	O
on	O
one	O
daily	O
aspirin	O
.	O

further	O
lifestyle	O
modifications	O
,	O
specifically	O
that	O
regarding	O
recreational	O
drug	B
abuse	I
and	O
tobacco	O
use	O
were	O
recommended	O
as	O
well	O
as	O
testing	O
a	O
baseline	O
lipid	O
panel	O
,	O
which	O
was	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

lymphadenopathy	B
.	O

during	O
her	O
medical	O
intensive	O
care	O
unit	O
stay	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
a	O
tender	O
left	O
submandibular	O
lymph	O
node	O
approximately	O
1	O
cm	O
to	O
2	O
cm	O
in	O
size	O
without	O
evidence	O
of	O
pharyngitis	B
or	O
other	O
oropharyngeal	O
lesions	B
.	O

in	O
light	O
of	O
this	O
,	O
an	O
hiv	O
test	O
was	O
sent	O
and	O
was	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
;	O
and	O
the	O
patient	O
was	O
instructed	O
to	O
followup	O
with	O
her	O
primary	O
care	O
physician	O
regarding	O
the	O
persistence	O
of	O
such	O
a	O
lesion	B
.	O

discharge	O
condition	O
:	O
stable	O
.	O

discharge	O
status	O
:	O
to	O
home	O
.	O

discharge	O
diagnoses	O
:	O
end	B
-	I
stage	I
renal	I
disease	I
.	O

hypertension	B
.	O

discharge	O
medications	O
:	O

1	O
.	O
enalapril	O
10	O
mg	O
4	O
tablets	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
clonidine	O
0	O
.	O
3	O
mg	O
per	O
24	O
hours	O
patch	O
,	O
1	O
patch	O
weekly	O
,	O
transdermal	O
.	O

3	O
.	O
amlodipine	O
5	O
mg	O
2	O
tablets	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
bumetanide	O
2	O
mg	O
1	O
tablet	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O

5	O
.	O
labetalol	O
200	O
mg	O
tablets	O
3	O
tablets	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

6	O
.	O
quetiapine	O
25	O
mg	O
1	O
tablet	O
p	O
.	O
o	O
q	O
.	O
a	O
.	O
m	O
.	O
and	O
2	O
tablets	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O

7	O
.	O
ferrous	O
gluconate	O
325	O
mg	O
1	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

follow	O
-	O
up	O
plans	O
:	O
the	O
patient	O
has	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1945	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
30	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
state	O
/	O
zipcode	O
1489	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1994	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2011	O
-	O
09	O
-	O
14	O
*	O
*	O
]	O
13	O
:	O
02	O
:	O
52	O

t	O
:	O
[	O
*	O
*	O
2011	O
-	O
09	O
-	O
14	O
*	O
*	O
]	O
14	O
:	O
46	O
:	O
36	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2720	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
ernst	O
on	O
:	O
tue	O
[	O
*	O
*	O
2011	O
-	O
09	O
-	O
20	O
*	O
*	O
]	O
10	O
:	O
36	O
am	O

(	O
end	O
of	O
report	O
)	O

36998	O
||||	O
7761	O
||||	O
6882	O
||||	O
ecg	O
_	O
report	O
||||	O
2017	O
-	O
12	O
-	O
11	O
11	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
tachycardia	I
.	O

low	O
limb	O
lead	O
voltage	O
is	O
non	O
-	O
specific	O
.	O

modest	O
non	B
-	I
specific	I
inferolateral	I
st	I
-	I
t	I
wave	I
changes	I
.	O

since	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2017	O
-	O
12	O
-	O
10	O
*	O
*	O
]	O
sinus	B
tachycardia	I
rate	O
is	O
faster	O
and	O
modest	O
st	B
-	I
t	I
wave	I
changes	I
are	O
seen	O
.	O

tracing	O
#2	O

347384	O
||||	O
7780	O
||||	O
23527	O
||||	O
radiology	O
_	O
report	O
||||	O
2017	O
-	O
07	O
-	O
30	O
20	O
:	O
06	O
:	O
00	O
.	O
0	O
||||	O
c15	O
chest	O
(	O
pre	O
-	O
op	O
pa	O
&	O
lat	O
)	O
||||	O
||||	O
clip	O
#	O
379	O
-	O
3082	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2017	O
-	O
07	O
-	O
30	O
*	O
*	O
]	O
8	O
:	O
06	O
pm	O

chest	O
(	O
pre	O
-	O
op	O
pa	O
&	O
lat	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
2923	O
*	O
*	O
]	O
reason	O
:	O
re	O
-	O
do	O
cabbage\coronary	O
artery	O
bypass	O
graft	O
,	O
re	O
-	O
do	O
admitting	O
diagnosis	O
:	O
re	O
-	O
do	O
cabbage\coronary	O
artery	O
bypass	O
graft	O
,	O
re	O
-	O
do	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

72	O
year	O
old	O
man	O
with	O
need	O
for	O
redo	O
cabg	O
[	O
*	O
*	O
2017	O
-	O
08	O
-	O
01	O
*	O
*	O
]	O

reason	O
for	O
this	O
examination	O
:	O

assess	O
for	O
cpp	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

history	O
:	O
preoperative	O
evaluation	O
for	O
redo	O
cabg	O
.	O

comparison	O
:	O
[	O
*	O
*	O
2017	O
-	O
07	O
-	O
03	O
*	O
*	O
]	O
.	O

findings	O
:	O
pa	O
and	O
lateral	O
views	O
of	O
the	O
chest	O
.	O

there	O
is	O
stable	O
cardiomegaly	B
with	O
evidence	O
of	O
cabg	O
.	O

the	O
superior	O
three	O
sternal	O
wires	O
are	O
broken	O
,	O
as	O
seen	O
previously	O
.	O

there	O
is	O
increased	O
upper	B
zone	I
redistribution	I
in	O
the	O
pulmonary	O
vascular	O
,	O
representing	O
mild	O
congestive	B
heart	I
failure	I
.	O

a	O
small	O
round	O
shadow	O
is	O
again	O
noted	O
overlying	O
the	O
right	O
lower	O
lung	O
field	O
on	O
the	O
pa	O
view	O
,	O
probably	O
representing	O
a	O
nipple	B
shadow	I
.	O

in	O
the	O
future	O
,	O
this	O
may	O
be	O
confirmed	O
by	O
using	O
nipple	O
markers	O
with	O
chest	O
radiographs	O
.	O

there	O
is	O
no	O
pleural	B
effusion	I
or	O
pulmonary	B
consolidation	I
.	O

the	O
aorta	O
is	O
tortuous	O
.	O

impression	O
:	O
mild	O
congestive	B
heart	I
failure	I
.	O

dfdkq	O

29701	O
||||	O
7786	O
||||	O
2725	O
||||	O
ecg	O
_	O
report	O
||||	O
2013	O
-	O
01	O
-	O
11	O
10	O
:	O
13	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

normal	O
sinus	O
rhythm	O
with	O
atrial	B
premature	I
depolarizations	I
.	O

borderline	O
low	O
qrs	B
voltage	O
in	O
the	O
limb	O
leads	O
.	O

non	O
-	O
diagnostic	O
repolarization	O
abnormalities	O
.	O

delayed	O
anterior	B
precordial	I
r	I
wave	I
progression	I
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
07	O
*	O
*	O
]	O
cardiac	O
rhythm	O
is	O
now	O
sinus	O
mechanism	O
.	O

88203	O
||||	O
7866	O
||||	O
22187	O
||||	O
ecg	O
_	O
report	O
||||	O
2014	O
-	O
04	O
-	O
24	O
14	O
:	O
54	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
tachycardia	I
.	O

non	O
-	O
specific	O
inferior	O
and	O
anterior	O
t	O
wave	O
changes	O
.	O

cannot	O
exclude	O
ischemia	B
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
the	O
sinus	B
tachycardia	I
and	O
the	O
t	B
wave	I
changes	I
are	O
new	O
.	O

129574	O
||||	O
7908	O
||||	O
3233	O
||||	O
radiology	O
_	O
report	O
||||	O
2010	O
-	O
07	O
-	O
19	O
10	O
:	O
31	O
:	O
00	O
.	O
0	O
||||	O
u311	O
abdomen	O
u	O
.	O
s	O
.	O
(	O
complete	O
study	O
)	O
||||	O
||||	O
clip	O
#	O
321	O
-	O
0526	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2010	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
10	O
:	O
31	O
am	O

abdomen	O
u	O
.	O
s	O
.	O
(	O
complete	O
study	O
)	O
;	O
duplex	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
378	O
*	O
*	O
]	O
abd	O
/	O
pel	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
3901	O
*	O
*	O
]	O
reason	O
:	O
assess	O
for	O
ascites	B
,	O
kidneys	O
,	O
portal	B
flow	I
,	O
liver	O
,	O
gallbladder	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

45	O
year	O
old	O
man	O
with	O
hep	B
c	I
cirrhosis	I
,	O
new	O
mental	B
status	I
change	I
,	O
possible	O
ascites	B
,	O
elevated	O
alk	O
phos	O
,	O
new	O
renal	B
failure	I

reason	O
for	O
this	O
examination	O
:	O

assess	O
for	O
ascites	B
,	O
kidneys	O
,	O
portal	B
flow	I
,	O
liver	O
,	O
gallbladder	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

wet	O
read	O
:	O

normal	O
direction	O
of	O
flow	O
of	O
the	O
hepatic	O
vessels	O
,	O
cirrhotic	B
liver	I
,	O
gallstone	B
,	O
no	O
hydro	B
,	O
not	O
enough	O
ascites	B
to	O
"mark	O
the	O
spot"	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
45	O
-	O
year	O
-	O
old	O
man	O
with	O
hepatitis	B
c	I
cirrhosis	I
with	O
new	O
mental	B
status	I
changes	I
and	O
probable	O
ascites	B
,	O
elevated	O
alk	O
phos	O
and	O
new	O
renal	B
failure	I
.	O

abdominal	O
ultrasound	O
with	O
doppler	O
:	O
again	O
,	O
the	O
liver	O
has	O
a	O
shrunken	B
and	O
nodular	B
appearance	O
compatible	O
with	O
cirrhosis	B
.	O

the	O
main	O
portal	O
vein	O
,	O
left	O
portal	O
vein	O
,	O
right	O
portal	O
vein	O
,	O
hepatic	O
arteries	O
and	O
hepatic	O
veins	O
are	O
all	O
patent	O
with	O
appropriate	O
direction	O
of	O
flow	O
.	O

there	O
is	O
blunting	O
of	O
the	O
hepatic	O
venous	O
wave	O
forms	O
as	O
expected	O
in	O
cirrhosis	B
.	O

there	O
is	O
normal	O
directional	O
flow	O
in	O
the	O
splenic	O
vein	O
.	O

there	O
is	O
splenomegaly	B
.	O

the	O
spleen	O
measures	O
16	O
.	O
4	O
cm	O
.	O

the	O
gallbladder	O
is	O
not	O
distended	O
and	O
contains	O
a	O
stone	O
within	O
its	O
neck	O
.	O

the	O
right	O
kidney	O
measures	O
11	O
.	O
1	O
cm	O
and	O
the	O
left	O
kidney	O
measures	O
11	O
.	O
2	O
cm	O
.	O

both	O
kidneys	O
are	O
free	O
of	O
hydronephrosis	B
.	O

the	O
common	O
bile	O
duct	O
appears	O
normal	O
and	O
measures	O
2	O
mm	O
.	O

there	O
is	O
only	O
limited	O
visualization	O
of	O
the	O
pancreas	O
.	O

within	O
the	O
lower	O
quadrants	O
there	O
is	O
a	O
small	O
amount	O
of	O
ascites	B
.	O

comparison	O
is	O
made	O
to	O
[	O
*	O
*	O
2010	O
-	O
07	O
-	O
15	O
*	O
*	O
]	O
and	O
demonstrates	O
no	O
significant	O
change	O
.	O

impression	O
:	O

1	O
)	O
small	O
nodular	B
liver	I
consistent	O
with	O
the	O
patient's	O
known	O
cirrhosis	B
with	O
appropriate	O
direction	O
of	O
the	O
hepatic	O
blood	O
flow	O
.	O

2	O
)	O
small	O
amount	O
of	O
ascites	B
.	O

3	O
)	O
splenomegaly	B
.	O

4	O
)	O
no	O
evidence	O
of	O
hydronephrosis	B
.	O

5	O
)	O
cholelithiasis	B
.	O

74957	O
||||	O
7968	O
||||	O
10145	O
||||	O
ecg	O
_	O
report	O
||||	O
2019	O
-	O
10	O
-	O
17	O
11	O
:	O
36	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

atrial	B
flutter	I
with	O
2	O
:	O
1	O
a	B
-	I
v	I
conduction	I
,	O
increased	O
compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2019	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
.	O

otherwise	O
,	O
no	O
diagnostic	O
interim	O
change	O
.	O

tracing	O
#2	O

322989	O
||||	O
7978	O
||||	O
14098	O
||||	O
radiology	O
_	O
report	O
||||	O
2012	O
-	O
09	O
-	O
23	O
08	O
:	O
03	O
:	O
00	O
.	O
0	O
||||	O
e252r	O
ankle	O
(	O
ap	O
,	O
mortise	O
&	O
lat	O
)	O
right	O
||||	O
||||	O
clip	O
#	O
380	O
-	O
4401	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2012	O
-	O
09	O
-	O
23	O
*	O
*	O
]	O
8	O
:	O
03	O
am	O

ankle	O
(	O
ap	O
,	O
mortise	O
&	O
lat	O
)	O
right	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
4537	O
*	O
*	O
]	O
reason	O
:	O
fracture?	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

27	O
year	O
old	O
man	O
s	O
/	O
p	O
mvc	O
reason	O
for	O
this	O
examination	O
:	O
fracture?	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

history	O
:	O
motor	O
vehicle	O
collision	O
.	O

comparison	O
:	O
no	O
previous	O
studies	O
.	O

findings	O
:	O
ap	O
,	O
oblique	O
and	O
lateral	O
views	O
of	O
the	O
right	O
ankle	O
.	O

there	O
is	O
no	O
fracture	B
or	O
malalignment	B
.	O

the	O
ankle	O
mortise	O
is	O
congruent	O
with	O
the	O
talar	O
dome	O
.	O

other	O
visualized	O
joints	O
also	O
appear	O
unremarkable	O
.	O

soft	B
tissue	I
swelling	I
is	O
noted	O
circumferentially	O
around	O
the	O
ankle	O
joint	O
.	O

impression	O
:	O
no	O
fracture	B
or	O
malalignment	B
.	O

97374	O
||||	O
8014	O
||||	O
27158	O
||||	O
echo	O
_	O
report	O
||||	O
2019	O
-	O
04	O
-	O
17	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O

height	O
:	O
(	O
in	O
)	O
62	O

weight	O
(	O
lb	O
)	O
:	O
118	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
53	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
116	O
/	O
80	O

hr	O
(	O
bpm	O
)	O
:	O
96	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
04	O
-	O
17	O
*	O
*	O
]	O
at	O
13	O
:	O
02	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thickness	O
.	O

normal	O
lv	O
cavity	O
size	O
.	O

depressed	B
lvef	I
.	O

no	O
resting	B
lvot	I
gradient	I
.	O

lv	O
wall	O
motion	O
:	O
regional	O
lv	B
wall	I
motion	I
abnormalities	I
include	O
:	O
mid	O
anterior	O
-	O
akinetic	B
;	O
mid	O
anteroseptal	O
-	O
akinetic	B
;	O
mid	O
inferoseptal	O
-	O
akinetic	B
;	O
mid	O
inferior	O
-	O
hypo	B
;	O
mid	O
inferolateral	O
-	O
hypo	B
;	O
septal	O
apex	O
-	O
akinetic	B
;	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
.	O

borderline	O
normal	O
rv	O
systolic	O
function	O
.	O

aorta	O
:	O
normal	O
aortic	O
diameter	O
at	O
the	O
sinus	O
level	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

trace	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

mild	O
to	O
moderate	O
(	O
[	O
*	O
*	O
02	O
-	O
12	O
*	O
*	O
]	O
+	O
)	O

mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
with	O
trivial	O
tr	B
.	O

borderline	O
pa	O
systolic	B
hypertension	I
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

pericardium	O
:	O
small	O
pericardial	B
effusion	I
.	O

no	O
echocardiographic	O
signs	O
of	O
tamponade	B
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
moderately	O
to	O
severely	O
depressed	O
with	O
septal	O
and	O
anterior	O
akinesis	B
/	O
hypokinesis	B
and	O
mid	O
inferior	O
/	O
inferolateral	O
hypokinesis	B
.	O

the	O
apex	O
is	O
not	O
fully	O
visualized	O
.	O

right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
and	O
free	O
wall	O
motion	O
is	O
borderline	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
.	O

there	O
is	O
no	O
aortic	B
valve	I
stenosis	I
.	O

trace	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mild	O
to	O
moderate	O
(	O
[	O
*	O
*	O
02	O
-	O
12	O
*	O
*	O
]	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
borderline	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

there	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade	B
.	O

99659	O
||||	O
8087	O
||||	O
1517	O
||||	O
echo	O
_	O
report	O
||||	O
2009	O
-	O
11	O
-	O
13	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
s	O
/	O
pcabg	O

height	O
:	O
(	O
in	O
)	O
70	O

weight	O
(	O
lb	O
)	O
:	O
185	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
02	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
113	O
/	O
62	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
13	O
*	O
*	O
]	O
at	O
15	O
:	O
11	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricle	O
:	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
moderately	O
dilated	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
.	O

right	O
ventricle	O
:	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	O
.	O

mild	O
(	O
1	O
+	O
)	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

mitral	O
valve	O
:	O
there	O
is	O
moderate	O
mitral	B
annular	I
calcification	I
.	O

moderate	O
(	O
2	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

tricuspid	O
valve	O
:	O
mild	O
tricuspid	O
[	O
1	O
+	O
]	O
regurgitation	O
is	O
seen	O
.	O

there	O
is	O
borderline	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

pericardium	O
:	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
moderately	O
dilated	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
with	O
anterior	O
,	O
septal	O
and	O
inferior	O
akinesis	B
with	O
some	O
preservation	O
of	O
function	O
of	O
the	O
base	O
.	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	O
.	O

mild	O
(	O
1	O
+	O
)	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

at	O
least	O
moderate	O
(	O
2	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
borderline	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

27513	O
||||	O
8114	O
||||	O
28155	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
01	O
-	O
25	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
15	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
25	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1955	O
-	O
07	O
-	O
30	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
565	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

60	O
year	O
old	O
white	O
female	O
s	O
/	O
p	O
cabg	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
05	O
*	O
*	O
]	O
with	O
fever	B
and	O
sternal	O
wound	B
drainage	I
.	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

sternal	O
debridement	O
and	O
pectoralis	O
flaps	O
.	O

history	O
of	O
present	O
illness	O
:	O

this	O
60	O
year	O
old	O
white	O
female	O
is	O
s	O
/	O
p	O
cabg	O
on	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
05	O
*	O
*	O
]	O
,	O
had	O
an	O
uncomplicated	O
post	O
op	O
course	O
,	O
and	O
was	O
discharged	O
to	O
home	O
on	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
12	O
*	O
*	O
]	O
.	O

on	O
[	O
*	O
*	O
01	O
-	O
14	O
*	O
*	O
]	O
she	O
was	O
readmitted	O
to	O
[	O
*	O
*	O
hospital	O
1872	O
*	O
*	O
]	O
with	O
fever	B
,	O
wbc	O
,	O
and	O
purulent	B
drainage	I
from	O
her	O
sternal	O
wound	O
.	O

she	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
79	O
*	O
*	O
]	O
for	O
definitive	O
treatment	O
.	O

past	O
medical	O
history	O
:	O

s	O
/	O
p	O
cabg	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
05	O
*	O
*	O
]	O

niddm	B

arthritis	I

anxiety	I

htn	I

depression	I

s	O
/	O
p	O
ccy	O

s	O
/	O
p	O
tah	O

s	O
/	O
p	O
tubal	O
ligation	O

social	O
history	O
:	O

lives	O
with	O
husband	O
.	O

cigs	O
:	O
none	O

etoh	O
:	O
none	O

family	O
history	O
:	O

unremarkable	O

physical	O
exam	O
:	O

elderly	O
white	O
female	O
in	O
nad	O

temp	O
:	O
100	O
vss	O

heent	O
:	O
nc	O
/	O
at	O
,	O
perla	O
,	O
eomi	O
,	O
oropharynx	O
benign	O

neck	O
:	O
supple	O
,	O
from	O
,	O
no	O
lymphadenopathy	B
or	O
thyromegaly	B
,	O
carotids	O
2	O
+	O
=bilat	O
.	O
without	O
bruits	O
.	O

lungs	O
:	O
clear	O
to	O
a	O
+	O
p	O

cv	O
:	O
rrr	O
without	O
r	B
/	O
g	B
/	O
m	B

abd	O
:	O
+	O
bs	O
,	O
soft	O
,	O
nontender	O
,	O
without	O
masses	O
or	O
hepatosplenomegaly	B
chest	O
:	O
wound	O
w	O
/	O
purulent	B
drainage	I
,	O
sternum	O
stable	O
.	O

neuro	O
:	O
nonfocal	O

pertinent	O
results	O
:	O

hematology	O

complete	O
blood	O
count	O
wbc	O
rbc	O
hgb	O
hct	O
mcv	O
mch	O
mchc	O
rdw	O
plt	O
ct	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
25	O
*	O
*	O
]	O
05	O
:	O
50am	O
9	O
.	O
6	O
4	O
.	O
07	O
*	O
11	O
.	O
8	O
*	O
36	O
.	O
7	O
90	O
29	O
.	O
1	O
32	O
.	O
2	O
15	O
.	O
2	O
735	O
*	O

basic	O
coagulation	O
(	O
pt	O
,	O
ptt	O
,	O
plt	O
,	O
inr	O
)	O
plt	O
ct	O

[	O
*	O
*	O
2016	O
-	O
01	O
-	O
25	O
*	O
*	O
]	O
05	O
:	O
50am	O
735	O
*	O

chemistry	O

renal	O
&	O
glucose	O
glucose	O
urean	O
creat	O
na	O
k	O
cl	O
hco3	O
angap	O

[	O
*	O
*	O
2016	O
-	O
01	O
-	O
25	O
*	O
*	O
]	O
05	O
:	O
50am	O
101	O
13	O
0	O
.	O
6	O
140	O
4	O
.	O
7	O
100	O
31	O
*	O
14	O

chemistry	O
totprot	O
albumin	O
globuln	O
calcium	O
phos	O
mg	O
uricacd	O
iron	O

[	O
*	O
*	O
2016	O
-	O
01	O
-	O
25	O
*	O
*	O
]	O
05	O
:	O
50am	O
8	O
.	O
9	O
4	O
.	O
7	O
*	O
1	O
.	O
9	O

brief	O
hospital	O
course	O
:	O

the	O
patient	O
was	O
admitted	O
on	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
15	O
*	O
*	O
]	O
and	O
was	O
the	O
wound	B
was	O
cultured	O
and	O
she	O
was	O
started	O
on	O
vanco	O
,	O
gent	O
,	O
and	O
flagyl	O
.	O

she	O
was	O
taken	O
to	O
the	O
or	O
and	O
underwent	O
sternal	O
debridement	O
and	O
pectoralis	O
flap	O
advancement	O
with	O
the	O
plastic	O
surgery	O
service	O
.	O

she	O
tolerated	O
the	O
procedure	O
well	O
and	O
was	O
transferred	O
to	O
the	O
csru	O
in	O
stable	O
condition	O
.	O

she	O
was	O
extubated	O
on	O
pod#1	O
and	O
id	O
was	O
consulted	O
.	O

on	O
pod#3	O
her	O
chest	O
tube	O
was	O
d	O
/	O
c'd	O
and	O
she	O
was	O
transferred	O
to	O
the	O
the	O
floor	O
.	O

her	O
wound	B
grew	O
out	O
mrsa	B
and	O
she	O
was	O
continued	O
on	O
vancomycin	O
.	O

she	O
continued	O
to	O
progress	O
and	O
had	O
a	O
picc	O
placed	O
.	O

she	O
initially	O
had	O
4	O
jp	O
drains	O
in	O
and	O
had	O
2	O
of	O
them	O
d	O
/	O
c'd	O
.	O

she	O
needs	O
6	O
weeks	O
of	O
iv	O
vanco	O
form	O
the	O
date	O
of	O
her	O
debridement	O
.	O

she	O
will	O
be	O
seen	O
in	O
plastic	O
surgery	O
clinic	O
in	O
1	O
week	O
for	O
evaluation	O
of	O
jp	O
removal	O
.	O

medications	O
on	O
admission	O
:	O

percocet	O
[	O
*	O
*	O
12	O
-	O
27	O
*	O
*	O
]	O
po	O
q	O
4	O
-	O
6	O
hours	O
prn	O

lasix	O
40	O
mg	O
po	O
daily	O

kcl	O
20	O
meq	O
po	O
daily	O

plavix	O
75	O
mg	O
po	O
daily	O

risperidone	O
1	O
mg	O
po	O
qhs	O

glipizide	O
5	O
mg	O
po	O
daily	O

metformin	O
500	O
mh	O
po	O
daily	O

asa	O
81	O
mg	O
po	O
daily	O

lopressor	O
75	O
mg	O
po	O
daily	O

discharge	O
medications	O
:	O

1	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

3	O
.	O
clopidogrel	O
bisulfate	O
75	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

4	O
.	O
metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

5	O
.	O
lorazepam	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q8h	O
(	O
every	O
8	O
hours	O
)	O
as	O
needed	O
.	O

6	O
.	O
glipizide	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

7	O
.	O
metformin	O
hcl	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

8	O
.	O
oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

9	O
.	O
vancomycin	O
hcl	O
1000	O
mg	O
iv	O
q8h	O

10	O
.	O

sodium	O
chloride	O
0	O
.	O
9%	O
flush	O
3	O
ml	O
iv	O
daily	O
:	O
prn	O

peripheral	O
iv	O
-	O
inspect	O
site	O
every	O
shift	O

11	O
.	O

risperidone	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
at	O
bedtime	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
location	O
(	O
un	O
)	O
1921	O
*	O
*	O
]	O
specialty	O
hospital	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
1873	O
*	O
*	O
]	O

discharge	O
diagnosis	O
:	O

sternal	O
wound	B
infection	I
.	O

discharge	O
condition	O
:	O

good	O
.	O

discharge	O
instructions	O
:	O

follow	O
medications	O
on	O
discharge	O
instructions	O
.	O

you	O
may	O
not	O
drive	O
for	O
4	O
weeks	O
.	O

you	O
may	O
not	O
lift	O
more	O
than	O
10	O
lbs	O
for	O
3	O
months	O
.	O

you	O
should	O
shower	O
,	O
let	O
water	O
flow	O
over	O
wounds	O
,	O
pat	O
dry	O
with	O
a	O
towel	O
.	O

followup	O
instructions	O
:	O

make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
4832	O
*	O
*	O
]	O
when	O
discharged	O
from	O
rehab	O
.	O

make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
for	O
4	O
[	O
*	O
*	O
e	O
-	O
mail	O
address	O
4833	O
*	O
*	O
]	O
make	O
an	O
appointment	O
with	O
plastic	O
surgery	O
clinic	O
for	O
1	O
week	O
for	O
jp	O
[	O
*	O
*	O
e	O
-	O
mail	O
address	O
4834	O
*	O
*	O
]	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
574	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
575	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
6	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
576	O
*	O
*	O
]	O
pa	O
80	O
-	O
bgs	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
25	O
*	O
*	O
]	O
@	O
1249	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2016	O
-	O
02	O
-	O
19	O
*	O
*	O
]	O
3	O
:	O
26	O
pm	O

(	O
end	O
of	O
report	O
)	O

43167	O
||||	O
8380	O
||||	O
20658	O
||||	O
ecg	O
_	O
report	O
||||	O
2017	O
-	O
11	O
-	O
10	O
08	O
:	O
51	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
.	O

since	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2017	O
-	O
11	O
-	O
09	O
*	O
*	O
]	O
the	O
p	O
wave	O
can	O
be	O
seen	O
clearer	O
and	O
raises	O
the	O
possibility	O
of	O
a	O
non	B
-	I
sinus	I
supraventricular	I
rhythm	I
.	O

clinical	O
correlation	O
is	O
suggested	O
.	O

tracing	O
#3	O

21487	O
||||	O
8703	O
||||	O
28634	O
||||	O
discharge	O
_	O
summary	O
||||	O
2017	O
-	O
05	O
-	O
08	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
05	O
-	O
01	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
05	O
-	O
08	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1971	O
-	O
05	O
-	O
16	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
number	O
5715	O
*	O
*	O
]	O

chief	O
complaint	O
:	O
chronic	B
aspiration	I
.	O

history	O
of	O
the	O
present	O
illness	O
:	O
this	O
is	O
a	O
45	O
-	O
year	O
-	O
old	O
male	O
with	O
down's	B
syndrome	I
with	O
frequent	O
aspirations	B
resulting	O
in	O
several	O
episodes	O
of	O
aspiration	B
pneumonia	I
.	O

the	O
patient	O
has	O
had	O
a	O
gastric	O
feeding	O
tube	O
since	O
[	O
*	O
*	O
2009	O
-	O
03	O
-	O
26	O
*	O
*	O
]	O
.	O

a	O
swallowing	O
video	O
fluoroscopy	O
in	O
[	O
*	O
*	O
2008	O
*	O
*	O
]	O
revealed	O
moderate	O
to	O
severe	O
oropharyngeal	B
swallowing	I
disturbance	I
with	O
aspiration	B
after	O
the	O
swallow	O
and	O
poor	B
laryngeal	I
sensitivity	I
noted	O
by	O
absent	O
cough	B
following	O
the	O
aspiration	B
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
down's	B
syndrome	I
with	O
profound	B
mental	I
retardation	I
.	O

2	O
.	O
hepatitis	B
b	I
carrier	I
.	O

3	O
.	O
osteoporosis	B
.	O

4	O
.	O
hiatal	B
hernia	I
.	O

5	O
.	O
allergic	B
rhinitis	I
.	O

6	O
.	O
constipation	B
.	O

7	O
.	O
left	O
retractile	B
testis	I
.	O

8	O
.	O
right	O
hip	B
subluxation	I
.	O

9	O
.	O
atopic	B
dermatitis	I
.	O

past	O
surgical	O
history	O
:	O

1	O
.	O
right	O
total	O
hip	O
replacement	O
in	O
[	O
*	O
*	O
2015	O
-	O
08	O
-	O
24	O
*	O
*	O
]	O
.	O

2	O
.	O
g	O
tube	O
placement	O
in	O
[	O
*	O
*	O
2009	O
-	O
03	O
-	O
26	O
*	O
*	O
]	O
.	O

3	O
.	O
excision	O
of	O
thigh	B
lipoma	I
in	O
[	O
*	O
*	O
2009	O
-	O
07	O
-	O
25	O
*	O
*	O
]	O
.	O

4	O
.	O
left	O
cataract	B
extraction	O
with	O
lens	O
implant	O
.	O

allergies	O
:	O
keflex	O
which	O
causes	O
a	O
rash	B
,	O
reglan	O
which	O
causes	O
dystonia	B
,	O
and	O
acetazolamide	O
.	O

admission	O
medications	O
:	O

1	O
.	O
protonix	O
40	O
b	O
.	O
i	O
.	O
d	O
.	O

2	O
.	O
theophylline	O
200	O
q	O
.	O
p	O
.	O
m	O
.	O

3	O
.	O
multivitamin	O
.	O

4	O
.	O
milk	O
of	O
magnesia	O
.	O

5	O
.	O
loratadine	O
10	O
mg	O
every	O
evening	O
.	O

6	O
.	O
lactobacillus	O
40	O
b	O
.	O
i	O
.	O
d	O
.	O

social	O
history	O
:	O
the	O
patient	O
is	O
a	O
resident	O
of	O
[	O
*	O
*	O
location	O
843	O
*	O
*	O
]	O
developmental	O
center	O
.	O

physical	O
examination	O
on	O
admission	O
:	O
cardiac	O
:	O
regular	O
rate	O
and	O
rhythm	O
.	O

lungs	O
:	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

abdomen	O
:	O
soft	O
,	O
nondistended	O
,	O
nontender	O
with	O
a	O
g	O
tube	O
in	O
place	O
.	O

extremities	O
:	O
severe	O
muscular	B
atrophy	I
,	O
no	O
edema	B
,	O
clubbing	B
,	O
or	O
cyanosis	B
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
preop	O
and	O
holding	O
where	O
he	O
underwent	O
narrow	O
-	O
field	O
laryngectomy	O
.	O

the	O
patient	O
tolerated	O
this	O
procedure	O
well	O
.	O

please	O
see	O
the	O
operative	O
note	O
for	O
details	O
.	O

chest	O
x	O
-	O
ray	O
postoperatively	O
revealed	O
a	O
tracheostomy	O
tube	O
in	O
good	O
position	O
with	O
no	O
pneumothorax	B
.	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
surgical	O

intensive	O
care	O
unit	O
on	O
the	O
ventilator	O
.	O

he	O
was	O
placed	O
on	O
iv	O

clindamycin	O
and	O
iv	O
flagyl	O
.	O

on	O
postoperative	O
day	O
number	O
one	O
,	O
it	O
was	O
attempted	O
to	O
wean	O
the	O
patient	O
off	O
the	O
ventilator	O
.	O

the	O
patient	O
was	O
weaned	O
to	O
cpap	O
;	O
however	O
,	O
he	O
was	O
placed	O
back	O
on	O
the	O
ventilator	O
due	O
to	O
desaturations	B
.	O

pink	O
frothy	B
sputum	I
was	O
noted	O
at	O
the	O
site	O
of	O
the	O
tracheostomy	O
.	O

chest	O
x	O
-	O
ray	O
showed	O
a	O
small	O
amount	O
of	O
chf	B
;	O
however	O
,	O
the	O
patient's	O
lungs	O
were	O
clear	O
to	O
auscultation	O
and	O
it	O
was	O
again	O
attempted	O
to	O
wean	O
the	O
ventilator	O
.	O

tube	O
feeds	O
were	O
also	O
started	O
on	O
postoperative	O
day	O
number	O
two	O
at	O
10	O
cc	O
per	O
hour	O
and	O
tube	O
feeds	O
were	O
advanced	O
conservatively	O
to	O
a	O
goal	O
of	O
50	O
cc	O
per	O
hour	O
.	O

the	O
patient	O
was	O
weaned	O
from	O
the	O
ventilator	O
on	O
postoperative	O
day	O
number	O
three	O
successfully	O
.	O

the	O
patient	O
was	O
transferred	O
from	O
the	O
icu	O
to	O
a	O
floor	O
bed	O
on	O
postoperative	O
day	O
number	O
five	O
.	O

his	O
tracheostomy	O
tube	O
was	O
removed	O
and	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
5716	O
*	O
*	O
]	O
-	O
singer	O
tracheostomy	O
tube	O
was	O
put	O
in	O
its	O
place	O
to	O
support	O
the	O
stoma	B
until	O
it	O
had	O
matured	O
.	O

duoderm	O
was	O
placed	O
in	O
the	O
parastomal	O
area	O
to	O
protect	O
skin	O
from	O
breakdown	O
.	O

the	O
patient	O
was	O
placed	O
in	O
a	O
continuous	O
02	O
sat	O
monitor	O
setting	O
.	O

he	O
was	O
kept	O
n	O
.	O
p	O
.	O
o	O
.	O
and	O
tube	O
feeds	O
were	O
advanced	O
to	O
goal	O
.	O

on	O
postoperative	O
day	O
number	O
seven	O
,	O
it	O
was	O
attempted	O
to	O
obtain	O
a	O
barium	O
swallow	O
study	O
to	O
test	O
for	O
any	O
esophageal	B
leak	I
;	O
however	O
,	O
per	O
the	O
radiology	O
staff	O
,	O
the	O
patient	O
was	O
unable	O
to	O
cooperate	O
with	O
the	O
barium	O
swallow	O
in	O
that	O
he	O
was	O
unable	O
to	O
maintain	O
proper	O
positioning	O
during	O
the	O
study	O
and	O
was	O
unable	O
to	O
follow	O
commands	O
as	O
to	O
when	O
to	O
swallow	O
the	O
barium	O
contrast	O
.	O

however	O
,	O
the	O
patient	O
was	O
felt	O
to	O
be	O
stable	O
and	O
was	O
discharged	O
on	O
postoperative	O
day	O
number	O
seven	O
.	O

throughout	O
his	O
hospital	O
stay	O
,	O
his	O
electrolytes	O
were	O
monitored	O
and	O
repleted	O
as	O
needed	O
.	O

nutrition	O
was	O
consulted	O
for	O
advice	O
regarding	O
the	O
patient's	O
tube	O
feeds	O
and	O
he	O
remained	O
stable	O
throughout	O
his	O
hospital	O
stay	O
.	O

condition	O
on	O
discharge	O
:	O
stable	O
.	O

discharge	O
status	O
:	O
to	O
an	O
extended	O
care	O
facility	O
.	O

discharge	O
diagnosis	O
:	O

1	O
.	O
chronic	B
aspiration	I
.	O

2	O
.	O
status	O
post	O
narrow	O
-	O
field	O
laryngectomy	O
.	O

discharge	O
instructions	O
:	O
the	O
patient	O
should	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
460	O
*	O
*	O
]	O
in	O
one	O
week	O
.	O

the	O
office	O
should	O
be	O
contacted	O
for	O
an	O
appointment	O
.	O

discharge	O
instructions	O
for	O
the	O
transfer	O
facility	O
:	O

1	O
.	O
remove	O
and	O
clean	O
the	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
5716	O
*	O
*	O
]	O
-	O
singer	O
tracheostomy	O
device	O
with	O
warm	O
water	O
twice	O
a	O
day	O
.	O

2	O
.	O
clean	O
the	O
crust	O
from	O
his	O
stoma	B
using	O
moist	O
q	O
-	O
tips	O
twice	O
a	O
day	O
.	O

3	O
.	O
keep	O
duoderm	O
on	O
the	O
parastomal	O
areas	O
.	O

4	O
.	O
continue	O
humidified	O
air	O
to	O
his	O
stoma	B
.	O

diet	O
:	O
the	O
patient	O
should	O
follow	O
a	O
clear	O
liquid	O
diet	O
.	O

he	O
should	O
receive	O
probalance	O
full	O
-	O
strength	O
tube	O
feeds	O
at	O
50	O
cc	O
per	O
hour	O
and	O
residuals	O
should	O
be	O
checked	O
every	O
four	O
hours	O
and	O
tube	O
feedings	O
should	O
be	O
held	O
for	O
residuals	O
greater	O
than	O
or	O
equal	O
to	O
150	O
milliliters	O
.	O

his	O
tube	O
should	O
be	O
flushed	O
with	O
30	O
milliliters	O
of	O
water	O
q	O
.	O
four	O
hours	O
and	O
as	O
needed	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
theophylline	O
200	O
mg	O
per	O
the	O
g	O
tube	O
once	O
a	O
day	O
.	O

2	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
374	O
*	O
*	O
]	O
60	O
mg	O
twice	O
a	O
day	O
per	O
g	O
tube	O
.	O

3	O
.	O
calcium	O
carbonate	O
12	O
.	O
5	O
milliliters	O
once	O
a	O
day	O
per	O
the	O
g	O
tube	O
.	O

4	O
.	O
flovent	O
inhaler	O
two	O
puffs	O
twice	O
a	O
day	O
.	O

5	O
.	O
colace	O
100	O
mg	O
twice	O
a	O
day	O
per	O
the	O
g	O
tube	O
.	O

6	O
.	O
percocet	O
[	O
*	O
*	O
07	O
-	O
03	O
*	O
*	O
]	O
milliliters	O
every	O
four	O
to	O
six	O
hours	O
as	O
needed	O
for	O
pain	B
.	O

7	O
.	O
benadryl	O
25	O
mg	O
one	O
capsule	O
every	O
six	O
hours	O
as	O
needed	O
for	O
itching	B
per	O
the	O
g	O
tube	O
.	O

8	O
.	O
albuterol	O
inhaler	O
,	O
one	O
nebulizer	O
treatment	O
every	O
six	O
hours	O
as	O
needed	O
for	O
shortness	B
of	I
breath	I
or	O
wheezing	B
.	O

9	O
.	O
protonix	O
40	O
mg	O
once	O
a	O
day	O
per	O
the	O
g	O
tube	O
.	O

10	O
.	O

lopressor	O
37	O
.	O
5	O
mg	O
three	O
times	O
a	O
day	O
per	O
the	O
g	O
tube	O
.	O

11	O
.	O

lasix	O
20	O
mg	O
one	O
tablet	O
twice	O
a	O
day	O
per	O
the	O
g	O
tube	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
4099	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
5717	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2017	O
-	O
05	O
-	O
08	O
*	O
*	O
]	O
12	O
:	O
22	O

t	O
:	O
[	O
*	O
*	O
2017	O
-	O
05	O
-	O
08	O
*	O
*	O
]	O
12	O
:	O
35	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
5718	O
*	O
*	O
]	O

cc	O
:	O
[	O
*	O
*	O
cc	O
contact	O
info	O
5719	O
*	O
*	O
]	O

61373	O
||||	O
8870	O
||||	O
8042	O
||||	O
ecg	O
_	O
report	O
||||	O
2009	O
-	O
12	O
-	O
23	O
16	O
:	O
42	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I

left	I
axis	I
deviation	I

anteroseptal	I
myocardial	I
infarction	I
with	O
anterolateral	B
st	I
elevation	I
-	O
may	O
be	O
acute	O
/	O
recent	O

consider	O
prior	O
inferior	B
myocardial	I
infarction	I

since	O
previous	O
tracing	O
same	O
date	O
:	O
no	O
significant	O
change	O

2958	O
||||	O
8951	O
||||	O
18099	O
||||	O
discharge	O
_	O
summary	O
||||	O
2009	O
-	O
01	O
-	O
10	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2009	O
-	O
01	O
-	O
06	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2009	O
-	O
01	O
-	O
10	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
sex	O
:	O
m	O

service	O
:	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
71	O
year	O
-	O
old	O
male	O
with	O
a	O
history	O
of	O
coronary	B
artery	I
disease	I
status	O
post	O
four	O
vessel	O
coronary	O
artery	O
bypass	O
graft	O
,	O
congestive	B
heart	I
failure	I
with	O
an	O
ejection	O
fraction	O
of	O
15%	O
,	O
diabetes	B
,	O
hypertension	B
,	O
chronic	B
obstructive	I
pulmonary	I
disease	I
,	O
recent	O
admission	O
to	O
[	O
*	O
*	O
hospital	O
719	O
*	O
*	O
]	O
in	O
[	O
*	O
*	O
2008	O
-	O
07	O
-	O
30	O
*	O
*	O
]	O
for	O
congestive	B
heart	I
failure	I
status	O
post	O
cardiac	O
catheterization	O
with	O
a	O
stent	O
to	O
saphenous	O
vein	O
graft	O
to	O
right	O
coronary	O
artery	O
graft	O
and	O
status	O
post	O
stent	O
to	O
saphenous	O
vein	O
graft	O
obtuse	O
marginal	O
graft	O
in	O
[	O
*	O
*	O
2004	O
*	O
*	O
]	O
.	O

over	O
the	O
last	O
two	O
weeks	O
the	O
patient	O
has	O
had	O
increasing	O
shortness	B
of	I
breath	I
,	O
two	O
pillow	O
orthopnea	B
,	O
paroxysmal	B
nocturnal	I
dyspnea	I
.	O

the	O
patient	O
has	O
also	O
complained	O
of	O
dyspnea	B
on	I
exertion	I
on	O
walking	O
200	O
feet	O
.	O

the	O
patient	O
presented	O
to	O
[	O
*	O
*	O
hospital	O
1472	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital3	O
*	O
*	O
]	O
and	O
was	O
admitted	O
on	O
friday	O
prior	O
to	O
admission	O
.	O

the	O
patient's	O
last	O
echocardiogram	O
done	O
on	O
[	O
*	O
*	O
2008	O
-	O
10	O
-	O
30	O
*	O
*	O
]	O
revealed	O
an	O
ejection	O
fraction	O
of	O
15	O
to	O
20%	O
,	O
global	O
hypokinesis	B
,	O
mild	O
aortic	B
stenosis	I
.	O

a	O
dobutamine	O
stress	O
test	O
done	O
on	O
[	O
*	O
*	O
32	O
-	O
05	O
-	O
02	O
*	O
*	O
]	O
revealed	O
a	O
fixed	O
inferior	B
posterolateral	I
defect	I
.	O

the	O
patient	O
underwent	O
cardiac	O
catheterization	O
today	O
,	O
revealing	O
a	O
wedge	O
pressure	O
of	O
29	O
,	O
left	O
ventricular	O
and	O
diastolic	O
pressure	O
of	O
25	O
,	O
ejection	O
fraction	O
of	O
20%	O
,	O
and	O
a	O
right	O
dominant	O
system	O
.	O

cardiac	O
catheterization	O
revealed	O
a	O
95%	O
left	O
main	O
occlusion	B
,	O
totally	O
occluded	B
left	O
anterior	O
descending	O
coronary	O
artery	O
,	O
left	O
circumflex	O
and	O
right	O
coronary	O
artery	O
.	O

the	O
saphenous	O
vein	O
graft	O
to	O
right	O
coronary	O
artery	O
graft	O
had	O
severe	O
origin	O
stenosis	B
.	O

the	O
left	O
internal	O
mammary	O
coronary	O
artery	O
to	O
left	O
anterior	O
descending	O
coronary	O
artery	O
graft	O
was	O
patent	O
.	O

the	O
saphenous	O
vein	O
graft	O
to	O
left	O
circumflex	O
graft	O
was	O
patent	O
.	O

the	O
saphenous	O
vein	O
graft	O
to	O
diagonal	O
graft	O
was	O
patent	O
.	O

the	O
patient	O
underwent	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
and	O
brachytherapy	O
of	O
the	O
saphenous	O
vein	O
graft	O
to	O
right	O
coronary	O
artery	O
graft	O
,	O
with	O
subsequent	O
timi	B
three	I
flow	I
.	O

the	O
patient	O
was	O
subsequently	O
given	O
40	O
mg	O
of	O
lasix	O
intravenously	O
after	O
cardiac	O
catheterization	O
and	O
intervention	O
with	O
a	O
urine	O
output	O
of	O
800	O
cc	O
.	O

past	O
medical	O
history	O
:	O
1	O
.	O
coronary	B
artery	I
disease	I
status	O
post	O
coronary	O
artery	O
bypass	O
graft	O
in	O
[	O
*	O
*	O
2002	O
*	O
*	O
]	O
,	O
left	O
internal	O
mammary	O
coronary	O
artery	O
to	O
left	O
anterior	O
descending	O
coronary	O
artery	O
,	O
saphenous	O
vein	O
graft	O
to	O
first	O
diagonal	O
and	O
obtuse	O
marginal	O
,	O
and	O
saphenous	O
vein	O
graft	O
to	O
right	O
coronary	O
artery	O
.	O

2	O
.	O
diabetes	B
.	O

3	O
.	O
hypertension	B
.	O

4	O
.	O
chronic	B
obstructive	I
pulmonary	I
disease	I
.	O

5	O
.	O
atrial	B
fibrillation	I
.	O

6	O
.	O
pacemaker	O
for	O
sick	B
sinus	I
syndrome	I
.	O

7	O
.	O
severe	O
degenerative	B
joint	I
disease	I
.	O

8	O
.	O
chronic	B
renal	I
insufficiency	I
with	O
a	O
baseline	O
creatinine	O
of	O
1	O
.	O
8	O
to	O
2	O
.	O

allergies	O
:	O
shellfish	O
and	O
iodine	O
.	O

medications	O
:	O
aspirin	O
325	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O
zantac	O
150	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
amiodarone	O
200	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
norvasc	O
5	O
mg	O
po	O
q	O
.	O
d	O
.	O
,	O

lopressor	O
50	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
lentis	O
120	O
mg	O
po	O
q	O
.	O
p	O
.	O
m	O
.	O
and	O
sliding	O
scale	O
insulin	O
.	O

imdur	O
60	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
augmentin	O
500	O
mg	O
po	O
t	O
.	O
i	O
.	O
d	O
.	O
for	O
three	O
weeks	O
,	O
nitrodur	O
0	O
.	O
4	O
mg	O
po	O
q	O
day	O
.	O

digoxin	O
0	O
.	O
125	O
mg	O
po	O
q	O
.	O
o	O
.	O
d	O
.	O
,	O
monopril	O
20	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
flovent	O
two	O
puffs	O
q	O
.	O
a	O
.	O
m	O
.	O
,	O
and	O
albuterol	O
inhaler	O
,	O
lasix	O
140	O
mg	O
po	O
q	O
.	O
d	O
.	O

physical	O
examination	O
on	O
admission	O
:	O
heart	O
rate	O
61	O
.	O

blood	O
pressure	O
128	O
/	O
109	O
.	O

oxygen	O
saturation	O
97%	O
on	O
4	O
liters	O
nasal	O
cannula	O
.	O

pulmonary	O
artery	O
pressure	O
58	O
/	O
25	O
.	O

general	O
,	O
the	O
patient	O
was	O
an	O
elderly	O
caucasian	O
male	O
in	O
no	O
acute	B
distress	I
.	O

head	O
and	O
neck	O
examination	O
,	O
oropharynx	O
clear	O
.	O

conjunctiva	O
clear	O
.	O

could	O
not	O
assess	O
jugulovenous	O
pressure	O
as	O
the	O
patient	O
was	O
lying	O
flat	O
post	O
cardiac	O
catheterization	O
.	O

cardiovascular	O
examination	O
regular	O
rate	O
and	O
rhythm	O
.	O

normal	O
s1	O
and	O
s2	O
.	O

no	O
s3	B
or	O
s4	B
.	O

there	O
is	O
a	O
2	O
out	O
of	O
6	O
systolic	B
murmur	I
auscultated	O
at	O
the	O
apex	O
and	O
right	O
upper	O
sternal	O
border	O
.	O

lungs	O
good	O
aeration	O
bilaterally	O
.	O

abdominal	O
examination	O
good	O
bowel	O
sounds	O
in	O
all	O
four	O
quadrants	O
.	O

soft	O
,	O
nontender	O
,	O
nondistended	O
.	O

right	O
groin	O
with	O
av	O
sheath	O
.	O

no	O
occult	B
bleeding	I
.	O

extremities	O
,	O
there	O
were	O
dopplerable	O
left	O
pulses	O
.	O

1	O
+	O
dorsalis	O
pedis	O
pulse	O
on	O
right	O
foot	O
.	O

there	O
was	O
a	O
1	O
cm	O
foot	B
ulcer	I
,	O
which	O
was	O
clear	O
with	O
no	O
drainage	O
.	O

laboratory	O
examination	O
on	O
admission	O
:	O
white	O
blood	O
cell	O
count	O
10	O
.	O
1	O
,	O
hematocrit	O
44	O
.	O
5	O
,	O
platelets	O
245	O
,	O
pt	O
15	O
.	O
1	O
,	O
ptt	O
32	O
,	O
inr	O

1	O
.	O
6	O
,	O
sodium	O
132	O
,	O
potassium	O
4	O
.	O
9	O
,	O
chloride	O
91	O
,	O
bicarbonate	O
28	O
,	O
bun	O
38	O
,	O
creatinine	O
1	O
.	O
3	O
,	O
glucose	O
432	O
.	O

arterial	O
blood	O
gas	O
showing	O
a	O
ph	O
of	O
7	O
.	O
43	O
,	O
pco2	O
40	O
,	O
po2	O
76	O
on	O
4	O
liters	O
nasal	O
cannula	O
.	O

electrocardiogram	O
v	O
paced	O
with	O
underlying	O
atrial	B
fibrillation	I
with	O
right	B
bundle	I
branch	I
block	I
morphology	O
.	O

hospital	O
course	O
:	O
the	O
impression	O
was	O
that	O
this	O
was	O
a	O
71	O
year	O
-	O
old	O
male	O
with	O
a	O
history	O
of	O
coronary	B
artery	I
disease	I
,	O
status	O
post	O
four	O
vessel	O
coronary	O
artery	O
bypass	O
graft	O
in	O
[	O
*	O
*	O
2002	O
*	O
*	O
]	O
,	O
recent	O
stent	O
to	O
the	O
saphenous	O
vein	O
graft	O
to	O
the	O
right	O
coronary	O
artery	O
in	O
[	O
*	O
*	O
2008	O
-	O
07	O
-	O
30	O
*	O
*	O
]	O
presenting	O
with	O
progressive	O
shortness	B
of	I
breath	I
.	O

the	O
patient	O
was	O
status	O
post	O
cardiac	O
catheterization	O
on	O
this	O
admission	O
,	O
status	O
post	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
and	O
brachytherapy	O
to	O
the	O
saphenous	O
vein	O
graft	O
to	O
right	O
coronary	O
artery	O
graft	O
and	O
hemodynamics	O
revealing	O
an	O
elevated	B
wedge	I
pressure	I
and	O
decreased	B
ejection	I
fraction	I
.	O

1	O
.	O
cardiovascular	O
:	O
a	O
:	O
coronary	B
artery	I
disease	I
:	O
the	O
patient	O
was	O
status	O
post	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
to	O
the	O
saphenous	O
vein	O
graft	O
to	O
the	O
right	O
coronary	O
artery	O
graft	O
.	O

the	O
patient	O
was	O
placed	O
on	O
an	O
integrilin	O
drip	O
for	O
18	O
hours	O
and	O
was	O
initiated	O
on	O
plavix	O
75	O
mg	O
po	O
q	O
day	O
for	O
thirty	O
days	O
.	O

the	O
patient	O
was	O
continued	O
on	O
aspirin	O
,	O
lopressor	O
50	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
norvasc	O
5	O
mg	O
po	O
q	O
.	O
d	O
.	O

the	O
patient	O
had	O
no	O
chest	B
pain	I
during	O
hospital	O
stay	O
.	O

b	O
:	O
pump	O
function	O
:	O
the	O
patient	O
had	O
an	O
elevated	O
wedge	O
pressure	O
and	O
depressed	O
ejection	O
fraction	O
on	O
hemodynamics	O
during	O
cardiac	O
catheterization	O
.	O

the	O
patient	O
was	O
initially	O
placed	O
on	O
intravenous	O
nitroglycerin	O
drip	O
.	O

while	O
in	O
the	O

cardiac	O
intensive	O
care	O
unit	O
,	O
the	O
patient	O
had	O
a	O
swan	O
-	O
ganz	O
catheter	O
in	O
place	O
to	O
measure	O
left	O
ventricular	O
and	O
diastolic	O
pressure	O
,	O
with	O
a	O
goal	O
of	O
keeping	O
this	O
pressure	O
at	O
20	O
mm	O
.	O

however	O
,	O
when	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
general	O
medical	O
floor	O
and	O
swan	O
-	O
ganz	O
catheter	O
was	O
removed	O
,	O
hemodynamics	O
could	O
no	O
longer	O
be	O
monitored	O
.	O

however	O
,	O
the	O
patient	O
was	O
symptomatically	O
improved	O
with	O
no	O
more	O
shortness	B
of	I
breath	I
.	O

the	O
patient	O
was	O
continued	O
on	O
lasix	O
80	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
monopril	O
20	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
and	O
was	O
started	O
on	O

aldactone	O
12	O
.	O
5	O
mg	O
po	O
q	O
.	O
d	O
.	O

the	O
patient	O
was	O
also	O
continued	O
on	O

digoxin	O
for	O
congestive	B
heart	I
failure	I
.	O

the	O
patient	O
remained	O
clinically	O
stable	O
with	O
respect	O
to	O
his	O
congestive	B
heart	I
failure	I
for	O
the	O
remainder	O
of	O
his	O
hospital	O
course	O
.	O

c	O
:	O
rhythm	O
:	O
the	O
patient	O
had	O
a	O
history	O
of	O
atrial	B
fibrillation	I
and	O
was	O
on	O
amiodarone	O
200	O
mg	O
po	O
b	O
.	O
i	O
.	O
d	O
.	O
with	O
a	O
history	O
of	O
pacemaker	O
placement	O
for	O
sick	B
sinus	I
syndrome	I
.	O

the	O
patient	O
had	O
a	O
v	O
paced	O
rhythm	O
with	O
baseline	O
atrial	B
fibrillation	I
on	O
his	O
admission	O
electrocardiogram	O
.	O

since	O
the	O
patient	O
had	O
this	O
baseline	O
atrial	B
fibrillation	I
anticoagulation	O
was	O
started	O
with	O
coumadin	O
5	O
mg	O
po	O
q	O
.	O
h	O
.	O
s	O
.	O

the	O
electrophysiology	O
service	O
was	O
consulted	O
and	O
given	O
that	O
the	O
patient	O
was	O
in	O
atrial	B
fibrillation	I
of	O
an	O
unknown	O
duration	O
,	O
the	O
patient	O
was	O
scheduled	O
for	O
dc	O
cardioversion	O
following	O
a	O
transesophageal	O
echocardiogram	O
,	O
which	O
was	O
done	O
during	O
this	O
hospital	O
stay	O
.	O

the	O
patient	O
was	O
successfully	O
cardioverted	O
and	O
was	O
subsequently	O
normal	B
sinus	I
rhythm	I
.	O

the	O
patient	O
was	O
discharged	O
on	O
lovenox	O
and	O
coumadin	O
and	O
was	O
scheduled	O
to	O
follow	O
up	O
iwth	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1473	O
*	O
*	O
]	O
.	O

2	O
.	O
pulmonary	O
:	O
the	O
patient	O
was	O
initially	O
sating	O
96%	O
on	O
4	O
liters	O
on	O
admission	O
.	O

however	O
,	O
with	O
continued	O
diuresis	O
the	O
patient	O
eventually	O
was	O
sating	O
mid	O
90%	O
on	O
room	O
air	O
on	O
discharge	O
.	O

3	O
.	O
renal	O
:	O
the	O
patient	O
had	O
a	O
history	O
of	O
chronic	B
renal	I
insufficiency	I
.	O

the	O
patient's	O
creatinine	O
was	O
followed	O
post	O
cardiac	O
catheterization	O
as	O
he	O
got	O
350	O
cc	O
of	O
dye	O
.	O

the	O
patient's	O
creatinine	O
remained	O
stable	O
throughout	O
his	O
hospital	O
course	O
.	O

4	O
.	O
infectious	O
disease	O
:	O
the	O
patient	O
was	O
continued	O
on	O

augmentin	O
for	O
a	O
left	O
toe	B
ulcer	I
,	O
which	O
he	O
had	O
developed	O
prior	O
to	O
admission	O
.	O

6	O
.	O
endocrine	O
:	O
the	O
patient	O
was	O
continued	O
on	O
lentis	O
and	O
regular	O
insulin	O
sliding	O
scale	O
for	O
diabetes	B
.	O

condition	O
on	O
discharge	O
:	O
stable	O
.	O

discharge	O
status	O
:	O
the	O
patient	O
is	O
to	O
be	O
discharged	O
to	O
home	O
.	O

medications	O
on	O
discharge	O
:	O
same	O
as	O
medications	O
on	O
admission	O
with	O
the	O
addition	O
of	O
plavix	O
75	O
mg	O
po	O
q	O
.	O
d	O
.	O
to	O
finish	O
a	O
thirty	O
day	O
course	O
,	O
coumadin	O
2	O
.	O
5	O
mg	O
po	O
q	O
.	O
h	O
.	O
s	O
.	O
,	O
lovenox	O
80	O
mg	O
subq	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
aldactone	O
12	O
.	O
5	O
mg	O
po	O
q	O
.	O
d	O
.	O

[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
491	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1474	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1475	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2009	O
-	O
04	O
-	O
22	O
*	O
*	O
]	O
19	O
:	O
11	O

t	O
:	O
[	O
*	O
*	O
2009	O
-	O
04	O
-	O
23	O
*	O
*	O
]	O
08	O
:	O
54	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
1476	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
491	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
67	O
*	O
*	O
]	O
[	O
*	O
*	O
2009	O
-	O
06	O
-	O
25	O
*	O
*	O
]	O
8	O
:	O
36	O
pm	O
(	O
end	O
of	O
report	O
)	O

36	O
||||	O
9001	O
||||	O
21969	O
||||	O
discharge	O
_	O
summary	O
||||	O
2008	O
-	O
10	O
-	O
23	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2008	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2008	O
-	O
10	O
-	O
22	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1920	O
-	O
10	O
-	O
09	O
*	O
*	O
]	O
sex	O
:	O
f	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
an	O
88	O
year	O
old	O
female	O
with	O
coronary	B
artery	I
disease	I
,	O
congestive	B
heart	I
failure	I
and	O
diabetes	B
mellitus	I
who	O
presented	O
with	O
fever	B
,	O
abdominal	B
pain	I
after	O
being	O
found	B
down	I
at	O
her	O
nursing	O
home	O
.	O

her	O
history	O
patient	O
is	O
a	O
resident	O
at	O
[	O
*	O
*	O
hospital	O
192	O
*	O
*	O
]	O
who	O
was	O
found	O
status	O
post	O
questionable	O
fall	B
the	O
morning	O
of	O
admission	O
and	O
was	O
noted	O
to	O
have	O
a	O
left	B
-	I
sided	I
weakness	I
without	O
head	B
trauma	I
or	O
loss	B
of	I
consciousness	I
.	O

the	O
fall	B
was	O
unwitnessed	O
.	O

subsequently	O
the	O
patient	O
had	O
a	O
large	O
occult	O
blood	O
positive	O
stool	O
and	O
was	O
also	O
found	O
to	O
have	O
complaints	O
of	O
abdominal	B
pain	I
.	O

at	O
the	O
nursing	O
home	O
the	O
temperature	O
was	O
102	O
.	O
1	O
with	O
a	O
pulse	O
of	O
126	O
,	O
blood	O
in	O
by	O
ambulance	O
to	O
[	O
*	O
*	O
hospital	O
86	O
*	O
*	O
]	O

emergency	O
department	O
for	O
evaluation	O
with	O
a	O
temperature	O
of	O

103	O
.	O
2	O
,	O
pulse	O
120	O
,	O
blood	O
pressure	O
108	O
/	O
40	O
and	O
respiratory	O
rate	O
of	O
30	O
with	O
an	O
oxygen	O
saturation	O
of	O
94%	O
.	O

in	O
the	O
emergency	O
department	O
the	O
patient	O
was	O
found	O
to	O
have	O
an	O
increased	O
respiratory	B
rate	I
.	O

she	O
denied	O
cough	B
,	O
chest	B
pain	I
,	O
shortness	B
of	I
breath	I
,	O
nausea	B
and	O
vomiting	B
or	O
dysuria	B
.	O

she	O
did	O
complain	O
of	O
abdominal	B
pain	I
and	O
diarrhea	B
.	O

the	O
patient	O
is	O
demented	B
at	O
baseline	O
.	O

the	O
patient	O
denied	O
any	O
fevers	B
or	O
chills	B
prior	O
though	O
it	O
is	O
unclear	O
but	O
it	O
is	O
possibly	O
p	B
.	I
o	I
.	I
intake	I
had	O
been	O
decreased	O
for	O
several	O
days	O
.	O

past	O
medical	O
history	O
:	O
coronary	B
artery	I
disease	I
,	O
status	O
post	O
congestive	B
heart	I
failure	I
with	O
last	O
admission	O
in	O
[	O
*	O
*	O
7	O
-	O
11	O
-	O
09	O
*	O
*	O
]	O
for	O
diastolic	B
heart	I
failure	I
,	O
type	B
2	I
diabetes	I
,	O
dementia	B
,	O
benign	B
positional	I
vertigo	I
,	O
status	O
post	O
cholecystectomy	O
,	O
status	O
post	O
femoral	B
neck	I
fracture	I
on	O
the	O
right	O
with	O
a	O
hemiarthroplasty	O
,	O
chronic	B
anemia	I
with	O
hematocrit	O
of	O
29	O
and	O

b12	B
deficiency	I
.	O

allergies	O
:	O
benzodiazepine	O
which	O
causes	O
severe	O
agitation	B
.	O

admission	O
medications	O
:	O

1	O
.	O
multivitamin	O

2	O
.	O
enteric	O
coated	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
lasix	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
prinivil	O
30	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

5	O
.	O
megace	O
400	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

6	O
.	O
lopressor	O
25	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

7	O
.	O
isordil	O
30	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

8	O
.	O
neurontin	O
100	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O

6	O

9	O
.	O
colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

physical	O
examination	O
:	O
physical	O
examination	O
revealed	O
a	O
temperature	O
of	O
103	O
.	O
2	O
,	O
pulse	O
120	O
,	O
blood	O
pressure	O
108	O
/	O
40	O
and	O
respiratory	O
rate	O
of	O
30	O
and	O
oxygen	O
saturation	O
of	O
94%	O
.	O

the	O
patient	O
was	O
an	O
awake	O
,	O
alert	O
,	O
tachypneic	B
elderly	O
white	O
female	O
in	O
mild	O
distress	B
.	O

pupils	O
were	O
left	O
,	O
surgical	O
,	O
minimally	O
reactive	O
,	O
right	O
reactive	O
.	O

extraocular	O
muscles	O
grossly	O
intact	O
.	O

oropharynx	O
,	O
mucous	O
membranes	O
were	O
dry	O
,	O
edentulous	B
.	O

neck	O
was	O
supple	O
with	O
jugulovenous	B
distension	I
of	O
10	O
cm	O
,	O
no	O
lymphadenopathy	B
.	O

cardiovascular	O
examination	O
,	O
tachycardiac	B
,	O
normal	O
s1	O
and	O
s2	O
.	O

lungs	O
with	O
decreased	B
breath	I
sounds	I
bilaterally	O
anteriorly	O
at	O
the	O
bases	O
,	O
otherwise	O
clear	O
to	O
auscultation	O
.	O

abdomen	O
was	O
diffusely	O
tender	O
with	O
bowel	O
sounds	O
,	O
no	O
masses	B
,	O
no	O
organomegaly	B
and	O
mild	O
distention	O
.	O

occult	O
blood	O
positive	O
brown	O
stool	O
per	O
the	O
emergency	O

department	O
.	O

back	O
examination	O
,	O
positive	O
costovertebral	B
angle	I
tenderness	I
bilaterally	O
per	O
emergency	O
department	O
.	O

extremities	O
with	O
1	O
+	O
pitting	B
bilaterally	I
with	O
no	O
edema	B
.	O

left	O
hip	O
with	O
5	O
cm	O
erythematous	B
abrasion	O
,	O
no	O
pelvic	B
instability	I
,	O
no	O
pain	B
to	O
passive	B
range	I
of	I
motion	I
of	O
the	O
left	O
hip	O
.	O

no	O
abrasions	B
on	O
the	O
upper	O
extremity	O
.	O

neurological	O
examination	O
,	O
per	O
the	O
emergency	O
department	O
,	O
alert	O
answering	O
questions	O
in	O
[	O
*	O
*	O
ethnicity	O
193	O
*	O
*	O
]	O
.	O

cranial	O
nerves	O
iii	O
through	O
xii	O
grossly	O
intact	O
.	O

left	O
arm	O
,	O
flaccid	B
,	O
no	O
response	O
to	O
pain	B
.	O

left	O
leg	O
withdraws	O
to	O
pain	B
but	O
also	O
flaccid	B
.	O

laboratory	O
data	O
:	O
admission	O
laboratory	O
data	O
revealed	O
a	O
white	O
blood	O
cell	O
count	O
17	O
.	O
1	O
,	O
hemoglobin	O
10	O
.	O
0	O
,	O
hematocrit	O
30	O
.	O
0	O
,	O
platelets	O
346	O
,	O
000	O
.	O

pt	O
was	O
12	O
.	O
2	O
,	O
ptt	O
19	O
.	O
1	O
,	O
inr	O
1	O
.	O
0	O
.	O

100	O
white	O
blood	O
cells	O
on	O
urinalysis	O
.	O

glucose	O
was	O
308	O
,	O
bun	O
74	O
,	O
creatinine	O
2	O
.	O
1	O
,	O
sodium	O
148	O
,	O
potassium	O
5	O
.	O
8	O
,	O
chloride	O
113	O
,	O
bicarbonate	O
12	O
,	O
alt	O
54	O
,	O
ast	O
125	O
,	O
ck	O
6	O
,	O
163	O
,	O
alkaline	O
phosphatase	O
53	O
,	O
total	O
bilirubin	O
0	O
.	O
5	O
,	O
ck	O
mb	O
84	O
.	O

albumin	O
3	O
.	O
8	O
,	O
calcium	O
9	O
.	O
1	O
,	O
phosphorus	O
6	O
.	O
3	O
,	O
magnesium	O
2	O
.	O
7	O
.	O

cardiac	O
troponin	O
greater	O
than	O
50	O
.	O

base	O
x	O
-	O
ray	O
on	O
[	O
*	O
*	O
10	O
-	O
10	O
*	O
*	O
]	O
revealed	O
a	O
right	O
lower	O
lobe	O
opacity	B
with	O
atelectasis	B
and	O
probable	O
pneumonia	O
.	O

computerized	O
tomography	O
scan	O
on	O
[	O
*	O
*	O
10	O
-	O
10	O
*	O
*	O
]	O
revealed	O
no	O
evidence	O
of	O
acute	O
intracranial	B
hemorrhage	I
.	O

computerized	O
tomography	O
scan	O
of	O
the	O
abdomen	O
on	O
[	O
*	O
*	O
10	O
-	O
10	O
*	O
*	O
]	O
revealed	O
a	O
small	O
right	O
pleural	B
effusion	I
with	O
bibasilar	O
atelectasis	B
right	I
greater	O
than	O
left	O
with	O
dense	O
vascular	B
calcification	I
.	O

there	O
was	O
a	O
large	O
hiatal	B
hernia	I
,	O
nonspecific	O
large	O
bowel	O
wall	O
thickening	B
without	O
stranding	B
or	O
pneumatosis	B
which	O
could	O
not	O
exclude	O
bowel	O
ischemia	B
,	O
probable	O
sacral	O
myelocele	B
was	O
there	O
as	O
well	O
.	O

computerized	O
tomography	O
scan	O
of	O
the	O
cervical	O
spine	O
on	O
[	O
*	O
*	O
10	O
-	O
10	O
*	O
*	O
]	O
revealed	O
degenerative	B
joint	I
disease	I
without	O
evidence	O
of	O
acute	O
fracture	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
medicine	O

intensive	O
care	O
unit	O
.	O

given	O
her	O
high	O
troponin	O
levels	O
,	O

cardiology	O
was	O
seen	O
in	O
consultation	O
and	O
they	O
felt	O
that	O
it	O
was	O
not	O
appropriate	O
to	O
cardiac	O
catheterize	O
the	O
patient	O
at	O
that	O
time	O
.	O

given	O
her	O
history	O
of	O
large	O
bloody	B
stool	I
,	O
the	O
patient	O
was	O
not	O
deemed	O
a	O
candidate	O
for	O
heparinization	O
either	O
.	O

she	O
was	O
maintained	O
on	O
aspirin	O
,	O
beta	O
blocker	O
and	O
as	O
lytes	O
improved	O
an	O
ace	O
inhibitor	O
was	O
added	O
as	O
well	O
.	O

during	O
her	O
course	O
in	O
the	O
hospital	O
the	O
patient	O
did	O
continue	O
to	O
have	O
transient	O
chest	B
pain	I
which	O
was	O
often	O
relieved	O
by	O
nitroglycerin	O
but	O
no	O
electrocardiogram	O
changes	O
were	O
found	O
.	O

some	O
episodes	O
of	O
chest	B
pain	I
did	O
have	O
to	O
be	O
treated	O
with	O
1	O
mg	O
of	O
intravenous	O
morphine	O
.	O

the	O
patient	O
was	O
placed	O
on	O
nitropaste	O
to	O
provide	O
longterm	B
pain	I
relief	O
and	O
the	O
patient's	O
episodes	O
of	O
chest	B
pain	I
subsided	O
.	O

infectious	O
disease	O
-	O
the	O
patient	O
was	O
seen	O
to	O
have	O
probable	O
sepsis	B
with	O
several	O
possible	O
etiologies	O
including	O
the	O
possibility	O
of	O
ischemic	B
bowel	I
as	O
indicated	O
by	O
the	O
computerized	O
tomography	O
scan	O
as	O
above	O
,	O
infectious	B
colitis	I
and	O
urosepsis	B
.	O

the	O
patient	O
was	O
treated	O
with	O
antibiotics	O
and	O
a	O

surgery	O
consultation	O
was	O
obtained	O
.	O

the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
[	O
*	O
*	O
10	O
-	O
11	O
*	O
*	O
]	O
for	O
an	O
exploratory	O
laparotomy	O
to	O
rule	O
out	O
ischemic	B
bowel	I
and	O
it	O
was	O
ruled	O
out	O
by	O
this	O
procedure	O
.	O

please	O
see	O
the	O
operative	O
note	O
dictation	O
for	O
further	O
details	O
of	O
this	O
procedure	O
.	O

to	O
continue	O
the	O
workup	O
of	O
her	O
diarrhea	B
,	O
the	O
patient	O
received	O
stool	O
cultures	O
which	O
were	O
all	O
negative	O
and	O
clostridium	O
difficile	O
cultures	O
which	O
were	O
negative	O
times	O
three	O
.	O

the	O
patient's	O
diarrhea	B
continued	O
and	O
ultimately	O
it	O
was	O
felt	O
that	O
possibly	O
the	O
diarrhea	B
was	O
caused	O
by	O
her	O
antibiotics	O
.	O

after	O
an	O
acceptable	O
course	O
of	O
antibiotic	O
therapy	O
for	O
her	O
urosepsis	B
and	O
pneumonia	B
these	O
were	O
discontinued	O
and	O
the	O
diarrhea	B
did	O
resolve	O
.	O

the	O
patient	O
did	O
receive	O
a	O
transfusion	O
of	O
4	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
over	O
her	O
stay	O
in	O
the	O
hospital	O
due	O
to	O
a	O
low	B
hematocrit	I
and	O
her	O
history	O
of	O
coronary	B
artery	I
disease	I
and	O
recent	O
myocardial	B
infarction	I
.	O

renal	O
-	O
the	O
patient	O
did	O
have	O
acid	O
based	O
abnormalities	O
with	O
a	O
respiratory	B
alkalosis	I
and	O
metabolic	B
acidosis	I
likely	O
lactic	B
acidosis	I
secondary	O
to	O
sepsis	B
with	O
an	O
anion	O
gap	O
.	O

there	O
was	O
no	O
evidence	O
of	O
ketones	O
.	O

electrolytes	O
and	O
bicarbonate	O
were	O
administered	O
to	O
adjust	O
the	O
patient's	O
electrolyte	O
status	O
.	O

the	O
patient's	O
renal	B
failure	I
was	O
attributed	O
to	O
prerenal	B
azotemia	I
and	O
she	O
was	O
hydrated	O
to	O
relieve	O
this	O
.	O

electrolyte	O
adjustment	O
continued	O
throughout	O
her	O
stay	O
in	O
the	O
medicine	O
intensive	O
care	O
unit	O
as	O
well	O
as	O
her	O
stay	O
on	O
the	O
floor	O
.	O

neurologic	O
-	O
the	O
patient	O
was	O
considered	O
as	O
possibly	O
having	O
had	O
a	O
cerebrovascular	B
accident	I
.	O

computerized	O
tomography	O
scan	O
in	O
the	O
emergency	O
department	O
was	O
negative	O
for	O
any	O
new	O
ischemia	B
.	O

it	O
was	O
felt	O
that	O
sepsis	B
and	O
/	O
or	O
ischemia	B
may	O
be	O
unmasking	O
left	B
-	I
sided	I
weakness	I
.	O

the	O
patient	O
was	O
followed	O
with	O
a	O
repeat	O
computerized	O
tomography	O
scan	O
and	O
was	O
seen	O
by	O
the	O

neurology	O
consult	O
service	O
.	O

the	O
patient's	O
weakness	B
did	O
resolve	O
.	O

no	O
further	O
workup	O
ensued	O
at	O
this	O
point	O
.	O

gastrointestinal	O
-	O
the	O
patient	O
was	O
admitted	O
with	O
bloody	B
diarrhea	I
as	O
described	O
above	O
.	O

the	O
workup	O
above	O
was	O
undertaken	O
and	O
in	O
addition	O
further	O
computerized	O
tomography	O
scans	O
were	O
obtained	O
after	O
the	O
patient	O
was	O
transferred	O
from	O
the	O
medicine	O
intensive	O
care	O
unit	O
to	O
the	O
general	O
medical	O
floor	O
because	O
of	O
ongoing	O
diarrhea	B
.	O

one	O
of	O
these	O
abdominal	O
computerized	O
tomography	O
scans	O
revealed	O
a	O
small	O
well	O
circumscribed	O
lesion	B
in	O
the	O
pancreas	O
.	O

the	O
patient's	O
lipase	O
was	O
elevated	O
.	O

the	O
question	O
was	O
raised	O
as	O
to	O
whether	O
or	O
not	O
the	O
patient	O
may	O
be	O
experiencing	O
pancreatitis	B
and	O
the	O
patient	O
was	O
maintained	O
on	O
a	O
brat	O
diet	O
,	O
lipase	B
levels	I
declined	O
.	O

it	O
was	O
felt	O
that	O
this	O
may	O
be	O
contributing	O
to	O
the	O
patient's	O
abdominal	B
complaint	I
.	O

an	O
abdominal	O
ultrasound	O
on	O
[	O
*	O
*	O
10	O
-	O
21	O
*	O
*	O
]	O
revealed	O
no	O
additional	O
changes	O
in	O
this	O
lesion	B
.	O

eventually	O
the	O
patient's	O
diarrhea	B
declined	O
.	O

genitourinary	O
-	O
one	O
of	O
the	O
aforementioned	O
computerized	O
tomography	O
scans	O
also	O
revealed	O
a	O
fluid	B
-	I
filled	I
uterus	I
.	O

to	O
workup	O
this	O
discovery	O
a	O
transvaginal	O
ultrasound	O
was	O
undertaken	O
which	O
revealed	O
a	O
uterine	B
stripe	I
of	O
0	O
.	O
45	O
cm	O
.	O

this	O
was	O
reviewed	O
with	O
the	O
gynecology	O
consult	O
service	O
and	O
they	O
recommended	O
the	O
patient	O
have	O
an	O
outpatient	O
uterine	O
biopsy	O
.	O

they	O
felt	O
that	O
there	O
were	O
no	O
urgency	O
to	O
working	O
up	O
this	O
problem	O
at	O
this	O
time	O
.	O

with	O
respect	O
to	O
the	O
above	O
issues	O
,	O
the	O
patient's	O
status	O
gradually	O
improved	O
.	O

cks	O
continued	O
to	O
trend	O
down	O
.	O

lipase	O
trended	O
down	O
.	O

electrolytes	O
improved	O
.	O

diarrhea	B
subsided	O
.	O

the	O
patient	O
was	O
also	O
seen	O
by	O
the	O
speech	O
and	O
swallow	O
service	O
who	O
felt	O
that	O
the	O
patient	O
could	O
tolerate	O
ground	O
food	O
given	O
her	O
swallowing	B
problems	I
.	O

the	O
patient	O
also	O
developed	O
a	O
urinary	B
tract	I
infection	I
with	O
yeast	O
.	O

this	O
was	O
treated	O
with	O
diflucan	O
.	O

on	O
[	O
*	O
*	O
2008	O
-	O
10	O
-	O
22	O
*	O
*	O
]	O
,	O
the	O
patient	O
was	O
deemed	O
stable	O
for	O
discharge	O
back	O
to	O
the	O
[	O
*	O
*	O
hospital	O
192	O
*	O
*	O
]	O
nursing	O
home	O
.	O

discharge	O
instructions	O
:	O
the	O
patient	O
should	O
continue	O
a	O
ground	O
diet	O
with	O
thick	O
liquids	O
to	O
resume	O
physical	O
therapy	O
as	O
tolerated	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
multivitamin	O
1	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
protonix	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
nystatin	O
swish	O
and	O
swallow	O
46	O
ml	O
p	O
.	O
o	O
.	O
q	O
.	O
i	O
.	O
d	O
.	O

5	O
.	O
lopressor	O
100	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

6	O
.	O
captopril	O
37	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

7	O
.	O
diflucan	O
400	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O
to	O
complete	O
a	O
four	O
day	O
course	O

final	O
diagnosis	O
:	O

1	O
.	O
myocardial	B
infarction	I

2	O
.	O
left	B
-	I
sided	I
weakness	I

3	O
.	O
lactic	B
acidosis	I

4	O
.	O
pancreatitis	B

5	O
.	O
pneumonia	B

6	O
.	O
urosepsis	B

7	O
.	O
diarrhea	B
,	O
unknown	O
origin	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
194	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
195	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
196	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
197	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2008	O
-	O
10	O
-	O
21	O
*	O
*	O
]	O
14	O
:	O
04	O

t	O
:	O
[	O
*	O
*	O
2008	O
-	O
10	O
-	O
21	O
*	O
*	O
]	O
16	O
:	O
17	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
198	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
194	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
195	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2008	O
-	O
10	O
-	O
22	O
*	O
*	O
]	O
10	O
:	O
29	O
am	O

(	O
end	O
of	O
report	O
)	O

87790	O
||||	O
9030	O
||||	O
27122	O
||||	O
ecg	O
_	O
report	O
||||	O
2019	O
-	O
05	O
-	O
19	O
16	O
:	O
07	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
tachycardia	I
.	O

since	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2019	O
-	O
05	O
-	O
18	O
*	O
*	O
]	O
the	O
rate	B
has	O
increased	O
.	O

other	O
features	O
are	O
as	O
previously	O
noted	O
.	O

anterior	O
t	O
waves	O
are	O
now	O
upright	O
.	O

clinical	O
correlation	O
is	O
suggested	O
.	O

52377	O
||||	O
9040	O
||||	O
8910	O
||||	O
ecg	O
_	O
report	O
||||	O
2013	O
-	O
10	O
-	O
03	O
15	O
:	O
30	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

regular	O
rhythm	O
with	O
low	B
amplitude	I
p	I
waves	I
and	O
upper	O
limits	O
of	O
normal	B
p	I
-	I
r	I
interval	I
.	O

left	B
axis	I
deviation	I
.	O

right	B
bundle	I
-	I
branch	I
block	I
.	O

st	B
-	I
t	I
wave	I
abnormalities	I
and	O
q	B
-	I
t	I
interval	I
prolongation	I
.	O

clinical	O
correlation	O
is	O
suggested	O
.	O

tracing	O
#1	O

409725	O
||||	O
9166	O
||||	O
11097	O
||||	O
radiology	O
_	O
report	O
||||	O
2020	O
-	O
04	O
-	O
01	O
20	O
:	O
44	O
:	O
00	O
.	O
0	O
||||	O
q311	O
ct	O
c	O
-	O
spine	O
w	O
/	O
o	O
contrast	O
||||	O
||||	O
clip	O
#	O
429	O
-	O
0503	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2020	O
-	O
04	O
-	O
01	O
*	O
*	O
]	O
8	O
:	O
44	O
pm	O

ct	O
c	O
-	O
spine	O
w	O
/	O
o	O
contrast	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
5817	O
*	O
*	O
]	O
reason	O
:	O
fracture?	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

26	O
year	O
old	O
woman	O
s	O
/	O
p	O
mvc	O
reason	O
for	O
this	O
examination	O
:	O
fracture?	O

no	O
contraindications	O
for	O
iv	O
contrast	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

wet	O
read	O
:	O

no	O
fracture	O
or	O
malalignment	B
of	O
the	O
c	O
-	O
spine	O
.	O

fractures	B
involving	O
both	O
maxillary	O
sinuses	O
,	O
other	O
fractures	O
of	O
the	O
skull	O
better	O
assessed	O
on	O
the	O
head	O
ct	O
performed	O
concurrently	O
.	O

large	O
left	O
apical	O
hematoma	B
.	O

cta	O
chest	O
recommended	O
to	O
rule	O
out	O
injury	B
to	O
the	O
great	O
vessels	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
26	O
-	O
year	O
-	O
old	O
female	O
status	O
post	O
motor	O
vehicle	O
collision	O
.	O

comparisons	O
:	O
non	O
-	O
contrast	O
head	O
ct	O
performed	O
concurrently	O
and	O
dictated	O
separately	O
.	O

technique	O
:	O
non	O
-	O
contrast	O
mdct	O
axial	O
images	O
of	O
the	O
cervical	O
spine	O
with	O
sagittal	O
and	O
coronal	O
reconstructions	O
.	O

findings	O
:	O
in	O
the	O
sagittal	O
view	O
,	O
the	O
skull	O
base	O
to	O
the	O
superior	O
endplate	O
of	O
c3	O
were	O
well	O
visualized	O
.	O

there	O
is	O
no	O
evidence	O
of	O
fracture	O
or	O
malalignment	B
of	O
the	O
component	O
vertebra	O
.	O

straightening	O
of	O
the	O
normal	O
cervical	O
lordosis	B
is	O
likely	O
secondary	O
to	O
the	O
cervical	O
collar	O
.	O

vertebral	O
body	O
and	O
disc	O
space	O
heights	O
are	O
preserved	O
.	O

multiple	B
facial	I
fractures	I
are	O
better	O
characterized	O
on	O
the	O
accompanying	O
head	O
ct	O
.	O

dense	O
consolidation	O
at	O
the	O
left	O
lung	O
apex	O
is	O
concerning	O
for	O
possible	O
hematoma	B
or	O
collapsed	B
lung	I
.	O

the	O
right	O
apex	O
is	O
grossly	O
clear	O
.	O

mixed	O
density	O
fluid	O
consistent	O
with	O
hemorrhage	B
is	O
seen	O
within	O
the	O
maxillary	O
,	O
sphenoid	O
and	O
ethmoid	O
sinuses	O
.	O

impression	O
:	O

1	O
.	O
no	O
fracture	O
or	O
malalignment	B
of	O
the	O
cervicle	O
spine	O
.	O

2	O
.	O
multiple	B
facial	I
fractures	I
.	O

please	O
referred	O
to	O
the	O
head	O
ct	O
performed	O
concurrently	O
for	O
further	O
details	O
(	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
5818	O
*	O
*	O
]	O
)	O
.	O

3	O
.	O
dense	O
consolidation	O
at	O
the	O
left	O
lung	O
apex	O
representing	O
possible	O
contusion	O
/	O
hematoma	B
versus	O
collapsed	B
lung	I
.	O

further	O
characterization	O
with	O
chest	O
ct	O
is	O
recommended	O
.	O

findings	O
were	O
discussed	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
1283	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
5819	O
*	O
*	O
]	O
upon	O
completion	O
of	O
the	O
study	O
.	O

18472	O
||||	O
9337	O
||||	O
17827	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
02	O
-	O
06	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
06	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1928	O
-	O
10	O
-	O
05	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
ccu	O

chief	O
complaint	O
:	O
the	O
patient	O
was	O
transferred	O
from	O
an	O
outside	O
hospital	O
for	O
management	O
of	O
acute	B
st	I
elevation	I
myocardial	I
infarction	I
.	O

history	O
of	O
present	O
illness	O
:	O
this	O
patient	O
is	O
an	O
84	O
-	O
year	O
-	O
old	O
woman	O
without	O
significant	O
past	O
medical	O
history	O
whose	O
only	O
cardiac	O
risk	O
factor	O
was	O
her	O
age	O
.	O

she	O
was	O
transferred	O
from	O
[	O
*	O
*	O
hospital	O
70	O
*	O
*	O
]	O
where	O
she	O
presented	O
the	O
morning	O
of	O
admission	O
with	O
chest	B
pain	I
radiating	I
to	O
her	O
jaw	O
.	O

at	O
[	O
*	O
*	O
hospital	O
70	O
*	O
*	O
]	O
she	O
was	O
found	O
to	O
have	O
st	B
elevations	I
anteriorly	I
and	O
inferiorly	O
.	O

she	O
was	O
started	O
on	O
aspirin	O
,	O
give	O
a	O
beta	O
blocker	O
and	O
started	O
on	O
a	O
heparin	O
drip	O
and	O
transferred	O
immediately	O
to	O
[	O
*	O
*	O
hospital	O
22	O
*	O
*	O
]	O
for	O
cardiac	O
catheterization	O
.	O

in	O
retrospect	O
the	O
patient	O
recalls	O
experiencing	O
chest	B
tightness	I
with	O
exertion	O
for	O
approximately	O
two	O
weeks	O
prior	O
to	O
admission	O
,	O
as	O
well	O
as	O
chest	B
tightness	I
over	O
the	O
two	O
days	O
prior	O
to	O
admission	O
even	O
at	O
times	O
of	O
rest	O
.	O

she	O
denies	O
any	O
other	O
complaints	B
.	O

the	O
patient	O
was	O
taken	O
immediately	O
to	O
the	O
cardiac	O
catheterization	O
laboratory	O
upon	O
arrival	O
before	O
coming	O
to	O
the	O
coronary	O
care	O
unit	O
.	O

there	O
she	O
was	O
found	O
to	O
have	O
a	O
right	O
dominant	O
system	O
with	O
two	B
-	I
vessel	I
coronary	I
artery	I
disease	I
.	O

the	O
left	O
main	O
coronary	O
artery	O
had	O
a	O
30%	O
ostial	B
lesion	I
.	O

the	O
left	O
anterior	O
descending	O
artery	O
was	O
occluded	B
proximally	O
with	O
fresh	O
thrombus	O
.	O

the	O
left	O
circumflex	O
had	O
mild	O
luminal	B
irregularities	I
.	O

there	O
was	O
a	O
medium	O
-	O
sized	O
ramus	O
intermedius	O
with	O
a	O
90%	O
proximal	O
lesion	B
.	O

the	O
right	O
coronary	O
artery	O
was	O
diffusely	O
diseased	B
with	O
50%	O
proximal	O
stenosis	O
and	O
then	O
was	O
occluded	O
at	O
the	O
midportion	O
.	O

the	O
distal	O
right	O
coronary	O
artery	O
was	O
reconstituted	O
with	O
right	O
-	O
to	O
-	O
right	O
collaterals	O
with	O
timi	O
1	O
flow	O
.	O

there	O
was	O
successful	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
and	O
stenting	O
of	O
the	O
proximal	O
to	O
mid	O
left	O
anterior	O
descending	O
coronary	O
artery	O
,	O
as	O
well	O
as	O
thrombectomy	O
with	O
a	O
final	O
result	O
of	O
timi	O
3	O
flow	O
.	O

right	O
heart	O
catheterization	O
was	O
done	O
as	O
well	O
showing	O
elevated	O
pressures	O
with	O
a	O
pulmonary	O
capillary	O
wedge	O
pressure	O
of	O
32	O
,	O
a	O
mean	O
right	O
atrial	O
pressure	O
of	O
22	O
mmhg	O
.	O

pa	O
pressure	O
was	O
56	O
/	O
25	O
.	O

the	O
cardiac	B
index	I
was	O
depressed	O
at	O
1	O
.	O
5	O
.	O

following	O
catheterization	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
coronary	O
care	O
unit	O
for	O
further	O
monitoring	O
.	O

past	O
medical	O
history	O
:	O
anxiety	B
.	O

medications	O
on	O
admission	O
:	O
buspar	O
and	O
remeron	O
.	O

allergies	O
:	O
the	O
patient	O
has	O
no	O
known	O
drug	O
allergies	O
.	O

family	O
history	O
:	O
no	O
history	O
of	O
coronary	B
artery	I
disease	I
.	O

social	O
history	O
:	O
the	O
patient	O
denies	O
use	O
of	O
tobacco	O
or	O
alcohol	O
.	O

she	O
lives	O
in	O
[	O
*	O
*	O
location	O
3282	O
*	O
*	O
]	O
independently	O
.	O

physical	O
examination	O
:	O
on	O
admission	O
to	O
the	O
coronary	O
care	O
unit	O
the	O
patient	O
was	O
afebrile	O
,	O
heart	O
rate	O
was	O
77	O
,	O
blood	O
pressure	O
103	O
/	O
56	O
,	O
oxygen	O
saturation	O
was	O
97%	O
on	O
four	O
liters	O
,	O
respiratory	O
rate	O
17	O
.	O

pa	O
pressure	O
at	O
that	O
time	O
was	O
33	O
/	O
14	O
.	O

pertinent	O
physical	O
findings	O
reveal	O
that	O
her	O
sclerae	O
were	O
anicteric	O
.	O

her	O
oropharynx	O
was	O
clear	O
and	O
dry	O
.	O

examination	O
of	O
the	O
neck	O
revealed	O
jugular	B
venous	I
distension	I
to	O
the	O
earlobes	O
bilaterally	O
.	O

her	O
lungs	O
had	O
crackles	B
at	O
the	O
left	O
base	O
but	O
were	O
otherwise	O
clear	O
.	O

her	O
abdomen	O
was	O
obese	O
,	O
soft	O
and	O
nontender	O
.	O

her	O
heart	O
examination	O
revealed	O
a	O
normal	O
s1	O
and	O
s2	O
,	O
no	O
murmurs	B
were	O
heard	O
.	O

extremity	O
examination	O
revealed	O
decreased	B
distal	I
pulses	I
bilaterally	I
,	O
no	O
edema	B
,	O
and	O
the	O
patient	O
had	O
significant	O
hematoma	B
at	O
the	O
right	O
groin	O
.	O

the	O
patient	O
had	O
had	O
an	O
angio	O
-	O
seal	O
placed	O
which	O
temporarily	O
became	O
unseated	O
after	O
the	O
case	O
as	O
the	O
patient	O
was	O
a	O
bit	O
agitated	B
.	O

the	O
hematoma	B
was	O
stable	O
after	O
compression	O
held	O
in	O
the	O
catheterization	O
laboratory	O
and	O
was	O
not	O
found	O
to	O
be	O
enlarging	O
on	O
examination	O
.	O

laboratory	O
studies	O
:	O
chem	O
-	O
7	O
was	O
unremarkable	O
.	O

initial	O
set	O
of	O
cardiac	O
enzymes	O
revealed	O
a	O
ck	O
of	O
817	O
with	O
an	O
mb	O
fraction	O
of	O

53	O
.	O

troponin	O
was	O
8	O
.	O
5	O
.	O

hospital	O
course	O
:	O
1	O
.	O
cardiovascular	O
:	O

a	O
.	O

coronary	B
artery	I
disease	I
:	O
the	O
patient	O
was	O
status	O
post	O
anterior	B
st	I
elevation	I
myocardial	I
infarction	I
.	O

she	O
was	O
continued	O
on	O
aspirin	O
after	O
the	O
procedure	O
as	O
well	O
as	O
integrilin	O
for	O
18	O
hours	O
post	O
catheterization	O
.	O

she	O
was	O
started	O
on	O
plavix	O
to	O
be	O
continued	O
for	O
30	O
days	O
.	O

immediately	O
post	O
catheterization	O
because	O
of	O
her	O
depressed	B
cardiac	I
output	I
and	O
index	O
,	O
her	O
beta	O
blocker	O
and	O
ace	O
inhibitors	O
were	O
held	O
.	O

eventually	O
as	O
her	O
hemodynamics	B
improved	O
and	O
her	O
blood	O
pressure	O
tolerated	O
,	O
she	O
was	O
restarted	O
on	O
beta	O
blocker	O
,	O
initially	O
lopressor	O
12	O
.	O
5	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

the	O
patient	O
was	O
called	O
out	O
of	O
the	O
coronary	O
care	O
unit	O
to	O
the	O
medical	O
floor	O
on	O
the	O
next	O
hospital	O
day	O
,	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
after	O
the	O
swan	O
-	O
ganz	O
catheter	O
had	O
been	O
discontinued	O
.	O

her	O
lipid	O
panel	O
was	O
checked	O
showing	O
that	O
she	O
had	O
an	O
ldl	O
of	O
90	O
and	O
hdl	O
of	O
58	O
.	O

with	O
these	O
numbers	O
the	O
patient	O
was	O
not	O
started	O
on	O
a	O
statin	O
.	O

her	O
beta	O
blocker	O
was	O
titrated	O
to	O
25	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
and	O
was	O
well	O
tolerated	O
.	O

b	O
.	O

rhythm	O
:	O
the	O
patient	O
was	O
in	O
sinus	O
rhythm	O
throughout	O
her	O
hospitalization	O
.	O

on	O
hospital	O
day	O
number	O
to	O
she	O
was	O
found	O
to	O
have	O
an	O
11	O
-	O
beat	O
run	O
of	O
nonsustained	B
ventricular	I
tachycardia	I
.	O

electrophysiology	O
was	O
consulted	O
regarding	O
risk	O
stratification	O
in	O
this	O
woman	O
peri	O
-	O
mi	B
.	O

it	O
was	O
felt	O
that	O
because	O
of	O
her	O
very	B
low	I
ejection	I
fraction	I
and	O
evidence	O
for	O
a	O
large	O
area	O
of	O
scarring	B
by	O
ekg	O
that	O
she	O
should	O
undergo	O
risk	O
stratification	O
for	O
arrhythmia	B
,	O
however	O
it	O
was	O
felt	O
that	O
given	O
that	O
she	O
had	O
just	O
completed	O
an	O
acute	B
anterior	I
myocardial	I
infarction	I
,	O
it	O
was	O
felt	O
that	O
invasive	O
electrophysiologic	O
studies	O
should	O
be	O
performed	O
approximately	O
one	O
month	O
after	O
this	O
admission	O
.	O

for	O
that	O
the	O
patient	O
will	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
207	O
*	O
*	O
]	O
approximately	O
one	O
month	O
after	O
discharge	O
.	O

c	O
.	O

congestive	B
heart	I
failure	I
:	O
the	O
patient	O
had	O
an	O
echocardiogram	O
on	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
revealing	O
an	O
ejection	O
fraction	O
of	O
less	O
than	O
25%	O
.	O

the	O
left	O
atrium	O
was	O
mildly	O
dilated	O
.	O

there	O
was	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

there	O
was	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	B
with	O
some	O
preservation	O
of	O
the	O
basal	O
lateral	O
and	O
basal	O
posterior	O
wall	O
segments	O
.	O

overall	O
however	O
the	O
left	O
ventricular	O
systolic	O
function	O
was	O
severely	O
depressed	O
.	O

on	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
while	O
being	O
transfused	O
for	O
an	O
hematocrit	O
of	O
27	O
.	O
2	O
,	O
the	O
patient	O
experienced	O
some	O
shortness	B
of	I
breath	I
and	O
clinical	O
findings	O
suggestive	O
of	O
congestive	B
heart	I
failure	I
.	O

she	O
was	O
diuresed	O
with	O
lasix	O
with	O
improvement	O
.	O

because	O
of	O
her	O
poor	B
ejection	I
fraction	I
and	O
anterior	B
myocardial	I
infarction	I
the	O
patient	O
was	O
anticoagulated	O
initially	O
with	O
a	O
heparin	O
drip	O
and	O
coumadin	O
was	O
begun	O
.	O

ultimately	O
she	O
was	O
changed	O
to	O
lovenox	O
at	O
the	O
time	O
of	O
discharge	O
until	O
her	O
warfarin	O
with	O
therapeutic	O
.	O

also	O
for	O
her	O
heart	B
failure	I
the	O
patient	O
was	O
placed	O
on	O
lisinopril	O
2	O
.	O
5	O
mg	O
to	O
be	O
titrated	O
as	O
her	O
blood	O
pressure	O
tolerated	O
.	O

2	O
.	O
psychiatry	O
:	O
the	O
patient	O
was	O
continued	O
on	O
her	O
outpatient	O
doses	O
of	O
remeron	O
and	O
buspirone	O
.	O

3	O
.	O
urinary	B
tract	I
infection	I
:	O
her	O
urinalysis	O
was	O
checked	O
on	O
the	O
evening	O
of	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
suggestive	O
of	O
urinary	B
tract	I
infection	I
with	O
leukocyte	O
esterase	O
,	O
greater	O
than	O
50	O
white	O
blood	O
cells	O
,	O
and	O
many	O
bacteria	O
.	O

the	O
patient	O
was	O
treated	O
with	O
ciprofloxacin	O
for	O
three	O
days	O
.	O

disposition	O
:	O
prior	O
to	O
discharge	O
physical	O
therapy	O
was	O
consulted	O
.	O

it	O
was	O
felt	O
that	O
the	O
patient	O
did	O
not	O
require	O
inpatient	O
rehabilitation	O
but	O
that	O
she	O
would	O
benefit	O
from	O
home	O
physical	O
therapy	O
and	O
vna	O
,	O
and	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
acute	B
anterior	I
st	I
elevation	I
myocardial	I
infarction	I
status	O
post	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
and	O
stenting	O
of	O
the	O
left	O
anterior	O
descending	O
coronary	O
artery	O
.	O

2	O
.	O
anxiety	B
.	O

3	O
.	O
urinary	B
tract	I
infection	I
.	O

discharge	O
medications	O
:	O

1	O
.	O
lovenox	O
60	O
mg	O
subcutaneous	O
q	O
.	O

12	O
.	O

2	O
.	O
enteric	O
-	O
coated	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
plavix	O
75	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
coumadin	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O

5	O
.	O
lisinopril	O
2	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

6	O
.	O
imdur	O
60	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

7	O
.	O
metoprolol	O
xl	O
50	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

8	O
.	O
remeron	O
7	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
h	O
.	O
s	O
.	O

9	O
.	O
buspar	O
10	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

follow	O
up	O
:	O
the	O
patient	O
was	O
to	O
have	O
a	O
pt	O
/	O
inr	O
drawn	O
by	O
the	O
vna	O
services	O
on	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
07	O
*	O
*	O
]	O
.	O

the	O
patient	O
was	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
207	O
*	O
*	O
]	O
four	O
weeks	O
following	O
decision	O
to	O
be	O
arranged	O
by	O
her	O
office	O
.	O

condition	O
on	O
discharge	O
:	O
stable	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
3893	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
3891	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
939	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
25	O
*	O
*	O
]	O
10	O
:	O
47	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
29	O
*	O
*	O
]	O
11	O
:	O
17	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
6805	O
*	O
*	O
]	O

s	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3893	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
32	O
*	O
*	O
]	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
12	O
*	O
*	O
]	O
8	O
:	O
25	O
am	O
(	O
end	O
of	O
report	O
)	O

99229	O
||||	O
9375	O
||||	O
8882	O
||||	O
echo	O
_	O
report	O
||||	O
2013	O
-	O
06	O
-	O
21	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
elevated	B
esr	I
and	O
wbc	O
.	O

weight	O
(	O
lb	O
)	O
:	O
118	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
103	O
/	O
58	O

hr	O
(	O
bpm	O
)	O
:	O
91	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2013	O
-	O
06	O
-	O
21	O
*	O
*	O
]	O
at	O
11	O
:	O
53	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
lv	B
wall	I
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

trivial	O
mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
with	O
trivial	O
tr	B
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
-	O
poor	O
echo	O
windows	O
.	O

conclusions	O
:	O

1	O
.	O
left	O
ventricular	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
are	O
normal	O
(	O
lvef>55%	O
)	O
.	O

due	O
to	O
suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
wall	B
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

2	O
.	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

3	O
.	O
no	O
clear	O
evidence	O
of	O
endocarditis	B
seen	O
.	O

102867	O
||||	O
9536	O
||||	O
21511	O
||||	O
echo	O
_	O
report	O
||||	O
2014	O
-	O
10	O
-	O
03	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
pericardial	B
effusion	I
.	O
?	O

tamponade	B

bp	O
(	O
mm	O
hg	O
)	O
:	O
90	O
/	O
60	O

status	O
:	O
outpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
03	O
*	O
*	O
]	O
at	O
12	O
:	O
08	O

test	O
:	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricle	O
:	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
.	O

there	O
is	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	B
.	O

right	O
ventricle	O
:	O
right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

right	O
ventricular	O
systolic	O
function	O
is	O
normal	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

mitral	O
valve	O
:	O
mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

pericardium	O
:	O
there	O
is	O
a	O
large	O
pericardial	B
effusion	I
.	O

there	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade	B
.	O

general	O
comments	O
:	O
a	O
left	O
pleural	B
effusion	I
is	O
present	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
moderate	O
to	O
severely	O
depressed	O
.	O

there	O
is	O
moderate	O
to	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	B
.	O

right	O
ventricular	O
systolic	O
function	O
is	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
a	O
large	O
pericardial	B
effusion	I
.	O

there	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade	B
.	O

by	O
report	O
,	O
compared	O
to	O
the	O
[	O
*	O
*	O
2013	O
-	O
11	O
-	O
16	O
*	O
*	O
]	O
the	O
pericardial	B
effusion	I
is	O
much	O
larger	O
and	O
the	O
lv	O
function	O
is	O
unchanged	O
.	O

67879	O
||||	O
9569	O
||||	O
12190	O
||||	O
ecg	O
_	O
report	O
||||	O
2016	O
-	O
06	O
-	O
06	O
09	O
:	O
48	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
bradycardia	I

anterolateral	I
myocardial	I
infarct	I
with	O
st	O
-	O
t	O
wave	O
configuration	O
consistent	O
with	O
acute	O
/	O
recent	O
/	O
in	O
evolution	O
process	O

clinical	O
correlation	O
is	O
suggested	O

since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2016	O
-	O
06	O
-	O
05	O
*	O
*	O
]	O
,	O
probably	O
no	O
significant	O
change	O

107853	O
||||	O
9584	O
||||	O
18774	O
||||	O
echo	O
_	O
report	O
||||	O
2015	O
-	O
06	O
-	O
12	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
coronary	B
artery	I
disease	I
.	O

left	B
ventricular	I
function	I
.	O

pericardial	B
effusion	I
.	O

height	O
:	O
(	O
in	O
)	O
64	O

weight	O
(	O
lb	O
)	O
:	O
160	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
78	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
125	O
/	O
65	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
12	O
*	O
*	O
]	O
at	O
12	O
:	O
57	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

left	O
ventricle	O
:	O
left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

right	O
ventricle	O
:	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

trace	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

there	O
is	O
moderate	O
mitral	B
annular	I
calcification	I
.	O

mitral	B
regurgitation	I
is	O
present	O
but	O
cannot	O
be	O
quantified	O
.	O

[	O
due	O
to	O
acoustic	O
shadowing	O
,	O
the	O
severity	O
of	O
mitral	B
regurgitation	I
may	O
be	O
significantly	O
underestimated	O
.	O
]	O

tricuspid	O
valve	O
:	O
the	O
tricuspid	O
valve	O
leaflets	O
are	O
normal	O
.	O

mild	O
tricuspid	O
[	O
1	O
+	O
]	O
regurgitation	O
is	O
seen	O
.	O

the	O
pulmonary	B
artery	I
systolic	I
pressure	I
could	O
not	O
be	O
determined	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
the	O
pulmonic	O
valve	O
leaflets	O
appear	O
structurally	O
normal	O
with	O
physiologic	O
pulmonic	B
regurgitation	I
.	O

pericardium	O
:	O
there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

the	O
effusion	B
appears	O
circumferential	O
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
-	O
poor	O
apical	O
views	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
probably	O
normal	O
,	O
although	O
apical	O
segments	O
not	O
optimally	O
visualized	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

trace	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mitral	B
regurgitation	I
is	O
present	O
but	O
cannot	O
be	O
quantified	O
(	O
due	O
to	O
acoustic	O
shadowing	O
from	O
mitral	B
annular	I
calcification	I
,	O
the	O
severity	O
of	O
mitral	B
regurgitation	I
may	O
be	O
significantly	O
underestimated	O
)	O
.	O

there	O
is	O
a	O
small	O
circumferential	O
pericardial	B
effusion	I
.	O

compared	O
with	O
the	O
prior	O
study	O
of	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
16	O
*	O
*	O
]	O
,	O
there	O
has	O
probably	O
been	O
no	O
significant	O
change	O
(	O
pericardial	B
effusion	I
was	O
small	O
,	O
not	O
physiologic	O
,	O
on	O
prior	O
study	O
)	O
.	O

ventricular	O
function	O
is	O
unchanged	O
.	O

87101	O
||||	O
9622	O
||||	O
26237	O
||||	O
ecg	O
_	O
report	O
||||	O
2018	O
-	O
10	O
-	O
13	O
09	O
:	O
51	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	O
rhythm	O
.	O

left	B
atrial	I
enlargement	I
.	O

left	B
ventricular	I
hypertrophy	I
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2018	O
-	O
10	O
-	O
12	O
*	O
*	O
]	O
no	O
diagnostic	O
interim	O
change	O
.	O

tracing	O
#1	O

101538	O
||||	O
9665	O
||||	O
18338	O
||||	O
echo	O
_	O
report	O
||||	O
2018	O
-	O
09	O
-	O
28	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
hypertension	B
.	O

left	B
ventricular	I
function	I
.	O

height	O
:	O
(	O
in	O
)	O
61	O

weight	O
(	O
lb	O
)	O
:	O
154	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
69	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
182	O
/	O
71	O

hr	O
(	O
bpm	O
)	O
:	O
75	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2018	O
-	O
09	O
-	O
28	O
*	O
*	O
]	O
at	O
16	O
:	O
23	O

test	O
:	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
mild	O
la	B
enlargement	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

left	O
ventricle	O
:	O
mild	O
symmetric	O
lvh	B
with	O
normal	O
cavity	O
size	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

normal	O
regional	O
lv	O
systolic	O
function	O
.	O

no	O
resting	B
lvot	I
gradient	I
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	I
valve	I
leaflets	I
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

mild	O
to	O
moderate	O
(	O
[	O
*	O
*	O
02	O
-	O
19	O
*	O
*	O
]	O
+	O
)	O

mr	B
.	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
36	O
*	O
*	O
]	O
lv	O
inflow	O
pattern	O
for	O
age	O
.	O

tricuspid	O
valve	O
:	O
mildly	O
thickened	O
tricuspid	O
valve	O
leaflets	O
.	O

mild	O
[	O
1	O
+	O
]	O
tr	B
.	O

moderate	O
pa	O
systolic	B
hypertension	I
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
no	O
ps	B
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
with	O
normal	O
cavity	O
size	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

regional	O
left	O
ventricular	O
wall	O
motion	O
is	O
normal	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	O
but	O
aortic	B
stenosis	I
is	O
not	O
present	O
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mild	O
to	O
moderate	O
(	O
[	O
*	O
*	O
02	O
-	O
19	O
*	O
*	O
]	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

416048	O
||||	O
9775	O
||||	O
2193	O
||||	O
radiology	O
_	O
report	O
||||	O
2013	O
-	O
02	O
-	O
15	O
20	O
:	O
19	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
335	O
-	O
3181	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2013	O
-	O
02	O
-	O
15	O
*	O
*	O
]	O
8	O
:	O
19	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
3020	O
*	O
*	O
]	O
reason	O
:	O
sp	O
re	O
intubation	O
admitting	O
diagnosis	O
:	O
sah	B
;	O
telemetry	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

35	O
year	O
old	O
man	O
with	O
chi	B
with	O
fever	B
and	O
purulent	B
sputum	I

reason	O
for	O
this	O
examination	O
:	O

sp	O
re	O
intubation	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
chi	B
with	O
fever	B
and	O
purulent	B
sputum	I
,	O
status	O
post	O
reintubation	O
.	O

comparison	O
is	O
made	O
to	O
a	O
prior	O
study	O
of	O
[	O
*	O
*	O
2013	O
-	O
02	O
-	O
11	O
*	O
*	O
]	O
.	O

chest	O
ap	O
semiupright	O
done	O
on	O
[	O
*	O
*	O
2013	O
-	O
02	O
-	O
15	O
*	O
*	O
]	O
at	O
2018	O
hours	O
.	O

findings	O
:	O
the	O
top	O
of	O
the	O
chest	O
has	O
been	O
excluded	O
from	O
the	O
film	O
.	O

the	O
external	O
support	O
tubes	O
(	O
the	O
right	O
subclavian	O
line	O
,	O
ett	O
and	O
ng	O
tube	O
)	O
are	O
in	O
good	O
position	O
as	O
described	O
earlier	O
.	O

note	O
is	O
made	O
of	O
a	O
new	O
infiltrate	B
in	O
the	O
right	O
lung	O
base	O
.	O

the	O
heart	O
and	O
mediastinal	O
contours	O
are	O
normal	O
.	O

the	O
osseous	O
structures	O
are	O
unremarkable	O
.	O

impression	O
:	O
findings	O
compatible	O
with	O
pneumonia	O
in	O
the	O
right	O
lung	O
base	O
.	O

257487	O
||||	O
9963	O
||||	O
24985	O
||||	O
radiology	O
_	O
report	O
||||	O
2014	O
-	O
08	O
-	O
22	O
15	O
:	O
18	O
:	O
00	O
.	O
0	O
||||	O
c91	O
chest	O
port	O
.	O

line	O
placement	O
||||	O
||||	O
clip	O
#	O
380	O
-	O
3850	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2014	O
-	O
08	O
-	O
22	O
*	O
*	O
]	O
3	O
:	O
18	O
pm	O

chest	O
port	O
.	O

line	O
placement	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
4882	O
*	O
*	O
]	O
reason	O
:	O
eval	O
rsc	O
line	O
placement	O
admitting	O
diagnosis	O
:	O
crohn's	B
disease	I
/	O
sda	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

50	O
year	O
old	O
man	O
with	O
s	O
/	O
p	O
ex	O
lap	O
reason	O
for	O
this	O
examination	O
:	O
eval	O
rsc	O
line	O
placement	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

portable	O
chest	O
,	O
[	O
*	O
*	O
2014	O
-	O
08	O
-	O
22	O
*	O
*	O
]	O
with	O
no	O
prior	O
films	O
for	O
comparison	O
.	O

indication	O
:	O
line	O
placement	O
.	O

a	O
right	O
internal	O
jugular	O
vascular	O
catheter	O
is	O
in	O
satisfactory	O
position	O
within	O
the	O
superior	O
vena	O
cava	O
.	O

there	O
is	O
no	O
pneumothorax	B
.	O

an	O
endotracheal	O
tube	O
terminates	O
approximately	O
3	O
-	O
1	O
/	O
2	O
cm	O
above	O
the	O
carina	O
and	O
a	O
nasogastric	O
tube	O
terminates	O
in	O
the	O
stomach	O
with	O
the	O
tip	O
directed	O
cephalad	O
in	O
the	O
fundus	O
.	O

the	O
heart	O
is	O
mildly	O
enlarged	O
.	O

pulmonary	O
vascularity	O
is	O
normal	O
for	O
technique	O
.	O

very	O
minimal	O
atelectatic	B
changes	I
are	O
noted	O
at	O
the	O
lung	O
bases	O
with	O
otherwise	O
clear	O
lungs	O
.	O

impression	O
:	O
central	O
venous	O
catheter	O
in	O
satisfactory	O
position	O
with	O
no	O
pneumothorax	B
.	O

12638	O
||||	O
10101	O
||||	O
10901	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
03	O
-	O
16	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
16	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1943	O
-	O
07	O
-	O
11	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

morphine	O
/	O
vicodin	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
2438	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

fatigue	B
and	O
weakness	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

72	O
y	O
/	O
o	O
male	O
with	O
pmhx	O
of	O
nsclc	B
,	O
pe	B
,	O
who	O
presented	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
03	O
-	O
14	O
*	O
*	O
]	O
with	O
generally	O
increasing	O
fatigue	B
and	O
tachypnea	B
.	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
,	O
he	O
underwent	O
cta	O
chest	O
and	O
abdomen	O
which	O
no	O
pe	B
but	O
marked	O
progression	O
of	O
metastatic	B
disease	I
including	O
innumerable	O
new	O
metastases	O
in	O
the	O
lungs	O
and	O
liver	O
and	O
increased	O
size	O
of	O
metastases	O
in	O
the	O
adrenals	O
,	O
kidneys	O
,	O
mesentary	O
,	O
soft	O
tissues	O
.	O

he	O
had	O
negative	O
ct	O
head	O
and	O
ekg	O
.	O

his	O
hematocrit	O
was	O
26	O
from	O
baseline	O
around	O
30	O
,	O
and	O
inr	O
was	O
3	O
.	O
6	O
on	O
admission	O
.	O

he	O
received	O
ffp	O
,	O
1	O
unit	O
prbc	O
,	O
and	O
a	O
dose	O
of	O
cefepime	O
vanc	O
.	O

due	O
to	O
slightly	O
low	B
blood	I
pressure	I
,	O
the	O
patient	O
was	O
also	O
given	O
steroids	O
and	O
1l	O
ns	O
and	O
admitted	O
to	O
the	O
ficu	O
.	O

in	O
the	O
icu	O
,	O
his	O
hct	B
improved	I
and	O
bp	O
remained	O
stable	O
in	O
the	O
100's	O
,	O
and	O
hr	O
in	O
the	O
90	O
-	O
100's	O
.	O

egd	O
or	O
further	O
gi	O
workup	O
was	O
refused	O
.	O

oncology	O
came	O
to	O
meet	O
with	O
the	O
patient	O
and	O
his	O
family	O
,	O
and	O
decided	O
that	O
focusing	O
goals	O
of	O
care	O
on	O
comfort	O
was	O
most	O
appropriate	O
.	O

he	O
was	O
made	O
dnr	B
/	O
dni	B
but	O
medications	O
were	O
continued	O
,	O
and	O
he	O
was	O
admitted	O
to	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
595	O
*	O
*	O
]	O
.	O

ros	O
:	O
he	O
denies	O
chest	B
pain	I
,	O
shortness	B
of	I
breath	I
.	O

he	O
does	O
feel	O
somewhat	O
fatigued	B
.	O

he	O
reports	O
some	O
right	O
flank	O
/	O
back	B
pain	I
,	O
[	O
*	O
*	O
08	O
-	O
29	O
*	O
*	O
]	O
before	O
receiving	O
iv	O
dialudid	O
.	O

he	O
denies	O
other	O
concerns	O
.	O

onc	O
history	O
:	O
initially	O
found	O
to	O
have	O
a	O
large	O
right	O
sided	O
mass	B
on	O
cxr	O
in	O
10	O
/	O
06	O
performed	O
for	O
1	O
month	O
history	O
of	O
cough	B
.	O

ct	O
scan	O
confirmed	O
the	O
mass	B
and	O
biopsy	O
of	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
2439	O
*	O
*	O
]	O
nodes	O
were	O
suspicious	O
,	O
but	O
fna	O
of	O
the	O
primary	O
mass	B
showed	O
likely	O
nsclc	B
.	O

pet	O
showed	O
abnormality	B
on	O
the	O
right	O
thyroid	O
.	O

he	O
started	O
radiation	O
therapy	O
in	O
11	O
/	O
06	O
and	O
started	O
cycle	O
1	O
of	O
cisplatin	O
/	O
etoposide	O
in	O
12	O
/	O
06	O
and	O
cycle	O
2	O
in	O
1	O
/	O
07	O
.	O

he	O
completed	O
xrt	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
.	O

he	O
was	O
hospitalized	O
for	O
chest	B
pain	I
and	O
found	O
to	O
have	O
a	O
pe	B
in	O
1	O
/	O
07	O
,	O
and	O
started	O
on	O
coumadin	O
.	O

pet	O
scan	O
in	O
2	O
/	O
06	O
demonstrated	O
metastatic	B
disease	I
to	O
the	O
adrenals	O
,	O
so	O
he	O
was	O
changed	O
to	O
taxotere	O
therapy	O
in	O
3	O
/	O
07	O
which	O
he	O
tolerated	O
reasonably	O
well	O
.	O

past	O
medical	O
history	O
:	O

pmh	O
:	O

1	O
.	O
nsclc	B
-	O
former	O
smoker	O
,	O
originally	O
presented	O
to	O
pcp	O
[	O
*	O
*	O
09	O
-	O
24	O
*	O
*	O
]	O
with	O
cough	B
x	O
1	O
mo	O
.	O
,	O
cxr	O
with	O
lg	O
r	O
-	O
lung	B
mass	I
,	O
ct	O
showed	O
right	O
upper	O
lobe	O
posterior	O
segment	O
mass	B
abutting	O
the	O
chest	O
wall	O
but	O
not	O
invading	O
with	O
an	O
enlarged	O
upper	O
r	O
paratracheal	O
node	O
and	O
lower	O
r	O
paratracheal	O
node	O
,	O
s	O
/	O
p	O
tbna	O
of	O
mediastinal	B
lad	I
[	O
*	O
*	O
10	O
-	O
14	O
*	O
*	O
]	O
showing	O
highly	B
atypical	I
cells	I
suggestive	O
of	O
nsclc	B
and	O
ct	O
-	O
guided	O
biopsy	O
of	O
the	O
lung	B
mass	I
[	O
*	O
*	O
10	O
-	O
21	O
*	O
*	O
]	O
confirming	O
nsclc	B
,	O
mri	O
brain	O
negative	O
for	O
met	B
,	O
s	O
/	O
p	O
2	O
cycles	O
of	O
cisplatinum	O
/	O
etoposide	O
+	O
xrt	O
(	O
completed	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
28	O
*	O
*	O
]	O
)	O
.	O

had	O
pet	O
scan	O

2	O
.	O
htn	B
-	O
per	O
son	O
used	O
to	O
be	O
on	O
meds	O
but	O
has	O
been	O
normotensive	O

3	O
.	O
hypercholesterolemia	B

4	O
.	O
lbp	B

social	O
history	O
:	O

sh	O
:	O
born	O
in	O
[	O
*	O
*	O
country	O
2440	O
*	O
*	O
]	O
,	O
lives	O
in	O
montreal	O
,	O
[	O
*	O
*	O
ethnicity	O
2441	O
*	O
*	O
]	O
citizen	O
,	O
3	O
children	O
who	O
live	O
in	O
the	O
area	O
.	O

retired	O
owner	O
of	O
a	O
restaurant	O
.	O

primarily	O
speaks	O
[	O
*	O
*	O
ethnicity	O
2442	O
*	O
*	O
]	O
,	O
speaks	O
little	O
english	O
.	O
+	O
remote	O
tobacco	O
,	O
40pk	O
-	O
yr	O
,	O
quit	O
at	O
age	O
36	O
,	O
extensive	O
passive	O
exposure	O
at	O
the	O
restaurant	O
.	O

no	O
asbestos	B
exposure	I
.	O

family	O
history	O
:	O

fh	O
:	O
no	O
history	O
of	O
malignancy	B
.	O

physical	O
exam	O
:	O

v	O
:	O
96	O
.	O
5	O
bp	O
120	O
/	O
60	O
hr	O
106	O
r	O
18	O
sat	O
98%	O
2l	O
,	O
93%	O
ra	O

gen	O
:	O
72	O
yo	O
m	O
sitting	O
in	O
a	O
chair	O
,	O
nad	B
,	O
comfortable	O

heent	O
:	O
at	O
/	O
nc	O
,	O
eomi	O
,	O
perrla	O
,	O
anicteric	O
,	O
mmm	O

neck	O
:	O
supple	O
no	O
jvd	B

lungs	O
:	O
decreased	B
bs	I
at	O
l	O
base	O
,	O
o	O
/	O
w	O
ctab	O
no	O
w	B
/	O
r	B
/	O
r	B

abd	O
:	O
soft	O
,	O
obese	O
,	O
nd	O
/	O
nt	O
+	O
bs	O

ext	O
:	O
trace	O
to	O
1	O
+	O
pretibial	O
edema	B
,	O
wwp	O
,	O
good	O
pulses	O

neuro	O
:	O
a&ox3	O
.	O

mild	O
intention	B
tremor	I
.	O

cn	O
ii	O
-	O
xii	O
in	O
tact	O
.	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2016	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
11	O
:	O
15am	O
pt	O
-	O
33	O
.	O
4	O
*	O
ptt	O
-	O
33	O
.	O
5	O
inr	O
(	O
pt	O
)	O
-	O
3	O
.	O
6	O
*	O

[	O
*	O
*	O
2016	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
11	O
:	O
15am	O
wbc	O
-	O
26	O
.	O
3	O
*	O
rbc	O
-	O
3	O
.	O
18	O
*	O
hgb	O
-	O
9	O
.	O
6	O
*	O
hct	O
-	O
30	O
.	O
5	O
*	O
mcv	O
-	O
96	O
mch	O
-	O
30	O
.	O
3	O
mchc	O
-	O
31	O
.	O
5	O
rdw	O
-	O
20	O
.	O
1	O
*	O

[	O
*	O
*	O
2016	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
11	O
:	O
15am	O
neuts	O
-	O
75	O
*	O
bands	O
-	O
9	O
*	O
lymphs	O
-	O
3	O
*	O
monos	O
-	O
9	O
eos	O
-	O
2	O
basos	O
-	O
0	O
atyps	O
-	O
1	O
*	O
metas	O
-	O
0	O
myelos	O
-	O
1	O
*	O

[	O
*	O
*	O
2016	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
11	O
:	O
53am	O
lactate	O
-	O
2	O
.	O
3	O
*	O

[	O
*	O
*	O
2016	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
04	O
:	O
46pm	O
ck	O
-	O
mb	O
-	O
notdone	O
ctropnt	O
-	O
<0	O
.	O
01	O

[	O
*	O
*	O
2016	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
12	O
:	O
55pm	O
glucose	O
-	O
137	O
*	O
urea	O
n	O
-	O
24	O
*	O
creat	O
-	O
0	O
.	O
7	O
sodium	O
-	O
126	O
*	O
potassium	O
-	O
4	O
.	O
6	O
chloride	O
-	O
94	O
*	O
total	O
co2	O
-	O
22	O
anion	O
gap	O
-	O
15	O

[	O
*	O
*	O
2016	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
11	O
:	O
36pm	O
urine	O
osmolal	O
-	O
234	O

brief	O
hospital	O
course	O
:	O

72	O
y	O
/	O
o	O
m	O
with	O
pmhx	O
of	O
ncslc	B
who	O
presents	O
with	O
increased	O
weakness	B
and	O
fatigue	B
with	O
progressive	O
lung	B
cancer	I
.	O

the	O
patient	O
had	O
a	O
brief	O
stay	O
in	O
the	O
ficu	O
and	O
was	O
transferred	O
to	O
the	O
floor	O
after	O
the	O
goals	O
of	O
care	O
were	O
transitioned	O
to	O
a	O
goal	O
for	O
a	O
move	O
to	O
hospice	O
.	O

he	O
arrived	O
on	O
the	O
floor	O
on	O
[	O
*	O
*	O
03	O
-	O
15	O
*	O
*	O
]	O
,	O
vitals	O
were	O
stable	O
.	O

overnight	O
,	O
the	O
patient	O
had	O
increased	O
work	B
of	I
breathing	I
and	O
became	O
diaphoretic	B
and	O
tachycardic	B
and	O
with	O
the	O
family	O
and	O
attending's	O
involvement	O
,	O
the	O
goal	O
of	O
care	O
became	O
comfort	B
measures	I
only	I
.	O

the	O
patient	O
passed	O
away	O
at	O
11	O
:	O
52am	O
on	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
16	O
*	O
*	O
]	O
.	O

medications	O
on	O
admission	O
:	O

home	O
meds	O
:	O

pantoprazole	O

docusate	O
sodium	O
100	O
mg	O
po	O
bid	O

senna	O
8	O
.	O
6	O
mg	O
po	O
bid	O

acetaminophen	O
325	O
mg	O

hydromorphone	O
2	O
mg	O
prn	O
q4	O
-	O
6	O

fentanyl	O
25	O
mcg	O
/	O
hr	O
patch	O
72hr	O

coumadin	O
2	O
.	O
5	O
mg	O
/	O
5mg	O
alternate	O
days	O
qhs	O

florinef	O
0	O
.	O
1	O

decadron	O
4	O
qd	O

meds	O
on	O
transfer	O

hydromorphone	O
(	O
dilaudid	O
)	O
2	O
-	O
4	O
mg	O
po	O
q4	O
-	O
6h	O
:	O
prn	O

dexamethasone	O
4	O
mg	O
po	O
daily	O

docusate	O
sodium	O
100	O
mg	O
po	O
bid	O

pantoprazole	O
40	O
mg	O
po	O
q24h	O

fentanyl	O
patch	O
50	O
mcg	O
/	O
hr	O
tp	O
q72h	O

senna	O
1	O
tab	O
po	O
bid	O
:	O
prn	O

fludrocortisone	O
acetate	O
0	O
.	O
1	O
mg	O
po	O
daily	O

discharge	O
medications	O
:	O

none	O

discharge	O
disposition	O
:	O

expired	O

discharge	O
diagnosis	O
:	O

non	B
small	I
cell	I
lung	I
cancer	I

discharge	O
condition	O
:	O

expired	O

discharge	O
instructions	O
:	O

n	O
/	O
a	O

followup	O
instructions	O
:	O

n	O
/	O
a	O

[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2443	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
423	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
424	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
425	O
*	O
*	O
]	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
16	O
*	O
*	O
]	O
@	O
1457	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
16	O
*	O
*	O
]	O
5	O
:	O
07	O
pm	O

(	O
end	O
of	O
report	O
)	O

289890	O
||||	O
10124	O
||||	O
11355	O
||||	O
radiology	O
_	O
report	O
||||	O
2016	O
-	O
04	O
-	O
11	O
12	O
:	O
20	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
432	O
-	O
5910	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2016	O
-	O
04	O
-	O
11	O
*	O
*	O
]	O
12	O
:	O
20	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
6247	O
*	O
*	O
]	O
reason	O
:	O
effusion?	O
infiltrate?	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

83	O
year	O
old	O
woman	O
with	O
low	B
sats	I
and	O
shortness	B
of	I
breath	I
reason	O
for	O
this	O
examination	O
:	O
effusion?	O
infiltrate?	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
83	O
-	O
year	O
-	O
old	O
woman	O
with	O
hypoxia	B
and	O
shortness	B
of	I
breath	I
.	O

previous	O
ascending	O
and	O
descending	O
dissection	O
.	O

comparison	O
:	O
cta	O
of	O
the	O
chest	O
from	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
01	O
*	O
*	O
]	O
,	O
chest	O
x	O
-	O
rays	O
from	O
[	O
*	O
*	O
08	O
-	O
17	O
*	O
*	O
]	O
,	O
2005	O
and	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
28	O
*	O
*	O
]	O
.	O

portable	O
ap	O
upright	O
chest	O
:	O
again	O
seen	O
is	O
an	O
enlarged	O
tortuous	B
thoracic	I
aorta	I
with	O
abnormally	O
located	O
calcifications	B
,	O
unchanged	O
in	O
appearance	O
since	O
[	O
*	O
*	O
2013	O
*	O
*	O
]	O
.	O

several	O
median	O
sternotomy	O
wires	O
are	O
again	O
seen	O
,	O
with	O
fracture	O
of	O
the	O
second	O
most	O
superior	O
wire	O
,	O
also	O
unchanged	O
.	O

heart	O
size	O
is	O
enlarged	O
but	O
stable	O
.	O

no	O
new	O
consolidation	B
is	O
identified	O
.	O

no	O
pulmonary	O
vascular	O
engorgement	B
is	O
identified	O
.	O

no	O
pleural	B
effusions	I
are	O
clearly	O
seen	O
.	O

impression	O
:	O
overall	O
stable	O
appearance	O
to	O
the	O
chest	O
.	O

a	O
pa	O
and	O
lateral	O
chest	O
radiograph	O
is	O
recommended	O
when	O
the	O
patient	O
is	O
able	O
.	O

276335	O
||||	O
10422	O
||||	O
9757	O
||||	O
radiology	O
_	O
report	O
||||	O
2019	O
-	O
06	O
-	O
30	O
17	O
:	O
58	O
:	O
00	O
.	O
0	O
||||	O
c11	O
chest	O
(	O
pa	O
&	O
lat	O
)	O
||||	O
||||	O
clip	O
#	O
407	O
-	O
1173	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2019	O
-	O
06	O
-	O
30	O
*	O
*	O
]	O
5	O
:	O
58	O
pm	O

chest	O
(	O
pa	O
&	O
lat	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
1128	O
*	O
*	O
]	O
reason	O
:	O
possible	O
aspiration	B
event	I
-	O
pt	O
.	O
w	O
/	O
hematemesis	B
intubated	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
1129	O
*	O
*	O
]	O
admitting	O
diagnosis	O
:	O
gastrointestinal	B
bleed	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

66	O
year	O
old	O
man	O
with	O
delta	B
ms	I
,	O
found	B
down	I
,	O
transiently	O
hypoxic	B

reason	O
for	O
this	O
examination	O
:	O

possible	O
aspiration	B
event	I
-	O
pt	O
.	O
w	O
/	O
hematemesis	B
intubated	O
earlier	O
this	O
week	O
.	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

two	O
view	O
chest	O
[	O
*	O
*	O
2019	O
-	O
06	O
-	O
30	O
*	O
*	O
]	O
.	O

comparison	O
:	O
[	O
*	O
*	O
2019	O
-	O
06	O
-	O
28	O
*	O
*	O
]	O
.	O

indication	O
:	O
aspiration	B
event	I
.	O

cardiac	O
silhouette	O
is	O
upper	O
limits	O
of	O
normal	O
in	O
size	O
and	O
stable	O
.	O

bibasilar	O
areas	O
of	O
discoid	B
atelectasis	I
are	O
again	O
demonstrated	O
,	O
likely	O
superimposed	O
upon	O
a	O
more	O
chronic	O
underlying	O
interstitial	B
basilar	I
abnormality	I
as	O
well	O
as	O
underlying	O
upper	O
lobe	O
emphysema	B
.	O

there	O
are	O
no	O
confluent	O
areas	O
of	O
consolidation	B
,	O
and	O
there	O
are	O
no	O
pleural	B
effusions	I
.	O

as	O
compared	O
to	O
the	O
recent	O
study	O
,	O
there	O
has	O
been	O
removal	O
of	O
endotracheal	O
tube	O
and	O
nasogastric	O
tube	O
.	O

impression	O
:	O
bibasilar	O
discoid	B
atelectasis	I
.	O

likely	O
underlying	O
upper	O
lobe	O
emphysema	B
and	O
basilar	O
fibrosis	B
.	O

105794	O
||||	O
10588	O
||||	O
20897	O
||||	O
echo	O
_	O
report	O
||||	O
2013	O
-	O
05	O
-	O
12	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
vf	B
arrest	I
sp	O
resuscitation	O

height	O
:	O
(	O
in	O
)	O
73	O

weight	O
(	O
lb	O
)	O
:	O
190	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
11	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
96	O
/	O
60	O

hr	O
(	O
bpm	O
)	O
:	O
62	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2013	O
-	O
05	O
-	O
12	O
*	O
*	O
]	O
at	O
12	O
:	O
48	O

test	O
:	O
portable	O
tte	O
(	O
focused	O
views	O
)	O

doppler	O
:	O
limited	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
mild	O
la	B
enlargement	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
dilated	B
ivc	I
(	O
>2	O
.	O
5	O
cm	O
)	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
.	O

mild	O
regional	O
lv	B
systolic	I
dysfunction	I
.	O

lv	O
wall	O
motion	O
:	O
regional	O
lv	B
wall	I
motion	I
abnormalities	I
include	O
:	O
mid	O
anterior	O
-	O
hypo	B
;	O
mid	O
anteroseptal	O
-	O
hypo	B
;	O
anterior	O
apex	O
-	O
hypo	B
;	O
remaining	O
lv	O
segments	O
contract	O
normally	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
normal	O
mitral	O
valve	O
leaflets	O
.	O

mild	O
to	O
moderate	O
(	O
[	O
*	O
*	O
03	O
-	O
04	O
*	O
*	O
]	O
+	O
)	O
mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
with	O
trivial	O
tr	B
.	O

indeterminate	O
pa	O
systolic	O
pressure	O
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
emergency	O
study	O
performed	O
by	O
the	O
cardiology	O
fellow	O
on	O
call	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

the	O
inferior	O
vena	O
cava	O
is	O
dilated	O
(	O
>2	O
.	O
5	O
cm	O
)	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

there	O
is	O
mild	O
regional	O
left	B
ventricular	I
systolic	I
dysfunction	I
with	O
hypokinesis	B
of	O
the	O
distal	O
half	O
of	O
the	O
anterior	O
septum	O
and	O
anterior	O
wall	O
.	O

the	O
remaining	O
left	O
ventricular	O
segments	O
contract	O
normally	O
and	O
overall	O
systolic	O
function	O
is	O
low	O
normal	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

mild	O
to	O
moderate	O
(	O
[	O
*	O
*	O
03	O
-	O
04	O
*	O
*	O
]	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
determined	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

imperssion	O
:	O
mild	O
left	B
ventricular	I
systolic	I
dysfunction	I
.	O

mild	O
-	O
moderate	O
mitral	B
regurgitation	I
.	O

47357	O
||||	O
10612	O
||||	O
15922	O
||||	O
ecg	O
_	O
report	O
||||	O
2012	O
-	O
03	O
-	O
12	O
15	O
:	O
43	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

atrial	B
sensed	I
ventricular	O
paced	B

since	O
last	O
ecg	O
,	O
no	O
significant	O
change	O

7491	O
||||	O
10644	O
||||	O
18870	O
||||	O
discharge	O
_	O
summary	O
||||	O
2019	O
-	O
04	O
-	O
04	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
04	O
-	O
04	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1940	O
-	O
12	O
-	O
06	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

amoxicillin	O
/	O
percocet	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
96	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

acute	B
confusional	I
state	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

lumbar	O
puncture	O

mechanical	O
ventillation	O

history	O
of	O
present	O
illness	O
:	O

the	O
patient	O
is	O
a	O
78	O
year	O
old	O
left	O
handed	O
man	O
with	O
hypertension	B
,	O
status	O
post	O
aortic	O
valve	O
replacement	O
in	O
[	O
*	O
*	O
2012	O
*	O
*	O
]	O
(	O
porcine	O
)	O
,	O
hypercholestrolemia	B
,	O
status	O
post	O
partial	O
lung	O
resection	O

[	O
*	O
*	O
2018	O
-	O
12	O
-	O
21	O
*	O
*	O
]	O
,	O
who	O
was	O
brought	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
77	O
*	O
*	O
]	O
[	O
*	O
*	O
03	O
-	O
19	O
*	O
*	O
]	O
after	O
confusion	B
x1	O
day	O
.	O

a	O
fellow	O
priest	O
noted	O
that	O
the	O
patient	O
was	O
confused	B
in	O
the	O
morning	O
of	O
the	O
day	O
of	O
presentation	O
.	O

the	O
confusion	B
progressed	O
and	O
by	O
pm	O
the	O
patient	O
was	O
only	O
able	O
to	O
mumble	B
.	O

he	O
also	O
had	O
an	O
acute	O
onset	O
of	O
frontal	B
headache	I
and	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
156	O
*	O
*	O
]	O
pain	B
that	O
started	O
10	O
hours	O
following	O
the	O
onset	O
of	O
confusion	B
.	O

the	O
pcp	O
was	O
contacted	O
and	O
after	O
evaluation	O
he	O
was	O
brought	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
77	O
*	O
*	O
]	O
per	O
ems	O
.	O

the	O
code	O
stroke	B
team	O
was	O
activated	O
as	O
it	O
was	O
not	O
clear	O
at	O
that	O
time	O
that	O
the	O
confusion	B
had	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
going	O
on	O
for	O
half	O
a	O
day	O
.	O

the	O
patient	O
was	O
noted	O
per	O
[	O
*	O
*	O
doctor	O
first	O
name	O
77	O
*	O
*	O
]	O
note	O
to	O
have	O
phonemic	B
paraphasias	I
,	O
r	B
sided	I
neglect	I
,	O
and	O
?	O

r	B
hemianopsia	I
.	O

nihss~6	O
.	O
a	O
ct	O
head	O
with	O
motion	O
artifact	O
showed	O
no	O
apparent	O
hemorrhage	B
,	O
mass	B
,	O
edema	B
,	O
and	O
no	O
obvious	O
infarct	B
except	O
for	O
a	O
chronic	O
appearing	O
infarct	B
in	O
the	O
l	O
caudate	O
head	O
.	O

at	O
that	O
time	O
,	O
the	O
patient	O
was	O
deemed	O
a	O
candidate	O
for	O
iv	O
tpa	O
.	O

after	O
tpa	O
he	O
was	O
tranferred	O
to	O
the	O
unit	O
for	O
further	O
observation	O
and	O
management	O
.	O

additionally	O
,	O
pt	O
denied	O
ha	B
,	O
diplopia	B
,	O
blurry	B
vision	I
,	O
tinnitus	B
,	O
vertigo	B
,	O
dysphagia	B
,	O
dysarthria	B
,	O
incoordination	B
,	O
focal	B
weakness	I
/	O
numbness	O
.	O

no	O
fever	B
or	O
chills	B
,	O
weight	B
loss	I
,	O
sob	B
,	O
chest	B
pain	I
or	O
pressure	O
,	O
palpitations	B
,	O
nausea	B
,	O
vomitting	B
,	O
abdominal	B
pain	I
,	O
constipation	B
,	O
diarrhea	B
,	O
muscle	B
aches	I
,	O
joint	B
pains	I
,	O
rash	B
or	O
dysuria	B
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
aortic	O
valve	O
replacement	O
/	O
coronary	O
artery	O
bypass	O
graft	O
with	O
lima	O
graft	O
1999	O

2	O
.	O
right	O
-	O
hip	O
replacemt	O
1997	O
with	O
revision	O

3	O
.	O
hypertension	B

4	O
.	O
ankylosing	B
spondylitis	I

5	O
.	O
right	O
thoracoscopy	O
with	O
multiple	O
wedge	O
excisions	O
[	O
*	O
*	O
2018	O
-	O
12	O
-	O
21	O
*	O
*	O
]	O
,	O
with	O
multiple	O
intercostal	O
nerve	O
blocks	O

6	O
.	O
left	B
pleural	I
effusion	I
,	O
trapped	B
left	I
lower	I
lobe	I
(	O
fibrothorax	B
)	O
in	O
09	O
/	O
05	O
7	O
.	O
hypertension	B

social	O
history	O
:	O

[	O
*	O
*	O
hospital1	O
992	O
*	O
*	O
]	O
priest	O
x	O
60	O
[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
993	O
*	O
*	O
]	O
,	O
lives	O
[	O
*	O
*	O
street	O
address	O
994	O
*	O
*	O
]	O
-	O
6th	O
floor	O
-	O
gets	O
meals	O
there	O

is	O
still	O
working	O
as	O
a	O
priest	O
.	O

drinks	O
alcohol	O
socially	O
.	O

family	O
history	O
:	O

non	O
-	O
contributory	O

physical	O
exam	O
:	O

per	O
[	O
*	O
*	O
doctor	O
first	O
name	O
77	O
*	O
*	O
]	O
note	O
:	O

vs	O
:	O
afebrile	O
80s	O
194	O
/	O
90s	O
18	O
95%ra	O

general	O
:	O
wnwd	O
,	O
nad	B

heent	O
:	O
anicteric	O
,	O
mmm	O
without	O
lesions	B
,	O
op	O
clear	O

neck	O
:	O
supple	O
,	O
no	O
lad	B
,	O
no	O
carotid	B
bruits	I
,	O
no	O
thyromegaly	B

cv	O
:	O
rrr	O
s1s2	O
2	O
/	O
6	O
sem	B

resp	O
:	O
ctab	O
no	O
r	B
/	O
w	B
/	O
r	B

abd	O
:	O
+	O
bs	O
soft	O
/	O
nt	O
/	O
nd	O
no	O
hsm	B
/	O
masses	B

ext	O
:	O
no	O
c	B
/	O
c	B
/	O
e	B
,	O
distal	O
pulses	O
intact	O

skin	O
:	O
no	O
rashes	B
,	O
petechiae	B

ms	O
:	O
alert	O
,	O
oriented	O
to	O
person	O
,	O
place	O
,	O
cannot	B
name	I
date	I
,	O
interactive	O
,	O
following	O
most	O
midline	O
and	O
appendicular	O
commands	O
memory	O
[	O
*	O
*	O
04	O
-	O
26	O
*	O
*	O
]	O
immediately	O
&	O
w	O
/	O
o	O
prompting	O
at	O
5	O
minutes	O
difficulty	B
naming	I
and	O
repeating	O
;	O
multiple	O
phonemic	B
paraphsias	I
evidence	O
of	O
r	B
sided	I
neglect	I
with	O
visual	O
and	O
tactile	O
stimulation	O
cn	O
:	O
i	O
-	O
not	O
tested	O
,	O
ii	O
,	O
iii	O
-	O
perrl	O
(	O
[	O
*	O
*	O
05	O
-	O
27	O
*	O
*	O
]	O
bilat	O
)	O
,	O
apparent	O
r	B
hemianopsia	I
versus	O
neglect	B
;	O
iii	O
,	O
iv	O
,	O
vi	O
-	O
eomi	O
though	O
attends	O
moreso	O
to	O
the	O
left	O
,	O
no	O
ptosis	B
,	O
no	O
nystagmus	B
;	O
v	O
-	O
sensation	O
intact	O

to	O
lt	O
/	O
pp	O
,	O
responds	O
to	O
nasal	O
tickle	O
,	O
masseters	O
strong	O
symmetrically	O
;	O
vii	O
-	O
no	O
apparent	O
facial	B
weakness	I
/	O
asymmetry	O
;	O
viii	O
-	O
hears	O
finger	O
rub	O
b	O
;	O
ix	O
,	O
x	O
-	O
voice	O
normal	O
,	O
palate	O
elevates	O
symmetrically	O
,	O
gag	O
intact	O
;	O
xi	O
-	O
scm	O
/	O
trapezii	O
[	O
*	O
*	O
06	O
-	O
28	O
*	O
*	O
]	O
b	O
;	O
xii	O
-	O
tongue	B
protrudes	I
midline	I
,	O
no	O
atrophy	O
or	O
fasciculations	O

motor	O
:	O
nl	O
bulk	O
and	O
tone	O
,	O
no	O
tremor	B
,	O
rigidity	B
or	O
bradykinesia	B
.	O

no	O

pronator	B
drift	I
.	O

deltd	O
bicep	O
tricp	O
ecr	O
/	O
u	O
exdig	O
fldig	O
dorsi	O
opppb	O
axill	O
mscut	O
[	O
*	O
*	O
month	O
/	O
day	O
(	O
1	O
)	O
637	O
*	O
*	O
]	O
[	O
*	O
*	O
name6	O
(	O
md	O
)	O
637	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
637	O
*	O
*	O
]	O
md	O
/	O
ul	O
ulnar	O
medin	O
c5	O
c5	O
-	O
6	O
c7	O
c6	O
-	O
7	O
c7	O
c8	O
t1	O

c8	O
-	O
t1	O

l	O
5	O
5	O
5	O
5	O
5	O
5	O
5	O
5	O

r	O
5	O
5	O
5	O
5	O
5	O
5	O
5	O
5	O

ilpso	O
qufem	O
hamst	O
tiban	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
638	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
185	O
*	O
*	O
]	O
femor	O
femor	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
639	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
640	O
*	O
*	O
]	O
tibil	O
dpper	O
l1	O
-	O
2	O
l3	O
-	O
4	O
l5	O
-	O
s2	O
l4	O
-	O
5	O
s1	O
-	O
2	O
l5	O

l	O
5	O
5	O
5	O
5	O
5	O
5	O

r	O
5	O
5	O
5	O
5	O
5	O
5	O

dtrs	O
:	O
[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
*	O
*	O
]	O
(	O
c56	O
)	O
br	O
(	O
c6	O
)	O
tri	O
(	O
c7	O
)	O
pa	O
(	O
l34	O
)	O
ac	O
(	O
s12	O
)	O
plantar	O
l	O
2	O
2	O
2	O
2	O
2	O
down	O

r	O
2	O
2	O
2	O
2	O
2	O
down	O

sensory	O
:	O
w	O
/	O
d	O
to	O
pinch	O
throughout	O
,	O
though	O
extinguishes	O
to	O
dss	O
on	O
right	O

coord	O
:	O
no	O
apparent	O
dysmetria	B
or	O
ataxia	B
with	O
mvmnts	O

gait	O
:	O
not	O
assessed	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2019	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
10	O
:	O
00pm	O
wbc	O
-	O
6	O
.	O
4	O
rbc	O
-	O
3	O
.	O
95	O
*	O
hgb	O
-	O
12	O
.	O
2	O
*	O
hct	O
-	O
36	O
.	O
7	O
*	O
mcv	O
-	O
93	O
mch	O
-	O
30	O
.	O
8	O
mchc	O
-	O
33	O
.	O
2	O
rdw	O
-	O
13	O
.	O
4	O

[	O
*	O
*	O
2019	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
10	O
:	O
00pm	O
neuts	O
-	O
76	O
*	O
bands	O
-	O
0	O
lymphs	O
-	O
9	O
*	O
monos	O
-	O
13	O
*	O
eos	O
-	O
2	O
basos	O
-	O
0	O
atyps	O
-	O
0	O
metas	O
-	O
0	O
myelos	O
-	O
0	O

[	O
*	O
*	O
2019	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
10	O
:	O
00pm	O
plt	O
count	O
-	O
206	O

[	O
*	O
*	O
2019	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
09	O
:	O
00pm	O
glucose	O
-	O
110	O
*	O
urea	O
n	O
-	O
23	O
*	O
creat	O
-	O
1	O
.	O
0	O
sodium	O
-	O
133	O
potassium	O
-	O
4	O
.	O
6	O
chloride	O
-	O
93	O
*	O
total	O
co2	O
-	O
29	O
anion	O
gap	O
-	O
16	O

[	O
*	O
*	O
2019	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
09	O
:	O
00pm	O
ck	O
(	O
cpk	O
)	O
-	O
104	O

[	O
*	O
*	O
2019	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
09	O
:	O
00pm	O
ck	O
-	O
mb	O
-	O
3	O
ctropnt	O
-	O
<0	O
.	O
01	O

[	O
*	O
*	O
2019	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
08	O
:	O
00pm	O
glucose	O
-	O
112	O
*	O
urea	O
n	O
-	O
23	O
*	O
creat	O
-	O
1	O
.	O
0	O
sodium	O
-	O
132	O
*	O
potassium	O
-	O
4	O
.	O
6	O
chloride	O
-	O
93	O
*	O
total	O
co2	O
-	O
28	O
anion	O
gap	O
-	O
16	O

[	O
*	O
*	O
2019	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
08	O
:	O
00pm	O
pt	O
-	O
11	O
.	O
7	O
ptt	O
-	O
26	O
.	O
4	O
inr	O
(	O
pt	O
)	O
-	O
0	O
.	O
9	O

ct	O
head	O
[	O
*	O
*	O
03	O
-	O
19	O
*	O
*	O
]	O
:	O
these	O
images	O
are	O
all	O
markedly	O
limited	O
by	O
motion	O
artifact	O
in	O
spite	O
of	O
being	O
repeated	O
three	O
additional	O
times	O
.	O

even	O
the	O
last	O
series	O
is	O
significantly	O
limited	O
.	O

however	O
,	O
there	O
is	O
no	O
obvious	O
intracranial	B
hemorrhage	I
.	O

there	O
are	O
mild	O
age	O
-	O
related	O
involutional	O
changes	O
,	O
and	O
greater	O
atrophy	B
within	O
the	O
cerebellum	O
.	O

there	O
is	O
no	O
mass	B
effect	I
,	O
hydrocephalus	B
or	O
shift	O
of	O
the	O
normally	O
midline	O
structures	O
.	O

the	O
gray	O
-	O
white	O
matter	O
differentiation	O
appears	O
preserved	O
but	O
there	O
are	O
hypodensities	B
in	O
the	O
right	O
subinsular	O
cortex	O
,	O
and	O
one	O
in	O
the	O
left	O
subinsular	O
cortex	O
as	O
well	O
as	O
left	O
cerebellum	O
,	O
probably	O
from	O
small	O
prior	B
infarctions	I
.	O

the	O
visualized	O
mastoid	O
air	O
cells	O
and	O
paranasal	O
sinuses	O
are	O
clear	O
.	O

there	O
are	O
calcifications	B
of	O
the	O
vertebral	O
and	O
cavernous	O
carotid	O
arteries	O
.	O

impression	O
:	O
no	O
evidence	O
of	O
intracranial	B
hemorrhage	I
or	O
acute	B
process	I
.	O

ct	O
head	O
[	O
*	O
*	O
03	O
-	O
11	O
*	O
*	O
]	O
:	O

comparison	O
is	O
limited	O
by	O
motion	O
on	O
the	O
prior	O
scan	O
.	O

however	O
,	O
there	O
appears	O
to	O
be	O
a	O
new	O
focus	O
of	O
hyperdensity	B
in	O
a	O
right	O
frontal	O
gyrus	O
(	O
image	O
22	O
)	O
.	O

although	O
partly	O
obscured	O
by	O
motion	O
on	O
the	O
prior	O
study	O
,	O
this	O
focus	O
was	O
not	O
seen	O
previously	O
.	O

a	O
tiny	O
calcification	B
in	O
the	O
left	O
cental	O
sulcus	O
.	O

in	O
retrospect	O
,	O
this	O
focus	O
was	O
probably	O
present	O
on	O
the	O
prior	O
study	O
.	O

there	O
is	O
no	O
evidence	O
of	O
infarction	B
,	O
and	O
there	O
are	O
no	O
other	O
areas	O
of	O
suspicion	O
for	O
hemorrhage	B
.	O

conclusion	O
:	O
possible	O
tiny	O
focus	O
of	O
hemorrhage	B
in	O
the	O
right	O
frontal	O
lobe	O
,	O
possibly	O
an	O
acute	B
bleed	I
.	O

this	O
appears	O
new	O
since	O
[	O
*	O
*	O
2019	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
,	O
but	O
the	O
prior	O
scan	O
was	O
limited	O
by	O
motion	O
.	O

there	O
is	O
a	O
tiny	O
calcification	B
in	O
the	O
left	O
central	O
sulcus	O
.	O

no	O
other	O
evidence	O
of	O
hemorrhage	B
or	O
infarction	B
.	O

cxr	O
:	O
impression	O
:	O
markedly	O
suboptimal	O
film	O
with	O
possible	O
process	O
involving	O
the	O
left	O
parenchymal	O
base	O
.	O

echo	O
:	O
the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

there	O
is	O
asymmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
small	O
.	O

left	O
ventricular	O
systolic	O
function	O
is	O
hyperdynamic	O
(	O
ef	O
70	O
-	O
80%	O
)	O
,	O
with	O
apical	O
cavity	O
obliteration	O
.	O

an	O
apical	O
intracavitary	O
gradient	O
is	O
identified	O
(	O
rest	O
:	O
7	O
mmhg	O
,	O
valsalva	O
:	O
58	O
mmhg	O
)	O
.	O

no	O
masses	O
or	O
thrombi	O
are	O
seen	O
in	O
the	O
left	O
ventricle	O
.	O

there	O
is	O
no	O
ventricular	B
septal	I
defect	I
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

a	O
bioprosthetic	O
aortic	O
valve	O
prosthesis	O
is	O
present	O
.	O

the	O
aortic	O
prosthesis	O
appears	O
well	O
seated	O
,	O
with	O
normal	O
leaflet	O
/	O
disc	O
motion	O
and	O
transvalvular	O
gradients	O
.	O

no	O
masses	B
or	O
vegetations	O
are	O
seen	O
on	O
the	O
aortic	O
valve	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

no	O
mass	B
or	O
vegetation	O
is	O
seen	O
on	O
the	O
mitral	O
valve	O
.	O

the	O
left	B
ventricular	I
inflow	I
pattern	I
suggests	O
impaired	O
relaxation	O
.	O

the	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
mild	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

no	O
vegetation	O
/	O
mass	B
is	O
seen	O
on	O
the	O
pulmonic	O
valve	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

compared	O
with	O
the	O
findings	O
of	O
the	O
prior	O
report	O
(	O
images	O
unavailable	O
for	O
review	O
)	O
of	O
[	O
*	O
*	O
2018	O
-	O
10	O
-	O
25	O
*	O
*	O
]	O
,	O
probably	O
no	O
major	O
change	O
.	O

the	O
absence	O
of	O
a	O
vegetation	B
by	O
2d	O
echocardiography	O
does	O
not	O
exclude	O
endocarditis	B
if	O
clinically	O
suggested	O
.	O

us	O
carotids	O
:	O
40	O
-	O
59%	O
right	O
ica	B
stenosis	I
.	O

less	O
than	O
40%	O
left	O
ica	B
stenosis	I

video	O
swallow	O
[	O
*	O
*	O
2019	O
-	O
04	O
-	O
03	O
*	O
*	O
]	O
:	O

pt	O
presents	O
with	O
a	O
mild	O
oral	O
and	O
pharyngeal	B
dysphagia	I
characterized	O
by	O
mildly	O
reduced	O
oral	B
control	I
,	O
mild	O
swallow	B
delay	I
and	O
delayed	B
laryngeal	I
valve	I
closure	I
.	O

the	O
pt	O
had	O
one	O
episode	O
of	O
trace	O
aspiration	O
when	O
taking	O
a	O
larger	O
sip	O
of	O
thin	O
liquid	O
.	O

aspiration	B
was	O
silent	O
,	O
but	O
cued	O
coughs	B
were	O
effective	O
at	O
clearing	O
the	O
aspirate	O
material	O
.	O

the	O
risk	O
for	O
trace	B
aspiration	I
was	O
reduced	O
by	O
taking	O
single	O
,	O
small	O
sips	O
of	O
thin	O
liquid	O
.	O

the	O
pt	O
was	O
also	O
noted	O
to	O
have	O
increased	O
oral	B
control	I
compared	O
to	O
the	O
last	O
videoswallow	O
and	O
is	O
now	O
able	O
to	O
tolerate	O
a	O
po	O
diet	O
of	O
thin	O
liquids	O
and	O
soft	O
consistency	O
solids	O
.	O

pt	O
should	O
only	O
take	O
single	O
,	O
small	O
sips	O
of	O
thin	O
liquid	O
.	O

pt	O
was	O
unable	O
to	O
swallow	O
the	O
barium	O
tablet	O
whole	O
during	O
the	O
study	O
,	O
and	O
should	O
continue	O
to	O
have	O
his	O
pills	O
crushed	O
with	O
purees	O
.	O

recommendations	O
:	O

1	O
.	O
suggest	O
advancing	O
to	O
a	O
po	O
diet	O
of	O
thin	O
liquids	O
and	O
soft	O
consistency	O
solids	O
.	O

2	O
.	O
pt	O
should	O
only	O
take	O
single	O
,	O
small	O
sips	O
of	O
thin	O
liquid	O
.	O

no	O
straws!	O
3	O
.	O
please	O
crush	O
all	O
pills	O
and	O
give	O
them	O
with	O
purees	O
.	O

brief	O
hospital	O
course	O
:	O

78m	O
with	O
hx	O
of	O
avr	O
/	O
cabg	O
,	O
s	O
/	O
p	O
lung	O
resection	O
who	O
presented	O
to	O
[	O
*	O
*	O
hospital1	O
33	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
03	O
-	O
19	O
*	O
*	O
]	O
with	O
confusion	B
and	O
found	O
to	O
have	O
global	B
aphasia	I
s	O
/	O
p	O
tpa	O
for	O
presumed	O
stroke	B
but	O
no	O
positive	O
imaging	O
who	O
was	O
initially	O
given	O
tpa	O
and	O
admitted	O
to	O
the	O
icu	O
.	O

he	O
was	O
then	O
re	O
-	O
transfered	O
to	O
the	O
icu	O
for	O
acute	O
bradycardia	B
with	O
hypotension	B
and	O
unresponsiveness	B
.	O

the	O
bradycardia	B
and	O
hypotension	B
was	O
felt	O
to	O
be	O
due	O
to	O
iv	O
lopressor	O
effect	O
,	O
and	O
possibly	O
due	O
to	O
pneumonia	B
and	O
sepsis	B
.	O

an	O
abg	O
at	O
that	O
time	O
returned	O
6	O
.	O
94	O
/	O
151	O
/	O
101	O
and	O
he	O
was	O
emergently	O
intubated	O
.	O

femoral	O
central	O
access	O
was	O
obtained	O
and	O
he	O
was	O
transiently	O
on	O
levophed	O
for	O
pressure	O
support	O
.	O

he	O
was	O
intubated	O
from	O
[	O
*	O
*	O
03	O
-	O
25	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
03	O
-	O
28	O
*	O
*	O
]	O
,	O
and	O
his	O
mental	B
status	I
then	O
resolved	O
after	O
treating	O
his	O
hypercapnea	B
and	O
pneumonia	B
.	O

he	O
was	O
continued	O
on	O
a	O
course	O
of	O
levaquin	O
for	O
staph	B
aureus	I
pneumonia	I
,	O
and	O
his	O
mental	B
status	I
remained	O
stable	O
.	O

he	O
was	O
re	O
-	O
evaluated	O
by	O
neurology	O
after	O
his	O
mental	B
status	I
improved	O
and	O
was	O
felt	O
to	O
have	O
no	O
focal	O
neurologic	B
deficits	I
.	O

in	O
fact	O
,	O
there	O
was	O
sufficient	O
doubt	O
as	O
to	O
whether	O
or	O
not	O
he	O
actually	O
had	O
a	O
stroke	B
on	O
presentation	O
since	O
no	O
evidence	O
of	O
a	O
stroke	B
was	O
ever	O
found	O
.	O

his	O
mental	B
status	I
changes	I
may	O
have	O
been	O
due	O
to	O
sepsis	B
and	O
respiratory	B
failure	I
-	O
toxic	O
/	O
metabolic	O
etiologies	O
.	O

for	O
the	O
3	O
-	O
4	O
days	O
prior	O
to	O
discharge	O
his	O
mental	B
status	I
remained	O
clear	O
and	O
he	O
continued	O
to	O
have	O
improving	O
swallowing	B
function	I
.	O

he	O
completed	O
a	O
course	O
of	O
levaquin	O
for	O
his	O
penumonia	B
,	O
and	O
he	O
was	O
afebrile	B
.	O

his	O
code	O
status	O
is	O
dnr	O
/	O
dni	O
.	O

medications	O
on	O
admission	O
:	O

aspirin	O
325mg	O
-	O
-	O
one	O
tablet	O
by	O
mouth	O
every	O
day	O

atenolol	O
25mg	O
-	O
-	O
take	O
[	O
*	O
*	O
02	O
-	O
25	O
*	O
*	O
]	O
tablet	O
daily	O

lipitor	O
20mg	O
-	O
-	O
one	O
tablet	O
by	O
mouth	O
every	O
day	O

naprosyn	O
375mg	O
-	O
-	O
one	O
tablet	O
by	O
mouth	O
every	O
day	O

univasc	O
7	O
.	O
5mg	O
-	O
-	O
one	O
tablet	O
by	O
mouth	O
every	O
day	O

discharge	O
medications	O
:	O

1	O
.	O
acetaminophen	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
fever	B
or	O
pain	B
:	O
not	O
to	O
exceed	O
4g	O
/	O
day	O
.	O

2	O
.	O
aspirin	O
325	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

3	O
.	O
docusate	O
sodium	O
150	O
mg	O
/	O
15	O
ml	O
liquid	O
sig	O
:	O
one	O
(	O
1	O
)	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

4	O
.	O
atorvastatin	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

5	O
.	O
thiamine	O
hcl	O
100	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

6	O
.	O
folic	O
acid	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

7	O
.	O
atenolol	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

8	O
.	O
lisinopril	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

9	O
.	O
multivitamin	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
hospital	O
995	O
*	O
*	O
]	O
friary	O

discharge	O
diagnosis	O
:	O

stroke	B

respiratory	I
failure	I

aspiration	I
pneumonia	I

hypertension	I

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

please	O
follow	O
-	O
up	O
with	O
your	O
primary	O
care	O
doctor	O
or	O
with	O
a	O
new	O
primary	O
care	O
doctor	O
in	O
1	O
-	O
2	O
weeks	O
.	O

followup	O
instructions	O
:	O

please	O
follow	O
-	O
up	O
with	O
your	O
primary	O
care	O
doctor	O
or	O
with	O
a	O
new	O
primary	O
care	O
doctor	O
in	O
1	O
-	O
2	O
weeks	O
.	O

provider	O
:	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
996	O
*	O
*	O
]	O
cc2	O
pulmonary	O
lab	O
-	O
cc2	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
03	O
-	O
25	O
*	O
*	O
]	O
2	O
:	O
30	O

provider	O
:	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
/	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
204	O
*	O
*	O
]	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
896	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
03	O
-	O
25	O
*	O
*	O
]	O
4	O
:	O
00	O

provider	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
,	O
md	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
997	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
04	O
-	O
08	O
*	O
*	O
]	O
9	O
:	O
45	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
108	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
109	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
998	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
999	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1000	O
*	O
*	O
]	O
[	O
*	O
*	O
2019	O
-	O
04	O
-	O
04	O
*	O
*	O
]	O
@	O
1021	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
parks	O
on	O
:	O
sun	O
[	O
*	O
*	O
2019	O
-	O
04	O
-	O
07	O
*	O
*	O
]	O
7	O
:	O
56	O
pm	O

(	O
end	O
of	O
report	O
)	O

107159	O
||||	O
10668	O
||||	O
17610	O
||||	O
echo	O
_	O
report	O
||||	O
2019	O
-	O
03	O
-	O
01	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
aortic	B
valve	I
disease	I
.	O

murmur	B
.	O

height	O
:	O
(	O
in	O
)	O
71	O

weight	O
(	O
lb	O
)	O
:	O
173	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
98	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
118	O
/	O
86	O

hr	O
(	O
bpm	O
)	O
:	O
70	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
03	O
-	O
01	O
*	O
*	O
]	O
at	O
12	O
:	O
38	O

test	O
:	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
mildly	O
dilated	B
ra	I
.	O

left	O
ventricle	O
:	O
severe	O
symmetric	O
lvh	B
.	O

normal	O
lv	O
cavity	O
size	O
.	O

normal	O
regional	O
lv	O
systolic	O
function	O
.	O

overall	O
normal	O
lvef	O
(	O
>55%	O
)	O
.	O

severe	O
resting	B
lvot	I
gradient	I
.	O

findings	O
consistent	O
with	O
hypertrophic	B
obstructive	I
cardiomyopathy	I
(	O
hocm	B
)	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
mildly	O
dilated	B
aortic	I
root	I
.	O

mildly	O
dilated	B
ascending	I
aorta	I
.	O

aortic	O
valve	O
:	O
bicuspid	B
aortic	I
valve	I
.	O

moderately	O
thickened	B
aortic	I
valve	I
leaflets	I
.	O

moderate	O
as	B
.	O

mild	O
(	O
1	O
+	O
)	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

severe	O
mitral	B
annular	I
calcification	I
.	O

trivial	O
mr	B
.	O

lv	O
inflow	O
pattern	O
c	O
/	O
w	O
impaired	B
relaxation	I
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
with	O
trivial	O
tr	B
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

pericardium	O
:	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

1	O
.	O
there	O
is	O
severe	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

regional	O
left	O
ventricular	O
wall	O
motion	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

there	O
is	O
a	O
severe	O
resting	O
left	B
ventricular	I
outflow	I
tract	I
obstruction	I
.	O

the	O
findings	O
are	O
consistent	O
with	O
hypertrophic	B
obstructive	I
cardiomyopathy	I
(	O
hocm	B
)	O
.	O

2	O
.	O
the	O
aortic	O
root	O
is	O
mildly	O
dilated	O
.	O

the	O
ascending	O
aorta	O
is	O
mildly	O
dilated	O
.	O

3	O
.	O
the	O
aortic	O
valve	O
is	O
bicuspid	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened	O
.	O

there	O
is	O
moderate	O
aortic	B
valve	I
stenosis	I
.	O

mild	O
(	O
1	O
+	O
)	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

4	O
.	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
severe	O
mitral	B
annular	I
calcification	I
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

5	O
.	O
there	O
is	O
a	O
trivial	O
pericardial	B
effusion	I
.	O

239022	O
||||	O
10668	O
||||	O
17610	O
||||	O
radiology	O
_	O
report	O
||||	O
2019	O
-	O
02	O
-	O
27	O
19	O
:	O
59	O
:	O
00	O
.	O
0	O
||||	O
c15	O
chest	O
(	O
pre	O
-	O
op	O
pa	O
&	O
lat	O
)	O
||||	O
||||	O
clip	O
#	O
391	O
-	O
5539	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2019	O
-	O
02	O
-	O
27	O
*	O
*	O
]	O
7	O
:	O
59	O
pm	O

chest	O
(	O
pre	O
-	O
op	O
pa	O
&	O
lat	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
3539	O
*	O
*	O
]	O
reason	O
:	O
cholangitisepsis	B

admitting	O
diagnosis	O
:	O
cholangitisepsis	B

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

52	O
year	O
old	O
man	O
with	O
reason	O
for	O
this	O
examination	O
:	O
pre	O
-	O
op	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

pa	O
and	O
lateral	O
chest	O
from	O
[	O
*	O
*	O
02	O
-	O
27	O
*	O
*	O
]	O

history	O
:	O
cholangitis	B
and	O
sepsis	B
.	O

impression	O
:	O
pa	O
and	O
lateral	O
chest	O
reviewed	O
in	O
the	O
absence	O
of	O
prior	O
chest	O
radiographs	O
:	O

frontal	O
view	O
shows	O
a	O
second	O
mediastinal	B
contour	I
parallel	O
to	O
the	O
aortic	O
knob	O
bridged	O
by	O
a	O
curvilinear	O
calcification	B
from	O
the	O
base	O
of	O
the	O
arch	O
.	O

this	O
is	O
likely	O
to	O
be	O
a	O
aortic	B
aneurysm	I
conceivably	O
in	O
association	O
with	O
dissection	B
and	O
,	O
given	O
the	O
superior	O
extent	O
,	O
probably	O
involving	O
the	O
origin	O
of	O
head	O
and	O
neck	O
vessels	O
.	O

elevation	O
of	O
the	O
lateral	O
aspect	O
of	O
the	O
left	O
hemidiaphragm	O
and	O
curvilinear	O
infrahilar	B
opacification	I
of	O
the	O
left	O
lower	O
lung	O
seen	O
on	O
the	O
lateral	O
view	O
probably	O
represent	O
pleural	O
parenchymal	B
scarring	I
.	O

there	O
is	O
no	O
indication	O
of	O
pleural	B
effusion	I
currently	O
.	O

heart	O
is	O
normal	O
size	O
,	O
and	O
there	O
is	O
no	O
pulmonary	B
edema	I
.	O

these	O
findings	O
were	O
discussed	O
by	O
telephone	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3540	O
*	O
*	O
]	O
covering	O
for	O
dr	O
.	O
[	O
*	O
*	O
doctor	O
last	O
name	O
3538	O
*	O
*	O
]	O
at	O
the	O
time	O
of	O
dictation	O
.	O

220707	O
||||	O
10691	O
||||	O
27392	O
||||	O
radiology	O
_	O
report	O
||||	O
2014	O
-	O
05	O
-	O
27	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
persantine	O
mibi	O
||||	O
||||	O
clip	O
#	O
433	O
-	O
3340	O
actual	O
report	O
||||	O

persantine	O
mibi	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
3791	O
*	O
*	O
]	O
reason	O
:	O
58	O
y	O
/	O
o	O
woman	O
with	O
dyspnea	B
on	I
exertion	I
,	O
r	O
/	O
o	O
ischemia	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

radiopharmeceutical	O
data	O
:	O

10	O
.	O
9	O
mci	O
tc	O
-	O
99m	O
sestamibi	O
rest	O
(	O
[	O
*	O
*	O
2014	O
-	O
05	O
-	O
27	O
*	O
*	O
]	O
)	O
;	O

33	O
.	O
0	O
mci	O
tc	O
-	O
99m	O
sestamibi	O
stress	O
(	O
[	O
*	O
*	O
2014	O
-	O
05	O
-	O
28	O
*	O
*	O
]	O
)	O
;	O

history	O
:	O

59	O
-	O
year	O
-	O
old	O
woman	O
referred	O
for	O
evaluation	O
of	O
dyspnea	B
.	O

summary	O
of	O
data	O
from	O
the	O
exercise	O
lab	O
:	O

dipyridamole	O
was	O
infused	O
intravenously	O
for	O
4	O
minutes	O
at	O
a	O
dose	O
of	O
0	O
.	O
142	O
mg	O
/	O
kg	O
/	O
min	O
.	O

she	O
had	O
no	O
ischemic	B
symptoms	I
or	O
ecg	B
changes	I
.	O

method	O
:	O

resting	O
perfusion	O
images	O
were	O
obtained	O
with	O
tc	O
-	O
99m	O
sestamibi	O
.	O

tracer	O
was	O
injected	O
approximately	O
one	O
hour	O
prior	O
to	O
obtaining	O
the	O
resting	O
images	O
.	O

two	O
minutes	O
after	O
the	O
cessation	O
of	O
infusion	O
of	O
dipyridamole	O
,	O
approximately	O
three	O
times	O
the	O
resting	O
dose	O
of	O
tc99m	O
sestamibi	O
was	O
administered	O
iv	O
.	O

stress	O
images	O
were	O
obtained	O
approximately	O
one	O
hour	O
following	O
tracer	O
injection	O
.	O

imaging	O
protocol	O
:	O
gated	O
spect	O
.	O

this	O
study	O
was	O
interpreted	O
using	O
the	O
17	O
-	O
segment	O
myocardial	O
perfusion	O
model	O
.	O

interpretation	O
:	O

the	O
image	O
quality	O
is	O
adequate	O
but	O
limited	O
due	O
to	O
breast	B
attenuation	I
.	O

left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

rest	O
and	O
stress	O
perfusion	O
images	O
reveal	O
uniform	O
tracer	O
uptake	O
throughout	O
the	O
left	O
ventricular	O
myocardium	O
.	O

gated	O
images	O
reveal	O
normal	O
wall	O
motion	O
.	O

the	O
calculated	O
left	O
ventricular	O
ejection	O
fraction	O
is	O
72%	O
with	O
an	O
edv	O
of	O
78	O
ml	O
.	O

impression	O
:	O

1	O
.	O
normal	O
myocardial	O
perfusion	O
.	O

2	O
.	O
normal	O
left	O
ventricular	O
cavity	O
size	O
and	O
systolic	O
function	O
.	O

(	O
over	O
)	O

persantine	O
mibi	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
3791	O
*	O
*	O
]	O
reason	O
:	O
58	O
y	O
/	O
o	O
woman	O
with	O
dyspnea	B
on	I
exertion	I
,	O
r	O
/	O
o	O
ischemia	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

(	O
cont	O
)	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
1205	O
*	O
*	O
]	O
[	O
*	O
*	O
initial	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3792	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
approved	O
:	O
fri	O
[	O
*	O
*	O
2014	O
-	O
05	O
-	O
30	O
*	O
*	O
]	O
1	O
:	O
26	O
pm	O

date	O
mailed	O
:	O
[	O
*	O
*	O
2014	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O

radline	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
1	O
)	O
282	O
*	O
*	O
]	O
;	O
a	O
radiology	O
consult	O
service	O
.	O

to	O
hear	O
preliminary	O
results	O
,	O
prior	O
to	O
transcription	O
,	O
call	O
the	O
radiology	O
listen	O
line	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
283	O
*	O
*	O
]	O
.	O

67559	O
||||	O
10906	O
||||	O
1705	O
||||	O
ecg	O
_	O
report	O
||||	O
2011	O
-	O
03	O
-	O
07	O
12	O
:	O
03	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
,	O
rate	O
90	O
.	O

prolonged	B
p	I
-	I
r	I
interval	I
.	O

occasional	O
failure	B
of	I
a	I
-	I
v	I
conduction	I
.	O

thiere	O
are	O
once	O
again	O
st	B
segment	I
elevations	I
in	O
the	O
anterior	O
precordial	O
leads	O
.	O

question	O
recurrent	O
injury	B
/	O
infarction	B
.	O

tracing	O
#4	O

103779	O
||||	O
10907	O
||||	O
555	O
||||	O
echo	O
_	O
report	O
||||	O
2015	O
-	O
04	O
-	O
17	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
pericardial	B
effusion	I
.	O

evaluation	O
of	O
fluid	O
distribution	O
pre	O
tap	O
.	O

height	O
:	O
(	O
in	O
)	O
69	O

weight	O
(	O
lb	O
)	O
:	O
200	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
07	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
142	O
/	O
90	O

hr	O
(	O
bpm	O
)	O
:	O
100	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
17	O
*	O
*	O
]	O
at	O
09	O
:	O
16	O

test	O
:	O
portable	O
tte	O
(	O
focused	O
views	O
)	O

doppler	O
:	O
no	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricle	O
:	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricle	O
:	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

pericardium	O
:	O
there	O
is	O
a	O
large	O
pericardial	B
effusion	I
.	O

there	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

no	O
color	O
doppler	O
was	O
performed	O
making	O
it	O
difficult	O
to	O
assess	O
valvular	B
regurgitation	I
.	O

there	O
is	O
a	O
large	O
circumferential	O
pericardial	B
effusion	I
.	O

there	O
are	O
strands	O
within	O
the	O
pericardial	O
fluid	O
that	O
are	O
most	O
consistent	O
with	O
inflammatory	O
or	O
fibrinous	B
material	I
.	O
there	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade	B
.	O

compared	O
with	O
the	O
findings	O
of	O
the	O
prior	O
study	O
(	O
tape	O
reviewed	O
)	O
of	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
14	O
*	O
*	O
]	O
,	O
the	O
pericardial	B
effusion	I
appears	O
larger	O
.	O

14138	O
||||	O
11439	O
||||	O
29105	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
05	O
-	O
25	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
23	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
25	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1955	O
-	O
01	O
-	O
22	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
60	O
-	O
year	O
-	O
old	O
male	O
with	O
no	O
significant	O
past	O
medical	O
history	O
who	O
was	O
seen	O
initially	O
in	O
the	O
emergency	O
department	O
on	O
[	O
*	O
*	O
05	O
-	O
22	O
*	O
*	O
]	O
after	O
presenting	O
with	O
melena	B
,	O
a	O
syncopal	B
episode	I
,	O
and	O
dyspnea	B
on	I
exertion	I
.	O

the	O
patient	O
described	O
three	O
days	O
of	O
black	O
and	O
tarry	B
stools	I
prior	O
to	O
the	O
[	O
*	O
*	O
05	O
-	O
22	O
*	O
*	O
]	O
emergency	O
room	O
visit	O
.	O

on	O
[	O
*	O
*	O
05	O
-	O
21	O
*	O
*	O
]	O
,	O
he	O
had	O
a	O
syncopal	B
episode	I
while	O
at	O
work	O
and	O
refused	O
transport	O
to	O
the	O
emergency	O
department	O
at	O
that	O
time	O
.	O

on	O
[	O
*	O
*	O
05	O
-	O
22	O
*	O
*	O
]	O
,	O
the	O
patient	O
was	O
seen	O
in	O
his	O
primary	O
care	O
physician's	O
office	O
complaining	O
fatigue	B
and	O
the	O
above	O
symptoms	O
where	O
he	O
was	O
found	O
to	O
be	O
orthostatic	B
and	O
with	O
guaiac	B
-	I
positive	I
stool	I
.	O

after	O
the	O
primary	O
care	O
physician's	O
and	O
wife's	O
urging	O
,	O
the	O
patient	O
agreed	O
to	O
be	O
seen	O
in	O
the	O
emergency	O
department	O
on	O
[	O
*	O
*	O
05	O
-	O
22	O
*	O
*	O
]	O
where	O
vital	O
signs	O
showed	O
a	O
temperature	O
of	O
99	O
.	O
3	O
,	O
heart	O
rate	O
of	O
105	O
,	O
blood	O
pressure	O
of	O
136	O
/	O
74	O
,	O
respiratory	O
rate	O
of	O
22	O
,	O
oxygen	O
saturation	O
of	O
98%	O
on	O
room	O
air	O
.	O

the	O
patient	O
denied	O
chest	B
pain	I
or	O
shortness	B
of	I
breath	I
.	O

however	O
,	O
the	O
patient	O
was	O
found	O
to	O
have	O
a	O
hematocrit	O
of	O
23	O
.	O
2	O
,	O
but	O
the	O
patient	O
refused	O
admission	O
and	O
signed	O
out	O
against	B
medical	I
advice	I
.	O

the	O
patient	O
returned	O
to	O
the	O
emergency	O
department	O
on	O
[	O
*	O
*	O
05	O
-	O
23	O
*	O
*	O
]	O
complaining	O
of	O
weakness	B
,	O
lightheadedness	B
,	O
and	O
continued	O
melena	B
.	O

his	O
hematocrit	O
was	O
found	O
to	O
be	O
20	O
.	O
3	O
.	O

he	O
denied	O
nausea	B
,	O
vomiting	B
,	O
and	O
abdominal	B
pain	I
.	O

an	O
nasogastric	O
lavage	O
was	O
performed	O
which	O
was	O
negative	O
for	O
blood	O
.	O

the	O
patient	O
was	O
transfused	O
with	O
2	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
starting	O
in	O
the	O
emergency	O
department	O
.	O

the	O
gastrointestinal	O
service	O
was	O
consulted	O
,	O
and	O
the	O
patient	O
was	O
taken	O
to	O
the	O
esophagogastroduodenoscopy	O
where	O
four	O
chronic	O
crater	O
nonbleeding	O
ulcers	O
(	O
3	O
mm	O
to	O
7	O
mm	O
)	O
were	O
found	O
in	O
the	O
posterior	O
and	O
distal	O
duodenal	O
bulb	O
.	O

empiric	O

helicobacter	O
pylori	O
therapy	O
was	O
started	O
with	O
protonix	O
40	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
times	O
five	O
days	O
,	O
clarithromycin	O
500	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
times	O
14	O
days	O
,	O
and	O
amoxicillin	O
1	O
g	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
times	O
14	O
days	O
.	O

following	O
esophagogastroduodenoscopy	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
blumgart	O
firm	O
for	O
admission	O
.	O

past	O
medical	O
history	O
:	O
none	O
.	O

medications	O
on	O
admission	O
:	O
none	O
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

social	O
history	O
:	O
the	O
patient	O
is	O
married	O
and	O
lives	O
in	O
[	O
*	O
*	O
location	O
3011	O
*	O
*	O
]	O
.	O

he	O
owns	O
an	O
electronic	O
store	O
.	O

he	O
drinks	O
approximately	O
two	O
to	O
three	O
glasses	O
of	O
wine	O
with	O
meals	O
.	O

no	O
tobacco	O
history	O
.	O

family	O
history	O
:	O
father	O
died	O
of	O
gastrointestinal	B
bleeding	I
.	O

review	O
of	O
systems	O
:	O
review	O
of	O
systems	O
revealed	O
weight	O
stable	O
at	O
160	O
pounds	O
.	O

no	O
fevers	B
,	O
chills	B
,	O
headache	B
,	O
nausea	B
,	O
vomiting	B
,	O
abdominal	B
pain	I
.	O

melena	B
per	O
the	O
history	O
of	O
present	O
illness	O
.	O

lightheadedness	B
,	O
dyspnea	B
on	I
exertion	I
,	O
and	O
syncope	B
all	O
positive	O
(	O
per	O
the	O
history	O
of	O
present	O
illness	O
)	O
.	O

positive	O
postprandial	O
epigastric	B
pain	I
with	O
fatty	O
foods	O
over	O
the	O
past	O
two	O
months	O
.	O

he	O
denies	O
a	O
history	O
of	O
peptic	B
ulcer	I
disease	I
,	O
nonsteroidal	O
antiinflammatory	O
drug	O
use	O
,	O
and	O
aspirin	O
use	O
.	O

physical	O
examination	O
on	O
presentation	O
:	O
temperature	O
of	O
99	O
.	O
1	O
,	O
pulse	O
of	O
60	O
,	O
blood	O
pressure	O
of	O
124	O
/	O
60	O
,	O
respiratory	O
rate	O
of	O
20	O
.	O

in	O
general	O
,	O
a	O
pleasant	O
and	O
attentive	O
male	O
in	O
no	O
apparent	B
distress	I
,	O
spoke	O
in	O
full	O
sentences	O
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
revealed	O
sclerae	O
were	O
clear	O
.	O

conjunctivae	O
were	O
pale	B
.	O

pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

mucous	O
membranes	O
were	O
moist	O
without	O
lesions	B
.	O

heart	O
had	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

no	O
third	B
heart	I
sound	I
or	O
fourth	B
heart	I
sound	I
or	O
murmurs	B
.	O

lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

the	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
.	O

no	O
masses	B
.	O

extremities	O
were	O
pale	B
without	O
edema	B
.	O

neurologically	O
,	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

cranial	O
nerves	O
ii	O
through	O
xii	O
were	O
intact	O
.	O

strength	O
was	O
[	O
*	O
*	O
04	O
-	O
26	O
*	O
*	O
]	O
in	O
the	O
upper	O
and	O
lower	O
extremities	O
bilaterally	O
.	O

sensation	O
was	O
intact	O
to	O
light	O
touch	O
throughout	O
.	O

pertinent	O
laboratory	O
data	O
on	O
presentation	O
:	O
laboratories	O
on	O
admission	O
revealed	O
a	O
white	O
blood	O
cell	O
count	O
of	O
14	O
.	O
8	O
,	O
hematocrit	O
of	O
20	O
.	O
3	O
,	O
platelets	O
of	O
230	O
.	O

inr	O
of	O
1	O
.	O
1	O
,	O
pt	O
of	O
12	O
.	O
6	O
,	O
ptt	O
of	O
23	O
.	O

sodium	O
of	O
137	O
,	O
potassium	O
of	O
3	O
.	O
8	O
,	O
chloride	O
of	O
101	O
,	O
bicarbonate	O
of	O
26	O
,	O
blood	O
urea	O
nitrogen	O
of	O
30	O
,	O
creatinine	O
of	O
0	O
.	O
9	O
,	O
and	O
blood	O
glucose	O
of	O
190	O
.	O

helicobacter	O
pylori	O
antibody	O
test	O
was	O
positive	O
.	O

hospital	O
course	O
by	O
system	O
:	O

1	O
.	O
gastrointestinal	O
:	O
the	O
patient	O
was	O
treated	O
with	O
clarithromycin	O
,	O
amoxicillin	O
,	O
and	O
protonix	O
.	O

as	O
listed	O
in	O
the	O
history	O
of	O
present	O
illness	O
,	O
the	O
helicobacter	O
pylori	O
antibody	O
returned	O
positive	O
.	O

the	O
patient	O
was	O
without	O
abdominal	B
pain	I
,	O
nausea	B
,	O
vomiting	B
,	O
or	O
significant	B
bowel	I
movements	I
during	O
this	O
admission	O
.	O

he	O
tolerated	O
a	O
regular	O
diet	O
by	O
the	O
time	O
of	O
discharge	O
.	O

2	O
.	O
hematology	O
:	O
because	O
of	O
the	O
patient's	O
severe	O
anemia	B
,	O
he	O
was	O
transfused	O
3	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
.	O

on	O
hospital	O
day	O
two	O
,	O
his	O
hematocrit	O
had	O
not	O
increased	O
approximately	O
(	O
20	O
to	O
26	O
following	O
3	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
)	O
.	O

he	O
was	O
transfused	O
a	O
fourth	O
and	O
final	O
unit	O
of	O
packed	O
red	O
blood	O
cells	O
,	O
and	O
his	O
hematocrit	O
was	O
monitored	O
.	O

his	O
hematocrit	O
remained	O
stable	O
throughout	O
the	O
remainder	O
of	O
the	O
admission	O
,	O
and	O
at	O
discharge	O
hematocrit	O
was	O
31	O
.	O
6	O
.	O

condition	O
at	O
discharge	O
:	O
condition	O
on	O
discharge	O
was	O
stable	O
.	O

discharge	O
status	O
:	O
to	O
home	O
.	O

discharge	O
diet	O
:	O
diet	O
as	O
tolerated	O
.	O

discharge	O
activity	O
:	O
activity	O
as	O
tolerated	O
.	O

discharge	O
instructions	O
:	O

1	O
.	O
continue	O
with	O
clarithromycin	O
and	O
amoxicillin	O
for	O
14	O
days	O
.	O

2	O
.	O
continue	O
with	O
protonix	O
40	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
for	O
three	O
days	O
;	O
followed	O
by	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O
for	O
at	O
least	O
six	O
weeks	O
.	O

3	O
.	O
the	O
patient	O
was	O
to	O
follow	O
up	O
with	O
the	O
gastrointestinal	O

clinic	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
monday	O
,	O
[	O
*	O
*	O
06	O
-	O
22	O
*	O
*	O
]	O
,	O
at	O
9	O
:	O
30	O
a	O
.	O
m	O
.	O
,	O
[	O
*	O
*	O
street	O
address	O
*	O
*	O
]	O
,	O
eighth	O
floor	O
;	O
(	O
telephone	O
number	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1770	O
*	O
*	O
]	O
)	O
.	O

4	O
.	O
the	O
patient	O
was	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
1362	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1537	O
*	O
*	O
]	O
(	O
primary	O
care	O
physician	O
)	O
one	O
week	O
following	O
discharge	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
chronic	B
duodenal	I
ulcers	I
.	O

2	O
.	O
anemia	B
.	O

medications	O
on	O
discharge	O
:	O

1	O
.	O
amoxicillin	O
1	O
g	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
(	O
times	O
11	O
days	O
)	O
.	O

2	O
.	O
clarithromycin	O
500	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
(	O
times	O
11	O
days	O
)	O
.	O

3	O
.	O
protonix	O
40	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
times	O
three	O
days	O
;	O
then	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O
for	O
at	O
least	O
six	O
weeks	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1748	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
6268	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
25	O
*	O
*	O
]	O
19	O
:	O
16	O

t	O
:	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
26	O
*	O
*	O
]	O
16	O
:	O
39	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
6269	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
on	O
:	O
sat	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
04	O
*	O
*	O
]	O
8	O
:	O
37	O
pm	O

(	O
end	O
of	O
report	O
)	O

27273	O
||||	O
11762	O
||||	O
13548	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
06	O
-	O
04	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1951	O
-	O
04	O
-	O
06	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
medicine	O

allergies	O
:	O

keflex	O
/	O
penicillins	O
/	O
erythromycin	O
base	O
/	O
demerol	O
/	O
ceclor	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
19	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

syncope	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

63	O
yo	O
female	O
with	O
history	O
of	O
schizoaffective	B
disorder	I
with	O
si	B
,	O
uc	B
s	O
/	O
p	O
sigmoidectomy	O
,	O
copd	B
who	O
was	O
recently	O
admitted	O
[	O
*	O
*	O
date	O
range	O
(	O
1	O
)	O
4225	O
*	O
*	O
]	O
for	O
pneumonia	B
and	O
suicidal	B
ideation	I
.	O

patient	O
presented	O
on	O

[	O
*	O
*	O
2014	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
s	O
/	O
p	O
fall	B
at	O
her	O
group	O
home	O
and	O
found	O
to	O
be	O
hypotensive	B
secondary	O
to	O
dehydration	B
and	O
atenolol	B
intake	I
.	O

of	O
note	O
,	O
she	O
has	O
had	O
multiple	O
admissions	O
in	O
the	O
past	O
for	O
lightheadness	B
and	O
was	O
admitted	O
to	O
[	O
*	O
*	O
hospital1	O
2926	O
*	O
*	O
]	O
for	O
the	O
same	O
complaint	O
from	O
[	O
*	O
*	O
date	O
range	O
(	O
1	O
)	O
4226	O
*	O
*	O
]	O
.	O

at	O
that	O
time	O
the	O
patient	O
fell	B
in	O
the	O
bathroom	O
and	O
hit	O
the	O
back	O
of	O
her	O
head	O
on	O
her	O
bath	O
tub	O
.	O

she	O
recalls	O
having	O
a	O
head	O
ct	O
which	O
was	O
negative	O
.	O

up	O
to	O
and	O
throughout	O
that	O
hospitalization	O
she	O
had	O
nausea	B
and	O
vomiting	B
which	O
only	O
resolved	O
on	O
her	O
day	O
prior	O
to	O
discharge	O
.	O

after	O
discharge	O
she	O
was	O
feeling	O
well	O
and	O
tolerating	O
po's	O
.	O

she	O
had	O
occassional	O
feelings	O
of	O
diziness	B
,	O
but	O
thought	O
it	O
was	O
due	O
to	O
the	O
psychosocial	B
stress	I
over	O
the	O
murder	O
of	O
her	O
grandson's	O
girlfriend	O
.	O

she	O
continued	O
to	O
eat	O
and	O
drink	O
well	O
with	O
no	O
diarrhea	B
,	O
melena	B
,	O
hematochezia	B
.	O

she	O
denied	O
headache	B
but	O
has	O
been	O
taking	O
motrin	O
600mg	O
qid	O
for	O
left	O
hip	B
pain	I
.	O

she	O
decided	O
to	O
take	O
her	O
atenolol	O
which	O
she	O
had	O
taken	O
in	O
the	O
past	O
but	O
was	O
no	O
longer	O
taking	O
on	O
the	O
morning	O
of	O
admission	O
.	O

the	O
diziness	B
progressed	O
and	O
she	O
felt	O
presyncopal	B
and	O
fell	B
onto	O
her	O
backside	O
with	O
her	O
left	O
foot	O
underneath	O
her	O
.	O

she	O
had	O
no	O
fecal	O
or	O
urinary	B
incontinence	I
.	O

in	O
[	O
*	O
*	O
doctor	O
first	O
name	O
45	O
*	O
*	O
]	O
,	O
her	O
sbp	O
was	O
in	O
the	O
70's	O
and	O
she	O
was	O
given	O
1	O
liter	O
fluid	O
with	O
good	O
response	O
.	O

it	O
was	O
initially	O
thought	O
to	O
be	O
due	O
to	O
atenolol	B
ovedose	I
and	O
she	O
was	O
given	O
glucagon	O
and	O
calcium	O
gluconate	O
with	O
no	O
further	O
improvement	O
.	O

pt	O
complained	O
of	O
foot	B
pain	I
and	O
had	O
negative	O
plain	O
x	O
-	O
ray	O
of	O
her	O
foot	O
,	O
but	O
after	O
she	O
was	O
given	O
1mg	O
of	O
morphine	O
her	O
sbp's	B
decreased	I
to	O
to	O
60's	O
which	O
didn't	O
respond	O
to	O
narcan	O
so	O
decision	O
was	O
made	O
for	O
icu	O
admission	O
.	O

patient	O
responded	O
well	O
to	O
ivf	O
in	O
the	O
icu	O
and	O
thought	O
that	O
her	O
symptoms	B
were	O
a	O
combination	O
of	O
atenolol	B
overdose	I
along	O
with	O
dehydration	B
from	O
decrease	O
po	B
intake	I
.	O

past	O
medical	O
history	O
:	O

pmhx	O
:	O

1	O
.	O
copd	B

2	O
.	O
schizoaffective	B
disorder	I

3	O
.	O
ulcerative	B
colitis	I
s	O
/	O
p	O
sigmoidectomy	O
1998	O

4	O
.	O
suicidal	B
ideation	I
(	O
psychiatrist	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
4227	O
*	O
*	O
]	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
4228	O
*	O
*	O
]	O
)	O

5	O
.	O
s	O
/	O
p	O
diverticular	B
rupture	I
with	O
colostomy	O
and	O
reversal	O
of	O
colostomy	O

6	O
.	O
osteoarthritis	B

7	O
.	O
h	O
/	O
o	O
of	O
rheumatic	B
fever	I
with	O
sydenham's	B
chorea	I

8	O
.	O
duodenal	B
ulcer	I

9	O
.	O
orthostatic	B
hypotension	I

social	O
history	O
:	O

she	O
smokes	O
1	O
pack	O
of	O
cigarettes	O
per	O
day	O
and	O
has	O
been	O
doing	O
so	O
for	O
that	O
past	O
50	O
years	O
.	O

she	O
denies	O
any	O
alcohol	O
and	O
illicit	O
drug	O
use	O
.	O

she	O
lives	O
in	O
[	O
*	O
*	O
location	O
4229	O
*	O
*	O
]	O
house	O
in	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
and	O
is	O
on	O
disability	O
.	O

she	O
has	O
one	O
daughter	O
who	O
is	O
on	O
disability	O
for	O
multiple	O
psychiatric	B
illnesses	I
.	O

one	O
son	O
died	O
secondary	O
to	O
drug	B
overdose	I
.	O

family	O
history	O
:	O

daughter	O
-	O
"psychiatric	O
illnesses"	O
,	O

no	O
family	O
hx	O
of	O
cad	B

physical	O
exam	O
:	O

vs	O
:	O
temp	O
98	O
.	O
2	O
,	O
bp	O
126	O
/	O
68	O
,	O
pulse	O
64	O
,	O
rr	O
18	O
,	O
o2	O
sat	O
98%	O
room	O
air	O
gen	O
:	O
comfortable	O
,	O
nad	O

heent	O
:	O
perrla	O
,	O
eomi	O

lungs	O
:	O
cta	O
bilateral	O
,	O
no	O
wheezes	B

heart	O
:	O
s1	O
,	O
s2	O
,	O
rrr	O
,	O
no	O
murmurs	B
,	O
rubs	B
,	O
gallops	B
appreciated	O

abd	O
:	O
soft	O
,	O
nd	O
,	O
nt	O
,	O
no	O
hsm	B
,	O
+	O
bowel	O
sounds	O

extrem	O
:	O
no	O
edema	B
,	O
cyanosis	B
,	O
clubbing	B
;	O
2	O
+	O
pulses	O
symmetrical	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2014	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
48pm	O
lactate	O
-	O
2	O
.	O
4	O
*	O

[	O
*	O
*	O
2014	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
45pm	O
glucose	O
-	O
107	O
*	O
urea	O
n	O
-	O
20	O
creat	O
-	O
1	O
.	O
1	O
sodium	O
-	O
137	O
potassium	O
-	O
3	O
.	O
3	O
chloride	O
-	O
102	O
total	O
co2	O
-	O
27	O
anion	O
gap	O
-	O
11	O

[	O
*	O
*	O
2014	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
45pm	O
tsh	O
-	O
2	O
.	O
9	O

[	O
*	O
*	O
2014	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
45pm	O
cortisol	O
-	O
2	O
.	O
1	O

[	O
*	O
*	O
2014	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
04	O
:	O
12pm	O
blood	O
cortsol	O
-	O
29	O
.	O
6	O
*	O

[	O
*	O
*	O
2014	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
05	O
:	O
27am	O
blood	O
caltibc	O
-	O
226	O
*	O
ferritn	O
-	O
35	O
trf	O
-	O
174	O
*	O

[	O
*	O
*	O
2014	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
05	O
:	O
27am	O
blood	O
albumin	O
-	O
2	O
.	O
7	O
*	O
calcium	O
-	O
7	O
.	O
6	O
*	O
phos	O
-	O
3	O
.	O
9	O
mg	O
-	O
1	O
.	O
8	O
iron	O
-	O
32	O

[	O
*	O
*	O
2014	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
05	O
:	O
18am	O
blood	O
glucose	O
-	O
85	O
urean	O
-	O
11	O
creat	O
-	O
0	O
.	O
6	O
na	O
-	O
137	O
k	O
-	O
4	O
.	O
1	O
cl	O
-	O
108	O
hco3	O
-	O
23	O
angap	O
-	O
10	O

[	O
*	O
*	O
2014	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
05	O
:	O
18am	O
blood	O
wbc	O
-	O
4	O
.	O
2	O
rbc	O
-	O
3	O
.	O
19	O
*	O
hgb	O
-	O
9	O
.	O
9	O
*	O
hct	O
-	O
27	O
.	O
8	O
*	O
mcv	O
-	O
87	O
mch	O
-	O
31	O
.	O
1	O
mchc	O
-	O
35	O
.	O
7	O
*	O
rdw	O
-	O
12	O
.	O
8	O
plt	O
ct	O
-	O
184	O

left	O
foot	O
x	O
-	O
ray	O
:	O
no	O
fracture	O
or	O
dislocation	O

brief	O
hospital	O
course	O
:	O

63	O
yo	O
female	O
with	O
multiple	O
medical	O
problems	O
who	O
presented	O
s	O
/	O
p	O
fall	B
and	O
found	O
to	O
be	O
hypotensive	B
secondary	O
to	O
dehydration	B
and	O
ingestion	B
of	I
atenolol	I
that	O
seemed	O
to	O
have	O
resolved	O
with	O
ivf	O
.	O

1	O
.	O
hypotension	B
:	O

-	O
likely	O
secondary	O
to	O
dehydration	B
as	O
responded	O
well	O
to	O
ivf	O
and	O
did	O
have	O
some	O
acute	B
renal	I
failure	I
that	O
resolved	O
with	O
fluids	O
-	O
could	O
have	O
been	O
superimposed	O
with	O
atenolol	B
overdose	I
although	O
patient	O
denies	O
taking	B
multiple	I
pills	I
.	O

bp	O
and	O
hr	O
have	O
returned	O
to	O
[	O
*	O
*	O
location	O
476	O
*	O
*	O
]	O
by	O
hd#2	O
.	O
will	O
continue	O
to	O
hold	O
atenolol	O
until	O
reevaluation	O
of	O
bp	O
as	O
an	O
outpatient	O
.	O

suggest	O
restarting	O
at	O
a	O
lower	O
dose	O
and	O
titrating	O
up	O
gradually	O
.	O
-	O
has	O
had	O
multiple	O
workups	O
in	O
the	O
past	O
including	O
a	O
pmibi	O
in	O
8	O
/	O
03	O
which	O
was	O
unremarkable	O
.	O

echo	O
done	O
[	O
*	O
*	O
2014	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
showed	O
ef	O
55	O
-	O
60%	O
with	O
mild	O
to	O
moderate	O
ar	B
and	O
mild	O
mr	B
;	O
no	O
evidence	O
of	O
any	O
wall	B
motion	I
abnormalities	I
-	O
was	O
ruled	O
out	O
with	O
3	O
sets	O
of	O
cardiac	O
enzymes	O
-	O
medications	O
adjusted	O
as	O
per	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
120	O
*	O
*	O
]	O
team	O
;	O
avoid	O
narcotics	O

2	O
.	O
heme	O
:	O

-	O
hct	B
drop	I
likely	O
secondary	O
to	O
volume	O
resuscitation	O
-	O
iron	O
studies	O
consistent	O
with	O
deficiency	O
of	O
chronic	B
disease	I
likely	O
from	O
her	O
ulcerative	B
colitis	I
with	O
inappropriately	O
low	O
retic	O
index	O
.	O

guaiac	O
neg	O
on	O
exam	O
.	O

instructed	O
to	O
f	O
/	O
u	O
with	O
pcp	O
for	O
further	O
monitoring	O
.	O

3	O
.	O
copd	B
:	O

-	O
not	O
wheezy	B
at	O
this	O
time	O
and	O
so	O
will	O
continue	O
on	O
outpatient	O
combivent	O
and	O
advair	O
mdi's	O
.	O
-	O
smoking	O
cessation	O
;	O
is	O
on	O
wellbutrin	O
which	O
will	O
facilitate	O
this	O
;	O
cont	O
nicotine	O
patch	O
to	O
prevent	O
withdrawal	O

4	O
.	O
foot	B
pain	I
:	O

-	O
findings	O
not	O
suggestive	O
of	O
severe	O
trauma	B
and	O
plain	O
films	O
show	O
no	O
fracture	B
-	O
continue	O
to	O
treat	O
with	O
ibuprofen	O
around	O
the	O
clock	O
,	O
and	O
tylenol	O
prn	O
,	O
and	O
be	O
gentle	O
with	O
narcotics	O
for	O
risk	O
of	O
hypotension	B
-	O
pt	O
evaluation	O
.	O

is	O
safe	O
to	O
go	O
to	O
home	O
with	O
cane	O
.	O

will	O
arrange	O
vna	O
home	O
pt	O
to	O
work	O
on	O
strength	O
and	O
use	O
of	O
cane	O
.	O

5	O
.	O
schizoaffective	B
d	I
/	I
o	I
:	O

-	O
denies	O
si	B
at	O
this	O
time	O
and	O
denies	O
taking	O
overdose	O
of	O
atenolol	O
-	O
seen	O
by	O
the	O
psychiatry	O
team	O
who	O
recommended	O
to	O
d	O
/	O
c	O
buspirone	O
,	O
reduce	O
trazodone	O
,	O
and	O
reduce	O
risperidone	O
and	O
move	O
it	O
to	O
qhs	O

did	O
not	O
need	O
sitter	O
at	O
any	O
point	O
.	O

no	O
si	B
/	O
ah	B
.	O

6	O
.	O
ulcerative	B
colitis	I
:	O

-	O
denies	O
diarrhea	B
as	O
precipitant	O
for	O
dehydration	B
and	O
labs	O
show	O
no	O
low	O
bicarb	O

-	O
cont	O
on	O
her	O
output	O
mesalamine	O
dose	O
.	O

is	O
guaiac	O
neg	O
.	O

7	O
.	O
renal	O
:	O

-	O
initially	O
presented	O
with	O
acute	B
renal	I
insufficiency	I
secondary	O
to	O
dehydration	B
as	O
resolved	O
with	O
ivf	O
from	O
1	O
.	O
7	O
to	O
0	O
.	O
7	O

medications	O
on	O
admission	O
:	O

1	O
.	O
fluoxetine	O
hcl	O
30mg	O
qd	O

2	O
.	O
bupropion	O
hcl	O
150	O
mg	O
bid	O

4	O
.	O
clonazepam	O
0	O
.	O
5	O
mg	O
tid	O

5	O
.	O
trazodone	O
hcl	O
150	O
mg	O
qhs	O

6	O
.	O
risperidone	O
3mg	O
qhs	O

7	O
.	O
buspirone	O
hcl	O
15mg	O
tid	O

8	O
.	O
mesalamine	O
800mg	O
tid	O

9	O
.	O
ranitidine	O
hcl	O
150	O
mg	O
tid	O

10	O
.	O

fluticasone	O
-	O
salmeterol	O
100	O
-	O
50	O
mcg	O
bid	O

11	O
.	O

pantoprazole	O
sodium	O
40	O
mg	O
qd	O

12	O
.	O

nicotine	O
patch	O

13	O
.	O

combivent	O
103	O
-	O
18	O
mdi	O
qid	O
prn	O

14	O
.	O

tiotropium	O
bromide	O
18	O
mcg	O
qd	O

discharge	O
medications	O
:	O

1	O
.	O
fluoxetine	O
hcl	O
10	O
mg	O
tablet	O
sig	O
:	O
three	O
(	O
3	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
mesalamine	O
400	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

3	O
.	O
albuterol	O
90	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
1	O
-	O
2	O
puffs	O
inhalation	O
every	O
4	O
-	O
6	O
hours	O
as	O
needed	O
for	O
shortness	B
of	I
breath	I
or	O
wheezing	B
.	O

4	O
.	O
atorvastatin	O
calcium	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

5	O
.	O
bupropion	O
hcl	O
150	O
mg	O
tablet	O
sustained	O
release	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
sustained	O
release	O
po	O
bid	O
(	O
)	O
as	O
needed	O
for	O
depression	B
.	O

6	O
.	O
clonazepam	O
0	O
.	O
5	O
mg	O
tablet	O
sig	O
:	O
as	O
directed	O
tablet	O
po	O
as	O

directed	O
as	O
needed	O
:	O
0	O
.	O
5	O
mg	O
by	O
mouth	O
every	O
morning	O

0	O
.	O
5	O
mg	O
by	O
mouth	O
every	O
afternoon	O

1	O
mg	O
by	O
mouth	O
every	O
evening	O
.	O

disp	O
:	O
*	O
120	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

7	O
.	O
risperidone	O
3	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

8	O
.	O
trazodone	O
hcl	O
100	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

9	O
.	O
physical	O
therapy	O
sig	O
:	O
as	O
directed	O
as	O
directed	O
:	O
evaluation	O
and	O
treatment	O
.	O

10	O
.	O

spiriva	O
with	O
handihaler	O
18	O
mcg	O
capsule	O
,	O
w	O
/	O
inhalation	O
device	O
sig	O
:	O
one	O
(	O
1	O
)	O
puff	O
inhalation	O
once	O
a	O
day	O
.	O

11	O
.	O

fluticasone	O
-	O
salmeterol	O
100	O
-	O
50	O
mcg	O
/	O
dose	O
disk	O
with	O
device	O
sig	O
:	O
one	O
(	O
1	O
)	O
puff	O
inhalation	O
twice	O
a	O
day	O
.	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

1	O
)	O
dizziness	B

2	O
)	O
hypotension	B

discharge	O
condition	O
:	O

stable	O
,	O
improved	O
condition	O
from	O
the	O
time	O
of	O
admission	O

discharge	O
instructions	O
:	O

please	O
call	O
your	O
doctor	O
or	O
return	O
to	O
the	O
er	O
if	O
you	O
experience	O
significant	O
dizziness	B
,	O
blurry	B
vision	I
,	O
fainting	B
,	O
chest	B
pain	I
,	O
difficulty	O
with	O
breathing	O
,	O
or	O
falling	B
down	I
.	O

take	O
your	O
medications	O
as	O
prescribed	O
with	O
the	O
following	O
changes	O
:	O

-	O
you	O
should	O
stop	O
taking	O
atenolol	O
and	O
buspar	O
.	O
-	O
your	O
trazodone	O
has	O
been	O
decreased	O
from	O
150mg	O
-	O
-	O
>	O
100mg	O
at	O
bedtime	O
.	O

-	O
you	O
should	O
continue	O
taking	O
risperdal	O
3mg	O
,	O
but	O
take	O
this	O
medication	O
at	O
bedtime	O
instead	O
of	O
taking	O
it	O
in	O
the	O
morning	O
-	O
your	O
klonopin	O
prescription	O
has	O
changed	O
,	O
you	O
will	O
now	O
take	O
0	O
.	O
5mg	O
in	O
the	O
morning	O
and	O
afternoon	O
,	O
and	O
1	O
mg	O
at	O
night	O
.	O

follow	O
up	O
as	O
scheduled	O
below	O
.	O

followup	O
instructions	O
:	O

an	O
appointment	O
has	O
been	O
made	O
for	O
you	O
to	O
follow	O
up	O
with	O
your	O
primary	O
care	O
physician	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
1823	O
*	O
*	O
]	O
,	O
on	O
wednesday	O
,	O
[	O
*	O
*	O
06	O
-	O
11	O
*	O
*	O
]	O
at	O
1	O
:	O
45	O
pm	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
39	O
*	O
*	O
]	O
md	O
,	O
phd	O
12	O
-	O
944	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
328	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2428	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2429	O
*	O
*	O
]	O
[	O
*	O
*	O
2014	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
@	O
1359	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
43	O
*	O
*	O
]	O
yang	O
on	O
:	O
mon	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
14	O
*	O
*	O
]	O
10	O
:	O
43	O
pm	O

(	O
end	O
of	O
report	O
)	O

104538	O
||||	O
11801	O
||||	O
20360	O
||||	O
echo	O
_	O
report	O
||||	O
2014	O
-	O
01	O
-	O
31	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
hypoxia	B
.	O

height	O
:	O
(	O
in	O
)	O
71	O

weight	O
(	O
lb	O
)	O
:	O
206	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
14	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
110	O
/	O
50	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2014	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
at	O
13	O
:	O
55	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
saline	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
a	O
catheter	O
or	O
pacing	O
wire	O
is	O
seen	O
in	O
the	O
right	O
atrium	O
and	O
/	O
or	O
right	O
ventricle	O
.	O

left	O
ventricle	O
:	O
lv	O
systolic	O
function	O
appears	O
depressed	O
.	O

lv	O
wall	O
motion	O
:	O
the	O
following	O
resting	O
regional	O
left	B
ventricular	I
wall	I
motion	I
abnormalities	I
are	O
seen	O
:	O
basal	O
inferoseptal	O
-	O
dyskinetic	B
;	O
mid	O
inferoseptal	O
-	O
hypokinetic	B
;	O
basal	O
inferior	O
-	O
akinetic	B
;	O
mid	O
inferior	O
-	O
akinetic	B
;	O
basal	O
inferolateral	O
-	O
akinetic	B
;	O
mid	O
inferolateral	O
-	O
akinetic	B
;	O

right	O
ventricle	O
:	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
mildly	O
dilated	O
.	O

the	O
ascending	O
aorta	O
is	O
mildly	O
dilated	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

there	O
is	O
no	O
significant	O
aortic	B
valve	I
stenosis	I
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

moderate	O
(	O
2	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
left	B
ventricular	I
inflow	I
pattern	I
suggests	O
delayed	O
relaxation	O
.	O

tricuspid	O
valve	O
:	O
the	O
tricuspid	O
valve	O
leaflets	O
are	O
normal	O
.	O

mild	O
to	O
moderate	O
[	O
[	O
*	O
*	O
02	O
-	O
26	O
*	O
*	O
]	O
+	O
]	O
tricuspid	B
regurgitation	I
is	O
seen	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
the	O
pulmonic	O
valve	O
leaflets	O
appear	O
structurally	O
normal	O
with	O
physiologic	O
pulmonic	B
regurgitation	I
.	O

pericardium	O
:	O
there	O
is	O
an	O
anterior	B
space	I
which	O
most	O
likely	O
represents	O
a	O
fat	O
pad	O
,	O
though	O
a	O
loculated	O
anterior	O
pericardial	B
effusion	I
cannot	O
be	O
excluded	O
.	O

general	O
comments	O
:	O
contrast	O
study	O
was	O
performed	O
with	O
one	O
iv	O
injection	O
of	O
8	O
ccs	O
of	O
agitated	O
normal	O
saline	O
at	O
rest	O
.	O

suboptimal	O
image	O
quality	O
due	O
to	O
poor	O
echo	O
windows	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

lv	O
systolic	O
function	O
appears	O
depressed	O
.	O

resting	O
regional	O
wall	O
motion	O
abnormalities	O
include	O
thinned	O
and	O
akinetic	B
inferior	O
and	O
inferolateral	O
segments	O
with	O
basal	O
inferoseptal	O
dyskinesis	B
and	O
mid	O
inferoseptal	O
hypokinesis	B
/	O
akinesis	B
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
root	O
is	O
mildly	O
dilated	O
.	O

the	O
ascending	O
aorta	O
is	O
mildly	O
dilated	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

there	O
is	O
no	O
significant	O
aortic	B
valve	I
stenosis	I
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

moderate	O
(	O
2	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
left	B
ventricular	I
inflow	I
pattern	I
suggests	O
delayed	O
relaxation	O
.	O

there	O
is	O
at	O
least	O
moderate	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

compared	O
to	O
prior	O
report	O
of	O
[	O
*	O
*	O
2014	O
-	O
01	O
-	O
20	O
*	O
*	O
]	O
,	O
there	O
is	O
probably	O
no	O
significant	O
change	O
.	O

7872	O
||||	O
11823	O
||||	O
13419	O
||||	O
discharge	O
_	O
summary	O
||||	O
2018	O
-	O
02	O
-	O
02	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
30	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1991	O
-	O
11	O
-	O
13	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
685	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

history	O
of	O
seizures	B
;	O
work	O
-	O
up	O
revealed	O
dilated	B
aortic	I
root	I
and	O
left	O
common	B
carotid	I
artery	I
aneurysm	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

ascending	O
aorta	O
-	O
left	O
common	O
carotid	O
artery	O
bypass	O
graft	O
[	O
*	O
*	O
01	O
-	O
30	O
*	O
*	O
]	O

history	O
of	O
present	O
illness	O
:	O

26	O
yo	O
male	O
who	O
developed	O
seizures	B
in	O
12	O
/	O
04	O
.	O

work	O
-	O
up	O
revealed	O
dilated	B
aortic	I
root	I
and	O
left	O
common	B
carotid	I
artery	I
aneursym	I
.	O

referred	O
to	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
for	O
surgical	O
repair	O
.	O

past	O
medical	O
history	O
:	O

seizures	B

gerd	I

left	O
common	B
carotid	I
aneursym	I

social	O
history	O
:	O

lives	O
with	O
parents	O

warehouse	O
worker	O

smokes	O
[	O
*	O
*	O
02	O
-	O
26	O
*	O
*	O
]	O
to	O
one	O
ppd	O
since	O
age	O
20	O

no	O
alcohol	O
use	O

family	O
history	O
:	O

mother	O
had	O
cabg	O

grandmother	O
had	O
cad	B

physical	O
exam	O
:	O

5'8"	O
175	O
#	O

nad	O

warm	O
dry	B
skin	I

no	O
c	B
/	O
c	B
/	O
e	B
with	O
2	O
+	O
bilat	O
.	O
fem	O
/	O
dp	O
/	O
pt	O
pulses	O

perrl	O
,	O
anicteric	O
sclera	O
,	O
op	O
benign	O
,	O
teeth	O
in	O
fair	O
repair	O
left	O
supraclavicular	B
nose	I
versus	O
small	O
mass	O

ctab	O

rrr	O
s1	O
s2	O
with	O
grade	O
[	O
*	O
*	O
02	O
-	O
26	O
*	O
*	O
]	O
/	O
6	O
sem	O

abd	O
unremarkable	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2018	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
04	O
:	O
19am	O
blood	O
wbc	O
-	O
13	O
.	O
3	O
*	O
rbc	O
-	O
2	O
.	O
96	O
*	O
hgb	O
-	O
9	O
.	O
3	O
*	O
hct	O
-	O
24	O
.	O
8	O
*	O
mcv	O
-	O
84	O
mch	O
-	O
31	O
.	O
4	O
mchc	O
-	O
37	O
.	O
5	O
*	O
rdw	O
-	O
12	O
.	O
8	O
plt	O
ct	O
-	O
170	O

[	O
*	O
*	O
2018	O
-	O
01	O
-	O
30	O
*	O
*	O
]	O
01	O
:	O
00pm	O
blood	O
pt	O
-	O
12	O
.	O
8	O
ptt	O
-	O
26	O
.	O
7	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2018	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
04	O
:	O
19am	O
blood	O
plt	O
ct	O
-	O
170	O

[	O
*	O
*	O
2018	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
04	O
:	O
19am	O
blood	O
glucose	O
-	O
102	O
urean	O
-	O
10	O
creat	O
-	O
0	O
.	O
7	O
na	O
-	O
136	O
k	O
-	O
4	O
.	O
4	O
cl	O
-	O
104	O
hco3	O
-	O
25	O
angap	O
-	O
11	O

[	O
*	O
*	O
2018	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
04	O
:	O
19am	O
blood	O
calcium	O
-	O
8	O
.	O
4	O
phos	O
-	O
1	O
.	O
8	O
*	O
mg	O
-	O
1	O
.	O
6	O

[	O
*	O
*	O
2018	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
cxr	O

small	O
left	O
apical	O
pneumothorax	B
unchanged	O
,	O
small	O
bilateral	B
pleural	I
effusions	I
increased	O
slightly	O
.	O

lungs	O
grossly	O
clear	O
.	O

normal	O
postoperative	O
cardiomediastinal	O
silhouette	O
stable	O
.	O

brief	O
hospital	O
course	O
:	O

admitted	O
on	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
30	O
*	O
*	O
]	O
and	O
underwent	O
ascending	O
aorta	O
to	O
left	O
common	O
carotid	O
artery	O
bypass	O
graft	O
with	O
drs	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
and	O
[	O
*	O
*	O
name5	O
(	O
ptitle	O
)	O
*	O
*	O
]	O
.	O

postoperatively	O
he	O
was	O
transferred	O
to	O
the	O
cardiac	O
surgical	O
intensive	O
care	O
unit	O
for	O
monitoring	O
.	O

on	O
postoperative	O
day	O
one	O
,	O
he	O
awoke	O
neurologically	O
intact	O
and	O
was	O
extubated	O
.	O

aspirin	O
and	O
beta	O
blockade	O
were	O
resumed	O
.	O

he	O
was	O
then	O
transferred	O
to	O
the	O
cardiac	O
surgical	O
step	O
down	O
unit	O
for	O
further	O
recovery	O
.	O

he	O
was	O
gently	O
diuresed	O
towards	O
his	O
preoperative	O
weight	O
.	O

his	O
drains	O
were	O
removed	O
per	O
protocol	O
.	O

the	O
physical	O
therapy	O
service	O
was	O
consulted	O
for	O
assistance	O
with	O
his	O
postoperative	O
strength	O
and	O
mobility	O
.	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
2798	O
*	O
*	O
]	O
continued	O
to	O
make	O
steady	O
progress	O
and	O
was	O
discharged	O
to	O
his	O
home	O
on	O
postoperative	O
day	O
three	O
.	O

he	O
will	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
,	O
his	O
cardiologist	O
,	O
his	O
neurologist	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
and	O
his	O
primary	O
care	O
physician	O
as	O
an	O
outpatient	O
.	O

medications	O
on	O
admission	O
:	O

dilantin	O
400	O
/	O
500	O
mg	O
alternating	O

discharge	O
medications	O
:	O

1	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
hydromorphone	O
2	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q2h	O
(	O
every	O
2	O
hours	O
)	O
as	O
needed	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

3	O
.	O
dilantin	O
100	O
mg	O
capsule	O
sig	O
:	O
4	O
tablets	O
on	O
even	O
days	O
(	O
400mg	O
)	O
;	O
5	O
tablets	O
on	O
odd	O
days	O
(	O
500mg	O
)	O
capsules	O
po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
150	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
toprol	O
xl	O
50	O
mg	O
tablet	O
sustained	O
release	O
24hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
sustained	O
release	O
24hr	O
po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
sustained	O
release	O
24hr	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
constipation	O
for	O
1	O
months	O
.	O

disp	O
:	O
*	O
30	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

s	O
/	O
p	O
l	O
common	B
carotid	I
aneurysm	I

seizures	I

heart	I
murmur	I

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

1	O
)	O
no	O
lotions	O
,	O
creams	O
or	O
powders	O
on	O
incision	B
until	O
it	O
has	O
healed	O
.	O

2	O
)	O
may	O
shower	O
over	O
incision	B
and	O
pat	O
dry	O

3	O
)	O
no	O
lifting	O
greater	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O
4	O
)	O
no	O
driving	O
for	O
one	O
month	O

5	O
)	O
monitor	O
wounds	B
for	O
signs	O
of	O
infection	B
.	O

these	O
include	O
redness	B
,	O
drainage	B
or	O
increased	O
pain	B
.	O

6	O
)	O
report	O
any	O
fever	B
greater	O
then	O
100	O
.	O
5	O
.	O

7	O
)	O
report	O
any	O
weight	B
gain	I
of	O
2	O
pounds	O
in	O
24	O
hours	O
or	O
5	O
pounds	O
in	O
one	O
week	O
.	O

8	O
)	O
call	O
with	O
any	O
questions	O
or	O
concerns	O
.	O

followup	O
instructions	O
:	O

follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
1	O
-	O
2	O
weeks	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2799	O
*	O
*	O
]	O
in	O
2	O
-	O
3	O
weeks	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
4	O
weeks	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
46	O
*	O
*	O
]	O
)	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
(	O
vasc	O
)	O
in	O
4	O
weeks	O
call	O
all	O
providers	O
for	O
appointments	O
.	O

[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
690	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
firstname	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
950	O
*	O
*	O
]	O
pa	O
80	O
-	O
bye	O
[	O
*	O
*	O
2018	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
@	O
1156	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
244	O
*	O
*	O
]	O
[	O
*	O
*	O
2018	O
-	O
02	O
-	O
27	O
*	O
*	O
]	O
12	O
:	O
50	O
pm	O
(	O
end	O
of	O
report	O
)	O

81563	O
||||	O
12050	O
||||	O
24125	O
||||	O
ecg	O
_	O
report	O
||||	O
2016	O
-	O
06	O
-	O
19	O
06	O
:	O
31	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

baseline	O
artifact	O
.	O

atrial	B
fibrillation	I
with	O
a	O
rapid	B
ventricular	I
response	I
.	O

low	O
limb	O
lead	O
voltage	O
is	O
non	O
-	O
specific	O
.	O

non	B
-	I
specific	I
st	I
-	I
t	I
wave	I
changes	I
.	O

since	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2016	O
-	O
06	O
-	O
14	O
*	O
*	O
]	O
the	O
ventricular	B
ectopy	I
is	O
absent	O
.	O

87134	O
||||	O
12152	O
||||	O
23210	O
||||	O
ecg	O
_	O
report	O
||||	O
2016	O
-	O
03	O
-	O
26	O
01	O
:	O
40	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

atrial	B
fibrillation	I
with	O
a	O
slow	B
ventricular	I
response	I
.	O

non	B
-	I
specific	I
st	I
-	I
t	I
wave	I
changes	I
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
25	O
*	O
*	O
]	O
the	O
rate	B
is	I
slower	I
and	O
the	O

st	B
-	I
t	I
wave	I
changes	I
are	O
less	O
prominent	O
.	O

67807	O
||||	O
12156	O
||||	O
23208	O
||||	O
ecg	O
_	O
report	O
||||	O
2014	O
-	O
04	O
-	O
01	O
10	O
:	O
11	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
tachycardia	I

possible	O
old	B
inferior	I
infarct	I

since	O
previous	O
tracing	O
,	O
no	O
significant	O
change	O

21750	O
||||	O
12748	O
||||	O
6875	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
12	O
-	O
08	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
11	O
-	O
10	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
08	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1933	O
-	O
09	O
-	O
06	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
nsu	O

repeat	O
head	O
ct	O
remains	O
stable	O
with	O
no	O
midline	B
shift	I
or	O
mass	B
effect	I
from	O
the	O
subdural	B
hematomas	I
and	O
the	O
cervical	O
spine	O
was	O
cleared	O
.	O

the	O
patient	O
had	O
a	O
repeat	O
head	O
ct	O
on	O
[	O
*	O
*	O
2016	O
-	O
11	O
-	O
12	O
*	O
*	O
]	O
which	O
again	O
was	O
stable	O
.	O

she	O
had	O
a	O
picc	O
line	O
placed	O
for	O
iv	O
access	O
and	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
regular	O
floor	O
on	O

[	O
*	O
*	O
2016	O
-	O
11	O
-	O
12	O
*	O
*	O
]	O
.	O

on	O
transfer	O
,	O
she	O
responded	O
when	O
her	O
name	O
was	O
called	O
,	O
but	O
did	O
not	O
follow	B
commands	I
.	O

she	O
was	O
not	O
oriented	B
.	O

her	O
pupils	O
were	O
equal	O
,	O
round	O
and	O
reacted	O
to	O
light	O
.	O

she	O
moved	O
all	O
four	O
extremities	O
spontaneously	O
.	O

she	O
had	O
a	O
nonfocal	O
exam	O
.	O

she	O
had	O
a	O
repeat	O
head	O
ct	O
again	O
on	O
the	O
4th	O
which	O
again	O
showed	O
no	O
change	O
.	O

she	O
remained	O
on	O
the	O
trauma	O
service	O
.	O

on	O
[	O
*	O
*	O
11	O
-	O
15	O
*	O
*	O
]	O
,	O
she	O
was	O
more	O
somnolent	B
,	O
but	O
was	O
alert	B
and	O
oriented	B
times	I
three	I
when	O
awake	O
.	O

she	O
had	O
a	O
repeat	O
head	O
ct	O
which	O
again	O
was	O
stable	O
.	O

she	O
had	O
a	O
bedside	O
swallow	O
that	O
was	O
done	O
which	O
they	O
recommended	O
advancing	O
to	O
ground	O
solids	O
and	O
nectar	O
-	O
thick	O
liquids	O
.	O

however	O
,	O
on	O
[	O
*	O
*	O
2016	O
-	O
11	O
-	O
16	O
*	O
*	O
]	O
,	O
she	O
became	O
minimally	O
responsive	B
to	I
painful	I
stimulation	I
only	O
.	O

she	O
had	O
a	O
head	O
ct	O
which	O
was	O
unchanged	O
.	O

she	O
also	O
had	O
a	O
chest	O
x	O
-	O
ray	O
which	O
showed	O
left	B
lower	I
lobe	I
pneumonia	I
and	O
a	O
dilantin	O
level	O
came	O
back	O
at	O
22	O
.	O

she	O
had	O
a	O
sodium	O
of	O
151	O
and	O
enlarged	B
pupil	I
.	O

on	O
[	O
*	O
*	O
11	O
-	O
17	O
*	O
*	O
]	O
,	O
the	O
patient	O
became	O
acutely	O
worse	O
with	O
a	O
nonreactive	B
pupil	I
on	O
the	O
right	O
side	O
.	O

the	O
left	O
pupil	O
was	O
sluggish	O
to	O
react	O
.	O

the	O
patient	O
was	O
taken	O
emergently	O
to	O
the	O
or	O
on	O
[	O
*	O
*	O
11	O
-	O
17	O
*	O
*	O
]	O
for	O
evacuation	O
of	O
the	O
subdural	B
hematoma	I
.	O

essentially	O
,	O
the	O
patient	O
herniated	B
just	O
prior	O
to	O
surgery	O
.	O

postop	O
,	O
the	O
patient	O
was	O
in	O
the	O
recovery	O
room	O
.	O

on	O
physical	O
examination	O
postop	O
,	O
the	O
patient's	O
pupils	O
were	O
equal	O
and	O
reacted	O
.	O

the	O
right	O
was	O
slightly	O
more	O
sluggish	O
than	O
the	O
left	O
.	O

the	O
right	O
was	O
4	O
down	O
to	O
3	O
.	O
3	O
mm	O
.	O

the	O
left	O
was	O
4	O
down	O
to	O
2	O
.	O
the	O
patient	O
had	O
a	O
positive	B
gag	I
and	O
cough	B
.	O

her	O
chest	O
was	O
clear	O
on	O
auscultation	O
.	O

her	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

extremities	O
-	O
she	O
had	O
some	O
bruising	B
noted	O
.	O

she	O
withdraw	O
to	O
noxious	O
stimulation	O
in	O
all	O
extremities	O
.	O

on	O
[	O
*	O
*	O
11	O
-	O
18	O
*	O
*	O
]	O
,	O
on	O
exam	O
,	O
she	O
was	O
awake	O
,	O
alert	B
and	O
localizing	O
but	O
not	O
following	B
commands	I
.	O

her	O
pupils	O
were	O
equal	O
and	O
reacted	O
to	O
light	O
.	O

she	O
had	O
a	O
repeat	O
head	O
ct	O
which	O
showed	O
pneumocephalus	B
and	O
she	O
was	O
put	O
on	O
100	O
percent	O
oxygen	O
.	O

on	O

[	O
*	O
*	O
2016	O
-	O
11	O
-	O
19	O
*	O
*	O
]	O
,	O
on	O
exam	O
,	O
she	O
was	O
following	B
commands	I
in	O
both	O
lower	O
extremities	O
.	O

her	O
pupils	O
were	O
3	O
.	O
5	O
down	O
to	O
3	O
.	O
she	O
was	O
more	O
sluggish	O
to	O
react	O
on	O
the	O
right	O
than	O
the	O
left	O
.	O

her	O
sensation	O
was	O
intact	O
.	O

she	O
localized	O
in	O
all	O
extremities	O
.	O

she	O
was	O
transfused	O
with	O
one	O
unit	O
of	O
packed	O
red	O
blood	O
cells	O
for	O
some	O
anemia	B
.	O

she	O
was	O
started	O
on	O
lopressor	O
50	O
bid	O
and	O
subcutaneous	O
heparin	O
for	O
dvt	B
prophylaxis	O
.	O

she	O
remained	O
stable	O
.	O

the	O
patient	O
was	O
started	O
on	O
levaquin	O
for	O
the	O
left	B
lower	I
lobe	I
pneumonia	I
.	O

id	O
was	O
following	O
the	O
patient	O
and	O
recommended	O
to	O
discontinue	O
the	O
levofloxacin	O
and	O
start	O
her	O
on	O
zosyn	O
for	O
empiric	O
coverage	O
of	O
aspiration	O
and	O
nosocomial	B
pneumonia	I
.	O

her	O
condition	O
remained	O
stable	O
.	O

a	O
family	O
meeting	O
was	O
held	O
on	O
[	O
*	O
*	O
11	O
-	O
25	O
*	O
*	O
]	O
and	O
the	O
patient	O
was	O
made	O
a	O
dnr	B
.	O

however	O
,	O
she	O
may	O
be	O
reintubated	O
and	O
trach	O
and	O
peg	O
if	O
she	O
fails	O
extubation	O
.	O

she	O
was	O
extubated	O
and	O
did	O
tolerate	O
that	O
.	O

she	O
had	O
a	O
peg	O
placed	O
and	O
was	O
transferred	O
to	O
the	O
regular	O
floor	O
on	O
[	O
*	O
*	O
2016	O
-	O
11	O
-	O
30	O
*	O
*	O
]	O
.	O

she	O
has	O
remained	O
neurologically	O
stable	O
,	O
moving	O
all	O
extremities	O
,	O
intermittently	O
following	O
commands	O
and	O
has	O
had	O
episodes	O
of	O
congestive	B
heart	I
failure	I
,	O
receiving	O
iv	O
lasix	O
.	O

she	O
also	O
had	O
a	O
filter	O
placed	O
.	O

on	O
[	O
*	O
*	O
12	O
-	O
02	O
*	O
*	O
]	O
,	O
the	O
patient	O
had	O
an	O
episode	O
of	O
respiratory	B
distress	I
.	O

the	O
family	O
was	O
consulted	O
and	O
they	O
did	O
not	O
want	O
the	O
patient	O
intubated	O
.	O

she	O
was	O
therefore	O
transferred	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
44	O
*	O
*	O
]	O
overnight	O
and	O
was	O
put	O
on	O
bipap	O
.	O

this	O
episode	O
did	O
resolve	O
and	O
the	O
patient	O
was	O
transferred	O
back	O
to	O
the	O
regular	O
floor	O
the	O
following	O
day	O
.	O

she	O
has	O
remained	O
neurologically	O
stable	O
and	O
respiratory	O
-	O
wise	O
has	O
been	O
stable	O
,	O
receiving	O
daily	O
doses	O
of	O
lasix	O
.	O

she	O
has	O
also	O
had	O
difficulty	O
with	O
hypertension	B
and	O
has	O
been	O
treated	O
with	O
hydralazine	O
,	O
lopressor	O
and	O
lisinopril	O
for	O
blood	O
pressure	O
control	O
.	O

she	O
was	O
afebrile	B
up	O
until	O
the	O
25th	O
when	O
she	O
did	O
spike	B
a	I
temperature	I
.	O

her	O
ua	O
came	O
back	O
positive	O
for	O
enterococcus	O
which	O
was	O
sensitive	O
to	O
ampicillin	O
and	O
she	O
was	O
started	O
on	O
ampicillin	O
for	O
that	O
.	O

she	O
is	O
also	O
currently	O
on	O
levofloxacin	O
for	O
her	O
left	B
lower	I
lobe	I
pneumonia	I
.	O

her	O
condition	O
remained	O
stable	O
.	O

her	O
medications	O
at	O
the	O
time	O
of	O
discharge	O
include	O
dilantin	O
100	O
mg	O
po	O
tid	O
,	O
metoprolol	O
75	O
mg	O
po	O
bid	O
,	O
hold	O
for	O
heart	O
rate	O
less	O
than	O
60	O
and	O
sbp	O
less	O
than	O
120	O
,	O
lisinopril	O
10	O
mg	O
po	O
daily	O
,	O
hydralazine	O
10	O
mg	O
iv	O
q4	O
prn	O
,	O
hold	O
for	O
sbp	O
less	O
than	O
120	O
,	O
ampicillin	O
500	O
mg	O
po	O
q6	O
for	O
three	O
days	O
which	O
was	O
started	O
on	O
the	O
27th	O
,	O
levofloxacin	O
250	O
mg	O
po	O
q24h	O
which	O
was	O
started	O
on	O
the	O
24th	O
for	O
a	O
total	O
of	O
seven	O
days	O
for	O
pneumonia	B
,	O
multivitamins	O
5	O
ml	O
po	O
daily	O
,	O
isosorbide	O
30	O
mg	O
po	O
tid	O
,	O
insulin	O
sliding	O
scale	O
,	O
ferrous	O
sulfate	O
300	O
mg	O
po	O
bid	O
,	O
folic	O
acid	O
1	O
mg	O
po	O
daily	O
,	O
heparin	O
5000	O
subcutaneous	O
q12h	O
,	O
lansoprazole	O
30	O
mg	O
per	O
ng	O
daily	O
.	O

her	O
condition	O
was	O
stable	O
at	O
the	O
time	O
of	O
discharge	O
.	O

she	O
will	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
one	O
month	O
with	O
repeat	O
head	O
ct	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
state	O
/	O
zipcode	O
6344	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
6279	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
08	O
*	O
*	O
]	O
11	O
:	O
14	O
:	O
26	O

t	O
:	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
08	O
*	O
*	O
]	O
12	O
:	O
07	O
:	O
59	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
6345	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
94	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
16	O
*	O
*	O
]	O
7	O
:	O
53	O
pm	O

(	O
end	O
of	O
report	O
)	O

20154	O
||||	O
13033	O
||||	O
4775	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
12	O
-	O
05	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
11	O
-	O
22	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
05	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1981	O
-	O
03	O
-	O
17	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
34	O
-	O
year	O
-	O
old	O
male	O
with	O
history	O
of	O
type	B
1	I
diabetes	I
complicated	O
by	O
autonomic	B
neuropathy	I
,	O

gastroparesis	B
,	O
and	O
chronic	B
renal	I
insufficiency	I
with	O
coronary	B
artery	I
disease	I
and	O
malignant	B
hypertension	I
that	O
has	O
led	O
to	O
multiple	O
admissions	O
to	O
[	O
*	O
*	O
hospital	O
126	O
*	O
*	O
]	O
fo	O

r	O

nausea	B
,	O
vomiting	B
,	O
abdominal	B
pain	I
,	O
and	O
hypertensive	B
urgency	I
,	O
wh	O
o	O
was	O
last	O
discharged	O
from	O
the	O
hospital	O
three	O
days	O
prior	O
,	O
and	O
wh	O
o	O
presents	O
again	O
with	O
abdominal	B
pain	I
for	O
two	O
hours	O
duration	O
with	O
associated	O
nausea	B
and	O
vomiting	B
for	O
the	O
past	O
hour	O
up	O
to	O
five	O
episodes	O
.	O

there	O
was	O
no	O
blood	O
in	O
the	O
vomitus	O
.	O

his	O
blood	O
press	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O

was	O
240	O
/	O
130	O
by	O
ems	O
.	O

in	O
the	O
emergency	O
department	O
,	O
he	O
received	O
labetalol	O
,	O
hydralazine	O
,	O
morphine	O
,	O
and	O
ativan	O
to	O
control	O
his	O
symptoms	B
.	O

he	O
denies	O
fevers	B
,	O
chills	B
,	O
diarrhea	B
,	O
chest	B
pain	I
,	O
changes	B
in	I
vision	I
,	O
dizziness	B
.	O

further	O
review	O
of	O
systems	O
was	O
noncontributory	O
.	O

patient	O
states	O
that	O
this	O
is	O
his	O
usual	O
presentation	O
of	O
his	O
symptoms	B
associated	O
with	O
high	B
blood	I
pressure	I
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
type	B
1	I
diabetes	I
diagnosed	O
13	O
years	O
ago	O
and	O
complicated	O
by	O
autonomic	B
neuropathy	I
,	O
gastroparesis	B
.	O

2	O
.	O
malignant	B
hypertension	I
with	O
poor	O
control	O
of	O
his	O
blood	O
pressure	O
which	O
is	O
quite	O
labile	O
and	O
has	O
led	O
to	O
multiple	O
admissions	O
to	O
[	O
*	O
*	O
hospital	O
126	O
*	O
*	O
]	O
for	O
abdominal	B
pain	I
,	O
nausea	B
,	O
and	O
vomiting	B
.	O

an	O
extensive	O
workup	O
to	O
date	O
has	O
revealed	O
no	O
cause	O
.	O

3	O
.	O
coronary	B
artery	I
disease	I
.	O

4	O
.	O
chronic	B
renal	I
insufficiency	I
with	O
a	O
baseline	O
creatinine	O
of	O

1	O
.	O
7	O
-	O
1	O
.	O
9	O
.	O

5	O
.	O
history	O
of	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
1309	O
*	O
*	O
]	O
-	O
weiss	B
tears	I
.	O

6	O
.	O
depression	B
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
:	O

1	O
.	O
aspirin	O
81	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
nifedipine	O
cr	O
60	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

3	O
.	O
clonidine	O
patch	O
.	O

4	O
.	O
famotidine	O
20	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

5	O
.	O
erythromycin	O
250	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
i	O
.	O
d	O
.	O

6	O
.	O
metoclopramide	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
i	O
.	O
d	O
.	O

7	O
.	O
lopressor	O
150	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

8	O
.	O
lisinopril	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

9	O
.	O
glargine	O
5	O
units	O
subq	O
q	O
.	O
h	O
.	O
s	O
.	O

10	O
.	O

ativan	O
2	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
6h	O
.	O

11	O
.	O

morphine	O
50	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
6h	O
.	O
prn	O
.	O

social	O
history	O
:	O
lives	O
in	O
[	O
*	O
*	O
location	O
1107	O
*	O
*	O
]	O
.	O

denies	O
alcohol	O
,	O
tobacco	O
,	O
or	O
intravenous	O
drug	O
use	O
.	O

family	O
history	O
:	O
his	O
father	O
has	O
diabetes	B
.	O

physical	O
examination	O
:	O
well	O
-	O
nourished	O
[	O
*	O
*	O
ethnicity	O
537	O
*	O
*	O
]	O
[	O
*	O
*	O
ethnicity	O
538	O
*	O
*	O
]	O
male	O
in	O
no	O
acute	B
distress	I
.	O

vital	O
signs	O
:	O
temperature	O
99	O
.	O
4	O
,	O
blood	O
pressure	O
130	O
/	O
80	O
,	O
heart	O
rate	O
84	O
,	O
respiratory	O
rate	O
22	O
,	O
and	O
pulse	O
oximetry	O
96%	O
on	O
room	O
air	O
.	O

heent	O
:	O
extraocular	O
muscles	O
are	O
intact	O
.	O

pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

anicteric	O
sclerae	O
.	O

oropharynx	O
is	O
clear	O
,	O
dry	O
mucosal	O
membranes	O
.	O

neck	O
:	O
no	O
lymphadenopathy	B
,	O
no	O
jvd	B
,	O
supple	O
.	O

heart	O
regular	O
,	O
rate	O
,	O
and	O
rhythm	O
,	O
normal	O
s1	O
,	O
s2	O
,	O
no	O
murmurs	B
,	O
rubs	B
,	O
or	O
gallops	B
.	O

lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
no	O
masses	B
.	O

extremities	O
:	O
no	O
clubbing	B
,	O
cyanosis	B
,	O
or	O
edema	B
.	O

neurologic	O
:	O
cranial	O
nerves	O
ii	O
through	O
xii	O
are	O
grossly	O
intact	O
.	O

laboratory	O
data	O
on	O
admission	O
:	O
white	O
count	O
9	O
.	O
3	O
.	O

differential	O
:	O
84	O
.	O
2%	O
neutrophils	O
,	O
10	O
.	O
2%	O
lymphocytes	O
,	O
3	O
.	O
9%	O
monocytes	O
.	O

hematocrit	O
33	O
.	O
9	O
,	O
platelet	O
count	O
236	O
.	O

electrolytes	O
:	O
sodium	O
137	O
,	O
potassium	O
4	O
.	O
4	O
,	O
chloride	O
103	O
,	O
bicarbonate	O
27	O
,	O
bun	O
33	O
,	O
creatinine	O
1	O
.	O
6	O
,	O
glucose	O
274	O
.	O

hospital	O
course	O
:	O

1	O
.	O
cardiovascular	O
:	O
patient	O
presented	O
with	O
prior	O
poor	O
control	O
of	O
his	O
hypertension	B
.	O

he	O
was	O
restarted	O
on	O
all	O
of	O
his	O
regular	O
antihypertensive	O
medications	O
including	O
lopressor	O
,	O
nifedipine	O
,	O
lisinopril	O
,	O
and	O
clonidine	O
,	O
and	O
for	O
poor	O
control	O
of	O
his	O
blood	O
pressure	O
,	O
hydralazine	O
and	O
labetalol	O
prn	O
were	O
added	O
.	O

as	O
further	O
history	O
was	O
gathered	O
during	O
his	O
hospital	O
stay	O
indicated	O
that	O
the	O
patient's	O
symptoms	B
may	O
have	O
been	O
preceded	O
by	O
micturition	B
.	O

the	O
possibility	O
of	O
an	O
intracystic	B
pheochromocytoma	I
was	O
considered	O
despite	O
the	O
fact	O
that	O
the	O
patient	O
has	O
had	O
negative	O
urine	O
metanephrines	O
in	O
the	O
past	O
.	O

to	O
evaluate	O
this	O
possibility	O
further	O
,	O
a	O
mibg	O
scan	O
was	O
scheduled	O
for	O
the	O
following	O
week	O
.	O

in	O
preparation	O
for	O
this	O
mibg	O
scan	O
,	O
the	O
patient	O
was	O
weaned	O
off	O
his	O
alpha	O
and	O
calcium	O
-	O
channel	O
blockers	O
as	O
this	O
was	O
necessary	O
for	O
an	O
accurate	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
655	O
*	O
*	O
]	O
.	O

during	O
this	O
time	O
,	O
his	O
blood	O
pressure	O
remained	O
quite	O
labile	O
.	O

the	O
first	O
labetalol	O
and	O
hydralazine	O
were	O
used	O
for	O
control	O
,	O
but	O
after	O
further	O
episodes	O
of	O
poorly	O
controlled	O
hypertension	B
,	O
nitroglycerin	O
iv	O
drip	O
was	O
used	O
as	O
needed	O
.	O

patient	O
was	O
transferred	O
to	O
the	O
west	O
campus	O
in	O
preparation	O
for	O
this	O
mibg	O
scan	O
.	O

as	O
his	O
blood	O
pressure	O
continued	O
to	O
be	O
quite	O
labile	O
,	O
it	O
was	O
clear	O
that	O
closer	O
monitoring	O
and	O
better	O
control	O
of	O
his	O
blood	O
pressure	O
was	O
indicated	O
,	O
therefore	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
44	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
12	O
-	O
01	O
*	O
*	O
]	O
,	O
where	O
a	O
nipride	O
drip	O
was	O
started	O
.	O

patient	O
was	O
weaned	O
off	O
all	O
of	O
his	O
calcium	O
-	O
channel	O
blockers	O
,	O
alpha	O
blockers	O
,	O
and	O
beta	O
blockers	O
in	O
preparation	O
for	O
the	O
mibg	O
scan	O
,	O
which	O
occurred	O
on	O
[	O
*	O
*	O
12	O
-	O
02	O
*	O
*	O
]	O
and	O
[	O
*	O
*	O
12	O
-	O
04	O
*	O
*	O
]	O
.	O

patient	O
was	O
transferred	O
back	O
to	O
medicine	O
floor	O
on	O
[	O
*	O
*	O
12	O
-	O
04	O
*	O
*	O
]	O
and	O
on	O
[	O
*	O
*	O
12	O
-	O
05	O
*	O
*	O
]	O
,	O
his	O
blood	O
pressure	O
was	O
well	O
controlled	O
on	O
his	O
regular	O
oral	O
antihypertensive	O
regimen	O
.	O

the	O
results	O
of	O
the	O
mibg	O
scan	O
were	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

2	O
.	O
endocrine	O
:	O
patient	O
has	O
a	O
history	O
of	O
type	B
1	I
diabetes	I
.	O

he	O
was	O
continued	O
on	O
his	O
regular	O
glargine	O
dose	O
with	O
regular	O
insulin	O
-	O
sliding	O
scale	O
to	O
cover	O
for	O
elevated	B
blood	I
sugars	I
,	O
fingersticks	O
continued	O
q	O
.	O
i	O
.	O
d	O
.	O

3	O
.	O
gastroparesis	B
:	O
when	O
the	O
patient	O
was	O
taking	O
p	O
.	O
o	O
.	O
diet	O
,	O
he	O
was	O
continued	O
on	O
his	O
regular	O
regimen	O
per	O
treatment	O
of	O
his	O
gastroparesis	B
including	O
erythromycin	O
,	O
reglan	O
,	O
and	O
famotidine	O
,	O
antiemetics	O
including	O
zofran	O
were	O
also	O
used	O
to	O
control	O
intermittent	O
nausea	B
.	O

4	O
.	O
fluids	O
,	O
electrolytes	O
,	O
and	O
nutrition	O
:	O
patient	O
was	O
advanced	O
slowly	O
to	O
his	O
regular	O
diet	O
on	O
admission	O
after	O
having	O
a	O
history	O
of	O
nausea	B
and	O
vomiting	B
.	O

as	O
his	O
symptoms	B
were	O
thought	O
to	O
sometimes	O
follow	O
eating	O
he	O
was	O
made	O
npo	O
to	O
evaluate	O
this	O
possible	O
connection	O
.	O

during	O
this	O
time	O
the	O
patient	O
received	O

ppn	O
and	O
then	O
tpn	O
and	O
then	O
nutrition	O
consultation	O
on	O
[	O
*	O
*	O
11	O
-	O
27	O
*	O
*	O
]	O
.	O

he	O
resumed	O
his	O
regular	O
diabetic	O
diet	O
.	O

iv	O
fluids	O
were	O
often	O
administered	O
during	O
his	O
hospital	O
stay	O
to	O
address	O
increase	O
in	O
creatinine	O
.	O

5	O
.	O
renal	O
:	O
patient	O
has	O
a	O
baseline	O
creatinine	O
of	O
1	O
.	O
7	O
to	O
1	O
.	O
9	O
.	O

during	O
his	O
hospital	O
stay	O
,	O
his	O
creatinine	O
rose	O
up	O
to	O
2	O
.	O
6	O
.	O

iv	O
fluids	O
were	O
administered	O
to	O
address	O
this	O
renal	B
failure	I
.	O

prerenal	B
etiology	I
was	O
initially	O
suspected	O
but	O
was	O
not	O
supported	O
by	O
fena	O
calculation	O
as	O
creatinine	O
elevation	O
was	O
thought	O
to	O
be	O
due	O
to	O
hypertensive	O
and	O
diabetic	B
nephropathy	I
.	O

at	O
the	O
time	O
of	O
discharge	O
,	O
his	O
creatinine	O
had	O
trended	O
towards	O
baseline	O
.	O

6	O
.	O
intravenous	O
access	O
:	O
patient	O
had	O
a	O
port	O
-	O
a	O
-	O
cath	O
and	O
a	O
right	O
ij	O
line	O
placed	O
during	O
his	O
hospital	O
stay	O
.	O

discharge	O
condition	O
:	O
hemodynamically	O
stable	O
,	O
afebrile	O
with	O
blood	O
pressure	O
well	O
controlled	O
on	O
p	O
.	O
o	O
.	O
medications	O
.	O

patient	O
is	O
asymptomatic	O
.	O

discharge	O
status	O
:	O
patient	O
is	O
being	O
discharged	O
to	O
home	O
.	O

he	O
will	O
be	O
visiting	O
his	O
father	O
,	O
who	O
is	O
hospitalized	O
at	O
a	O
local	O
hospital	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
malignant	B
hypertension	I
.	O

2	O
.	O
gastroparesis	B
.	O

3	O
.	O
type	B
1	I
diabetes	I
.	O

4	O
.	O
renal	B
failure	I
.	O

discharge	O
medications	O
:	O

1	O
.	O
aspirin	O
81	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

2	O
.	O
azithromycin	O
250	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
i	O
.	O
d	O
.	O

3	O
.	O
lisinopril	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

4	O
.	O
metoclopramide	O
10	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
i	O
.	O
d	O
.	O

5	O
.	O
hydralazine	O
25	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
4h	O
.	O

6	O
.	O
metoprolol	O
tartrate	O
100	O
mg	O
1	O
.	O
5	O
tablets	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

7	O
.	O
clonidine	O
0	O
.	O
1	O
mg	O
/	O
24	O
hour	O
patch	O
one	O
patch	O
q	O
.	O
d	O
.	O

8	O
.	O
nifedipine	O
60	O
mg	O
one	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

9	O
.	O
famotidine	O
20	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

10	O
.	O

lorazepam	O
1	O
mg	O
1	O
-	O
2	O
tablets	O
p	O
.	O
o	O
.	O
q	O
.	O
6h	O
.	O
prn	O
nausea	B
.	O

11	O
.	O

morphine	O
sulfate	O
15	O
mg	O
one	O
tablet	O
p	O
.	O
o	O
.	O
q	O
.	O
6h	O
.	O
prn	O
pain	B
.	O

12	O
.	O

glargine	O
8	O
units	O
subcutaneous	O
q	O
.	O
d	O
.	O

13	O
.	O

humulin	O
insulin	O
-	O
sliding	O
scale	O
as	O
previously	O
prescribed	O
.	O

discharge	O
instructions	O
:	O
please	O
take	O
all	O
medications	O
as	O
prescribed	O
.	O

please	O
continue	O
to	O
check	O
your	O
blood	O
pressure	O
at	O
least	O
two	O
times	O
per	O
day	O
.	O

if	O
systolic	O
blood	O
pressures	O
greater	O
than	O
150	O
,	O
please	O
contact	O
your	O
primary	O
care	O
physician	O
.	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
*	O
*	O
]	O
systolic	O
blood	O
pressures	O
greater	O
than	O
170	O
,	O
please	O
report	O
to	O
the	O
emergency	O
department	O
for	O
blood	O
pressure	O
control	O
.	O

please	O
return	O
to	O
the	O
emergency	O
department	O
if	O
you	O
have	O
nausea	B
,	O
vomiting	B
,	O
abdominal	B
pain	I
,	O
headache	B
,	O
or	O
other	O
worrisome	O
symptoms	B
.	O

recommended	O
followup	O
:	O
please	O
contact	O
your	O
primary	O
care	O
physician	O
for	O
an	O
appointment	O
on	O
[	O
*	O
*	O
12	O
-	O
07	O
*	O
*	O
]	O
or	O
[	O
*	O
*	O
12	O
-	O
08	O
*	O
*	O
]	O
to	O
monitor	O
your	O
blood	O
pressure	O
and	O
manage	O
your	O
medications	O
.	O

please	O
keep	O
the	O
following	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
2143	O
*	O
*	O
]	O
in	O
the	O
[	O
*	O
*	O
doctor	O
last	O
name	O
232	O
*	O
*	O
]	O
center	O
neurology	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
24	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1116	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1248	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
2144	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
22	O
*	O
*	O
]	O
10	O
:	O
28	O

t	O
:	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
25	O
*	O
*	O
]	O
08	O
:	O
48	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2145	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1116	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
6	O
:	O
13	O
pm	O
(	O
end	O
of	O
report	O
)	O

48474	O
||||	O
13101	O
||||	O
21807	O
||||	O
ecg	O
_	O
report	O
||||	O
2014	O
-	O
09	O
-	O
23	O
08	O
:	O
06	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
and	O
underlying	O
sinus	B
rhythm	I
without	O
ventricular	O
sensing	O
of	O
the	O
atrial	O
pacemaker	O
.	O

there	O
is	O
intermittent	O
appearance	O
of	O
apparent	O
atrial	B
pacemaker	I
artifact	I
without	O
capture	O
.	O

clinical	O
correlation	O
is	O
suggested	O
.	O

tracing	O
#2	O

104380	O
||||	O
13265	O
||||	O
28330	O
||||	O
echo	O
_	O
report	O
||||	O
2018	O
-	O
02	O
-	O
02	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O

recent	O
vf	B
arrest	I
.	O

re	O
-	O
evaluate	O
lv	B
function	I
height	O
:	O
(	O
in	O
)	O
66	O

weight	O
(	O
lb	O
)	O
:	O
148	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
76	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
88	O
/	O
56	O

hr	O
(	O
bpm	O
)	O
:	O
94	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2018	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
at	O
12	O
:	O
06	O

test	O
:	O
portable	O
tte	O
(	O
focused	O
views	O
)	O

doppler	O
:	O
limited	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

this	O
study	O
was	O
compared	O
to	O
the	O
prior	O
study	O
of	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
.	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

left	O
ventricle	O
:	O
moderate	O
symmetric	O
lvh	B
.	O

small	O
lv	O
cavity	O
.	O

mild	O
-	O
moderate	O
global	O
left	O
ventricular	O
hypokinesis	B
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

mildly	O
dilated	B
ascending	I
aorta	I
.	O

aortic	O
valve	O
:	O
severely	O
thickened	O
/	O
deformed	B
aortic	I
valve	I
leaflets	I
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

trivial	O
mr	B
.	O

lv	B
inflow	I
pattern	I
c	O
/	O
w	O
impaired	O
relaxation	O
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
with	O
trivial	O
tr	B
.	O

indeterminate	O
pa	B
systolic	I
pressure	I
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

there	O
is	O
moderate	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
unusually	O
small	O
.	O

there	O
is	O
mild	O
to	O
moderate	O
global	O
left	O
ventricular	O
hypokinesis	B
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
ascending	O
aorta	O
is	O
mildly	O
dilated	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
severely	O
thickened	O
/	O
deformed	O
.	O

aortic	B
stenosis	I
is	O
estimated	O
as	O
severe	O
although	O
severity	O
may	O
be	O
overestimated	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
left	B
ventricular	I
inflow	I
pattern	I
suggests	O
impaired	O
relaxation	O
.	O

the	O
pulmonary	B
artery	I
systolic	I
pressure	I
could	O
not	O
be	O
determined	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

compared	O
with	O
the	O
prior	O
study	O
(	O
images	O
reviewed	O
)	O
of	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
,	O
there	O
is	O
no	O
definite	O
change	O
.	O

66846	O
||||	O
13594	O
||||	O
13988	O
||||	O
ecg	O
_	O
report	O
||||	O
2012	O
-	O
09	O
-	O
08	O
07	O
:	O
47	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
.	O

since	O
the	O
previous	O
tracing	O
the	O
rate	B
has	O
decreased	O
and	O
there	O
is	O
q	B
-	I
t	I
interval	I
prolongation	I
.	O

clinical	O
correlation	O
is	O
suggested	O
.	O

tracing	O
#3	O

106200	O
||||	O
13913	O
||||	O
5755	O
||||	O
echo	O
_	O
report	O
||||	O
2011	O
-	O
11	O
-	O
21	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
congestive	B
heart	I
failure	I
.	O

coronary	B
artery	I
disease	I
.	O

aortic	B
valve	I
disease	I
.	O

height	O
:	O
(	O
in	O
)	O
60	O

weight	O
(	O
lb	O
)	O
:	O
126	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
54	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
119	O
/	O
48	O

hr	O
(	O
bpm	O
)	O
:	O
72	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2011	O
-	O
11	O
-	O
21	O
*	O
*	O
]	O
at	O
09	O
:	O
01	O

test	O
:	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

left	O
ventricle	O
:	O
symmetric	O
lvh	B
.	O

normal	O
lv	O
cavity	O
size	O
.	O

depressed	B
lvef	I
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

aortic	O
valve	O
:	O
moderately	O
thickened	B
aortic	I
valve	I
leaflets	I
.	O

severe	O
as	B
.	O

right	O
parasternal	O
view	O
used	O
for	O
as	B
gradient	O
.	O

mild	O
(	O
1	O
+	O
)	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

severe	O
mitral	B
annular	I
calcification	I
.	O

moderate	O
(	O
2	O
+	O
)	O
mr	B
.	O

eccentric	O
mr	B
jet	O
.	O

tricuspid	O
valve	O
:	O
moderate	O
[	O
2	O
+	O
]	O
tr	B
.	O

moderate	O
pa	O
systolic	B
hypertension	I
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
compared	O
to	O
the	O
findings	O
of	O
the	O
prior	O
study	O
,	O
the	O
severity	O
of	O
aortic	B
stenosis	I
has	O
increased	O
.	O

conclusions	O
:	O

1	O
.	O
there	O
is	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

lv	O
systolic	O
function	O
appears	O
depressed	O
.	O

distal	O
septal	O
and	O
apical	O
hypokinesis	B
is	O
probably	O
present	O
.	O

2	O
.	O
the	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened	O
.	O

there	O
is	O
severe	O
aortic	B
valve	I
stenosis	I
.	O

mild	O
(	O
1	O
+	O
)	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

3	O
.	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
severe	O
mitral	B
annular	I
calcification	I
.	O

moderate	O
(	O
2	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	B
regurgitation	I
jet	O
is	O
eccentric	O
.	O

4	O
.	O
moderate	O
[	O
2	O
+	O
]	O
tricuspid	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

5	O
.	O
compared	O
to	O
the	O
findings	O
of	O
the	O
prior	O
study	O
of	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
04	O
*	O
*	O
]	O
,	O
the	O
severity	O
of	O
aortic	B
stenosis	I
has	O
increased	O
.	O

340203	O
||||	O
14108	O
||||	O
17954	O
||||	O
radiology	O
_	O
report	O
||||	O
2013	O
-	O
12	O
-	O
09	O
22	O
:	O
05	O
:	O
00	O
.	O
0	O
||||	O
t9411	O
mr	O
cervical	O
spine	O
||||	O
||||	O
clip	O
#	O
354	O
-	O
3895	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
09	O
*	O
*	O
]	O
10	O
:	O
05	O
pm	O

mr	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
101	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
102	O
*	O
*	O
]	O
;	O
mr	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
103	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
102	O
*	O
*	O
]	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
484	O
*	O
*	O
]	O
reason	O
:	O
ligamentous	B
injury	I
?	O

admitting	O
diagnosis	O
:	O
s	O
/	O
p	O
fall	B
temp	I
.	I

fracture	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

53	O
year	O
old	O
man	O
s	O
/	O
p	O
fall	B
from	I
ladder	I
reason	O
for	O
this	O
examination	O
:	O
ligamentous	B
injury	I
?can	O
go	O
off	O
tele	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
status	O
post	O
fall	B
from	I
ladder	I
,	O
evaluate	O
for	O
ligamentous	B
injury	I
.	O

comparison	O
:	O
ct	O
of	O
the	O
cervical	O
spine	O
from	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
07	O
*	O
*	O
]	O
.	O

mri	O
of	O
the	O
cervical	O
spine	O
:	O

technique	O
:	O
sagittal	O
t1w	O
,	O
t2w	O
,	O
stir	O
,	O
and	O
axial	O
gre	O
and	O
t2w	O
images	O
of	O
the	O
cervical	O
spine	O
were	O
performed	O
.	O

findings	O
:	O
study	O
is	O
limited	O
secondary	O
to	O
patient	O
motion	O
.	O

allowing	O
for	O
this	O
,	O
there	O
is	O
no	O
evidence	O
of	O
abnormal	B
alignment	I
of	O
the	O
cervical	O
vertebral	O
bodies	O
,	O
fracture	B
,	O
or	O
abnormal	B
signal	I
within	O
the	O
cervical	O
spine	O
.	O

the	O
extent	O
of	O
degenerative	B
change	I
and	O
spinal	B
stenosis	I
cannot	O
be	O
fully	O
assessed	O
because	O
of	O
patient	O
motion	O
.	O

no	O
abnormal	B
signal	I
is	O
demonstrated	O
within	O
the	O
prevertebral	O
soft	O
tissues	O
.	O

impression	O
:	O
limited	O
study	O
secondary	O
to	O
patient	O
motion	O
.	O

no	O
abnormal	B
signal	I
demonstrated	O
within	O
the	O
cervical	O
spine	O
to	O
suggest	O
ligamentous	B
injury	I
.	O

no	O
definite	O
fracture	B
seen	O
.	O

mri	O
of	O
the	O
thoracic	O
spine	O
:	O

technique	O
:	O
sagittal	O
t1w	O
,	O
t2w	O
,	O
and	O
stir	O
images	O
were	O
performed	O
.	O

findings	O
:	O
two	O
small	O
round	O
foci	O
of	O
increased	O
t1	O
&	O
t2	B
signal	I
are	O
demonstrated	O
within	O
the	O
t6	O
and	O
t9	O
vertebral	O
bodies	O
consistent	O
with	O
hemangiomas	B
.	O

alignment	O
of	O
the	O
thoracic	O
spine	O
is	O
normal	O
.	O

no	O
areas	O
of	O
abnormal	B
signal	I
are	O
demonstrated	O
within	O
the	O
thoracic	O
spine	O
or	O
spinal	O
cord	O
are	O
present	O
.	O

height	O
of	O
the	O
vertebral	O
bodies	O
and	O
intervertebral	O
discs	O
is	O
normal	O
.	O

alignment	O
of	O
the	O
vertebral	O
bodies	O
is	O
normal	O
.	O

impression	O
:	O
no	O
abnormal	B
alignment	I
,	O
fractures	B
,	O
or	O
signal	O
demonstrated	O
within	O
the	O
thoracic	O
spine	O
.	O

75452	O
||||	O
14158	O
||||	O
22616	O
||||	O
ecg	O
_	O
report	O
||||	O
2012	O
-	O
07	O
-	O
23	O
12	O
:	O
50	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I

first	I
degree	I
a	I
-	I
v	I
delay	I

left	I
atrial	I
abnormality	I

prior	O
anteroseptal	O
myocardial	B
infarction	I

since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
23	O
*	O
*	O
]	O
,	O
poor	B
r	I
wave	I
progression	I
is	O
more	O
prominent	O

110891	O
||||	O
14493	O
||||	O
6336	O
||||	O
radiology	O
_	O
report	O
||||	O
2014	O
-	O
01	O
-	O
01	O
06	O
:	O
27	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
359	O
-	O
5741	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2014	O
-	O
01	O
-	O
01	O
*	O
*	O
]	O
6	O
:	O
27	O
am	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
4143	O
*	O
*	O
]	O
reason	O
:	O
please	O
assess	O
interval	B
change	I
admitting	O
diagnosis	O
:	O
lung	B
cancer	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

60	O
year	O
old	O
man	O
with	O
nsclc	B
,	O
encasement	O
of	O
l	O
mainstem	O
,	O
intubated	O
,	O
awaiting	O
stent	O
s	O
/	O
p	O
thoracentesis	O
and	O
bronch	O
.	O

please	O
assess	O
interval	B
change	I
.	O

reason	O
for	O
this	O
examination	O
:	O
please	O
assess	O
interval	B
change	I
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
history	O
of	O
lung	B
cancer	I
,	O
assess	O
for	O
interval	B
change	I
.	O

comparison	O
:	O
portable	O
ap	O
chest	O
of	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
31	O
*	O
*	O
]	O
.	O

ap	O
upright	O
chest	O
:	O
endotracheal	O
tube	O
identified	O
,	O
approximately	O
6	O
cm	O
above	O
the	O
carina	O
.	O

there	O
is	O
a	O
right	O
-	O
sided	O
central	O
line	O
,	O
with	O
its	O
tip	O
in	O
the	O
distal	O
svc	O
.	O

ng	O
tube	O
identified	O
,	O
with	O
its	O
tip	O
off	O
the	O
inferior	O
margin	O
of	O
the	O
film	O
.	O

again	O
identified	O
is	O
a	O
large	O
left	O
hilar	B
mass	I
,	O
somewhat	O
impinging	O
on	O
the	O
left	O
main	O
bronchus	O
,	O
corresponding	O
to	O
the	O
patient's	O
known	O
lung	B
cancer	I
.	O

elevation	O
of	O
the	O
left	O
hemidiaphragm	O
.	O

interval	O
resolution	O
of	O
left	O
-	O
sided	O
pleural	B
effusion	I
;	O
however	O
,	O
there	O
remains	O
a	O
small	O
pocket	O
of	O
loculated	B
effusion	I
seen	O
on	O
the	O
lateral	O
wall	O
.	O

interval	O
improvement	O
in	O
right	O
-	O
sided	O
pulmonary	B
edema	I
.	O

no	O
new	O
infiltrates	B
identified	O
.	O

visualized	O
osseous	O
and	O
soft	O
tissue	O
structures	O
are	O
unremarkable	O
.	O

impression	O
:	O

1	O
)	O
interval	O
improvement	O
in	O
predominantly	O
right	O
-	O
sided	O
pulmonary	B
edema	I
.	O

2	O
)	O
interval	O
resolution	O
of	O
left	O
-	O
sided	O
pleural	B
effusion	I
.	O

3	O
)	O
stable	O
appearance	O
of	O
left	O
-	O
sided	O
hilar	B
mass	I
.	O

104279	O
||||	O
14522	O
||||	O
29437	O
||||	O
echo	O
_	O
report	O
||||	O
2018	O
-	O
07	O
-	O
10	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
intra	O
-	O
op	O
tee	O
for	O
cabg	O

height	O
:	O
(	O
in	O
)	O
62	O

weight	O
(	O
lb	O
)	O
:	O
140	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
64	O
m2	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2018	O
-	O
07	O
-	O
10	O
*	O
*	O
]	O
at	O
08	O
:	O
52	O

test	O
:	O
tee	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
mild	O
la	B
enlargement	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

normal	O
interatrial	O
septum	O
.	O

no	O
asd	B
by	O
2d	O
or	O
color	O
doppler	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thickness	O
.	O

mildly	O
dilated	B
lv	I
cavity	O
.	O

mild	O
regional	O
lv	B
systolic	I
dysfunction	I
.	O

mildly	O
depressed	B
lvef	I
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
diameter	O
at	O
the	O
sinus	O
level	O
.	O

focal	O
calcifications	B
in	O
aortic	O
root	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

normal	O
aortic	O
arch	O
diameter	O
.	O

focal	O
calcifications	B
in	O
aortic	O
arch	O
.	O

normal	O
descending	O
aorta	O
diameter	O
.	O

simple	O
atheroma	B
in	O
descending	O
aorta	O
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

mild	O
mitral	B
annular	I
calcification	I
.	O

no	O
ms	B
.	O

moderate	O
(	O
2	O
+	O
)	O
mr	B
.	O

tricuspid	O
valve	O
:	O
physiologic	O
tr	B
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
physiologic	O
(	O
normal	O
)	O
pr	B
.	O

general	O
comments	O
:	O
a	O
tee	O
was	O
performed	O
in	O
the	O
location	O
listed	O
above	O
.	O

i	O
certify	O
i	O
was	O
present	O
in	O
compliance	O
with	O
hcfa	O
regulations	O
.	O

no	O
tee	B
related	I
complications	I
.	O

the	O
patient	O
was	O
under	O
general	O
anesthesia	O
throughout	O
the	O
procedure	O
.	O

the	O
patient	O
appears	O
to	O
be	O
in	O
sinus	B
rhythm	I
.	O

results	O
were	O
personally	O
reviewed	O
with	O
the	O
md	O
caring	O
for	O
the	O
patient	O
.	O

see	O
conclusions	O
for	O
post	O
-	O
bypass	O
data	O

conclusions	O
:	O

pre	O
-	O
bypass	O
:	O

1	O
.	O
the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

no	O
atrial	B
septal	I
defect	I
is	O
seen	O
by	O
2d	O
or	O
color	O
doppler	O
.	O

2	O
.	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
mildly	O
dilated	O
.	O

there	O
is	O
mild	O
regional	O
left	B
ventricular	I
systolic	I
dysfunction	I
with	O
hypokinesis	B
of	O
the	O
mid	O
inferior	O
,	O
infero	O
septal	O
walls	O
,	O
lateral	O
apical	O
walls	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	O
depressed	O
.	O

3	O
.	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

4	O
.	O
there	O
are	O
focal	O
calcifications	B
in	O
the	O
aortic	O
arch	O
.	O

there	O
are	O
simple	O
atheroma	B
in	O
the	O
descending	O
thoracic	O
aorta	O
.	O

5	O
.	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

6	O
.	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

high	O
mild	O
to	O
moderate	O
/	O
borderline	O
moderate	O
(	O
[	O
*	O
*	O
02	O
-	O
27	O
*	O
*	O
]	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
jet	O
is	O
central	O
with	O
a	O
2	O
-	O
4	O
mm	O
vena	O
contracta	O
.	O

pulmonary	O
vein	O
flow	O
pattern	O
is	O
normal	O
.	O

post	O
-	O
bypass	O
:	O

1	O
.	O
perserved	O
biventricular	O
function	O
with	O
slight	O
improvement	O
in	O
inferior	B
wall	I
function	I
.	O

lvef	O
40	O
-	O
45%	O

2	O
.	O
mitral	B
regurgitation	I
is	O
now	O
moderate	O
(	O
2	O
+	O
)	O

3	O
.	O
there	O
is	O
now	O
mild	O
tricuspid	B
regurgitation	I
.	O

4	O
.	O
aortic	O
contours	O
are	O
intact	O
.	O

5	O
.	O
remaining	O
exam	O
is	O
unchanged	O
.	O

6	O
.	O
all	O
findings	O
discussed	O
with	O
surgeons	O
at	O
the	O
time	O
of	O
the	O
exam	O
.	O

6815	O
||||	O
14708	O
||||	O
26911	O
||||	O
discharge	O
_	O
summary	O
||||	O
2018	O
-	O
06	O
-	O
20	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
20	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1978	O
-	O
01	O
-	O
20	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
3116	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

altered	B
mental	I
status	I
,	O
s	O
/	O
p	O
opioid	B
overdose	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

patient	O
is	O
a	O
40	O
year	O
old	O
man	O
who	O
presented	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
2	O
*	O
*	O
]	O
with	O
change	B
in	I
mental	I
status	I
.	O

he	O
has	O
a	O
history	O
of	O
schizoaffective	B
disorder	I
,	O
anxiety	B
and	O
benzodiazepine	B
abuse	I
.	O

he	O
was	O
admitted	O
to	O
[	O
*	O
*	O
hospital1	O
6419	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2018	O
-	O
04	O
-	O
06	O
*	O
*	O
]	O
from	O
[	O
*	O
*	O
street	O
address	O
6420	O
*	O
*	O
]	O
inn	O
with	O
suicidal	B
ideation	I
.	O

he	O
had	O
been	O
discharged	O
from	O
[	O
*	O
*	O
hospital1	O
3385	O
*	O
*	O
]	O
in	O
february	O
to	O
his	O
parent's	O
house	O
.	O
while	O
there	O
he	O
was	O
disruptive	B
.	O

he	O
destroyed	O
property	O
and	O
od'd	B
on	O
motrin	O
.	O

his	O
parents	O
got	O
a	O
restraining	O
order	O
against	O
him	O
and	O
he	O
moved	O
[	O
*	O
*	O
street	O
address	O
6421	O
*	O
*	O
]	O
in	O
.	O

he	O
was	O
admitted	O
to	O
[	O
*	O
*	O
hospital1	O
27	O
*	O
*	O
]	O
briefly	O
from	O
[	O
*	O
*	O
06	O
-	O
02	O
*	O
*	O
]	O
to	O
22	O
due	O
to	O
decreased	B
responsiveness	I
.	O

full	O
medical	O
workup	O
was	O
negative	O
and	O
his	O
mental	B
status	I
was	O
thought	O
to	O
be	O
due	O
to	O
over	B
medication	I
.	O

one	O
the	O
day	O
of	O
admission	O
patient	O
had	O
been	O
out	O
on	O
a	O
day	O
pass	O
and	O
returned	O
poorly	B
responsive	I
.	O

on	O
return	O
he	O
was	O
noted	O
to	O
be	O
drooling	B
and	O
disoriented	B
.	O

his	O
pupils	O
were	O
sluggish	O
and	O
his	O
o2	O
sat	O
was	O
88%	O
.	O

he	O
woke	O
up	O
with	O
narcan	O
.	O

he	O
responded	O
to	O
narcan	O
initially	O
and	O
was	O
transfered	O
to	O
our	O
[	O
*	O
*	O
doctor	O
first	O
name	O
2	O
*	O
*	O
]	O
for	O
further	O
care	O
.	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
2	O
*	O
*	O
]	O
he	O
was	O
sleepy	B
but	O
awoke	O
to	O
verbal	O
stimuli	O
.	O

he	O
was	O
given	O
narcan	O
1	O
mg	O
at	O
22	O
:	O
20	O
.	O

this	O
was	O
repeated	O
at	O
1	O
:	O
50	O
.	O

he	O
also	O
recieved	O
levofloxacin	O
and	O
flagyl	O
for	O
aspiration	B
pneumonia	I
.	O

ros	O
:	O
denies	O
headache	B
,	O
visual	B
changes	I
,	O
cough	B
,	O
nausea	B
,	O
vomiting	B
,	O
shortness	B
of	I
breath	I
,	O
chest	B
pain	I
,	O
dysuria	B
,	O
abdominal	B
pain	I

past	O
medical	O
history	O
:	O

1	O
.	O
schizoaffective	B
disorder	I
s	O
/	O
p	O
multiple	B
suicide	I
attempts	I
,	O
most	O
recent	O
[	O
*	O
*	O
2018	O
-	O
03	O
-	O
14	O
*	O
*	O
]	O
od	B
on	O
motrin	O
.	O
originally	O
admitted	O
to	O
the	O
[	O
*	O
*	O
hospital1	O
6419	O
*	O
*	O
]	O
[	O
*	O
*	O
04	O
-	O
06	O
*	O
*	O
]	O
with	O
suicidal	B
thoughts	I
.	O

2	O
.	O
anxiety	B

3	O
.	O
hepatitis	B
c	I

4	O
.	O
head	B
injury	I

5	O
.	O
bendoziadepine	B
withdrawl	I
seizure	I

6	O
.	O
s	O
/	O
p	O
motrin	B
od	I

7	O
.	O
heroin	B
abuse	I

8	O
.	O
drug	B
abuse	I

9	O
.	O
s	O
/	O
p	O
ect	O

10	O
.	O
alcaholic	B
hepatitis	I
;	O
hx	O
of	O
etoh	B
abuse	I
with	O
hx	O
of	O
dts	B

social	O
history	O
:	O

unemployed	O
,	O
on	O
ssi	O
,	O
last	O
employment	O
4yrs	O
ago	O
,	O
lives	O
at	O
[	O
*	O
*	O
hospital1	O
3385	O
*	O
*	O
]	O
,	O
high	O
school	O
graduate	O
;	O
tob	O
1	O
/	O
2ppd	O

family	O
history	O
:	O

nc	O

physical	O
exam	O
:	O

vs	O
:	O
t	O
97	O
.	O
8	O
hr	O
122	O
bp	O
146	O
/	O
18	O
rr	O
16	O
o2	O
sat	O
92%	O
ra	O

gen	O
:	O
well	O
appearing	O
,	O
comfortable	O
,	O
lying	O
in	O
bed	O
asleep	O
.	O

arousable	O
to	O
voice	O
.	O

oriented	O
x	O
3	O
.	O
dysarthric	B
speech	I
.	O

heent	O
:	O
pupils	O
5mm	O
-	O
-	O
>3mm	O
,	O
eomi	O
,	O
sclera	O
anicteric	B
,	O
mm	B
dry	I
.	O

neck	O
:	O
no	O
lad	B
,	O
jvd	B
or	O
thyromegly	B
.	O

cv	O
:	O
rrr	O
with	O
no	O
m	B
/	O
r	B
/	O
g	B

lungs	O
:	O
decreased	B
breath	I
sounds	I
on	O
the	O
right	O
.	O

no	O
crackles	B
or	O
wheezes	B
.	O

percussion	O
normal	O
in	O
all	O
lung	O
fields	O
.	O

abd	O
:	O
soft	O
,	O
nt	O
,	O
nd	O
active	O
bs	O
,	O
no	O
hepatosplenomegly	B
.	O
ext	O
:	O
no	O
clubbing	B
,	O
cyanosis	B
or	O
edema	B
.	O

neuro	O
:	O
moves	O
all	O
extremities	O
.	O

oriented	O
x	O
3	O
.	O
cn	O
ii	O
-	O
xii	O
intact	O
and	O
symmetric	O
.	O

strength	O
intact	O
.	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
:	O
denies	O
hallucinations	B
.	O

reports	O
depression	B
.	O

pertinent	O
results	O
:	O

labs	O
:	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
18	O
*	O
*	O
]	O
11	O
:	O
00pm	O
blood	O
wbc	O
-	O
12	O
.	O
8	O
*	O
#	O
rbc	O
-	O
4	O
.	O
46	O
*	O
hgb	O
-	O
14	O
.	O
1	O
hct	O
-	O
39	O
.	O
4	O
*	O
mcv	O
-	O
89	O
mch	O
-	O
31	O
.	O
6	O
mchc	O
-	O
35	O
.	O
7	O
*	O
rdw	O
-	O
13	O
.	O
2	O
plt	O
ct	O
-	O
253	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
20	O
*	O
*	O
]	O
05	O
:	O
28am	O
blood	O
wbc	O
-	O
5	O
.	O
4#	O
rbc	O
-	O
4	O
.	O
51	O
*	O
hgb	O
-	O
14	O
.	O
2	O
hct	O
-	O
40	O
.	O
7	O
mcv	O
-	O
90	O
mch	O
-	O
31	O
.	O
4	O
mchc	O
-	O
34	O
.	O
9	O
rdw	O
-	O
13	O
.	O
3	O
plt	O
ct	O
-	O
258	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
18	O
*	O
*	O
]	O
11	O
:	O
00pm	O
blood	O
neuts	O
-	O
74	O
.	O
6	O
*	O
lymphs	O
-	O
17	O
.	O
4	O
*	O
monos	O
-	O
6	O
.	O
5	O
eos	O
-	O
1	O
.	O
3	O
baso	O
-	O
0	O
.	O
3	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
18	O
*	O
*	O
]	O
11	O
:	O
00pm	O
blood	O
glucose	O
-	O
112	O
*	O
urean	O
-	O
14	O
creat	O
-	O
0	O
.	O
8	O
na	O
-	O
135	O
k	O
-	O
3	O
.	O
5	O
cl	O
-	O
98	O
hco3	O
-	O
23	O
angap	O
-	O
18	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
20	O
*	O
*	O
]	O
05	O
:	O
28am	O
blood	O
glucose	O
-	O
116	O
*	O
urean	O
-	O
14	O
creat	O
-	O
0	O
.	O
8	O
na	O
-	O
138	O
k	O
-	O
4	O
.	O
3	O
cl	O
-	O
104	O
hco3	O
-	O
27	O
angap	O
-	O
11	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
03	O
:	O
36am	O
blood	O
alt	O
-	O
37	O
ast	O
-	O
17	O
alkphos	O
-	O
103	O
totbili	O
-	O
0	O
.	O
3	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
03	O
:	O
36am	O
blood	O
albumin	O
-	O
4	O
.	O
5	O
calcium	O
-	O
9	O
.	O
2	O
phos	O
-	O
3	O
.	O
2	O
mg	O
-	O
2	O
.	O
3	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
18	O
*	O
*	O
]	O
11	O
:	O
00pm	O
blood	O
asa	O
-	O
neg	O
ethanol	O
-	O
neg	O
acetmnp	O
-	O
neg	O
bnzodzp	O
-	O
neg	O
barbitr	O
-	O
neg	O
tricycl	O
-	O
neg	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
18	O
*	O
*	O
]	O
11	O
:	O
34pm	O
urine	O
bnzodzp	O
-	O
neg	O
barbitr	O
-	O
neg	O
opiates	O
-	O
pos	O
cocaine	O
-	O
neg	O
amphetm	O
-	O
neg	O
mthdone	O
-	O
neg	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
18	O
*	O
*	O
]	O
11	O
:	O
34pm	O
urine	O
color	O
-	O
straw	O
appear	O
-	O
clear	O
sp	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
-	O
1	O
.	O
007	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
18	O
*	O
*	O
]	O
11	O
:	O
34pm	O
urine	O
blood	O
-	O
neg	O
nitrite	O
-	O
neg	O
protein	O
-	O
neg	O
glucose	O
-	O
neg	O
ketone	O
-	O
neg	O
bilirub	O
-	O
neg	O
urobiln	O
-	O
neg	O
ph	O
-	O
5	O
.	O
0	O
leuks	O
-	O
neg	O

micro	O
:	O
urine	O
culture	O
(	O
final	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
20	O
*	O
*	O
]	O
)	O
:	O
no	O
growth	O
.	O

rads	O
:	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
18	O
*	O
*	O
]	O
non	O
-	O
contrast	O
head	O
ct	O
:	O

findings	O
:	O
no	O
intra	O
-	O
or	O
extra	O
-	O
axial	O
hemorrhage	B
is	O
identified	O
.	O

there	O
is	O
no	O
mass	B
effect	I
or	O
shift	B
of	O
normally	O
midline	O
structures	O
.	O

the	O
ventricles	O
are	O
normal	O
in	O
size	O
and	O
symmetric	O
,	O
and	O
the	O
basal	O
cisterns	O
are	O
well	O
visualized	O
.	O

the	O
density	O
of	O
the	O
brain	O
parenchyma	O
appears	O
unremarkable	O
.	O

the	O
visualized	O
paranasal	O
sinuses	O
demonstrate	O
marked	O
mucosal	B
thickening	I
of	O
the	O
left	O
maxillary	O
sinus	O
,	O
unchanged	O
.	O

the	O
mastoid	O
air	O
cells	O
are	O
clear	O
.	O

the	O
orbits	O
appear	O
unremarkable	O
.	O

the	O
surrounding	O
soft	O
tissue	O
structures	O
do	O
not	O
demonstrate	O
any	O
abnormalities	O
.	O

impression	O
:	O
no	O
evidence	O
of	O
intracranial	B
hemorrhage	I
or	O
mass	B
effect	I
.	O

chronic	B
mucosal	I
changes	I
in	O
the	O
left	O
maxillary	O
sinus	O
.	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
18	O
*	O
*	O
]	O
cxr	O
:	O

findings	O
:	O
there	O
is	O
an	O
ill	O
-	O
defined	O
opacity	B
in	O
the	O
right	O
lower	O
lobe	O
partially	O
obscuring	O
the	O
right	O
diaphragm	O
that	O
likely	O
represents	O
small	O
amount	O
of	O
atelectasis	B
.	O

the	O
lungs	O
are	O
otherwise	O
clear	O
.	O

the	O
left	O
costophrenic	O
angle	O
was	O
not	O
imaged	O
and	O
thus	O
a	O
small	O
left	O
pleural	B
effusion	I
cannot	O
be	O
excluded	O
.	O

the	O
cardiac	O
and	O
mediastinal	O
contours	O
are	O
stable	O
allowing	O
for	O
differences	O
in	O
projection	O
.	O

pulmonary	O
vasculature	O
is	O
normal	O
.	O

impression	O
:	O
right	O
lower	O
lobe	O
atelectasis	B

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
18	O
*	O
*	O
]	O
ecg	O
:	O
baseline	O
artifact	O

sinus	B
tachycardia	I
.	O

modest	O
nonspecific	B
st	I
-	I
t	I
wave	I
changes	I
are	O
suggested	O
but	O
baseline	O
artifact	O
makes	O
assessment	O
difficult	O
.	O

since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
02	O
*	O
*	O
]	O
,	O
sinus	B
tachycardia	I
and	O
slight	O

st	B
-	I
t	I
wave	I
changes	I
present	O

[	O
*	O
*	O
2018	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
cxr	O
:	O
lung	B
volumes	I
are	I
low	I
with	O
several	O
bibasilar	O
areas	O
of	O
atelectasis	B
.	O

the	O
heart	O
size	O
is	O
normal	O
.	O

the	O
pleural	O
surfaces	O
are	O
smooth	O
with	O
no	O
pleural	B
effusion	I
.	O

impression	O
:	O
bilateral	O
bibasilar	O
atelectasis	B
with	O
no	O
overt	O
evidence	O
of	O
pneumonia	B
.	O

brief	O
hospital	O
course	O
:	O

1	O
)	O
altered	B
mental	I
status	I
,	O
narcotic	B
overdose	I
:	O
tox	O
screen	O
negative	O
for	O
everything	O
except	O
opiates	O
.	O

patient	O
was	O
initially	O
poorly	B
responsive	I
,	O
but	O
came	O
around	O
with	O
narcan	O
.	O

admited	O
to	O
icu	O
for	O
close	O
monitoring	O
.	O

after	O
first	O
12hours	O
in	O
the	O
hospital	O
,	O
he	O
became	O
more	O
interactive	O
and	O
stated	O
that	O
while	O
out	O
on	O
his	O
day	O
pass	O
from	O
the	O
[	O
*	O
*	O
hospital1	O
6419	O
*	O
*	O
]	O
house	O
he	O
took	O
what	O
he	O
thought	O
were	O
tylenol	O
that	O
a	O
friend	O
gave	O
him	O
.	O

he	O
also	O
stated	O
that	O
on	O
occassion	O
he	O
takes	O
percocet	O
for	O
r	O
knee	B
pain	I
,	O
unclear	O
if	O
this	O
is	O
prescribed	O
for	O
him	O
and	O
if	O
so	O
which	O
md	O
prescribes	O
it	O
.	O

he	O
denied	O
taking	O
it	O
on	O
the	O
day	O
of	O
his	O
admit	O
.	O

in	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
3	O
*	O
*	O
]	O
,	O
his	O
mental	O
status	O
remained	O
stable	O
after	O
his	O
first	O
24	O
hours	O
.	O

though	O
he	O
denied	O
si	B
on	O
admit	O
,	O
he	O
does	O
have	O
a	O
strong	O
h	O
/	O
o	O
si	B
and	O
later	O
during	O
course	O
noted	O
that	O
he	O
was	O
hearing	B
voices	I
telling	O
him	O
to	O
hurt	B
himself	I
.	O

he	O
had	O
insight	O
that	O
this	O
was	O
from	O
his	O
pscyh	B
illness	I
.	O

2	O
)	O
aspiration	B
pneumonitis	I
:	O
patient	O
received	O
levofloxacin	O
and	O
flagyl	O
in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
2	O
*	O
*	O
]	O
for	O
presumed	O
asp	B
pneumonia	I
,	O
though	O
abx	O
were	O
stopped	O
once	O
he	O
arrived	O
in	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
3	O
*	O
*	O
]	O
as	O
it	O
was	O
felt	O
that	O
he	O
was	O
stable	O
and	O
likely	O
had	O
a	O
chemical	B
pneumonitis	I
from	O
aspiration	B
rather	O
than	O
pna	B
.	O

his	O
wbc	B
trended	I
down	I
,	O
he	O
remained	O
afebrile	B
,	O
and	O
his	O
respiratory	B
status	I
improved	O
.	O

3	O
)	O
substance	B
abuse	I
:	O
substance	B
abuse	I
counsellor	O
consulted	O
.	O

avoided	O
narcotics	O
or	O
sedating	O
meds	O
while	O
in	O
house	O
.	O

4	O
)	O
schizoaffective	B
disorder	I
:	O
restarted	O
psychiatric	O
medications	O
once	O
he	O
was	O
awake	O
enough	O
to	O
eat	O
,	O
except	O
for	O
neurontin	O
,	O
benadryl	O
and	O
remeron	O
at	O
the	O
advice	O
of	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
team	O
in	O
house	O
.	O

as	O
noted	O
above	O
,	O
he	O
continued	O
to	O
have	O
ah	B
regarding	O
hurting	B
himself	I
and	O
per	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
was	O
kept	O
on	O
a	O
1	O
:	O
1	O
sitter	O
,	O
despite	O
his	O
statements	O
that	O
he	O
was	O
not	O
going	O
to	O
hurt	B
himself	I
.	O

will	O
need	O
further	O
management	O
of	O
his	O
condition	O
in	O
a	O
monitored	O
locked	O
unit	O
after	O
discharge	O
from	O
medical	O
care	O
.	O

5	O
)	O
elevated	B
blood	I
glucose	I
:	O
his	O
daily	O
fasting	O
am	O
blood	O
glucose	O
values	O
ranged	O
110	O
-	O
120	O
,	O
with	O
no	O
values	O
over	O
126	O
.	O

started	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
diet	O
.	O

should	O
have	O
outpt	O
gtt	O
to	O
eval	O
for	O
impaired	B
glucose	I
tolerance	I
.	O

will	O
benefit	O
from	O
weight	O
loss	O
regimen	O
.	O

6	O
)	O
prophylaxis	O
:	O
heparin	O
sc	O
,	O
ppi	O
.	O

folate	O
,	O
thiamine	O
,	O
mvi	O
.	O

7	O
)	O
code	O
:	O
full	O
code	O

medications	O
on	O
admission	O
:	O

cogentin	O
1	O
mg	O
po	O
bid	O

clozaril	O
250	O
mg	O
po	O
qhs	O

klonopin	O
1	O
mg	O
po	O
bid	O

remeron	O
15	O
mg	O
po	O
qhs	O

neurontin	O
300	O
mg	O
po	O
qhs	O

haldol	O
5	O
mg	O
po	O
tid	O

benadryl	O
50	O
mg	O
po	O
q	O
hs	O
prn	O

mom	O
30	O
cc	O
po	O
daily	O
prn	O

mylanta	O
30	O
cc	O
po	O
q	O
4	O
prn	O

nicorette	O
gum	O
2	O
mg	O
q1	O
-	O
2	O
hrs	O
prn	O

discharge	O
medications	O
:	O

1	O
.	O
benztropine	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

2	O
.	O
clozapine	O
100	O
mg	O
tablet	O
sig	O
:	O
2	O
.	O
5	O
tablets	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
.	O

3	O
.	O
clonazepam	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

4	O
.	O
haloperidol	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
hospital	O
6419	O
*	O
*	O
]	O
hospital	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
497	O
*	O
*	O
]	O

discharge	O
diagnosis	O
:	O

altered	B
mental	I
status	I
,	O
likely	O
from	O
opiod	B
overdose	I
suicidal	I
ideation	I

schizoaffective	I
disorder	I

discharge	O
condition	O
:	O

hemodynamically	O
stable	O
,	O
with	O
no	O
further	O
evidence	O
of	O
intoxication	B
.	O

heard	B
voices	I
on	O
the	O
am	O
of	O
discharge	O
telling	O
him	O
to	O
hurt	B
himself	I
,	O
though	O
he	O
has	O
insight	O
that	O
this	O
is	O
related	O
to	O
his	O
schizoaffective	B
disorder	I
and	O
is	O
cooperative	O
with	O
his	O
treatment	O
plan	O
.	O

denies	O
a	O
desire	O
to	O
hurt	B
himself	I
currently	O
.	O

discharge	O
instructions	O
:	O

please	O
continue	O
to	O
take	O
your	O
medications	O
as	O
prescribed	O
and	O
to	O
cooperate	O
with	O
your	O
healthcare	O
team	O
.	O

also	O
,	O
if	O
you	O
hear	O
any	O
voices	O
of	O
people	O
who	O
are	O
not	O
present	O
around	O
you	O
,	O
or	O
if	O
you	O
feel	O
like	O
hurting	B
yourself	I
or	O
someone	O
else	O
around	O
you	O
,	O
please	O
let	O
your	O
caretakers	O
know	O
immediately	O
.	O

followup	O
instructions	O
:	O

please	O
follow	O
up	O
with	O
your	O
pcp	O
and	O
your	O
psychiatrist	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
3122	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
3123	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
4132	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
4133	O
*	O
*	O
]	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
20	O
*	O
*	O
]	O
@	O
1525	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
44	O
*	O
*	O
]	O
[	O
*	O
*	O
2018	O
-	O
06	O
-	O
21	O
*	O
*	O
]	O
8	O
:	O
58	O
pm	O
(	O
end	O
of	O
report	O
)	O

161	O
||||	O
14822	O
||||	O
21887	O
||||	O
discharge	O
_	O
summary	O
||||	O
2008	O
-	O
09	O
-	O
05	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2008	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2008	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1935	O
-	O
04	O
-	O
22	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
cardiothoracic	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
73	O
-	O
year	O
-	O
old	O
woman	O
with	O
known	O
three	B
-	I
vessel	I
coronary	I
artery	I
disease	I
who	O
refused	O
coronary	O
artery	O
bypass	O
grafting	O
in	O
the	O
past	O
,	O
admitted	O
two	O
days	O
prior	O
to	O
this	O
admission	O
with	O
chest	B
pain	I
,	O
ruled	O
out	O
,	O
refused	O
catheterization	O
at	O
that	O
time	O
.	O

she	O
now	O
returns	O
to	O
[	O
*	O
*	O
hospital	O
86	O
*	O
*	O
]	O
with	O
chest	B
pain	I
[	O
*	O
*	O
08	O
-	O
29	O
*	O
*	O
]	O
x	O
2	O
hours	O
associated	O
with	O
nausea	B
and	O
vomiting	B
,	O
unrelieved	O
by	O
nitroglycerin	O
.	O

in	O
the	O
emergency	O
room	O
the	O
patient	O
was	O
noted	O
to	O
be	O
pain	B
free	O
after	O
sublingual	O
nitroglycerin	O
as	O
well	O
as	O
intravenous	O
nitroglycerin	O
and	O
intravenous	O
heparin	O
.	O

her	O
electrocardiogram	O
showed	O
[	O
*	O
*	O
street	O
address	O
18	O
*	O
*	O
]	O
depressions	B
in	I
v3	I
through	I
v6	I
resolved	O
after	O
the	O
patient	O
became	O
pain	B
free	O
.	O

the	O
patient	O
has	O
agreed	O
to	O
undergo	O
coronary	O
artery	O
catheterization	O
on	O
this	O
admission	O
.	O

past	O
medical	O
history	O
:	O
her	O
past	O
medical	O
history	O
is	O
significant	O
for	O
coronary	B
artery	I
disease	I
.	O

she	O
underwent	O
a	O
catheterization	O
in	O
[	O
*	O
*	O
2003	O
*	O
*	O
]	O
,	O
which	O
showed	O
three	B
-	I
vessel	I
disease	I
including	O
80%	O
right	O
coronary	O
artery	O
,	O
90%	O
left	O
anterior	O
descending	O
coronary	O
artery	O
,	O
80%	O
circumflex	O
,	O
and	O
an	O
echocardiogram	O
in	O
[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
200	O
*	O
*	O
]	O
of	O
this	O
year	O
,	O
which	O
showed	O
normal	O
left	O
ventricle	O
and	O
right	O
ventricle	O
with	O
an	O
ejection	O
fraction	O
of	O
55%	O
and	O
no	O
abnormal	B
wall	I
motion	I
activity	I
.	O

also	O
,	O
the	O
patient	O
has	O
diabetes	B
mellitus	I
type	I
2	I
and	O
hypertension	B
,	O
as	O
well	O
as	O
hypercholesterolemia	B
.	O

medications	O
prior	O
to	O
admission	O
:	O
atenolol	O
25	O
mg	O
once	O
daily	O
;	O

isordil	O
20	O
mg	O
t	O
.	O
i	O
.	O
d	O
.	O
;	O
plavix	O
75	O
mg	O
once	O
daily	O
;	O
zestril	O
10	O
mg	O
once	O
daily	O
;	O
nph	O
insulin	O
30	O
units	O
q	O
.	O
a	O
.	O
m	O
.	O
and	O
20	O
units	O
q	O
.	O
p	O
.	O
m	O
.	O
;	O
protonix	O
40	O
mg	O
once	O
daily	O
;	O
aspirin	O
325	O
once	O
daily	O
;	O
and	O

lipitor	O
dose	O
undisclosed	O
.	O

social	O
history	O
:	O
there	O
is	O
no	O
tobacco	O
use	O
,	O
no	O
etoh	O
use	O
.	O

the	O
patient	O
lives	O
alone	O
and	O
has	O
supportive	O
children	O
who	O
look	O
in	O
on	O
her	O
frequently	O
.	O

physical	O
examination	O
:	O
examination	O
on	O
admission	O
showed	O
vital	O
signs	O
afebrile	O
,	O
heart	O
rate	O
90	O
-	O
120	O
,	O
blood	O
pressure	O
100	O
-	O
130	O
/	O
70	O
-	O
80	O
,	O
respiratory	O
rate	O
20	O
,	O
o2	O
saturation	O
96%	O
on	O
two	O
liters	O
.	O

in	O
general	O
the	O
patient	O
appeared	O
pale	B
,	O
weak	B
,	O
but	O
in	O
no	O
acute	B
distress	I
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
showed	O
mucous	O
membranes	O
moist	O
;	O
pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
;	O
extraocular	O
movements	O
intact	O
.	O

heart	O
sounds	O
showed	O
a	O
regular	O
rate	O
and	O
rhythm	O
,	O
s1	O
and	O
s2	O
,	O
no	O
murmur	B
,	O
no	O
jugular	B
venous	I
distension	I
.	O

pulmonary	O
examination	O
was	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

abdominal	O
examination	O
was	O
soft	O
,	O
nontender	O
,	O
nondistended	O
;	O
guaiac	O
negative	O
rectal	O
examination	O
.	O

extremities	O
were	O
warm	O
with	O
no	O
edema	B
.	O

neurological	O
examination	O
was	O
alert	O
and	O
oriented	O
x	O
3	O
,	O
grossly	O
intact	O
.	O

laboratory	O
studies	O
:	O
on	O
admission	O
the	O
white	O
count	O
was	O
10	O
.	O
7	O
,	O
hematocrit	O
29	O
.	O
9	O
,	O
platelet	O
count	O
223	O
,	O
ptt	O
37	O
.	O
4	O
,	O
inr	O
1	O
.	O
1	O
,	O
sodium	O
136	O
,	O
potassium	O
4	O
.	O
3	O
,	O
chloride	O
103	O
,	O
co2	O
21	O
,	O
bun	O
20	O
,	O
creatinine	O
1	O
.	O
2	O
,	O
glucose	O
204	O
,	O
ck	O
352	O
with	O
an	O
mb	O
of	O
12	O
,	O
and	O
troponin	O
21	O
.	O
2	O
.	O

chest	O
x	O
-	O
ray	O
showed	O
no	O
congestive	B
heart	I
failure	I
or	O
infiltrates	B
.	O

electrocardiogram	O
was	O
normal	O
sinus	O
rhythm	O
at	O
115	O
,	O
normal	O
axis	O
,	O
normal	O
intervals	O
,	O
[	O
*	O
*	O
street	O
address	O
18	O
*	O
*	O
]	O
depressions	B
in	I
v3	I
through	I
v6	I
;	O
[	O
*	O
*	O
street	O
address	O
726	O
*	O
*	O
]	O
depression	B
in	I
2	I
;	O
t	B
wave	I
inversions	I
in	I
2	I
,	O
3	O
,	O
and	O
v3	O
through	O
6	O
,	O
that	O
was	O
with	O
8	O
/	O
10	O
chest	B
pain	I
.	O

when	O
the	O
patient	O
was	O
pain	B
free	O
after	O
sublingual	O
nitroglycerin	O
and	O
intravenous	O
nitroglycerin	O
as	O
well	O
as	O
heparin	O
,	O
the	O
electrocardiogram	O
showed	O
normal	O
sinus	O
rhythm	O
at	O
a	O
rate	O
of	O
92	O
with	O
[	O
*	O
*	O
street	O
address	O
726	O
*	O
*	O
]	O
depression	B
in	I
v4	I
and	O
5	O
and	O
t	B
wave	I
inversions	I
in	I
v3	I
through	I
5	I
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
cardiology	O
service	O
with	O
a	O
diagnosis	O
of	O
unstable	B
angina	I
for	O
cardiac	O
catheterization	O
.	O

the	O
patient	O
was	O
brought	O
to	O
the	O
catheterization	O
laboratory	O
.	O

please	O
see	O
the	O
catheterization	O
report	O
for	O
full	O
details	O
.	O

in	O
summary	O
,	O
the	O
catheterization	O
showed	O
40%	O
left	O
main	O
,	O
90%	O
left	O
anterior	O
descending	O
coronary	O
artery	O
,	O
95%	O
circumflex	O
coronary	O
artery	O
,	O
and	O
90%	O
right	O
coronary	O
artery	O
.	O

no	O
ejection	O
fraction	O
was	O
obtained	O
at	O
that	O
time	O
.	O

the	O
patient	O
continued	O
to	O
experience	O
pain	B
during	O
the	O
catheterization	O
procedure	O
and	O
for	O
that	O
reason	O
,	O
an	O
intra	O
-	O
aortic	O
balloon	O
pump	O
was	O
placed	O
without	O
complication	O
.	O

following	O
the	O
catheterization	O
,	O
ct	O
surgery	O
was	O
consulted	O
.	O

the	O
patient	O
was	O
seen	O
by	O
ct	O
surgery	O
and	O
accepted	O
for	O
coronary	O
artery	O
bypass	O
grafting	O
.	O

on	O
[	O
*	O
*	O
2008	O
-	O
08	O
-	O
31	O
*	O
*	O
]	O
the	O
patient	O
was	O
brought	O
to	O
the	O
operating	O
room	O
at	O
which	O
time	O
she	O
underwent	O
coronary	O
artery	O
bypass	O
grafting	O
x	O
5	O
including	O
a	O
left	O
internal	O
mammary	O
artery	O
to	O
the	O
left	O
anterior	O
descending	O
coronary	O
artery	O
,	O
a	O
vein	O
graft	O
to	O
d2	O
,	O
a	O
vein	O
graft	O
to	O
obtuse	O
marginal	O
#1	O
and	O
obtuse	O
marginal	O
#3	O
sequentially	O
,	O
and	O
a	O
vein	O
graft	O
to	O
the	O
posterior	O
descending	O
coronary	O
artery	O
.	O

she	O
tolerated	O
the	O
operation	O
well	O
and	O
was	O
transferred	O
from	O
the	O
operating	O
room	O
to	O
the	O
cardiothoracic	O
intensive	O
care	O
unit	O
.	O

at	O
the	O
time	O
of	O
transfer	O
the	O
patient	O
had	O
an	O
intra	O
-	O
aortic	O
balloon	O
pump	O
at	O
1	O
:	O
1	O
propofol	O
,	O
milrinone	O
at	O
5	O
mcg	O
per	O
kg	O
per	O
minute	O
,	O

neo	O
-	O
synephrine	O
and	O
nitroglycerin	O
infusing	O
.	O

the	O
patient	O
did	O
well	O
in	O
the	O
immediate	O
postoperative	O
period	O
.	O

her	O
anesthetics	O
were	O
reversed	O
.	O

she	O
was	O
weaned	O
from	O
the	O
ventilator	O
and	O
extubated	O
,	O
however	O
her	O
balloon	O
pump	O
was	O
left	O
in	O
place	O
,	O
and	O
she	O
was	O
left	O
on	O
her	O
milrinone	O
throughout	O
the	O
course	O
of	O
her	O
first	O
operative	O
day	O
.	O

on	O
postoperative	O
day	O
one	O
the	O
patient	O
was	O
weaned	O
from	O
the	O
intra	O
-	O
aortic	O
balloon	O
pump	O
,	O
which	O
was	O
discontinued	O
at	O
that	O
time	O
.	O

she	O
did	O
,	O
however	O
,	O
continue	O
to	O
require	O
small	O
doses	O
of	O
milrinone	O
to	O
maintain	O
adequate	O
cardiovascular	O
function	O
.	O

on	O
postoperative	O
day	O
two	O
the	O
patient	O
remained	O
hemodynamically	O
stable	O
.	O

her	O
cardiac	O
function	O
was	O
good	O
.	O

her	O
milrinone	O
was	O
weaned	O
to	O
off	O
and	O
discontinued	O
.	O

she	O
did	O
however	O
,	O
on	O
that	O
day	O
,	O
experience	O
an	O
episode	O
of	O
atrial	B
fibrillation	I
,	O
which	O
was	O
treated	O
with	O
intravenous	O
lopressor	O
and	O
amiodarone	O
,	O
after	O
which	O
an	O
initial	O
loading	O
dose	O
the	O
patient	O
converted	O
to	O
normal	O
sinus	O
rhythm	O
.	O

also	O
on	O
postoperative	O
day	O
two	O
the	O
patient's	O
chest	O
tubes	O
and	O
foley	O
catheter	O
were	O
discontinued	O
,	O
and	O
she	O
was	O
transferred	O
to	O
the	O
floor	O
for	O
continuing	O
postoperative	O
care	O
and	O
cardiac	O
rehabilitation	O
.	O

over	O
the	O
next	O
several	O
days	O
the	O
patient's	O
activity	O
level	O
was	O
slowly	O
progressed	O
with	O
the	O
assistant	O
of	O
physical	O
therapy	O
.	O

she	O
remained	O
hemodynamically	O
stable	O
,	O
and	O
on	O
postoperative	O
day	O
five	O
it	O
was	O
deemed	O
that	O
she	O
was	O
stable	O
and	O
ready	O
for	O
transfer	O
to	O
a	O
rehabilitation	O
setting	O
for	O
continuing	O
postoperative	O
care	O
and	O
cardiac	O
rehabilitation	O
.	O

at	O
the	O
time	O
of	O
transfer	O
the	O
patient's	O
physical	O
examination	O
was	O
as	O
follows	O
:	O
vital	O
signs	O
-	O
temperature	O
98	O
.	O
8	O
,	O
heart	O
rate	O
80	O
and	O
sinus	O
rhythm	O
,	O
blood	O
pressure	O
145	O
/	O
85	O
,	O
respiratory	O
rate	O
18	O
,	O
o2	O
saturation	O
96%	O
on	O
room	O
air	O
.	O

her	O
weight	O
preoperatively	O
was	O
92	O
.	O
2	O
kg	O
;	O
at	O
discharge	O
was	O
97	O
.	O
4	O
kg	O
.	O

laboratory	O
data	O
showed	O
an	O
hematocrit	O
of	O
28	O
,	O
potassium	O
4	O
.	O
2	O
,	O

bun	O
22	O
,	O
creatinine	O
0	O
.	O
9	O
,	O
magnesium	O
2	O
.	O

the	O
patient	O
was	O
alert	O
and	O
oriented	O
x	O
3	O
,	O
moved	O
all	O
extremities	O
,	O
followed	O
commands	O
.	O

her	O
breath	O
sounds	O
were	O
clear	O
to	O
auscultation	O
on	O
the	O
right	O
,	O
diminished	O
at	O
the	O
left	O
base	O
[	O
*	O
*	O
01	O
-	O
23	O
*	O
*	O
]	O
of	O
the	O
way	O
up	O
.	O

heart	O
sounds	O
were	O
regular	O
rate	O
and	O
rhythm	O
,	O
s1	O
and	O
s2	O
,	O
no	O
murmurs	B
.	O

sternum	O
was	O
stable	O
,	O
incision	O
was	O
with	O

steri	O
-	O
strips	O
,	O
open	O
to	O
air	O
,	O
clean	O
and	O
dry	O
.	O

abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
nondistended	O
;	O
positive	O
bowel	O
sounds	O
with	O
well	O
-	O
healed	O
scars	B
from	O
a	O
prior	O
cholecystectomy	O
and	O
hysterectomy	O
.	O

extremities	O
are	O
warm	O
and	O
well	O
perfused	O
with	O
2	O
+	O
edema	B
.	O

left	O
leg	O
incision	O
had	O
steri	O
-	O
strips	O
,	O
open	O
to	O
air	O
,	O
small	O
amount	O
of	O
serosanguinous	O
drainage	O
from	O
the	O
upper	O
thigh	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
furosemide	O
40	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
x	O
7	O
days	O
.	O

2	O
.	O
potassium	O
chloride	O
20	O
meq	O
b	O
.	O
i	O
.	O
d	O
.	O
x	O
7	O
days	O
.	O

3	O
.	O
colace	O
100	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

4	O
.	O
aspirin	O
81	O
mg	O
once	O
daily	O
.	O

5	O
.	O
protonix	O
40	O
mg	O
once	O
daily	O
.	O

6	O
.	O
amiodarone	O
400	O
mg	O
t	O
.	O
i	O
.	O
d	O
.	O
through	O
[	O
*	O
*	O
2008	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
,	O
then	O
b	O
.	O
i	O
.	O
d	O
.	O
from	O
[	O
*	O
*	O
2008	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O
through	O
[	O
*	O
*	O
2008	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
,	O
then	O
once	O
daily	O
.	O

7	O
.	O
lopressor	O
25	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

8	O
.	O
captopril	O
50	O
mg	O
q	O
.	O

8	O
hours	O
.	O

9	O
.	O
nph	O
insulin	O
30	O
units	O
q	O
.	O
a	O
.	O
m	O
.	O
,	O
20	O
units	O
q	O
.	O
p	O
.	O
m	O
.	O
.	O

10	O
.	O

regular	O
insulin	O
via	O
sliding	O
scale	O
q	O
.	O

6	O
hours	O
.	O

11	O
.	O

ibuprofen	O
400	O
mg	O
q	O
.	O

6	O
hours	O
p	O
.	O
r	O
.	O
n	O
.	O

12	O
.	O

tylenol	O
#3	O
one	O
to	O
two	O
tablets	O
q	O
.	O

4	O
h	O
.	O
p	O
.	O
r	O
.	O
n	O
.	O

disposition	O
:	O
the	O
patient	O
is	O
to	O
be	O
discharged	O
to	O
[	O
*	O
*	O
hospital	O
727	O
*	O
*	O
]	O
in	O
the	O
acute	O
setting	O
.	O

she	O
is	O
to	O
have	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
three	O
to	O
four	O
weeks	O
,	O
and	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
in	O
three	O
to	O
four	O
weeks	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
coronary	B
artery	I
disease	I
status	O
post	O
coronary	O
artery	O
bypass	O
grafting	O
x	O
5	O
.	O

2	O
.	O
diabetes	B
mellitus	I
type	I
2	I
.	O

3	O
.	O
hypertension	B
.	O

4	O
.	O
hypercholesterolemia	B
.	O

5	O
.	O
status	O
post	O
cholecystectomy	O
.	O

6	O
.	O
status	O
post	O
total	O
abdominal	O
hysterectomy	O
/	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
12	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
13	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
14	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
54	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2008	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
11	O
:	O
01	O

t	O
:	O
[	O
*	O
*	O
2008	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
12	O
:	O
27	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
728	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
12	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
13	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2008	O
-	O
09	O
-	O
17	O
*	O
*	O
]	O
4	O
:	O
11	O
pm	O

(	O
end	O
of	O
report	O
)	O

325902	O
||||	O
14835	O
||||	O
24494	O
||||	O
radiology	O
_	O
report	O
||||	O
2017	O
-	O
04	O
-	O
15	O
10	O
:	O
41	O
:	O
00	O
.	O
0	O
||||	O
q111	O
ct	O
head	O
w	O
/	O
o	O
contrast	O
||||	O
||||	O
clip	O
#	O
369	O
-	O
4642	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2017	O
-	O
04	O
-	O
15	O
*	O
*	O
]	O
10	O
:	O
41	O
am	O

ct	O
head	O
w	O
/	O
o	O
contrast	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
6909	O
*	O
*	O
]	O
reason	O
:	O
bleed	B
admitting	O
diagnosis	O
:	O
subdural	B
hematoma	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

83	O
year	O
old	O
man	O
with	O
reason	O
for	O
this	O
examination	O
:	O
bleed	B
no	O
contraindications	O
for	O
iv	O
contrast	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
this	O
is	O
a	O
patient	O
with	O
bilateral	O
subdural	B
hematomas	I
.	O

comparison	O
:	O
comparison	O
is	O
made	O
to	O
[	O
*	O
*	O
2017	O
-	O
04	O
-	O
14	O
*	O
*	O
]	O
.	O

technique	O
:	O
64	O
-	O
mdct	O
axial	O
images	O
of	O
the	O
head	O
and	O
were	O
obtained	O
without	O
iv	O
contrast	O
.	O

findings	O
:	O
there	O
is	O
no	O
evidence	O
of	O
new	O
intracranial	B
hemorrhage	I
.	O

there	O
is	O
again	O
noted	O
post	O
-	O
surgical	O
changes	O
of	O
the	O
bilateral	B
hematoma	I
evacuation	O
.	O

there	O
is	O
again	O
noted	O
pneumocephalus	B
in	O
a	O
similar	O
amount	O
when	O
compared	O
to	O
the	O
prior	O
study	O
.	O

there	O
is	O
more	O
pneumocephalus	B
in	O
the	O
posterior	O
aspect	O
of	O
the	O
left	O
hemisphere	O
.	O

this	O
is	O
most	O
likely	O
due	O
to	O
the	O
shift	O
of	O
air	O
.	O

there	O
is	O
again	O
noted	O
loculated	B
fluid	I
/	O
hemorrhage	O
posteriorly	O
,	O
which	O
is	O
unchanged	O
in	O
size	O
when	O
compared	O
to	O
the	O
prior	O
study	O
.	O

the	O
amount	O
of	O
mass	O
effect	O
is	O
unchanged	O
.	O

there	O
is	O
no	O
ct	O
evidence	O
of	O
major	O
vascular	B
territorial	I
infarcts	I
or	O
herniations	O
.	O

the	O
ventricles	O
are	O
essentially	O
of	O
normal	O
size	O
.	O

surgical	O
drains	O
in	O
the	O
subcutaneous	O
tissues	O
are	O
unchanged	O
in	O
position	O
.	O

the	O
bone	O
structures	O
are	O
unchanged	O
when	O
compared	O
to	O
the	O
prior	O
study	O
.	O

impression	O
:	O
overall	O
stable	O
appearance	O
of	O
the	O
brain	O
.	O

there	O
is	O
no	O
evidence	O
of	O
new	O
intracranial	B
hemorrhage	I
.	O

14879	O
||||	O
14888	O
||||	O
4203	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
03	O
-	O
29	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
18	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
29	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1937	O
-	O
01	O
-	O
19	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
77	O
-	O
year	O
-	O
old	O
woman	O
with	O
a	O
long	O
history	O
of	O
aortic	B
stenosis	I
followed	O
with	O
serial	O
echocardiograms	O
.	O

the	O
patient	O
is	O
currently	O
undergoing	O
evaluation	O
for	O
orthopedic	O
procedure	O
which	O
prompted	O
repeat	O
tte	O
and	O
cardiac	O
catheterization	O
.	O

the	O
new	O
tte	O
and	O
cardiac	O
catheterization	O
revealed	O
severe	O
aortic	B
stenosis	I
with	O
preserved	O
left	O
ventricular	O
ejection	O
fraction	O
and	O
one	B
vessel	I
coronary	I
artery	I
disease	I
.	O

the	O
patient	O
is	O
asymptomatic	O
with	O
no	O
orthopnea	B
,	O
paroxysmal	B
nocturnal	I
dyspnea	I
or	O
edema	B
,	O
but	O
is	O
very	O
sedentary	B
secondary	O
to	O
degenerative	B
joint	I
disease	I
.	O

no	O
history	O
of	O
cerebrovascular	B
accident	I
of	O
transient	B
ischemic	I
attack	I
.	O

no	O
history	O
of	O
atrial	B
fibrillation	I
.	O

the	O
patient	O
denies	O
claudication	B
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
aortic	B
stenosis	I

2	O
.	O
coronary	B
artery	I
disease	I

3	O
.	O
degenerative	B
joint	I
disease	I

4	O
.	O
history	O
of	O
[	O
*	O
*	O
first	O
name5	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
7713	O
*	O
*	O
]	O
disease	O
diagnosis	O

past	O
surgical	O
history	O
:	O

1	O
.	O
open	O
reduction	O
internal	O
fixation	O
of	O
right	O
hip	O

2	O
.	O
cesarean	O
section	O

3	O
.	O
total	O
abdominal	O
hysterectomy	O

4	O
.	O
left	O
knee	O
scope	O

5	O
.	O
carpal	O
tunnel	O
surgery	O

6	O
.	O
breast	O
biopsy	O

physical	O
exam	O
:	O

head	O
,	O
ears	O
,	O
eyes	O
,	O
nose	O
and	O
throat	O
:	O
murmur	B
radiating	I
to	O
bilateral	O
carotids	O
.	O

lungs	O
:	O
clear	O

heart	O
:	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	O
3	O
/	O
6	O
systolic	B
murmur	I
.	O

abdomen	O
:	O
slightly	O
obese	O
,	O
soft	O
,	O
nontender	O
.	O

extremities	O
:	O
warm	O
,	O
no	O
edema	B
,	O
palpable	O
pulses	O
bilaterally	O
.	O

labs	O
:	O
hematocrit	O
30	O
.	O
3	O
,	O
white	O
count	O
8	O
.	O
6	O
,	O
platelets	O
266	O
.	O

chem	O
-	O
7	O
144	O
.	O
0	O
,	O
102	O
,	O
29	O
,	O
24	O
,	O
1	O
.	O
0	O
and	O
113	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
on	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
18	O
*	O
*	O
]	O
and	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
for	O
an	O
aortic	O
valve	O
replacement	O
and	O
coronary	O
artery	O
bypass	O
graft	O
x1	O
with	O
saphenous	O
vein	O
graft	O
to	O
the	O
rca	O
.	O

a	O
#23	O
ce	O
bovine	O
pericardial	O
valve	O
was	O
used	O
for	O
the	O
aortic	O
valve	O
repair	O
.	O

postoperatively	O
,	O
the	O
patient	O
did	O
well	O
and	O
was	O
transferred	O
to	O
the	O
csru	O
.	O

on	O
postoperative	O
day	O
#1	O
,	O
the	O
patient's	O
nitroglycerin	O
drip	O
was	O
weaned	O
off	O
.	O

the	O
patient's	O
swan	O
-	O
ganz	O
catheter	O
was	O
removed	O
and	O
the	O
patient's	O
chest	O
tube	O
was	O
removed	O
.	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
postoperative	O
day	O
#1	O
.	O

on	O
postoperative	O
day	O
#2	O
,	O
the	O
patient	O
continued	O
to	O
do	O
well	O
,	O
but	O
was	O
noted	O
to	O
be	O
atrial	B
fibrillation	I
.	O

an	O
amiodarone	O
bolus	O
was	O
started	O
and	O
the	O
patient	O
was	O
started	O
on	O
amiodarone	O
po	O
tid	O
.	O

on	O
postoperative	O
day	O
#2	O
,	O
the	O
patient	O
was	O
seen	O
by	O
physical	O
therapy	O
who	O
felt	O
that	O
at	O
that	O
time	O
she	O
might	O
need	O
cardiac	O
rehabilitation	O
.	O

on	O
postoperative	O
day	O
#3	O
,	O
the	O
patient	O
continued	O
to	O
do	O
well	O
and	O
her	O
wires	O
were	O
removed	O
.	O

the	O
patient	O
was	O
still	O
in	O
atrial	B
fibrillation	I
,	O
but	O
with	O
a	O
rate	O
of	O
approximately	O
80	O
.	O

on	O
postoperative	O
day	O
#4	O
,	O
the	O
patient	O
was	O
in	O
sinus	B
rhythm	I
with	O
a	O
rate	O
of	O
73	O
.	O

plans	O
were	O
made	O
for	O
discharge	O
to	O
rehabilitation	O
the	O
following	O
day	O
.	O

on	O
the	O
evening	O
of	O
postoperative	O
day	O
#4	O
,	O
the	O
patient	O
had	O
nausea	B
and	O
bilious	B
emesis	I
.	O

an	O
obstruction	O
series	O
was	O
obtained	O
and	O
the	O
patient	O
looked	O
as	O
though	O
she	O
had	O
small	B
bowel	I
obstruction	I
with	O
dilated	B
loops	I
of	O
small	O
bowel	O
and	O
assisted	O
living	O
facility	O
.	O

an	O
nasogastric	O
tube	O
was	O
placed	O
.	O

the	O
patient	O
was	O
made	O
npo	O
and	O
started	O
on	O
intravenous	O
fluids	O
.	O

the	O
patient	O
was	O
given	O
a	O

fleet's	O
enema	O
and	O
multiple	O
dulcolax	O
suppositories	O
for	O
significant	O
stool	B
impaction	I
seen	O
on	O
the	O
kub	O
.	O

the	O
patient	O
was	O
continued	O
npo	O
with	O
intravenous	O
fluids	O
until	O
postoperative	O
day	O
#8	O
when	O
the	O
patient	O
began	O
passing	B
gas	I
spontaneously	O
.	O

the	O
patient's	O
nasogastric	O
tube	O
was	O
removed	O
on	O
postoperative	O
day	O
#8	O
.	O
the	O
patient	O
was	O
started	O
on	O
sips	O
of	O
clears	O
.	O

the	O
patient	O
was	O
seen	O
again	O
by	O
physical	O
therapy	O
who	O
felt	O
that	O
at	O
this	O
time	O
the	O
patient	O
was	O
independent	O
and	O
could	O
be	O
discharged	O
to	O
home	O
without	O
rehabilitation	O
.	O

on	O
postoperative	O
day	O
#9	O
,	O
the	O
patient	O
was	O
advanced	O
to	O
a	O
regular	O
diet	O
.	O

plans	O
for	O
discharge	O
were	O
made	O
for	O
postoperative	O
day	O
#10	O
,	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
29	O
*	O
*	O
]	O
.	O

the	O
patient	O
was	O
told	O
that	O
she	O
should	O
probably	O
see	O
her	O
outpatient	O
gastroenterologist	O
for	O
work	O
up	O
,	O
as	O
this	O
small	B
bowel	I
obstruction	I
questioned	O
cancer	B
vs	O
adhesions	B
from	O
prior	O
abdominal	O
surgery	O
.	O

the	O
patient	O
was	O
discharged	O
to	O
home	O
on	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
29	O
*	O
*	O
]	O
in	O
good	O
condition	O
on	O
the	O
following	O
medications	O
:	O

1	O
.	O
colace	O
100	O
mg	O
po	O
bid	O

2	O
.	O
mobic	O
7	O
.	O
5	O
mg	O
po	O
qd	O

3	O
.	O
lipitor	O
30	O
mg	O
po	O
q	O
hs	O

4	O
.	O
amiodarone	O
400	O
mg	O
po	O
bid	O
x7	O
days	O
,	O
then	O
amiodarone	O
400	O
mg	O
po	O
qd	O
x7	O
days	O
,	O
then	O
off	O

5	O
.	O
percocet	O
5	O
/	O
325	O
1	O
to	O
2	O
tablets	O
po	O
q	O
4	O
to	O
6	O
hours	O
prn	O

6	O
.	O
lopressor	O
50	O
mg	O
po	O
bid	O

discharge	O
diagnoses	O
:	O

1	O
.	O
status	O
post	O
avr	O

2	O
.	O
coronary	O
artery	O
bypass	O
graft	O
x2	O

follow	O
up	O
:	O
the	O
patient	O
is	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
four	O
weeks	O
and	O
with	O
her	O
primary	O
care	O
physician	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
7714	O
*	O
*	O
]	O
,	O
in	O
three	O
to	O
four	O
weeks	O
.	O

the	O
patient	O
had	O
been	O
previously	O
scheduled	O
for	O
colonoscopy	O
.	O

she	O
was	O
advised	O
to	O
keep	O
this	O
appointment	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
640	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
3084	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
7059	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
28	O
*	O
*	O
]	O
10	O
:	O
21	O

t	O
:	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
28	O
*	O
*	O
]	O
10	O
:	O
29	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
7715	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
640	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
28	O
*	O
*	O
]	O
1	O
:	O
41	O
pm	O

(	O
end	O
of	O
report	O
)	O

25566	O
||||	O
14897	O
||||	O
2287	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
05	O
-	O
10	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
23	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
10	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1979	O
-	O
02	O
-	O
20	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O

history	O
of	O
present	O
illness	O
:	O
this	O
33	O
year	O
old	O
white	O
male	O
is	O
status	O
post	O
aortic	O
valve	O
replacement	O
with	O
a	O
homograft	O
in	O

[	O
*	O
*	O
2008	O
*	O
*	O
]	O
.	O

over	O
the	O
summer	O
he	O
had	O
increased	O
chest	B
tightness	I
and	O
shortness	B
of	I
breath	I
after	O
running	O
a	O
mile	O
.	O

he	O
saw	O
his	O
primary	O
care	O
physician	O
in	O
the	O
fall	O
of	O
[	O
*	O
*	O
2011	O
*	O
*	O
]	O
.	O

he	O
has	O
had	O
palpitations	B
.	O

in	O
[	O
*	O
*	O
8	O
-	O
04	O
-	O
02	O
*	O
*	O
]	O
he	O
had	O
a	O
stress	O
echocardiogram	O
which	O
revealed	O
an	O
ejection	O
fraction	O
of	O
60%	O
,	O
mild	O
left	B
ventricular	I
hypertrophy	I
,	O
ascending	O
aorta	O
of	O
3	O
.	O
9	O
cm	O
,	O
3	O
.	O
7	O
cm	O
of	O
the	O
arch	O
,	O
aortic	B
stenosis	I
with	O
a	O
peak	O
gradient	O
of	O
80	O
mm	O
of	O
mercury	O
and	O
a	O
mean	O
gradient	O
of	O
50	O
mm	O
of	O
mercury	O
,	O
with	O
an	O
aortic	O
valve	O
area	O
of	O
0	O
.	O
8	O
cm	O
squared	O
.	O

he	O
has	O
1	O
to	O
2	O
+	O
aortic	B
insufficiency	I
and	O
1	O
+	O
mitral	B
regurgitation	I
.	O

he	O
is	O
now	O
admitted	O
for	O
elective	O
redo	O
aortic	O
valve	O
replacement	O
.	O

past	O
medical	O
history	O
:	O
significant	O
for	O
a	O
history	O
of	O
aortic	B
stenosis	I
,	O
a	O
history	O
of	O
hypercholesterolemia	B
,	O
a	O
history	O
of	O
status	O
post	O
pericardial	B
effusion	I
with	O
pericarditis	B
repleted	O
with	O
steroids	O
,	O
history	O
of	O
a	O
right	O
flank	O
lipoma	B
and	O
status	O
post	O
homograft	O
aortic	O
valve	O
replacement	O
in	O
[	O
*	O
*	O
2008	O
*	O
*	O
]	O
.	O

medications	O
on	O
admission	O
:	O
minoxidil	O
1	O
drop	O
topically	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
amoxicillin	O
at	O
dental	O
examinations	O
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

his	O
last	O
dental	O
examination	O
was	O
two	O
to	O
three	O
months	O
ago	O
and	O
was	O
unremarkable	O
.	O

family	O
history	O
:	O
unremarkable	O
.	O

social	O
history	O
:	O
he	O
lives	O
with	O
his	O
wife	O
,	O
quit	O
smoking	O
,	O
drinks	O
alcohol	O
occasionally	O
.	O

physical	O
examination	O
:	O
on	O
physical	O
examination	O
he	O
is	O
a	O
well	O
developed	O
,	O
young	O
man	O
in	O
no	O
apparent	B
distress	I
.	O

vital	O
signs	O
were	O
stable	O
and	O
afebrile	O
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
examination	O
,	O
normocephalic	O
,	O
atraumatic	O
,	O
extraocular	O
movements	O
intact	O
.	O

oropharynx	O
benign	O
.	O

neck	O
was	O
supple	O
.	O

full	O
range	O
of	O
motion	O
,	O
no	O
lymphadenopathy	B
or	O
thyromegaly	B
.	O

carotids	O
2	O
+	O
and	O
equal	O
bilaterally	O
with	O
radiating	O
murmurs	O
bilaterally	O
.	O

lungs	O
were	O
clear	O
to	O
auscultation	O
and	O
percussion	O
.	O

cardiovascular	O
examination	O
,	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	O
iv	O
/	O
vi	O
holosystolic	B
murmur	I
.	O

abdomen	O
was	O
soft	O
,	O
nontender	O
with	O
positive	O
bowel	O
sounds	O
.	O

no	O
masses	B
or	O
hepatosplenomegaly	B
.	O

extremities	O
were	O
without	O
cyanosis	B
,	O
clubbing	B
or	O
edema	B
.	O

neurological	O
examination	O
was	O
nonfocal	O
.	O

pulses	O
were	O
2	O
+	O
and	O
equal	O
bilaterally	O
throughout	O
.	O

hospital	O
course	O
:	O
on	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
23	O
*	O
*	O
]	O
,	O
he	O
underwent	O
a	O
redo	O
aortic	O
valve	O
replacement	O
with	O
a	O
#19	O
st	O
.	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
regent	O
valve	O
.	O

crossclamp	O
time	O
was	O
117	O
min	O
.	O

total	O
bypass	O
time	O
was	O
166	O
minutes	O
.	O

circum	O
rest	O
time	O
8	O
minutes	O
.	O

he	O
was	O
transferred	O
to	O
the	O
cardiac	O
surgery	O
recovery	O
unit	O
on	O
neo	O
-	O
synephrine	O
and	O

propofol	O
in	O
stable	O
condition	O
.	O

his	O
postoperative	O
night	O
he	O
went	O
into	O
atrial	B
fibrillation	I
,	O
he	O
also	O
had	O
spontaneous	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
movement	O
but	O
was	O
not	O
following	B
commands	I
and	O
was	O
not	O
moving	O
his	O
extremities	O
.	O

he	O
was	O
seen	O
by	O
neurology	O
the	O
following	O
morning	O
and	O
also	O
he	O
began	O
to	O
have	O
seizures	B
.	O

he	O
was	O
loaded	O
with	O
dilantin	O
and	O
he	O
had	O
a	O
head	O
computerized	O
tomography	O
scan	O
which	O
revealed	O
a	O
right	O
frontal	O
hypodensity	B
and	O
left	O
cerebellar	O
hypodensity	B
and	O
a	O
left	O
occipital	O
hypodensity	B
.	O

he	O
remained	O
intubated	O
as	O
he	O
was	O
not	O
following	B
commands	I
.	O

he	O
had	O
his	O
chest	O
tube	O
discontinued	O
on	O
postoperative	O
day	O
#2	O
.	O
he	O
continued	O
to	O
be	O
followed	O
by	O
neurology	O
.	O

he	O
had	O
an	O
magnetic	O
resonance	O
imaging	O
scan	O
on	O
postoperative	O
day	O
#2	O
which	O
confirmed	O
these	O
multiple	B
infarcts	I
.	O

he	O
slowly	O
became	O
more	O
arousable	O
.	O

also	O
,	O
on	O
postoperative	O
day	O
#3	O
,	O
he	O
desaturated	B
and	O
had	O
a	O
lot	O
of	O
secretions	O
removed	O
but	O
recovered	O
well	O
from	O
that	O
.	O

he	O
also	O
was	O
started	O
on	O
anticoagulation	O
.	O

he	O
was	O
bronchoscoped	O
a	O
few	O
more	O
times	O
on	O
subsequent	O
days	O
and	O
tolerated	O
this	O
well	O
.	O

he	O
remained	O
intubated	O
and	O
slowly	O
regained	O
more	O
neurologic	O
and	O
became	O
more	O
awake	O
and	O
was	O
following	B
commands	I
somewhat	O
.	O

he	O
eventually	O
had	O
regained	O
his	O
extremity	O
movement	O
.	O

he	O
was	O
extubated	O
on	O
postoperative	O
day	O
#6	O
.	O
he	O
was	O
able	O
to	O
swallow	O
well	O
and	O
eat	O
.	O

he	O
was	O
followed	O
by	O
aggressive	O
occupational	O
therapy	O
and	O
physical	O
therapy	O
.	O

on	O
[	O
*	O
*	O
04	O
-	O
27	O
*	O
*	O
]	O
and	O
[	O
*	O
*	O
04	O
-	O
28	O
*	O
*	O
]	O
he	O
grew	O
out	O
coagulase	O
negative	O
staphylococcus	O
in	O
his	O
blood	O
.	O

this	O
was	O
treated	O
with	O
vancomycin	O
,	O
and	O
he	O
was	O
followed	O
closely	O
by	O
infectious	O
disease	O
.	O

on	O
postoperative	O
day	O
#8	O
he	O
was	O
transferred	O
to	O
the	O
floor	O
instrument	O
table	O
condition	O
.	O

he	O
continued	O
to	O
improve	O
neurologically	O
.	O

he	O
did	O
have	O
some	O
confusion	B
at	O
night	O
.	O

he	O
had	O
a	O
picc	O
line	O
placed	O
,	O
and	O
he	O
did	O
eventually	O
have	O
a	O
transesophageal	O
echocardiogram	O
which	O
revealed	O
on	O
the	O
posterior	O
of	O
his	O
prosthetic	O
aortic	O
valve	O
a	O
small	O
mobile	B
mass	I
which	O
was	O
felt	O
to	O
be	O
suture	O
,	O
not	O
endocarditis	B
,	O
but	O
he	O
will	O
need	O
to	O
be	O
followed	O
closely	O
for	O
this	O
.	O

infectious	O
disease	O
recommended	O
six	O
weeks	O
of	O
total	O
intravenous	O
vancomycin	O
and	O
on	O
postoperative	O
day	O
#17	O
,	O
he	O
was	O
discharged	O
to	O
rehabilitation	O
in	O
stable	O
condition	O
.	O

he	O
had	O
some	O
elevated	B
liver	I
function	I
tests	I
on	O
dilantin	O
and	O
was	O
switched	O
to	O
keppra	O
and	O
his	O
liver	B
function	I
tests	I
returned	O
to	O
very	O
close	O
to	O
normal	O
.	O

medications	O
on	O
discharge	O
:	O
his	O
medications	O
on	O
discharge	O
are	O

colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
ecotrin	O
81	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
,	O

lopressor	O
50	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
amiodarone	O
200	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
for	O
one	O
week	O
,	O
vancomycin	O
1500	O
mg	O
intravenously	O
q	O
.	O

12	O
hours	O
times	O
and	O
keppra	O
1000	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
coumadin	O
2	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
for	O
an	O
inr	O
goal	O
of	O
2	O
to	O
2	O
.	O
5	O
.	O

his	O
laboratory	O
data	O
on	O
discharge	O
revealed	O
hematocrit	O
of	O
25	O
.	O
7	O
,	O
white	O
count	O
7	O
,	O
300	O
,	O
platelets	O
513	O
,	O
000	O
,	O
sodium	O
141	O
,	O
potassium	O

4	O
.	O
0	O
,	O
chloride	O
104	O
,	O
carbon	O
dioxide	O
30	O
,	O
bun	O
13	O
,	O
creatinine	O
1	O
.	O
1	O
,	O
blood	O
sugar	O
86	O
,	O
pt	O
18	O
.	O
2	O
,	O
inr	O
2	O
.	O
2	O
.	O

his	O
alt	O
was	O
155	O
,	O
ast	O
73	O
,	O
alkaline	O
phosphatase	O
149	O
,	O
total	O
bilirubin	O
0	O
.	O
4	O
.	O

discharge	O
diagnosis	O
:	O

1	O
.	O
aortic	B
stenosis	I
,	O
status	O
post	O
aortic	O
valve	O
replacement	O
.	O

2	O
.	O
multiple	O
small	O
cerebrovascular	B
accidents	I
.	O

3	O
.	O
staphylococcus	O
coagulase	O
negative	O
bacteremia	O
.	O

4	O
.	O
atrial	B
fibrillation	I
.	O

follow	O
up	O
:	O
he	O
will	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
one	O
week	O
following	O
discharge	O
from	O
rehabilitation	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
four	O
weeks	O
,	O
dr	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
from	O
infectious	O
disease	O
on	O
[	O
*	O
*	O
49	O
-	O
01	O
-	O
13	O
*	O
*	O
]	O
at	O
11	O
:	O
30	O
am	O
and	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
747	O
*	O
*	O
]	O
from	O
neurology	O
if	O
needed	O
.	O

the	O
patient	O
will	O
also	O
every	O
week	O
while	O
on	O
vancomycin	O
have	O
a	O
trough	O
vancomycin	O
level	O
,	O
creatinine	O
,	O
complete	O
blood	O
count	O
,	O
esr	O
and	O
crp	O
which	O
will	O
be	O
called	O
to	O
the	O
infectious	O

disease	O
clinic	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
71	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
228	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
4852	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
10	O
*	O
*	O
]	O
11	O
:	O
43	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
10	O
*	O
*	O
]	O
12	O
:	O
21	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
7476	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
15	O
*	O
*	O
]	O
4	O
:	O
35	O
pm	O

(	O
end	O
of	O
report	O
)	O

102321	O
||||	O
15013	O
||||	O
13914	O
||||	O
echo	O
_	O
report	O
||||	O
2011	O
-	O
05	O
-	O
24	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
f	O
/	O
u	O
pericardial	B
effusion	I
;	O
6	O
hrs	O
s	O
/	O
p	O
tap	O

height	O
:	O
(	O
in	O
)	O
65	O

weight	O
(	O
lb	O
)	O
:	O
140	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
70	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
139	O
/	O
62	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
24	O
*	O
*	O
]	O
at	O
17	O
:	O
38	O

test	O
:	O
portable	O
tte	O
(	O
focused	O
views	O
)	O

doppler	O
:	O
no	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
ventricle	O
:	O
lv	O
systolic	O
function	O
appears	O
depressed	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

pericardium	O
:	O
there	O
is	O
a	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

lv	O
systolic	O
function	O
appears	O
depressed	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

there	O
is	O
a	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

compared	O
to	O
the	O
prior	O
study	O
earlier	O
today	O
,	O
there	O
has	O
been	O
no	O
significant	O
reaccumulation	O
of	O
fluid	B
.	O

8249	O
||||	O
15128	O
||||	O
16309	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
01	O
-	O
31	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1959	O
-	O
01	O
-	O
13	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1383	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

hemetemesis	B
and	O
melena	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

upper	O
endoscopy	O

history	O
of	O
present	O
illness	O
:	O

pt	O
is	O
a	O
55y	O
/	O
o	O
m	O
w	O
/	O
a	O
pmh	O
significant	O
for	O
etoh	B
abuse	I
resulting	O
in	O
cirrhosis	B
(	O
s	O
/	O
p	O
variceal	B
bleed	I
in	O
5	O
/	O
05	O
)	O
who	O
presented	O
to	O
an	O
osh	O
w	O
/	O
hemetematsis	B
and	O
melena	B
.	O

he	O
was	O
transfused	O
5u	O
prbc	O
,	O
2u	O
ffp	O
,	O
and	O
5u	O
plts	O
at	O
the	O
osh	O
and	O
intubated	O
for	O
airway	O
protection	O
.	O

egd	O
there	O
demonstrated	O
non	B
-	I
bleeding	I
varices	I
and	O
a	O
bleeding	B
gastric	I
ulcer	I
(	O
unable	O
to	O
successfully	O
cauterize	O
/	O
epi	O
inject	O
)	O
.	O

he	O
was	O
transfered	O
here	O
for	O
further	O
care	O
.	O

on	O
transfer	O
,	O
the	O
patient	O
was	O
hemodynamically	O
stable	O
in	O
the	O
er	O
and	O
was	O
started	O
on	O
octreotide	O
,	O
nadolol	O
,	O
protonix	O
,	O
and	O
levaquin	O
.	O

he	O
received	O
a	O
repeat	O
egd	O
which	O
showed	O
grade	O
iii	O
non	B
-	I
bleeding	I
varices	I
in	O
the	O
lower	O
3rd	O
of	O
the	O
esophagus	O
along	O
with	O
extensive	O
esophageal	B
ulceration	I
.	O

in	O
the	O
stomach	O
,	O
they	O
noted	O
severe	O
gastropathy	B
along	O
with	O
a	O
non	B
-	I
bleeding	I
proximal	I
stomach	I
lesion	I
.	O

he	O
was	O
maintained	O
on	O
a	O
ciwa	O
scale	O
throughout	O
his	O
stay	O
.	O

he	O
has	O
not	O
received	O
blood	O
products	O
since	O
admission	O
.	O

the	O
patient	O
was	O
extubated	O
on	O
[	O
*	O
*	O
01	O
-	O
27	O
*	O
*	O
]	O
,	O
tolerated	O
this	O
well	O
,	O
and	O
was	O
weaned	O
off	O
supplemental	O
o2	O
by	O
the	O
time	O
he	O
was	O
called	O
out	O
to	O
the	O
floor	O
.	O

today	O
,	O
the	O
patient	O
complains	O
of	O
intermittant	O
diffuse	O
abdominal	B
pain	I
that	O
is	O
relieved	O
with	O
passing	B
gas	I
/	O
bowel	O
movements	O
.	O

he	O
also	O
notes	O
intermittant	O
l	B
sided	I
cp	I
that	O
has	O
happened	O
on	O
and	O
off	O
for	O
the	O
past	O
several	O
months	O
only	O
while	O
he	O
is	O
active	O
.	O

he	O
denies	O
radiation	O
or	O
associated	O
symptoms	O
and	O
states	O
that	O
it	O
is	O
happening	O
~	O
1x	O
/	O
d	O
and	O
abates	O
after	O
approximately	O
1min	O
.	O

he	O
denies	O
any	O
cp	B
currently	O
and	O
also	O
denies	O
current	O
abdominal	B
pain	I
,	O
sob	B
,	O
ha	B
,	O
weakness	B
,	O
palpatations	B
,	O
paresthesias	B
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
alcoholism	B
:	O
pt	O
still	O
actively	O
drinking	O
6	O
pack	O
per	O
day	O
,	O
never	O
been	O
treated	O
for	O
w	B
/	I
d	I
,	O
never	O
seized	B

2	O
.	O
etoh	B
cirrhosis	I
s	O
/	O
p	O
variceal	B
bleed	I
[	O
*	O
*	O
05	O
-	O
30	O
*	O
*	O
]	O

3	O
.	O
inguinal	B
hernia	I
repair	O
2003	O

4	O
.	O
htn	B

5	O
.	O
pancytopenia	B
(	O
?secondary	O
to	O
etohism	B
)	O

6	O
.	O
s	O
/	O
p	O
finger	O
amputation	O

social	O
history	O
:	O

etoh	O
:	O
12	O
beers	O
/	O
day	O

no	O
tobacco	O

lives	O
with	O
wife	O
in	O
[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
3973	O
*	O
*	O
]	O
,	O
worked	O
as	O
a	O
meat	O
cutter	O
32yrs	O
.	O
states	O
sober	O
for	O
6	O
wks	O
after	O
his	O
last	O
variceal	B
bleed	I
but	O
started	O
drinking	O
after	O
this	O
because	O
of	O
the	O
stress	O
of	O
his	O
job	O
and	O
caring	O
for	O
his	O
mother	O
and	O
father	O
-	O
in	O
-	O
law	O

family	O
history	O
:	O

n	O
/	O
c	O

physical	O
exam	O
:	O

98	O
.	O
7	O
,	O
108	O
/	O
66	O
,	O
77	O
,	O
19	O
,	O
95%	O
ra	O

gen	O
:	O
well	O
appearing	O
male	O
lying	O
in	O
bed	O
in	O
nad	O

heent	O
:	O
eyes	O
-	O
nl	O
visual	O
fields	O
,	O
eomi	O
,	O
perrla	O
ears	O
-	O
tms	O
clear	O
,	O
cnviii	O
intact	O
,	O
weber	O
midline	O
mouth	O
-	O
mmm	O
,	O
red	O
/	O
purple	O
ecchymoses	B
on	O
posterior	O
palate	O
,	O
uvula	O

neck	O
:	O
small	O
2mm	O
l	O
cervical	O
ln	O
,	O
non	O
-	O
tender	O

cv	O
:	O
nl	O
pmi	O
,	O
rrr	O
,	O
-	O
m	B
/	O
r	B
/	O
g	B

lungs	O
:	O
good	O
air	O
entry	O
,	O
clear	O
to	O
percussion	O
,	O
cta	O
bilaterally	O
abd	O
:	O
s	O
/	O
nt	O
,	O
mildly	O
distended	O
,	O
+	O
bs	O
,	O
-	O
hsm	B
,	O
liver	O
span	O
4cm	O
in	O
midclavicular	O
line	O
,	O
-	O
caput	B
medusa	I
/	O
spider	B
angiomata	I
/	O
palmar	B
erythema	I

ext	O
:	O
-	O
c	B
/	O
c	B
/	O
e	B
,	O
no	O
rashes	B

neuro	O
:	O
cn	O
[	O
*	O
*	O
03	O
-	O
09	O
*	O
*	O
]	O
grossly	O
intact	O
,	O
strength	O
5	O
/	O
5	O
in	O
ue	O
and	O
le	O
bilat	O
,	O
2	O
+	O
patellar	O
reflexes	O
,	O
aao	O
x3	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2014	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
07	O
:	O
23pm	O
pt	O
-	O
13	O
.	O
9	O
*	O
ptt	O
-	O
26	O
.	O
7	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
3	O

[	O
*	O
*	O
2014	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
07	O
:	O
23pm	O
plt	O
smr	O
-	O
very	O
low	O
plt	O
count	O
-	O
78	O
*	O

[	O
*	O
*	O
2014	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
07	O
:	O
23pm	O
wbc	O
-	O
6	O
.	O
9	O
rbc	O
-	O
3	O
.	O
54	O
*	O
hgb	O
-	O
11	O
.	O
8	O
*	O
hct	O
-	O
32	O
.	O
3	O
*	O
mcv	O
-	O
91	O
mch	O
-	O
33	O
.	O
3	O
*	O
mchc	O
-	O
36	O
.	O
4	O
*	O
rdw	O
-	O
16	O
.	O
3	O
*	O

[	O
*	O
*	O
2014	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
07	O
:	O
23pm	O
albumin	O
-	O
3	O
.	O
0	O
*	O
calcium	O
-	O
6	O
.	O
6	O
*	O
phosphate	O
-	O
2	O
.	O
2	O
*	O
magnesium	O
-	O
1	O
.	O
6	O

[	O
*	O
*	O
2014	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
07	O
:	O
23pm	O
ck	O
-	O
mb	O
-	O
8	O
ctropnt	O
-	O
<0	O
.	O
01	O

[	O
*	O
*	O
2014	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
07	O
:	O
23pm	O
glucose	O
-	O
229	O
*	O
urea	O
n	O
-	O
10	O
creat	O
-	O
0	O
.	O
8	O
sodium	O
-	O
143	O
potassium	O
-	O
3	O
.	O
2	O
*	O
chloride	O
-	O
112	O
*	O
total	O
co2	O
-	O
21	O
*	O
anion	O
gap	O
-	O
13	O

[	O
*	O
*	O
2014	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
07	O
:	O
23pm	O
glucose	O
-	O
229	O
*	O
urea	O
n	O
-	O
10	O
creat	O
-	O
0	O
.	O
8	O
sodium	O
-	O
143	O
potassium	O
-	O
3	O
.	O
2	O
*	O
chloride	O
-	O
112	O
*	O
total	O
co2	O
-	O
21	O
*	O
anion	O
gap	O
-	O
13	O

[	O
*	O
*	O
2014	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
09	O
:	O
06pm	O
type	O
-	O
art	O
rates	O
-	O
/	O
15	O
tidal	O
vol	O
-	O
600	O
o2	O
-	O
40	O
po2	O
-	O
87	O
pco2	O
-	O
41	O
ph	O
-	O
7	O
.	O
37	O
total	O
co2	O
-	O
25	O
base	O
xs	O
-	O
-	O
1	O
-	O
assist	O
/	O
con	O
intubated	O
-	O
intubated	O

abd	O
u	O
/	O
s	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
27	O
*	O
*	O
]	O
:	O

1	O
.	O
nodular	B
cirrhotic	I
liver	I
.	O

2	O
.	O
small	O
amount	O
of	O
ascites	B
in	O
the	O
right	O
upper	O
quadrant	O
.	O

too	O
small	O
to	O
mark	O
a	O
spot	O
for	O
paracentesis	O
.	O

3	O
.	O
normal	O
hepatic	O
dopplers	O
.	O

4	O
.	O
gallbladder	O
wall	O
edema	B
,	O
likely	O
secondary	O
to	O
underlying	O
liver	B
disease	I

egd	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
:	O
lesion	O
in	O
proximal	O
stomach	O
body	O
as	O
previously	O
noted	O
,	O
but	O
not	O
actively	O
bleeding	B
.	O

varices	O
at	O
the	O
lower	O
third	O
of	O
the	O
esophagus	O

small	O
amounts	O
of	O
older	B
clotted	I
blood	I
was	O
seen	O
in	O
the	O
body	O
and	O
fundus	O
,	O
but	O
no	O
active	O
bleeding	B
was	O
seen	O
.	O

extensive	O
ulceration	O
of	O
the	O
mid	O
-	O
distal	O
esophagus	O
.	O

severe	O
erythema	B
,	O
congestion	B
and	O
nodularity	B
in	O
the	O
stomach	O
body	O
and	O
fundus	O
compatible	O
with	O
severe	O
portal	B
gastrophathy	I
.	O

otherwise	O
normal	O
egd	O
to	O
second	O
part	O
of	O
the	O
duodenum	O

brief	O
hospital	O
course	O
:	O

pt	O
presented	O
to	O
osh	O
,	O
with	O
hemetemesis	B
and	O
melena	B
.	O

there	O
,	O
his	O
bp	O
was	O
147	O
/	O
87	O
and	O
hr	O
was	O
100	O
.	O

an	O
ngt	O
was	O
placed	O
.	O

aspirate	O
revealed	O
1400cc	O
of	O
red	O
blood	O
.	O

an	O
egd	O
revealed	O
an	O
actively	O
bleeding	B
gastric	I
ulcer	I
and	O
nonbleeding	B
esophageal	I
varices	I
.	O

initial	O
hct	O
was	O
found	O
to	O
be	O
28	O
.	O
8	O
and	O
platelets	O
were	O
found	O
to	O
be	O
37	O
,	O
000	O
.	O

pt	O
was	O
transfused	O
5u	O
prbc	O
,	O
2u	O
ffp	O
,	O
5u	O
plts	O
.	O

pt	O
was	O
intubated	O
for	O
airway	O
protection	O
and	O
started	O
on	O
octreotide	O
,	O
protonix	O
,	O
levofloxacin	O
,	O
flagyl	O
and	O
ativan	O
.	O

pt	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
33	O
*	O
*	O
]	O
for	O
further	O
treatment	O
.	O

on	O
transfer	O
to	O
[	O
*	O
*	O
hospital1	O
33	O
*	O
*	O
]	O
,	O
pt's	O
vital	O
signs	O
were	O
stable	O
.	O

a	O
repeat	O
egd	O
was	O
performed	O
,	O
which	O
showed	O
non	O
-	O
bleeding	O
grade	O
iii	O
esophageal	O
varices	O
in	O
the	O
lower	O
[	O
*	O
*	O
01	O
-	O
28	O
*	O
*	O
]	O
of	O
the	O
esophagus	O
.	O

in	O
addition	O
,	O
there	O
were	O
extensive	O
ulcerations	O
in	O
both	O
esophagus	O
and	O
stomach	O
.	O

the	O
stomach	O
was	O
found	O
to	O
be	O
diffusely	O
erythematous	B
,	O
congested	B
and	O
nodular	B
with	O
evidence	O
of	O
severe	O
gastropathy	B
.	O

there	O
were	O
a	O
few	O
dark	O
clots	O
with	O
no	O
active	O
bleeding	B
.	O

in	O
the	O
greater	O
curvature	O
,	O
there	O
was	O
heaped	B
up	I
mucosa	I
,	O
likely	O
the	O
area	O
of	O
recent	O
hemorrhage	B
.	O

the	O
nature	O
of	O
the	O
lesion	B
,	O
(	O
a	O
gastric	B
varix	I
versus	O
focal	O
bleed	B
of	I
gastropathy	I
versus	O
bleeding	B
ulcer	I
)	O
was	O
unable	O
to	O
be	O
determined	O
.	O

no	O
intervention	O
was	O
performed	O
.	O

in	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
,	O
pt	O
was	O
stable	O
.	O

he	O
has	O
not	O
required	O
any	O
further	O
blood	O
products	O
.	O

hct	O
has	O
been	O
stable	O
,	O
fluctuating	O
within	O
a	O
range	O
of	O
30	O
.	O
5	O
-	O
33	O
.	O
8	O
.	O

he	O
passed	O
2	O
more	O
melenic	B
stools	I
in	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
.	O

pt	O
was	O
extubated	O
on	O
[	O
*	O
*	O
01	O
-	O
27	O
*	O
*	O
]	O
and	O
tolerated	O
a	O
wean	O
of	O
supplemental	O
o2	O
.	O

a	O
ruq	O
u	O
/	O
s	O
was	O
obtained	O
,	O
which	O
showed	O
a	O
small	O
amount	O
of	O
ascites	B
.	O

the	O
liver	B
was	I
nodular	I
and	O
superior	O
mesenteric	O
,	O
portal	O
and	O
splenic	O
veins	O
and	O
hepatic	O
arteries	O
and	O
veins	O
were	O
patent	O
.	O

pt	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
[	O
*	O
*	O
01	O
-	O
29	O
*	O
*	O
]	O
.	O

his	O
vital	O
signs	O
remained	O
stable	O
.	O

his	O
hct	O
remained	O
stable	O
at	O
30	O
-	O
34	O
with	O
no	O
further	O
episodes	O
of	O
hemetemesis	B
or	O
melena	B
.	O

pt	O
will	O
obtain	O
a	O
repeat	O
egd	O
as	O
well	O
as	O
a	O
colonoscopy	O
as	O
an	O
outpatient	O
.	O

he	O
will	O
follow	O
up	O
the	O
liver	O
clinic	O
(	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3974	O
*	O
*	O
]	O
)	O
on	O
tuesday	O
[	O
*	O
*	O
02	O
-	O
04	O
*	O
*	O
]	O
,	O
to	O
have	O
a	O
repeat	O
egd	O
.	O

given	O
the	O
pt's	O
history	O
of	O
chronic	B
etoh	I
abuse	I
,	O
dt	B
prophylaxis	O
with	O
diazepam	O
was	O
continued	O
,	O
following	O
a	O
ciwa	O
scale	O
.	O

on	O
[	O
*	O
*	O
01	O
-	O
28	O
*	O
*	O
]	O
and	O
[	O
*	O
*	O
01	O
-	O
29	O
*	O
*	O
]	O
the	O
patient	O
had	O
2	O
episodes	O
of	O
asymptomatic	O
nsvt	B
.	O

mg	O
and	O
k	O
were	O
repleted	O
as	O
they	O
were	O
low	O
normal	O
.	O

an	O
echo	O
was	O
performed	O
which	O
revealed	O
preserved	O
biventricular	O
function	O
.	O

he	O
continued	O
to	O
have	O
low	O
normal	O
potassium	O
and	O
magnesium	O
which	O
was	O
aggressively	O
repleted	O
.	O

his	O
electrolyte	B
loss	I
was	O
attributed	O
to	O
his	O
alcoholic	B
liver	I
disease	I
.	O

the	O
pt	O
was	O
also	O
found	O
to	O
be	O
pancytopenic	B
which	O
platelet	O
counts	O
in	O
the	O
40s	O
to	O
60s	O
and	O
mild	O
leukopenia	B
ranging	O
aroun	O
3700	O
.	O

platelet	O
counts	O
and	O
leukocytes	O
remained	O
stable	O
.	O

pt	O
met	O
with	O
social	O
worker	O
to	O
discuss	O
outpatient	O
addiction	B
services	O
.	O

after	O
contacting	O
several	O
programs	O
,	O
the	O
patient	O
decided	O
to	O
attend	O
a	O
daily	O
group	O
program	O
with	O
his	O
son	O
.	O

his	O
family	O
is	O
supportive	O
of	O
this	O
decision	O
.	O

medications	O
on	O
admission	O
:	O

octreotide	O
gtt	O

levofloxacin	O
500mg	O
iv	O
x	O
1	O

flagyl	O
500	O
mg	O
iv	O
x	O
1	O

protonix	O
80	O
mg	O
iv	O
x	O
1	O

ativan	O
gtt	O

discharge	O
medications	O
:	O

1	O
.	O
thiamine	O
hcl	O
100	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
levofloxacin	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
for	O
5	O
days	O
.	O

disp	O
:	O
*	O
5	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

3	O
.	O
venlafaxine	O
37	O
.	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
tid	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
90	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
folic	O
acid	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
mag	O
-	O
caps	O
140	O
mg	O
capsule	O
sig	O
:	O
three	O
(	O
3	O
)	O
capsule	O
po	O
three	O
times	O
a	O
day	O
:	O
do	O
not	O
take	O
together	O
with	O
levofloxacin	O
.	O

disp	O
:	O
*	O
180	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

6	O
.	O
nadolol	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

7	O
.	O
potassium	O
chloride	O
20	O
meq	O
tab	O
sust	O
.	O
rel	O
.	O

particle	O
/	O
crystal	O
sig	O
:	O
two	O
(	O
2	O
)	O
tab	O
sust	O
.	O
rel	O
.	O

particle	O
/	O
crystal	O
po	O
twice	O
a	O
day	O
.	O

disp	O
:	O
*	O
120	O
tab	O
sust	O
.	O
rel	O
.	O

particle	O
/	O
crystal	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

8	O
.	O
pantoprazole	O
40	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
twice	O
a	O
day	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

gastrointestinal	B
bleed	I
,	O
originating	O
most	O
likely	O
from	O
gastric	B
lesion	I
.	O

no	O
evidence	O
of	O
bleeding	O
from	O
esophageal	O
varices	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O
.	O

liver	B
cirrhosis	I

esophageal	I
varices	I

mild	O
mitral	B
regurgitation	I

small	O
ascites	B

discharge	O
condition	O
:	O

stable	O
hematocrit	O
,	O
good	O
condition	O

discharge	O
instructions	O
:	O

please	O
come	O
back	O
to	O
the	O
hospital	O
or	O
see	O
your	O
primary	O
care	O
doctor	O
if	O
you	O
have	O
any	O
,	O
nausea	B
,	O
vomiting	B
,	O
bloody	O
or	O
dark	B
stools	I
,	O
lightheadedness	B
,	O
dizziness	B
or	O
any	O
other	B
concerns	I
.	O

please	O
take	O
all	O
the	O
medications	O
as	O
instructed	O
.	O

followup	O
instructions	O
:	O

please	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
314	O
*	O
*	O
]	O
on	O
the	O
[	O
*	O
*	O
02	O
-	O
04	O
*	O
*	O
]	O
.	O

please	O
be	O
at	O
the	O
[	O
*	O
*	O
wardname	O
266	O
*	O
*	O
]	O
building	O
at	O
8am	O
to	O
have	O
your	O
endoscopy	O
at	O
9am	O
.	O

afterwards	O
you	O
will	O
see	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
314	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1387	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
2339	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2340	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2341	O
*	O
*	O
]	O
[	O
*	O
*	O
2014	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
@	O
1847	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
sun	O
[	O
*	O
*	O
2014	O
-	O
03	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
36	O
pm	O

(	O
end	O
of	O
report	O
)	O

26154	O
||||	O
15272	O
||||	O
27483	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
05	O
-	O
21	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

[	O
*	O
*	O
unit	O
number	O
8819	O
*	O
*	O
]	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
14	O
*	O
*	O
]	O

discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
21	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1960	O
-	O
08	O
-	O
17	O
*	O
*	O
]	O

sex	O
:	O
f	O

service	O
:	O
csu	O

history	O
of	O
present	O
illness	O
:	O
this	O
51	O
-	O
year	O
-	O
old	O
female	O
had	O
an	O
aortic	O
valvuloplasty	O
performed	O
via	O
a	O
sternotomy	O
in	O
[	O
*	O
*	O
1987	O
*	O
*	O
]	O
at	O
[	O
*	O
*	O
hospital	O
422	O
*	O
*	O
]	O
with	O
a	O
known	O
diagnostic	O
of	O
bicuspid	B
aortic	I
valve	I
and	O
complaints	O
of	O
increasing	O
fatigue	B
and	O
decreasing	O
exercise	B
tolerance	I
over	O
the	O
past	O
year	O
.	O

she	O
had	O
been	O
followed	O
by	O
cardiologists	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
879	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
7729	O
*	O
*	O
]	O
and	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
8820	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
8821	O
*	O
*	O
]	O
at	O
[	O
*	O
*	O
hospital	O
422	O
*	O
*	O
]	O
.	O

recently	O
,	O
echocardiogram	O
and	O
cath	O
were	O
performed	O
which	O
revealed	O
severe	O
aortic	B
stenosis	I
.	O

preoperatively	O
,	O
a	O
cardiac	O
cath	O
was	O
performed	O
at	O
[	O
*	O
*	O
hospital	O
8239	O
*	O
*	O
]	O
hospital	O
.	O

it	O
showed	O
normal	O
coronaries	O
and	O
aortic	O
valve	O
area	O
of	O
0	O
.	O
6	O
cm	O
to	O
0	O
.	O
8	O
cm2	O
,	O
and	O
a	O
gradient	O
of	O
60	O
mmhg	O
.	O

cardiac	O
echo	O
performed	O
on	O
[	O
*	O
*	O
2012	O
-	O
04	O
-	O
19	O
*	O
*	O
]	O
showed	O
a	O
bicuspid	B
aortic	I
valve	I
with	O
a	O
gradient	O
of	O
103	O
mmhg	O
,	O
normal	O
lv	O
function	O
,	O
normal	O
sinus	O
,	O
normal	O
aortic	O
root	O
,	O
and	O
no	O
aortic	B
regurgitation	I
.	O

her	O
ascending	O
aorta	O
was	O
3	O
.	O
9	O
cm	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
aortic	O
valvuloplasty	O
in	O
[	O
*	O
*	O
1987	O
*	O
*	O
]	O
.	O

2	O
.	O
prior	O
surgical	O
history	O
also	O
includes	O
inguinal	O
herniorrhaphy	O
on	O
the	O
right	O
in	O
[	O
*	O
*	O
2003	O
*	O
*	O
]	O
.	O

3	O
.	O
tonsillectomy	O
and	O
adenoidectomy	O
as	O
a	O
child	O
.	O

4	O
.	O
laparotomy	O
in	O
[	O
*	O
*	O
1998	O
*	O
*	O
]	O
.	O

medications	O
prior	O
to	O
admission	O
:	O

1	O
.	O
calcium	O
and	O
vitamin	O
d	O
daily	O
.	O

2	O
.	O
multivitamin	O
1	O
daily	O
.	O

3	O
.	O
antibiotics	O
p	O
.	O
r	O
.	O
n	O
.	O
for	O
dental	O
procedures	O
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

family	O
history	O
:	O
noncontributory	O
.	O

social	O
history	O
:	O
she	O
lives	O
with	O
her	O
husband	O
and	O
works	O
as	O
a	O
housewife	O
.	O

she	O
had	O
a	O
dental	O
exam	O
in	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
21	O
*	O
*	O
]	O
.	O

she	O
has	O
no	O
tobacco	O
history	O
.	O

consumed	O
1	O
glass	O
of	O
wine	O
periodically	O
.	O

she	O
had	O
no	O
history	O
of	O
other	O
recreational	O
drugs	O
.	O

preop	O
lab	O
work	O
:	O
white	O
count	O
7	O
.	O
5	O
,	O
hematocrit	O
41	O
.	O
8	O
,	O
platelet	O
count	O
330	O
,	O
000	O
,	O
pt	O
12	O
.	O
1	O
,	O
ptt	O
27	O
.	O
7	O
,	O
inr	O
1	O
.	O
0	O
.	O

urinalysis	O
negative	O
.	O

sodium	O
142	O
,	O
k	O
3	O
.	O
8	O
,	O
chloride	O
101	O
,	O
bicarb	O
31	O
,	O
bun	O
14	O
,	O
creatinine	O
0	O
.	O
8	O
,	O
blood	O
sugar	O
79	O
,	O
hpa1c	O
of	O
5	O
.	O
2%	O
.	O

alt	O
17	O
,	O
ast	O
20	O
,	O
alkaline	O
phosphatase	O
73	O
,	O
total	O
bilirubin	O
0	O
.	O
5	O
,	O
total	O
protein	O
7	O
.	O
1	O
,	O
albumin	O
4	O
.	O
8	O
,	O
globulin	O
2	O
.	O
3	O
.	O

preop	O
chest	O
x	O
-	O
ray	O
showed	O
prior	O
median	O
sternotomy	O
with	O
a	O
tortuous	B
aorta	I
.	O

lungs	O
were	O
clear	O
.	O

prior	O
ekg	O
preoperatively	O
showed	O
sinus	B
rhythm	I
at	O
60	O
with	O
a	O
poor	B
r	I
wave	I
progression	I
.	O

exam	O
:	O
she	O
was	O
in	O
sinus	O
rate	O
at	O
a	O
rate	O
of	O
80	O
,	O
respiratory	O
rate	O
16	O
,	O
blood	O
pressure	O
118	O
/	O
78	O
on	O
the	O
left	O
,	O
height	O
5	O
feet	O
1	O
inch	O
tall	O
,	O
weight	O
118	O
pounds	O
.	O

she	O
appeared	O
her	O
stated	O
age	O
and	O
was	O
in	O
no	O
apparent	O
distress	O
.	O

she	O
had	O
no	O
obvious	O
skin	B
lesions	I
and	O
was	O
unremarkable	O
.	O

her	O
eoms	O
were	O
intact	O
.	O

her	O
pupils	O
were	O
round	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

her	O
neck	O
was	O
supple	O
.	O

she	O
had	O
full	O
range	O
of	O
motion	O
with	O
no	O
lymphadenopathy	B
or	O
thyromegaly	B
noted	O
.	O

her	O
lungs	O
were	O
clear	O
bilaterally	O
without	O
any	O
rales	B
or	O
rhonchi	B
.	O

she	O
had	O
a	O
well	O
-	O
healed	O
sternal	O
incision	O
from	O
her	O
aortic	O
valvuloplasty	O
.	O

heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	O
grade	B
iv	I
/	I
vi	I
systolic	I
ejection	I
murmur	I
that	O
radiated	O
throughout	O
her	O
chest	O
.	O

her	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
nondistended	O
with	O
positive	O
bowel	O
sounds	O
.	O

extremities	O
were	O
warm	O
and	O
well	O
-	O
perfused	O
with	O
no	O
peripheral	B
edema	I
.	O

she	O
had	O
no	O
obvious	O
large	O
varicosities	B
.	O

she	O
was	O
grossly	O
intact	O
neurologically	O
with	O
cranial	O
nerves	O
ii	O
through	O
xii	O
grossly	O
intact	O
with	O
a	O
nonfocal	O
exam	O
,	O
was	O
alert	O
and	O
oriented	O
x3	O
.	O

she	O
had	O
bilateral	O
2	O
+	O
femoral	O
,	O
dp	O
and	O
pt	O
pulses	O
.	O

she	O
had	O
no	O
carotid	B
bruit	I
noted	O
.	O

sh	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
8822	O
*	O
*	O
]	O
admitted	O
on	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
14	O
*	O
*	O
]	O
and	O
underwent	O
redo	O
sternotomy	O
and	O
aortic	O
valve	O
replacement	O
with	O
a	O
21	O
mm	O
ce	O
magna	O
thermafix	O
pericardial	O
valve	O
and	O
a	O
22	O
mm	O
gelweave	O
thoracic	O
outlet	O
ascending	O
aorta	O
graft	O
by	O
dr	O
.	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
162	O
*	O
*	O
]	O
and	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
8823	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
doctor	O
last	O
name	O
5000	O
*	O
*	O
]	O
of	O
[	O
*	O
*	O
hospital	O
422	O
*	O
*	O
]	O
.	O

she	O
was	O
transferred	O
to	O
the	O
cardiothoracic	O
icu	O
in	O
a	O
stable	O
condition	O
in	O
sinus	B
rhythm	I
on	O
an	O
epinephrine	O
drip	O
at	O
0	O
.	O
02	O
mcg	O
/	O
kg	O
/	O
min	O
,	O
a	O
levophed	O
drip	O
of	O
0	O
.	O
03	O
mcg	O
/	O
kg	O
/	O
min	O
,	O
and	O
a	O
propofol	O
drip	O
of	O
50	O
mcg	O
/	O
kg	O
/	O
min	O
.	O

of	O
note	O
,	O
the	O
patient	O
did	O
have	O
2	O
separate	O
cardiopulmonary	O
bypass	O
runs	O
.	O

please	O
refer	O
to	O
the	O
operative	O
dictated	O
report	O
.	O

on	O
postoperative	O
day	O
1	O
,	O
the	O
patient	O
was	O
weaning	O
slowly	O
,	O
was	O
agitated	B
on	O
cpap	O
,	O
with	O
a	O
cardiac	O
index	O
of	O
3	O
.	O
34	O
,	O
a	O
stable	O
blood	O
pressure	O
of	O
93	O
/	O
62	O
,	O
and	O
t	O
-	O
max	O
of	O
100	O
.	O
6	O
.	O

she	O
was	O
in	O
sinus	B
rhythm	I
at	O
86	O
with	O
a	O
postoperative	O
white	O
count	O
of	O
8	O
.	O
4	O
,	O
hematocrit	O
27	O
.	O
9	O
,	O
and	O
creatinine	O
of	O
0	O
.	O
7	O
.	O

she	O
was	O
in	O
no	O
apparent	O
distress	B
and	O
was	O
alert	O
.	O

her	O
heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
,	O
and	O
her	O
chest	O
was	O
stable	O
.	O

her	O
lungs	O
were	O
clear	O
bilaterally	O
.	O

she	O
had	O
2	O
+	O
peripheral	B
edema	I
in	O
her	O
extremities	O
.	O

she	O
was	O
on	O
a	O
nitroglycerin	O
drip	O
at	O
1	O
.	O
0	O
and	O
an	O
epinephrine	O
drip	O
at	O
0	O
.	O
02	O
,	O
as	O
well	O
as	O
an	O
insulin	O
drip	O
at	O
3	O
units	O
/	O
h	O
,	O
and	O
was	O
started	O
on	O
her	O
low	O
-	O
dose	O
aspirin	O
.	O

she	O
also	O
began	O
lasix	O
diuresis	O
.	O

she	O
was	O
seen	O
postoperatively	O
also	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
8824	O
*	O
*	O
]	O
,	O
her	O
surgeon	O
from	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
,	O
as	O
well	O
as	O
the	O
cardiology	O
fellow	O
from	O
[	O
*	O
*	O
hospital	O
422	O
*	O
*	O
]	O
.	O

she	O
was	O
also	O
seen	O
and	O
evaluated	O
by	O
case	O
management	O
.	O

on	O
postoperative	O
day	O
2	O
,	O
she	O
was	O
off	O
her	O
epinephrine	O
drip	O
and	O
began	O
gentle	O
beta	O
blockade	O
with	O
lopressor	O
12	O
.	O
5	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

she	O
was	O
in	O
sinus	B
rhythm	I
with	O
a	O
pressure	O
of	O
92	O
/	O
46	O
.	O

she	O
also	O
had	O
decreased	B
breath	I
sounds	I
at	O
her	O
bases	O
.	O

chest	O
tubes	O
remained	O
in	O
place	O
,	O
and	O
the	O
patient	O
had	O
been	O
extubated	O
the	O
day	O
prior	O
.	O

on	O
postoperative	O
day	O
2	O
,	O
the	O
patient	O
was	O
also	O
transferred	O
out	O
to	O
the	O
floor	O
and	O
was	O
encouraged	O
to	O
increase	O
her	O
pulmonary	O
toilet	O
with	O
incentive	O
spirometry	O
,	O
was	O
started	O
on	O
a	O
low	O
dosed	O
statin	O
,	O
and	O
was	O
given	O
toradol	O
iv	O
q	O
.	O

6	O
for	O
several	O
doses	O
and	O
then	O
switched	O
over	O
to	O
ultram	O
.	O

mediastinal	O
chest	O
tubes	O
and	O
pacing	O
wires	O
were	O
removed	O
.	O

lasix	O
was	O
switched	O
over	O
to	O
p	O
.	O
o	O
.	O
dosing	O
20	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

the	O
patient	O
was	O
encouraged	O
to	O
increase	O
her	O
activity	O
level	O
.	O

she	O
remained	O
in	O
sinus	B
rhythm	I
with	O
a	O
stable	O
creatinine	O
of	O
0	O
.	O
6	O
,	O
and	O
a	O
stable	O
hematocrit	O
at	O
26	O
.	O
2	O
.	O

her	O
sternal	O
incision	O
was	O
clean	O
,	O
dry	O
and	O
intact	O
and	O
was	O
stable	O
.	O

the	O
patient	O
had	O
some	O
flatus	B
that	O
morning	O
,	O
but	O
no	O
bowel	B
movement	I
at	O
the	O
time	O
,	O
and	O
was	O
again	O
encouraged	O
to	O
increase	O
her	O
activity	O
level	O
and	O
fluid	O
intake	O
.	O

of	O
note	O
,	O
on	O
postoperative	O
day	O
3	O
,	O
the	O
patient	O
had	O
a	O
blood	O
pressure	O
of	O
90	O
-	O
100	O
/	O
50	O
with	O
a	O
little	O
bit	O
of	O
elevated	O
jvp	B
.	O

she	O
was	O
also	O
seen	O
and	O
evaluated	O
by	O
her	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
cardiology	O
attending	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
940	O
*	O
*	O
]	O
.	O

her	O
lopressor	O
was	O
held	O
for	O
her	O
blood	O
pressure	O
at	O
that	O
time	O
.	O

the	O
patient	O
remained	O
pleasant	O
and	O
cooperative	O
and	O
well	O
-	O
oriented	O
.	O

she	O
received	O
1	O
unit	O
of	O
packed	O
cells	O
on	O
the	O
26th	O
with	O
a	O
blood	O
pressure	O
of	O
83	O
/	O
42	O
prior	O
to	O
transfusion	O
.	O

she	O
continued	O
to	O
work	O
with	O
nurses	O
and	O
physical	O
therapist	O
.	O

her	O
mediastinal	O
chest	O
tube	O
and	O
her	O
pacing	O
wires	O
had	O
been	O
removed	O
that	O
morning	O
also	O
.	O

her	O
beta	O
blockade	O
was	O
discontinued	O
.	O

pleural	O
tubes	O
remained	O
in	O
place	O
.	O

her	O
foley	O
was	O
on	O
gravity	O
drainage	O
with	O
a	O
plan	O
to	O
discontinue	O
the	O
foley	O
later	O
in	O
the	O
afternoon	O
.	O

on	O
postoperative	O
day	O
5	O
,	O
the	O
patient	O
had	O
no	O
events	O
overnight	O
,	O
remained	O
off	O
her	O
beta	O
blockade	O
.	O

a	O
chest	O
x	O
-	O
ray	O
was	O
ordered	O
.	O

she	O
was	O
encouraged	O
to	O
continue	O
ambulating	O
,	O
and	O
discharge	O
planning	O
was	O
begun	O
.	O

she	O
had	O
a	O
moderate	O
amount	O
of	O
drainage	O
from	O
her	O
left	O
pleural	O
chest	O
tube	O
site	O
.	O

her	O
central	O
venous	O
line	O
had	O
already	O
been	O
removed	O
,	O
and	O
pacing	O
wires	O
had	O
already	O
also	O
been	O
removed	O
.	O

she	O
was	O
alert	O
and	O
oriented	O
and	O
nonfocal	O
.	O

her	O
heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
,	O
and	O
sternal	O
incision	O
was	O
clean	O
,	O
dry	O
and	O
intact	O
.	O

she	O
remained	O
afebrile	O
.	O

on	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
233	O
*	O
*	O
]	O
perative	O
day	O
6	O
,	O
the	O
patient	O
continue	O
on	O
diuresis	O
with	O
lasix	O
20	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

hematocrit	O
remained	O
stable	O
at	O
29	O
.	O
2	O
,	O
and	O
her	O
exam	O
was	O
otherwise	O
unremarkable	O
.	O

her	O
peripheral	B
edema	I
remained	O
only	O
trace	O
at	O
that	O
time	O
,	O
and	O
she	O
continued	O
to	O
make	O
excellent	O
progress	O
.	O

her	O
left	O
pleural	O
tube	O
was	O
also	O
removed	O
on	O
postoperative	O
day	O
6	O
,	O
and	O
she	O
was	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
with	O
vna	O
services	O
on	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
21	O
*	O
*	O
]	O
with	O
the	O
following	O
recommendations	O
for	O
follow	O
-	O
up	O
:	O
she	O
was	O
instructed	O
to	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
8825	O
*	O
*	O
]	O
in	O
2	O
-	O
3	O
weeks	O
postdischarge	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
8826	O
*	O
*	O
]	O
,	O
her	O
primary	O
care	O
,	O
in	O
1	O
-	O
2	O
weeks	O
postdischarge	O
,	O
to	O
see	O
her	O
cardiologist	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
7729	O
*	O
*	O
]	O
,	O
postoperatively	O
,	O
and	O
to	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
162	O
*	O
*	O
]	O
in	O
the	O
office	O
at	O
4	O
weeks	O
for	O
postop	O
surgical	O
visit	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
status	O
post	O
redo	O
sternotomy	O
with	O
aortic	O
valve	O
replacement	O
and	O
replacement	O
of	O
ascending	O
aorta	O
.	O

2	O
.	O
status	O
post	O
aortic	O
valvuloplasty	O
in	O
[	O
*	O
*	O
1987	O
*	O
*	O
]	O
.	O

3	O
.	O
status	O
post	O
right	O
inguinal	O
herniorrhaphy	O
,	O
tonsillectomy	O
and	O
adenoidectomy	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
for	O
30	O
days	O
.	O

2	O
.	O
enteric	O
-	O
coated	O
aspirin	O
81	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

3	O
.	O
tramadol	O
50	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
[	O
*	O
*	O
03	O
-	O
28	O
*	O
*	O
]	O
h	O
.	O
as	O
needed	O
.	O

4	O
.	O
potassium	O
chloride	O
20	O
meq	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
for	O
7	O
days	O
.	O

5	O
.	O
lasix	O
20	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
for	O
7	O
days	O
.	O

6	O
.	O
zantac	O
150	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

the	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
on	O
[	O
*	O
*	O
49	O
-	O
02	O
-	O
12	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
160	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
161	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
162	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
02351	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
239	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
06	O
*	O
*	O
]	O
11	O
:	O
09	O
:	O
48	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
06	O
*	O
*	O
]	O
11	O
:	O
49	O
:	O
54	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
8827	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
16	O
*	O
*	O
]	O
5	O
:	O
35	O
pm	O

(	O
end	O
of	O
report	O
)	O

348292	O
||||	O
15295	O
||||	O
12622	O
||||	O
radiology	O
_	O
report	O
||||	O
2013	O
-	O
02	O
-	O
17	O
09	O
:	O
37	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
389	O
-	O
7196	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2013	O
-	O
02	O
-	O
17	O
*	O
*	O
]	O
9	O
:	O
37	O
am	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
1913	O
*	O
*	O
]	O
reason	O
:	O
effusion?	O

admitting	O
diagnosis	O
:	O
chf\coronary	O
artery	O
bypass	O
graft	O
;	O
epicardial	O
lead	O
placement	O
/	O
sda	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

s	O
/	O
p	O
cabgx3	O
/	O
epicardial	O
lead	O
placement	O

reason	O
for	O
this	O
examination	O
:	O

effusion?	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

chest	O
,	O
single	O
view	O

history	O
:	O
status	O
post	O
cabg	O
and	O
epicardial	O
lead	O
placement	O
,	O
question	O
effusion	B
.	O

reference	O
exam	O
:	O
[	O
*	O
*	O
02	O
-	O
16	O
*	O
*	O
]	O

findings	O
:	O
again	O
noted	O
are	O
epicardial	O
leads	O
projecting	O
over	O
the	O
cardiac	O
apex	O
.	O

the	O
patient	O
is	O
status	O
post	O
median	O
sternotomy	O
with	O
skin	O
staples	O
in	O
place	O
.	O

there	O
is	O
a	O
right	O
ij	O
swan	O
-	O
ganz	O
catheter	O
with	O
tip	O
poorly	O
visualized	O
.	O

it	O
is	O
unclear	O
where	O
the	O
tip	O
of	O
the	O
catheter	O
is	O
located	O
.	O

if	O
clinically	O
indicated	O
,	O
this	O
film	O
should	O
be	O
repeated	O
to	O
ascertain	O
location	O
of	O
the	O
tip	O
of	O
swan	O
-	O
ganz	O
catheter	O
.	O

there	O
are	O
bilateral	B
pleural	I
effusions	I
,	O
right	O
greater	O
than	O
left	O
.	O

there	O
is	O
left	O
lower	O
lobe	O
consolidation	B
/	O
volume	B
loss	I
.	O

77411	O
||||	O
15621	O
||||	O
17910	O
||||	O
ecg	O
_	O
report	O
||||	O
2011	O
-	O
11	O
-	O
07	O
11	O
:	O
04	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
tachycardia	I

probable	O
left	B
ventricular	I
hypertrophy	I
with	O
st	B
-	I
t	I
changes	I

consider	O
left	B
atrial	I
abnormality	I

cannot	O
exclude	O
ischemia	B
-	O
clinical	O
correlation	O
is	O
suggested	O

no	O
previous	O
tracing	O
for	O
comparison	O

95456	O
||||	O
15737	O
||||	O
9261	O
||||	O
echo	O
_	O
report	O
||||	O
2014	O
-	O
07	O
-	O
25	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
atrial	B
fibrillation	I
/	O
flutter	O
.	O

weight	O
(	O
lb	O
)	O
:	O
233	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
91	O
/	O
50	O

hr	O
(	O
bpm	O
)	O
:	O
86	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
25	O
*	O
*	O
]	O
at	O
15	O
:	O
12	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
definity	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
moderate	O
la	B
enlargement	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

left	O
ventricle	O
:	O
moderate	O
symmetric	O
lvh	B
.	O

small	O
lv	O
cavity	O
.	O

suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
lv	B
wall	I
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

hyperdynamic	B
lvef	I
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

focal	O
calcifications	B
in	O
aortic	O
root	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

focal	O
calcifications	B
in	O
ascending	O
aorta	O
.	O

aortic	O
valve	O
:	O
?#	O
aortic	O
valve	O
leaflets	O
.	O

mildly	O
thickened	B
aortic	O
valve	O
leaflets	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

no	O
mvp	B
.	O

mild	O
mitral	B
annular	I
calcification	I
.	O

mild	O
thickening	B
of	O
mitral	O
valve	O
chordae	O
.	O

calcified	B
tips	I
of	O
papillary	O
muscles	O
.	O

no	O
ms	B
.	O

trivial	O
mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
with	O
trivial	O
tr	B
.	O

normal	O
tricuspid	O
valve	O
supporting	O
structures	O
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
-	O
poor	O
echo	O
windows	O
.	O

suboptimal	O
image	O
quality	O
-	O
poor	O
parasternal	O
views	O
.	O

suboptimal	O
image	O
quality	O
-	O
poor	O
apical	O
views	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

there	O
is	O
moderate	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
unusually	O
small	O
.	O

due	O
to	O
suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
wall	B
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

left	O
ventricular	O
systolic	O
function	O
is	O
hyperdynamic	O
(	O
ef	O
70	O
-	O
80%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
number	O
of	O
aortic	O
valve	O
leaflets	O
cannot	O
be	O
determined	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

there	O
is	O
no	O
aortic	B
valve	I
stenosis	I
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

109559	O
||||	O
15770	O
||||	O
8679	O
||||	O
echo	O
_	O
report	O
||||	O
2014	O
-	O
09	O
-	O
11	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O

bubble	O
study	O
.	O

height	O
:	O
(	O
in	O
)	O
66	O

weight	O
(	O
lb	O
)	O
:	O
264	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
25	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
87	O
/	O
54	O

hr	O
(	O
bpm	O
)	O
:	O
122	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
11	O
*	O
*	O
]	O
at	O
11	O
:	O
38	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
saline	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

no	O
asd	B
or	O
pfo	B
by	O
2d	O
,	O
color	O
doppler	O
or	O
saline	O
contrast	O
with	O
maneuvers	O
.	O

left	O
ventricle	O
:	O
mild	O
symmetric	O
lvh	B
.	O

small	O
lv	O
cavity	O
.	O

hyperdynamic	B
lvef	I
.	O

no	O
resting	B
lvot	I
gradient	I
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
wall	O
thickness	O
.	O

normal	O
rv	O
chamber	O
size	O
.	O

normal	O
rv	O
systolic	O
function	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
normal	O
mitral	O
valve	O
leaflets	O
with	O
trivial	O
mr	B
.	O

no	O
mvp	B
.	O

normal	O
mitral	O
valve	O
supporting	O
structures	O
.	O

normal	O
lv	O
inflow	O
pattern	O
for	O
age	O
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
with	O
trivial	O
tr	B
.	O

normal	O
tricuspid	O
valve	O
supporting	O
structures	O
.	O

moderate	O
pa	O
systolic	B
hypertension	I
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

normal	O
main	O
pa	O
.	O

no	O
doppler	O
evidence	O
for	O
pda	B

pericardium	O
:	O
small	O
to	O
moderate	O
pericardial	B
effusion	I
.	O

effusion	B
circumferential	O
.	O

no	O
echocardiographic	O
signs	O
of	O
tamponade	B
.	O

no	O
ra	O
or	O
rv	B
diastolic	I
collapse	I
.	O

no	O
significant	O
respiratory	O
variation	O
in	O
mitral	O
/	O
tricuspid	O
valve	O
flows	O
.	O

general	O
comments	O
:	O
contrast	O
study	O
was	O
performed	O
with	O
1	O
iv	O
injection	O
of	O
8	O
ccs	O
of	O
agitated	O
normal	O
saline	O
at	O
rest	O
.	O

patient	O
was	O
unable	O
to	O
cooperate	O
with	O
maneuvers	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

no	O
atrial	B
septal	I
defect	I
or	O
patent	B
foramen	I
ovale	I
is	O
seen	O
by	O
2d	O
,	O
color	O
doppler	O
or	O
saline	O
contrast	O
with	O
maneuvers	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
unusually	O
small	O
.	O

left	O
ventricular	O
systolic	O
function	O
is	O
hyperdynamic	O
(	O
ef	O
80%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

right	O
ventricular	O
systolic	O
function	O
is	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

there	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
a	O
small	O
to	O
moderate	O
sized	O
pericardial	B
effusion	I
.	O

the	O
effusion	B
appears	O
circumferential	O
.	O

there	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade	B
.	O

no	O
right	O
atrial	O
or	O
right	B
ventricular	I
diastolic	I
collapse	I
is	O
seen	O
.	O

15541	O
||||	O
16013	O
||||	O
23655	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
04	O
-	O
16	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
04	O
-	O
15	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
04	O
-	O
16	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1924	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
-	O
m	O

history	O
of	O
present	O
illness	O
:	O
miss	O
[	O
*	O
*	O
lastname	O
*	O
*	O
]	O
is	O
an	O
87	O
year	O
old	O
portugese	O
-	O
creole	O
speaking	O
only	O
woman	O
who	O
presented	O
to	O
the	O
[	O
*	O
*	O
hospital	O
1026	O
*	O
*	O
]	O
emergency	O
room	O
on	O
[	O
*	O
*	O
53	O
-	O
02	O
-	O
25	O
*	O
*	O
]	O
,	O
complaining	O
of	O
left	O
lower	O
quadrant	O
abdominal	O
pain	O
,	O
sharp	O
or	O
knife	O
-	O
like	O
in	O
quality	O
,	O
which	O
had	O
begun	O
the	O
night	O
prior	O
to	O
admission	O
and	O
increased	O
with	O
bowel	B
movements	I
.	O

there	O
was	O
no	O
blood	B
in	I
the	I
stool	I
per	O
the	O
patient	O
.	O

she	O
denied	O
vaginal	B
bleeding	I
,	O
urinary	B
symptoms	I
,	O
dysuria	B
,	O
recent	O
travel	O
or	O
fevers	B
.	O

in	O
the	O
emergency	O
room	O
,	O
there	O
was	O
some	O
question	O
of	O
whether	O
the	O
patient	O
was	O
having	O
chest	B
pain	I
and	O
in	O
fact	O
the	O
patient	O
was	O
found	O
to	O
have	O
a	O
left	B
bundle	I
branch	I
block	I
with	O
a	O
tachycardia	B
superimposed	O
to	O
the	O
140	O
range	O
.	O

in	O
the	O
emergency	O
room	O
,	O
the	O
patient	O
was	O
placed	O
on	O
a	O
diltiazem	O
drip	O
as	O
well	O
as	O
heparin	O
and	O
her	O
systolic	O
blood	O
pressure	O
at	O
one	O
point	O
was	O
noted	O
to	O
be	O
above	O
200	O
,	O
lowered	O
to	O
an	O
acceptable	O
range	O
.	O

she	O
received	O
chest	O
ct	O
scan	O
for	O
a	O
question	O
of	O
a	O
pulmonary	B
embolism	I
and	O
was	O
sent	O
initially	O
to	O
the	O
medical	O

intensive	O
care	O
unit	O
for	O
question	O
of	O
hypertensive	B
crisis	I
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
ppd	B
positive	I
.	O

2	O
.	O
chronic	B
renal	I
insufficiency	I
.	O

3	O
.	O
diabetes	B
mellitus	I
.	O

4	O
.	O
transient	B
ischemic	I
attacks	I
.	O

5	O
.	O
peripheral	B
vascular	I
disease	I
.	O

6	O
.	O
chronic	B
obstructive	I
pulmonary	I
disease	I
(	O
asthma	B
)	O
,	O
home	O
o2	O
.	O

7	O
.	O
coronary	B
artery	I
disease	I
status	O
post	O
coronary	O
artery	O
bypass	O
graft	O
in	O
[	O
*	O
*	O
2003	O
*	O
*	O
]	O
,	O
status	O
post	O
cholecystectomy	O
.	O

8	O
.	O
history	O
of	O
pulmonary	B
embolism	I
in	O
[	O
*	O
*	O
2009	O
*	O
*	O
]	O
;	O
recently	O
on	O

coumadin	O
for	O
anti	O
-	O
coagulation	O
.	O

9	O
.	O
history	O
of	O
what	O
were	O
evidently	O
had	O
been	O
multiple	O
myocardial	B
infarctions	I
.	O

medications	O
at	O
the	O
time	O
of	O
admission	O
:	O

1	O
.	O
imdur	O
60	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

2	O
.	O
nph	O
[	O
*	O
*	O
06	O
-	O
28	O
*	O
*	O
]	O
.	O

3	O
.	O
lisinopril	O
20	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

4	O
.	O
protonix	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

5	O
.	O
klonopin	O
0	O
.	O
5	O
mg	O
.	O

6	O
.	O
lipitor	O
.	O

7	O
.	O
atenolol	O
.	O

8	O
.	O
paxil	O
,	O
10	O
mg	O
q	O
.	O
day	O
.	O

9	O
.	O
colace	O
.	O

10	O
.	O

diltiazem	O
120	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

11	O
.	O

atenolol	O
25	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

physical	O
examination	O
:	O
at	O
the	O
time	O
of	O
admission	O
in	O
the	O

emergency	O
department	O
,	O
the	O
patient	O
had	O
vital	O
signs	O
noted	O
97	O
.	O
2	O
f	O
.	O
,	O
temperature	O
;	O
heart	O
rate	O
139	O
decreasing	O
to	O
110	O
on	O
a	O
diltiazem	O
drip	O
;	O
blood	O
pressure	O
180	O
/	O
120	O
decreasing	O
to	O
145	O
/	O
61	O
,	O
again	O
on	O
the	O
diltiazem	O
drip	O
;	O
respiratory	O
rate	O
was	O
39	O
;	O
99%	O
was	O
the	O
pulse	O
oxygenation	O
.	O

in	O
general	O
,	O
a	O
moderately	O
obese	B
woman	O
in	O
respiratory	B
distress	I
.	O

she	O
was	O
noted	O
to	O
be	O
normocephalic	O
with	O
raccoon	B
eyes	I
.	O

oropharynx	O
was	O
clear	O
.	O

there	O
were	O
no	O
bruits	B
appreciated	O
.	O

no	O
jugular	B
venous	I
distention	I
was	O
noted	O
.	O

there	O
was	O
thought	O
to	O
be	O
some	O
accessory	O
muscle	O
use	O
.	O

breath	O
sounds	O
were	O
coarse	O
at	O
the	O
bases	O
with	O
rare	O
rales	B
.	O

the	O
patient	O
was	O
,	O
on	O
cardiac	O
examination	O
,	O
tachycardic	B
.	O

s1	O
and	O
s2	O
were	O
normal	O
.	O

no	O
murmurs	B
,	O
rubs	B
or	O
gallops	B
.	O

the	O
abdomen	O
was	O
softly	O
distended	O
with	O
tenderness	O
to	O
palpation	O
epigastrically	O
and	O
in	O
the	O
left	O
lower	O
quadrant	O
.	O

the	O
rectal	O
examination	O
was	O
negative	O
with	O
no	O
stool	O
.	O

there	O
is	O
no	O
cyanosis	B
,	O
clubbing	B
or	O
edema	B
.	O

physical	O
examination	O
:	O
at	O
the	O
time	O
of	O
admission	O
to	O
the	O
floor	O
some	O
hours	O
later	O
was	O
as	O
follows	O
:	O
temperature	O
96	O
.	O
9	O
f	O
.	O
;	O
blood	O
pressure	O
162	O
/	O
90	O
;	O
pulse	O
90	O
;	O
respirations	O
20	O
;	O
96%	O
on	O
two	O
liters	O
.	O

the	O
patient	O
speaking	O
fluent	O
creole	O
/	O
portugese	O
,	O
however	O
,	O
not	O
clearly	O
oriented	B
to	I
place	I
or	I
time	I
,	O
although	O
difficulties	O
with	O
initial	O
interpretation	O
.	O

extraocular	O
movements	O
were	O
intact	O
.	O

pupils	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
bilaterally	O
and	O
directly	O
and	O
consensually	O
with	O
fundi	B
obscured	I
bilaterally	O
with	O
cataracts	B
.	O

extraocular	O
movements	O
did	O
not	O
show	O
evidence	O
for	O
nystagmus	B
.	O

there	O
was	O
some	O
left	O
conjunctival	B
hemorrhage	I
.	O

mucous	O
membranes	O
were	O
moist	O
.	O

racoon's	B
eyes	I
were	O
noted	O
again	O
bilaterally	O
without	O
battle	B
signs	I
.	O

tympanic	O
membranes	O
were	O
poorly	O
visualized	O
,	O
but	O
there	O
was	O
no	O
clear	O
evidence	O
for	O
hemotympanum	B
.	O

the	O
neck	O
was	O
supple	O
.	O

there	O
was	O
no	O
jugular	B
venous	I
distention	I
.	O

cardiac	O
examination	O
was	O
unremarkable	O
.	O

the	O
chest	O
was	O
clear	O
with	O
a	O
left	O
sided	O
pleural	B
rub	I
heard	O
throughout	O
the	O
left	O
side	O
of	O
the	O
chest	O
.	O

the	O
abdomen	O
was	O
soft	O
with	O
positive	B
bowel	I
sounds	I
,	O
not	O
significantly	O
distended	O
,	O
but	O
some	O
minor	O
tenderness	O
to	O
palpation	O
in	O
the	O
left	O
lower	O
quadrant	O
.	O

there	O
was	O
a	O
bruise	B
of	O
the	O
right	O
shin	O
and	O
the	O
left	O
heel	O
appeared	O
to	O
be	O
between	O
1	O
and	O
3	O
cm	O
lower	O
than	O
the	O
right	O
.	O

laboratory	O
data	O
:	O
cbc	O
was	O
as	O
follows	O
at	O
admission	O
,	O
7	O
.	O
7	O
was	O
the	O
white	O
blood	O
cell	O
count	O
,	O
hematocrit	O
41	O
.	O
7	O
,	O
with	O
67%	O
neutrophils	O
,	O
25%	O
lymphocytes	O
,	O
5%	O
monocytes	O
.	O

platelet	O
count	O
of	O
214	O
.	O

pt	O
on	O
admission	O
was	O
16	O
.	O
1	O
,	O
with	O
an	O
inr	O
of	O
1	O
.	O
8	O
.	O

ptt	O
was	O
26	O
.	O
9	O
.	O

urinalysis	O
was	O
negative	O
.	O

chem	O
-	O
7	O
at	O
time	O
of	O
admission	O
showed	O
a	O
sodium	O
of	O
141	O
,	O
potassium	O
of	O
3	O
.	O
7	O
,	O
chloride	O
101	O
,	O
bicarbonate	O
29	O
,	O
bun	O
22	O
,	O
creatinine	O
of	O

1	O
.	O
1	O
,	O
glucose	O
368	O
at	O
first	O
measure	O
.	O

cardiac	O
enzymes	O
were	O
repeatedly	O
cycled	O
with	O
values	O
all	O
within	O
the	O
20	O
to	O
25	O
range	O
.	O

troponin	O
were	O
less	O
than	O
or	O
equal	O
to	O
0	O
.	O
4	O
.	O

amylase	O
was	O
190	O
;	O
lipase	O
of	O
20	O
,	O
alt	O
18	O
,	O
ast	O
18	O
,	O
alkaline	O
phosphatase	O
117	O
,	O
total	O
bilirubin	O
0	O
.	O
4	O
,	O
albumin	O
3	O
.	O
2	O
,	O
calcium	O

9	O
.	O
0	O
,	O
phosphate	O
2	O
.	O
8	O
,	O
magnesium	O
1	O
.	O
7	O
.	O

tsh	O
is	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

stool	O
studies	O
are	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

urine	O
culture	O
showed	O
10	O
to	O
100	O
,	O
000	O
organisms	O
of	O
proteus	O
mirabilis	O
.	O

chest	O
x	O
-	O
ray	O
on	O
[	O
*	O
*	O
04	O
-	O
15	O
*	O
*	O
]	O
,	O
was	O
as	O
follows	O
:	O
no	O
acute	O
cardiopulmonary	B
process	I
.	O

a	O
chest	O
ct	O
scan	O
performed	O
on	O
the	O
same	O
day	O
showed	O
no	O
pulmonary	B
embolus	I
,	O
left	O
pleural	O
and	O
parenchymal	O
calcifications	B
and	O
left	O
lower	O
lobe	O
volume	B
loss	I
,	O
i	O
.	O
e	O
.	O
fibrothorax	B
from	O
prior	O
inflammatory	B
process	I
as	O
well	O
as	O
traction	B
bronchiectasis	I
.	O

the	O
head	O
ct	O
scan	O
was	O
performed	O
on	O
[	O
*	O
*	O
04	O
-	O
16	O
*	O
*	O
]	O
,	O
with	O
the	O
following	O
impression	O
:	O
no	O
intracranial	B
hemorrhage	I
,	O
no	O
evidence	O
of	O
skull	B
fracture	I
.	O

hip	O
x	O
-	O
rays	O
are	O
pending	O
at	O
the	O
time	O
of	O
this	O
dictation	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
medical	O

intensive	O
care	O
unit	O
with	O
the	O
above	O
-	O
stated	O
complaints	O
on	O
a	O
heparin	O
drip	O
as	O
well	O
as	O
a	O
diltiazem	O
drip	O
.	O

the	O
patient's	O
cardiac	B
issues	I
rapidly	O
settled	O
with	O
the	O
patient	O
once	O
again	O
developing	O
a	O
regular	O
rate	O
.	O

the	O
patient's	O
ekg	O
was	O
felt	O
to	O
represent	O
tachycardia	B
with	O
left	B
bundle	I
branch	I
block	I
but	O
without	O
other	O
pathology	O
.	O

the	O
patient	O
ruled	O
out	O
by	O
cardiac	O
enzymes	O
.	O

once	O
the	O
patient	O
was	O
stabilized	O
,	O
the	O
patient	O
was	O
rapidly	O
transferred	O
to	O
the	O
floor	O
for	O
further	O
management	O
.	O

secondary	O
to	O
concerns	O
surrounding	O
the	O
additional	O
history	O
that	O
the	O
patient	O
gave	O
of	O
a	O
fall	B
approximately	O
three	O
days	O
prior	O
to	O
admission	O
with	O
racoon's	B
eyes	I
on	O
examination	O
,	O
the	O
patient	O
was	O
sent	O
for	O
a	O
ct	O
scan	O
of	O
the	O
head	O
to	O
rule	O
out	O
intra	B
-	I
cranial	I
bleeding	I
or	O
base	O
of	O
the	O
skull	B
fracture	I
.	O

this	O
study	O
was	O
negative	O
.	O

in	O
the	O
absence	O
of	O
evidence	O
to	O
suggest	O
acute	O
cardiac	B
process	I
,	O
heparin	O
was	O
discontinued	O
.	O

stool	O
studies	O
were	O
sent	O
which	O
are	O
pending	O
at	O
the	O
time	O
of	O
this	O
discharge	O
.	O

the	O
patient's	O
urine	O
did	O
grow	O
out	O
between	O
10	O
and	O
100	O
,	O
000	O
organisms	O
of	O
proteus	O
mirabilis	O
as	O
stated	O
above	O
.	O

on	O
[	O
*	O
*	O
04	O
-	O
16	O
*	O
*	O
]	O
,	O
the	O
patient	O
was	O
thought	O
to	O
be	O
much	O
improved	O
with	O
no	O
significant	O
abdominal	B
tenderness	I
and	O
no	O
telemetry	B
events	I
overnight	O
with	O
a	O
pulse	O
in	O
the	O
80s	O
and	O
systolic	O
blood	O
pressure	O
in	O
the	O
160s	O
.	O

as	O
the	O
patient	O
had	O
formerly	O
multiple	O
times	O
been	O
evaluated	O
for	O
abdominal	B
pain	I
including	O
mesenteric	O
angiography	O
and	O
ct	O
scan	O
of	O
the	O
abdomen	O
without	O
a	O
diagnosis	O
being	O
reached	O
,	O
the	O
decision	O
was	O
made	O
to	O
discharge	O
the	O
patient	O
home	O
or	O
appropriate	O
outpatient	O
follow	O
-	O
up	O
with	O
her	O
outpatient	O
provider	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
367	O
*	O
*	O
]	O
.	O

medications	O
at	O
discharge	O
:	O

1	O
.	O
imdur	O
60	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

2	O
.	O
nph	O
[	O
*	O
*	O
06	O
-	O
28	O
*	O
*	O
]	O
.	O

3	O
.	O
lisinopril	O
20	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

4	O
.	O
protonix	O
40	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

5	O
.	O
klonopin	O
0	O
.	O
5	O
mg	O
.	O

6	O
.	O
lipitor	O
.	O

7	O
.	O
atenolol	O
.	O

8	O
.	O
paxil	O
,	O
10	O
mg	O
q	O
.	O
day	O
.	O

9	O
.	O
colace	O
.	O

10	O
.	O

diltiazem	O
120	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

11	O
.	O

atenolol	O
25	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
day	O
.	O

12	O
.	O

bactrim	O
ds	O
,	O
one	O
tablet	O
p	O
.	O
o	O
.	O
three	O
times	O
a	O
day	O
times	O
ten	O
days	O
for	O
presumed	O
proteus	O
mirabilis	O
urinary	B
tract	I
infection	I
.	O

13	O
.	O

please	O
note	O
that	O
the	O
patient	O
will	O
also	O
be	O
discharged	O
on	O
metered	O
-	O
dose	O
inhalers	O
for	O
presumed	O
chronic	B
obstructive	I
pulmonary	I
disease	I
with	O
reactive	B
component	I
and	O
will	O
follow	O
-	O
up	O
with	O
her	O
primary	O
care	O
physician	O
to	O
determine	O
whether	O
this	O
treatment	O
is	O
necessary	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
ruled	O
out	O
for	O
myocardial	B
infarction	I
.	O

2	O
.	O
no	O
evidence	O
for	O
pulmonary	B
embolism	I
.	O

3	O
.	O
no	O
evidence	O
of	O
acute	O
intracranial	B
process	I
.	O

4	O
.	O
recurrence	O
of	O
chronic	O
intermittent	O
abdominal	O
pain	O
of	O
unexplained	O
etiology	O
.	O

5	O
.	O
diabetes	B
mellitus	I
.	O

6	O
.	O
asthma	B
.	O

condition	O
at	O
discharge	O
:	O
stable	O
.	O

discharge	O
instructions	O
:	O

[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
m	O
.	O
d	O
[	O
*	O
*	O
md	O
number	O
6143	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
6367	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2011	O
-	O
04	O
-	O
16	O
*	O
*	O
]	O
16	O
:	O
05	O

t	O
:	O
[	O
*	O
*	O
2011	O
-	O
04	O
-	O
18	O
*	O
*	O
]	O
13	O
:	O
55	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
8903	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2011	O
-	O
05	O
-	O
13	O
*	O
*	O
]	O
2	O
:	O
04	O
pm	O

(	O
end	O
of	O
report	O
)	O

19401	O
||||	O
16044	O
||||	O
3166	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
11	O
-	O
26	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
22	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
26	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1954	O
-	O
07	O
-	O
02	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
cardiothoracic	O
surgery	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
58	O
year	O
old	O
female	O
patient	O
with	O
known	O
aortic	B
stenosis	I
and	O
aortic	B
insufficiency	I
.	O

recent	O
echocardiogram	O
revealed	O
a	O
decreased	O
in	O
left	B
ventricular	I
function	I
and	O
she	O
was	O
referred	O
to	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
220	O
*	O
*	O
]	O
for	O
an	O
aortic	O
valve	O
replacement	O
.	O

on	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
01	O
*	O
*	O
]	O
,	O
she	O
underwent	O
cardiac	O
catheterization	O
which	O
revealed	O
normal	O
coronary	O
arteries	O
,	O
[	O
*	O
*	O
04	O
-	O
03	O
*	O
*	O
]	O
+	O
aortic	B
regurgitation	I
,	O
mild	O
to	O
moderate	O
aortic	B
stenosis	I
and	O
ejection	O
fraction	O
of	O
25%	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
recent	O
congestive	B
heart	I
failure	I
admission	O
to	O
an	O
outside	O
hospital	O
.	O

2	O
.	O
status	O
post	O
total	O
abdominal	O
hysterectomy	O
approximately	O
twenty	O
years	O
ago	O
.	O

3	O
.	O
status	O
post	O
cholecystectomy	O
approximately	O
fifteen	O
years	O
ago	O
.	O

4	O
.	O
status	O
post	O
back	O
surgery	O
times	O
three	O
including	O
fusion	O
with	O
rods	O
placed	O
.	O

medications	O
on	O
admission	O
:	O

1	O
.	O
desipramine	O
50	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

2	O
.	O
quinine	O
325	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

3	O
.	O
lasix	O
40	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

4	O
.	O
gemfibrozil	O
600	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

5	O
.	O
zoloft	O
50	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

6	O
.	O
digitek	O
0	O
.	O
125	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

7	O
.	O
omeprazole	O
20	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

8	O
.	O
zestril	O
5	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

9	O
.	O
lopressor	O
12	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

10	O
.	O

allopurinol	O
300	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

11	O
.	O

celebrex	O
once	O
daily	O
.	O

12	O
.	O

tylenol	O
with	O
codeine	O
two	O
to	O
four	O
tablets	O
per	O
day	O
as	O
needed	O
for	O
chronic	O
complaints	O
of	O
back	O
pain	O
.	O

allergies	O
:	O
the	O
patient	O
states	O
an	O
allergy	O
to	O
sulfa	O
which	O
causes	O
itching	B
and	O
she	O
claims	O
that	O
she	O
is	O
also	O
lactose	B
intolerant	I
.	O

physical	O
examination	O
:	O
her	O
physical	O
examination	O
preoperatively	O
was	O
unremarkable	O
.	O

the	O
patient	O
did	O
have	O
a	O
preoperative	O
positive	O
urinalysis	O
for	O
which	O
she	O
was	O
placed	O
on	O
three	O
days	O
of	O
oral	O
ciprofloxacin	O
prior	O
to	O
her	O
surgical	O
procedure	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
on	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
22	O
*	O
*	O
]	O
,	O
where	O
she	O
was	O
admitted	O
directly	O
to	O
the	O
preoperative	O
holding	O
area	O
.	O

she	O
underwent	O
an	O
aortic	O
valve	O
replacement	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
220	O
*	O
*	O
]	O
on	O
that	O
day	O
with	O
a	O
#19mm	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
716	O
*	O
*	O
]	O
aortic	O
valve	O
replacement	O
.	O

postoperatively	O
,	O
she	O
was	O
transported	O
to	O
the	O
cardiac	O
surgery	O

recovery	O
unit	O
in	O
good	O
condition	O
.	O

she	O
was	O
later	O
weaned	O
from	O
mechanical	O
ventilation	O
and	O
extubated	O
on	O
the	O
day	O
of	O
surgery	O
.	O

due	O
to	O
what	O
appeared	O
to	O
be	O
vegetations	B
on	O
the	O
valve	O
found	O
in	O
the	O
operating	O
room	O
,	O
an	O
infectious	B
disease	I
consultation	O
was	O
obtained	O
although	O
the	O
patient	O
had	O
no	O
fever	B
or	O
elevation	O
in	O
white	O
blood	O
cell	O
count	O
.	O

postoperatively	O
,	O
the	O
patient	O
was	O
on	O
dobutamine	O
and	O
neo	O
-	O
synephrine	O
intravenous	O
drip	O
and	O
these	O
were	O
subsequently	O
weaned	O
off	O
by	O
postoperative	O
day	O
one	O
in	O
the	O

cardiac	O
surgery	O
recovery	O
unit	O
.	O

the	O
infectious	B
disease	I
consultation	O
was	O
obtained	O
.	O

there	O
were	O
recommendations	O
for	O
repeat	O
blood	O
culture	O
as	O
well	O
as	O
urine	O
culture	O
,	O
and	O
everything	O
has	O
subsequently	O
come	O
back	O
negative	O
with	O
the	O
exception	O
of	O
urine	O
which	O
was	O
positive	O
for	O
diphtheroids	O
.	O

during	O
her	O
course	O
of	O
stay	O
in	O
the	O
hospital	O
,	O
the	O
patient	O
was	O
empirically	O
covered	O
with	O
vancomycin	O
and	O

levofloxacin	O
until	O
the	O
final	O
culture	O
of	O
the	O
aortic	O
valve	O
was	O
obtained	O
and	O
these	O
antibiotics	O
were	O
discontinued	O
this	O
morning	O
.	O

the	O
patient	O
has	O
progressed	O
well	O
from	O
a	O
physical	O
therapy	O
standpoint	O
.	O

she	O
is	O
ambulating	O
independently	O
.	O

she	O
has	O
had	O
no	O
hemodynamic	B
complications	I
whatsoever	O
.	O

she	O
was	O
begun	O
on	O

coumadin	O
for	O
her	O
aortic	O
valve	O
replacement	O
.	O

she	O
is	O
ready	O
to	O
be	O
discharged	O
home	O
today	O
on	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
26	O
*	O
*	O
]	O
,	O
on	O
postoperative	O
day	O
four	O
.	O

physical	O
examination	O
today	O
is	O
as	O
follows	O
:	O
the	O
patient	O
is	O
afebrile	B
.	O

neurologically	O
,	O
she	O
is	O
alert	O
and	O
oriented	O
.	O

her	O
lungs	O
are	O
clear	O
.	O

cardiac	O
examination	O
is	O
regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B
.	O

her	O
abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
.	O

she	O
has	O
no	O
peripheral	B
edema	I
.	O

most	O
recent	O
laboratory	O
values	O
include	O
a	O
white	O
blood	O
cell	O
count	O
of	O
12	O
.	O
3	O
,	O
hematocrit	O
25	O
.	O
4	O
,	O
and	O
a	O
platelet	O
count	O
of	O
265	O
,	O
000	O
.	O

sodium	O
134	O
,	O
potassium	O
3	O
.	O
8	O
,	O
chloride	O
98	O
,	O
co2	O
27	O
,	O
blood	O
urea	O
nitrogen	O
18	O
,	O
creatinine	O
1	O
.	O
2	O
,	O
glucose	O
114	O
.	O

most	O
recent	O
inr	O
is	O
1	O
.	O
7	O
today	O
for	O
which	O
she	O
is	O
to	O
receive	O
5	O
mg	O
of	O

coumadin	O
this	O
evening	O
.	O

medications	O
on	O
discharge	O
:	O

1	O
.	O
percocet	O
5	O
/	O
325	O
one	O
to	O
two	O
tablets	O
q3	O
-	O
4hours	O
p	O
.	O
r	O
.	O
n	O
.	O
pain	B
.	O

2	O
.	O
colace	O
100	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

3	O
.	O
desipramine	O
50	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

4	O
.	O
warfarin	O
5	O
mg	O
p	O
.	O
o	O
.	O
today	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
26	O
*	O
*	O
]	O
,	O
and	O
tomorrow	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
27	O
*	O
*	O
]	O
.	O

the	O
patient	O
is	O
then	O
to	O
see	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
8657	O
*	O
*	O
]	O
in	O
his	O
office	O
wednesday	O
morning	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
,	O
at	O
8	O
:	O
30	O
a	O
.	O
m	O
.	O
to	O
have	O
an	O
inr	O
drawn	O
and	O
his	O
office	O
will	O
be	O
dosing	O
her	O
coumadin	O
.	O

target	O
inr	O
for	O
this	O
patient	O
should	O
be	O
2	O
.	O
5	O
to	O
3	O
.	O
0	O
for	O
mechanical	O
aortic	O
valve	O
.	O

5	O
.	O
levofloxacin	O
250	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

this	O
is	O
for	O
one	O
week	O
for	O
empiric	O
coverage	O
of	O
her	O
previously	O
discussed	O
infectious	B
disease	I
issues	O
as	O
well	O
as	O
positive	O
urinary	B
tract	I
infection	I
.	O

6	O
.	O
metoprolol	O
50	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

7	O
.	O
aspirin	O
81	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

8	O
.	O
quinine	O
sulfate	O
325	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

9	O
.	O
gemfibrozil	O
600	O
mg	O
p	O
.	O
o	O
.	O
twice	O
a	O
day	O
.	O

10	O
.	O

omeprazole	O
20	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

11	O
.	O

allopurinol	O
300	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

12	O
.	O

zoloft	O
50	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

follow	O
-	O
up	O
:	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
220	O
*	O
*	O
]	O
in	O
approximately	O
four	O
weeks	O
.	O

she	O
is	O
also	O
to	O
follow	O
-	O
up	O
with	O
her	O
primary	O
care	O
physician	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
8658	O
*	O
*	O
]	O
,	O
in	O
renthem	O
in	O
two	O
to	O
three	O
weeks	O
.	O

she	O
is	O
also	O
to	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
8657	O
*	O
*	O
]	O
,	O
also	O
in	O
renthem	O
,	O
who	O
will	O
be	O
dosing	O
her	O
coumadin	O
in	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
8659	O
*	O
*	O
]	O
office	O
and	O
she	O
is	O
following	O
up	O
with	O
him	O
as	O
previously	O
stated	O
the	O
day	O
after	O
tomorrow	O
,	O

[	O
*	O
*	O
2012	O
-	O
11	O
-	O
28	O
*	O
*	O
]	O
,	O
for	O
coumadin	O
dose	O
.	O

condition	O
on	O
discharge	O
:	O
good	O
.	O

discharge	O
diagnosis	O
:	O
aortic	B
stenosis	I
/	O
aortic	B
regurgitation	I
,	O
status	O
post	O
aortic	O
valve	O
replacement	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
221	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
222	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
2312	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
26	O
*	O
*	O
]	O
17	O
:	O
37	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
26	O
*	O
*	O
]	O
18	O
:	O
17	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
8660	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
221	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
27	O
*	O
*	O
]	O
6	O
:	O
40	O
am	O

(	O
end	O
of	O
report	O
)	O

11230	O
||||	O
16093	O
||||	O
10797	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
05	O
-	O
18	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
05	O
-	O
12	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
05	O
-	O
18	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1940	O
-	O
01	O
-	O
02	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

penicillins	O
/	O
lipitor	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1380	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

tracheobronchomalacia	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

tracheobronchoplasty	O
via	O
right	O
thoracotomy	O

history	O
of	O
present	O
illness	O
:	O

the	O
patient	O
is	O
a	O
74	O
-	O
year	O
-	O
old	O
man	O
who	O
has	O
had	O
a	O
chronic	O
and	O
severe	O
cough	O
since	O

[	O
*	O
*	O
2013	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
.	O

it	O
is	O
severely	O
limiting	O
to	O
his	O
activities	O
of	O
daily	O
life	O
,	O
and	O
he	O
has	O
severe	O
dyspnea	B
on	I
exertion	I
.	O

he	O
has	O
had	O
several	O
bouts	O
of	O
upper	B
respiratory	I
infections	I
treated	O
with	O
antibiotics	O
.	O

he	O
is	O
unable	O
to	O
clear	O
his	O
secretions	B
readily	O
.	O

mr	O
.	O
[	O
*	O
*	O
name13	O
(	O
stitle	O
)	O
20	O
*	O
*	O
]	O
had	O
undergone	O
a	O
stent	O
trial	O
with	O
a	O
y	O
-	O
stent	O
placed	O
on	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
15	O
*	O
*	O
]	O
and	O
noted	O
that	O
his	O
breathing	B
and	O
cough	B
improved	O
,	O
however	O
the	O
stent	O
was	O
removed	O
on	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
23	O
*	O
*	O
]	O
.	O

he	O
was	O
recently	O
admitted	O
to	O
the	O
hospital	O
for	O
treatment	O
of	O
a	O
left	B
lower	I
lobe	I
pneumonia	I
.	O
,	O
treated	O
with	O
antibiotics	O
at	O
home	O
.	O

past	O
medical	O
history	O
:	O

hypertension	B

hypercholesterolemia	I

cad	I
status	O
post	O
mi	B
s	O
/	O
p	O
cabg	O
in	O
[	O
*	O
*	O
2007	O
*	O
*	O
]	O

gerd	B

osa	I

tracheobronchomalacia	I
s	O
/	O
p	O
y	O
stent	O
placement	O
and	O
removal	O
[	O
*	O
*	O
04	O
-	O
23	O
*	O
*	O
]	O

basal	B
cell	I
carcinoma	I
of	O
the	O
skin	O

status	O
post	O
resection	O

squamous	B
cell	I
carcinoma	I
of	I
the	I
skin	I
status	O

post	O
resection	O

melanoma	B
status	O
post	O
resection	O

prostate	B
cancer	I
diagnosed	O
in	O
[	O
*	O
*	O
1997	O
*	O
*	O
]	O
status	O
post	O
radical	O
prostatectomy	O
diverticular	B
disease	I
s	O
/	O
p	O
colon	O
resection	O

cholecystectomy	O

inguinal	B
hernia	I
repair	O
multiple	O
times	O
,	O
last	O
time	O
in	O
[	O
*	O
*	O
2006	O
*	O
*	O
]	O
.	O

social	O
history	O
:	O

he	O
is	O
married	O
,	O
retired	O
,	O
used	O
to	O
work	O
in	O
construction	O
,	O
drinks	O
alcohol	O
socially	O
,	O
used	O
to	O
smoke	O
20	O
-	O
pack	O
-	O
year	O
quit	O
15	O
years	O
ago	O
,	O
and	O
has	O
been	O
exposed	B
to	I
asbestos	I
.	O

family	O
history	O
:	O

his	O
father	O
died	O
secondary	O
to	O
prostate	B
cancer	I
,	O
mother	O
had	O

alzheimer's	B
,	O
and	O
brother	O
had	O
lung	B
cancer	I
.	O

physical	O
exam	O
:	O

vs	O
:	O
t	O
96	O
.	O
6	O
bp	O
125	O
/	O
62	O
hr	O
72	O
rr	O
16	O
95%	O
ra	O

general	O
:	O
well	O
-	O
nourished	O
,	O
well	O
-	O
appearing	O
,	O
speaking	O
in	O
full	O
sentences	O
with	O
occasional	O
coughing	B

heent	O
:	O
nc	O
/	O
at	O
,	O
eomi	O
,	O
op	O
clear	O
,	O
mmm	O
,	O
anicteric	O

neck	O
:	O
supple	O
,	O
no	O
lad	B
,	O
no	O
carotid	B
bruits	I

cv	O
:	O
rrr	O
,	O
normal	O
s1	O
/	O
s2	O
,	O
no	O
m	B
/	O
r	B
/	O
g	B
noted	O

lungs	O
:	O
scattered	O
rhonchi	B
thorughout	O
with	O
scattered	O
inspiratory	B
wheezes	I

abdomen	O
:	O
soft	O
,	O
nt	O
/	O
nd	O
,	O
normoactive	O
bs	O
,	O
no	O
masses	B
,	O
no	O
rebound	O
or	O
tenderness	O
.	O

ext	O
:	O
warm	O
,	O
no	O
edema	B

skin	O
:	O
no	O
rashes	B
,	O
no	O
lesions	B

neuro	O
:	O
aao	O
x3	O
,	O
muscle	O
strength	O
5	O
/	O
5	O
in	O
all	O
4	O
extremities	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2014	O
-	O
05	O
-	O
12	O
*	O
*	O
]	O
03	O
:	O
32pm	O
blood	O
wbc	O
-	O
9	O
.	O
7	O
rbc	O
-	O
3	O
.	O
42	O
*	O
hgb	O
-	O
11	O
.	O
5	O
*	O
hct	O
-	O
32	O
.	O
8	O
*	O
mcv	O
-	O
96	O
mch	O
-	O
33	O
.	O
7	O
*	O
mchc	O
-	O
35	O
.	O
1	O
*	O
rdw	O
-	O
13	O
.	O
4	O
plt	O
ct	O
-	O
250	O

[	O
*	O
*	O
2014	O
-	O
05	O
-	O
12	O
*	O
*	O
]	O
03	O
:	O
32pm	O
blood	O
pt	O
-	O
13	O
.	O
8	O
*	O
ptt	O
-	O
26	O
.	O
3	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O
*	O

[	O
*	O
*	O
2014	O
-	O
05	O
-	O
12	O
*	O
*	O
]	O
03	O
:	O
32pm	O
blood	O
glucose	O
-	O
200	O
*	O
urean	O
-	O
16	O
creat	O
-	O
0	O
.	O
4	O
*	O
na	O
-	O
138	O
k	O
-	O
4	O
.	O
5	O
cl	O
-	O
105	O
hco3	O
-	O
26	O
angap	O
-	O
12	O

[	O
*	O
*	O
2014	O
-	O
05	O
-	O
12	O
*	O
*	O
]	O
03	O
:	O
32pm	O
blood	O
calcium	O
-	O
8	O
.	O
8	O
mg	O
-	O
1	O
.	O
7	O

[	O
*	O
*	O
05	O
-	O
12	O
*	O
*	O
]	O
cxr	O
:	O
left	O
basilar	O
opacity	B
is	O
likely	O
effusion	B
and	O
atelectasis	B
,	O
though	O
an	O
infectious	B
consolidation	I
cannot	O
be	O
excluded	O
.	O

two	O
right	O
-	O
sided	O
chest	O
tubes	O
with	O
no	O
evidence	O
of	O
pneumothorax	B
.	O

ng	O
tube	O
tip	O
lies	O
within	O
the	O
stomach	O
,	O
though	O
the	O
tube	O
could	O
be	O
advanced	O
to	O
ensure	O
that	O
the	O
side	O
hole	O
is	O
within	O
the	O
stomach	O
.	O

mediastinal	O
and	O
subcutaneous	B
emphysema	I
are	O
consistent	O
with	O
recent	O
tracheobronchoplasty	O
and	O
chest	O
tube	O
insertion	O
.	O

[	O
*	O
*	O
05	O
-	O
13	O
*	O
*	O
]	O
cxr	O
:	O
status	O
post	O
removal	O
of	O
right	O
apical	O
chest	O
tube	O
,	O
with	O
no	O
residual	O
right	B
pneumothorax	I
.	O

right	O
basilar	O
chest	O
tube	O
is	O
still	O
in	O
place	O
.	O

also	O
,	O
status	O
post	O
removal	O
of	O
the	O
nasogastric	O
tube	O
.	O

otherwise	O
,	O
unchanged	O
appearance	O
since	O
yesterday	O

[	O
*	O
*	O
05	O
-	O
14	O
*	O
*	O
]	O
cxr	O
:	O
there	O
is	O
no	O
pneumothorax	B
after	O
removal	O
of	O
the	O
right	O
chest	O
tube	O
,	O
given	O
the	O
limitation	O
of	O
patient	O
motion	O
.	O

there	O
are	O
small	O
bilateral	B
pleural	I
effusions	I
,	O
possibly	O
loculated	B
.	O

the	O
aorta	O
remains	O
dilated	O
and	O
tortuous	B
.	O

no	O
new	O
consolidations	B
.	O

[	O
*	O
*	O
05	O
-	O
15	O
*	O
*	O
]	O
cxr	O
:	O
moderate	O
right	O
and	O
small	O
left	O
pleural	B
effusions	I
are	O
unchanged	O
,	O
with	O
apparent	O
loculation	O
of	O
the	O
right	O
effusion	O
laterally	O
.	O

no	O
pneumothorax	B
is	O
identified	O
.	O

cardiac	O
and	O
mediastinal	O
contours	O
are	O
stable	O

brief	O
hospital	O
course	O
:	O

mr	O
.	O
[	O
*	O
*	O
lastname	O
5275	O
*	O
*	O
]	O
was	O
admitted	O
to	O
the	O
thoracic	O
surgery	O
service	O
under	O
the	O
care	O
of	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
2014	O
-	O
05	O
-	O
12	O
*	O
*	O
]	O
after	O
undergoing	O
a	O
tracheobronchoplast	O
for	O
his	O
tracheobronchomalacia	B
.	O

please	O
refer	O
to	O
the	O
operative	O
note	O
for	O
details	O
of	O
this	O
procedure	O
.	O

postoperatively	O
,	O
he	O
was	O
cared	O
for	O
in	O
the	O
csru	O
.	O

on	O
postoperative	O
day	O
one	O
,	O
his	O
pain	B
was	O
controlled	O
with	O
an	O
epidural	O
.	O

his	O
chest	O
tube	O
was	O
removed	O
.	O

his	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
drain	O
remained	O
until	O
pod2	O
.	O

he	O
was	O
noted	O
to	O
be	O
in	O
atrial	B
fibrillation	I
,	O
and	O
was	O
begun	O
on	O
an	O
amiodarone	O
and	O
a	O
diltiazem	O
drip	O
.	O

the	O
diltiazem	O
was	O
stopped	O
.	O

his	O
rhythm	O
had	O
converted	O
to	O
sinus	O
.	O

on	O
pod3	O
,	O
he	O
was	O
transferred	O
to	O
the	O
[	O
*	O
*	O
wardname	O
5276	O
*	O
*	O
]	O
floor	O
unit	O
.	O

his	O
amiodarone	O
was	O
converted	O
to	O
an	O
oral	O
dose	O
of	O
400	O
mg	O
twice	O
a	O
day	O
,	O
to	O
continue	O
for	O
a	O
total	O
of	O
7	O
days	O
,	O
and	O
then	O
taper	O
to	O
a	O
dose	O
of	O
200	O
mg	O
daily	O
.	O

on	O
pod4	O
,	O
he	O
was	O
seen	O
by	O
physical	O
therapy	O
,	O
who	O
felt	O
he	O
may	O
be	O
able	O
to	O
go	O
home	O
with	O
services	O
,	O
however	O
,	O
his	O
wife	O
is	O
currently	O
disabled	O
,	O
and	O
his	O
family	O
felt	O
strongly	O
about	O
his	O
being	O
placed	O
in	O
a	O
rehabilitation	O
facilty	O
for	O
a	O
short	O
time	O
.	O

he	O
continued	O
to	O
do	O
well	O
,	O
and	O
was	O
discharged	O
to	O
a	O
rehabilitation	O
facility	O
on	O
pod6	O
.	O

medications	O
on	O
admission	O
:	O

lopressor	O
50a	O
/	O
25p	O
,	O
norvasc	O
5a	O
/	O
2	O
.	O
5p	O
,	O
isordil	O
60"	O
,	O
xanax	O
5	O
/	O
prn	O
,	O
citalopram	O
40'	O
,	O
detrol	O
la5'	O
,	O
omeprazole	O
20'	O
,	O
folate	O
1'	O
,	O
vit	O
e	O
400'	O
,	O
vit	O
c	O
500'	O
,	O
asa	O
81'	O
,	O
albuterol	O
,	O
pulmoicort	O
,	O
zetia	O
10'	O

discharge	O
medications	O
:	O

1	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
amlodipine	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qam	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
morning	O
)	O
)	O
.	O

3	O
.	O
amlodipine	O
5	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
qpm	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
evening	O
)	O
)	O
.	O

4	O
.	O
metoprolol	O
tartrate	O
50	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qam	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
morning	O
)	O
)	O
.	O

5	O
.	O
metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qpm	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
evening	O
)	O
)	O
.	O

6	O
.	O
isosorbide	O
dinitrate	O
20	O
mg	O
tablet	O
sig	O
:	O
three	O
(	O
3	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

7	O
.	O
citalopram	O
20	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

8	O
.	O
tolterodine	O
1	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

9	O
.	O
amiodarone	O
200	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
:	O
beginning	O
after	O
400	O
bid	O
dosing	O
has	O
completed	O
.	O

10	O
.	O

amiodarone	O
400	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
for	O
4	O
days	O
.	O

11	O
.	O

xanax	O
0	O
.	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q8h	O
prn	O
as	O
needed	O
.	O

12	O
.	O

omeprazole	O
20	O
mg	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
once	O
a	O
day	O
.	O

13	O
.	O

folic	O
acid	O
1	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

14	O
.	O

ezetimibe	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

15	O
.	O

vitamin	O
e	O
400	O
unit	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

16	O
.	O

vitamin	O
c	O
500	O
mg	O
tablet	O
,	O
chewable	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O

chewable	O
po	O
once	O
a	O
day	O
.	O

17	O
.	O

albuterol	O
90	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
two	O
(	O
2	O
)	O
puffs	O

inhalation	O
every	O
four	O
(	O
4	O
)	O
hours	O
as	O
needed	O
for	O
shortness	B
of	I
breath	I
or	O
wheezing	B
.	O

18	O
.	O

pulmicort	O
turbuhaler	O
200	O
mcg	O
/	O
inhalation	O
aerosol	O
powdr	O
breath	O
activated	O
sig	O
:	O
two	O
(	O
2	O
)	O
puffs	O
inhalation	O
twice	O
a	O
day	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
hospital1	O
930	O
*	O
*	O
]	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
3061	O
*	O
*	O
]	O

discharge	O
diagnosis	O
:	O

tracheobronchomalacia	B

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

call	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1437	O
*	O
*	O
]	O
office	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
960	O
*	O
*	O
]	O
if	O
you	O
develop	O
:	O
-	O
-	O
chest	B
pain	I

-	O
-	O
shortness	B
of	I
breath	I

-	O
-	O
difficulty	B
swallowing	I

-	O
-	O
fever	B
greater	O
than	O
101	O
.	O
5	O
f	O

-	O
-	O
redness	B
or	O
drainage	O
from	O
your	O
incision	O
sites	O
.	O

no	O
lifting	O
anything	O
greater	O
than	O
10	O
pounds	O
for	O
6	O
weeks	O
.	O

do	O
not	O
drive	O
while	O
taking	O
pain	B
medication	O
.	O

followup	O
instructions	O
:	O

call	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1437	O
*	O
*	O
]	O
office	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
960	O
*	O
*	O
]	O
for	O
a	O
follow	O
up	O
appointment	O
in	O
2	O
weeks	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1383	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1384	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
792	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1573	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1574	O
*	O
*	O
]	O
[	O
*	O
*	O
2014	O
-	O
05	O
-	O
18	O
*	O
*	O
]	O
@	O
1012	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1388	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2014	O
-	O
05	O
-	O
21	O
*	O
*	O
]	O
10	O
:	O
15	O
am	O

(	O
end	O
of	O
report	O
)	O

34160	O
||||	O
16333	O
||||	O
5120	O
||||	O
ecg	O
_	O
report	O
||||	O
2010	O
-	O
04	O
-	O
20	O
05	O
:	O
48	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
bradycardia	I
.	O

prior	O
anteroseptal	B
lateral	I
myocardial	I
infarction	I
without	O
change	O
compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2010	O
-	O
04	O
-	O
19	O
*	O
*	O
]	O
.	O

tracing	O
#2	O

23618	O
||||	O
16597	O
||||	O
6845	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
06	O
-	O
11	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
09	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
11	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1932	O
-	O
06	O
-	O
25	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
an	O
82	O
year	O
old	O
male	O
who	O
has	O
apparently	O
not	O
sought	O
medical	O
care	O
over	O
50	O
years	O
,	O
now	O
being	O
transferred	O
from	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
32	O
*	O
*	O
]	O
after	O
having	O
family	O
meetings	O
and	O
needing	O
to	O
be	O
cmo	O
.	O

initially	O
,	O
the	O
patient	O
was	O
admitted	O
to	O
an	O
outside	O
hospital	O
on	O
the	O
[	O
*	O
*	O
06	O
-	O
07	O
*	O
*	O
]	O
for	O
increased	O
confusion	B
,	O
lethargy	B
and	O
decreased	B
po	I
intake	I
times	O
one	O
to	O
two	O
weeks	O
.	O

on	O
his	O
initial	O
evaluation	O
at	O
this	O
outside	O
hospital	O
,	O
he	O
was	O
found	O
to	O
have	O
marked	O
electrolyte	B
abnormalities	I
including	O
hyperkalemia	B
to	O
7	O
and	O
azotemia	B
with	O

bun	O
of	O
greater	O
than	O
150	O
and	O
creatinine	O
of	O
10	O
.	O

he	O
was	O
initially	O
treated	O
aggressively	O
for	O
hyperkalemia	B
with	O
calcium	O
,	O
d50	O
and	O
insulin	O
and	O
also	O
bicarbonate	O
and	O
then	O
subsequently	O
transferred	O
over	O
to	O
the	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
for	O
possible	O
evaluation	O
for	O
hemodialysis	O
.	O

here	O
,	O
at	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
,	O
the	O
patient	O
again	O
was	O
found	O
to	O
be	O
hyperkalemic	B
and	O
uremic	B
.	O

he	O
was	O
initially	O
started	O
on	O
aggressive	O
iv	O
fluid	O
resuscitation	O
with	O
bicarbonate	O
.	O

an	O
abg	O
was	O
performed	O
which	O
was	O
consistent	O
with	O
a	O
metabolic	B
acidosis	I
.	O

the	O
patient	O
was	O
subsequently	O
evaluated	O
by	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
32	O
*	O
*	O
]	O
team	O
,	O
the	O
renal	O
team	O
and	O
the	O
urology	O
team	O
.	O

he	O
had	O
minimal	O
amounts	O
of	O
urine	B
output	I
.	O

subsequently	O
,	O
a	O
renal	O
ultrasound	O
was	O
done	O
which	O
showed	O
bilateral	B
hydronephrosis	I
.	O

he	O
also	O
had	O
a	O
bladder	O
ultrasound	O
which	O
showed	O
a	O
large	O
mass	B
in	O
the	O
superior	O
and	O
posterior	O
aspects	O
of	O
the	O
bladder	O
.	O

the	O
mass	B
was	O
presumed	O
to	O
be	O
malignant	B
.	O

there	O
were	O
initially	O
several	O
discussions	O
with	O
renal	O
and	O
urology	O
for	O
potential	O
placement	O
of	O
either	O
nephrostomy	O
tubes	O
or	O
suprapubic	O
catheters	O
.	O

however	O
,	O
right	O
after	O
discussion	O
with	O
the	O
patient's	O
family	O
and	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
32	O
*	O
*	O
]	O
team	O
,	O
it	O
was	O
decided	O
that	O
the	O
patient	O
would	O
not	O
be	O
interested	O
in	O
aggressive	O
interventional	O
treatment	O
modalities	O
that	O
may	O
not	O
be	O
able	O
to	O
cure	O
an	O
incurable	B
disease	I
.	O

at	O
this	O
point	O
,	O
his	O
code	O
status	O
was	O
changed	O
to	O
dnr	B
/	O
dni	B
and	O
specifically	O
cmo	O
with	O
goal	O
of	O
comfort	O
care	O
only	O
.	O

he	O
was	O
subsequently	O
transferred	O
from	O
the	O
icu	O
to	O
the	O
floor	O
for	O
this	O
matter	O
.	O

past	O
medical	O
history	O
:	O
he	O
had	O
not	O
seen	O
an	O
m	O
.	O
d	O
.	O
over	O
50	O
years	O
,	O
although	O
apparently	O
has	O
had	O
cataract	B
surgery	O
in	O
the	O
recent	O
past	O
.	O

medications	O
:	O
none	O
on	O
admission	O
or	O
that	O
he	O
was	O
taking	O
as	O
an	O
outpatient	O
.	O

on	O
transfer	O
,	O
he	O
was	O
on	O
morphine	O
prn	O
and	O
ativan	O
prn	O
.	O

social	O
history	O
:	O
the	O
patient	O
reportedly	O
lived	O
alone	O
.	O

physical	O
examination	O
:	O
the	O
patient	O
was	O
found	O
to	O
be	O
afebrile	B
,	O
slightly	O
tachycardic	B
to	O
about	O
100	O
with	O
blood	O
pressures	O
around	O
100	O
/	O
60	O
,	O
breathing	O
comfortably	O
at	O
14	O
and	O
98	O
percent	O
on	O
room	O
air	O
.	O

in	O
general	O
,	O
he	O
was	O
a	O
cachectic	B
,	O
elderly	O
male	O
,	O
mildly	O
disoriented	B
and	O
confused	B
but	O
comfortable	O
.	O

heent	O
exam	O
was	O
significant	O
for	O
markedly	O
dry	B
mucous	I
membranes	I
.	O

his	O
heart	O
was	O
tachycardic	B
but	O
regular	O
.	O

lungs	O
were	O
clear	O
at	O
least	O
with	O
limited	O
exam	O
anteriorly	O
.	O

abdominal	O
exam	O
had	O
mild	O
diffuse	O
lower	B
abdominal	I
tenderness	I
.	O

no	O
masses	B
were	O
able	O
to	O
be	O
appreciated	O
.	O

the	O
lower	O
extremities	O
were	O
negative	O
for	O
any	O
edema	O
.	O

hospital	O
course	O
:	O
as	O
mentioned	O
above	O
,	O
the	O
patient	O
initially	O
was	O
transferred	O
to	O
the	O
icu	O
for	O
evaluation	O
of	O
acute	B
renal	I
failure	I
with	O
radiographic	O
evidence	O
to	O
suggest	O
there	O
may	O
be	O
a	O
post	B
-	I
obstructive	I
component	O
to	O
his	O
renal	B
failure	I
.	O

he	O
was	O
also	O
admitted	O
with	O
leukocytosis	B
of	O
unclear	O
etiology	O
.	O

after	O
discussions	O
with	O
the	O
icu	O
,	O
renal	O
and	O
urology	O
teams	O
and	O
the	O
patient's	O
family	O
,	O
it	O
was	O
decided	O
that	O
the	O
patient	O
would	O
not	O
want	O
aggressive	O
medical	O
treatment	O
.	O

subsequently	O
,	O
the	O
patient's	O
code	O
status	O
was	O
changed	O
to	O
dnr	B
/	O
dni	B
and	O
he	O
was	O
made	O
cmo	O
.	O

the	O
family	O
understands	O
at	O
this	O
point	O
that	O
the	O
patient's	O
main	O
goal	O
will	O
be	O
comfort	O
.	O

to	O
that	O
end	O
,	O
he	O
will	O
be	O
receiving	O
morphine	O
prn	O
,	O
ativan	O
and	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
prn	O
.	O

he	O
was	O
allowed	O
to	O
take	O
po's	O
as	O
tolerated	O
.	O

his	O
abdominal	O
exam	O
was	O
unremarkable	O
during	O
his	O
hospital	O
course	O
on	O
the	O
floor	O
and	O
he	O
did	O
not	O
exhibit	O
any	O
evidence	O
of	O
significant	O
pain	B
from	O
urinary	B
retention	I
.	O

should	O
this	O
occur	O
,	O
one	O
could	O
consider	O
possible	O
suprapubic	O
catheter	O
placement	O
for	O
palliative	O
purposes	O
although	O
this	O
will	O
need	O
to	O
be	O
discussed	O
with	O
the	O
family	O
.	O

meanwhile	O
,	O
discussions	O
were	O
held	O
between	O
case	O
management	O
and	O
the	O
patient's	O
family	O
in	O
regards	O
to	O
the	O
optimum	O
place	O
for	O
the	O
patient	O
to	O
live	O
the	O
remainder	O
of	O
his	O
life	O
in	O
a	O
comfortable	O
and	O
dignified	O
manner	O
.	O

currently	O
,	O
the	O
patient	O
is	O
being	O
planned	O
for	O
hospice	O
placement	O
.	O

here	O
,	O
the	O
patient	O
will	O
be	O
treated	O
with	O
maximal	O
amounts	O
of	O
comfort	O
and	O
care	O
.	O

discharge	O
diagnoses	O
:	O
acute	B
renal	I
failure	I
,	O
presumed	O
post	B
-	I
obstructive	I
.	O

bladder	B
mass	I
,	O
presumed	O
to	O
be	O
malignant	B
.	O

discharge	O
medications	O
:	O
morphine	O
sulfate	O
prn	O
,	O
ativan	O
prn	O
and	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
prn	O
.	O

please	O
see	O
discharge	O
addendum	O
for	O
final	O
disposition	O
.	O

condition	O
on	O
discharge	O
:	O
serious	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1605	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
state	O
/	O
zipcode	O
1606	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
1607	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
10	O
*	O
*	O
]	O
21	O
:	O
36	O
:	O
20	O

t	O
:	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
10	O
*	O
*	O
]	O
22	O
:	O
33	O
:	O
53	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2757	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initial	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
55	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
06	O
-	O
11	O
*	O
*	O
]	O
10	O
:	O
37	O
pm	O
(	O
end	O
of	O
report	O
)	O

199016	O
||||	O
16660	O
||||	O
19936	O
||||	O
radiology	O
_	O
report	O
||||	O
2019	O
-	O
12	O
-	O
09	O
09	O
:	O
45	O
:	O
00	O
.	O
0	O
||||	O
j32	O
carotid	O
series	O
complete	O
||||	O
||||	O
clip	O
#	O
420	O
-	O
6269	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2019	O
-	O
12	O
-	O
09	O
*	O
*	O
]	O
9	O
:	O
45	O
am	O

carotid	O
series	O
complete	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
5911	O
*	O
*	O
]	O
reason	O
:	O
cad	B
,	O
preop	O
cabg	O
and	O
valve	O
repair	O

admitting	O
diagnosis	O
:	O
coronary	B
artery	I
disease	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

70	O
year	O
old	O
man	O
with	O
cad	B
reason	O
for	O
this	O
examination	O
:	O
assess	O
for	O
carotid	B
artery	I
thrombosis	I
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
for	O
exam	O
:	O
this	O
is	O
a	O
78	O
-	O
year	O
-	O
old	O
man	O
with	O
cad	B
,	O
with	O
suspected	O
carotid	B
artery	I
thrombosis	I
.	O

radiologists	O
:	O
this	O
exam	O
was	O
read	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
425	O
*	O
*	O
]	O
and	O
[	O
*	O
*	O
doctor	O
last	O
name	O
2158	O
*	O
*	O
]	O
.	O

technique	O
:	O
extracranial	O
ultrasound	O
evaluation	O
of	O
bilateral	O
carotids	O
was	O
performed	O
by	O
b	O
-	O
mode	O
,	O
spectral	O
,	O
and	O
color	O
doppler	O
ultrasound	O
modes	O
.	O

findings	O
:	O
on	O
grayscale	O
examination	O
,	O
there	O
is	O
minimal	O
amount	O
of	O
plaque	O
seen	O
within	O
bilateral	O
internal	O
carotid	O
arteries	O
.	O

on	O
the	O
right	O
,	O
peak	O
systolic	O
velocities	O
are	O
77	O
,	O
68	O
,	O
and	O
55	O
cm	O
/	O
sec	O
in	O
the	O
internal	O
,	O
common	O
,	O
and	O
external	O
carotid	O
arteries	O
,	O
respectively	O
.	O

the	O
right	O
ica	O
to	O
cca	O
ratio	O
is	O
1	O
.	O
28	O
.	O

left	O
peak	O
systolic	O
velocities	O
are	O
71	O
,	O
74	O
,	O
and	O
66	O
cm	O
/	O
sec	O
in	O
the	O
internal	O
,	O
common	O
,	O
and	O
external	O
carotid	O
arteries	O
,	O
respectively	O
.	O

the	O
left	O
ica	O
to	O
cca	O
ratio	O
is	O
0	O
.	O
95	O
.	O

both	O
vertebral	O
arteries	O
present	O
with	O
antegrade	O
flow	O
.	O

comparison	O
:	O
none	O
available	O
.	O

impression	O
:	O
no	O
evidence	O
of	O
internal	B
carotid	I
artery	I
stenosis	I
on	O
either	O
side	O
,	O
in	O
their	O
extracranial	O
portion	O
.	O

77812	O
||||	O
16817	O
||||	O
23170	O
||||	O
ecg	O
_	O
report	O
||||	O
2016	O
-	O
02	O
-	O
01	O
23	O
:	O
49	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

baseline	O
artifact	O

sinus	B
tachycardia	I

indeterminate	O
qrs	O
axis	O

low	O
limb	O
leads	O
voltage	O
-	O
is	O
nonspecific	O

prominent	O
inferolateral	O
q	O
waves	O
-	O
are	O
nondiagnostic	O

consider	O
chronic	B
pulmonary	I
disease	I

since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2011	O
-	O
09	O
-	O
05	O
*	O
*	O
]	O
,	O
sinus	B
tachycardia	I
present	O

3484	O
||||	O
16888	O
||||	O
27843	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
12	O
-	O
20	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
11	O
-	O
22	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1965	O
-	O
10	O
-	O
20	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
cardiothoracic	O

allergies	O
:	O

bactrim	O
/	O
epinephrine	O
/	O
percocet	O
/	O
codeine	O
/	O
latex	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
189	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

sscp	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

[	O
*	O
*	O
11	O
-	O
23	O
*	O
*	O
]	O
rvad	O
insertion	O
/	O
ecmo	O
decannulation	O

history	O
of	O
present	O
illness	O
:	O

48	O
yo	O
f	O
presented	O
to	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
1871	O
*	O
*	O
]	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
[	O
*	O
*	O
11	O
-	O
22	O
*	O
*	O
]	O
with	O
new	O
onset	O
sscp	B
,	O
+	O
stemi	B
.	O

she	O
was	O
taken	O
emergently	O
to	O
the	O
cath	O
lab	O
,	O
where	O
3	O
bare	O
metal	O
stents	O
were	O
placed	O
in	O
a	O
totally	O
occluded	B
rca	I
.	O

she	O
became	O
hypotensive	B
,	O
an	O
iabp	O
was	O
placed	O
,	O
doapmine	O
and	O
levophed	O
were	O
started	O
.	O

she	O
then	O
suffered	O
a	O
pea	B
arrest	I
,	O
after	O
acls	O
she	O
was	O
stabilized	O
and	O
transferred	O
with	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
for	O
definitive	O
treatment	O
.	O

past	O
medical	O
history	O
:	O

epstein's	O
cardiac	O
valve	O
anomaly	O
(	O
congenital	O
)	O

junctional	B
rhythm	I
with	O
reentry	O

right	O
heart	B
dilatation	I
with	O
h	O
/	O
o	O
syncopal	B
events	I
and	O
palpitations	B
thalassemia	I
minor	I

hypothyroidism	I

hypertension	I

depression	I

low	I
back	I
pain	I

polycystic	I
ovaries	I

glaucoma	I

hypertriglyceridemia	I

social	O
history	O
:	O

pt	O
smokes	O
[	O
*	O
*	O
01	O
-	O
28	O
*	O
*	O
]	O
ppd	O
.	O

rarely	O
consumes	O
alcohol	O

family	O
history	O
:	O

non	O
-	O
contributory	O

physical	O
exam	O
:	O

deferred	O
,	O
intubated	O
,	O
sedated	O
,	O
taken	O
emergently	O
to	O
the	O
or	O
.	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O
03	O
:	O
00am	O
blood	O
wbc	O
-	O
9	O
.	O
3	O
rbc	O
-	O
3	O
.	O
07	O
*	O
hgb	O
-	O
9	O
.	O
7	O
*	O
hct	O
-	O
26	O
.	O
6	O
*	O
mcv	O
-	O
87	O
mch	O
-	O
31	O
.	O
5	O
mchc	O
-	O
36	O
.	O
4	O
*	O
rdw	O
-	O
15	O
.	O
8	O
*	O
plt	O
ct	O
-	O
48	O
*	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
19	O
*	O
*	O
]	O
03	O
:	O
09am	O
blood	O
wbc	O
-	O
11	O
.	O
4	O
*	O
rbc	O
-	O
3	O
.	O
82	O
*	O
hgb	O
-	O
11	O
.	O
5	O
*	O
hct	O
-	O
32	O
.	O
3	O
*	O
mcv	O
-	O
85	O
mch	O
-	O
30	O
.	O
0	O
mchc	O
-	O
35	O
.	O
5	O
*	O
rdw	O
-	O
15	O
.	O
6	O
*	O
plt	O
ct	O
-	O
68	O
*	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O
03	O
:	O
00am	O
blood	O
pt	O
-	O
17	O
.	O
2	O
*	O
ptt	O
-	O
30	O
.	O
8	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
6	O
*	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O
03	O
:	O
00am	O
blood	O
glucose	O
-	O
70	O
urean	O
-	O
103	O
*	O
creat	O
-	O
2	O
.	O
4	O
*	O
na	O
-	O
153	O
*	O
k	O
-	O
4	O
.	O
1	O
cl	O
-	O
121	O
*	O
hco3	O
-	O
25	O
angap	O
-	O
11	O

[	O
*	O
*	O
2013	O
-	O
12	O
-	O
19	O
*	O
*	O
]	O
03	O
:	O
13pm	O
blood	O
urean	O
-	O
114	O
*	O
creat	O
-	O
2	O
.	O
8	O
*	O
na	O
-	O
150	O
*	O
cl	O
-	O
118	O
*	O
hco3	O
-	O
23	O

brief	O
hospital	O
course	O
:	O

she	O
was	O
initially	O
stable	O
after	O
transfer	O
but	O
after	O
2	O
-	O
3	O
hours	O
decompensated	O
and	O
was	O
taken	O
to	O
the	O
cath	O
lab	O
.	O

she	O
was	O
found	O
to	O
have	O
patent	O
stents	O
,	O
but	O
she	O
continued	O
to	O
deteriorate	O
.	O

she	O
was	O
placed	O
on	O
ecmo	O
,	O
and	O
then	O
was	O
taken	O
to	O
the	O
or	O
with	O
vascular	O
surgery	O
for	O
repair	O
of	O
her	O
left	O
cfa	O
,	O
cfv	O
,	O
and	O
eia	O
at	O
the	O
site	O
of	O
the	O
previous	O
iabp	O
.	O

tee	O
showed	O
ebsteins	B
anomaly	I
with	O
markedly	O
dilated	B
ra	I
/	O
rv	O
with	O
focal	O
rv	O
hypokinesis	B
,	O
severe	O
tr	B
,	O
small	O
lv	O
with	O
focal	O
inferior	O
hypokinesis	B
with	O
ef	O
>	O
60%	O
,	O
trace	O
mr	B
,	O
no	O
ai	B
.	O

on	O
[	O
*	O
*	O
11	O
-	O
23	O
*	O
*	O
]	O
she	O
was	O
taken	O
to	O
the	O
operating	O
room	O
where	O
she	O
underwent	O
placement	O
of	O
and	O
rvad	O
and	O
removal	O
of	O
ecmo	O
.	O

she	O
was	O
transferred	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
8	O
*	O
*	O
]	O
on	O
epinephrine	O
,	O
milrinone	O
,	O
levophed	O
and	O
propofol	O
as	O
well	O
as	O
nitric	O
oxide	O
.	O

she	O
developed	O
fevers	B
for	O
which	O
she	O
was	O
cultured	O
and	O
id	O
was	O
consulted	O
.	O

cultures	O
remained	O
negative	O
,	O
she	O
was	O
placed	O
on	O
broad	O
antibiotic	O
coverage	O
.	O

she	O
remained	O
intubated	O
and	O
paralyzed	O
,	O
with	O
likely	O
ards	B
.	O

she	O
was	O
seen	O
by	O
hematology	O
for	O
difficulty	O
maintaining	O
a	O
therapeutic	O
ptt	O
and	O
thrombocytopenia	B
.	O

she	O
was	O
hit	B
-	O
,	O
and	O
the	O
thrombocytopenia	B
was	O
thought	O
to	O
be	O
secondary	O
to	O
the	O
vad	O
as	O
well	O
as	O
illness	B
.	O

she	O
was	O
started	O
on	O
tube	O
feeds	O
.	O

vascular	O
continued	O
to	O
follow	O
her	O
for	O
her	O
groin	O
incisions	O
,	O
which	O
eventually	O
required	O
vac	O
dressing	O
.	O

her	O
sternal	O
wound	O
developed	O
purulent	O
draiange	O
,	O
and	O
the	O
wound	B
was	O
opened	O
and	O
a	O
vac	O
dressing	O
was	O
applied	O
there	O
as	O
well	O
.	O

she	O
remained	O
on	O
vanco	O
,	O
zosyn	O
and	O
flagyl	O
.	O

ct	O
scan	O
of	O
head	O
/	O
chest	O
abdomen	O
/	O
pelvis	O
on	O
[	O
*	O
*	O
12	O
-	O
02	O
*	O
*	O
]	O
was	O
essentially	O
negative	O
for	O
infection	B
with	O
the	O
exception	O
of	O
a	O
7	O
.	O
3	O
cm	O
right	O
groin	O
fluid	B
collection	I
.	O

there	O
as	O
no	O
bleed	B
or	O
infarct	B
on	O
head	O
ct	O
.	O

she	O
was	O
seen	O
by	O
optho	O
for	O
conjunctivitis	B
and	O
placed	O
on	O
erythromycin	O
ointment	O
.	O

she	O
continued	O
to	O
have	O
fever	B
and	O
white	O
count	O
,	O
but	O
negative	O
cultures	O
.	O

tee	O
on	O
[	O
*	O
*	O
12	O
-	O
04	O
*	O
*	O
]	O
showed	O
no	O
eveidence	O
of	O
endocarditis	B
.	O

her	O
respiratory	B
status	I
improved	O
and	O
her	O
sedation	O
was	O
weaned	O
.	O

cxr	O
showed	O
slow	O
resolution	O
of	O
ards	B
.	O

her	O
zosyn	O
was	O
changed	O
to	O
meropenum	O
given	O
the	O
continued	O
fevers	B
,	O
as	O
well	O
as	O
fluconazole	O
for	O
some	O
yeast	O
growth	O
from	O
her	O
wounds	O
.	O

she	O
remained	O
febrile	B
despite	O
antibiotic	O
change	O
,	O
however	O
her	O
white	O
count	O
began	O
to	O
improve	O
.	O

she	O
was	O
taken	O
to	O
the	O
cath	O
lab	O
on	O
[	O
*	O
*	O
12	O
-	O
16	O
*	O
*	O
]	O
for	O
placement	O
of	O
a	O
pa	O
cath	O
in	O
preparation	O
for	O
rvad	O
weaning	O
.	O

fevers	B
continued	O
,	O
she	O
remained	O
on	O
vanco	O
,	O
fluc	O
,	O
and	O
ceftaz	O
was	O
started	O
on	O
[	O
*	O
*	O
12	O
-	O
17	O
*	O
*	O
]	O
.	O

on	O
[	O
*	O
*	O
12	O
-	O
17	O
*	O
*	O
]	O
she	O
was	O
found	O
to	O
have	O
melena	B
and	O
hct	B
drop	I
,	O
and	O
gi	O
was	O
consulted	O
.	O

gastric	O
lavage	O
showed	O
maroon	O
/	O
black	O
but	O
no	O
fresh	O
blood	B
.	O

she	O
was	O
started	O
on	O
a	O
protonix	O
drip	O
.	O

egd	O
showed	O
blood	B
in	I
the	I
stomach	I
,	O
and	O
findings	O
consistent	O
with	O
hemorrhagic	B
gastritis	I
.	O

her	O
heparin	O
was	O
stopped	O
and	O
she	O
was	O
started	O
on	O
dextran	O
.	O

her	O
lfts	B
increased	I
,	O
and	O
then	O
began	O
to	O
improve	O
.	O

her	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
3685	O
*	O
*	O
]	O
was	O
dc'd	O
.	O

hepatitis	O
serologies	O
were	O
sent	O
.	O

her	O
fever	B
started	O
on	O
improve	O
and	O
at	O
the	O
time	O
of	O
discharge	O
she	O
was	O
afebrile	B
for	O
about	O
48	O
hours	O
.	O

medications	O
on	O
admission	O
:	O

hydrocodone	O
,	O
omeprazole	O
,	O
levoxyl	O
,	O
lexapro	O
,	O
hctz	O
,	O
kcl	O
,	O
verapamil	O

discharge	O
medications	O
:	O

1	O
.	O
clopidogrel	O
75	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
chewable	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
chewable	O
po	O
daily	O
(	O
daily	O
)	O
.	O

3	O
.	O
docusate	O
sodium	O
150	O
mg	O
/	O
15	O
ml	O
liquid	O
sig	O
:	O
one	O
(	O
1	O
)	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

4	O
.	O
insulin	O
regular	O
human	O
100	O
unit	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
injection	O
infusion	O
(	O
continuous	O
infusion	O
)	O
.	O

5	O
.	O
timolol	O
maleate	O
0	O
.	O
5	O
%	O
drops	O
sig	O
:	O
one	O
(	O
1	O
)	O
drop	O
ophthalmic	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

6	O
.	O
acetaminophen	O
160	O
mg	O
/	O
5	O
ml	O
solution	O
sig	O
:	O
[	O
*	O
*	O
01	O
-	O
28	O
*	O
*	O
]	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
fever	B
.	O

7	O
.	O
polyvinyl	O
alcohol	O
1	O
.	O
4	O
%	O
drops	O
sig	O
:	O
1	O
-	O
2	O
drops	O
ophthalmic	O
q8h	O
(	O
every	O
8	O
hours	O
)	O
as	O
needed	O
.	O

8	O
.	O
albuterol	O
-	O
ipratropium	O
103	O
-	O
18	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
four	O
(	O
4	O
)	O
puff	O
inhalation	O
q4h	O
(	O
every	O
4	O
hours	O
)	O
.	O

9	O
.	O
fluticasone	O
110	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
two	O
(	O
2	O
)	O
puff	O

inhalation	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

10	O
.	O

miconazole	O
nitrate	O
2	O
%	O
powder	O
sig	O
:	O
one	O
(	O
1	O
)	O
appl	O
topical	O
qid	O
(	O
4	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

11	O
.	O

miconazole	O
nitrate	O
2	O
%	O
cream	O
sig	O
:	O
one	O
(	O
1	O
)	O
appl	O
topical	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

12	O
.	O

potassium	O
chloride	O
20	O
meq	O
/	O
50	O
ml	O
sw	O
iv	O
prn	O
k<4	O
.	O
4	O
and	O
cr<2	O
.	O
0	O

*	O
*	O
concentrated	O
kcl	O
must	O
be	O
given	O
via	O
central	O
line	O
only	O
*	O
*	O

13	O
.	O

erythromycin	O
5	O
mg	O
/	O
g	O
ointment	O
sig	O
:	O
one	O
(	O
1	O
)	O
ophthalmic	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

14	O
.	O

ibuprofen	O
100	O
mg	O
/	O
5	O
ml	O
suspension	O
sig	O
:	O
one	O
(	O
1	O
)	O
po	O
q8h	O
(	O
every	O
8	O
hours	O
)	O
as	O
needed	O
for	O
t>102	O
.	O

15	O
.	O

pantoprazole	O
40	O
mg	O
recon	O
soln	O
sig	O
:	O
eight	O
(	O
8	O
)	O
recon	O
soln	O
intravenous	O
infusion	O
(	O
continuous	O
infusion	O
)	O
.	O

16	O
.	O

furosemide	O
80	O
mg	O
iv	O
bid	O

17	O
.	O

metoclopramide	O
10	O
mg	O
iv	O
q6h	O
:	O
prn	O
nausea	B
/	O
vomiting	B

18	O
.	O

vancomycin	O
hcl	O
1000	O
mg	O
iv	O
q	O
24h	O

19	O
.	O

metoprolol	O
10	O
mg	O
iv	O
q4h	O

20	O
.	O

dextran	O
40	O
in	O
d5w	O
500	O
ml	O
iv	O
500	O
ml	O
q	O
24	O

21	O
.	O

ceftazidime	O
1	O
gm	O
iv	O
q12h	O

22	O
.	O

hydralazine	O
hcl	O
20	O
mg	O
iv	O
q6h	O
:	O
prn	O
sbp>160	O

23	O
.	O

morphine	O
sulfate	O
1	O
-	O
5	O
mg	O
iv	O
q4h	O
:	O
prn	O

24	O
.	O

lorazepam	O
0	O
.	O
5	O
-	O
1	O
mg	O
iv	O
q4h	O
:	O
prn	O

25	O
.	O

insulin	O
nph	O
human	O
recomb	O
100	O
unit	O
/	O
ml	O
suspension	O
sig	O
:	O
thirty	O
five	O
(	O
35	O
)	O
units	O
subcutaneous	O
breakfast	O
(	O
breakfast	O
)	O
:	O
35	O
units	O
qam	O
25	O
units	O
qpm	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

discharge	O
diagnosis	O
:	O

acute	B
mi	I
,	O
cardiogenic	B
shock	I
,	O
rv	B
failure	I
,	O
recent	O
rca	O
stents	O

ebsteins	B
anomaly	I

s	O
/	O
p	O
left	O
thr	O
3	O
weeks	O
ago	O
secondary	O
to	O
avn	B
(	O
[	O
*	O
*	O
2013	O
-	O
10	O
-	O
17	O
*	O
*	O
]	O
)	O

inferior	B
stemi	I

lipids	O

lbp	B

hypothyroid	I

thallesemia	I
minor	I

dm2	I

pud	I

gerd	I

glaucoma	I
s	O
/	O
p	O
multiple	O
surgeries	O

obesity	B

tobacco	I
abuse	I

h	O
/	O
o	O
junctional	B
rhythm	I

depression	I

discharge	O
condition	O
:	O

stable	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
200	O
*	O
*	O
]	O

completed	O
by	O
:	O
mark	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2502	O
*	O
*	O
]	O
np	O
80	O
-	O
auo	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O
@	O
1358	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name7	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2013	O
-	O
12	O
-	O
24	O
*	O
*	O
]	O
2	O
:	O
15	O
pm	O

(	O
end	O
of	O
report	O
)	O

22078	O
||||	O
16994	O
||||	O
609	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
07	O
-	O
26	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
26	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1947	O
-	O
07	O
-	O
09	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O

allergies	O
:	O

motrin	O
/	O
lipitor	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
7105	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

shortness	B
of	I
breath	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

intubation	O
.	O

history	O
of	O
present	O
illness	O
:	O

68	O
yo	O
f	O
with	O
hiv	B
(	O
cd4	O
385	O
)	O
,	O
esrd	B
on	O
hd	O
,	O
cad	B
s	O
/	O
p	O
2	O
mi's	O
,	O
dm2	B
,	O
chf	B
,	O
copd	B
who	O
presented	O
with	O
resp	B
failure	I
secondary	O
to	O
diast	B
dysf	I
and	O
htn	B
.	O

pt	O
was	O
sobx	O
1	O
day	O
no	O
cp	B
,	O
n	B
,	O
v	B
.	O

cousin	O
called	O
911	O
and	O
brought	O
to	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
w	O
/	O
o2	O
sats	O
53%	O
and	O
rr	O
in	O
30's	O
.	O

past	O
medical	O
history	O
:	O

past	O
medical	O
history	O
:	O
coronary	B
artery	I
disease	I
status	O
post	O
non	B
-	I
st	I
elevation	I
mi	I
in	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
29	O
*	O
*	O
]	O
,	O
status	O
post	O
ptca	O
/	O
stent	O
to	O
the	O
left	O
circumflex	O
,	O
status	O
post	O
ptca	O
/	O
stent	O
of	O
mid	O
left	O
circumflex	O
in	O
[	O
*	O
*	O
2014	O
-	O
05	O
-	O
29	O
*	O
*	O
]	O
,	O
latest	O
catheterization	O
in	O
[	O
*	O
*	O
2014	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
with	O
two	B
-	I
vessel	I
disease	I
.	O

ett	O
mibi	O
done	O
on	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
21	O
*	O
*	O
]	O
significant	O
for	O
no	O
symptoms	B
,	O
ekg	B
changes	I
,	O
and	O
with	O
only	O
a	O
fixed	B
inferior	I
defect	I
,	O
ejection	O
fraction	O
58	O
percent	O
.	O

diabetes	B
mellitus	I
type	I
2	I
,	O
diet	O
controlled	O
.	O

hiv	B
.	O

last	O
viral	O
load	O
undetectable	O
.	O

cd	O
count	O
41	O
in	O
[	O
*	O
*	O
2015	O
-	O
01	O
-	O
29	O
*	O
*	O
]	O
.	O

factor	B
viii	I
deficiency	I
diagnosed	O
in	O
[	O
*	O
*	O
2010	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
thought	O
secondary	O
to	O
a	O
rapid	B
steroid	I
taper	I
.	O

end	B
-	I
stage	I
renal	I
disease	I
on	O
hemodialysis	O
.	O

history	O
of	O
gi	B
bleed	I
in	O
the	O
setting	O
of	O
coagulopathy	B
and	O
nsaid	B
use	I
.	O

recent	O
pericarditis	B
.	O

eosinophilic	B
pneumonia	I
diagnosed	O
in	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
30	O
*	O
*	O
]	O
and	O
treated	O
with	O
prednisone	O
.	O

chronic	B
anemia	I
of	O
end	B
-	I
stage	I
renal	I
disease	I
.	O

vulvar	B
intraepithelial	I
neoplasia	I
diagnosed	O
in	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
29	O
*	O
*	O
]	O
.	O

chf	B
with	O
her	O
latest	O
echo	O
in	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
30	O
*	O
*	O
]	O
with	O
an	O
ejection	O
fraction	O
of	O
60	O
percent	O
and	O
3	O
plus	O
mr	B
.	O

copd	B
.	O

social	O
history	O
:	O

social	O
history	O
:	O
the	O
patient	O
currently	O
lives	O
in	O
[	O
*	O
*	O
location	O
7106	O
*	O
*	O
]	O
with	O
her	O
niece	O
.	O

she	O
was	O
previously	O
a	O
housewife	O
.	O

she	O
denies	O
alcohol	O
or	O
drug	O
use	O
.	O

she	O
smoked	O
2	O
packs	O
a	O
day	O
for	O
40	O
years	O
.	O

physical	O
exam	O
:	O

vs	O
t98	O
.	O
5	O
p107	O
bp	O
138	O
/	O
60	O
r18	O
o2	O
100%	O
on	O
ac	O

gen	O
intubated	O
,	O
sedated	O
on	O
propofol	O

heent	O
-	O
anicteric	B
,	O
no	O
jvd	B

cv	O
-	O
tachy	B
,	O
no	O
mormurs	B

lungs	O
-	O
good	O
air	O
mvt	O
b	O
/	O
l	O
,	O
mild	O
exp	B
wheezes	I
,	O
no	O
rhonchi	B

abd	O
-	O
s	O
/	O
nt	O
/	O
nd	O
+	O
bs	O

ext	O
l	O
avf	B
+	O
bruit	B
/	O
thrill	B
,	O
no	O
le	B
edema	I

pertinent	O
results	O
:	O

[	O
*	O
*	O
2015	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
06	O
:	O
40pm	O
pt	O
-	O
12	O
.	O
2	O
ptt	O
-	O
21	O
.	O
4	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
0	O

[	O
*	O
*	O
2015	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
06	O
:	O
40pm	O
plt	O
count	O
-	O
170	O

[	O
*	O
*	O
2015	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
06	O
:	O
40pm	O
wbc	O
-	O
13	O
.	O
8	O
*	O
rbc	O
-	O
2	O
.	O
96	O
*	O
hgb	O
-	O
12	O
.	O
7	O
hct	O
-	O
40	O
.	O
2	O
mcv	O
-	O
136	O
*	O
mch	O
-	O
42	O
.	O
9	O
*	O
mchc	O
-	O
31	O
.	O
6	O
rdw	O
-	O
18	O
.	O
2	O
*	O

[	O
*	O
*	O
2015	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
06	O
:	O
40pm	O
calcium	O
-	O
8	O
.	O
4	O
phosphate	O
-	O
5	O
.	O
9	O
*	O
#	O
magnesium	O
-	O
2	O
.	O
6	O

[	O
*	O
*	O
2015	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
06	O
:	O
40pm	O
ck	O
-	O
mb	O
-	O
3	O
ctropnt	O
-	O
0	O
.	O
11	O
*	O

[	O
*	O
*	O
2015	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
06	O
:	O
40pm	O
ck	O
(	O
cpk	O
)	O
-	O
123	O

[	O
*	O
*	O
2015	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
06	O
:	O
40pm	O
glucose	O
-	O
267	O
*	O
urea	O
n	O
-	O
66	O
*	O
creat	O
-	O
6	O
.	O
8	O
*	O
sodium	O
-	O
136	O
potassium	O
-	O
6	O
.	O
4	O
*	O
chloride	O
-	O
91	O
*	O
total	O
co2	O
-	O
27	O
anion	O
gap	O
-	O
24	O
*	O

[	O
*	O
*	O
2015	O
-	O
07	O
-	O
19	O
*	O
*	O
]	O
07	O
:	O
25pm	O
urine	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
opiates	O
-	O
neg	O
cocaine	O
-	O
neg	O
amphetmn	O
-	O
neg	O
mthdone	O
-	O
neg	O

brief	O
hospital	O
course	O
:	O

resp	O
-	O
pt	O
was	O
intubated	O
shortly	O
after	O
admission	O
.	O

upon	O
intubation	O
the	O
pt's	O
sats	O
returned	O
to	O
high	O
90's	O
.	O

pt	O
thought	O
to	O
be	O
experiencing	O
copd	B
exacerbation	I
and	O
given	O
azith	O
and	O
steroids	O
,	O
but	O
cxr	O
was	O
more	O
consistant	O
with	O
heart	B
failure	I
.	O

she	O
stabalized	O
with	O
aggresive	O
bp	O
control	O
and	O
dialysis	O
removoal	O
of	O
6	O
-	O
7	O
l	O
.	O

pt	O
weaned	O
from	O
vent	O
and	O
extubated	O
on	O
[	O
*	O
*	O
07	O
-	O
21	O
*	O
*	O
]	O
and	O
developed	O
flash	B
edema	I
.	O

the	O
edema	B
resolved	O
on	O
dialysis	O
,	O
hydralyzine	O
,	O
and	O
lasix	O
.	O

she	O
was	O
transfered	O
to	O
the	O
floor	O
on	O
[	O
*	O
*	O
07	O
-	O
22	O
*	O
*	O
]	O
.	O

pt	O
received	O
an	O
echo	O
in	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
44	O
*	O
*	O
]	O
which	O
demonsrtated	O
no	O
change	O
in	O
pts	O
3	O
+	O
mr	B
.	O

pt	O
had	O
decided	O
against	O
surgical	O
options	O
with	O
outpt	O
cardiologist	O
in	O
past	O
and	O
no	O
further	O
work	O
up	O
of	O
mr	B
was	O
done	O
.	O

id	O
-	O
[	O
*	O
*	O
07	O
-	O
21	O
*	O
*	O
]	O
urine	O
cx	O
grew	O
enterococcus	O
and	O
vanc	O
started	O
.	O

this	O
was	O
later	O
found	O
to	O
be	O
vre	O
and	O
linezolid	O
started	O
[	O
*	O
*	O
07	O
-	O
22	O
*	O
*	O
]	O
.	O

also	O
bal	O
from	O
bronch	O
[	O
*	O
*	O
07	O
-	O
21	O
*	O
*	O
]	O
revealed	O
pseudomonas	O
and	O
ceftaz	O
started	O
[	O
*	O
*	O
07	O
-	O
22	O
*	O
*	O
]	O
.	O

upon	O
arival	O
to	O
floor	O
sbp	B
fell	I
to	O
hihg	O
80's	O
which	O
was	O
thought	O
to	O
be	O
due	O
to	O
dialysis	O
or	O
possible	O
sepsis	B
from	O
uti	B
,	O
lungs	O
,	O
or	O
line	O
.	O

she	O
received	O
ivf	O
.	O

by	O
[	O
*	O
*	O
07	O
-	O
23	O
*	O
*	O
]	O
pt's	O
sbp	B
came	I
back	I
to	O
>100	O
and	O
has	O
remained	O
stable	O
.	O

also	O
pt	O
has	O
remained	O
afebrile	B
.	O

esrd	B
-	O
cont	O
on	O
dialysis	O
mon	O
,	O
wed	O
,	O
fri	O
.	O

dm	B
-	O
insulin	O
sliding	O
scale	O
.	O

glucose	O
was	O
fairly	O
well	O
controlled	O
during	O
stay	O
.	O

gi	O
-	O
pt	O
had	O
3	O
episodes	O
of	O
diarrhea	B
on	O
[	O
*	O
*	O
04	O
-	O
22	O
*	O
*	O
]	O
.	O

cdiff	O
was	O
negative	O
.	O

only	O
one	O
episode	O
since	O
.	O

medications	O
on	O
admission	O
:	O

1	O
.	O
zidovudine	O
200	O
mg	O
po	O
bid	O
.	O

2	O
.	O
nevirapine	O
200	O
mg	O
po	O
bid	O
.	O

3	O
.	O
lamivudine	O
50	O
mg	O
po	O
qd	O
.	O

4	O
.	O
nephrocaps	O
1	O
cap	O
po	O
qd	O
.	O

5	O
.	O
metoprolol	O
50	O
mg	O
po	O
qd	O
.	O

6	O
.	O
isosorbide	O
dinitrate	O
10	O
mg	O
po	O
bid	O
.	O

7	O
.	O
aspirin	O
,	O
enteric	O
-	O
coated	O
,	O
325	O
mg	O
po	O
qd	O
.	O

8	O
.	O
pantoprazole	O
40	O
mg	O
po	O
qd	O
.	O

9	O
.	O
calcium	O
carbonate	O
1	O
,	O
000	O
mg	O
po	O
bid	O
prn	O
.	O

10	O
.	O

nitroglycerin	O
sublingual	O
prn	O
chest	B
pain	I
.	O

11	O
.	O

senna	O
2	O
tablets	O
po	O
bid	O
.	O

12	O
.	O

colace	O
100	O
mg	O
po	O
bid	O
.	O

13	O
.	O

calcium	O
acetate	O
667	O
mg	O
2	O
tablets	O
po	O
tid	O
with	O
meals	O
.	O

14	O
.	O

metoclopramine	O
10	O
mg	O
po	O
qd	O
.	O

15	O
.	O

albuterol	O
1	O
-	O
2	O
puffs	O
inhaled	O
q	O
6	O
h	O
prn	O
.	O

16	O
.	O

atroven	O
1	O
puff	O
inhaled	O
qid	O
prn	O
shortness	B
of	I
breath	I
or	O
wheezing	B
.	O

17	O
.	O

albuterol	O
1	O
neb	O
q	O
6	O
h	O
prn	O
shortness	B
of	I
breath	I
or	O
wheezing	B
.	O

18	O
.	O

epo	O
at	O
hd	O

19	O
.	O

loratadine	O
10	O
mg	O
po	O
qod	O
for	O
1	O
month	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
zidovudine	O
100	O
mg	O
capsule	O
sig	O
:	O
two	O
(	O
2	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

2	O
.	O
nevirapine	O
200	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

3	O
.	O
lamivudine	O
10	O
mg	O
/	O
ml	O
solution	O
sig	O
:	O
five	O
(	O
5	O
)	O
ml	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

4	O
.	O
b	O
complex	O
-	O
vitamin	O
c	O
-	O
folic	O
acid	O
1	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
cap	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
30	O
cap	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

5	O
.	O
aspirin	O
325	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

6	O
.	O
insulin	O
regular	O
human	O
100	O
unit	O
/	O
ml	O
solution	O
sig	O
:	O
as	O
directed	O
injection	O
asdir	O
(	O
as	O
directed	O
)	O
:	O
pt	O
has	O
an	O
insulin	O
sliding	O
scale	O
at	O
home	O
.	O

she	O
checks	O
3	O
times	O
per	O
day	O
.	O

7	O
.	O
linezolid	O
600	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
for	O
6	O
days	O
:	O
take	O
for	O
6	O
days	O
.	O

disp	O
:	O
*	O
12	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

8	O
.	O
famotidine	O
20	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
.	O

9	O
.	O
lisinopril	O
5	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
15	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

10	O
.	O

albuterol	O
sulfate	O
0	O
.	O
083	O
%	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
inhalation	O
four	O
times	O
a	O
day	O
as	O
needed	O
for	O
shortness	B
of	I
breath	I
or	O
wheezing	B
.	O

11	O
.	O

atrovent	O
18	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
one	O
(	O
1	O
)	O
puff	O

inhalation	O
four	O
times	O
a	O
day	O
as	O
needed	O
for	O
shortness	B
of	I
breath	I
or	O
wheezing	B
.	O

12	O
.	O

albuterol	O
90	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
1	O
-	O
2	O
puffs	O
inhalation	O
four	O
times	O
a	O
day	O
as	O
needed	O
for	O
shortness	B
of	I
breath	I
or	O
wheezing	B
.	O

13	O
.	O

metoprolol	O
tartrate	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

14	O
.	O

cipro	O
250	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
twice	O
a	O
day	O
for	O
10	O
days	O
.	O

disp	O
:	O
*	O
20	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

repiratory	B
failure	I
due	O
to	O
chf	B
.	O

uti	B
with	O
vre	O

pseudomonas	O
in	O
sputum	O
.	O

discharge	O
condition	O
:	O

stable	O

discharge	O
instructions	O
:	O

pt	O
to	O
go	O
home	O
with	O
vna	O
services	O
.	O

please	O
call	O
primary	O
care	O
provider	O
if	O
fevers	B
,	O
shortness	B
of	I
breath	I
,	O
or	O
chest	B
pain	I
develops	O
.	O

followup	O
instructions	O
:	O

provider	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
where	O
:	O
[	O
*	O
*	O
hospital	O
2626	O
*	O
*	O
]	O
cardiac	O
services	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3635	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2015	O
-	O
09	O
-	O
08	O
*	O
*	O
]	O
11	O
:	O
45	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
7107	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
7108	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
7109	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
7110	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
26	O
*	O
*	O
]	O
@	O
1444	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2015	O
-	O
09	O
-	O
11	O
*	O
*	O
]	O
8	O
:	O
41	O
am	O

(	O
end	O
of	O
report	O
)	O

26395	O
||||	O
17090	O
||||	O
29256	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
07	O
-	O
17	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

[	O
*	O
*	O
unit	O
number	O
872	O
*	O
*	O
]	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
14	O
*	O
*	O
]	O

discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
17	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1947	O
-	O
04	O
-	O
25	O
*	O
*	O
]	O

sex	O
:	O
m	O

service	O
:	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
752	O
*	O
*	O
]	O

chief	O
complaint	O
:	O
right	O
femoral	O
artery	O
pseudoaneurysm	B
.	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
65	O
year	O
old	O
male	O
who	O
was	O
transferred	O
from	O
[	O
*	O
*	O
hospital	O
873	O
*	O
*	O
]	O
as	O
a	O
direct	O
admit	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
47	O
*	O
*	O
]	O
for	O
bleeding	B
,	O
status	O
post	O
right	O
hip	O
replacement	O
surgery	O
.	O

surgery	O
underwent	O
with	O
the	O
same	O
intraop	B
bleeding	I
noted	O
yesterday	O
a	O
.	O
m	O
.	O
,	O
which	O
apparently	O
stopped	O
at	O
the	O
end	O
of	O
the	O
case	O
,	O
but	O
total	O
blood	O
loss	O
was	O
estimated	O
at	O
2000	O
cc	O
.	O

the	O
patient	O
was	O
given	O
1	O
unit	O
of	O
autologous	O
packed	O
red	O
blood	O
cells	O
and	O
2	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
during	O
the	O
case	O
,	O
as	O
well	O
as	O
2	O
units	O
of	O
ffp	O
.	O

the	O
patient	O
apparently	O
was	O
hemodynamically	O
stable	O
postoperatively	O
until	O
about	O
0300	O
on	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
14	O
*	O
*	O
]	O
,	O
when	O
he	O
became	O
hypotensive	B
with	O
the	O
systolic	O
blood	O
pressures	O
in	O
the	O
40's	O
.	O

hematocrit	B
dropped	I
from	O
30	O
.	O
7	O
to	O
21	O
.	O
7	O
.	O

the	O
patient	O
was	O
given	O
4	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
,	O
as	O
well	O
as	O
vitamin	O
k	O
and	O
2	O
units	O
of	O
ffp	O
.	O

the	O
patient	O
was	O
taken	O
emergently	O
to	O
angiography	O
,	O
where	O
the	O
femoral	O
arterial	O
sheath	O
placed	O
.	O

the	O
patient	O
was	O
found	O
to	O
have	O
left	O
common	B
femoral	I
artery	I
injury	I
with	O
active	O
blushing	O
of	O
contrast	O
dye	O
.	O

the	O
patient	O
continued	O
to	O
require	O
blood	O
products	O
and	O
transferred	O
to	O
[	O
*	O
*	O
hospital	O
617	O
*	O
*	O
]	O
for	O

definitive	O
management	O
.	O

the	O
patient	O
arrived	O
,	O
oriented	O
x3	O
,	O
systolic	O
blood	O
pressure	O
in	O
the	O
150's	O
,	O
o2	O
sats	O
98%	O
with	O
a	O
heart	O
rate	O
in	O
the	O
90's	O
.	O

not	O
intubated	O
,	O
but	O
in	O
severe	O
right	O
pain	B
hip	I
and	O
right	O
thigh	B
pain	I
.	O

the	O
patient	O
now	O
is	O
admitted	O
to	O
the	O
[	O
*	O
*	O
hospital	O
874	O
*	O
*	O
]	O
for	O
definitive	O
management	O
.	O

past	O
medical	O
history	O
:	O
hypertension	B
,	O
gerd	B
,	O
dysphagia	B
,	O
ankylosing	B
spondylitis	I
and	O
history	O
of	O
bph	B
.	O

past	O
surgical	O
history	O
:	O
significant	O
for	O
esophageal	O
dilatation	O
x2	O
,	O
right	O
total	O
hip	O
replacement	O
in	O
[	O
*	O
*	O
2002	O
*	O
*	O
]	O
,	O
a	O
left	O
total	O
hip	O
replacement	O
in	O
[	O
*	O
*	O
1999	O
*	O
*	O
]	O
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
:	O
medications	O
on	O
transfer	O
were	O
morphine	O
,	O
bactrim	O
,	O
ancef	O
,	O
senna	O
tabs	O
and	O
multivitamin	O
tablets	O
,	O
aspirin	O
,	O

phenergan	O
,	O
lipitor	O
,	O
quinapril	O
and	O
xanax	O
.	O

social	O
history	O
:	O
negative	O
for	O
tobacco	O
use	O
.	O

he	O
does	O
admit	O
to	O
a	O
glass	O
of	O
red	O
wine	O
daily	O
.	O

family	O
history	O
:	O
noncontributory	O
.	O

physical	O
examination	O
:	O
physical	O
exam	O
on	O
admission	O
:	O

temperature	O
100	O
.	O
7	O
.	O

blood	O
pressure	O
171	O
/	O
64	O
.	O

pulse	O
82	O
.	O

respirations	O
33	O
.	O

o2	O
sat	O
99%	O
on	O
room	O
air	O
.	O

general	O
appearance	O
:	O
oriented	O
x3	O
.	O

anxious	B
and	O
in	O
pain	B
.	O

heart	O
is	O
regular	O
rate	O
and	O
rhythm	O
without	O
murmurs	B
.	O

lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

abdominal	O
exam	O
was	O
unremarkable	O
.	O

the	O
right	O
hip	O
dressing	O
is	O
saturated	O
with	O
blood	O
with	O
drains	O
to	O
suction	O
canisters	O
full	O
of	O
blood	O
.	O

the	O
right	O
thigh	O
is	O
tense	B
and	O
with	O
tenderness	B
out	O
of	O
proportion	O
to	O
the	O
exam	O
.	O

sensory	O
motor	O
intact	O
bilateral	O
lower	O
extremities	O
.	O

pulse	O
exam	O
shows	O
palpable	O
radials	O
,	O
brachial's	O
,	O
carotids	O
bilaterally	O
,	O
2	O
+	O
femoral	O
on	O
the	O
right	O
.	O

i	O
was	O
not	O
able	O
to	O
examine	O
the	O
left	O
groin	O
.	O

he	O
had	O
a	O
sheath	O
in	O
it	O
.	O

the	O
popliteal	O
on	O
the	O
right	O
could	O
not	O
be	O
examined	O
,	O
and	O
on	O
the	O
left	O
he	O
had	O
a	O
2	O
+	O
palpable	O
pulse	O
.	O

the	O
dorsalis	O
pedis	O
and	O
posterior	O
tibial	O
pulses	O
were	O
palpable	O
bilaterally	O
2	O
+	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
underwent	O
transfer	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
47	O
*	O
*	O
]	O
and	O
then	O
underwent	O
an	O
urgent	O
repair	O
of	O
the	O
right	O
common	O
femoral	O
arterial	B
laceration	I
,	O
and	O
drainage	O
of	O
a	O
thigh	B
hematoma	I
.	O

the	O
patient	O
tolerated	O
the	O
procedure	O
well	O
.	O

the	O
patient	O
had	O
2	O
hemovacs	O
placed	O
.	O

the	O
patient	O
was	O
transferred	O
to	O
the	O
pacu	O
,	O
extubated	O
and	O
hemodynamically	O
stable	O
with	O
pain	B
well	O
controlled	O
.	O

admitting	O
labs	O
:	O
white	O
count	O
was	O
9	O
.	O
0	O
,	O
hematocrit	O
29	O
.	O
3	O
,	O
platelets	O
103k	O
.	O

bun	O
14	O
,	O
creatinine	O
1	O
.	O
0	O
.	O

postoperative	O
white	O
count	O
was	O
10	O
.	O
1	O
,	O
hematocrit	O
32	O
.	O
1	O
.	O

bun	O
and	O
creatinine	O
remained	O
stable	O
.	O

the	O
patient	O
had	O
2	O
+	O
dp	O
and	O
pt	O
pulses	O
with	O
a	O
warm	O
right	O
lower	O
extremity	O
.	O

sensory	O
and	O
motor	O
were	O
intact	O
.	O

the	O
patient	O
remained	O
in	O
the	O
pacu	O
and	O
then	O
was	O
transferred	O
to	O
the	O
vicu	O
for	O
continued	O
hemodynamic	O
monitoring	O
.	O

postoperative	O
day	O
1	O
there	O
were	O
no	O
overnight	O
events	O
.	O

the	O
patient	O
was	O
hemodynamically	O
stable	O
.	O

t	O
-	O
max	O
was	O
101	O
.	O
1	O
to	O
100	O
.	O
2	O
.	O

lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

incisions	O
were	O
clean	O
,	O
dry	O
and	O
intact	O
.	O

there	O
is	O
minimal	O
erythema	B
with	O
a	O
small	O
amount	O
of	O
oozing	B
at	O
the	O
superior	O
aspect	O
of	O
the	O
incision	O
.	O

this	O
was	O
likely	O
secondary	O
to	O
skin	B
bleeding	I
.	O

the	O
right	O
foot	O
pulses	O
remained	O
palpable	O
.	O

hematocrit	O
was	O
unmonitored	O
.	O

the	O
patient	O
remained	O
in	O
the	O
vicu	O
.	O

postoperative	O
day	O
2	O
t	O
-	O
max	O
was	O
101	O
to	O
100	O
.	O
1	O
.	O

the	O
patient	O
was	O
begun	O
on	O
lovenox	O
and	O
aspirin	O
.	O

exam	O
remained	O
unchanged	O
.	O

continued	O
our	O
perioperative	O
kefzol	O
.	O

the	O
drains	O
were	O
managed	O
by	O
orthopedic	O
service	O
and	O
those	O
were	O
removed	O
on	O
postoperative	O
day	O
#2	O
.	O
the	O
patient	O
will	O
be	O
allowed	O
partial	O
weightbearing	O
with	O
weightbearing	O
as	O
tolerated	O
.	O

the	O
lovenox	O
will	O
be	O
continued	O
40	O
mg	O
subcu	O
daily	O
for	O
a	O
total	O
of	O
4	O
weeks	O
from	O
the	O
date	O
of	O
surgery	O
.	O

keflex	O
500	O
mg	O
q	O
.	O
i	O
.	O
d	O
.	O
will	O
be	O
continued	O
for	O
10	O
days	O
.	O

the	O
patient	O
was	O
seen	O
by	O
physical	O
therapy	O
,	O
who	O
thought	O
he	O
would	O
be	O
able	O
to	O
be	O
discharged	O
to	O
home	O
.	O

the	O
remaining	O
hospital	O
course	O
was	O
unremarkable	O
.	O

the	O
patient	O
was	O
discharged	O
home	O
on	O
postoperative	O
day	O
4	O
and	O
no	O
post	O
voiding	B
difficulties	I
.	O

he	O
will	O
continue	O
his	O
keflex	O
for	O
a	O
total	O
of	O
10	O
days	O
.	O

he	O
should	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
875	O
*	O
*	O
]	O
,	O
his	O
orthopedist	O
,	O
as	O
directed	O
.	O

he	O
will	O
continue	O
the	O
lovenox	O
as	O
directed	O
.	O

he	O
will	O
be	O
given	O

percocet	O
tablets	O
for	O
pain	B
and	O
he	O
will	O
resume	O
all	O
preadmission	O
medications	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
right	O
common	B
femoral	I
laceration	I
,	O
status	O
post	O
repair	O
.	O

2	O
.	O
status	O
post	O
total	O
right	O
hip	O
replacement	O
.	O

3	O
.	O
hypertension	B
,	O
controlled	O
.	O

4	O
.	O
postoperative	O
blood	B
loss	I
anemia	I
,	O
corrected	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
02aaj	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
876	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
17	O
*	O
*	O
]	O
08	O
:	O
51	O
:	O
31	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
17	O
*	O
*	O
]	O
09	O
:	O
35	O
:	O
00	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
877	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
23	O
*	O
*	O
]	O
7	O
:	O
08	O
am	O

(	O
end	O
of	O
report	O
)	O

11306	O
||||	O
17217	O
||||	O
24048	O
||||	O
discharge	O
_	O
summary	O
||||	O
2020	O
-	O
01	O
-	O
21	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2020	O
-	O
01	O
-	O
20	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2020	O
-	O
01	O
-	O
21	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1977	O
-	O
11	O
-	O
23	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

lipitor	O
/	O
codeine	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
5505	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

gib	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

endoscopy	O
[	O
*	O
*	O
2020	O
-	O
01	O
-	O
20	O
*	O
*	O
]	O

history	O
of	O
present	O
illness	O
:	O

42	O
yom	O
with	O
pmh	O
of	O
htn	B
,	O
hyperchol	B
admitted	O
to	O
osh	O
1	O
day	O
ago	O
with	O
black	B
tarry	I
stools	I
x	O
2	O
days	O
.	O

patient	O
states	O
that	O
he	O
had	O
chronically	O
had	O
loose	O
stools	O
but	O
over	O
2	O
preeceeding	O
days	O
noticed	O
the	O
stool	O
to	O
be	O
dark	O
and	O
tarry	O
.	O
+	O
epigastric	B
discomfort	I
,	O
gurgling	B
gas	I
-	I
like	I
pain	I
,	O
no	O
association	O
with	O
food	O
.	O
+	O
lightheadedness	B
when	O
he	O
stood	O
up	O
prompting	O
him	O
to	O
go	O
to	O
osh	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
.	O

he	O
states	O
that	O
he	O
takes	O
asa	O
daily	O
and	O
takes	O
motrin	O
800	O
mg	O
tid	O
sometimes	O
for	O
pain	B
,	O
last	O
use	O
2	O
wks	O
pta	O
.	O

denies	O
brbpr	B
,	O
n	B
/	O
v	B
/	O
d	B
.	O

denies	O
recent	O
fevers	B
,	O
chills	B
.	O

denies	O
any	O
hemetemesis	B
.	O

at	O
osh	O
initial	O
hct=	O
26	O
,	O
and	O
22	O
upon	O
repeat	O
.	O

he	O
was	O
also	O
orthostatic	B
given	O
3	O
units	O
prbc	O
and	O
ivf	O
.	O

egd	O
attempted	O
but	O
pt	O
unable	O
to	O
tolerate	O
.	O

he	O
is	O
now	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
16	O
*	O
*	O
]	O
for	O
futher	O
workup	O
and	O
rx	O
.	O

on	O
transfer	O
pt	O
denies	O
any	O
complaints	B
.	O

states	O
that	O
lightheadedness	B
is	O
resolved	O
.	O

past	O
medical	O
history	O
:	O

htn	B

hyperchol	I

h	O
/	O
o	O
a	B
.	I
fib	I
6	O
yrs	O
ago	O
-	O
>	O
cardioverted	O
.	O

social	O
history	O
:	O

social	O
hx	O
:	O
works	O
as	O
a	O
police	O
oficer	O
,	O
married	O
,	O
denies	O
smoking	O
,	O
etoh	O
.	O

family	O
history	O
:	O

family	O
hx	O
:	O
father	O
with	O
lung	B
ca	I
.	O

physical	O
exam	O
:	O

physical	O
exam	O
:	O

vitals	O
:	O

t	O
:	O
98	O
p	O
:	O
66	O
r	O
:	O
15	O
bp	O
:	O
122	O
/	O
51	O
sao2	O
:	O
100%ra	O

general	O
:	O
young	O
male	O
in	O
nad	B
,	O
awake	O
alert	O
oriented	O

heent	O
:	O
mmm	O
,	O
eomi	O
,	O
op	O
clear	O

neck	O
:	O
supple	O
,	O
no	O
jvd	B

pulmonary	O
:	O
lungs	O
cta	O
bilaterally	O
without	O
r	B
/	O
r	B
/	O
w	B

cardiac	O
:	O
rrr	O
,	O
nl	O
.	O

s1s2	O
,	O
no	O
m	B
/	O
r	B
/	O
g	B
noted	O

abdomen	O
:	O
obese	B
,	O
soft	O
,	O
mild	O
epigastric	B
tenderness	I
,	O
nabs	O

extremities	O
:	O
no	O
c	B
/	O
c	B
/	O
e	B
bilaterally	O
,	O
2	O
+	O
radial	O
,	O
dp	O
and	O
pt	O
pulses	O
b	O
/	O
l	O
.	O

rectal	O
:	O
no	O
hemrroiids	B
,	O
guiac	B
positive	I
brown	I
stool	I
.	O

pertinent	O
results	O
:	O

osh	O
27	O
.	O
5	O
hct	O
at	O
2	O
:	O
50	O
am	O
[	O
*	O
*	O
01	O
-	O
20	O
*	O
*	O
]	O
.	O

ekg	O
:	O
osh	O
-	O
sinus	B
tach	I
at	O
108	O
,	O
nl	O
axis	O
,	O
nl	O
intevals	O
.	O

no	O
st	B
-	I
t	I
abnormalities	I
.	O

[	O
*	O
*	O
2020	O
-	O
01	O
-	O
20	O
*	O
*	O
]	O
06	O
:	O
17am	O
pt	O
-	O
13	O
.	O
2	O
*	O
ptt	O
-	O
27	O
.	O
2	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2020	O
-	O
01	O
-	O
20	O
*	O
*	O
]	O
06	O
:	O
17am	O
plt	O
count	O
-	O
259	O

[	O
*	O
*	O
2020	O
-	O
01	O
-	O
20	O
*	O
*	O
]	O
06	O
:	O
17am	O
wbc	O
-	O
9	O
.	O
3	O
rbc	O
-	O
3	O
.	O
21	O
*	O
hgb	O
-	O
9	O
.	O
6	O
*	O
hct	O
-	O
27	O
.	O
3	O
*	O
mcv	O
-	O
85	O
mch	O
-	O
29	O
.	O
9	O
mchc	O
-	O
35	O
.	O
2	O
*	O
rdw	O
-	O
15	O
.	O
6	O
*	O

[	O
*	O
*	O
2020	O
-	O
01	O
-	O
20	O
*	O
*	O
]	O
09	O
:	O
50pm	O
wbc	O
-	O
8	O
.	O
0	O
rbc	O
-	O
3	O
.	O
20	O
*	O
hgb	O
-	O
9	O
.	O
6	O
*	O
hct	O
-	O
27	O
.	O
8	O
*	O
mcv	O
-	O
87	O
mch	O
-	O
30	O
.	O
1	O
mchc	O
-	O
34	O
.	O
7	O
rdw	O
-	O
15	O
.	O
7	O
*	O

[	O
*	O
*	O
2020	O
-	O
01	O
-	O
20	O
*	O
*	O
]	O
09	O
:	O
50pm	O
plt	O
count	O
-	O
264	O

[	O
*	O
*	O
2020	O
-	O
01	O
-	O
20	O
*	O
*	O
]	O
12	O
:	O
38pm	O
wbc	O
-	O
7	O
.	O
4	O
rbc	O
-	O
3	O
.	O
38	O
*	O
hgb	O
-	O
10	O
.	O
1	O
*	O
hct	O
-	O
29	O
.	O
2	O
*	O
mcv	O
-	O
86	O
mch	O
-	O
29	O
.	O
8	O
mchc	O
-	O
34	O
.	O
5	O
rdw	O
-	O
15	O
.	O
5	O

brief	O
hospital	O
course	O
:	O

assessment	O
and	O
plan	O
:	O
42	O
yom	O
with	O
h	O
/	O
o	O
nsaid	O
use	O
transferred	O
from	O
osh	O
with	O
black	B
tarry	I
stools	I
at	O
home	O
.	O

patient	O
was	O
admitted	O
to	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
with	O
tid	O
hct	O
check	O
.	O

gi	O
was	O
consulted	O
and	O
performed	O
endoscopy	O
under	O
general	O
anesthesia	O
which	O
revealed	O
a	O
non	B
bleeding	I
ulcer	I
and	O
gastritis	B
.	O

patient	O
was	O
continued	O
on	O
bid	O
ppi	O
,	O
h	O
.	O

pylori	O
serology	O
checked	O
(	O
pending	O
at	O
time	O
of	O
discharge	O
)	O
.	O

his	O
antihypertensives	O
were	O
held	O
given	O
concern	O
for	O
gi	B
bleed	I
and	O
should	O
be	O
restarted	O
at	O
follow	O
up	O
appointment	O
with	O
pcp	O
.	O
[	O
*	O
*	O
name10	O
(	O
nameis	O
)	O
*	O
*	O
]	O
was	O
discharged	O
with	O
goal	O
ppi	O
twice	O
day	O
for	O
1	O
month	O
followed	O
by	O
once	O
a	O
day	O
.	O

he	O
is	O
scheduled	O
to	O
follow	O
up	O
with	O
daughter	O
in	O
2	O
days	O
.	O

medications	O
on	O
admission	O
:	O

medications	O
on	O
transfer	O
:	O

esmopreazole	O
40	O
mg	O
iv	O
bid	O

hydrochlorthiazide	O
25	O
mg	O
daily	O

lisinopril	O
5	O
mg	O
daily	O

loratadine	O
10	O
mg	O
daily	O

metprolol	O
150	O
mg	O
daily	O

multivitamin	O

niacin	O
500	O
mg	O
daily	O

-	O

medications	O
at	O
home	O
:	O

asa	O
325mg	O
daily	O

motrin	O
800	O
mg	O
tid	O

lisinopril	O
5	O
mg	O
daily	O

hydrochlorthiazide	O
25	O
mg	O
daily	O

toprol	O
xl	O
150mg	O
daily	O

niaspan	O
500	O
mg	O
daily	O

loratidine	O
10	O
mg	O
daily	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
niacin	O
500	O
mg	O
capsule	O
,	O
sustained	O
release	O
sig	O
:	O
one	O
(	O
1	O
)	O

capsule	O
,	O
sustained	O
release	O
po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
pantoprazole	O
40	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
:	O
twice	O
a	O
day	O
for	O
one	O
month	O
,	O
followed	O
by	O
one	O
tablet	O
per	O
day	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

gi	B
bleeding	I

peptic	I
ulcer	I
disease	I

gastritis	I

hypertension	I

hypercholestrolemia	I

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

please	O
continue	O
to	O
take	O
all	O
your	O
medicaitons	O
and	O
follow	O
up	O
with	O
your	O
appointments	O
as	O
below	O
.	O

you	O
should	O
avoid	O
aspirin	O
,	O
motrin	O
or	O
any	O
other	O
nonsteroidal	O
antiinflammatory	O
agents	O
.	O

you	O
should	O
restart	O
your	O
bp	O
medications	O
after	O
you	O
see	O
your	O
pcp	O
.	O

if	O
you	O
have	O
any	O
further	O
black	B
stools	I
,	O
bleeding	B
,	O
lightheadedness	B
or	O
any	O
other	O
concerning	O
symptoms	B
please	O
contact	O
your	O
pcp	O
or	O
return	O
to	O
the	O
emergency	O
room	O
.	O

followup	O
instructions	O
:	O

please	O
call	O
your	O
pcp	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3874	O
*	O
*	O
]	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
5506	O
*	O
*	O
]	O
to	O
set	O
up	O
an	O
appointment	O
by	O
friday	O
this	O
week	O
.	O

[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
5507	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
5508	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
5509	O
*	O
*	O
]	O
[	O
*	O
*	O
2020	O
-	O
01	O
-	O
21	O
*	O
*	O
]	O
@	O
1445	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2020	O
-	O
09	O
-	O
25	O
*	O
*	O
]	O
1	O
:	O
30	O
pm	O

(	O
end	O
of	O
report	O
)	O

21181	O
||||	O
17336	O
||||	O
16636	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
09	O
-	O
09	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
08	O
-	O
10	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
09	O
-	O
09	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1998	O
-	O
05	O
-	O
12	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
trauma	O
surgery	O

history	O
of	O
the	O
present	O
illness	O
:	O
the	O
patient	O
is	O
an	O
18	O
-	O
year	O
-	O
old	O
female	O
who	O
was	O
an	O
unrestrained	O
driver	O
of	O
a	O
truck	O
after	O
where	O
she	O
lost	O
control	O
and	O
rolled	O
over	O
.	O

she	O
was	O
ejected	O
and	O
ended	O
up	O
becoming	O
entrapped	O
underneath	O
some	O
of	O
the	O
wreckage	O
.	O

the	O
extrication	O
time	O
was	O
approximately	O
one	O
hour	O
.	O

there	O
was	O
a	O
question	O
of	O
loc	B
.	O

medflight	O
arrived	O
on	O
the	O
scene	O
where	O
her	O
gcs	O
was	O
15	O
and	O
she	O
was	O
hemodynamically	O
stable	O
.	O

she	O
was	O
flown	O
to	O
[	O
*	O
*	O
hospital1	O
189	O
*	O
*	O
]	O
for	O
trauma	O
resuscitation	O
.	O

past	O
medical	O
history	O
:	O
none	O
.	O

admission	O
medications	O
:	O
none	O
.	O

allergies	O
:	O
the	O
patient	O
has	O
no	O
known	O
drug	O
allergies	O
.	O

physical	O
examination	O
:	O
on	O
arrival	O
to	O
the	O
trauma	O
bay	O
,	O
her	O
heart	O
rate	O
was	O
88	O
,	O
blood	O
pressure	O
90	O
/	O
palpable	O
.	O

she	O
was	O
breathing	O
at	O
20	O
,	O
100%	O
on	O
room	O
air	O
.	O

she	O
was	O
in	O
moderate	O
distress	B
.	O

she	O
had	O
multiple	O
facial	B
lacerations	I
but	O
her	O
face	O
was	O
stable	O
.	O

her	O
tms	O
were	O
clear	O
.	O

her	O
neck	O
was	O
in	O
a	O
c	O
collar	O
with	O
the	O
trachea	O
midline	O
.	O

the	O
chest	O
had	O
equal	O
breath	O
sounds	O
bilaterally	O
and	O
there	O
was	O
no	O
instability	B
of	O
the	O
chest	O
wall	O
.	O

her	O
heart	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

the	O
abdomen	O
was	O
soft	O
and	O
nontender	O
with	O
a	O
negative	O
fast	O
.	O

she	O
had	O
on	O
the	O
right	O
upper	O
extremity	O
a	O
large	O
degloving	B
injury	I
to	O
her	O
forearm	O
and	O
an	O
obvious	O
deformity	B
.	O

she	O
had	O
good	O
neurovascular	O
examination	O
.	O

her	O
right	O
lower	O
extremity	O
had	O
a	O
large	O
thigh	O
deformity	B
laceration	I
and	O
large	O
area	O
of	O
abrasion	B
.	O

her	O
distal	O
neurovascular	O
examination	O
on	O
the	O
lower	O
extremities	O
was	O
intact	O
.	O

the	O
pelvis	O
was	O
stable	O
.	O

laboratory	O
/	O
radiologic	O
data	O
:	O
on	O
admission	O
,	O
hematocrit	O
35	O
,	O
inr	O
1	O
.	O
3	O
.	O

bun	O
and	O
creatinine	O
16	O
and	O
0	O
.	O
9	O
.	O

amylase	O
29	O
.	O

tox	O
screen	O
was	O
negative	O
.	O

there	O
was	O
large	O
blood	B
in	I
the	I
urine	I
,	O
[	O
*	O
*	O
07	O
-	O
05	O
*	O
*	O
]	O
rbcs	O
.	O

the	O
patient	O
underwent	O
multiple	O
studies	O
.	O

a	O
ct	O
of	O
the	O
head	O
was	O
negative	O
for	O
any	O
bleed	B
.	O

c	O
-	O
spine	O
ct	O
was	O
negative	O
for	O
fracture	B
or	O
dislocation	B
or	O
canal	O
impingement	B
.	O

ct	O
of	O
the	O
abdomen	O
and	O
pelvis	O
demonstrated	O
a	O
right	O
superior	B
pubic	I
rami	I
fracture	I
,	O
right	O
l4	O
-	O
5	O
transverse	B
process	I
fracture	I
,	O
a	O
right	O
sacral	B
fracture	I
extending	O
to	O
the	O
sacroiliac	O
joint	O
with	O
no	O
diastasis	B
.	O

the	O
right	O
upper	O
extremity	O
revealed	O
no	O
solid	B
organ	I
injury	I
and	O
no	O
free	B
air	I
in	O
the	O
abdomen	O
.	O

an	O
x	O
-	O
ray	O
of	O
the	O
right	O
upper	O
extremity	O
demonstrated	O
radial	B
ulnar	I
fracture	I
of	O
the	O
forearm	O
.	O

right	O
lower	O
extremity	O
demonstrated	O
a	O
displaced	O
right	O
femoral	O
fracture	O
,	O
nondisplaced	B
fracture	I
of	O
the	O
proximal	O
right	O
fibula	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
stabilized	O
in	O
the	O
trauma	O
bay	O
,	O
remained	O
hemodynamically	O
stable	O
and	O
after	O
uncovering	O
the	O
extensive	O
orthopedic	B
injuries	I
,	O
she	O
was	O
taken	O
to	O
the	O
operating	O
room	O
by	O
the	O
orthopedic's	O
team	O
.	O

at	O
this	O
time	O
,	O
the	O
patient	O
was	O
also	O
noted	O
to	O
have	O
a	O
significant	O
perineal	B
injury	I
and	O
the	O

general	O
surgery	O
and	O
colorectal	O
surgery	O
teams	O
were	O
involved	O
.	O

at	O
that	O
initial	O
operating	O
room	O
intervention	O
,	O
the	O
patient	O
underwent	O
multiple	O
procedures	O
which	O
included	O
incision	O
and	O
drainage	O
of	O
the	O
right	O
forearm	O
,	O
external	O
fixation	O
of	O
the	O
right	O
forearm	B
fractures	I
,	O
and	O
im	O
rodding	O
of	O
the	O
right	O
femur	O
.	O

a	O
perineal	O
debridement	O
followed	O
by	O
rectal	O
washout	O
and	O
a	O
diverting	O
end	O
-	O
colostomy	O
.	O

the	O
patient	O
tolerated	O
all	O
of	O
these	O
procedure	O
well	O
,	O
remained	O
hemodynamically	O
stable	O
and	O
was	O
transferred	O
to	O
the	O
trauma	O

intensive	O
care	O
unit	O
for	O
close	O
monitoring	O
,	O
ventilatory	O
support	O
and	O
continued	O
workup	O
for	O
injuries	B
.	O

the	O
patient's	O
ensuing	O
hospital	O
course	O
was	O
significant	O
for	O
multiple	O
trips	O
to	O
the	O
operating	O
room	O
for	O
debridement	O
of	O
her	O
right	O
thigh	O
and	O
buttock	O
region	O
.	O

there	O
were	O
multiple	O
swab	O
cultures	O
taken	O
and	O
the	O
patient	O
was	O
placed	O
on	O
the	O
appropriate	O
antibiotics	O
.	O

she	O
tolerated	O
all	O
of	O
these	O
procedures	O
well	O
and	O
to	O
facilitate	O
the	O
multiple	O
trips	O
to	O
the	O
operating	O
room	O
,	O
the	O
patient	O
required	O
ventilatory	O
support	O
and	O
remained	O
intubated	O
during	O
this	O
period	O
of	O
time	O
.	O

for	O
sedation	O
,	O
she	O
remained	O
on	O
narcotic	O
and	O
benzodiazepine	O
drips	O
which	O
maintained	O
her	O
appropriate	O
sedation	O
levels	O
.	O

on	O
[	O
*	O
*	O
2016	O
-	O
08	O
-	O
16	O
*	O
*	O
]	O
,	O
while	O
undergoing	O
the	O
debridement	O
of	O
the	O
right	O
buttock	O
and	O
thigh	B
wound	I
,	O
underwent	O
an	O
ultrasound	O
of	O
the	O
rectum	O
which	O
demonstrated	O
an	O
intact	O
sphincter	O
.	O

she	O
also	O
was	O
noted	O
at	O
this	O
time	O
to	O
have	O
right	O
purulent	B
drainage	I
from	O
the	O
right	O
forearm	O
where	O
the	O
external	O
fixator	O
had	O
been	O
placed	O
and	O
this	O
was	O
opened	O
and	O
debrided	O
.	O

approximately	O
a	O
week	O
after	O
the	O
initial	O
injury	B
and	O
multiple	O
debridements	O
,	O
plastic	O
surgery	O
was	O
involved	O
and	O
after	O
careful	O
consideration	O
it	O
was	O
considered	O
for	O
a	O
vac	O
drain	O
placement	O
to	O
allow	O
the	O
bed	O
of	O
tissue	O
to	O
granulate	O
and	O
look	O
towards	O
wound	B
closure	O
at	O
some	O
future	O
point	O
.	O

this	O
was	O
placed	O
and	O
she	O
was	O
continued	O
on	O
appropriate	O
antibiotics	O
.	O

her	O
nutrition	O
was	O
addressed	O
with	O
tpn	O
initially	O
and	O
she	O
was	O
converted	O
to	O
tube	O
feeds	O
which	O
she	O
has	O
tolerated	O
.	O

infectious	O
disease	O
consultation	O
was	O
obtained	O
.	O

due	O
to	O
the	O
extensive	O
debridement	O
of	O
the	O
right	O
thigh	O
and	O
buttock	O
region	O
which	O
was	O
essentially	O
down	O
to	O
the	O
bone	O
,	O
the	O
patient	O
was	O
diagnosed	O
with	O
osteomyelitis	B
and	O
she	O
was	O
placed	O
on	O
broad	O
spectrum	O
antibiotics	O
which	O
will	O
be	O
continued	O
for	O
an	O
extensive	O
period	O
of	O
time	O
beyond	O
this	O
admission	O
.	O

beginning	O
on	O
[	O
*	O
*	O
2016	O
-	O
08	O
-	O
19	O
*	O
*	O
]	O
,	O
the	O
patient	O
began	O
to	O
have	O
temperature	B
spikes	I
and	O
she	O
was	O
pan	O
cultured	O
.	O

she	O
was	O
maintained	O
on	O
her	O
broad	O
spectrum	O
antibiotics	O
.	O

on	O
[	O
*	O
*	O
2016	O
-	O
08	O
-	O
24	O
*	O
*	O
]	O
,	O
she	O
was	O
taken	O
back	O
to	O
the	O
operating	O
room	O
by	O
the	O

orthopedics	O
team	O
where	O
her	O
right	O
femur	O
rod	O
was	O
removed	O
and	O
she	O
had	O
a	O
replacement	O
im	O
rod	O
placed	O
.	O

she	O
had	O
an	O
echocardiogram	O
which	O
did	O
not	O
demonstrate	O
any	O
vegetations	B
.	O

after	O
that	O
orthopedic	O
procedure	O
,	O
the	O
patient	O
actually	O
defervesced	B
.	O

she	O
was	O
maintained	O
on	O
her	O
antibiotic	O
course	O
.	O

the	O
vac	O
drains	O
have	O
been	O
periodically	O
changed	O
every	O
three	O
to	O
five	O
days	O
.	O

in	O
early	O
august	O
,	O
the	O
patient	O
was	O
weaned	O
to	O
extubation	O
which	O
she	O
has	O
tolerated	O
.	O

she	O
was	O
weaned	O
off	O
of	O
her	O
sedation	O
which	O
had	O
resulted	O
actually	O
in	O
high	O
levels	O
of	O
narcotic	O
and	O
benzodiazepines	O
.	O

in	O
order	O
to	O
combat	O
withdrawal	B
,	O
she	O
was	O
placed	O
on	O
an	O
around	O
the	O
clock	O
dose	O
of	O
ativan	O
to	O
combat	O
any	O
tremulousness	B
or	O
withdrawal	B
symptoms	I
.	O

on	O
[	O
*	O
*	O
2016	O
-	O
08	O
-	O
30	O
*	O
*	O
]	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O

room	O
with	O
plastic	O
surgery	O
where	O
she	O
underwent	O
a	O
split	O
-	O
thickness	O
skin	O
graft	O
taken	O
from	O
her	O
left	O
thigh	O
donor	O
site	O
and	O
placed	O
on	O
the	O
right	O
thigh	O
and	O
buttock	O
area	O
.	O

she	O
tolerated	O
this	O
procedure	O
well	O
.	O

post	O
procedure	O
,	O
a	O
vac	O
dressing	O
was	O
placed	O
over	O
the	O
skin	O
graft	O
.	O

on	O
[	O
*	O
*	O
2016	O
-	O
09	O
-	O
01	O
*	O
*	O
]	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O

room	O
where	O
she	O
underwent	O
an	O
orif	O
of	O
the	O
right	O
forearm	B
fracture	I
.	O

she	O
tolerated	O
this	O
procedure	O
well	O
.	O

the	O
right	O
forearm	O
vac	O
was	O
placed	O
.	O

the	O
remainder	O
of	O
her	O
stay	O
in	O
the	O
icu	O
has	O
remained	O
stable	O
.	O

she	O
defervesced	B
without	O
any	O
temperature	B
spikes	I
.	O

all	O
of	O
her	O
recent	O
cultures	O
have	O
been	O
negative	O
to	O
date	O
.	O

she	O
continues	O
on	O
her	O
broad	O
spectrum	O
antibiotics	O
per	O
infectious	O
disease	O
and	O
will	O
remain	O
so	O
for	O
an	O
approximate	O
length	O
of	O
12	O
weeks	O
.	O

there	O
are	O
plans	O
for	O
plastic	O
surgery	O
to	O
return	O
to	O
remove	O
the	O
buttock	O
vac	O
to	O
examine	O
the	O
skin	O
graft	O
.	O

upon	O
completion	O
of	O
the	O
examination	O
of	O
the	O
skin	O
graft	O
,	O
the	O
patient	O
will	O
be	O
ready	O
for	O
discharge	O
to	O
rehabilitation	O
to	O
continue	O
her	O
likely	O
long	O
rehabilitation	O
course	O
.	O

she	O
has	O
actually	O
done	O
quite	O
well	O
despite	O
the	O
numerous	O
and	O
severity	O
of	O
her	O
injuries	B
.	O

the	O
patient's	O
list	O
of	O
injuries	O
at	O
this	O
point	O
include	O
the	O
following	O
:	O

1	O
.	O
right	O
femur	B
fracture	I
,	O
status	O
post	O
rodding	O
times	O
two	O
.	O

2	O
.	O
right	O
bone	O
forearm	B
fracture	I
,	O
status	O
post	O
open	O
reduction	O
and	O
internal	O
fixation	O
.	O

3	O
.	O
a	O
right	O
open	B
pelvic	I
fracture	I
and	O
a	O
right	O
superior	B
rami	I
fracture	I
.	O

4	O
.	O
a	O
right	O
proximal	B
fibula	I
fracture	I
.	O

5	O
.	O
right	O
l4	O
-	O
5	O
transverse	B
process	I
fracture	I
(	O
neurosurgery	O
had	O
been	O
consulted	O
with	O
regards	O
to	O
this	O
injury	O
.	O

they	O
recommended	O
a	O
tlso	O
brace	O
times	O
one	O
month	O
)	O
.	O

6	O
.	O
right	O
sacral	B
fracture	I
and	O
right	O
iliac	B
bone	I
fracture	I
.	O

7	O
.	O
perineal	B
injury	I
requiring	O
a	O
diverting	O
colostomy	O
and	O
perineal	O
washout	O
.	O

discharge	O
diagnosis	O
:	O

1	O
.	O
status	O
post	O
motor	O
vehicle	O
crash	O
with	O
the	O
injuries	B
as	O
above	O
.	O

2	O
.	O
pseudomonas	O
sputum	O
culture	O
,	O
multiorganism	O
.	O

3	O
.	O
osteomyelitis	B
of	O
the	O
right	O
pelvis	O
and	O
deep	B
tissue	I
infection	I
.	O

4	O
.	O
extended	O
ventilatory	O
wean	O
secondary	O
to	O
multiple	O
operations	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
vancomycin	O
2	O
grams	O
iv	O
q	O
.	O

12	O
hours	O
.	O

2	O
.	O
meropenem	O
2	O
grams	O
iv	O
q	O
.	O
eight	O
.	O

3	O
.	O
clindamycin	O
600	O
mg	O
iv	O
q	O
.	O
eight	O
.	O

4	O
.	O
lovenox	O
40	O
mg	O
subcutaneously	O
q	O
.	O
d	O
.	O

5	O
.	O
albuterol	O
and	O
atrovent	O
inhalers	O
one	O
to	O
two	O
puffs	O
q	O
.	O
four	O
hours	O
p	O
.	O
r	O
.	O
n	O
.	O

6	O
.	O
zinc	O
sulfate	O
220	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O

7	O
.	O
ativan	O
1	O
mg	O
iv	O
q	O
.	O
six	O
hours	O
.	O

8	O
.	O
methadone	O
20	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O

9	O
.	O
nystatin	O
swish	O
and	O
swallow	O
q	O
.	O
i	O
.	O
d	O
.	O
p	O
.	O
r	O
.	O
n	O
.	O

10	O
.	O

miconazole	O
powder	O
applied	O
as	O
needed	O
.	O

11	O
.	O

tylenol	O
650	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
four	O
to	O
six	O
hours	O
p	O
.	O
r	O
.	O
n	O
.	O

12	O
.	O

bacitracin	O
ointment	O
,	O
apply	O
as	O
needed	O
.	O

disposition	O
:	O
the	O
patient	O
remains	O
neurologically	O
intact	O
,	O
is	O
ready	O
for	O
rehabilitation	O
.	O

she	O
will	O
require	O
extensive	O
physical	O
therapy	O
and	O
occupational	O
therapy	O
.	O

she	O
will	O
continue	O
to	O
have	O
wound	B
monitoring	O
and	O
final	O
recommendations	O
will	O
be	O
placed	O
with	O
her	O
discharge	O
information	O
per	O
plastics	O
and	O
hand	O

orthopedic	O
team	O
.	O

she	O
will	O
require	O
continued	O
nutritional	O
support	O
and	O
as	O
she	O
tolerates	O
her	O
diet	O
,	O
her	O
tube	O
feeds	O
can	O
be	O
weaned	O
and	O
adjusted	O
as	O
necessary	O
.	O

she	O
will	O
continue	O
her	O
antibiotic	O
course	O
and	O
final	O
recommendations	O
will	O
be	O
left	O
per	O
her	O
infectious	O
disease	O
consultation	O
and	O
a	O
picc	O
line	O
will	O
be	O
assessed	O
and	O
placed	O
if	O
necessary	O
.	O

condition	O
on	O
discharge	O
:	O
stable	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
165	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
5082	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2016	O
-	O
09	O
-	O
06	O
*	O
*	O
]	O
05	O
:	O
06	O

t	O
:	O
[	O
*	O
*	O
2016	O
-	O
09	O
-	O
06	O
*	O
*	O
]	O
17	O
:	O
27	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
5083	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2016	O
-	O
09	O
-	O
23	O
*	O
*	O
]	O
2	O
:	O
02	O
pm	O

(	O
end	O
of	O
report	O
)	O

147855	O
||||	O
17451	O
||||	O
14564	O
||||	O
radiology	O
_	O
report	O
||||	O
2015	O
-	O
05	O
-	O
11	O
19	O
:	O
44	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
314	O
-	O
8807	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
11	O
*	O
*	O
]	O
7	O
:	O
44	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
3876	O
*	O
*	O
]	O
reason	O
:	O
eval	O
after	O
intubation	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

39	O
year	O
old	O
man	O
with	O
poly	B
substance	I
od	I
,	O
ms	B
change	I

reason	O
for	O
this	O
examination	O
:	O

eval	O
after	O
intubation	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
polysubstance	B
abuse	I
,	O
overdose	B
mental	I
status	I
changes	I
after	O
intubation	O
.	O

no	O
prior	O
chest	O
radiographs	O
available	O
for	O
comparison	O
.	O

ap	O
chest	O
radiograph	O
:	O
the	O
endotracheal	O
tube	O
tip	O
is	O
at	O
the	O
thoracic	O
inlet	O
.	O

heart	O
size	O
is	O
within	O
normal	O
limits	O
.	O

the	O
mediastinal	O
contours	O
appear	O
slightly	O
widened	O
,	O
but	O
this	O
may	O
be	O
due	O
to	O
low	B
lung	I
volumes	I
.	O

follow	O
up	O
with	O
dedicated	O
pa	O
and	O
lateral	O
chest	O
radiograph	O
is	O
recommended	O
when	O
clinically	O
feasible	O
.	O

linear	O
areas	O
of	O
atelectasis	B
are	O
present	O
in	O
the	O
right	O
lung	O
.	O

hazy	O
areas	O
of	O
opacity	B
are	O
present	O
in	O
the	O
left	O
hilum	O
and	O
in	O
the	O
left	O
lung	O
base	O
which	O
may	O
represent	O
developing	O
aspiration	B
.	O

note	O
is	O
made	O
of	O
a	O
markedly	O
distended	B
stomach	I
.	O

impression	O
:	O
endotracheal	O
tube	O
tip	O
at	O
thoracic	O
inlet	O
.	O

apparent	O
widening	B
of	I
mediastinal	I
contours	I
,	O
follow	O
up	O
with	O
dedicated	O
pa	O
and	O
lateral	O
chest	O
radiograph	O
when	O
clinically	O
feasible	O
.	O

possible	O
developing	O
aspiration	B
in	O
the	O
left	O
lung	O
and	O
markedly	O
distended	B
stomach	I
.	O

consider	O
ng	O
tube	O
placement	O
.	O

673	O
||||	O
17473	O
||||	O
21290	O
||||	O
discharge	O
_	O
summary	O
||||	O
2010	O
-	O
10	O
-	O
29	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
10	O
-	O
23	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1967	O
-	O
03	O
-	O
27	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
gynecology	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
43	O
-	O
year	O
-	O
old	O
gravida	O
2	O
,	O
para	O
2	O
-	O
0	O
-	O
0	O
-	O
2	O
with	O
a	O
history	O
of	O
abnormal	B
periods	I
with	O
heavier	B
periods	I
lasting	O
increased	O
number	O
of	O
days	O
,	O
coming	O
more	O
frequently	O
,	O
every	O
23	O
days	O
,	O
for	O
over	O
the	O
course	O
of	O
the	O
last	O
year	O
.	O

the	O
patient	O
reports	O
several	O
ultrasounds	O
done	O
in	O
the	O
past	O
with	O
findings	O
of	O
small	O
fibroids	B
.	O

the	O
patient	O
was	O
recently	O
started	O
on	O
oral	O
contraceptive	O
pills	O
by	O
her	O
gynecology	O
doctor	O
.	O

she	O
was	O
started	O
on	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
762	O
*	O
*	O
]	O
tri	O
-	O
cyclen	O
three	O
weeks	O
ago	O
.	O

the	O
patient	O
reports	O
heavy	B
bleeding	I
began	O
three	O
days	O
ago	O
.	O

she	O
reports	O
soaking	O
up	O
to	O
one	O
pad	O
or	O
tampon	O
per	O
hour	O
with	O
large	B
clots	I
.	O

she	O
denies	O
cramping	B
.	O

she	O
denies	O
abdominal	B
pain	I
.	O

the	O
patient	O
reports	O
she	O
has	O
not	O
had	O
an	O
endometrial	O
biopsy	O
for	O
evaluation	O
.	O

she	O
reports	O
some	O
lightheadedness	B
and	O
dizziness	B
today	O
.	O

her	O
last	O
ultrasound	O
was	O
done	O
on	O
[	O
*	O
*	O
09	O
-	O
16	O
*	O
*	O
]	O
which	O
showed	O
hydrosalpinx	B
on	O
the	O
right	O
,	O
reportedly	O
unchanged	O
from	O
prior	O
examination	O
10	O
months	O
ago	O
,	O
and	O
a	O
small	O
uterine	B
fibroid	I
.	O

prior	O
to	O
that	O
,	O
her	O
ultrasound	O
was	O
done	O
on	O
[	O
*	O
*	O
2010	O
-	O
03	O
-	O
11	O
*	O
*	O
]	O
,	O
which	O
showed	O
an	O
anteverted	B
uterus	I
with	O
central	O
hypoechogenic	O
mass	B
of	O
about	O
2	O
.	O
2	O
cm	O
butting	O
into	O
the	O
endometrium	O
with	O
lining	O
about	O
9	O
mm	O
,	O
but	O
with	O
a	O
posterior	O
fundal	O
fibroid	B
.	O

past	O
gynecological	O
history	O
:	O
the	O
patient	O
had	O
menarche	O
at	O
age	O
12	O
.	O

her	O
cycles	O
use	O
to	O
be	O
28	O
to	O
30	O
days	O
.	O

over	O
the	O
course	O
of	O
the	O
past	O
year	O
have	O
become	O
every	O
23	O
days	O
with	O
bleeding	B
increasing	O
from	O
5	O
to	O
7	O
days	O
in	O
the	O
past	O
up	O
to	O
7	O
to	O
10	O
days	O
this	O
past	O
year	O
.	O

over	O
the	O
course	O
of	O
the	O
past	O
year	O
she	O
has	O
had	O
heavy	B
bleeding	I
,	O
using	O
an	O
increasing	O
number	O
of	O
pads	O
during	O
her	O
cycles	O
.	O

she	O
has	O
no	O
history	O
of	O
abnormal	B
pap	I
smears	I
.	O

she	O
denies	O
any	O
sexually	B
transmitted	I
diseases	I
.	O

her	O
last	O
menstrual	O
period	O
was	O
[	O
*	O
*	O
2010	O
-	O
09	O
-	O
24	O
*	O
*	O
]	O
.	O

past	O
obstetrical	O
history	O
:	O
past	O
obstetrical	O
history	O
is	O
significant	O
for	O
two	O
normal	O
spontaneous	O
vaginal	O
deliveries	O
10	O
years	O
ago	O
and	O
15	O
years	O
ago	O
with	O
two	O
full	O
-	O
term	O
babies	O
.	O

past	O
medical	O
history	O
:	O
the	O
patient	O
is	O
status	O
post	O
thyroidectomy	O
in	O
[	O
*	O
*	O
1985	O
*	O
*	O
]	O
,	O
status	O
post	O
neurofibroma	B
removal	O
from	O
her	O
spinal	O
canal	O
in	O
[	O
*	O
*	O
1996	O
*	O
*	O
]	O
times	O
two	O
of	O
the	O
sacrum	O
with	O
both	O
anterior	O
x	O
2	O
and	O
posterior	O
approach	O
,	O
parotid	B
tumor	I
removal	O
several	O
years	O
ago	O
.	O

medications	O
on	O
admission	O
:	O
synthroid	O
.	O

allergies	O
:	O
penicillin	O
causes	O
a	O
rash	B
.	O

social	O
history	O
:	O
denies	O
any	O
tobacco	O
,	O
alcohol	O
or	O
drugs	O
.	O

the	O
patient	O
teaches	O
computers	O
.	O

family	O
history	O
:	O
denies	O
any	O
gynecological	B
cancers	I
.	O

physical	O
examination	O
on	O
admission	O
:	O
vital	O
signs	O
on	O
admission	O
were	O
temperature	O
99	O
.	O
1	O
,	O
pulse	O
80	O
,	O
blood	O
pressure	O
of	O
100	O
/	O
58	O
,	O
respiratory	O
rate	O
of	O
18	O
,	O
100%	O
oxygen	O
saturation	O
on	O
room	O
air	O
.	O

physical	O
examination	O
in	O
general	O
,	O
the	O
patient	O
appeared	O
pale	B
and	O
weak	B
.	O

cardiovascular	O
examination	O
was	O
a	O
regular	O
rate	O
and	O
rhythm	O
,	O
with	O
a	O
normal	O
s1	O
and	O
s2	O
.	O

pulmonary	O
examination	O
revealed	O
the	O
patient	O
was	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

abdominal	O
examination	O
revealed	O
positive	O
bowel	O
sounds	O
,	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
.	O

pelvic	O
examination	O
revealed	O
large	B
amounts	I
of	I
blood	I
and	O
clot	O
came	O
from	O
the	O
os	O
.	O

normal	O
vulva	O
and	O
vagina	O
were	O
seen	O
.	O

no	O
lesions	O
or	O
polyps	O
were	O
seen	O
on	O
the	O
cervix	O
.	O

no	O
cervical	B
motion	I
tenderness	I
or	O
adnexal	B
tenderness	I
was	O
elicited	O
.	O

much	B
pooling	I
in	O
the	O
os	O
occurred	O
even	O
after	O
cleaning	O
out	O
the	O
vault	O
.	O

extremities	O
had	O
no	O
clubbing	B
,	O
cyanosis	B
or	O
edema	B
.	O

laboratory	O
data	O
on	O
admission	O
:	O
the	O
patient	O
had	O
a	O
white	O
blood	O
cell	O
count	O
of	O
9	O
.	O
3	O
,	O
hemoglobin	O
of	O
6	O
.	O
5	O
,	O
hematocrit	O
of	O
20	O
.	O
4	O
,	O
platelets	O
of	O
360	O
.	O

pt	O
was	O
13	O
.	O
1	O
,	O
ptt	O
was	O
24	O
.	O
9	O
,	O
inr	O
was	O
1	O
.	O
1	O
.	O

chemistry	O
was	O
sodium	O
136	O
,	O
potassium	O
4	O
,	O
chloride	O
101	O
,	O
bicarbonate	O
23	O
,	O
bun	O
15	O
,	O
creatinine	O
0	O
.	O
8	O
,	O
and	O
a	O
glucose	O
of	O
111	O
.	O

hospital	O
course	O
:	O
this	O
43	O
-	O
year	O
-	O
old	O
gravida	O
2	O
,	O
para	O
2	O
was	O
admitted	O
for	O
heavy	B
vaginal	I
bleeding	I
for	O
emergent	O
medical	O
management	O
.	O

initially	O
,	O
the	O
patient	O
had	O
a	O
hematocrit	O
of	O
20	O
.	O
4	O
on	O
admission	O
,	O
but	O
was	O
clinically	O
stable	O
.	O

the	O
patient	O
was	O
initially	O
started	O
on	O
intravenous	O
premarin	O
25	O
mg	O
q	O
.	O
4h	O
.	O
times	O
two	O
doses	O
and	O
provera	O
10	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

she	O
was	O
kept	O
n	O
.	O
p	O
.	O
o	O
.	O
over	O
the	O
course	O
of	O
the	O
night	O
and	O
had	O
a	O
repeat	O
hematocrit	O
after	O
four	O
hours	O
of	O
premarin	O
therapy	O
.	O

her	O
repeat	O
hematocrit	O
came	O
back	O
15	O
.	O
3	O
.	O

the	O
patient	O
was	O
still	O
clinically	O
stable	O
with	O
normotensive	O
blood	O
pressure	O
and	O
heart	O
rate	O
.	O

the	O
patient	O
was	O
consented	O
for	O
blood	O
transfusion	O
and	O
received	O
2	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
and	O
intravenous	O
fluids	O
,	O
and	O
was	O
consented	O
for	O
the	O
operating	O
room	O
.	O

the	O
patient	O
received	O
4	O
units	O
preoperatively	O
with	O
a	O
hematocrit	O
preoperatively	O
of	O
33	O
.	O
2	O
.	O

the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
[	O
*	O
*	O
2010	O
-	O
10	O
-	O
24	O
*	O
*	O
]	O
,	O
and	O
underwent	O
a	O
supracervical	O
hysterectomy	O
and	O
a	O
right	O
salpingo	O
-	O
oophorectomy	O
for	O
heavy	B
vaginal	I
bleeding	I
,	O
and	O
lysis	O
of	O
adhesions	B
.	O

gynecology	O
/	O
oncology	O
team	O
was	O
consulted	O
intraoperatively	O
.	O

the	O
patient	O
underwent	O
the	O
procedure	O
and	O
tolerated	O
the	O
procedure	O
well	O
.	O

postoperatively	O
,	O
her	O
hematocrit	O
was	O
30	O
.	O
4	O
,	O
pt	O
was	O
13	O
.	O
9	O
,	O
ptt	O
was	O
28	O
.	O
7	O
,	O
inr	O
was	O
1	O
.	O
3	O
.	O

she	O
was	O
admitted	O
to	O
the	O
gynecology	O

service	O
for	O
postoperative	O
care	O
.	O

the	O
patient	O
remained	O
stable	O
with	O
a	O
stable	O
hematocrit	O
,	O
and	O
clinically	O
adequate	O
urine	O
output	O
,	O
and	O
vital	O
signs	O
over	O
the	O
course	O
of	O
her	O
postoperative	O
stay	O
.	O

she	O
had	O
a	O
slow	B
return	I
of	I
bowel	I
function	I
.	O

however	O
,	O
by	O
postoperative	O
day	O
three	O
she	O
was	O
tolerating	O
clears	O
,	O
and	O
by	O
postoperative	O
day	O
four	O
she	O
was	O
tolerating	O
solids	O
.	O

the	O
patient's	O
pain	B
was	O
controlled	O
with	O
tylenol	O
no	O
.	O

3	O
.	O
her	O
urine	O
output	O
remained	O
adequate	O
throughout	O
her	O
stay	O
,	O
and	O
she	O
was	O
ambulating	O
,	O
and	O
appeared	O
well	O
.	O

on	O
postoperative	O
day	O
five	O
,	O
she	O
was	O
discharged	O
to	O
home	O
with	O
tylenol	O
no	O
.	O

3	O
,	O
motrin	O
,	O
and	O
colace	O
.	O

the	O
patient	O
was	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2202	O
*	O
*	O
]	O
in	O
two	O
weeks	O
.	O

discharge	O
diagnoses	O
:	O
status	O
post	O
supracervical	O
hysterectomy	O
,	O
and	O
right	O
salpingo	O
-	O
oophorectomy	O
,	O
and	O
lysis	O
of	O
adhesions	B
secondary	O
to	O
heavy	B
vaginal	I
bleeding	I
.	O

condition	O
at	O
discharge	O
:	O
the	O
patient's	O
condition	O
on	O
discharge	O
was	O
stable	O
.	O

medications	O
on	O
discharge	O
:	O
tylenol	O
no	O
.	O

3	O
and	O
motrin	O
for	O
pain	B
,	O
and	O
colace	O
.	O

discharge	O
followup	O
:	O
the	O
patient	O
was	O
to	O
follow	O
up	O
with	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2202	O
*	O
*	O
]	O
in	O
two	O
weeks'	O
time	O
.	O

[	O
*	O
*	O
doctor	O
first	O
name	O
2203	O
*	O
*	O
]	O
[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
2204	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
917	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2010	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
17	O
:	O
54	O

t	O
:	O
[	O
*	O
*	O
2010	O
-	O
10	O
-	O
31	O
*	O
*	O
]	O
09	O
:	O
47	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2205	O
*	O
*	O
]	O

(	O
cclist	O
)	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
2203	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
12	O
*	O
*	O
]	O
2	O
:	O
03	O
am	O

(	O
end	O
of	O
report	O
)	O

24788	O
||||	O
17522	O
||||	O
1112	O
||||	O
discharge	O
_	O
summary	O
||||	O
2017	O
-	O
06	O
-	O
11	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
06	O
-	O
08	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
06	O
-	O
11	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1940	O
-	O
10	O
-	O
21	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
coronary	O
care	O
unit	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
76	O
-	O
year	O
-	O
old	O
female	O
with	O
a	O
history	O
of	O
hypercholesterolemia	B
presenting	O
with	O
shortness	B
of	I
breath	I
on	O
the	O
day	O
prior	O
to	O
admission	O
.	O

she	O
called	O
the	O
emergency	O
medical	O
service	O
who	O
took	O
her	O
to	O
the	O
[	O
*	O
*	O
hospital	O
452	O
*	O
*	O
]	O
hospital	O
.	O

in	O
the	O
emergency	O
department	O
there	O
,	O
she	O
was	O
found	O
to	O
be	O
in	O
congestive	B
heart	I
failure	I
with	O
severe	B
respiratory	I
distress	I
.	O

she	O
was	O
subsequently	O
intubated	O
,	O
and	O
her	O
initial	O
arterial	O
blood	O
gas	O
was	O
7	O
.	O
17	O
/	O
50	O
/	O
83	O
.	O

she	O
was	O
given	O
80	O
mg	O
of	O
intravenous	O
lasix	O
with	O
a	O
good	O
800	O
cc	O
of	O
urine	O
output	O
initially	O
.	O

her	O
electrocardiogram	O
showed	O
a	O
new	O
left	B
bundle	I
-	I
branch	I
block	I
,	O
and	O
her	O
cardiac	O
enzymes	O
were	O
negative	O
except	O
for	O
a	O
mildly	O
elevated	B
troponin	I
.	O

the	O
patient	O
was	O
given	O
medication	O
for	O
agitation	B
,	O
and	O
her	O
blood	O
pressure	O
was	O
noted	O
to	O
drop	O
to	O
a	O
systolic	O
blood	O
pressure	O
in	O
the	O
80s	O
.	O

the	O
patient	O
was	O
given	O
some	O
intravenous	O
fluids	O
initially	O
and	O
then	O
started	O
on	O
a	O
dopamine	O
drip	O
for	O
blood	O
pressure	O
maintenance	O
.	O

the	O
patient	O
was	O
transferred	O
here	O
for	O
emergent	O
cardiac	O
catheterization	O
after	O
a	O
bedside	O
echocardiogram	O
was	O
performed	O
with	O
a	O
read	O
of	O
an	O
ejection	O
fraction	O
of	O
10%	O
to	O
20%	O
.	O

her	O
cardiac	O
catheterization	O
here	O
revealed	O
minimal	O
coronary	B
artery	I
disease	I
,	O
with	O
a	O
pulmonary	O
capillary	O
wedge	O
pressure	O
of	O
25	O
,	O
moderate	O
mitral	B
regurgitation	I
,	O
and	O
an	O
ejection	O
fraction	O
of	O
about	O
30%	O
to	O
40%	O
(	O
on	O
dopamine	O
)	O
.	O

the	O
patient	O
was	O
quickly	O
weaned	O
off	O
dopamine	O
to	O
a	O
pressure	O
support	O
of	O
5	O
/	O
5	O
on	O
the	O
ventilator	O
.	O

she	O
still	O
continued	O
to	O
have	O
good	O
urine	O
output	O
after	O
the	O
80	O
mg	O
of	O
lasix	O
at	O
the	O
outside	O
hospital	O
.	O

physical	O
examination	O
on	O
presentation	O
:	O
ventilator	O
ac	O
600	O
x	O
16	O
,	O
fio2	O
of	O
100%	O
,	O
positive	O
end	O
-	O
expiratory	O
pressure	O
of	O
5	O
.	O

drips	O
:	O
dopamine	O
5	O
mcg	O
/	O
kg	O
per	O
minute	O
.	O

vital	O
signs	O
revealed	O
her	O
temperature	O
was	O
96	O
.	O
5	O
degrees	O
fahrenheit	O
,	O
her	O
heart	O
rate	O
was	O
87	O
,	O
her	O
blood	O
pressure	O
was	O
111	O
/	O
50	O
,	O
her	O
respiratory	O
rate	O
was	O
14	O
,	O
and	O
her	O
oxygen	O
saturation	O
was	O
96%	O
.	O

generally	O
,	O
she	O
was	O
in	O
no	O
acute	B
distress	I
.	O

she	O
was	O
intubated	O
and	O
sedated	O
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
examination	O
revealed	O
the	O
mucous	O
membranes	O
were	O
moist	O
.	O

cardiovascular	O
examination	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

a	O
[	O
*	O
*	O
03	O
-	O
17	O
*	O
*	O
]	O
holosystolic	B
murmur	I
at	O
the	O
apex	O
.	O

pulmonary	O
examination	O
revealed	O
some	O
bibasilar	O
crackles	B
.	O

the	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
.	O

there	O
were	O
normal	O
active	O
bowel	O
sounds	O
.	O

the	O
extremities	O
were	O
without	O
edema	B
.	O

dorsalis	O
pedis	O
and	O
posterior	O
tibialis	O
pulses	O
were	O
2	O
+	O
.	O

a	O
right	O
groin	O
venous	O
sheath	O
was	O
in	O
place	O
.	O

pertinent	O
laboratory	O
values	O
on	O
presentation	O
:	O
white	O
blood	O
cell	O
count	O
was	O
11	O
,	O
her	O
hematocrit	O
was	O
38	O
.	O
4	O
,	O
and	O
her	O
platelets	O
were	O
177	O
.	O

sodium	O
was	O
145	O
,	O
potassium	O
was	O
3	O
.	O
5	O
,	O
chloride	O
was	O
112	O
,	O
bicarbonate	O
was	O
21	O
,	O
blood	O
urea	O
nitrogen	O
was	O
20	O
,	O
creatinine	O
was	O
1	O
.	O
4	O
,	O
and	O
her	O
blood	O
glucose	O
was	O
119	O
.	O

calcium	O
was	O
8	O
.	O
1	O
,	O
her	O
phosphate	O
was	O
4	O
.	O
4	O
,	O
and	O
her	O
magnesium	O
was	O
1	O
.	O
8	O
.	O

creatine	O
kinase	O
was	O
124	O
.	O

troponin	O
t	O
was	O
less	O
than	O
0	O
.	O
05	O
.	O

arterial	O
blood	O
gas	O
was	O
7	O
.	O
34	O
/	O
43	O
/	O
110	O
.	O

bat	O
high	O
of	O
82	O
.	O

pertinent	O
radiology	O
/	O
imaging	O
:	O
electrocardiogram	O
revealed	O
a	O
left	B
bundle	I
-	I
branch	I
block	I
,	O
a	O
normal	O
sinus	O
rhythm	O
,	O
and	O
a	O
heart	O
rate	O
of	O
106	O
.	O

a	O
new	O
left	B
bundle	I
-	I
branch	I
block	I
from	O
[	O
*	O
*	O
2014	O
*	O
*	O
]	O
.	O

a	O
chest	O
x	O
-	O
ray	O
was	O
consistent	O
with	O
congestive	B
heart	I
failure	I
.	O

catheterization	O
revealed	O
a	O
right	O
atrial	O
pressure	O
of	O
10	O
,	O
pulmonary	O
artery	O
pressure	O
of	O
42	O
/	O
28	O
,	O
and	O
pulmonary	O
capillary	O
wedge	O
pressure	O
of	O
25	O
.	O

oxygen	O
saturation	O
of	O
81%	O
,	O
fvc	O
saturation	O
of	O
82%	O
.	O

no	O
significant	O
coronary	B
artery	I
disease	I
.	O

a	O
small	O
right	O
coronary	O
artery	O
in	O
a	O
left	O
-	O
dominant	O
system	O
.	O

mild	O
-	O
to	O
-	O
moderate	O
depressed	B
left	I
ventricular	I
function	I
.	O

cardiac	O
output	O
of	O
7	O
.	O
8	O
.	O

cardiac	O
index	O
of	O
4	O
.	O
3	O
.	O

systemic	O
vascular	O
resistance	O
of	O
872	O
.	O

an	O
echocardiogram	O
revealed	O
an	O
ejection	O
fraction	O
of	O
20%	O
,	O
severe	O
left	B
ventricular	I
dilatation	I
,	O
and	O
hypokinesis	B
.	O

mild	O
aortic	B
root	I
dilatation	I
.	O

moderate	O
-	O
to	O
-	O
severe	O
mitral	B
regurgitation	I
(	O
3	O
+	O
)	O
.	O

summary	O
of	O
hospital	O
course	O
by	O
issue	O
/	O
system	O
:	O

1	O
.	O
cardiovascular	O
issues	O
(	O
pump	O
)	O
:	O
the	O
patient	O
with	O
an	O
ejection	O
fraction	O
of	O
25%	O
to	O
30%	O
by	O
echocardiogram	O
.	O

the	O
patient	O
was	O
continued	O
on	O
aspirin	O
,	O
toprol	O
25	O
mg	O
,	O
lipitor	O
,	O
and	O
valsartan	O
.	O

the	O
patient	O
was	O
ruled	O
out	O
for	O
a	O
myocardial	B
infarction	I
with	O
cycled	O
enzymes	O
and	O
telemetry	O
.	O

in	O
terms	O
of	O
her	O
new	O
left	B
bundle	I
-	I
branch	I
block	I
,	O
this	O
may	O
be	O
a	O
degenerative	B
change	I
.	O

the	O
patient	O
was	O
ruled	O
out	O
for	O
a	O
myocardial	B
infarction	I
without	O
events	O
on	O
telemetry	O
.	O

2	O
.	O
pulmonary	O
issues	O
:	O
the	O
patient	O
with	O
respiratory	B
arrest	I
,	O
suspicious	O
for	O
flash	B
pulmonary	I
edema	I
in	O
the	O
setting	O
of	O
possible	O
underlying	O
diastolic	B
dysfunction	I
with	O
severe	O
hypertension	B
with	O
systolic	O
blood	O
pressures	O
in	O
the	O
180s	O
to	O
190s	O
in	O
the	O
ambulance	O
.	O

although	O
,	O
after	O
diuresis	O
,	O
the	O
patient	O
weaned	O
easily	O
off	O
of	O
the	O
ventilator	O
and	O
was	O
saturating	O
well	O
on	O
room	O
air	O
.	O

she	O
responded	O
well	O
to	O
intravenous	O
lasix	O
and	O
will	O
be	O
continued	O
on	O
40	O
mg	O
of	O
by	O
mouth	O
lasix	O
as	O
an	O
outpatient	O
.	O

the	O
patient	O
was	O
instructed	O
to	O
weigh	O
herself	O
daily	O
and	O
notify	O
her	O
doctor	O
if	O
she	O
gained	B
more	I
than	I
three	I
pounds	I
at	O
a	O
time	O
.	O

3	O
.	O
acute	B
renal	I
failure	I
issues	O
:	O
superimposed	O
on	O
chronic	B
renal	I
insufficiency	I
.	O

the	O
patient	O
with	O
a	O
likely	O
baseline	O
creatinine	O
of	O
1	O
.	O
3	O
and	O
likely	O
acute	O
worsening	O
of	O
her	O
creatinine	O
secondary	O
to	O
hypotensive	B
episodes	I
.	O

the	O
patient's	O
creatinine	B
improved	I
to	O
a	O
baseline	O
level	O
of	O
1	O
.	O
3	O
.	O

she	O
likely	O
has	O
chronic	B
renal	I
insufficiency	I
secondary	O
to	O
atherosclerotic	B
disease	I
.	O

4	O
.	O
pernicious	B
anemia	I
issues	O
:	O
the	O
patient	O
was	O
continued	O
on	O

b12	O
while	O
she	O
was	O
in	O
the	O
hospital	O
.	O

her	O
hematocrit	O
remained	O
normal	O
.	O

condition	O
at	O
discharge	O
:	O
stable	O
.	O

discharge	O
status	O
:	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
with	O
home	O
visiting	O
nurse	O
association	O
services	O
.	O

discharge	O
instructions	O
/	O
followup	O
:	O

1	O
.	O
the	O
patient	O
was	O
instructed	O
to	O
follow	O
up	O
with	O
her	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
of	O
cardiology	O
in	O
one	O
to	O
two	O
weeks	O
.	O

she	O
was	O
to	O
call	O
telephone	O
number	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1027	O
*	O
*	O
]	O
to	O
schedule	O
an	O
appointment	O
.	O

2	O
.	O
the	O
patient	O
was	O
also	O
instructed	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
267	O
*	O
*	O
]	O
regarding	O
the	O
possible	O
need	O
for	O
a	O
pacemaker	O
in	O
the	O
future	O
.	O

she	O
was	O
to	O
call	O
telephone	O
number	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
487	O
*	O
*	O
]	O
for	O
an	O
appointment	O
.	O

3	O
.	O
the	O
patient	O
was	O
also	O
instructed	O
to	O
follow	O
up	O
with	O
her	O
primary	O
care	O
provider	O
(	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
5814	O
*	O
*	O
]	O
)	O
in	O
one	O
to	O
two	O
weeks	O
.	O

medications	O
on	O
discharge	O
:	O

1	O
.	O
aspirin	O
81	O
mg	O
by	O
mouth	O
once	O
per	O
day	O
.	O

2	O
.	O
lipitor	O
20	O
mg	O
by	O
mouth	O
once	O
per	O
day	O
.	O

3	O
.	O
lasix	O
40	O
mg	O
by	O
mouth	O
once	O
per	O
day	O
.	O

4	O
.	O
toprol	O
25	O
mg	O
by	O
mouth	O
once	O
per	O
day	O
.	O

5	O
.	O
spironolactone	O
25	O
mg	O
by	O
mouth	O
once	O
per	O
day	O
.	O

6	O
.	O
valsartan	O
80	O
mg	O
by	O
mouth	O
once	O
per	O
day	O
.	O

7	O
.	O
ciprofloxacin	O
500	O
mg	O
by	O
mouth	O
once	O
per	O
day	O
(	O
times	O
three	O
days	O
for	O
a	O
urinary	B
tract	I
infection	I
)	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initial	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
5066	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2017	O
-	O
06	O
-	O
11	O
*	O
*	O
]	O
20	O
:	O
31	O

t	O
:	O
[	O
*	O
*	O
2017	O
-	O
06	O
-	O
13	O
*	O
*	O
]	O
09	O
:	O
34	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
5815	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
pinto	O
on	O
:	O
fri	O
[	O
*	O
*	O
2017	O
-	O
06	O
-	O
16	O
*	O
*	O
]	O
5	O
:	O
37	O
pm	O

(	O
end	O
of	O
report	O
)	O

104422	O
||||	O
17582	O
||||	O
28867	O
||||	O
echo	O
_	O
report	O
||||	O
2020	O
-	O
06	O
-	O
09	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
source	O
of	O
embolism	B
.	O

height	O
:	O
(	O
in	O
)	O
62	O

weight	O
(	O
lb	O
)	O
:	O
250	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
10	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
134	O
/	O
64	O

hr	O
(	O
bpm	O
)	O
:	O
77	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2020	O
-	O
06	O
-	O
09	O
*	O
*	O
]	O
at	O
14	O
:	O
04	O

test	O
:	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
saline	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

this	O
study	O
was	O
compared	O
to	O
the	O
prior	O
study	O
of	O
[	O
*	O
*	O
2020	O
-	O
02	O
-	O
26	O
*	O
*	O
]	O
.	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

no	O
asd	B
or	O
pfo	B
by	O
2d	O
,	O
color	O
doppler	O
or	O
saline	O
contrast	O
with	O
maneuvers	O
.	O

left	O
ventricle	O
:	O
mild	O
symmetric	O
lvh	B
with	O
normal	O
cavity	O
size	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

normal	O
regional	O
lv	O
systolic	O
function	O
.	O

no	O
resting	B
lvot	I
gradient	I
.	O

aorta	O
:	O
normal	O
aortic	O
diameter	O
at	O
the	O
sinus	O
level	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

normal	O
aortic	O
arch	O
diameter	O
.	O

normal	O
descending	O
aorta	O
diameter	O
.	O

no	O
2d	O
or	O
doppler	O
evidence	O
of	O
distal	B
arch	I
coarctation	I
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

trace	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

no	O
mvp	B
.	O

mild	O
mitral	B
annular	I
calcification	I
.	O

mild	O
thickening	B
of	O
mitral	O
valve	O
chordae	O
.	O

trivial	O
mr	B
.	O

normal	O
lv	O
inflow	O
pattern	O
for	O
age	O
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
.	O

no	O
tr	B
.	O

normal	O
pa	O
systolic	O
pressure	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

pericardium	O
:	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

no	O
atrial	B
septal	I
defect	I
or	O
patent	B
foramen	I
ovale	I
is	O
seen	O
by	O
2d	O
,	O
color	O
doppler	O
or	O
saline	O
contrast	O
with	O
maneuvers	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
with	O
normal	O
cavity	O
size	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

regional	O
left	O
ventricular	O
wall	O
motion	O
is	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
.	O

there	O
is	O
no	O
aortic	B
valve	I
stenosis	I
.	O

trace	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal	O
.	O

there	O
is	O
a	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

compared	O
with	O
the	O
prior	O
study	O
(	O
images	O
reviewed	O
)	O
of	O
[	O
*	O
*	O
2020	O
-	O
02	O
-	O
26	O
*	O
*	O
]	O
,	O
estimated	O
pulmonary	O
artery	O
pressures	O
are	O
lower	O
.	O

no	O
intracardiac	B
shunt	I
is	O
evident	O
.	O

246143	O
||||	O
18076	O
||||	O
16803	O
||||	O
radiology	O
_	O
report	O
||||	O
2015	O
-	O
04	O
-	O
10	O
06	O
:	O
31	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
284	O
-	O
2737	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
10	O
*	O
*	O
]	O
6	O
:	O
31	O
am	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
1177	O
*	O
*	O
]	O
reason	O
:	O
54	O
yo	O
s	O
/	O
p	O
pea	B
arrest	I
;	O
?aspiration	O
pna	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

54	O
year	O
old	O
man	O
with	O
hepatic	B
abscess	I
,	O
intubated	O
for	O
resp	B
failure	I
,	O
with	O
ett	O
on	O
previous	O
cxr	O
near	O
carina	O
.	O

code	O
called	O
for	O
acute	O
resp	B
arrest	I

reason	O
for	O
this	O
examination	O
:	O

54	O
yo	O
s	O
/	O
p	O
pea	B
arrest	I
;	O
?aspiration	O
pna	B

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indications	O
:	O
repositioning	O
of	O
endotracheal	O
tube	O
in	O
patient	O
with	O
respiratory	B
failure	I
.	O

compared	O
to	O
study	O
done	O
one	O
day	O
earlier	O
.	O

an	O
endotracheal	O
tube	O
is	O
present	O
,	O
in	O
satisfactory	O
position	O
.	O

a	O
right	O
internal	O
jugular	O
central	O
venous	O
catheter	O
left	O
picc	O
line	O
and	O
nasogastric	O
tube	O
also	O
remain	O
in	O
satisfactory	O
position	O
.	O

note	O
is	O
again	O
made	O
of	O
an	O
additional	O
picc	O
line	O
in	O
the	O
left	O
axilla	O
,	O
which	O
does	O
not	O
enter	O
the	O
thoracic	O
cavity	O
.	O

the	O
cardiac	O
and	O
mediastinal	O
contours	O
are	O
stable	O
in	O
the	O
interval	O
.	O

there	O
remains	O
evidence	O
of	O
an	O
asymmetric	O
bilateral	O
perihilar	B
alveolar	I
pattern	I
,	O
worse	O
on	O
the	O
right	O
than	O
the	O
left	O
.	O

a	O
small	O
left	O
pleural	B
effusion	I
is	O
noted	O
.	O

please	O
note	O
the	O
right	O
lateral	O
costophrenic	O
sulcus	O
region	O
has	O
been	O
excluded	O
from	O
the	O
study	O
and	O
cannnot	O
be	O
assessed	O
.	O

impression	O
:	O

1	O
.	O
bilateral	O
asymmetric	O
perihilar	B
alveolar	I
pattern	I
,	O
which	O
may	O
be	O
due	O
to	O
either	O
asymmetric	O
pulmonary	B
edema	I
or	O
infection	O
.	O

2	O
.	O
two	O
left	O
picc	O
lines	O
are	O
present	O
,	O
one	O
terminating	O
in	O
the	O
left	O
axilla	O
and	O
the	O
second	O
terminating	O
in	O
the	O
superior	O
vena	O
cava	O
.	O

102656	O
||||	O
18318	O
||||	O
11005	O
||||	O
echo	O
_	O
report	O
||||	O
2018	O
-	O
03	O
-	O
31	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
right	B
ventricular	I
function	I
.	O

shortness	B
of	I
breath	I
.	O

height	O
:	O
(	O
in	O
)	O
71	O

weight	O
(	O
lb	O
)	O
:	O
370	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
74	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
97	O
/	O
69	O

hr	O
(	O
bpm	O
)	O
:	O
102	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2018	O
-	O
03	O
-	O
31	O
*	O
*	O
]	O
at	O
13	O
:	O
52	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
moderate	O
la	B
enlargement	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
moderately	O
dilated	B
ra	I
.	O

a	O
catheter	O
or	O
pacing	O
wire	O
is	O
seen	O
in	O
the	O
ra	O
and	O
extending	O
into	O
the	O
rv	O
.	O

left	O
ventricle	O
:	O
mild	O
symmetric	O
lvh	B
with	O
normal	O
cavity	O
size	O
.	O

suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
lv	B
wall	I
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

hyperdynamic	B
lvef	I
>75%	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
moderately	O
dilated	B
aortic	I
sinus	I
.	O

aortic	O
valve	O
:	O
aortic	O
valve	O
not	O
well	O
seen	O
.	O

mitral	O
valve	O
:	O
normal	O
mitral	O
valve	O
leaflets	O
with	O
trivial	O
mr	B
.	O

tricuspid	O
valve	O
:	O
tricuspid	O
valve	O
not	O
well	O
visualized	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
pulmonic	O
valve	O
not	O
well	O
seen	O
.	O

pericardium	O
:	O
moderate	O
to	O
large	O
pericardial	B
effusion	I
.	O

rv	B
diastolic	I
collapse	I
,	O
c	O
/	O
w	O
impaired	O
fillling	O
/	O
tamponade	B
physiology	I
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
-	O
poor	O
echo	O
windows	O
.	O

suboptimal	O
image	O
quality	O
-	O
ventilator	O
.	O

echocardiographic	O
results	O
were	O
reviewed	O
by	O
telephone	O
with	O
the	O
houseofficer	O
caring	O
for	O
the	O
patient	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
and	O
right	O
atria	O
are	O
moderately	O
dilated	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
with	O
normal	O
cavity	O
size	O
.	O

due	O
to	O
suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
wall	B
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

left	O
ventricular	O
systolic	O
function	O
is	O
hyperdynamic	O
(	O
ef>75%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
root	O
is	O
moderately	O
dilated	O
at	O
the	O
sinus	O
level	O
.	O

the	O
aortic	O
valve	O
is	O
not	O
well	O
seen	O
.	O

the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

there	O
is	O
a	O
moderate	O
to	O
large	O
sized	O
pericardial	B
effusion	I
(	O
1	O
.	O
5	O
-	O
2	O
.	O
0	O
cm	O
)	O
.	O

there	O
is	O
right	B
ventricular	I
diastolic	I
collapse	I
,	O
consistent	O
with	O
impaired	O
fillling	O
/	O
tamponade	B
physiology	I
.	O

impression	O
:	O
moderate	O
to	O
large	O
circumferential	O
pericardial	B
effusion	I
with	O
signs	O
of	O
tamponade	B
physiology	I
.	O

mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
with	O
hyperdynamic	B
left	I
ventricular	I
function	I

22756	O
||||	O
18321	O
||||	O
963	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
10	O
-	O
16	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
10	O
-	O
13	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
10	O
-	O
16	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1961	O
-	O
02	O
-	O
15	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O

allergies	O
:	O

nifedipine	O
/	O
penicillins	O
/	O
codeine	O
/	O
sulfonamides	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
6368	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

vommiting	B
blood	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

upper	O
endoscopy	O

history	O
of	O
present	O
illness	O
:	O

pt	O
is	O
a	O
50	O
yo	O
woman	O
presenting	O
complaining	O
to	O
7	O
episodes	O
of	O
vomitting	B
bright	I
red	I
blood	I
.	O

for	O
past	O
several	O
days	O
pt	O
has	O
been	O
gagging	B
and	O
vomimitting	B
up	O
mucous	O
secondary	O
to	O
post	B
nasal	I
drip	I
.	O

on	O
day	O
of	O
admission	O
she	O
ate	O
a	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
1065	O
*	O
*	O
]	O
and	O
immedately	O
after	O
vommitted	O
about	O
a	O
glass	O
and	O
a	O
half	O
worth	O
of	O
blood	O
.	O

after	O
vommitting	B
about	O
seven	O
more	O
times	O
that	O
day	O
she	O
began	O
to	O
feel	O
dizzy	B
and	O
so	O
cam	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
.	O

pt	O
denies	O
chest	B
pain	I
,	O
sob	B
,	O
syncope	B
,	O
melena	B
,	O
hematochezeia	B
.	O

pt	O
staes	O
this	O
has	O
never	O
happened	O
before	O
,	O
she	O
has	O
no	O
history	O
of	O
bleeding	B
problems	I
,	O
no	O
liver	B
problems	I
,	O
no	O
gerd	B
,	O
no	O
nsaid	O
or	O
steroid	B
use	I
.	O

past	O
medical	O
history	O
:	O

irregular	B
menstrual	I
cycle	I

lbp	I
s	O
/	O
p	O
mva	O

htn	B

social	O
history	O
:	O

occassional	O
alcohol	O
,	O
no	O
tob	O
,	O
no	O
drugs	O
.	O

lives	O
with	O
husband	O
.	O

family	O
history	O
:	O

father	O
with	O
mi	B
-	O
age	O
unknown	O

physical	O
exam	O
:	O

afebrile	O
,	O
hr	O
88	O
,	O
bp	O
162	O
/	O
88	O
,	O
rr	O
14	O
99%	O
on	O
ra	O

heent	O
:	O
perrla	O
,	O
anicteric	B
,	O
no	O
subconjunctival	O
pallor	B

neck	O
:	O
supple	O
,	O
no	O
jvd	B
,	O
no	O
thyromegaly	B

card	O
:	O
rrr	O
nl	O
s1s2	O
no	O
m	B
/	O
r	B
/	O
g	B

lungs	O
:	O
cta	O

abd	O
:	O
soft	O
,	O
nt	O
,	O
nd	O
,	O
normal	O
bs	O

ext	O
:	O
wwp	O
,	O
no	O
c	B
/	O
c	B
/	O
e	B

neuro	O
:	O
aaox3	O
,	O
mae	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2011	O
-	O
10	O
-	O
13	O
*	O
*	O
]	O
08	O
:	O
30pm	O
wbc	O
-	O
5	O
.	O
0	O
rbc	O
-	O
3	O
.	O
29	O
*	O
hgb	O
-	O
11	O
.	O
3	O
*	O
hct	O
-	O
33	O
.	O
5	O
*	O
mcv	O
-	O
102	O
*	O
mch	O
-	O
34	O
.	O
4	O
*	O
mchc	O
-	O
33	O
.	O
8	O
rdw	O
-	O
14	O
.	O
2	O

[	O
*	O
*	O
2011	O
-	O
10	O
-	O
13	O
*	O
*	O
]	O
10	O
:	O
40pm	O
wbc	O
-	O
5	O
.	O
9	O
rbc	O
-	O
2	O
.	O
72	O
*	O
hgb	O
-	O
9	O
.	O
5	O
*	O
hct	O
-	O
27	O
.	O
4	O
*	O
mcv	O
-	O
100	O
*	O
mch	O
-	O
34	O
.	O
9	O
*	O
mchc	O
-	O
34	O
.	O
7	O
rdw	O
-	O
14	O
.	O
3	O

egd	O
showed	O
hiatal	B
hernia	I
and	O
vertical	O
laceration	O
in	O
distal	O
esphagus	O
with	O
blood	B
in	I
stomach	I
and	O
overlying	O
lac	O
.	O

brief	O
hospital	O
course	O
:	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
pt	O
had	O
several	O
more	O
episodes	O
,	O
ng	O
lavage	O
showed	B
bright	I
red	I
blood	I
,	O
decreasing	B
hct	I
over	O
the	O
course	O
of	O
the	O
several	O
hours	O
she	O
was	O
in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
.	O

upon	O
arrival	O
to	O
the	O
icu	O
pt	O
was	O
transfused	O
2u	O
prbc	O
and	O
was	O
hemodynamically	O
stable	O
.	O

gastroenterology	O
arrived	O
and	O
an	O
egd	O
was	O
performed	O
within	O
1	O
hour	O
of	O
arrival	O
on	O
the	O
unit	O
.	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
1309	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1310	O
*	O
*	O
]	O
tear	B
was	O
found	O
by	O
egd	O
and	O
was	O
treated	O
with	O
clipping	O
and	O
application	O
of	O
epinephrine	O
at	O
the	O
site	O
.	O

there	O
was	O
no	O
further	O
bleeding	B
throughout	O
the	O
hospital	O
stay	O
.	O

pt	O
was	O
noted	O
to	O
be	O
hypertensive	B
to	O
a	O
maximum	O
of	O
200	O
/	O
110	O
and	O
was	O
restarted	O
on	O
her	O
home	O
blood	O
pressure	O
medications	O
and	O
treated	O
episodically	O
with	O
hydralazine	O
.	O

during	O
periods	O
of	O
hypertension	B
there	O
were	O
no	O
signs	B
or	I
symptoms	I
of	O
end	B
organ	I
damage	I
.	O

blood	O
pressure	O
was	O
improved	O
on	O
these	O
medications	O
but	O
pt	O
remained	O
on	O
average	O
above	O
140's	O
/	O
90's	O
.	O

she	O
advanced	O
her	O
diet	O
without	O
difficulty	O
and	O
was	O
d	O
/	O
c'd	O
directly	O
from	O
the	O
icu	O
to	O
home	O
with	O
instruction	O
to	O
take	O
prilosec	O
and	O
follow	O
up	O
with	O
gi	O
clinic	O
,	O
and	O
to	O
see	O
her	O
pcp	O
to	O
regain	O
tighter	O
control	O
of	O
her	O
bp	O
,	O
and	O
address	O
work	O
-	O
up	O
of	O
possible	O
secondary	O
etiologies	O
.	O

medications	O
on	O
admission	O
:	O

1	O
.	O
hydrochlorothiazide	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
7554	O
*	O
*	O
]	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O
2	O
.	O
lisinopril	O
20	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
7554	O
*	O
*	O
]	O
:	O
*	O
120	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O
3	O
.	O
metoprolol	O
tartrate	O
50	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
7554	O
*	O
*	O
]	O
:	O
*	O
120	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

discharge	O
medications	O
:	O

1	O
.	O
hydrochlorothiazide	O
25	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
qd	O
(	O
once	O
a	O
day	O
)	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
7554	O
*	O
*	O
]	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O
2	O
.	O
lisinopril	O
20	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
7554	O
*	O
*	O
]	O
:	O
*	O
120	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O
3	O
.	O
metoprolol	O
tartrate	O
50	O
mg	O
tablet	O
sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
7554	O
*	O
*	O
]	O
:	O
*	O
120	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O
4	O
.	O
compazine	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
three	O
times	O
a	O
day	O
as	O
needed	O
for	O
nausea	B
for	O
5	O
days	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
7554	O
*	O
*	O
]	O
:	O
*	O
15	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O
5	O
.	O
prilosec	O
40	O
mg	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
once	O
a	O
day	O
for	O
14	O
days	O
:	O
continue	O
until	O
instructed	O
to	O
discontinue	O
by	O
gastrointestinal	O
doctor	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
7554	O
*	O
*	O
]	O
:	O
*	O
14	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
8756	O
*	O
*	O
]	O

[	O
*	O
*	O
female	O
first	O
name	O
(	O
un	O
)	O
*	O
*	O
]	O
weiss	B
tear	I

blood	I
loss	I
anemia	I

thrombocytopenia	I

hypertensive	I
urgency	I

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

you	O
have	O
anemia	B
from	O
the	O
bleeding	O
in	O
your	O
esophagus	O
and	O
your	O
need	O
to	O
take	O
a	O
medication	O
to	O
help	O
your	O
esophagus	O
heal	O
.	O

it	O
is	O
called	O
prilosec	O
.	O

please	O
continue	O
the	O
same	O
blood	O
pressure	O
medications	O
you	O
take	O
at	O
home	O
.	O

followup	O
instructions	O
:	O

talk	O
with	O
your	O
doctor	O
about	O
having	O
testing	O
for	O
your	O
high	B
blood	I
pressure	I
to	O
see	O
if	O
it	O
has	O
other	O
causes	O

have	O
your	O
anemia	B
checked	O
and	O
your	O
renal	B
function	I
checked	O
at	O
your	O
next	O
appointment	O
with	O
your	O
primary	O
care	O
doctor	O
in	O
2	O
weeks	O

see	O
the	O
gastroenterologists	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1252	O
*	O
*	O
]	O
in	O
4	O
-	O
8	O
weeks	O
.	O

call	O
to	O
make	O
an	O
appointment	O
at	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
318	O
*	O
*	O
]	O
.	O

provider	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
8757	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
8758	O
*	O
*	O
]	O
,	O
md	O
,	O
phd	O
where	O
:	O
[	O
*	O
*	O
hospital	O
2626	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital	O
2693	O
*	O
*	O
]	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1652	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2011	O
-	O
11	O
-	O
01	O
*	O
*	O
]	O
6	O
:	O
30	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
6373	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
6374	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
8409	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
8410	O
*	O
*	O
]	O
[	O
*	O
*	O
2011	O
-	O
10	O
-	O
18	O
*	O
*	O
]	O
@	O
1324	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2011	O
-	O
11	O
-	O
29	O
*	O
*	O
]	O
2	O
:	O
50	O
pm	O

(	O
end	O
of	O
report	O
)	O

60090	O
||||	O
18426	O
||||	O
11079	O
||||	O
ecg	O
_	O
report	O
||||	O
2015	O
-	O
03	O
-	O
18	O
07	O
:	O
37	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

marked	O
sinus	B
bradycardia	I
.	O

incomplete	B
right	I
bundle	I
-	I
branch	I
block	I
.	O

leftward	O
axis	O
is	O
non	O
-	O
specific	O
.	O

since	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
17	O
*	O
*	O
]	O
sinus	B
bradycardia	I
rate	O
is	O
slower	O
and	O
axis	O
is	O
less	O
leftward	O
.	O

tracing	O
#2	O

102519	O
||||	O
18673	O
||||	O
26732	O
||||	O
echo	O
_	O
report	O
||||	O
2019	O
-	O
07	O
-	O
16	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
congestive	B
heart	I
failure	I
.	O

height	O
:	O
(	O
in	O
)	O
61	O

weight	O
(	O
lb	O
)	O
:	O
180	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
81	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
115	O
/	O
49	O

hr	O
(	O
bpm	O
)	O
:	O
82	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
07	O
-	O
16	O
*	O
*	O
]	O
at	O
10	O
:	O
52	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

this	O
study	O
was	O
compared	O
to	O
the	O
prior	O
study	O
of	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
29	O
*	O
*	O
]	O
.	O

left	O
atrium	O
:	O
marked	O
la	B
enlargement	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
moderately	O
dilated	B
ra	I
.	O

normal	O
ivc	O
diameter	O
with	O
>50%	O
decrease	O
during	O
respiration	O
(	O
estimated	O
rap	O
[	O
*	O
*	O
06	O
-	O
27	O
*	O
*	O
]	O
mmhg	O
)	O
.	O

left	O
ventricle	O
:	O
mild	O
symmetric	O
lvh	B
.	O

mildly	O
dilated	B
lv	I
cavity	O
.	O

suboptimal	O
technical	O
quality	O
,	O
a	O
focal	O
lv	B
wall	I
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

overall	O
normal	O
lvef	O
(	O
>55%	O
)	O
.	O

no	O
resting	B
lvot	I
gradient	I
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
diameter	O
at	O
the	O
sinus	O
level	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

mild	O
as	B
(	O
aova	O
1	O
.	O
2	O
-	O
1	O
.	O
9cm2	O
)	O
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
normal	O
mitral	O
valve	O
leaflets	O
with	O
trivial	O
mr	B
.	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
1	O
*	O
*	O
]	O
lv	O
inflow	O
pattern	O
for	O
age	O
.	O

tricuspid	O
valve	O
:	O
indeterminate	O
pa	B
systolic	I
pressure	I
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

pericardium	O
:	O
there	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
fat	O
pad	O
,	O
though	O
a	O
loculated	O
anterior	O
pericardial	B
effusion	I
cannot	O
be	O
excluded	O
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
-	O
poor	O
echo	O
windows	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
markedly	O
dilated	O
.	O

the	O
right	O
atrium	O
is	O
moderately	O
dilated	O
.	O

the	O
estimated	O
right	O
atrial	O
pressure	O
is	O
[	O
*	O
*	O
06	O
-	O
27	O
*	O
*	O
]	O
mmhg	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
mildly	O
dilated	O
.	O

due	O
to	O
suboptimal	O
technical	O
quality	O
,	O
a	O
focal	B
wall	I
motion	I
abnormality	I
cannot	O
be	O
fully	O
excluded	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

there	O
is	O
mild	O
aortic	B
valve	I
stenosis	I
(	O
area	O
1	O
.	O
2	O
-	O
1	O
.	O
9cm2	O
)	O
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

the	O
pulmonary	B
artery	I
systolic	I
pressure	I
could	O
not	O
be	O
determined	O
.	O

there	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
fat	O
pad	O
.	O

compared	O
with	O
the	O
prior	O
study	O
(	O
images	O
reviewed	O
)	O
of	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
29	O
*	O
*	O
]	O
,	O
overall	O
left	B
ventricular	I
systolic	I
function	I
now	O
appears	O
improved	O
.	O

previously	O
described	O
anteroseptal	O
and	O
apical	O
wall	B
motion	I
abnormalities	I
are	O
probably	O
still	O
present	O
,	O
but	O
current	O
study	O
is	O
technically	O
suboptimal	O
for	O
full	O
evaluation	O
of	O
regional	B
wall	I
motion	I
.	O

the	O
severity	O
of	O
aortic	B
stenosis	I
has	O
increased	O
.	O

109838	O
||||	O
18908	O
||||	O
7799	O
||||	O
echo	O
_	O
report	O
||||	O
2016	O
-	O
11	O
-	O
02	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
18	O
hrs	O
s	O
/	O
p	O
pericardial	O
tap	O
.	O

focused	O
study	O
to	O
reassess	O
for	O
residual	B
fluid	I
.	O

height	O
:	O
(	O
in	O
)	O
66	O

weight	O
(	O
lb	O
)	O
:	O
240	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
16	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
120	O
/	O
60	O

hr	O
(	O
bpm	O
)	O
:	O
82	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2016	O
-	O
11	O
-	O
02	O
*	O
*	O
]	O
at	O
10	O
:	O
28	O

test	O
:	O
portable	O
tte	O
(	O
focused	O
views	O
)	O

doppler	O
:	O
limited	O
doppler	O
and	O
no	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

study	O
done	O
on	O
the	O
day	O
following	O
pericardiocentesis	O
.	O

this	O
study	O
was	O
compared	O
to	O
the	O
prior	O
study	O
of	O
[	O
*	O
*	O
2016	O
-	O
11	O
-	O
01	O
*	O
*	O
]	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

a	O
catheter	O
or	O
pacing	O
wire	O
is	O
seen	O
in	O
the	O
ra	O
and	O
/	O
or	O
rv	O
.	O

left	O
ventricle	O
:	O
mild	O
symmetric	O
lvh	B
with	O
normal	O
cavity	O
size	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

paradoxic	B
septal	I
motion	I
consistent	O
with	O
prior	O
cardiac	O
surgery	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

aortic	O
valve	O
:	O
bileaflet	O
aortic	O
valve	O
prosthesis	O
(	O
avr	O
)	O
.	O

mitral	O
valve	O
:	O
normal	O
mitral	O
valve	O
leaflets	O
with	O
trivial	O
mr	B
.	O

tricuspid	O
valve	O
:	O
mild	O
[	O
1	O
+	O
]	O
tr	B
.	O

mild	O
pa	O
systolic	B
hypertension	I
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
pulmonic	O
valve	O
not	O
well	O
seen	O
.	O

pericardium	O
:	O
small	O
pericardial	B
effusion	I
.	O

no	O
echocardiographic	O
signs	O
of	O
tamponade	O
.	O

no	O
ra	O
diastolic	B
collapse	I
.	O

no	O
rv	O
diastolic	B
collapse	I
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
due	O
to	O
poor	O
echo	O
windows	O
.	O

the	O
patient	O
appears	O
to	O
be	O
in	O
sinus	B
rhythm	I
.	O

compared	O
with	O
the	O
findings	O
of	O
the	O
prior	O
study	O
,	O
the	O
size	O
of	O
the	O
pericardial	B
effusion	I
has	O
decreased	O
.	O

conclusions	O
:	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
with	O
normal	O
cavity	O
size	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

a	O
bileaflet	O
aortic	O
valve	O
prosthesis	O
is	O
present	O
.	O

the	O
aortic	O
prosthesis	O
leaflets	O
appear	O
to	O
move	O
normally	O
.	O

the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

there	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade	B
.	O

no	O
right	O
atrial	O
diastolic	O
or	O
right	O
ventricular	O
diastolic	B
collapse	I
is	O
seen	O
.	O

compared	O
with	O
the	O
prior	O
study	O
(	O
tape	O
reviewed	O
)	O
of	O
[	O
*	O
*	O
2016	O
-	O
11	O
-	O
01	O
*	O
*	O
]	O
,	O
the	O
size	O
of	O
the	O
pericardial	B
effusion	I
has	O
decreased	O
.	O

impression	O
:	O

a	O
small	O
circumferential	O
pericardial	B
effusion	I
with	O
no	O
echocardiographic	O
signs	O
of	O
tamponade	O
.	O

67495	O
||||	O
18912	O
||||	O
18700	O
||||	O
ecg	O
_	O
report	O
||||	O
2009	O
-	O
03	O
-	O
23	O
12	O
:	O
47	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

normal	B
sinus	I
rhythm	I
.	O

left	B
atrial	I
enlargement	I
.	O

small	O
q	O
waves	O
in	O
ii	O
,	O
iii	O
and	O
avf	O
,	O
although	O
non	O
-	O
diagnostic	O
.	O

no	O
previous	O
tracing	O
available	O
for	O
comparison	O
.	O

89185	O
||||	O
19012	O
||||	O
730	O
||||	O
ecg	O
_	O
report	O
||||	O
2015	O
-	O
04	O
-	O
10	O
12	O
:	O
12	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
.	O

prior	B
inferior	I
myocardial	I
infarction	I
.	O

diffuse	O
st	B
segment	I
abnormalities	I
without	O
change	O
compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
08	O
*	O
*	O
]	O
.	O

the	O
rate	O
has	O
slowed	O
.	O

tracing	O
#1	O

56193	O
||||	O
19140	O
||||	O
15637	O
||||	O
ecg	O
_	O
report	O
||||	O
2012	O
-	O
03	O
-	O
24	O
20	O
:	O
52	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I

short	I
pr	I
interval	I

considerold	O
lateral	B
myocardial	I
infarct	I

biphasis	I
t	I
wave	I
in	O
v1	O
-	O
v2	O
-	O
?	O
ischemia	B

since	O
last	O
ecg	O
,	O
t	B
wave	I
changes	I
improved	O

103735	O
||||	O
19155	O
||||	O
10572	O
||||	O
echo	O
_	O
report	O
||||	O
2014	O
-	O
01	O
-	O
22	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O

myocardial	B
infarction	I
.	O

weight	O
(	O
lb	O
)	O
:	O
182	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
110	O
/	O
58	O

hr	O
(	O
bpm	O
)	O
:	O
88	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2014	O
-	O
01	O
-	O
22	O
*	O
*	O
]	O
at	O
15	O
:	O
38	O

test	O
:	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
elongated	B
la	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
mildly	O
dilated	B
ra	I
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thickness	O
.	O

moderately	O
dilated	B
lv	I
cavity	O
.	O

mild	O
regional	O
lv	B
systolic	I
dysfunction	I
.	O

lv	O
wall	O
motion	O
:	O
regional	O
lv	B
wall	I
motion	I
abnormalities	I
include	O
:	O
basal	O
inferior	O
-	O
hypo	B
;	O
mid	O
inferior	O
-	O
hypo	B
;	O
basal	O
inferolateral	O
-	O
hypo	B
;	O
mid	O
inferolateral	O
-	O
hypo	B
;	O
remaining	O
lv	O
segments	O
contract	O
normally	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
diameter	O
at	O
the	O
sinus	O
level	O
.	O

mildly	O
dilated	B
ascending	I
aorta	I
.	O

aortic	O
valve	O
:	O
three	O
aortic	O
valve	O
leaflets	O
.	O

moderately	O
thickened	B
aortic	O
valve	O
leaflets	O
.	O

cannot	O
exclude	O
as	B
.	O

mild	O
(	O
1	O
+	O
)	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

calcified	B
tips	O
of	O
papillary	O
muscles	O
.	O

mild	O
(	O
1	O
+	O
)	O
mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
.	O

mild	O
[	O
1	O
+	O
]	O
tr	B
.	O

moderate	O
pa	O
systolic	B
hypertension	I
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

pericardium	O
:	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
-	O
patient	O
unable	O
to	O
cooperate	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
elongated	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

there	O
is	O
mild	O
regional	O
left	B
ventricular	I
systolic	I
dysfunction	I
with	O
focal	O
severe	O
hypokinesis	O
of	O
the	O
basal	O
half	O
of	O
the	O
inferior	O
and	O
inferolateral	O
walls	O
.	O

the	O
remaining	O
left	O
ventricular	O
segments	O
contract	O
normally	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
ascending	O
aorta	O
is	O
mildly	O
dilated	O
.	O

there	O
are	O
three	O
aortic	O
valve	O
leaflets	O
.	O

significant	O
aortic	B
stenosis	I
cannot	O
cannot	O
be	O
excluded	O
,	O
but	O
severe	O
stenosis	O
is	O
unlikely	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened	B
.	O

mild	O
(	O
1	O
+	O
)	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
a	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

suboptimal	O
image	O
quality	O
-	O
patient	O
unable	O
to	O
cooperate	O
.	O

impression	O
:	O
regional	O
left	B
ventricular	I
systolic	I
dysfunction	I
c	O
/	O
w	O
cad	B
.	O

mild	O
aortic	B
regurgitation	I
.	O
?aortic	O
stenosis	B
.	O

pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

dilated	B
ascending	I
aorta	I
.	O

clinical	O
implications	O
:	O

based	O
on	O
1997	O
aha	O
endocarditis	B
prophylaxis	O
recommendations	O
,	O
the	O
echo	O
findings	O
indicate	O
a	O
moderate	O
risk	O
(	O
prophylaxis	O
recommended	O
)	O
.	O

clinical	O
decisions	O
regarding	O
the	O
need	O
for	O
prophylaxis	O
should	O
be	O
based	O
on	O
clinical	O
and	O
echocardiographic	O
data	O
.	O

39952	O
||||	O
19230	O
||||	O
832	O
||||	O
ecg	O
_	O
report	O
||||	O
2012	O
-	O
11	O
-	O
19	O
18	O
:	O
46	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

baseline	O
artifact	O

sinus	B
tachycardia	I
with	O
atrial	B
premature	I
complexes	I

low	O
limb	O
lead	O
qrs	O
voltages	O
-	O
is	O
nonspecific	O
and	O
probably	O
within	O
normal	O
limits	O
since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
15	O
*	O
*	O
]	O
,	O
sinus	B
tachycardia	I
rate	O
faster	O
and	O
atrial	B
ectopy	I
present	O

93639	O
||||	O
19246	O
||||	O
14504	O
||||	O
ecg	O
_	O
report	O
||||	O
2010	O
-	O
04	O
-	O
22	O
20	O
:	O
18	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

dual	O
chamber	O
pacemaker	O
,	O
rate	O
70	O
.	O

since	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2010	O
-	O
03	O
-	O
17	O
*	O
*	O
]	O
,	O
other	O
than	O
the	O
slower	B
rate	I
,	O
there	O
are	O
probably	O
no	O
significant	O
changes	O
.	O

104724	O
||||	O
19267	O
||||	O
11156	O
||||	O
echo	O
_	O
report	O
||||	O
2018	O
-	O
03	O
-	O
16	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
congestive	B
heart	I
failure	I
.	O

coronary	B
artery	I
disease	I
.	O

left	B
ventricular	I
function	I
.	O

myocardial	B
infarction	I
.	O

preoperative	O
assessment	O
.	O

height	O
:	O
(	O
in	O
)	O
62	O

weight	O
(	O
lb	O
)	O
:	O
160	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
74	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
110	O
/	O
60	O

hr	O
(	O
bpm	O
)	O
:	O
84	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2018	O
-	O
03	O
-	O
16	O
*	O
*	O
]	O
at	O
19	O
:	O
16	O

test	O
:	O
portable	O
tte	O
(	O
focused	O
views	O
)	O

doppler	O
:	O
limited	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
ivc	O
is	O
normal	O
in	O
diameter	O
with	O
<50%	O
decrease	O
during	O
respiration	O
(	O
estimated	O
rap	O
11	O
-	O
15mmhg	O
)	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
.	O

no	O
lv	B
mass	I
/	O
thrombus	O
.	O

trabeculated	O
lv	O
apex	O
.	O

severely	O
depressed	B
lvef	I
.	O

no	O
resting	B
lvot	I
gradient	I
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
.	O

mild	O
global	O
rv	O
free	O
wall	O
hypokinesis	B
.	O

aortic	O
valve	O
:	O
?#	O
aortic	O
valve	O
leaflets	O
.	O

mildly	O
thickened	B
aortic	I
valve	I
leaflets	I
.	O

mitral	O
valve	O
:	O
mild	O
mitral	B
annular	I
calcification	I
.	O

no	O
ms	B
.	O

moderate	O
(	O
2	O
+	O
)	O
mr	B
.	O

[	O
due	O
to	O
acoustic	O
shadowing	O
,	O
the	O
severity	O
of	O
mr	B
may	O
be	O
significantly	O
underestimated	O
.	O
]	O

normal	O
lv	O
inflow	O
pattern	O
for	O
age	O
.	O

tricuspid	O
valve	O
:	O
physiologic	O
tr	B
.	O

indeterminate	O
pa	O
systolic	O
pressure	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
pulmonic	O
valve	O
not	O
well	O
seen	O
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
-	O
poor	O
parasternal	O
views	O
.	O

suboptimal	O
image	O
quality	O
-	O
ventilator	O
.	O

emergency	O
study	O
performed	O
by	O
the	O
cardiology	O
fellow	O
on	O
call	O
.	O

conclusions	O
:	O

the	O
estimated	O
right	O
atrial	O
pressure	O
is	O
11	O
-	O
15mmhg	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

no	O
masses	B
or	O
thrombi	B
are	O
seen	O
in	O
the	O
left	O
ventricle	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
with	O
global	O
hypokinesis	B
and	O
akinesis	B
of	O
the	O
distal	O
lv	O
and	O
apex	O
.	O

right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

there	O
is	O
mild	O
global	O
right	O
ventricular	O
free	O
wall	O
hypokinesis	B
.	O

the	O
number	O
of	O
aortic	O
valve	O
leaflets	O
cannot	O
be	O
determined	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	B
.	O

moderate	O
(	O
2	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

[	O
due	O
to	O
acoustic	O
shadowing	O
,	O
the	O
severity	O
of	O
mitral	B
regurgitation	I
may	O
be	O
significantly	O
underestimated	O
.	O
]	O

the	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
determined	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

178988	O
||||	O
19584	O
||||	O
22272	O
||||	O
radiology	O
_	O
report	O
||||	O
2011	O
-	O
02	O
-	O
07	O
11	O
:	O
13	O
:	O
00	O
.	O
0	O
||||	O
c11	O
chest	O
(	O
pa	O
&	O
lat	O
)	O
||||	O
||||	O
clip	O
#	O
307	O
-	O
7368	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2011	O
-	O
02	O
-	O
07	O
*	O
*	O
]	O
11	O
:	O
13	O
am	O

chest	O
(	O
pa	O
&	O
lat	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
5541	O
*	O
*	O
]	O
reason	O
:	O
evaluate	O
for	O
effusion	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

86	O
year	O
old	O
woman	O
s	O
/	O
p	O
mva	O
with	O
multiple	B
injuries	I
-	O
s	O
/	O
p	O
b	O
/	O
l	O
cts	O
,	O
now	O
with	O
?	O
aspiration	B
,	O
poor	B
inspir	I
effort	I
,	O
sats	O
high	O
80s	O
on	O
ra	O

reason	O
for	O
this	O
examination	O
:	O

evaluate	O
for	O
effusion	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

history	O
:	O
status	O
post	O
mva	O
with	O
multiple	B
injuries	I
.	O

poor	B
inspiratory	I
effort	I
and	O
poor	B
oxygenation	I
.	O

ap	O
and	O
lateral	O
chest	O
:	O
comparison	O
[	O
*	O
*	O
2011	O
-	O
02	O
-	O
06	O
*	O
*	O
]	O
.	O

allowing	O
for	O
differences	O
in	O
technique	O
,	O
there	O
is	O
no	O
significant	O
interval	O
change	O
.	O

the	O
lung	B
volumes	I
are	I
low	I
.	O

there	O
are	O
bilateral	B
pleural	I
effusions	I
,	O
right	O
greater	O
than	O
left	O
.	O

there	O
is	O
patchy	B
opacity	I
in	O
the	O
right	O
mid	O
-	O
lung	O
zone	O
laterally	O
,	O
stable	O
.	O

there	O
is	O
bibasilar	O
atelectasis	B
.	O

there	O
is	O
no	O
chf	B
or	O
new	O
focal	O
consolidation	B
.	O

there	O
are	O
unusual	O
calcific	B
densities	I
in	O
the	O
soft	O
tissues	O
of	O
the	O
left	O
neck	O
,	O
of	O
uncertain	O
etiology	O
.	O

85193	O
||||	O
19623	O
||||	O
19644	O
||||	O
ecg	O
_	O
report	O
||||	O
2018	O
-	O
01	O
-	O
15	O
02	O
:	O
44	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
.	O

right	B
bundle	I
-	I
branch	I
block	I
.	O

low	O
voltage	O
in	O
the	O
precordial	O
leads	O
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2018	O
-	O
01	O
-	O
14	O
*	O
*	O
]	O
no	O
significant	O
change	O
.	O

tracing	O
#3	O

21294	O
||||	O
19649	O
||||	O
3200	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
07	O
-	O
26	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
23	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
26	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1957	O
-	O
05	O
-	O
11	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
ccu	O

history	O
of	O
present	O
illness	O
:	O
patient	O
is	O
a	O
54	O
-	O
year	O
-	O
old	O
male	O
with	O
a	O
history	O
of	O
myocardial	B
infarction	I
in	O
[	O
*	O
*	O
1999	O
*	O
*	O
]	O
,	O
two	O
stents	O
placed	O
in	O
[	O
*	O
*	O
2007	O
*	O
*	O
]	O
,	O
as	O
well	O
as	O
diabetes	B
,	O
who	O
presented	O
after	O

[	O
*	O
*	O
10	O
-	O
14	O
*	O
*	O
]	O
sharp	O
substernal	B
chest	I
pain	I
that	O
woke	O
him	O
from	O
sleep	O
at	O
3	O
am	O
on	O
the	O
19th	O
.	O

patient	O
noted	O
diaphoresis	B
,	O
shortness	B
of	I
breath	I
,	O
nausea	B
,	O
and	O
radiation	B
to	I
his	I
jaw	I
,	O
and	O
generalized	B
weakness	I
.	O

patient	O
at	O
that	O
time	O
took	O
two	O
sublingual	O
nitroglycerin	O
with	O
no	O
improvement	O
in	O
his	O
chest	B
pain	I
.	O

the	O
paramedics	O
were	O
then	O
called	O
,	O
and	O
arrived	O
,	O
and	O
gave	O
him	O
two	O
aspirin	O
,	O
and	O
he	O
was	O
then	O
taken	O
to	O
the	O
emergency	O
department	O
.	O

the	O
paramedics	O
noted	O
him	O
to	O
have	O
a	O
heart	O
rate	O
between	O
38	O
and	O
42	O
and	O
a	O
blood	O
pressure	O
that	O
was	O
70	O
/	O
palp	O
.	O

in	O
route	O
,	O
he	O
was	O
given	O
atropine	O
with	O
no	O
effect	O
.	O

in	O
the	O
emergency	O
department	O
,	O
the	O
patient	O
was	O
found	O
to	O
be	O
bradycardic	B
at	O
38	O
with	O
a	O
blood	O
pressure	O
of	O
84	O
/	O
50	O
.	O

in	O
the	O

emergency	O
department	O
,	O
he	O
received	O
6	O
liters	O
of	O
normal	O
saline	O
,	O
and	O
his	O
electrocardiogram	O
noted	O
him	O
to	O
have	O
st	B
elevation	I
inferior	O
leads	O
.	O

also	O
of	O
note	O
,	O
he	O
had	O
a	B
-	I
v	I
dissociation	I
.	O

because	O
of	O
this	O
,	O
a	O
temporary	O
pacing	O
wire	O
was	O
successfully	O
inserted	O
as	O
heart	O
rate	O
was	O
then	O
paced	O
to	O
the	O
90s	O
and	O
his	O
blood	O
pressure	O
rose	O
.	O

during	O
that	O
time	O
dopamine	O
and	O
morphine	O
were	O
also	O
given	O
.	O

because	O
of	O
the	O
patient's	O
acute	B
myocardial	I
infarction	I
,	O
he	O
was	O
taken	O
to	O
the	O
catheterization	O
laboratory	O
,	O
and	O
was	O
found	O
to	O
have	O
reocclusion	O
of	O
his	O
previus	O
rca	O
stent	O
which	O
was	O
reopened	O
and	O
two	O
new	O
stents	O
were	O
placed	O
.	O

also	O
a	O
distal	O
mid	O
pda	B
disease	O
was	O
found	O
,	O
but	O
it	O
was	O
left	O
untreated	O
because	O
of	O
good	O
flow	O
.	O

he	O
was	O
also	O
found	O
to	O
have	O
equalization	O
of	O
filling	O
pressures	O
.	O

follow	O
-	O
up	O
echocardiogram	O
was	O
ordered	O
,	O
which	O
showed	O
no	O
tamponade	B
and	O
only	O
trace	O
pericardial	B
effusion	I
with	O
good	O
ejection	O
fraction	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
diabetes	B
.	O

2	O
.	O
coronary	B
artery	I
disease	I
.	O

3	O
.	O
history	O
of	O
two	O
myocardial	B
infarctions	I
.	O

4	O
.	O
asthma	B
.	O

5	O
.	O
left	O
knee	B
arthritis	I
.	O

6	O
.	O
sleep	B
apnea	I
.	O

family	O
history	O
:	O
two	O
brothers	O
with	O
coronary	B
artery	I
disease	I
and	O
a	O
father	O
with	O
coronary	B
artery	I
disease	I
.	O

medications	O
on	O
admission	O
:	O

1	O
.	O
aspirin	O
.	O

2	O
.	O
multivitamin	O
.	O

3	O
.	O
glyburide	O
.	O

4	O
.	O
lipitor	O
.	O

5	O
.	O
triamterene	O
/	O
hydrochlorothiazide	O
.	O

6	O
.	O
norvasc	O
.	O

7	O
.	O
vitamin	O
e	O
.	O

8	O
.	O
isosorbide	O
.	O

9	O
.	O
albuterol	O
.	O

10	O
.	O

metoprolol	O
50	O
.	O

social	O
history	O
:	O
was	O
significant	O
for	O
positive	O
tobacco	O
use	O
of	O
a	O
30	O
pack	O
year	O
history	O
,	O
no	O
alcohol	O
.	O

he	O
is	O
retired	O
.	O

upon	O
admission	O
,	O
the	O
patient	O
was	O
placed	O
on	O
aspirin	O
,	O

integrilin	O
,	O
plavix	O
75	O
,	O
lipitor	O
10	O
,	O
captopril	O
12	O
.	O
5	O
tid	O
,	O
and	O
put	O
on	O
an	O
insulin	O
-	O
sliding	O
scale	O
,	O
ranitidine	O
bid	O
,	O
and	O
ipratropium	O
nebulizer	O
prn	O
.	O

physical	O
examination	O
:	O
patient's	O
vital	O
signs	O
on	O
admission	O
:	O
temperature	O
of	O
98	O
.	O
7	O
.	O

heart	O
rate	O
ranged	O
between	O
84	O
-	O
94	O
.	O

respirations	O
ranged	O
17	O
-	O
22	O
.	O

blood	O
pressure	O
systolic	O
ranged	O
112	O
-	O
144	O
/	O
46	O
-	O
83	O
.	O

his	O
pulmonary	O
artery	O
pressures	O
systolic	O
ranged	O
31	O
-	O
40	O
/	O
14	O
-	O
21	O
.	O

he	O
was	O
net	O
positive	O
800	O
in	O
with	O
his	O
in's	O
at	O
1	O
,	O
021	O
.	O

out's	O
220	O
.	O

on	O
examination	O
,	O
the	O
patient	O
was	O
calm	O
in	O
no	O
apparent	B
distress	I
.	O

head	O
and	O
neck	O
examination	O
:	O
his	O
mucosa	O
were	O
moist	O
,	O
nonicteric	O
.	O

his	O
lungs	O
are	O
clear	O
to	O
auscultation	O
anteriorly	O
and	O
posteriorly	O
.	O

cardiac	O
examination	O
:	O
he	O
had	O
a	O
regular	O
rate	O
,	O
s1	O
,	O
s2	O
,	O
no	O
murmurs	B
or	O
rubs	B
were	O
noted	O
.	O

his	O
abdomen	O
was	O
obese	B
with	O
positive	O
bowel	O
sounds	O
,	O
nontender	O
,	O
and	O
nondistended	O
.	O

his	O
extremities	O
:	O
he	O
had	O
a	O
right	O
groin	O
catheter	O
at	O
that	O
time	O
with	O
good	O
distal	O
pulses	O
1	O
+	O
bilaterally	O
,	O
feet	O
were	O
warm	O
to	O
the	O
touch	O
.	O

neurologic	O
examination	O
:	O
he	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

extraocular	O
movements	O
are	O
intact	O
,	O
grossly	O
nonfocal	O
.	O

laboratories	O
:	O
white	O
count	O
of	O
15	O
.	O
6	O
,	O
hemoglobin	O
13	O
.	O
1	O
,	O
hematocrit	O
38	O
.	O
7	O
,	O
platelets	O
233	O
.	O

sodium	O
139	O
,	O
potassium	O
3	O
.	O
9	O
,	O
chloride	O
of	O
105	O
,	O
bicarb	O
24	O
,	O
bun	O
29	O
,	O
creatinine	O
of	O
1	O
.	O
3	O
,	O
and	O
a	O
glucose	O
of	O
316	O
.	O

his	O
pt	O
was	O
17	O
.	O
8	O
,	O
ptt	O
29	O
.	O
6	O
,	O
inr	O
of	O
1	O
.	O
1	O
.	O

patient	O
initially	O
had	O
a	O
calcium	O
of	O
5	O
.	O
4	O
,	O
phosphorus	O
of	O
2	O
.	O
6	O
,	O
magnesium	O
of	O
1	O
.	O
7	O
,	O
which	O
followup	O
levels	O
revealed	O
a	O
calcium	O
of	O
7	O
.	O
7	O
,	O
phosphorus	O
4	O
.	O
0	O
,	O
magnesium	O
of	O
1	O
.	O
8	O
.	O

his	O
cpk	O
peaked	O
at	O
2722	O
on	O
the	O
19th	O
at	O
10	O
am	O
.	O

his	O
echocardiogram	O
showed	O
left	O
ventricle	O
of	O
normal	O
size	O
with	O
an	O
ejection	O
fraction	O
of	O
over	O
55%	O
,	O
small	O
pericardial	B
effusion	I
,	O
no	O
sinus	O
tamponade	B
.	O

his	O
catheterization	O
was	O
significant	O
for	O
marked	O
increased	O
filling	B
pressures	I
,	O
a	O
right	B
dominant	I
heart	I
with	O
rca	B
occlusion	I
of	O
previous	O
stents	O
.	O

two	O
stents	O
were	O
placed	O
with	O
timi	O
-	O
iii	O
flow	O
.	O

there	O
is	O
also	O
a	O
distant	O
occlusion	B
which	O
tried	O
to	O
be	O
manipulated	O
with	O
a	O
wire	O
,	O
which	O
could	O
not	O
be	O
reopened	O
,	O
and	O
the	O
patient	O
was	O
given	O
190	O
cc	O
of	O
contrast	O
.	O

hospital	O
course	O
:	O
the	O
day	O
following	O
his	O
admission	O
his	O

swan	O
-	O
ganz	O
catheter	O
was	O
removed	O
as	O
well	O
as	O
his	O
temporary	O
pacer	O
.	O

his	O
ace	O
inhibitor	O
was	O
continued	O
,	O
and	O
was	O
increased	O
to	O
25	O
mg	O
bid	O
.	O

also	O
a	O
beta	O
blocker	O
was	O
added	O
at	O
that	O
time	O
,	O
metoprolol	O
12	O
.	O
5	O
bid	O
.	O

at	O
that	O
time	O
,	O
he	O
was	O
also	O
transferred	O
to	O
the	O
floor	O
.	O

on	O
the	O
following	O
day	O
,	O
[	O
*	O
*	O
07	O
-	O
25	O
*	O
*	O
]	O
,	O
he	O
was	O
on	O
the	O
floor	O
.	O

he	O
was	O
switched	O
from	O
captopril	O
to	O
lisinopril	O
10	O
mg	O
q	O
day	O
.	O

on	O
telemetry	O
,	O
some	O
ectopic	B
beats	I
were	O
noted	O
as	O
well	O
as	O
a	O
right	B
bundle	I
branch	I
block	I
.	O

the	O
following	O
day	O
on	O
[	O
*	O
*	O
07	O
-	O
26	O
*	O
*	O
]	O
,	O
telemetry	O
showed	O
decreased	O
frequency	O
of	O
these	O
ectopic	B
beats	I
,	O
but	O
continued	O
right	B
bundle	I
branch	I
block	I
.	O

his	O
lisinopril	O
was	O
increased	O
to	O
15	O
mg	O
q	O
day	O
,	O
and	O
patient	O
was	O
discharged	O
.	O

condition	O
on	O
discharge	O
:	O
good	O
.	O

discharge	O
diagnosis	O
:	O
acute	B
myocardial	I
infarction	I
.	O

discharge	O
medications	O
:	O

1	O
.	O
aspirin	O
.	O

2	O
.	O
plavix	O
.	O

3	O
.	O
lipitor	O
.	O

4	O
.	O
metoprolol	O
50	O
mg	O
bid	O
.	O

5	O
.	O
lisinopril	O
15	O
mg	O
q	O
day	O
.	O

6	O
.	O
glyburide	O
10	O
mg	O
am	O
,	O
5	O
mg	O
in	O
the	O
pm	O
.	O

patient	O
was	O
also	O
given	O
a	O
prescription	O
for	O
accu	O
-	O
chek	O
machine	O
as	O
well	O
as	O
glucose	O
strips	O
to	O
monitor	O
his	O
diabetes	B
.	O

follow	O
-	O
up	O
instructions	O
:	O
the	O
patient	O
was	O
told	O
to	O
followup	O
with	O
his	O
primary	O
care	O
physician	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
5321	O
*	O
*	O
]	O
.	O

patient	O
noted	O
that	O
he	O
would	O
make	O
an	O
appointment	O
within	O
the	O
next	O
1	O
-	O
2	O
weeks	O
.	O

the	O
patient	O
also	O
noted	O
he	O
also	O
had	O
a	O
follow	O
-	O
up	O
appointment	O
with	O
his	O
cardiologist	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
5322	O
*	O
*	O
]	O
,	O
who	O
is	O
a	O
cardiologist	O
at	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
.	O

the	O
patient	O
notes	O
that	O
he	O
has	O
an	O
appointment	O
this	O
coming	O
monday	O
.	O

patient's	O
cardiac	O
risk	O
factors	O
were	O
discussed	O
,	O
and	O
the	O
patient	O
has	O
decided	O
to	O
stop	O
smoking	O
to	O
prevent	O
future	O
cardiac	O
events	O
,	O
and	O
the	O
patient	O
notes	O
that	O
he	O
will	O
take	O
his	O
medication	O
as	O
prescribed	O
,	O
and	O
was	O
told	O
if	O
he	O
had	O
any	O
recurrent	O
chest	B
pains	I
,	O
shortness	B
of	I
breath	I
,	O
nausea	B
,	O
lightheadedness	B
,	O
palpitations	B
,	O
that	O
he	O
should	O
return	O
to	O
the	O

emergency	O
department	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
290	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1441	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
5088	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2011	O
-	O
07	O
-	O
26	O
*	O
*	O
]	O
16	O
:	O
23	O

t	O
:	O
[	O
*	O
*	O
2011	O
-	O
08	O
-	O
03	O
*	O
*	O
]	O
12	O
:	O
41	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
5323	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
290	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2011	O
-	O
08	O
-	O
05	O
*	O
*	O
]	O
12	O
:	O
14	O
pm	O

(	O
end	O
of	O
report	O
)	O

26760	O
||||	O
19709	O
||||	O
25007	O
||||	O
discharge	O
_	O
summary	O
||||	O
2018	O
-	O
08	O
-	O
23	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2018	O
-	O
08	O
-	O
23	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1996	O
-	O
03	O
-	O
19	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
orthopaedics	O

allergies	O
:	O

azithromycin	O
/	O
cefazolin	O
/	O
vancomycin	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1795	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

motor	O
vehicle	O
collision	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

orif	O
right	O
tibia	O
&	O
fibula	B
fractures	I

closed	O
reduction	O
right	O
radial	B
head	I
fracture	I

history	O
of	O
present	O
illness	O
:	O

the	O
patient	O
was	O
an	O
unrestrained	O
driver	O
in	O
a	O
high	O
-	O
speed	O
motor	O
vehicle	O
collision	O
vs	O
tree	O
.	O

she	O
was	O
ejected	O
approximately	O
40	O
feet	O
and	O
arrived	O
to	O
the	O
[	O
*	O
*	O
hospital1	O
79	O
*	O
*	O
]	O
[	O
*	O
*	O
doctor	O
first	O
name	O
45	O
*	O
*	O
]	O
amnestic	B
to	O
the	O
event	O
.	O

a	O
passenger	O
in	O
the	O
same	O
vehicle	O
was	O
found	O
to	O
have	O
fixed	O
&	O
dilated	B
pupils	I
and	O
subsequently	O
expired	O
.	O

+	O
etoh	O

past	O
medical	O
history	O
:	O

low	O
back	O
disc	B
herniation	I

chronic	I
back	I
pain	I

social	O
history	O
:	O

+	O
etoh	O
,	O
denies	O
smoking	O
,	O
other	O
drugs	O

family	O
history	O
:	O

noncontributory	O

physical	O
exam	O
:	O

98	O
.	O
8	O
106	O
108	O
/	O
p	O
20	O
100%ra	O

a&ox3	O
perrla	O
,	O
eomi	O

small	O
amount	O
blood	B
in	I
oropharynx	I
,	O
teeth	O
intact	O
,	O
midface	O
stable	O
,	O
tms	O
clear	O
,	O
nares	O
w	O
/	O
o	O
blood	O
/	O
fluid	O
large	O
approx	O
8cm	O
cresentic	O
head	B
lac	I
left	O
parieto	O
-	O
occipital	O
trachea	O
midline	O

rrr	O

cta	O
bilaterally	O

+	O
ruq	B
tenderness	I
,	O
soft	O
,	O
nondistended	B

pelvis	O
stable	O

+	O
sacral	O
tenderness	B
,	O
no	O
other	O
midline	O
or	O
paraspinous	O
tenderness	B
,	O
no	O
deformity	B
or	O
step	B
-	I
off	I
,	O
no	O
abrasions	O
or	O
ecchymoses	B
to	O
back	O
right	O
tib	O
/	O
fib	B
deformity	I
,	O
abrasion	O
right	O
lateral	O
knee	O
abrasion	O
left	O
ankle	O

+	O
deformity	O
right	O
elbow	O

+	O
femoral	O
,	O
dp	O
,	O
pt	O
,	O
radial	O
pulses	O
bilaterally	O

guiac	O
negative	O
,	O
normal	O
tone	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
08	O
:	O
45pm	O
urine	O
rbc	O
-	O
>50	O
wbc	O
-	O
[	O
*	O
*	O
05	O
-	O
05	O
*	O
*	O
]	O
bacteria	O
-	O
occ	O
yeast	O
-	O
none	O
epi	O
-	O
[	O
*	O
*	O
05	O
-	O
05	O
*	O
*	O
]	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
08	O
:	O
45pm	O
urine	O
blood	O
-	O
lge	O
nitrite	O
-	O
neg	O
protein	O
-	O
100	O
glucose	O
-	O
neg	O
ketone	O
-	O
neg	O
bilirubin	O
-	O
neg	O
urobilngn	O
-	O
neg	O
ph	O
-	O
8	O
.	O
0	O
leuk	O
-	O
tr	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
08	O
:	O
45pm	O
urine	O
color	O
-	O
yellow	O
appear	O
-	O
hazy	O
sp	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
83	O
*	O
*	O
]	O
-	O
1	O
.	O
007	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
08	O
:	O
45pm	O
fibrinoge	O
-	O
166	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
08	O
:	O
45pm	O
pt	O
-	O
13	O
.	O
4	O
*	O
ptt	O
-	O
28	O
.	O
1	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
08	O
:	O
45pm	O
plt	O
count	O
-	O
268	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
08	O
:	O
45pm	O
wbc	O
-	O
17	O
.	O
1	O
*	O
rbc	O
-	O
3	O
.	O
62	O
*	O
hgb	O
-	O
12	O
.	O
0	O
hct	O
-	O
35	O
.	O
5	O
*	O
mcv	O
-	O
98	O
mch	O
-	O
33	O
.	O
2	O
*	O
mchc	O
-	O
33	O
.	O
9	O
rdw	O
-	O
13	O
.	O
0	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
08	O
:	O
45pm	O
urine	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
opiates	O
-	O
neg	O
cocaine	O
-	O
neg	O
amphetmn	O
-	O
neg	O
mthdone	O
-	O
neg	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
08	O
:	O
45pm	O
asa	O
-	O
neg	O
ethanol	O
-	O
166	O
*	O
acetmnphn	O
-	O
neg	O
bnzodzpn	O
-	O
neg	O
barbitrt	O
-	O
neg	O
tricyclic	O
-	O
neg	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
08	O
:	O
45pm	O
amylase	O
-	O
38	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
08	O
:	O
45pm	O
urea	O
n	O
-	O
9	O
creat	O
-	O
0	O
.	O
6	O

[	O
*	O
*	O
2018	O
-	O
08	O
-	O
11	O
*	O
*	O
]	O
09	O
:	O
01pm	O
hgb	O
-	O
12	O
.	O
8	O
calchct	O
-	O
38	O

r	O
elbow	O
[	O
*	O
*	O
08	O
-	O
11	O
*	O
*	O
]	O
:	O
there	O
is	O
a	O
slightly	O
angulated	B
fracture	I
through	O
the	O
right	O
radial	O
neck	O
.	O

there	O
are	O
no	O
other	O
fractures	B
identified	O
.	O

r	O
tib	O
/	O
fib	O
[	O
*	O
*	O
08	O
-	O
11	O
*	O
*	O
]	O
:	O
two	O
views	O
of	O
the	O
femur	O
and	O
three	O
views	O
of	O
the	O
right	O
tibia	O
and	O
fibula	O
were	O
obtained	O
.	O

there	O
are	O
obliquely	O
oriented	O
displaced	B
fractures	I
through	O
the	O
distal	O
right	O
tibia	O
and	O
fibula	O
with	O
significant	O
lateral	O
and	O
posterior	B
displacement	I
of	O
the	O
distal	O
fracture	O
fragments	O
.	O

there	O
are	O
several	O
small	O
associated	O
bony	O
fragments	O
.	O

a	O
minimally	O
displaced	B
fracture	I
is	O
also	O
noted	O
through	O
the	O
proximal	O
right	O
fibula	O
.	O

the	O
femur	O
demonstrates	O
no	O
evidence	O
of	O
fracture	B
.	O

ct	O
head	O
:	O
neg	O

ct	O
cspine	O
:	O
neg	O

ct	O
abd	O
:	O
technique	O
:	O
multidetector	O
ct	O
scanning	O
of	O
the	O
chest	O
,	O
abdomen	O
and	O
pelvis	O
was	O
performed	O
following	O
administration	O
of	O
150	O
cc	O
of	O
optiray	O
contrast	O
.	O

coronal	O
and	O
sagittal	O
reformations	O
were	O
also	O
obtained	O
.	O

ct	O
of	O
the	O
chest	O
with	O
intravenous	O
contrast	O
.	O

the	O
heart	O
,	O
pericardium	O
and	O
great	O
vessels	O
are	O
within	O
normal	O
limits	O
.	O

the	O
airways	O
are	O
patent	O
to	O
the	O
segmental	O
level	O
bilaterally	O
.	O

there	O
are	O
patchy	O
bilateral	O
areas	O
of	O
parenchymal	B
opacity	I
best	O
appreciated	O
in	O
the	O
posterior	O
aspects	O
of	O
the	O
upper	O
lobes	O
as	O
well	O
as	O
the	O
lower	O
lobes	O
bilaterally	O
consistent	O
with	O
contusions	B
.	O

linear	B
densities	I
are	O
also	O
appreciated	O
in	O
the	O
lower	O
lobes	O
bilaterally	O
which	O
could	O
be	O
consistent	O
with	O
atelectatic	B
change	O
.	O

there	O
is	O
no	O
pneumothorax	B
or	O
effusion	B
.	O

ct	O
of	O
the	O
abdomen	O
with	O
intravenous	O
contrast	O
.	O

there	O
is	O
a	O
linear	O
defect	O
through	O
the	O
right	O
inferior	O
and	O
posterior	O
aspect	O
of	O
the	O
liver	O
consistent	O
with	O
a	O
laceration	O
.	O

a	O
tiny	O
punctate	O
focus	O
of	O
hyperdensity	O
is	O
appreciated	O
along	O
the	O
medial	O
aspect	O
of	O
this	O
laceration	B
within	O
the	O
liver	O
parenchyma	O
which	O
is	O
felt	O
to	O
be	O
most	O
consistent	O
with	O
a	O
small	O
vessel	O
rather	O
than	O
active	O
extravasation	B
.	O

the	O
remainder	O
of	O
the	O
liver	O
,	O
gallbladder	O
,	O
spleen	O
and	O
pancreas	O
are	O
unremarkable	O
.	O

the	O
intra	O
-	O
abdominal	O
loops	O
of	O
large	O
and	O
small	O
bowel	O
are	O
within	O
normal	O
limits	O
.	O

there	O
is	O
a	O
moderate	O
amount	O
of	O
high	B
density	I
material	I
in	O
the	O
right	O
retroperitoneal	O
region	O
expanding	O
the	O
perirenal	O
space	O
with	O
associated	O
perirenal	B
stranding	I
.	O

the	O
kidneys	O
are	O
otherwise	O
within	O
normal	O
limits	O
with	O
symmetric	O
nephrograms	O
.	O

the	O
adrenals	O
are	O
unremarkable	O
.	O

there	O
is	O
no	O
free	B
air	I
.	O

ct	O
of	O
the	O
pelvis	O
with	O
intravenous	O
contrast	O
.	O

a	O
foley	O
is	O
present	O
within	O
the	O
nondistended	B
bladder	O
.	O

the	O
distal	O
ureters	O
,	O
rectum	O
,	O
uterus	O
and	O
adnexa	O
are	O
within	O
normal	O
limits	O
.	O

there	O
is	O
no	O
pathologic	B
adenopathy	I
.	O

bone	O
windows	O
:	O
there	O
are	O
no	O
suspicious	O
lytic	O
or	O
sclerotic	B
lesions	I
.	O

no	O
fractures	B
are	O
identified	O
.	O

ct	O
reconstructions	O
:	O
the	O
above	O
findings	O
were	O
confirmed	O
with	O
coronal	O
and	O
sagittal	O
reformations	O
.	O

impression	O
:	O

1	O
.	O
liver	B
laceration	I
of	O
the	O
right	O
posterior	O
liver	O
.	O

2	O
.	O
right	O
-	O
sided	O
perirenal	O
/	O
retroperitoneal	B
hematoma	I
with	O
preserved	O
renal	O
function	O
.	O

3	O
.	O
pulmonary	B
contusions	I
.	O

cxr	O
:	O
[	O
*	O
*	O
08	O
-	O
15	O
*	O
*	O
]	O
:	O
patchy	B
opacities	I
in	O
bilateral	O
lower	O
lobes	O
,	O
probably	O
representing	O
combination	O
of	O
contusion	B
and	O
atelectasis	B
in	O
this	O
patient	O
status	O
post	O
motor	O
vehicle	O
accident	O
.	O

brief	O
hospital	O
course	O
:	O

the	O
patient	O
was	O
admitted	O
to	O
the	O
trauma	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
47	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
08	O
-	O
11	O
*	O
*	O
]	O
with	O
the	O
injuries	O
listed	O
above	O
.	O

she	O
remained	O
hemodynamically	O
stable	O
on	O
presentation	O
and	O
throughout	O
her	O
stay	O
.	O

on	O
hd#2	O
she	O
went	O
to	O
the	O
or	O
with	O
orthopedics	O
for	O
orif	O
right	O
tib	O
/	O
fib	O
,	O
closed	O
reduction	O
right	O
radial	O
head	O
.	O

on	O
hd#3	O
she	O
was	O
transferred	O
to	O
the	O
floor	O
.	O

her	O
pain	B
was	O
initially	O
controlled	O
with	O
a	O
dilaudid	O
pca	O
.	O

she	O
was	O
still	O
having	O
persistent	O
pain	B
all	O
over	O
and	O
acute	O
pain	B
service	O
was	O
consulted	O
.	O

she	O
was	O
switched	O
to	O
oral	O
oxycodone	O
and	O
percocet	O
,	O
with	O
adequate	O
pain	B
control	O
during	O
the	O
rest	O
of	O
her	O
stay	O
.	O

on	O
hd#4	O
her	O
hct	O
had	O
trended	O
down	O
to	O
20	O
and	O
she	O
was	O
transfused	O
2	O
units	O
prbc	O
with	O
appropriate	O
increase	O
of	O
her	O
hct	O
.	O

her	O
hct	O
remained	O
stable	O
during	O
the	O
rest	O
of	O
her	O
stay	O
.	O

repeat	O
ct	O
of	O
her	O
abdomen	O
showed	O
improved	O
perirenal	B
hematoma	I
,	O
improved	O
liver	B
laceration	I
.	O

she	O
was	O
seen	O
by	O
pt	O
&	O
ot	O
and	O
her	O
activity	O
advanced	O
.	O

she	O
was	O
also	O
seen	O
by	O
social	O
work	O
and	O
psychiatry	O
for	O
occasionally	O
voiced	O
suicidal	B
thoughts	I
.	O

she	O
was	O
cleared	O
by	O
psychiatry	O
,	O
although	O
it	O
was	O
thought	O
that	O
she	O
would	O
benefit	O
from	O
continued	O
evaluation	O
by	O
psychiatry	O
at	O
her	O
rehab	O
center	O
and	O
eventual	O
outpatient	O
psychiatry	O
follow	O
-	O
up	O
.	O
she	O
was	O
seen	O
by	O
dr	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
259	O
*	O
*	O
]	O
and	O
he	O
felt	O
she	O
was	O
developing	O
an	O
eschar	B
on	O
her	O
rt	O
medial	O
leg	O
she	O
was	O
transfered	O
to	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
258	O
*	O
*	O
]	O
and	O
started	O
on	O
abx	O
her	O
wound	B
over	O
the	O
next	O
three	O
days	O
remain	O
unchanged	O
and	O
she	O
was	O
accepted	O
to	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
she	O
was	O
starting	O
to	O
put	O
more	O
effort	O
in	O
to	O
her	O
ot	O
of	O
her	O
rt	O
elbow	O
and	O
was	O
ready	O
for	O
transfer	O
to	O
rehab	O

medications	O
on	O
admission	O
:	O

percocet	O

discharge	O
medications	O
:	O

1	O
.	O
acetaminophen	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

2	O
.	O
trazodone	O
50	O
mg	O
tablet	O
sig	O
:	O
0	O
.	O
5	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
as	O
needed	O
.	O

3	O
.	O
nicotine	O
14	O
mg	O
/	O
24	O
hr	O
patch	O
24hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
patch	O
24hr	O

transdermal	O
daily	O
(	O
daily	O
)	O
.	O

4	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

5	O
.	O
senna	O
8	O
.	O
6	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

6	O
.	O
oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q3	O
-	O
4h	O
(	O
)	O
as	O
needed	O
for	O
pain	B
.	O

7	O
.	O
oxycodone	O
5	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q3	O
-	O
4h	O
(	O
)	O
as	O
needed	O
for	O
breakthrough	O
pain	B
.	O

8	O
.	O
bisacodyl	O
5	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
two	O
(	O
2	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
as	O
needed	O
.	O

9	O
.	O
haloperidol	O
lactate	O
5	O
mg	O
/	O
ml	O
solution	O
sig	O
:	O
0	O
.	O
5	O
-	O
2	O
mg	O
injection	O
q4h	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
agitation	B
.	O

10	O
.	O

enoxaparin	O
sodium	O
40	O
mg	O
/	O
0	O
.	O
4ml	O
syringe	O
sig	O
:	O
one	O
(	O
1	O
)	O

subcutaneous	O
q	O
24h	O
(	O
every	O
24	O
hours	O
)	O
.	O

11	O
.	O

oxycodone	O
20	O
mg	O
tablet	O
sustained	O
release	O
12hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
sustained	O
release	O
12hr	O
po	O
q12h	O
(	O
every	O
12	O
hours	O
)	O
.	O

12	O
.	O

pantoprazole	O
sodium	O
40	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
q24h	O
(	O
every	O
24	O
hours	O
)	O
.	O

13	O
.	O

clindamycin	O
phosphate	O
150	O
mg	O
/	O
ml	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O

injection	O
q8h	O
(	O
every	O
8	O
hours	O
)	O
:	O
till	O
follow	O
up	O
with	O
dr	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
259	O
*	O
*	O
]	O
in	O
one	O
week	O
.	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

[	O
*	O
*	O
hospital	O
54	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
55	O
*	O
*	O
]	O

discharge	O
diagnosis	O
:	O

motor	O
vehicle	O
collision	O

liver	B
laceration	I

perirenal	I
hematoma	I
-	O
right	O

bilateral	O
pulmonary	B
contusions	I

displaced	O
distal	O
right	O
tibia	O
and	O
fibula	O
fractures	O

minimally	O
displaced	O
proximal	O
right	O
fibula	O
fracture	O

right	O
radial	B
neck	I
fracture	I

discharge	O
condition	O
:	O

fair	O

discharge	O
instructions	O
:	O

keep	O
your	O
splints	O
and	O
casts	O
clean	O
and	O
dry	O
.	O

take	O
the	O
pain	B
medication	O
as	O
prescribed	O
as	O
needed	O
.	O

physical	O
therapy	O
:	O

activity	O
:	O
activity	O
as	O
tolerated	O

right	O
lower	O
extremity	O
:	O
non	O
weight	O
bearing	O

right	O
upper	O
extremity	O
:	O
non	O
weight	O
bearing	O

walker	O
with	O
arm	O
support	O

treatments	O
frequency	O
:	O

site	O
:	O
r	O
leg	O

type	O
:	O
surgical	O

cleansing	O
[	O
*	O
*	O
doctor	O
last	O
name	O
460	O
*	O
*	O
]	O
:	O
saline	O

dressing	O
:	O
gauze	O
-	O
dry	O

comment	O
:	O
to	O
remain	O
in	O
ao	O
splint	O
-	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
team	O
to	O
do	O
any	O
dressing	O
changes	O

site	O
:	O
r	O
arm	O

type	O
:	O
other	O

dressing	O
:	O
other	O

comment	O
:	O
splint	O
with	O
sling	O
-	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
*	O
*	O
]	O
team	O
to	O
do	O
any	O
splint	O
changes	O

rt	O
popiteal	O
fossa	O
leave	O
open	O
to	O
iar	O

followup	O
instructions	O
:	O

with	O
orthopedics	O
in	O
1	O
week	O
.	O

please	O
call	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
2561	O
*	O
*	O
]	O
as	O
soon	O
as	O
possible	O
to	O
schedule	O
a	O
follow	O
-	O
up	O
appointment	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1797	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1798	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
106	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
pa	O
80	O
-	O
bhe	O
[	O
*	O
*	O
2018	O
-	O
08	O
-	O
23	O
*	O
*	O
]	O
@	O
1518	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
tue	O
[	O
*	O
*	O
2018	O
-	O
09	O
-	O
04	O
*	O
*	O
]	O
4	O
:	O
25	O
pm	O

(	O
end	O
of	O
report	O
)	O

3873	O
||||	O
19791	O
||||	O
19646	O
||||	O
discharge	O
_	O
summary	O
||||	O
2019	O
-	O
01	O
-	O
31	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
19	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1963	O
-	O
08	O
-	O
10	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
surgery	O

allergies	O
:	O

sulfa	O
(	O
sulfonamides	O
)	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
2145	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

abdominal	B
pain	I

jaundice	I

nausea	I
/	O
vomiting	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

small	O
bowel	O
resection	O
;	O
ious	O

roux	O
-	O
en	O
-	O
y	O
cholecysto	O
-	O
jejunostomy	O

pseudocyst	O
-	O
jejunosotmy	O

j	O
-	O
tube	O
placement	O

history	O
of	O
present	O
illness	O
:	O

this	O
55	O
-	O
year	O
-	O
old	O
lady	O
has	O
a	O
history	O
of	O
chronic	B
alcoholic	I
-	I
induced	I
pancreatitis	I
.	O

she	O
has	O
had	O
a	O
pseudocyst	B
problem	O
in	O
the	O
past	O
that	O
resolved	O
over	O
time	O
and	O
has	O
previously	O
had	O
an	O
open	O
j	O
tube	O
placement	O
in	O
the	O
last	O
year	O
for	O
malnutrition	B
during	O
this	O
period	O
.	O

she	O
recently	O
presented	O
with	O
overt	O
jaundice	B
from	O
bile	B
duct	I
obstruction	I
and	O
a	O
history	O
of	O
many	O
weeks	O
of	O
decline	O
.	O

she	O
has	O
only	O
lost	O
4	O
pounds	O
over	O
this	O
period	O
of	O
time	O
,	O
but	O
has	O
been	O
malnourished	B
and	O
unable	O
to	O
eat	O
regular	O
foods	O
and	O
has	O
sustained	O
herself	O
only	O
on	O
liquids	O
because	O
of	O
gastric	B
outlet	I
obstruction	I
.	O

she	O
was	O
transferred	O
to	O
our	O
care	O
for	O
assessment	O
of	O
her	O
biliary	B
obstruction	I
and	O
thoughts	O
of	O
therapeutic	O
approaches	O
to	O
this	O
and	O
the	O
large	O
pseudocyst	B
that	O
was	O
identified	O
that	O
was	O
on	O
the	O
order	O
of	O
10	O
x	O
10	O
cm	O
in	O
her	O
mid	O
-	O
abdomen	O
.	O

when	O
we	O
assessed	O
her	O
cat	O
scan	O
,	O
it	O
was	O
clear	O
that	O
she	O
had	O
three	O
problems	O
.	O

1	O
.	O
biliary	B
obstruction	I
from	O
an	O
obstructed	B
bile	I
duct	I
.	O

2	O
.	O
gastric	B
outlet	I
obstruction	I
from	O
the	O
duodenum	O
being	O
splayed	O
across	O
this	O
large	O
pseudocyst	B
in	O
the	O
head	O
of	O
the	O
pancreas	O
.	O

3	O
.	O
sinistral	B
hypertension	I
from	O
her	O
pseudocyst	B
as	O
well	O
.	O

it	O
was	O
clear	O
that	O
the	O
whole	O
upper	O
abdomen	O
was	O
full	O
of	O
massive	O
venous	B
collaterals	I
in	O
that	O
in	O
fact	O
the	O
superior	O
mesenteric	O
vein	O
drained	O
into	O
the	O
splenic	O
vein	O
in	O
order	O
to	O
drain	O
her	O
bowels	O
.	O

the	O
interface	O
between	O
the	O
lower	O
aspect	O
of	O
the	O
portal	O
vein	O
and	O
the	O
superior	O
mesenteric	O
vein	O
was	O
completely	O
splayed	O
out	O
and	O
attenuated	O
and	O
probably	O
thrombosed	B
by	O
the	O
pseudocyst	B
mass	O
effect	O
.	O

with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
1453	O
*	O
*	O
]	O
,	O
we	O
decided	O
that	O
there	O
was	O
no	O
value	O
in	O
any	O
endoscopic	O
approaches	O
to	O
either	O
the	O
pseudocyst	B
or	O
the	O
biliary	B
obstruction	I
and	O
it	O
was	O
clear	O
that	O
an	O
operative	O
approach	O
was	O
the	O
safest	O
and	O
only	O
way	O
to	O
approach	O
this	O
.	O

past	O
medical	O
history	O
:	O

alcoholic	B
pancreatitis	I
,	O
hyperlipidemia	B
,	O
etoh	B
abuse	I
(	O
last	O
drink	O
10	O
days	O
ago	O
)	O
,	O
h	O
/	O
o	O
regional	O
thrombosis	B
,	O
cirrhosis	B
,	O
glaucoma	B
psh	O
:	O
j	O
-	O
tube	O
(	O
removed	O
[	O
*	O
*	O
08	O
-	O
07	O
*	O
*	O
]	O
)	O
,	O
c	O
-	O
section	O
x2	O
,	O
tonsillectomy	O

social	O
history	O
:	O

no	O
tobacco	O

last	O
drink	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
09	O
*	O
*	O
]	O

lives	O
with	O
husband	O
,	O
2	O
boys	O
,	O
and	O
her	O
mother	O

[	O
*	O
*	O
name	O
(	O
ni	O
)	O
2614	O
*	O
*	O
]	O
as	O
consultant	O

family	O
history	O
:	O

father	O
with	O
bladder	B
ca	I

family	O
htn	B
in	O
f	O

physical	O
exam	O
:	O

vs	O
:	O
100	O
.	O
6	O
,	O
85	O
,	O
140	O
/	O
80	O
,	O
18	O
,	O
96%	O
ra	O

gen	O
:	O
fatigued	B
appearing	O
,	O
thin	O
woman	O
,	O
nad	B
.	O

jaundice	B
,	O
scleral	O
icteric	B

chest	O
:	O
cta	O
bilat	O
.	O

cv	O
:	O
rrr	O
,	O
normal	O
s1	O
,	O
s2	O
.	O

no	O
m	B
/	O
r	B
/	O
g	B
.	O

abd	O
:	O
soft	O
,	O
nd	O
,	O
+	O
bs	O
,	O
ttp	O
over	O
epigastrim	O
,	O
no	O
ascities	B
.	O

ext	O
:	O
2	O
+	O
dp	O
pulses	O
,	O
warm	O
,	O
no	O
c	B
/	O
c	B
/	O
e	B

pertinent	O
results	O
:	O

[	O
*	O
*	O
2019	O
-	O
01	O
-	O
24	O
*	O
*	O
]	O
02	O
:	O
43am	O
blood	O
wbc	O
-	O
10	O
.	O
3	O
rbc	O
-	O
3	O
.	O
85	O
*	O
hgb	O
-	O
11	O
.	O
5	O
*	O
hct	O
-	O
34	O
.	O
0	O
*	O
mcv	O
-	O
88	O
mch	O
-	O
29	O
.	O
8	O
mchc	O
-	O
33	O
.	O
7	O
rdw	O
-	O
15	O
.	O
5	O
plt	O
ct	O
-	O
389	O

[	O
*	O
*	O
2019	O
-	O
01	O
-	O
24	O
*	O
*	O
]	O
02	O
:	O
43am	O
blood	O
glucose	O
-	O
156	O
*	O
urean	O
-	O
3	O
*	O
creat	O
-	O
0	O
.	O
6	O
na	O
-	O
138	O
k	O
-	O
4	O
.	O
5	O
cl	O
-	O
105	O
hco3	O
-	O
25	O
angap	O
-	O
13	O

[	O
*	O
*	O
2019	O
-	O
01	O
-	O
19	O
*	O
*	O
]	O
09	O
:	O
45pm	O
blood	O
alt	O
-	O
83	O
*	O
ast	O
-	O
55	O
*	O
alkphos	O
-	O
611	O
*	O
amylase	O
-	O
58	O
totbili	O
-	O
12	O
.	O
5	O
*	O
dirbili	O
-	O
9	O
.	O
4	O
*	O
indbili	O
-	O
3	O
.	O
1	O

[	O
*	O
*	O
2019	O
-	O
01	O
-	O
23	O
*	O
*	O
]	O
08	O
:	O
28pm	O
blood	O
alt	O
-	O
43	O
*	O
ast	O
-	O
54	O
*	O
alkphos	O
-	O
311	O
*	O
amylase	O
-	O
26	O
totbili	O
-	O
10	O
.	O
1	O
*	O

[	O
*	O
*	O
2019	O
-	O
01	O
-	O
24	O
*	O
*	O
]	O
02	O
:	O
43am	O
blood	O
phos	O
-	O
4	O
.	O
5	O
mg	O
-	O
1	O
.	O
7	O

chest	O
port	O
.	O

line	O
placement	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
24	O
*	O
*	O
]	O
11	O
:	O
00	O
am	O

chest	O
port	O
.	O

line	O
placement	O

reason	O
:	O
?	O
line	O
position	O

underlying	O
medical	O
condition	O
:	O

55	O
year	O
old	O
woman	O
with	O
cholecystojeje	O
and	O
pancreatic	B
pseudocyst	I
jeje	O
with	O
new	O
rij	O
cvl	O

reason	O
for	O
this	O
examination	O
:	O

?	O
line	O
position	O

ap	O
portable	O
chest	O
for	O
line	O
placement	O
on	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
24	O
*	O
*	O
]	O
at	O
10	O
:	O
55	O
a	O
.	O
m	O
.	O

history	O
:	O
new	O
right	O
internal	O
jugular	O
approach	O
central	O
venous	O
catheter	O
.	O

comparison	O
:	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
23	O
*	O
*	O
]	O
.	O

findings	O
:	O
patient	O
has	O
been	O
extubated	O
and	O
the	O
nasogastric	O
tube	O
removed	O
.	O

the	O
large	O
right	O
internal	O
jugular	O
sheath	O
has	O
been	O
removed	O
as	O
well	O
.	O

there	O
is	O
an	O
indwelling	O
right	O
internal	O
jugular	O
approach	O
central	O
line	O
with	O
the	O
distal	O
tip	O
at	O
the	O
cavoatrial	O
junction	O
.	O

lung	B
volumes	I
are	O
markedly	O
diminished	O
,	O
however	O
,	O
there	O
is	O
no	O
focal	O
consolidation	O
.	O

minimal	O
left	O
basilar	O
atelectasis	B
is	O
seen	O
.	O

no	O
pleural	B
effusion	I
or	O
pneumothorax	B
is	O
evident	O
.	O

there	O
is	O
residual	B
contrast	I
within	O
the	O
colon	O
.	O

midline	O
surgical	O
skin	O
staples	O
are	O
seen	O
overlying	O
the	O
abdomen	O
.	O

impression	O
:	O
central	O
venous	O
catheter	O
as	O
above	O
.	O

no	O
pneumothorax	B
.	O

brief	O
hospital	O
course	O
:	O

she	O
was	O
transferred	O
here	O
from	O
an	O
osh	O
with	O
a	O
larger	O
pancreatic	B
pseudocyst	I
.	O

after	O
reviewing	O
the	O
ct	O
from	O
the	O
osh	O
,	O
it	O
was	O
determined	O
that	O
she	O
will	O
need	O
a	O
biliary	O
drainage	O
.	O

an	O
ercp	O
was	O
considered	O
,	O
but	O
then	O
felt	O
that	O
there	O
was	O
no	O
value	O
in	O
any	O
endoscopic	O
approaches	O
to	O
either	O
the	O
pseudocyst	B
or	O
the	O
biliary	B
obstruction	I
and	O
it	O
was	O
clear	O
that	O
an	O
operative	O
approach	O
was	O
the	O
safest	O
and	O
only	O
way	O
to	O
approach	O

this	O
.	O

she	O
was	O
npo	O
,	O
with	O
an	O
ngt	O
and	O
iv	O
fluids	O
.	O

she	O
was	O
receiving	O
a	O
banana	O
bag	O
for	O
electrolyte	O
replacement	O
.	O

she	O
was	O
receiving	O
iv	O
antibiotics	O
empirically	O
.	O

she	O
received	O
2	O
days	O
of	O
vitamin	O
k	O
prior	O
to	O
the	O
or	O
.	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

she	O
went	O
to	O
the	O
or	O
on	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
23	O
*	O
*	O
]	O
.	O

she	O
tolerated	O
the	O
procedure	O
well	O
.	O

she	O
had	O
a	O
feeding	O
j	O
-	O
tube	O
placed	O
and	O
cyst	O
j	O
-	O
tube	O
to	O
gravity	O
.	O

she	O
remained	O
intubated	O
overnight	O
and	O
was	O
extubated	O
in	O
the	O
morning	O
.	O

she	O
was	O
slightly	O
hypotensive	B
post	O
-	O
operatively	O
and	O
responded	O
well	O
to	O
iv	O
fluids	O
.	O

pain	B
:	O
she	O
was	O
receiving	O
dilaudid	O
for	O
pain	B
control	O
with	O
good	O
effect	O
.	O

she	O
continued	O
on	O
a	O
pca	O
until	O
she	O
was	O
tolerating	O
clears	O
and	O
then	O
switched	O
to	O
po	O
pain	O
meds	O
on	O
pod	O
6	O
.	O

fen	O
:	O
she	O
initially	O
was	O
npo	O
,	O
with	O
iv	O
fluids	O
.	O

she	O
was	O
started	O
on	O
tube	O
feedings	O
at	O
a	O
slow	O
rate	O
and	O
her	O
rate	O
was	O
increased	O
over	O
the	O
next	O
few	O
days	O
.	O

she	O
was	O
started	O
on	O
sips	O
on	O
pod	O
4	O
and	O
advanced	O
to	O
clears	O
,	O
then	O
fulls	O
and	O
a	O
regular	O
diet	O
on	O
pod	O
8	O
.	O
she	O
had	O
a	O
feeding	O
j	O
-	O
tube	O
in	O
place	O
and	O
was	O
tolerating	O
1	O
/	O
2	O
strength	O
tube	O
feedings	O
.	O

the	O
feedings	O
were	O
stopped	O
on	O
pod	O
9	O
.	O

abd	O
:	O
she	O
had	O
an	O
ascitic	B
abdomen	O
that	O
was	O
very	O
large	O
,	O
round	O
,	O
and	O
soft	O
.	O

the	O
jp	O
drain	O
in	O
the	O
rlq	O
was	O
draining	O
large	O
amounts	O
of	O
sero	O
-	O
sanguinous	O
fluid	O
.	O

a	O
jp	O
amylase	O
was	O
4	O
on	O
pod	O
5	O
.	O
the	O
drain	O
was	O
d	O
/	O
c'd	O
on	O
pod	O
7	O
and	O
a	O
u	O
-	O
stitch	O
placed	O
.	O

she	O
was	O
appropriately	O
tender	O
with	O
good	O
bowel	O
sounds	O
.	O

the	O
staples	O
were	O
in	O
place	O
.	O

these	O
were	O
left	O
in	O
place	O
due	O
to	O
her	O
abdominal	B
distension	I
.	O

the	O
staples	O
will	O
be	O
removed	O
at	O
her	O
follow	O
-	O
up	O
appointment	O
.	O

she	O
had	O
a	O
cyst	O
j	O
-	O
tube	O
to	O
gravity	O
that	O
drained	O
initially	O
,	O
but	O
there	O
was	O
no	O
drainage	O
by	O
pod	O
4	O
.	O
the	O
j	O
-	O
tube	O
was	O
capped	O
and	O
will	O
remain	O
in	O
place	O
.	O

activity	O
:	O
she	O
was	O
seen	O
by	O
pt	O
and	O
performed	O
stairs	O
without	O
difficulty	O
.	O

she	O
was	O
cleared	O
to	O
go	O
home	O
.	O

medications	O
on	O
admission	O
:	O

cosopt	O
1	O
gtt	O
each	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
151	O
*	O
*	O
]	O
bid	O

discharge	O
medications	O
:	O

1	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

2	O
.	O
hydromorphone	O
2	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
4	O
weeks	O
.	O

disp	O
:	O
*	O
50	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

3	O
.	O
pantoprazole	O
40	O
mg	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

abdominal	B
pain	I

jaundice	I

pancreatic	I
pseudocyst	I
hop	O

biliary	B
obstruction	I

portal	I
hypertension	I

ascities	I

discharge	O
condition	O
:	O

good	O

discharge	O
instructions	O
:	O

you	O
should	O
contact	O
your	O
md	O
if	O
you	O
experience	O
:	O
*	O
increasing	O
pain	B

*	O
fever	B
(	O
>101	O
.	O
5	O
f	O
)	O

*	O
inability	B
to	I
eat	I
or	O
persistent	B
vomiting	I

*	O
inability	B
to	I
pass	I
gas	I
or	O
stool	O

*	O
increasing	O
shortness	B
of	I
breath	I

*	O
chest	B
pain	I

please	O
resume	O
all	O
of	O
your	O
regular	O
medications	O
and	O
take	O
any	O
new	O
meds	O
as	O
ordered	O
.	O

continue	O
to	O
ambulate	O
several	O
times	O
per	O
day	O
.	O

staples	O
to	O
be	O
removed	O
at	O
follow	O
-	O
up	O
appointment	O
.	O

followup	O
instructions	O
:	O

please	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
3	O
weeks	O
.	O

call	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
2157	O
*	O
*	O
]	O
to	O
schedule	O
an	O
appointment	O
.	O

please	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1443	O
*	O
*	O
]	O
(	O
pancreatologist	O
)	O
.	O

call	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
4841	O
*	O
*	O
]	O
to	O
schedule	O
an	O
appointment	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2158	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
2159	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2461	O
*	O
*	O
]	O
np	O
80	O
-	O
cbx	O
[	O
*	O
*	O
2019	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
@	O
1131	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2019	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
9	O
:	O
18	O
am	O

(	O
end	O
of	O
report	O
)	O

28322	O
||||	O
20038	O
||||	O
22494	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
02	O
-	O
13	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
08	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
13	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1971	O
-	O
10	O
-	O
15	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
csu	O

hi	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
1560	O
*	O
*	O
]	O
of	O
present	O
illness	O
:	O
this	O
40	O
year	O
old	O
female	O
,	O
who	O
has	O
no	O
symptoms	B
at	O
this	O
time	O
,	O
presented	O
with	O
right	B
sided	I
weakness	I
.	O

a	O
neurologic	O
workup	O
revealed	O
the	O
presence	O
of	O
2	O
strokes	B
.	O

cardiology	O
workup	O
revealed	O
a	O
patent	B
foramen	I
ovale	I
and	O
the	O
patient	O
was	O
referred	O
to	O
dr	O
.	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
3	O
*	O
*	O
]	O
for	O
patent	B
foramen	I
ovale	I
closure	O
.	O

the	O
patient	O
did	O
not	O
have	O
cardiac	O
catheterization	O
.	O

a	O
transesophageal	O
echocardiography	O
showed	O
a	O
patent	B
foramen	I
ovale	I
with	O
left	O
to	O
right	O
flow	O
.	O

past	O
medical	O
history	O
:	O
patent	B
foramen	I
ovale	I
.	O

depression	B
.	O

cerebrovascular	B
accident	I
.	O

past	O
surgical	O
history	O
:	O
cesarean	O
section	O
x2	O
.	O

medications	O
on	O
admission	O
:	O
medications	O
at	O
preoperative	O
workup	O
were	O
as	O
follows	O
:	O

1	O
.	O
celexa	O
20	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

2	O
.	O
coumadin	O
5	O
mg	O
p	O
.	O
o	O
.	O

4	O
times	O
a	O
week	O
and	O
7	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O

3	O
times	O
a	O
week	O
.	O

allergies	O
:	O
she	O
is	O
allergic	O
to	O
penicillin	O
which	O
caused	O
hives	B
.	O

family	O
history	O
:	O
noncontributory	O
.	O

social	O
history	O
:	O
she	O
lived	O
with	O
her	O
husband	O
and	O
had	O
no	O
smoking	O
or	O
alcohol	O
history	O
and	O
no	O
use	O
of	O
recreational	O
drugs	O
.	O

laboratory	O
data	O
:	O
preoperative	O
laboratory	O
work	O
as	O
follows	O
:	O

white	O
count	O
7	O
.	O
2	O
,	O
hematocrit	O
39	O
.	O
0	O
,	O
platelet	O
count	O
284	O
,	O
000	O
.	O

pt	O
16	O
.	O
8	O
,	O
ptt	O
37	O
.	O
2	O
with	O
an	O
inr	O
of	O
1	O
.	O
8	O
.	O

this	O
was	O
all	O
approximately	O
a	O
week	O
and	O
one	O
half	O
preoperatively	O
when	O
the	O
patient	O
was	O
still	O
on	O
coumadin	O
.	O

her	O
urinalysis	O
showed	O
some	O
hematuria	B
with	O
a	O
small	O
amount	O
of	O
bacteria	O
.	O

sodium	O
138	O
,	O
potassium	O
3	O
.	O
6	O
,	O
chloride	O
101	O
,	O
bicarbonate	O
30	O
,	O
bun	O
9	O
,	O
creatinine	O
0	O
.	O
6	O
,	O
with	O
a	O
blood	O
sugar	O
of	O
76	O
,	O
alt	O
41	O
,	O
ast	O
43	O
,	O
alkaline	O
phosphatase	O
75	O
,	O
total	O
bilirubin	O
0	O
.	O
4	O
,	O
total	O
protein	O
7	O
.	O
8	O
,	O
albumin	O
4	O
.	O
4	O
,	O
globulin	O
3	O
.	O
4	O
.	O

hba1c	O
5	O
.	O
4%	O
.	O

chest	O
x	O
-	O
ray	O
showed	O
no	O
acute	O
cardiopulmonary	B
process	I
.	O

ekg	O
showed	O
sinus	B
rhythm	I
at	O
67	O
with	O
nonspecific	O
st	O
-	O
t	O
wave	O
flattening	O
.	O

physical	O
examination	O
:	O
on	O
examination	O
,	O
she	O
had	O
a	O
heart	O
rate	O
of	O
66	O
and	O
sinus	B
rhythm	I
with	O
a	O
blood	O
pressure	O
of	O
120	O
/	O
61	O
,	O
height	O
5	O
feet	O
five	O
inches	O
tall	O
,	O
weight	O
105	O
pounds	O
.	O

she	O
was	O
in	O
no	O
apparent	O
distress	O
.	O

she	O
had	O
no	O
obvious	O
skin	B
lesions	I
.	O

her	O
extraocular	O
movements	O
were	O
intact	O
.	O

the	O
pupils	O
are	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

her	O
neck	O
was	O
supple	O
.	O

her	O
lungs	O
were	O
clear	O
bilaterally	O
without	O
any	O
rhonchi	B
or	O
rales	B
.	O

the	O
heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
,	O
with	O
s1	O
and	O
s2	O
tones	O
and	O
no	O
murmurs	B
,	O
rubs	B
or	O
gallops	B
.	O

her	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
nondistended	O
with	O
positive	O
bowel	O
sounds	O
.	O

her	O
extremities	O
are	O
warm	O
and	O
dry	O
with	O
no	O
cyanosis	B
,	O
clubbing	B
or	O
edema	B
.	O

she	O
had	O
no	O
obvious	O
varicosities	B
.	O

she	O
was	O
alert	O
and	O
oriented	O
and	O
grossly	O
neurologically	O
intact	O
cranial	O
nerves	O
ii	O
through	O
xii	O
.	O

she	O
had	O
2	O
+	O
bilateral	O
femoral	O
,	O
dp	O
,	O
pt	O
and	O
radial	O
pulses	O
and	O
no	O
carotid	B
bruits	I
.	O

ho	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
on	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
08	O
*	O
*	O
]	O
,	O
after	O
stopping	O
her	O
coumadin	O
at	O
home	O
.	O

on	O

[	O
*	O
*	O
2012	O
-	O
02	O
-	O
08	O
*	O
*	O
]	O
,	O
she	O
underwent	O
minimally	O
invasive	O
atrial	B
septal	I
defect	I
repair	O
through	O
a	O
mini	O
right	O
thoracotomy	O
by	O
dr	O
.	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
3	O
*	O
*	O
]	O
and	O
was	O
transferred	O
to	O
the	O
cardiothoracic	O
icu	O
in	O
stable	O
condition	O
on	O
a	O
propofol	O
drip	O
.	O

she	O
had	O
a	O
small	O
right	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
2812	O
*	O
*	O
]	O
drain	O
for	O
thoracotomy	O
drainage	O
.	O

she	O
was	O
given	O
morphine	O
and	O
toradol	O
for	O
good	O
pain	B
control	O
.	O

she	O
was	O
extubated	O
overnight	O
and	O
remained	O
on	O
a	O
neo	O
-	O
synephrine	O
drip	O
at	O
1	O
mcg	O
/	O
kg	O
/	O
minute	O
.	O

she	O
had	O
a	O
good	O
blood	O
pressure	O
of	O
88	O
/	O
53	O
and	O
sinus	B
rhythm	I
at	O
75	O
and	O
temperature	O
maximum	O
of	O
99	O
.	O
9	O
postoperatively	O
.	O

white	O
count	O
rose	O
to	O
13	O
.	O
0	O
,	O
hematocrit	O
25	O
.	O
2	O
,	O
and	O
platelet	O
count	O
303	O
,	O
000	O
.	O

potassium	O
4	O
.	O
0	O
,	O
bun	O
10	O
,	O
creatinine	O
0	O
.	O
6	O
.	O

she	O
had	O
coarse	O
breath	O
sounds	O
which	O
were	O
decreased	O
on	O
the	O
right	O
.	O

her	O
foley	O
and	O
her	O
chest	O
tubes	O
remained	O
in	O
place	O
.	O

diet	O
was	O
advanced	O
.	O

she	O
had	O
been	O
extubated	O
and	O
her	O
[	O
*	O
*	O
male	O
first	O
name	O
(	O
un	O
)	O
2812	O
*	O
*	O
]	O
drain	O
was	O
placed	O
to	O
water	O
seal	O
and	O
she	O
remained	O
on	O
neo	O
-	O
synephrine	O
drip	O
overnight	O
.	O

this	O
was	O
weaned	O
the	O
following	O
morning	O
down	O
to	O
0	O
.	O
25	O
.	O

her	O
hematocrit	O
dropped	O
slightly	O
to	O
20	O
.	O
2	O
,	O
white	O
count	O
remained	O
at	O
9	O
.	O
6	O
.	O

she	O
finished	O
her	O
perioperative	O
vancomycin	O
.	O

her	O
creatinine	O
was	O
stable	O
at	O
0	O
.	O
5	O
.	O

her	O
chest	O
tube	O
was	O
discontinued	O
.	O

repeat	O
chest	O
x	O
-	O
ray	O
was	O
done	O
.	O

she	O
was	O
hemodynamically	O
stable	O
in	O
sinus	B
rhythm	I
with	O
a	O
pressure	O
of	O
110	O
/	O
58	O
and	O
was	O
transferred	O
out	O
to	O
the	O
floor	O
.	O

lasix	O
diuresis	O
was	O
begun	O
.	O

on	O
the	O
floor	O
,	O
the	O
patient	O
was	O
evaluated	O
by	O
physical	O
therapy	O
to	O
begin	O
ambulation	O
and	O
activity	O
tolerance	O
and	O
was	O
seen	O
by	O
case	O
management	O
also	O
for	O
evaluation	O
.	O

her	O
foley	O
was	O
removed	O
that	O
afternoon	O
.	O

on	O
postoperative	O
day	O
#3	O
,	O
she	O
did	O
complain	O
of	O
some	O
sharp	O
right	O
inner	O
thigh	B
pain	I
with	O
some	O
activity	O
.	O

she	O
was	O
alert	O
and	O
oriented	O
,	O
began	O
her	O
aspirin	O
,	O
vitamins	O
,	O
iron	O
and	O
was	O
restarted	O
on	O
her	O
celexa	O
as	O
well	O
as	O
zantac	O
.	O

she	O
was	O
given	O
vitamin	O
b6	O
for	O
neurologic	B
pain	I
.	O

her	O
aspirin	O
was	O
increased	O
to	O
325	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

she	O
was	O
hemodynamically	O
stable	O
.	O

her	O
weight	O
was	O
88	O
.	O
2	O
kilograms	O
.	O

she	O
was	O
saturating	O
96%	O
in	O
room	O
air	O
.	O

her	O
white	O
count	O
dropped	O
to	O
8	O
.	O
0	O
,	O
her	O
hematocrit	O
rose	O
to	O
25	O
.	O
4	O
and	O
her	O
creatinine	O
remained	O
stable	O
at	O
0	O
.	O
7	O
.	O

she	O
continued	O
to	O
work	O
with	O
physical	O
therapy	O
.	O

she	O
did	O
have	O
some	O
incisional	O
pain	B
under	O
her	O
right	O
breast	O
,	O
the	O
site	O
of	O
her	O
mini	O
thoracotomy	O
.	O

this	O
was	O
treated	O
with	O
p	O
.	O
o	O
.	O

percocet	O
.	O

she	O
had	O
decreased	B
breath	I
sounds	I
at	O
the	O
bases	O
.	O

she	O
was	O
tolerating	O
her	O
p	O
.	O
o	O
.	O
well	O
and	O
was	O
medicated	O
for	O
pain	B
control	O
.	O

on	O
postoperative	O
day	O
#4	O
,	O
her	O
right	O
inner	O
thigh	O
tingling	B
decreased	O
.	O

she	O
put	O
out	O
almost	O
6	O
liters	O
of	O
urine	O
.	O

her	O
heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

her	O
lungs	O
were	O
clear	O
bilaterally	O
.	O

her	O
abdomen	O
was	O
soft	O
,	O
nontender	O
.	O

she	O
was	O
doing	O
very	O
well	O
.	O

the	O
patient	O
complained	O
of	O
a	O
visual	O
field	O
deficit	O
from	O
the	O
right	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
82	O
*	O
*	O
]	O
since	O
surgery	O
without	O
prior	O
history	O
.	O

on	O
examination	O
,	O
appeared	O
to	O
be	O
nontoxic	O
.	O

her	O
visual	O
fields	O
were	O
intact	O
.	O

her	O
extraocular	O
movements	O
were	O
intact	O
.	O

cranial	O
nerves	O
ii	O
through	O
xii	O
were	O
intact	O
,	O
and	O
she	O
had	O
no	O
neurologic	B
deficit	I
.	O

question	O
was	O
whether	O
the	O
patient	O
had	O
an	O
embolic	B
stroke	I
at	O
that	O
time	O
.	O

a	O
ct	O
of	O
the	O
head	O
was	O
ordered	O
.	O

neurology	O
consultation	O
was	O
ordered	O
and	O
plans	O
were	O
for	O
discharge	O
were	O
placed	O
on	O
hold	O
,	O
given	O
the	O
patient's	O
complaint	O
of	O
right	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
82	O
*	O
*	O
]	O
blurriness	O
.	O

an	O
ophthalmology	O
consultation	O
was	O
obtained	O
.	O

the	O
diagnosis	O
was	O
a	O
small	O
right	O
macular	O
area	O
hemorrhage	B
.	O

per	O
initial	O
consultation	O
ophthalmology	O
,	O
it	O
was	O
recommended	O
that	O
the	O
patient	O
have	O
a	O
follow	O
-	O
up	O
at	O
her	O
ophthalmologist	O
in	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
or	O
at	O
the	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
clinic	O
in	O
[	O
*	O
*	O
doctor	O
last	O
name	O
*	O
*	O
]	O
,	O
fifth	O
floor	O
.	O

telephone	O
number	O
was	O
given	O
to	O
the	O
patient	O
,	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
6809	O
*	O
*	O
]	O
,	O
to	O
make	O
an	O
appointment	O
on	O
monday	O
after	O
discharge	O
.	O

on	O
postoperative	O
day	O
#5	O
,	O
neurology	O
saw	O
the	O
patient	O
on	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
12	O
*	O
*	O
]	O
,	O
after	O
ophthalmology	O
consultation	O
.	O

at	O
the	O
time	O
,	O
this	O
was	O
also	O
noted	O
about	O
the	O
sensory	B
changes	I
of	O
her	O
right	O
thigh	O
in	O
the	O
distribution	O
of	O
the	O
femoral	O
nerve	O
and	O
lateral	O
femoral	O
cutaneous	O
nerve	O
.	O

neurology	O
recommended	O
a	O
state	O
ct	O
of	O
the	O
pelvis	O
with	O
stat	O
coagulation	O
studies	O
to	O
assess	O
for	O
retroperitoneal	O
bleed	B
as	O
well	O
as	O
mra	O
of	O
the	O
brain	O
with	O
a	O
stroke	B
protocol	O
to	O
evaluate	O
for	O
any	O
infarctions	B
,	O
either	O
water	O
shed	O
or	O
embolic	O
,	O
given	O
her	O
various	O
neurologic	B
complaints	I
.	O

this	O
was	O
discussed	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
1263	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
2797	O
*	O
*	O
]	O
and	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
2327	O
*	O
*	O
]	O
,	O
neurology	O
attendings	O
.	O

ophthalmology	O
consultation	O
was	O
performed	O
as	O
previously	O
noted	O
.	O

on	O
postoperative	O
day	O
#5	O
,	O
the	O
patient	O
was	O
then	O
in	O
sinus	B
rhythm	I
at	O
72	O
,	O
was	O
stable	O
hemodynamically	O
,	O
had	O
trace	O
peripheral	B
edema	I
.	O

her	O
thoracotomy	O
incision	O
was	O
clean	O
,	O
dry	O
and	O
intact	O
.	O

her	O
pacing	O
wires	O
had	O
been	O
removed	O
.	O

her	O
central	O
venous	O
line	O
was	O
out	O
.	O

mri	O
was	O
performed	O
,	O
awaiting	O
final	O
result	O
.	O

the	O
mr	O
scan	O
was	O
negative	O
per	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2797	O
*	O
*	O
]	O
,	O
and	O
the	O
patient	O
was	O
neurologically	O
cleared	O
.	O

the	O
patient	O
was	O
also	O
evaluated	O
to	O
go	O
home	O
with	O
vna	O
services	O
by	O
case	O
management	O
.	O

the	O
patient	O
was	O
instructed	O
to	O
follow	O
-	O
up	O
with	O
ophthalmologist	O
and	O
was	O
discharged	O
home	O
with	O
vna	O
services	O
on	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
13	O
*	O
*	O
]	O
.	O

discharge	O
diagnoses	O
:	O
status	O
post	O
minimally	O
invasive	O
atrial	B
septal	I
defect	I
repair	O
.	O

status	O
post	O
cerebrovascular	B
accident	I
.	O

right	O
macular	O
hemorrhage	B
.	O

depression	B
.	O

status	O
post	O
cesarean	O
section	O
x2	O
.	O

discharge	O
instructions	O
:	O

1	O
.	O
to	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
1697	O
*	O
*	O
]	O
,	O
her	O
primary	O
care	O
physician	O
in	O
approximately	O
2	O
-	O
3	O
weeks	O
postdischarge	O
with	O
specific	O
instructions	O
to	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
1697	O
*	O
*	O
]	O
on	O
the	O
right	O
kidney	B
mass	I
and	O
left	O
pelvic	O
cyst	B
that	O
were	O
both	O
found	O
on	O
ct	O
scan	O
in	O
the	O
hospital	O
.	O

2	O
.	O
the	O
patient	O
was	O
also	O
instructed	O
to	O
follow	O
-	O
up	O
at	O
the	O
ophthalmology	O
clinic	O
here	O
at	O
[	O
*	O
*	O
hospital	O
5104	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
6809	O
*	O
*	O
]	O
,	O
or	O
to	O
see	O
her	O
own	O
ophthalmologist	O
in	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
as	O
discussed	O
for	O
follow	O
-	O
up	O
of	O
her	O
right	O
retinal	B
hemorrhage	I
.	O

3	O
.	O
the	O
patient	O
was	O
also	O
instructed	O
to	O
follow	O
-	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
9	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
3	O
*	O
*	O
]	O
in	O
approximately	O
4	O
weeks	O
for	O
her	O
postoperative	O
surgical	O
visit	O
in	O
the	O
office	O
.	O

medications	O
on	O
discharge	O
:	O

1	O
.	O
celexa	O
20	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

2	O
.	O
ferrous	O
sulfate	O
325	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

3	O
.	O
vitamin	O
c	O
500	O
mg	O
p	O
.	O
o	O
.	O
twice	O
daily	O
.	O

4	O
.	O
pyridoxine	O
hydrochloride	O
50	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

5	O
.	O
enteric	O
-	O
coated	O
aspirin	O
325	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
.	O

6	O
.	O
percocet	O
5	O
/	O
325	O
one	O
tablet	O
p	O
.	O
o	O
.	O
p	O
.	O
r	O
.	O
n	O
.	O
q	O
.	O
4hours	O
for	O
pain	B
.	O

7	O
.	O
ibuprofen	O
400	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
6hours	O
p	O
.	O
r	O
.	O
n	O
.	O
for	O
pain	O
.	O

discharge	O
status	O
:	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
with	O
vna	O
services	O
on	O
[	O
*	O
*	O
2012	O
-	O
02	O
-	O
13	O
*	O
*	O
]	O
.	O

[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
9	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
2	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
3	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
02351	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
471	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
27	O
*	O
*	O
]	O
16	O
:	O
12	O
:	O
56	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
03	O
-	O
27	O
*	O
*	O
]	O
19	O
:	O
43	O
:	O
38	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
6810	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
prefix	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
prefixes	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
18	O
*	O
*	O
]	O
10	O
:	O
52	O
am	O

(	O
end	O
of	O
report	O
)	O

